<?xml version="1.0" encoding="UTF-8"?>
<root id="root" uuid="2e3c23ca-eedf-4272-88d0-d9a48e7f7f34-lbl">
   <Additions id="adds" size="713">
      <Effectual id="effadds" size="549">
         <Strengthening id="st" size="108">
            <Change id="1">
               <Axiom>Acantholytic Acanthoma EquivalentTo Acanthoma and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Acantholysis) and (Disease_Has_Normal_Cell_Origin only Keratinocyte)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Acantholytic Acanthoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Acantholytic Acanthoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Acantholytic Acanthoma SubClassOf Disease_Has_Finding only Acantholysis</Axiom>
               </Source>
            </Change>
            <Change id="2">
               <Axiom>Acanthoma EquivalentTo Benign Epithelial Skin Neoplasm and (Disease_Excludes_Primary_Anatomic_Site only Hair Follicle Infundibulum) and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Seborrheic Keratosis</Concept>
                        <WitnessAxioms>
                           <Axiom>Seborrheic Keratosis SubClassOf Benign Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Acanthoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="3">
               <Axiom>Actinic (Solar) Keratosis EquivalentTo Pre-Malignant Skin Epithelial Lesion and (Disease_May_Have_Finding some Parakeratosis) and (Disease_Has_Finding only Hyperkeratosis)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Actinic (Solar) Keratosis SubClassOf Pre-Malignant Skin Epithelial Lesion</Axiom>
               </Source>
            </Change>
            <Change id="4">
               <Axiom>Adult Brain Oligodendroglioma EquivalentTo Adult Oligodendroglioma and Brain Oligodendroglioma</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Adult Brain Oligodendroglioma SubClassOf Brain Oligodendroglioma</Axiom>
               </Source>
            </Change>
            <Change id="5">
               <Axiom>Advanced Malignant Neoplasm EquivalentTo Metastatic Malignant Neoplasm and (Disease_Has_Finding only Extensive Stage Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Advanced Malignant Neoplasm SubClassOf Metastatic Malignant Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="6">
               <Axiom>Aggravated Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Aggravated Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Aggravated Malignant Neoplasm SubClassOf Disease_Has_Finding only Aggravated Disease</Axiom>
               </Source>
            </Change>
            <Change id="7">
               <Axiom>Anaplastic Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Anaplastic Lesion)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Thymic Sarcomatoid Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Thymic Sarcomatoid Carcinoma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Thymic Sarcomatoid Carcinoma SubClassOf Neoplasm by Special Category</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Anaplastic Malignant Neoplasm SubClassOf Malignant Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="8">
               <Axiom>Apocrine Adenoma EquivalentTo Benign Apocrine Neoplasm and Sweat Gland Adenoma</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Apocrine Hidrocystoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Apocrine Hidrocystoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Apocrine Hidrocystoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Apocrine Adenoma SubClassOf Benign Apocrine Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="9">
               <Axiom>Apocrine Hidrocystoma EquivalentTo Apocrine Adenoma and Hidrocystoma</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Apocrine Hidrocystoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Apocrine Hidrocystoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Apocrine Hidrocystoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Apocrine Hidrocystoma SubClassOf Hidrocystoma</Axiom>
               </Source>
            </Change>
            <Change id="10">
               <Axiom>Apocrine Neoplasm EquivalentTo Sweat Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Apocrine Cell) and (Disease_Has_Finding only Apocrine Differentiation) and (Disease_Has_Normal_Cell_Origin only Apocrine Cell) and (Disease_Has_Primary_Anatomic_Site only Apocrine Sweat Gland)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Apocrine Hidrocystoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Apocrine Hidrocystoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Apocrine Neoplasm SubClassOf Disease_Has_Abnormal_Cell only Neoplastic Apocrine Cell</Axiom>
               </Source>
            </Change>
            <Change id="11">
               <Axiom>Asbestos-Related Malignant Neoplasm EquivalentTo Occupational Malignant Neoplasm and (Disease_Has_Finding only Asbestos Exposure)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Asbestos-Related Malignant Neoplasm SubClassOf Disease_Has_Finding only Asbestos Exposure</Axiom>
               </Source>
            </Change>
            <Change id="12">
               <Axiom>Benign Apocrine Neoplasm EquivalentTo Apocrine Neoplasm and Benign Sweat Gland Neoplasm</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Apocrine Hidrocystoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Apocrine Hidrocystoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Apocrine Hidrocystoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Benign Apocrine Neoplasm SubClassOf Benign Sweat Gland Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="13">
               <Axiom>Benign Childhood Central Nervous System Neoplasm EquivalentTo Childhood Central Nervous System Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell with Large Nucleus and Abundant Eosinophilic Cytoplasm) and (Disease_Excludes_Abnormal_Cell only Malignant Neuroectodermal Cell) and (Disease_Excludes_Abnormal_Cell only Melanoma Cell) and (Disease_Excludes_Abnormal_Cell only Neoplastic Ependymal Cell) and (Disease_Excludes_Abnormal_Cell only Neoplastic Germ Cell) and (Disease_Excludes_Abnormal_Cell only Neoplastic Oligodendrocyte-Like Cell) and (Disease_Excludes_Abnormal_Cell only Neoplastic Oligodendrocyte) and (Disease_Excludes_Finding only Anaplastic Lesion) and (Disease_Has_Primary_Anatomic_Site only Central Nervous System)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Childhood Choroid Plexus Papilloma</Concept>
                        <WitnessAxioms>
                           <Axiom>Childhood Choroid Plexus Papilloma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Childhood Intracranial Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Childhood Brain Neoplasm SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Desmoplastic Infantile Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Benign Childhood Cerebral Neoplasm SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Desmoplastic Infantile Ganglioglioma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Choroid Plexus Papilloma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Benign Childhood Supratentorial Neoplasm SubClassOf Childhood Intracranial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Benign Childhood Central Nervous System Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Central Nervous System</Axiom>
               </Source>
            </Change>
            <Change id="14">
               <Axiom>Benign Dermal Neoplasm EquivalentTo Benign Skin Neoplasm and Dermal Neoplasm and (Disease_Has_Normal_Tissue_Origin only Dermis)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Benign Dermal Neoplasm SubClassOf Disease_Has_Normal_Tissue_Origin only Dermis</Axiom>
               </Source>
            </Change>
            <Change id="15">
               <Axiom>Benign Eccrine Neoplasm EquivalentTo Benign Sweat Gland Neoplasm and Eccrine Neoplasm</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Syringoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Syringoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Syringoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Syringoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Syringoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Benign Eccrine Neoplasm SubClassOf Benign Sweat Gland Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="16">
               <Axiom>Benign Epithelial Skin Neoplasm EquivalentTo Benign Epithelial Neoplasm and Benign Skin Neoplasm and Epithelial Skin Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Benign Epithelial Skin Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Epithelial Skin Neoplasm SubClassOf Benign Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Trichoadenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichoadenoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Trichoadenoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Trichoadenoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Trichoadenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Benign Epithelial Skin Neoplasm SubClassOf Epithelial Skin Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="17">
               <Axiom>Benign Germinative Follicular Epithelium Neoplasm EquivalentTo Benign Epithelial Skin Neoplasm and Benign Hair Follicle Neoplasm and Germinative Follicular Epithelium Neoplasm</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Benign Germinative Follicular Epithelium Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Germinative Follicular Epithelium Neoplasm SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Epithelial Skin Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Germinative Follicular Epithelium Neoplasm SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Vulvar Trichoblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Vulvar Trichoblastoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Vulvar Trichoblastoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Benign Germinative Follicular Epithelium Neoplasm SubClassOf Benign Hair Follicle Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="18">
               <Axiom>Benign Hair Follicle Neoplasm EquivalentTo Benign Skin Appendage Neoplasm and Hair Follicle Neoplasm</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Benign Hair Follicle Neoplasm SubClassOf Benign Skin Appendage Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="19">
               <Axiom>Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm EquivalentTo Benign Hair Follicle Neoplasm and Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm SubClassOf Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="21">
               <Axiom>Benign Outer Hair Sheath and Infundibulum Neoplasm EquivalentTo Benign Epithelial Skin Neoplasm and Benign Hair Follicle Neoplasm and Outer Hair Sheath and Infundibulum Neoplasm</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Benign Outer Hair Sheath and Infundibulum Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Outer Hair Sheath and Infundibulum Neoplasm SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Epithelial Skin Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Outer Hair Sheath and Infundibulum Neoplasm SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Trichoadenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichoadenoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Trichoadenoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Trichoadenoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Trichoadenoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Trichoadenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Benign Outer Hair Sheath and Infundibulum Neoplasm SubClassOf Outer Hair Sheath and Infundibulum Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="22">
               <Axiom>Benign Placental Neoplasm EquivalentTo Placental Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Excludes_Finding only Human Chorionic Gonadotropin Positive Neoplastic Cells Present) and (Disease_Has_Primary_Anatomic_Site only Placenta)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Benign Placental Neoplasm SubClassOf Disease_Excludes_Abnormal_Cell only Malignant Cell</Axiom>
               </Source>
            </Change>
            <Change id="23">
               <Axiom>Benign Skin Appendage Neoplasm EquivalentTo Benign Skin Neoplasm and Skin Appendage Neoplasm</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Nodular Hidradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Nodular Hidradenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Benign Skin Appendage Neoplasm SubClassOf Benign Skin Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="24">
               <Axiom>Benign Skin Neoplasm EquivalentTo Skin Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Excludes_Finding only Dysplasia) and (Disease_Excludes_Finding only Invasive Lesion) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Nodular Hidradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Nodular Hidradenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Benign Skin Neoplasm SubClassOf Disease_Excludes_Abnormal_Cell only Malignant Cell</Axiom>
               </Source>
            </Change>
            <Change id="25">
               <Axiom>Benign Sweat Gland Neoplasm EquivalentTo Benign Epithelial Skin Neoplasm and Benign Skin Appendage Neoplasm and Sweat Gland Neoplasm</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Benign Sweat Gland Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Sweat Gland Neoplasm SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Epithelial Skin Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Sweat Gland Neoplasm SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Syringoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Syringoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Syringoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Syringoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Syringoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Benign Sweat Gland Neoplasm SubClassOf Sweat Gland Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="26">
               <Axiom>Bilateral Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Bilateral Disease)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Bilateral Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Bilateral Carcinoma SubClassOf Neoplasm by Special Category</Axiom>
                           <Axiom>Bilateral Carcinoma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Bilateral Malignant Neoplasm SubClassOf Malignant Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="27">
               <Axiom>Bowenoid Papulosis EquivalentTo Pre-Malignant Skin Epithelial Lesion and (Disease_May_Have_Associated_Disease some Human Papilloma Virus Infection) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Multifocal Lesion) and (Disease_Has_Finding only Severe Dysplasia)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Bowenoid Papulosis SubClassOf Disease_Has_Finding only Severe Dysplasia</Axiom>
               </Source>
            </Change>
            <Change id="28">
               <Axiom>Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Intraductal and Lobular Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Intraductal and Lobular Carcinoma SubClassOf Mixed Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Carcinoma SubClassOf Disease_Has_Finding only Carcinomatous Component Present</Axiom>
               </Source>
            </Change>
            <Change id="82">
               <Axiom>Cerebral Lymphoma in Immunocompetent Host EquivalentTo Cerebral Lymphoma and (Disease_Excludes_Finding only Immunodeficiency)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Cerebral Lymphoma in Immunocompetent Host SubClassOf Cerebral Lymphoma</Axiom>
               </Source>
            </Change>
            <Change id="29">
               <Axiom>Childhood Intracranial Neoplasm EquivalentTo Childhood Central Nervous System Neoplasm and Intracranial Neoplasm</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Childhood Intracranial Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Childhood Intracranial Neoplasm SubClassOf Childhood Central Nervous System Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Childhood Choroid Plexus Papilloma</Concept>
                        <WitnessAxioms>
                           <Axiom>Childhood Choroid Plexus Papilloma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Childhood Intracranial Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Childhood Optic Nerve Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Infratentorial Ependymoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Infratentorial Ependymoblastoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Cerebellar Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Benign Childhood Supratentorial Neoplasm SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Cerebral Ependymoblastoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Atypical Teratoid/Rhabdoid Tumor SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Visual Pathway Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Supratentorial Ependymoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Visual Pathway Glioma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Brain Germinoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Brain Stem Glioma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Brain Stem Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Desmoplastic Infantile Ganglioglioma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Choroid Plexus Papilloma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Cerebral Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Optic Nerve Glioma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Cerebellar Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Cerebral Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Brain Anaplastic Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Medulloblastoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Visual Pathway Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Desmoplastic Infantile Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Cerebral Ependymoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Cerebral Diffuse Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Supratentorial Ependymoblastoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Benign Childhood Brain Neoplasm SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Brain Stem Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Benign Childhood Cerebral Neoplasm SubClassOf Childhood Intracranial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Childhood Intracranial Neoplasm SubClassOf Intracranial Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="30">
               <Axiom>Childhood Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Childhood Lesion)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Childhood Intracranial Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Childhood Intracranial Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Childhood Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
               </Source>
            </Change>
            <Change id="31">
               <Axiom>Classic Type Trichilemmoma EquivalentTo Tricholemmoma and (Disease_Excludes_Finding only Desmoplastic Stroma Formation)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Classic Type Trichilemmoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Classic Type Trichilemmoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Classic Type Trichilemmoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Classic Type Trichilemmoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Classic Type Trichilemmoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Classic Type Trichilemmoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Classic Type Trichilemmoma SubClassOf Tricholemmoma</Axiom>
               </Source>
            </Change>
            <Change id="32">
               <Axiom>Classical Poroma EquivalentTo Poroma and (Disease_Has_Finding only Dermal Involvement) and (Disease_Has_Finding only Epidermal Involvement)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Classical Poroma</Concept>
                        <WitnessAxioms>
                           <Axiom>Classical Poroma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Classical Poroma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Classical Poroma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Classical Poroma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Classical Poroma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Classical Poroma SubClassOf Poroma</Axiom>
               </Source>
            </Change>
            <Change id="33">
               <Axiom>Clear Cell Hidradenoma EquivalentTo Clear Cell Adenoma and Hidradenoma</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Clear Cell Hidradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Clear Cell Hidradenoma SubClassOf Clear Cell Adenoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Clear Cell Hidradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Clear Cell Hidradenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Clear Cell Hidradenoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Clear Cell Hidradenoma SubClassOf Hidradenoma</Axiom>
               </Source>
            </Change>
            <Change id="34">
               <Axiom>Contributing_Source Range: {"CDISC"^^string , "CTCAE"^^string , "FDA"^^string}</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Contributing_Source Range: string</Axiom>
               </Source>
            </Change>
            <Change id="38">
               <Axiom>Dermal Duct Tumor EquivalentTo Poroma and (Disease_Excludes_Finding only Epidermal Involvement) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Dermal Involvement)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Dermal Duct Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Dermal Duct Tumor SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Dermal Duct Tumor SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Dermal Duct Tumor SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Dermal Duct Tumor SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Dermal Duct Tumor SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Dermal Duct Tumor SubClassOf Poroma</Axiom>
               </Source>
            </Change>
            <Change id="35">
               <Axiom>Dermal Neoplasm EquivalentTo Skin Neoplasm and (Disease_Has_Primary_Anatomic_Site only Dermis)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Dermal Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Dermis</Axiom>
               </Source>
            </Change>
            <Change id="36">
               <Axiom>Desmoplastic Tricholemmoma EquivalentTo Tricholemmoma and (Disease_Has_Finding only Desmoplastic Stroma Formation)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Desmoplastic Tricholemmoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Desmoplastic Tricholemmoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Desmoplastic Tricholemmoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Desmoplastic Tricholemmoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Desmoplastic Tricholemmoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Desmoplastic Tricholemmoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Desmoplastic Tricholemmoma SubClassOf Tricholemmoma</Axiom>
               </Source>
            </Change>
            <Change id="37">
               <Axiom>Eccrine Hidrocystoma EquivalentTo Benign Eccrine Neoplasm and Hidrocystoma</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Eccrine Hidrocystoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Eccrine Hidrocystoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Eccrine Hidrocystoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Eccrine Hidrocystoma SubClassOf Hidrocystoma</Axiom>
               </Source>
            </Change>
            <Change id="39">
               <Axiom>Eccrine Neoplasm EquivalentTo Sweat Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Eccrine Cell) and (Disease_Has_Finding only Eccrine Differentiation) and (Disease_Has_Normal_Cell_Origin only Eccrine Cell) and (Disease_Has_Primary_Anatomic_Site only Eccrine Sweat Gland)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Syringofibroadenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringofibroadenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Eccrine Neoplasm SubClassOf Disease_Has_Finding only Eccrine Differentiation</Axiom>
               </Source>
            </Change>
            <Change id="41">
               <Axiom>Embryonal Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Normal_Cell_Origin only Embryonic Cell) and (Disease_Has_Normal_Tissue_Origin only Embryonic Tissue)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Neuroblastic Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Neuroblastic Tumor SubClassOf Neoplasm by Special Category</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Embryonal Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
               </Source>
            </Change>
            <Change id="42">
               <Axiom>Encapsulated Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Encapsulated Mass)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Encapsulated Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
               </Source>
            </Change>
            <Change id="43">
               <Axiom>Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Trichoadenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichoadenoma SubClassOf Neoplasm by Morphology</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Epithelial Neoplasm SubClassOf Neoplasm by Morphology</Axiom>
               </Source>
            </Change>
            <Change id="44">
               <Axiom>Epithelial Skin Neoplasm EquivalentTo Epithelial Neoplasm and Skin Neoplasm</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Trichoadenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichoadenoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Trichoadenoma SubClassOf Neoplasm by Morphology</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Epithelial Skin Neoplasm SubClassOf Epithelial Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="45">
               <Axiom>Eyelid Seborrheic Keratosis EquivalentTo Benign Eyelid Neoplasm and Seborrheic Keratosis</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Eyelid Seborrheic Keratosis</Concept>
                        <WitnessAxioms>
                           <Axiom>Eyelid Seborrheic Keratosis SubClassOf Benign Eyelid Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Eyelid Seborrheic Keratosis</Concept>
                        <WitnessAxioms>
                           <Axiom>Eyelid Seborrheic Keratosis SubClassOf Eye Disorder</Axiom>
                           <Axiom>Eyelid Seborrheic Keratosis SubClassOf Benign Eye Neoplasm</Axiom>
                           <Axiom>Eyelid Seborrheic Keratosis SubClassOf Eyelid Neoplasm</Axiom>
                           <Axiom>Eyelid Seborrheic Keratosis SubClassOf Acanthoma</Axiom>
                           <Axiom>Eyelid Seborrheic Keratosis SubClassOf Eyelid Disorder</Axiom>
                           <Axiom>Eyelid Seborrheic Keratosis SubClassOf Eye Neoplasm</Axiom>
                           <Axiom>Eyelid Seborrheic Keratosis SubClassOf Benign Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Acanthoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Eyelid Seborrheic Keratosis SubClassOf Acanthoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Eyelid Seborrheic Keratosis SubClassOf Seborrheic Keratosis</Axiom>
               </Source>
            </Change>
            <Change id="46">
               <Axiom>FDA_Table Range: {"Dosage Form (C-DRG-00201)"^^string , "Package Type (C-DRG-00907)"^^string , "Patient Code (Appendix B)"^^string , "Potency (C-DRG-00501)"^^string , "Route of Administration (C-DRG-00301)"^^string , "SPL Color (C-DRG-00927)"^^string , "SPL DEA Schedule (C-DRG-0933)"^^string , "SPL Shape (C-DRG-00929)"^^string}</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>FDA_Table Range: string</Axiom>
               </Source>
            </Change>
            <Change id="48">
               <Axiom>Germinative Follicular Epithelium Neoplasm EquivalentTo Epithelial Skin Neoplasm and Hair Follicle Neoplasm and (Disease_Has_Normal_Tissue_Origin only Germinative Follicular Epithelium)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Germinative Follicular Epithelium Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Germinative Follicular Epithelium Neoplasm SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Vulvar Trichoblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Vulvar Trichoblastoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Germinative Follicular Epithelium Neoplasm SubClassOf Disease_Has_Normal_Tissue_Origin only Germinative Follicular Epithelium</Axiom>
               </Source>
            </Change>
            <Change id="49">
               <Axiom>Hair Follicle Neoplasm EquivalentTo Hair Disorder and Skin Appendage Neoplasm and (Disease_Has_Primary_Anatomic_Site only Hair Follicle)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Hair Follicle Neoplasm SubClassOf Hair Disorder</Axiom>
               </Source>
            </Change>
            <Change id="50">
               <Axiom>Hereditary Glomangioma EquivalentTo Glomangioma and (Disease_Has_Finding only Hereditary Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Hereditary Glomangioma SubClassOf Glomangioma</Axiom>
               </Source>
            </Change>
            <Change id="51">
               <Axiom>Hidroacanthoma Simplex EquivalentTo Poroma and (Disease_Excludes_Finding only Dermal Involvement) and (Disease_Has_Finding only Epidermal Involvement)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Hidroacanthoma Simplex</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidroacanthoma Simplex SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Hidroacanthoma Simplex SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Hidroacanthoma Simplex SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Hidroacanthoma Simplex SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Hidroacanthoma Simplex SubClassOf Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Hidroacanthoma Simplex SubClassOf Poroma</Axiom>
               </Source>
            </Change>
            <Change id="52">
               <Axiom>Hidrocystoma EquivalentTo Benign Sweat Gland Neoplasm and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Cystic Change)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Apocrine Hidrocystoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Apocrine Hidrocystoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Apocrine Hidrocystoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Hidrocystoma SubClassOf Benign Sweat Gland Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="53">
               <Axiom>Hypothalamic Neoplasm EquivalentTo Diencephalic Neoplasm and (Disease_Has_Associated_Anatomic_Site only Hypothalamus)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Hypothalamic Neoplasm SubClassOf Diencephalic Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="54">
               <Axiom>Immunodeficiency-Related Malignant Neoplasm EquivalentTo Immunodeficiency-Related Neoplasm and Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Immunodeficiency-Related Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Immunodeficiency-Related Malignant Neoplasm SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>AIDS-Related Lymphoma</Concept>
                        <WitnessAxioms>
                           <Axiom>AIDS-Related Lymphoma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Immunodeficiency-Related Malignant Neoplasm SubClassOf Immunodeficiency-Related Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="55">
               <Axiom>Immunodeficiency-Related Neoplasm EquivalentTo Immunodeficiency-Related Disorder and Neoplasm by Cause</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Immunodeficiency-Related Neoplasm SubClassOf Neoplasm by Cause</Axiom>
               </Source>
            </Change>
            <Change id="56">
               <Axiom>Inverted Follicular Keratosis EquivalentTo Seborrheic Keratosis and (Disease_Has_Finding only Prominent Squamous Eddies Present) and (Disease_Has_Primary_Anatomic_Site only Hair Follicle)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Inverted Follicular Keratosis</Concept>
                        <WitnessAxioms>
                           <Axiom>Inverted Follicular Keratosis SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Inverted Follicular Keratosis SubClassOf Acanthoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Acanthoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Vulvar Inverted Follicular Keratosis SubClassOf Acanthoma</Axiom>
                           <Axiom>Inverted Follicular Keratosis SubClassOf Acanthoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Inverted Follicular Keratosis SubClassOf Disease_Has_Primary_Anatomic_Site only Hair Follicle</Axiom>
               </Source>
            </Change>
            <Change id="57">
               <Axiom>Keratoacanthoma EquivalentTo Epithelial Skin Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte) and (Disease_Has_Finding only Dome-Shaped Lesion) and (Disease_Has_Finding only Endophytic Tumor Growth) and (Disease_Has_Finding only Exophytic Papillary Lesion) and (Disease_Has_Finding only Rapidly Enlarging Mass) and (Disease_Has_Finding only Spontaneous Regression) and (Disease_Has_Finding only Well Differentiated Lesion) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Keratoacanthoma SubClassOf Disease_Has_Finding only Spontaneous Regression</Axiom>
               </Source>
            </Change>
            <Change id="58">
               <Axiom>Large Cell Acanthoma EquivalentTo Acanthoma and (Disease_May_Have_Finding some Skin Patch) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Has_Abnormal_Cell only Large Keratinocyte) and (Disease_Has_Normal_Cell_Origin only Keratinocyte)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Large Cell Acanthoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Large Cell Acanthoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Large Cell Acanthoma SubClassOf Acanthoma</Axiom>
               </Source>
            </Change>
            <Change id="59">
               <Axiom>Localized Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Localized Disease)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Localized Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Localized Carcinoma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Localized Carcinoma SubClassOf Neoplasm by Special Category</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Localized Malignant Neoplasm SubClassOf Malignant Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="60">
               <Axiom>Malignant Eccrine Neoplasm EquivalentTo Eccrine Neoplasm and Malignant Sweat Gland Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Eccrine Cell)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Malignant Eccrine Neoplasm SubClassOf Malignant Sweat Gland Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="61">
               <Axiom>Malignant Germinative Follicular Epithelium Neoplasm EquivalentTo Germinative Follicular Epithelium Neoplasm and Malignant Hair Follicle Neoplasm</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Malignant Germinative Follicular Epithelium Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Malignant Germinative Follicular Epithelium Neoplasm SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Malignant Germinative Follicular Epithelium Neoplasm SubClassOf Malignant Hair Follicle Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="62">
               <Axiom>Malignant Hair Follicle Neoplasm EquivalentTo Hair Follicle Neoplasm and Malignant Skin Appendage Neoplasm</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Malignant Hair Follicle Neoplasm SubClassOf Malignant Skin Appendage Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="63">
               <Axiom>Malignant Outer Hair Sheath and Infundibulum Neoplasm EquivalentTo Malignant Hair Follicle Neoplasm and Outer Hair Sheath and Infundibulum Neoplasm</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Malignant Outer Hair Sheath and Infundibulum Neoplasm SubClassOf Malignant Hair Follicle Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="64">
               <Axiom>Malignant Skin Appendage Neoplasm EquivalentTo Malignant Skin Neoplasm and Skin Appendage Neoplasm</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Spiradenocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Spiradenocarcinoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Spiradenocarcinoma SubClassOf Skin Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Malignant Skin Appendage Neoplasm SubClassOf Malignant Skin Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="65">
               <Axiom>Malignant Sweat Gland Neoplasm EquivalentTo Malignant Skin Appendage Neoplasm and Sweat Gland Neoplasm</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Spiradenocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Spiradenocarcinoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Spiradenocarcinoma SubClassOf Skin Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Malignant Sweat Gland Neoplasm SubClassOf Sweat Gland Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="66">
               <Axiom>Malignant Thalamic Neoplasm EquivalentTo Malignant Diencephalic Neoplasm and Thalamic Neoplasm</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Malignant Thalamic Neoplasm SubClassOf Malignant Diencephalic Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="67">
               <Axiom>Melanoacanthoma EquivalentTo Seborrheic Keratosis and (Disease_Has_Finding only Melanin Pigment Present)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Melanoacanthoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Melanoacanthoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Melanoacanthoma SubClassOf Acanthoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Acanthoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Melanoacanthoma SubClassOf Acanthoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Melanoacanthoma SubClassOf Seborrheic Keratosis</Axiom>
               </Source>
            </Change>
            <Change id="68">
               <Axiom>Metastatic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Bone Ewing's Sarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Bone Ewing's Sarcoma SubClassOf Metastatic Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Metastatic Neoplasm SubClassOf Disease_Has_Finding only Metastatic Lesion</Axiom>
               </Source>
            </Change>
            <Change id="69">
               <Axiom>Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm EquivalentTo Hair Follicle Neoplasm and Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Connective and Soft Tissue Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Finding only Mesenchymal Component Present) and (Disease_Has_Normal_Cell_Origin only Connective and Soft Tissue Cell) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm SubClassOf Disease_Has_Normal_Cell_Origin only Connective and Soft Tissue Cell</Axiom>
               </Source>
            </Change>
            <Change id="70">
               <Axiom>Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Intraductal and Lobular Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Intraductal and Lobular Carcinoma SubClassOf Mixed Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Mixed Neoplasm SubClassOf Disease_Has_Finding only Mixed Cellular Population</Axiom>
               </Source>
            </Change>
            <Change id="20">
               <Axiom>Mixed Tumor of the Skin (Chondroid Syringoma) EquivalentTo Benign Sweat Gland Neoplasm and Mixed Neoplasm and (Disease_May_Have_Finding some Cartilagenous Component Present) and (Disease_May_Have_Finding some Fibrotic Stroma Formation) and (Disease_May_Have_Finding some Myxoid Stroma Formation) and (Disease_May_Have_Finding some Slow Growing Mass) and (Disease_Has_Finding only Mesenchymal Component Present)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Mixed Tumor of the Skin (Chondroid Syringoma)</Concept>
                        <WitnessAxioms>
                           <Axiom>Mixed Tumor of the Skin (Chondroid Syringoma) SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Mixed Tumor of the Skin (Chondroid Syringoma) SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Mixed Tumor of the Skin (Chondroid Syringoma) SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Mixed Tumor of the Skin (Chondroid Syringoma) SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Mixed Tumor of the Skin (Chondroid Syringoma) SubClassOf Mixed Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="71">
               <Axiom>Multiple Adenomatous Polyps EquivalentTo Adenomatous Polyp and (Disease_Has_Finding only Multifocal Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Multiple Adenomatous Polyps SubClassOf Adenomatous Polyp</Axiom>
               </Source>
            </Change>
            <Change id="72">
               <Axiom>Nodular Hidradenoma EquivalentTo Hidradenoma and (Disease_Has_Finding only Nodular Pattern)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Nodular Hidradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Nodular Hidradenoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Nodular Hidradenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Nodular Hidradenoma SubClassOf Hidradenoma</Axiom>
               </Source>
            </Change>
            <Change id="73">
               <Axiom>Osteolytic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Lytic Bone Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Osteolytic Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
               </Source>
            </Change>
            <Change id="74">
               <Axiom>Outer Hair Sheath and Infundibulum Neoplasm EquivalentTo Hair Follicle Neoplasm and (Disease_Has_Primary_Anatomic_Site only Hair Follicle Infundibulum) and (Disease_Has_Primary_Anatomic_Site only Outer Hair Sheath)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Outer Hair Sheath and Infundibulum Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Hair Follicle Infundibulum</Axiom>
               </Source>
            </Change>
            <Change id="75">
               <Axiom>Papillary Carcinoma EquivalentTo Carcinoma and Papillary Epithelial Neoplasm</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Plantar Verrucous Skin Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Plantar Verrucous Skin Carcinoma SubClassOf Papillary Epithelial Neoplasm</Axiom>
                           <Axiom>Plantar Verrucous Skin Carcinoma SubClassOf Papillary Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Papillary Carcinoma SubClassOf Carcinoma</Axiom>
               </Source>
            </Change>
            <Change id="76">
               <Axiom>Papillary Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and Papillary Neoplasm</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Plantar Verrucous Skin Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Plantar Verrucous Skin Carcinoma SubClassOf Papillary Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Papillary Epithelial Neoplasm SubClassOf Papillary Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="77">
               <Axiom>Papillary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Papillary Pattern)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Stage IVB Oral Cavity Verrucous Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Stage IVB Oral Cavity Verrucous Carcinoma SubClassOf Neoplasm by Special Category</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Papillary Neoplasm SubClassOf Disease_Has_Finding only Papillary Pattern</Axiom>
               </Source>
            </Change>
            <Change id="78">
               <Axiom>Paraganglioma-Like Dermal Melanocytic Tumor EquivalentTo Benign Dermal Neoplasm and Melanocytic Skin Neoplasm and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Finding only Nested Pattern)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Paraganglioma-Like Dermal Melanocytic Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Paraganglioma-Like Dermal Melanocytic Tumor SubClassOf Melanocytic Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Paraganglioma-Like Dermal Melanocytic Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Paraganglioma-Like Dermal Melanocytic Tumor SubClassOf Neoplasm by Special Category</Axiom>
                           <Axiom>Paraganglioma-Like Dermal Melanocytic Tumor SubClassOf Melanocytic Neoplasm</Axiom>
                           <Axiom>Paraganglioma-Like Dermal Melanocytic Tumor SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Paraganglioma-Like Dermal Melanocytic Tumor SubClassOf Common Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Paraganglioma-Like Dermal Melanocytic Tumor SubClassOf Benign Dermal Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="80">
               <Axiom>Poroma EquivalentTo Benign Sweat Gland Neoplasm and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_May_Have_Finding some Skin Plaque)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Classical Poroma</Concept>
                        <WitnessAxioms>
                           <Axiom>Classical Poroma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Classical Poroma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Classical Poroma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Classical Poroma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Classical Poroma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Poroma SubClassOf Benign Sweat Gland Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="81">
               <Axiom>Pre-Malignant Skin Epithelial Lesion EquivalentTo Cutaneous Precancerous Condition and Epithelial Skin Neoplasm and (Disease_Excludes_Finding only Malignant Cellular Infiltrate) and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte) and (Disease_Has_Finding only Absence of Invasion) and (Disease_Has_Finding only Atypia) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Normal_Tissue_Origin only Epidermis) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Pre-Malignant Skin Epithelial Lesion SubClassOf Disease_Has_Finding only Absence of Invasion</Axiom>
               </Source>
            </Change>
            <Change id="79">
               <Axiom>Proliferating Pilar Tumor EquivalentTo Benign Outer Hair Sheath and Infundibulum Neoplasm and (Disease_Has_Finding only Lobular Pattern) and (Disease_Has_Finding only Slow Growing Mass) and (Disease_Has_Primary_Anatomic_Site only Head)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Proliferating Pilar Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Proliferating Pilar Tumor SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Proliferating Pilar Tumor SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Proliferating Pilar Tumor SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Proliferating Pilar Tumor SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Proliferating Pilar Tumor SubClassOf Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Proliferating Pilar Tumor SubClassOf Benign Outer Hair Sheath and Infundibulum Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="83">
               <Axiom>Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Lip and Oral Cavity Cancer</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Lip and Oral Cavity Cancer SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Lip and Oral Cavity Cancer SubClassOf Neoplasm by Special Category</Axiom>
                           <Axiom>Recurrent Lip and Oral Cavity Cancer SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Recurrent Malignant Neoplasm SubClassOf Recurrent Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="84">
               <Axiom>Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Lip and Oral Cavity Cancer</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Lip and Oral Cavity Cancer SubClassOf Neoplasm by Special Category</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Recurrent Neoplasm SubClassOf Disease_Has_Finding only Recurrent Disease</Axiom>
               </Source>
            </Change>
            <Change id="85">
               <Axiom>Refractory Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Refractory Disease)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Refractory Hematologic Malignancy</Concept>
                        <WitnessAxioms>
                           <Axiom>Refractory Hematologic Malignancy SubClassOf Neoplasm by Special Category</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Refractory Neoplasm SubClassOf Disease_Has_Finding only Refractory Disease</Axiom>
               </Source>
            </Change>
            <Change id="86">
               <Axiom>Sebaceous Gland Neoplasm EquivalentTo Skin Appendage Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Sebocyte) and (Disease_Has_Finding only Sebaceous Differentiation) and (Disease_Has_Normal_Cell_Origin only Sebocyte) and (Disease_Has_Primary_Anatomic_Site only Sebaceous Gland)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Sebaceous Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Sebaceous Adenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Sebaceous Gland Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Sebaceous Gland</Axiom>
               </Source>
            </Change>
            <Change id="87">
               <Axiom>Seborrheic Keratosis EquivalentTo Acanthoma and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Normal_Cell_Origin only Basal Cell of the Squamous Epithelium)</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Seborrheic Keratosis</Concept>
                        <WitnessAxioms>
                           <Axiom>Seborrheic Keratosis SubClassOf Acanthoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Seborrheic Keratosis</Concept>
                        <WitnessAxioms>
                           <Axiom>Seborrheic Keratosis SubClassOf Benign Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Acanthoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Melanoacanthoma SubClassOf Acanthoma</Axiom>
                           <Axiom>Eyelid Seborrheic Keratosis SubClassOf Acanthoma</Axiom>
                           <Axiom>Vulvar Inverted Follicular Keratosis SubClassOf Acanthoma</Axiom>
                           <Axiom>Vulvar Seborrheic Keratosis SubClassOf Acanthoma</Axiom>
                           <Axiom>Inverted Follicular Keratosis SubClassOf Acanthoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Seborrheic Keratosis SubClassOf Disease_Has_Finding only Acanthosis</Axiom>
               </Source>
            </Change>
            <Change id="88">
               <Axiom>Secondary Malignant Neoplasm EquivalentTo Malignant Neoplasm and Secondary Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Secondary Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Malignant Neoplasm SubClassOf Secondary Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Secondary Glioblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Glioblastoma SubClassOf Secondary Neoplasm</Axiom>
                           <Axiom>Secondary Glioblastoma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Secondary Malignant Neoplasm SubClassOf Malignant Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="89">
               <Axiom>Secondary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Secondary Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Secondary Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
               </Source>
            </Change>
            <Change id="90">
               <Axiom>Semantic_Type Range: {"Acquired Abnormality"^^string , "Activity"^^string , "Age Group"^^string , "Alga"^^string , "Amino Acid Sequence"^^string , "Amino Acid, Peptide, or Protein"^^string , "Amphibian"^^string , "Anatomical Abnormality"^^string , "Anatomical Structure"^^string , "Animal"^^string , "Antibiotic"^^string , "Archaeon"^^string , "Bacterium"^^string , "Behavior"^^string , "Biologic Function"^^string , "Biologically Active Substance"^^string , "Biomedical Occupation or Discipline"^^string , "Biomedical or Dental Material"^^string , "Bird"^^string , "Body Location or Region"^^string , "Body Part, Organ, or Organ Component"^^string , "Body Space or Junction"^^string , "Body Substance"^^string , "Body System"^^string , "Carbohydrate"^^string , "Carbohydrate Sequence"^^string , "Cell"^^string , "Cell Component"^^string , "Cell Function"^^string , "Cell or Molecular Dysfunction"^^string , "Chemical"^^string , "Chemical Viewed Functionally"^^string , "Chemical Viewed Structurally"^^string , "Classification"^^string , "Clinical Attribute"^^string , "Clinical Drug"^^string , "Conceptual Entity"^^string , "Congenital Abnormality"^^string , "Daily or Recreational Activity"^^string , "Diagnostic Procedure"^^string , "Disease or Syndrome"^^string , "Drug Delivery Device"^^string , "Educational Activity"^^string , "Eicosanoid"^^string , "Element, Ion, or Isotope"^^string , "Embryonic Structure"^^string , "Entity"^^string , "Environmental Effect of Humans"^^string , "Enzyme"^^string , "Event"^^string , "Experimental Model of Disease"^^string , "Family Group"^^string , "Finding"^^string , "Fish"^^string , "Food"^^string , "Fully Formed Anatomical Structure"^^string , "Functional Concept"^^string , "Fungus"^^string , "Gene or Genome"^^string , "Genetic Function"^^string , "Geographic Area"^^string , "Governmental or Regulatory Activity"^^string , "Group"^^string , "Group Attribute"^^string , "Hazardous or Poisonous Substance"^^string , "Health Care Activity"^^string , "Health Care Related Organization"^^string , "Hormone"^^string , "Human"^^string , "Human-caused Phenomenon or Process"^^string , "Idea or Concept"^^string , "Immunologic Factor"^^string , "Indicator, Reagent, or Diagnostic Aid"^^string , "Individual Behavior"^^string , "Injury or Poisoning"^^string , "Inorganic Chemical"^^string , "Intellectual Product"^^string , "Invertebrate"^^string , "Laboratory Procedure"^^string , "Laboratory or Test Result"^^string , "Language"^^string , "Lipid"^^string , "Machine Activity"^^string , "Mammal"^^string , "Manufactured Object"^^string , "Medical Device"^^string , "Mental Process"^^string , "Mental or Behavioral Dysfunction"^^string , "Molecular Biology Research Technique"^^string , "Molecular Function"^^string , "Molecular Sequence"^^string , "Natural Phenomenon or Process"^^string , "Neoplastic Process"^^string , "Neuroreactive Substance or Biogenic Amine"^^string , "Nucleic Acid, Nucleoside, or Nucleotide"^^string , "Nucleotide Sequence"^^string , "Occupation or Discipline"^^string , "Occupational Activity"^^string , "Organ or Tissue Function"^^string , "Organic Chemical"^^string , "Organism"^^string , "Organism Attribute"^^string , "Organism Function"^^string , "Organization"^^string , "Organophosphorus Compound"^^string , "Pathologic Function"^^string , "Patient or Disabled Group"^^string , "Pharmacologic Substance"^^string , "Phenomenon or Process"^^string , "Physical Object"^^string , "Physiologic Function"^^string , "Plant"^^string , "Population Group"^^string , "Professional Society"^^string , "Professional or Occupational Group"^^string , "Qualitative Concept"^^string , "Quantitative Concept"^^string , "Receptor"^^string , "Regulation or Law"^^string , "Reptile"^^string , "Research Activity"^^string , "Research Device"^^string , "Rickettsia or Chlamydia"^^string , "Self-help or Relief Organization"^^string , "Sign or Symptom"^^string , "Social Behavior"^^string , "Spatial Concept"^^string , "Steroid"^^string , "Substance"^^string , "Temporal Concept"^^string , "Therapeutic or Preventive Procedure"^^string , "Tissue"^^string , "Vertebrate"^^string , "Virus"^^string , "Vitamin"^^string}</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Semantic_Type Range: string</Axiom>
               </Source>
            </Change>
            <Change id="91">
               <Axiom>Skin Appendage Adenoma EquivalentTo Adenoma and Benign Epithelial Skin Neoplasm and Benign Skin Appendage Neoplasm</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Skin Appendage Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Skin Appendage Adenoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Epithelial Skin Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Skin Appendage Adenoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Nodular Hidradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Nodular Hidradenoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Nodular Hidradenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Skin Appendage Adenoma SubClassOf Adenoma</Axiom>
               </Source>
            </Change>
            <Change id="92">
               <Axiom>Skin Appendage Neoplasm EquivalentTo Skin Neoplasm and (Disease_Has_Finding only Adnexal Differentiation) and (Disease_Has_Primary_Anatomic_Site only Exocrine System) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Nodular Hidradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Nodular Hidradenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Skin Appendage Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Exocrine System</Axiom>
               </Source>
            </Change>
            <Change id="93">
               <Axiom>Skin Neoplasm EquivalentTo Neoplasm by Site and Skin Disorder and (Disease_Has_Associated_Anatomic_Site only Skin)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Warty Dyskeratoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Warty Dyskeratoma SubClassOf Neoplasm</Axiom>
                           <Axiom>Warty Dyskeratoma SubClassOf Neoplasm by Site</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Skin Neoplasm SubClassOf Neoplasm by Site</Axiom>
               </Source>
            </Change>
            <Change id="94">
               <Axiom>Sporadic Cylindroma EquivalentTo Cylindroma and (Disease_Has_Finding only Non-Hereditary Lesion)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Sporadic Cylindroma</Concept>
                        <WitnessAxioms>
                           <Axiom>Sporadic Cylindroma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Sporadic Cylindroma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Sporadic Cylindroma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Sporadic Cylindroma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Sporadic Cylindroma SubClassOf Neoplasm by Morphology</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Sporadic Cylindroma SubClassOf Cylindroma</Axiom>
               </Source>
            </Change>
            <Change id="95">
               <Axiom>Sweat Gland Adenoma EquivalentTo Benign Sweat Gland Neoplasm and Skin Appendage Adenoma and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Sweat Gland Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Sweat Gland Adenoma SubClassOf Benign Sweat Gland Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Sweat Gland Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Sweat Gland Adenoma SubClassOf Benign Sweat Gland Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Nodular Hidradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Nodular Hidradenoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Nodular Hidradenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Sweat Gland Adenoma SubClassOf Skin Appendage Adenoma</Axiom>
               </Source>
            </Change>
            <Change id="96">
               <Axiom>Sweat Gland Neoplasm EquivalentTo Skin Appendage Neoplasm and (Disease_Has_Primary_Anatomic_Site only Sweat Gland)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Nodular Hidradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Nodular Hidradenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Sweat Gland Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Sweat Gland</Axiom>
               </Source>
            </Change>
            <Change id="97">
               <Axiom>Syringoacanthoma EquivalentTo Poroma and (Disease_Has_Finding only Acanthosis)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Syringoacanthoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringoacanthoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Syringoacanthoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Syringoacanthoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Syringoacanthoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Syringoacanthoma SubClassOf Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Syringoacanthoma SubClassOf Poroma</Axiom>
               </Source>
            </Change>
            <Change id="40">
               <Axiom>Syringofibroadenoma EquivalentTo Benign Eccrine Neoplasm and Sweat Gland Adenoma and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Anastomosing Strands of Tumor Cells Present)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Syringofibroadenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringofibroadenoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Syringofibroadenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Syringofibroadenoma SubClassOf Sweat Gland Adenoma</Axiom>
               </Source>
            </Change>
            <Change id="98">
               <Axiom>Syringoma EquivalentTo Benign Eccrine Neoplasm and (Disease_May_Have_Finding some Multifocal Lesion) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Cord-Like Pattern) and (Disease_Has_Finding only Dense Collagenized Tissue Present) and (Disease_Has_Finding only Tubular Pattern)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Syringoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Syringoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Syringoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Syringoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Syringoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Syringoma SubClassOf Benign Eccrine Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="100">
               <Axiom>Therapy Related Malignant Neoplasm EquivalentTo Malignant Neoplasm and Therapy-Related Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Therapy Related Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Therapy Related Malignant Neoplasm SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Transplant-Related Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Transplant-Related Malignant Neoplasm SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Therapy Related Malignant Neoplasm SubClassOf Therapy-Related Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="99">
               <Axiom>Therapy-Related Neoplasm EquivalentTo Neoplasm by Cause and (Disease_Has_Finding only Therapy-Related Toxicity)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Therapy-Related Neoplasm SubClassOf Disease_Has_Finding only Therapy-Related Toxicity</Axiom>
               </Source>
            </Change>
            <Change id="101">
               <Axiom>Trichoadenoma EquivalentTo Benign Outer Hair Sheath and Infundibulum Neoplasm and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Finding only Cystic Change)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Trichoadenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichoadenoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Trichoadenoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Trichoadenoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Trichoadenoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Trichoadenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Trichoadenoma SubClassOf Benign Outer Hair Sheath and Infundibulum Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="102">
               <Axiom>Tubular Apocrine Adenoma EquivalentTo Apocrine Adenoma and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Finding only Lobulated Growth Pattern) and (Disease_Has_Finding only Tubular Pattern)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Tubular Apocrine Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Tubular Apocrine Adenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Tubular Apocrine Adenoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Tubular Apocrine Adenoma SubClassOf Apocrine Adenoma</Axiom>
               </Source>
            </Change>
            <Change id="47">
               <Axiom>Tumor of the Follicular Infundibulum EquivalentTo Benign Outer Hair Sheath and Infundibulum Neoplasm and (Disease_May_Have_Finding some Macular Lesion) and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte) and (Disease_Has_Primary_Anatomic_Site only Hair Follicle Infundibulum)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Tumor of the Follicular Infundibulum</Concept>
                        <WitnessAxioms>
                           <Axiom>Tumor of the Follicular Infundibulum SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Tumor of the Follicular Infundibulum SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Tumor of the Follicular Infundibulum SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Tumor of the Follicular Infundibulum SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Tumor of the Follicular Infundibulum SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Tumor of the Follicular Infundibulum SubClassOf Disease_Has_Primary_Anatomic_Site only Hair Follicle Infundibulum</Axiom>
               </Source>
            </Change>
            <Change id="103">
               <Axiom>Turban Tumor EquivalentTo Cylindroma and (Disease_Has_Finding only Multifocal Lesion) and (Disease_Has_Primary_Anatomic_Site only Head)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Turban Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Turban Tumor SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Turban Tumor SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Turban Tumor SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Turban Tumor SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Turban Tumor SubClassOf Neoplasm by Morphology</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Turban Tumor SubClassOf Cylindroma</Axiom>
               </Source>
            </Change>
            <Change id="104">
               <Axiom>Verruca Plantaris EquivalentTo Benign Epithelial Skin Neoplasm and Benign Squamous Cell Neoplasm and Verrucous Lesion and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Finding only Parakeratosis) and (Disease_Has_Primary_Anatomic_Site only Foot) and (Disease_Has_Primary_Anatomic_Site only Plantar Region)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Verruca Plantaris</Concept>
                        <WitnessAxioms>
                           <Axiom>Verruca Plantaris SubClassOf Benign Squamous Cell Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Verruca Plantaris</Concept>
                        <WitnessAxioms>
                           <Axiom>Verruca Plantaris SubClassOf Squamous Cell Neoplasm</Axiom>
                           <Axiom>Verruca Plantaris SubClassOf Benign Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Verruca Plantaris SubClassOf Verrucous Lesion</Axiom>
               </Source>
            </Change>
            <Change id="105">
               <Axiom>Verruca Vulgaris EquivalentTo Benign Epithelial Skin Neoplasm and Benign Squamous Cell Neoplasm and Verrucous Lesion and (Disease_Excludes_Primary_Anatomic_Site only Foot) and (Disease_Excludes_Primary_Anatomic_Site only Plantar Region) and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Finding only Parakeratosis)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Verruca Vulgaris</Concept>
                        <WitnessAxioms>
                           <Axiom>Verruca Vulgaris SubClassOf Benign Squamous Cell Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Verruca Vulgaris</Concept>
                        <WitnessAxioms>
                           <Axiom>Verruca Vulgaris SubClassOf Squamous Cell Neoplasm</Axiom>
                           <Axiom>Verruca Vulgaris SubClassOf Benign Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Verruca Vulgaris SubClassOf Verrucous Lesion</Axiom>
               </Source>
            </Change>
            <Change id="106">
               <Axiom>Vulvar Nodular Hidradenoma EquivalentTo Benign Vulvar Neoplasm and Nodular Hidradenoma and Vulvar Neoplasm of Skin Appendage Origin</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Vulvar Nodular Hidradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Vulvar Nodular Hidradenoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Vulvar Nodular Hidradenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Vulvar Nodular Hidradenoma SubClassOf Nodular Hidradenoma</Axiom>
               </Source>
            </Change>
            <Change id="107">
               <Axiom>Vulvar Syringoma EquivalentTo Benign Vulvar Neoplasm and Syringoma and Vulvar Neoplasm of Skin Appendage Origin</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Vulvar Syringoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Vulvar Syringoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Vulvar Syringoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Vulvar Syringoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Vulvar Syringoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Vulvar Syringoma SubClassOf Neoplasm by Morphology</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Vulvar Syringoma SubClassOf Benign Vulvar Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="108">
               <Axiom>Vulvar Trichoblastoma EquivalentTo Benign Vulvar Neoplasm and Trichoblastoma and Vulvar Neoplasm of Skin Appendage Origin</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Vulvar Trichoblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Vulvar Trichoblastoma SubClassOf Trichoblastoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Vulvar Trichoblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Vulvar Trichoblastoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Vulvar Trichoblastoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Vulvar Trichoblastoma SubClassOf Benign Vulvar Neoplasm</Axiom>
               </Source>
            </Change>
         </Strengthening>
         <StrengtheningWithNewTerms id="stnt" size="8">
            <Change id="109">
               <Axiom>Anterior Foramen Magnum Meningioma EquivalentTo Foramen Magnum Meningioma and (Disease_Has_Primary_Anatomic_Site only Anterior Foramen Magnum)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Anterior Foramen Magnum Meningioma SubClassOf Foramen Magnum Meningioma</Axiom>
               </Source>
               <New_Terms>Anterior Foramen Magnum</New_Terms>
            </Change>
            <Change id="110">
               <Axiom>Anterior Visual Pathway Meningioma EquivalentTo Visual Pathway Meningioma and (Disease_Has_Primary_Anatomic_Site only Anterior Visual Pathway)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Anterior Visual Pathway Meningioma SubClassOf Visual Pathway Meningioma</Axiom>
               </Source>
               <New_Terms>Anterior Visual Pathway</New_Terms>
            </Change>
            <Change id="111">
               <Axiom>Epidermolytic Acanthoma EquivalentTo Acanthoma and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Epidermolytic Hyperkeratosis) and (Disease_Has_Normal_Cell_Origin only Keratinocyte)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Epidermolytic Acanthoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Epidermolytic Acanthoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Epidermolytic Acanthoma SubClassOf Acanthoma</Axiom>
               </Source>
               <New_Terms>Epidermolytic Hyperkeratosis</New_Terms>
            </Change>
            <Change id="112">
               <Axiom>Pilar Sheath Acanthoma EquivalentTo Acanthoma and Benign Outer Hair Sheath and Infundibulum Neoplasm and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Follicular Differentiation) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Primary_Anatomic_Site only Pilar Sheath)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Pilar Sheath Acanthoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Pilar Sheath Acanthoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Pilar Sheath Acanthoma SubClassOf Acanthoma</Axiom>
               </Source>
               <New_Terms>Follicular Differentiation</New_Terms>
            </Change>
            <Change id="113">
               <Axiom>Pilomatricoma EquivalentTo Benign Germinative Follicular Epithelium Neoplasm and (Disease_May_Have_Finding some Calcification) and (Disease_Excludes_Finding only Invasive Lesion) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Follicular Differentiation) and (Disease_Has_Finding only Shadow Cells Present) and (Disease_Has_Finding only Skin Nodule)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Pilomatricoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Pilomatricoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Pilomatricoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Pilomatricoma SubClassOf Disease_Excludes_Finding only Invasive Lesion</Axiom>
               </Source>
               <New_Terms>Follicular Differentiation, Shadow Cells Present</New_Terms>
            </Change>
            <Change id="114">
               <Axiom>Posterior Foramen Magnum Meningioma EquivalentTo Foramen Magnum Meningioma and (Disease_Has_Primary_Anatomic_Site only Posterior Foramen Magnum)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Posterior Foramen Magnum Meningioma SubClassOf Foramen Magnum Meningioma</Axiom>
               </Source>
               <New_Terms>Posterior Foramen Magnum</New_Terms>
            </Change>
            <Change id="116">
               <Axiom>Trichoblastoma EquivalentTo Benign Germinative Follicular Epithelium Neoplasm and (Disease_Has_Finding only Fenestrated Pattern) and (Disease_Has_Finding only Papular Lesion) and (Disease_Has_Finding only Trichoblastic Differentiation)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Vulvar Trichoblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Vulvar Trichoblastoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Vulvar Trichoblastoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Trichoblastoma SubClassOf Benign Germinative Follicular Epithelium Neoplasm</Axiom>
               </Source>
               <New_Terms>Fenestrated Pattern, Trichoblastic Differentiation</New_Terms>
            </Change>
            <Change id="115">
               <Axiom>Tricholemmoma EquivalentTo Benign Outer Hair Sheath and Infundibulum Neoplasm and (Disease_May_Have_Finding some Dome-Shaped Lesion) and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Finding only Parakeratosis) and (Disease_Has_Finding only Tricholemmal Differentiation)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Desmoplastic Tricholemmoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Desmoplastic Tricholemmoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Desmoplastic Tricholemmoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Desmoplastic Tricholemmoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Desmoplastic Tricholemmoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Desmoplastic Tricholemmoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Tricholemmoma SubClassOf Benign Outer Hair Sheath and Infundibulum Neoplasm</Axiom>
               </Source>
               <New_Terms>Tricholemmal Differentiation</New_Terms>
            </Change>
         </StrengtheningWithNewTerms>
         <NewDescription id="newdesc" size="105">
            <Change id="211">
               <Axiom>14C BMS-275183 SubClassOf Radioconjugate</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>14C BMS-275183</Concept>
                        <WitnessAxioms>
                           <Axiom>14C BMS-275183 SubClassOf Radioconjugate</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>14C BMS-275183</Concept>
                        <WitnessAxioms>
                           <Axiom>14C BMS-275183 SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>14C BMS-275183 SubClassOf Radiopharmaceutical Compound</Axiom>
                           <Axiom>14C BMS-275183 SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                           <Axiom>14C BMS-275183 SubClassOf Drug or Chemical</Axiom>
                           <Axiom>14C BMS-275183 SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>14C BMS-275183</New_Terms>
            </Change>
            <Change id="212">
               <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some G2 Phase Arrest</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>2-Methoxyestradiol Nanocrystal Colloidal Dispersion</Concept>
                        <WitnessAxioms>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>2-Methoxyestradiol Nanocrystal Colloidal Dispersion</New_Terms>
            </Change>
            <Change id="213">
               <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Induction of Apoptosis</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>2-Methoxyestradiol Nanocrystal Colloidal Dispersion</Concept>
                        <WitnessAxioms>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>2-Methoxyestradiol Nanocrystal Colloidal Dispersion</New_Terms>
            </Change>
            <Change id="214">
               <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Inhibition of Cell Proliferation</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>2-Methoxyestradiol Nanocrystal Colloidal Dispersion</Concept>
                        <WitnessAxioms>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>2-Methoxyestradiol Nanocrystal Colloidal Dispersion</New_Terms>
            </Change>
            <Change id="215">
               <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Mitosis Inhibition</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>2-Methoxyestradiol Nanocrystal Colloidal Dispersion</Concept>
                        <WitnessAxioms>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>2-Methoxyestradiol Nanocrystal Colloidal Dispersion</New_Terms>
            </Change>
            <Change id="216">
               <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Selective Estrogen Receptor Modulator</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>2-Methoxyestradiol Nanocrystal Colloidal Dispersion</Concept>
                        <WitnessAxioms>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Selective Estrogen Receptor Modulator</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>2-Methoxyestradiol Nanocrystal Colloidal Dispersion</Concept>
                        <WitnessAxioms>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Chemopreventive Agent</Axiom>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Antiestrogen</Axiom>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Hormone Antagonist</Axiom>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Drug or Chemical</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>2-Methoxyestradiol Nanocrystal Colloidal Dispersion</New_Terms>
            </Change>
            <Change id="217">
               <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Steroid Compound</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>2-Methoxyestradiol Nanocrystal Colloidal Dispersion</Concept>
                        <WitnessAxioms>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Steroid Compound</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>2-Methoxyestradiol Nanocrystal Colloidal Dispersion</Concept>
                        <WitnessAxioms>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Organic Chemical</Axiom>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Lipid</Axiom>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                           <Axiom>2-Methoxyestradiol Nanocrystal Colloidal Dispersion SubClassOf Drug or Chemical</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>2-Methoxyestradiol Nanocrystal Colloidal Dispersion</New_Terms>
            </Change>
            <Change id="117">
               <Axiom>Accepted SubClassOf General Qualifier</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Accepted</Concept>
                        <WitnessAxioms>
                           <Axiom>Accepted SubClassOf General Qualifier</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Accepted</Concept>
                        <WitnessAxioms>
                           <Axiom>Accepted SubClassOf Qualifier</Axiom>
                           <Axiom>Accepted SubClassOf Properties_or_Attributes_Kind</Axiom>
                           <Axiom>Accepted SubClassOf Property or Attribute</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Accepted</New_Terms>
            </Change>
            <Change id="118">
               <Axiom>Aflatoxins Toxicity SubClassOf Toxicity</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Aflatoxins Toxicity</Concept>
                        <WitnessAxioms>
                           <Axiom>Aflatoxins Toxicity SubClassOf Toxicity</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Aflatoxins Toxicity</Concept>
                        <WitnessAxioms>
                           <Axiom>Aflatoxins Toxicity SubClassOf Injury</Axiom>
                           <Axiom>Aflatoxins Toxicity SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Aflatoxins Toxicity SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Aflatoxins Toxicity SubClassOf Finding</Axiom>
                           <Axiom>Aflatoxins Toxicity SubClassOf Finding by Cause</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Aflatoxins Toxicity</New_Terms>
            </Change>
            <Change id="119">
               <Axiom>Agent Combination SubClassOf Chemotherapy Regimen or Agent Combination</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Agent Combination</Concept>
                        <WitnessAxioms>
                           <Axiom>Agent Combination SubClassOf Chemotherapy Regimen or Agent Combination</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Agent Combination</Concept>
                        <WitnessAxioms>
                           <Axiom>Agent Combination SubClassOf Chemotherapy_Regimen_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Agent Combination</New_Terms>
            </Change>
            <Change id="120">
               <Axiom>Anterior Foramen Magnum SubClassOf Anatomic_Structure_Is_Physical_Part_Of some Foramen Magnum</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Anterior Foramen Magnum</Concept>
                        <WitnessAxioms>
                           <Axiom>Anterior Foramen Magnum SubClassOf Anatomy_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Anterior Foramen Magnum</New_Terms>
            </Change>
            <Change id="121">
               <Axiom>Anterior Foramen Magnum SubClassOf Skeletal System Part</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Anterior Foramen Magnum</Concept>
                        <WitnessAxioms>
                           <Axiom>Anterior Foramen Magnum SubClassOf Skeletal System Part</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Anterior Foramen Magnum</Concept>
                        <WitnessAxioms>
                           <Axiom>Anterior Foramen Magnum SubClassOf Body Part</Axiom>
                           <Axiom>Anterior Foramen Magnum SubClassOf Anatomy_Kind</Axiom>
                           <Axiom>Anterior Foramen Magnum SubClassOf Musculoskeletal System Part</Axiom>
                           <Axiom>Anterior Foramen Magnum SubClassOf Anatomic Structure, System, or Substance</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Anterior Foramen Magnum</New_Terms>
            </Change>
            <Change id="122">
               <Axiom>Anterior Visual Pathway SubClassOf Anatomic_Structure_Is_Physical_Part_Of some Visual Pathway</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Anterior Visual Pathway</Concept>
                        <WitnessAxioms>
                           <Axiom>Anterior Visual Pathway SubClassOf Anatomy_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Anterior Visual Pathway</New_Terms>
            </Change>
            <Change id="123">
               <Axiom>Anterior Visual Pathway SubClassOf Peripheral Nervous System Part</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Anterior Visual Pathway</Concept>
                        <WitnessAxioms>
                           <Axiom>Anterior Visual Pathway SubClassOf Peripheral Nervous System Part</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Anterior Visual Pathway</Concept>
                        <WitnessAxioms>
                           <Axiom>Anterior Visual Pathway SubClassOf Nervous System Part</Axiom>
                           <Axiom>Anterior Visual Pathway SubClassOf Anatomic Structure, System, or Substance</Axiom>
                           <Axiom>Anterior Visual Pathway SubClassOf Body Part</Axiom>
                           <Axiom>Anterior Visual Pathway SubClassOf Anatomy_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Anterior Visual Pathway</New_Terms>
            </Change>
            <Change id="124">
               <Axiom>Antilymphocyte Serum SubClassOf Antiserum</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Antilymphocyte Serum</Concept>
                        <WitnessAxioms>
                           <Axiom>Antilymphocyte Serum SubClassOf Antiserum</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Antilymphocyte Serum</Concept>
                        <WitnessAxioms>
                           <Axiom>Antilymphocyte Serum SubClassOf Biological Agent</Axiom>
                           <Axiom>Antilymphocyte Serum SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Antilymphocyte Serum SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                           <Axiom>Antilymphocyte Serum SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                           <Axiom>Antilymphocyte Serum SubClassOf Biological Response Modifier</Axiom>
                           <Axiom>Antilymphocyte Serum SubClassOf Drug or Chemical</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Antilymphocyte Serum</New_Terms>
            </Change>
            <Change id="125">
               <Axiom>Aurora Kinase Inhibitor SubClassOf Enzyme Inhibitor</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Aurora Kinase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor SubClassOf Enzyme Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Aurora Kinase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                           <Axiom>Aurora Kinase Inhibitor SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Aurora Kinase Inhibitor SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                           <Axiom>Aurora Kinase Inhibitor SubClassOf Drug or Chemical</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Aurora Kinase Inhibitor</New_Terms>
            </Change>
            <Change id="126">
               <Axiom>Bonding Restorative Material SubClassOf Restorative Material</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Bonding Restorative Material</Concept>
                        <WitnessAxioms>
                           <Axiom>Bonding Restorative Material SubClassOf Restorative Material</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Restorative Material</Concept>
                        <WitnessAxioms>
                           <Axiom>Bonding Restorative Material SubClassOf Restorative Material</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Bonding Restorative Material</Concept>
                        <WitnessAxioms>
                           <Axiom>Bonding Restorative Material SubClassOf Biomaterial</Axiom>
                           <Axiom>Bonding Restorative Material SubClassOf Dental Material</Axiom>
                           <Axiom>Bonding Restorative Material SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                           <Axiom>Bonding Restorative Material SubClassOf Drug or Chemical</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Restorative Material, Bonding Restorative Material</New_Terms>
            </Change>
            <Change id="127">
               <Axiom>Bronchiolitis Obliterans SubClassOf Bronchiolitis</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Bronchiolitis Obliterans</Concept>
                        <WitnessAxioms>
                           <Axiom>Bronchiolitis Obliterans SubClassOf Bronchiolitis</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Bronchiolitis Obliterans</Concept>
                        <WitnessAxioms>
                           <Axiom>Bronchiolitis Obliterans SubClassOf Lung Disorder</Axiom>
                           <Axiom>Bronchiolitis Obliterans SubClassOf Non-Neoplastic Thoracic Disorder</Axiom>
                           <Axiom>Bronchiolitis Obliterans SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Bronchiolitis Obliterans SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Bronchiolitis Obliterans SubClassOf Disorder by Site</Axiom>
                           <Axiom>Bronchiolitis Obliterans SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Bronchiolitis Obliterans SubClassOf Thoracic Disorder</Axiom>
                           <Axiom>Bronchiolitis Obliterans SubClassOf Respiratory Disorder</Axiom>
                           <Axiom>Bronchiolitis Obliterans SubClassOf Non-Neoplastic Disorder</Axiom>
                           <Axiom>Bronchiolitis Obliterans SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                           <Axiom>Bronchiolitis Obliterans SubClassOf Non-Neoplastic Lung Disorder</Axiom>
                           <Axiom>Bronchiolitis Obliterans SubClassOf Respiratory and Thoracic Disorder</Axiom>
                           <Axiom>Bronchiolitis Obliterans SubClassOf Non-Neoplastic Respiratory Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Bronchiolitis Obliterans</New_Terms>
            </Change>
            <Change id="128">
               <Axiom>Burning Mouth Syndrome SubClassOf Non-Neoplastic Oral Cavity Disorder</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Burning Mouth Syndrome</Concept>
                        <WitnessAxioms>
                           <Axiom>Burning Mouth Syndrome SubClassOf Non-Neoplastic Oral Cavity Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Burning Mouth Syndrome</Concept>
                        <WitnessAxioms>
                           <Axiom>Burning Mouth Syndrome SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Burning Mouth Syndrome SubClassOf Head and Neck Disorder</Axiom>
                           <Axiom>Burning Mouth Syndrome SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Burning Mouth Syndrome SubClassOf Non-Neoplastic Disorder</Axiom>
                           <Axiom>Burning Mouth Syndrome SubClassOf Disorder by Site</Axiom>
                           <Axiom>Burning Mouth Syndrome SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Burning Mouth Syndrome SubClassOf Non-Neoplastic Head and Neck Disorder</Axiom>
                           <Axiom>Burning Mouth Syndrome SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                           <Axiom>Burning Mouth Syndrome SubClassOf Non-Neoplastic Oral Disorder</Axiom>
                           <Axiom>Burning Mouth Syndrome SubClassOf Oral Cavity Disorder</Axiom>
                           <Axiom>Burning Mouth Syndrome SubClassOf Oral Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Burning Mouth Syndrome</New_Terms>
            </Change>
            <Change id="129">
               <Axiom>CHP-HER-2 Peptide Vaccine SubClassOf Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>CHP-HER-2 Peptide Vaccine</Concept>
                        <WitnessAxioms>
                           <Axiom>CHP-HER-2 Peptide Vaccine SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>CHP-HER-2 Peptide Vaccine</New_Terms>
            </Change>
            <Change id="130">
               <Axiom>CHP-HER-2 Peptide Vaccine SubClassOf Chemical_Or_Drug_Has_Mechanism_Of_Action some Antigen Sensitization</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>CHP-HER-2 Peptide Vaccine</Concept>
                        <WitnessAxioms>
                           <Axiom>CHP-HER-2 Peptide Vaccine SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>CHP-HER-2 Peptide Vaccine</New_Terms>
            </Change>
            <Change id="131">
               <Axiom>CHP-HER-2 Peptide Vaccine SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>CHP-HER-2 Peptide Vaccine</Concept>
                        <WitnessAxioms>
                           <Axiom>CHP-HER-2 Peptide Vaccine SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>CHP-HER-2 Peptide Vaccine</New_Terms>
            </Change>
            <Change id="132">
               <Axiom>CHP-HER-2 Peptide Vaccine SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>CHP-HER-2 Peptide Vaccine</Concept>
                        <WitnessAxioms>
                           <Axiom>CHP-HER-2 Peptide Vaccine SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>CHP-HER-2 Peptide Vaccine</New_Terms>
            </Change>
            <Change id="133">
               <Axiom>CHP-HER-2 Peptide Vaccine SubClassOf Peptide Vaccine</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>CHP-HER-2 Peptide Vaccine</Concept>
                        <WitnessAxioms>
                           <Axiom>CHP-HER-2 Peptide Vaccine SubClassOf Peptide Vaccine</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>CHP-HER-2 Peptide Vaccine</Concept>
                        <WitnessAxioms>
                           <Axiom>CHP-HER-2 Peptide Vaccine SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>CHP-HER-2 Peptide Vaccine SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                           <Axiom>CHP-HER-2 Peptide Vaccine SubClassOf Drug or Chemical</Axiom>
                           <Axiom>CHP-HER-2 Peptide Vaccine SubClassOf Biological Response Modifier</Axiom>
                           <Axiom>CHP-HER-2 Peptide Vaccine SubClassOf Vaccine</Axiom>
                           <Axiom>CHP-HER-2 Peptide Vaccine SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                           <Axiom>CHP-HER-2 Peptide Vaccine SubClassOf Biological Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>CHP-HER-2 Peptide Vaccine</New_Terms>
            </Change>
            <Change id="134">
               <Axiom>CHP-NY-ESO-1 Peptide Vaccine SubClassOf Antineoplastic Vaccine</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>CHP-NY-ESO-1 Peptide Vaccine</Concept>
                        <WitnessAxioms>
                           <Axiom>CHP-NY-ESO-1 Peptide Vaccine SubClassOf Antineoplastic Vaccine</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>CHP-NY-ESO-1 Peptide Vaccine</Concept>
                        <WitnessAxioms>
                           <Axiom>CHP-NY-ESO-1 Peptide Vaccine SubClassOf Vaccine</Axiom>
                           <Axiom>CHP-NY-ESO-1 Peptide Vaccine SubClassOf Drug or Chemical</Axiom>
                           <Axiom>CHP-NY-ESO-1 Peptide Vaccine SubClassOf Biological Response Modifier</Axiom>
                           <Axiom>CHP-NY-ESO-1 Peptide Vaccine SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                           <Axiom>CHP-NY-ESO-1 Peptide Vaccine SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                           <Axiom>CHP-NY-ESO-1 Peptide Vaccine SubClassOf Biological Agent</Axiom>
                           <Axiom>CHP-NY-ESO-1 Peptide Vaccine SubClassOf Pharmacologic Substance</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>CHP-NY-ESO-1 Peptide Vaccine</New_Terms>
            </Change>
            <Change id="135">
               <Axiom>California Verbal Learning Test, Children's Version SubClassOf Clinical Assessment Tool</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>California Verbal Learning Test, Children's Version</Concept>
                        <WitnessAxioms>
                           <Axiom>California Verbal Learning Test, Children's Version SubClassOf Clinical Assessment Tool</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>California Verbal Learning Test, Children's Version</Concept>
                        <WitnessAxioms>
                           <Axiom>California Verbal Learning Test, Children's Version SubClassOf NCI_Kind</Axiom>
                           <Axiom>California Verbal Learning Test, Children's Version SubClassOf NCI Administrative Concept</Axiom>
                           <Axiom>California Verbal Learning Test, Children's Version SubClassOf Document</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>California Verbal Learning Test, Children's Version</New_Terms>
            </Change>
            <Change id="136">
               <Axiom>Canker Sore SubClassOf Non-Neoplastic Oral Cavity Disorder</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Canker Sore</Concept>
                        <WitnessAxioms>
                           <Axiom>Canker Sore SubClassOf Non-Neoplastic Oral Cavity Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Canker Sore</Concept>
                        <WitnessAxioms>
                           <Axiom>Canker Sore SubClassOf Non-Neoplastic Head and Neck Disorder</Axiom>
                           <Axiom>Canker Sore SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                           <Axiom>Canker Sore SubClassOf Oral Disorder</Axiom>
                           <Axiom>Canker Sore SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Canker Sore SubClassOf Oral Cavity Disorder</Axiom>
                           <Axiom>Canker Sore SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Canker Sore SubClassOf Head and Neck Disorder</Axiom>
                           <Axiom>Canker Sore SubClassOf Disorder by Site</Axiom>
                           <Axiom>Canker Sore SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Canker Sore SubClassOf Non-Neoplastic Disorder</Axiom>
                           <Axiom>Canker Sore SubClassOf Non-Neoplastic Oral Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Canker Sore</New_Terms>
            </Change>
            <Change id="137">
               <Axiom>Capillary Leak Syndrome SubClassOf Non-Neoplastic Vascular Disorder</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Capillary Leak Syndrome</Concept>
                        <WitnessAxioms>
                           <Axiom>Capillary Leak Syndrome SubClassOf Non-Neoplastic Vascular Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Capillary Leak Syndrome</Concept>
                        <WitnessAxioms>
                           <Axiom>Capillary Leak Syndrome SubClassOf Non-Neoplastic Disorder</Axiom>
                           <Axiom>Capillary Leak Syndrome SubClassOf Cardiovascular Disorder</Axiom>
                           <Axiom>Capillary Leak Syndrome SubClassOf Non-Neoplastic Cardiovascular Disorder</Axiom>
                           <Axiom>Capillary Leak Syndrome SubClassOf Vascular Disorder</Axiom>
                           <Axiom>Capillary Leak Syndrome SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Capillary Leak Syndrome SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Capillary Leak Syndrome SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Capillary Leak Syndrome SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                           <Axiom>Capillary Leak Syndrome SubClassOf Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Capillary Leak Syndrome</New_Terms>
            </Change>
            <Change id="138">
               <Axiom>Capillary Leak Syndrome SubClassOf Vascular Disorder</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Capillary Leak Syndrome</Concept>
                        <WitnessAxioms>
                           <Axiom>Capillary Leak Syndrome SubClassOf Cardiovascular Disorder</Axiom>
                           <Axiom>Capillary Leak Syndrome SubClassOf Vascular Disorder</Axiom>
                           <Axiom>Capillary Leak Syndrome SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Capillary Leak Syndrome SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Capillary Leak Syndrome SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Capillary Leak Syndrome SubClassOf Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Capillary Leak Syndrome</New_Terms>
            </Change>
            <Change id="139">
               <Axiom>Cerebrovascular SubClassOf Anatomy Qualifier</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Cerebrovascular</Concept>
                        <WitnessAxioms>
                           <Axiom>Cerebrovascular SubClassOf Anatomy Qualifier</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Cerebrovascular</Concept>
                        <WitnessAxioms>
                           <Axiom>Cerebrovascular SubClassOf Property or Attribute</Axiom>
                           <Axiom>Cerebrovascular SubClassOf Qualifier</Axiom>
                           <Axiom>Cerebrovascular SubClassOf Properties_or_Attributes_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Cerebrovascular</New_Terms>
            </Change>
            <Change id="140">
               <Axiom>Characterization SubClassOf Action</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Characterization</Concept>
                        <WitnessAxioms>
                           <Axiom>Characterization SubClassOf Action</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Characterization</Concept>
                        <WitnessAxioms>
                           <Axiom>Characterization SubClassOf Activity</Axiom>
                           <Axiom>Characterization SubClassOf Activity_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Characterization</New_Terms>
            </Change>
            <Change id="141">
               <Axiom>Chemotherapy Regimen SubClassOf Chemotherapy Regimen or Agent Combination</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Chemotherapy Regimen</Concept>
                        <WitnessAxioms>
                           <Axiom>Chemotherapy Regimen SubClassOf Chemotherapy Regimen or Agent Combination</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Chemotherapy Regimen</Concept>
                        <WitnessAxioms>
                           <Axiom>Chemotherapy Regimen SubClassOf Chemotherapy_Regimen_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Chemotherapy Regimen</New_Terms>
            </Change>
            <Change id="142">
               <Axiom>Chimerism SubClassOf Other Finding</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Chimerism</Concept>
                        <WitnessAxioms>
                           <Axiom>Chimerism SubClassOf Other Finding</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Chimerism</Concept>
                        <WitnessAxioms>
                           <Axiom>Chimerism SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Chimerism SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Chimerism SubClassOf Finding</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Chimerism</New_Terms>
            </Change>
            <Change id="143">
               <Axiom>Clinica Center SubClassOf Professional Organization or Group</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Clinica Center</Concept>
                        <WitnessAxioms>
                           <Axiom>Clinica Center SubClassOf Professional Organization or Group</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Clinica Center</Concept>
                        <WitnessAxioms>
                           <Axiom>Clinica Center SubClassOf NCI_Kind</Axiom>
                           <Axiom>Clinica Center SubClassOf Conceptual Entity</Axiom>
                           <Axiom>Clinica Center SubClassOf Population Group</Axiom>
                           <Axiom>Clinica Center SubClassOf Group</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Clinica Center</New_Terms>
            </Change>
            <Change id="144">
               <Axiom>Coagulase-Negative Staphylococcus SubClassOf Staphylococcus</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Coagulase-Negative Staphylococcus</Concept>
                        <WitnessAxioms>
                           <Axiom>Coagulase-Negative Staphylococcus SubClassOf Staphylococcus</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Staphylococcus</Concept>
                        <WitnessAxioms>
                           <Axiom>Coagulase-Negative Staphylococcus SubClassOf Staphylococcus</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Coagulase-Negative Staphylococcus</Concept>
                        <WitnessAxioms>
                           <Axiom>Coagulase-Negative Staphylococcus SubClassOf Bacteria</Axiom>
                           <Axiom>Coagulase-Negative Staphylococcus SubClassOf Organism_Kind</Axiom>
                           <Axiom>Coagulase-Negative Staphylococcus SubClassOf Organism</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Coagulase-Negative Staphylococcus, Staphylococcus</New_Terms>
            </Change>
            <Change id="145">
               <Axiom>Coagulase-Positive Staphylococcus SubClassOf Staphylococcus</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Coagulase-Positive Staphylococcus</Concept>
                        <WitnessAxioms>
                           <Axiom>Coagulase-Positive Staphylococcus SubClassOf Staphylococcus</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Staphylococcus</Concept>
                        <WitnessAxioms>
                           <Axiom>Coagulase-Positive Staphylococcus SubClassOf Staphylococcus</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Coagulase-Positive Staphylococcus</Concept>
                        <WitnessAxioms>
                           <Axiom>Coagulase-Positive Staphylococcus SubClassOf Organism</Axiom>
                           <Axiom>Coagulase-Positive Staphylococcus SubClassOf Organism_Kind</Axiom>
                           <Axiom>Coagulase-Positive Staphylococcus SubClassOf Bacteria</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Staphylococcus</Concept>
                        <WitnessAxioms>
                           <Axiom>Staphylococcus aureus SubClassOf Staphylococcus</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Staphylococcus, Coagulase-Positive Staphylococcus</New_Terms>
            </Change>
            <Change id="146">
               <Axiom>Collaborative Staging SubClassOf Staging System</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Collaborative Staging</Concept>
                        <WitnessAxioms>
                           <Axiom>Collaborative Staging SubClassOf Staging System</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Collaborative Staging</Concept>
                        <WitnessAxioms>
                           <Axiom>Collaborative Staging SubClassOf Conceptual Entity</Axiom>
                           <Axiom>Collaborative Staging SubClassOf NCI_Kind</Axiom>
                           <Axiom>Collaborative Staging SubClassOf Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Collaborative Staging</New_Terms>
            </Change>
            <Change id="147">
               <Axiom>Computer Operation SubClassOf Computer Sciences</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Computer Operation</Concept>
                        <WitnessAxioms>
                           <Axiom>Computer Operation SubClassOf Computer Sciences</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Computer Operation</Concept>
                        <WitnessAxioms>
                           <Axiom>Computer Operation SubClassOf NCI Administrative Concept</Axiom>
                           <Axiom>Computer Operation SubClassOf Occupation or Discipline</Axiom>
                           <Axiom>Computer Operation SubClassOf Technology</Axiom>
                           <Axiom>Computer Operation SubClassOf NCI_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Computer Operation</New_Terms>
            </Change>
            <Change id="218">
               <Axiom>Concept Status SubClassOf Status</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Concept Status</Concept>
                        <WitnessAxioms>
                           <Axiom>Concept Status SubClassOf Status</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Concept Status</Concept>
                        <WitnessAxioms>
                           <Axiom>Concept Status SubClassOf Properties_or_Attributes_Kind</Axiom>
                           <Axiom>Concept Status SubClassOf Property or Attribute</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Concept Status</New_Terms>
            </Change>
            <Change id="148">
               <Axiom>Concept_Status Range: {"Concept_Pending_Approval"^^string , "Deprecated_Concept"^^string , "Header_Concept"^^string , "Obsolete_Concept"^^string , "Provisional_Concept"^^string , "Retired_Concept"^^string}</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Concept_Status</New_Terms>
            </Change>
            <Change id="149">
               <Axiom>Cryptogenic Organizing Pneumonia SubClassOf Pneumonia</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Cryptogenic Organizing Pneumonia</Concept>
                        <WitnessAxioms>
                           <Axiom>Cryptogenic Organizing Pneumonia SubClassOf Pneumonia</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Cryptogenic Organizing Pneumonia</Concept>
                        <WitnessAxioms>
                           <Axiom>Cryptogenic Organizing Pneumonia SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                           <Axiom>Cryptogenic Organizing Pneumonia SubClassOf Disorder by Site</Axiom>
                           <Axiom>Cryptogenic Organizing Pneumonia SubClassOf Thoracic Disorder</Axiom>
                           <Axiom>Cryptogenic Organizing Pneumonia SubClassOf Non-Neoplastic Respiratory Disorder</Axiom>
                           <Axiom>Cryptogenic Organizing Pneumonia SubClassOf Non-Neoplastic Thoracic Disorder</Axiom>
                           <Axiom>Cryptogenic Organizing Pneumonia SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Cryptogenic Organizing Pneumonia SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Cryptogenic Organizing Pneumonia SubClassOf Lung Disorder</Axiom>
                           <Axiom>Cryptogenic Organizing Pneumonia SubClassOf Non-Neoplastic Lung Disorder</Axiom>
                           <Axiom>Cryptogenic Organizing Pneumonia SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Cryptogenic Organizing Pneumonia SubClassOf Respiratory and Thoracic Disorder</Axiom>
                           <Axiom>Cryptogenic Organizing Pneumonia SubClassOf Respiratory Disorder</Axiom>
                           <Axiom>Cryptogenic Organizing Pneumonia SubClassOf Non-Neoplastic Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Cryptogenic Organizing Pneumonia</New_Terms>
            </Change>
            <Change id="150">
               <Axiom>Cyclodextrin-Based Polymer-Camptothecin SubClassOf Topoisomerase-I Inhibitor</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Cyclodextrin-Based Polymer-Camptothecin</Concept>
                        <WitnessAxioms>
                           <Axiom>Cyclodextrin-Based Polymer-Camptothecin SubClassOf Topoisomerase-I Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Cyclodextrin-Based Polymer-Camptothecin</Concept>
                        <WitnessAxioms>
                           <Axiom>Cyclodextrin-Based Polymer-Camptothecin SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                           <Axiom>Cyclodextrin-Based Polymer-Camptothecin SubClassOf Enzyme Inhibitor</Axiom>
                           <Axiom>Cyclodextrin-Based Polymer-Camptothecin SubClassOf Drug or Chemical</Axiom>
                           <Axiom>Cyclodextrin-Based Polymer-Camptothecin SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Cyclodextrin-Based Polymer-Camptothecin SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                           <Axiom>Cyclodextrin-Based Polymer-Camptothecin SubClassOf Topoisomerase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Cyclodextrin-Based Polymer-Camptothecin</New_Terms>
            </Change>
            <Change id="151">
               <Axiom>Definitive SubClassOf General Qualifier</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Definitive</Concept>
                        <WitnessAxioms>
                           <Axiom>Definitive SubClassOf General Qualifier</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Definitive</Concept>
                        <WitnessAxioms>
                           <Axiom>Definitive SubClassOf Property or Attribute</Axiom>
                           <Axiom>Definitive SubClassOf Qualifier</Axiom>
                           <Axiom>Definitive SubClassOf Properties_or_Attributes_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Definitive</New_Terms>
            </Change>
            <Change id="152">
               <Axiom>Delayed Puberty SubClassOf Other Finding</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Delayed Puberty</Concept>
                        <WitnessAxioms>
                           <Axiom>Delayed Puberty SubClassOf Other Finding</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Delayed Puberty</Concept>
                        <WitnessAxioms>
                           <Axiom>Delayed Puberty SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Delayed Puberty SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Delayed Puberty SubClassOf Finding</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Delayed Puberty</New_Terms>
            </Change>
            <Change id="153">
               <Axiom>Dental Base SubClassOf Dental Material</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Dental Base</Concept>
                        <WitnessAxioms>
                           <Axiom>Dental Base SubClassOf Dental Material</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Dental Base</Concept>
                        <WitnessAxioms>
                           <Axiom>Dental Base SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                           <Axiom>Dental Base SubClassOf Biomaterial</Axiom>
                           <Axiom>Dental Base SubClassOf Drug or Chemical</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Dental Base</New_Terms>
            </Change>
            <Change id="154">
               <Axiom>Dental Dam SubClassOf Medical Device</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Dental Dam</Concept>
                        <WitnessAxioms>
                           <Axiom>Dental Dam SubClassOf Medical Device</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Dental Dam</Concept>
                        <WitnessAxioms>
                           <Axiom>Dental Dam SubClassOf Diagnostic, Therapeutic, and Research Equipment</Axiom>
                           <Axiom>Dental Dam SubClassOf Equipment_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Dental Dam</New_Terms>
            </Change>
            <Change id="155">
               <Axiom>Dental Prophylaxis SubClassOf Dental Procedure</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Dental Prophylaxis</Concept>
                        <WitnessAxioms>
                           <Axiom>Dental Prophylaxis SubClassOf Dental Procedure</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Dental Prophylaxis</Concept>
                        <WitnessAxioms>
                           <Axiom>Dental Prophylaxis SubClassOf Clinical or Research Activity</Axiom>
                           <Axiom>Dental Prophylaxis SubClassOf Activity</Axiom>
                           <Axiom>Dental Prophylaxis SubClassOf Procedure</Axiom>
                           <Axiom>Dental Prophylaxis SubClassOf Activity_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Dental Prophylaxis</New_Terms>
            </Change>
            <Change id="156">
               <Axiom>Dyskeratosis SubClassOf Morphologic Finding</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Dyskeratosis</Concept>
                        <WitnessAxioms>
                           <Axiom>Dyskeratosis SubClassOf Morphologic Finding</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Dyskeratosis</Concept>
                        <WitnessAxioms>
                           <Axiom>Dyskeratosis SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Dyskeratosis SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Dyskeratosis SubClassOf Finding</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Dyskeratosis</New_Terms>
            </Change>
            <Change id="157">
               <Axiom>Edition SubClassOf Conceptual Entity</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Edition</Concept>
                        <WitnessAxioms>
                           <Axiom>Edition SubClassOf Conceptual Entity</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Edition</Concept>
                        <WitnessAxioms>
                           <Axiom>Edition SubClassOf NCI_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Edition</New_Terms>
            </Change>
            <Change id="158">
               <Axiom>Epidermolytic Hyperkeratosis SubClassOf Hyperkeratosis</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Epidermolytic Hyperkeratosis</Concept>
                        <WitnessAxioms>
                           <Axiom>Epidermolytic Hyperkeratosis SubClassOf Hyperkeratosis</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Epidermolytic Hyperkeratosis</Concept>
                        <WitnessAxioms>
                           <Axiom>Epidermolytic Hyperkeratosis SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Epidermolytic Hyperkeratosis SubClassOf Morphologic Finding</Axiom>
                           <Axiom>Epidermolytic Hyperkeratosis SubClassOf Finding</Axiom>
                           <Axiom>Epidermolytic Hyperkeratosis SubClassOf Disease, Disorder or Finding</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Epidermolytic Hyperkeratosis</New_Terms>
            </Change>
            <Change id="159">
               <Axiom>FDA Center For Devices and Radiological Health Terminology SubClassOf Terminology Subset</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>FDA Center For Devices and Radiological Health Terminology</Concept>
                        <WitnessAxioms>
                           <Axiom>FDA Center For Devices and Radiological Health Terminology SubClassOf Terminology Subset</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>FDA Center For Devices and Radiological Health Terminology</Concept>
                        <WitnessAxioms>
                           <Axiom>FDA Center For Devices and Radiological Health Terminology SubClassOf Research Resources</Axiom>
                           <Axiom>FDA Center For Devices and Radiological Health Terminology SubClassOf NCI Administrative Concept</Axiom>
                           <Axiom>FDA Center For Devices and Radiological Health Terminology SubClassOf Information Resources</Axiom>
                           <Axiom>FDA Center For Devices and Radiological Health Terminology SubClassOf NCI_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>FDA Center For Devices and Radiological Health Terminology</New_Terms>
            </Change>
            <Change id="160">
               <Axiom>Facility SubClassOf Conceptual Entity</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Facility</Concept>
                        <WitnessAxioms>
                           <Axiom>Facility SubClassOf Conceptual Entity</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Facility</Concept>
                        <WitnessAxioms>
                           <Axiom>Facility SubClassOf NCI_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Facility</New_Terms>
            </Change>
            <Change id="161">
               <Axiom>Federal Wide Assurance SubClassOf Conceptual Entity</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Federal Wide Assurance</Concept>
                        <WitnessAxioms>
                           <Axiom>Federal Wide Assurance SubClassOf Conceptual Entity</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Federal Wide Assurance</Concept>
                        <WitnessAxioms>
                           <Axiom>Federal Wide Assurance SubClassOf NCI_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Federal Wide Assurance</New_Terms>
            </Change>
            <Change id="162">
               <Axiom>Fenestrated Pattern SubClassOf Morphologic Architectural Pattern</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Fenestrated Pattern</Concept>
                        <WitnessAxioms>
                           <Axiom>Fenestrated Pattern SubClassOf Morphologic Architectural Pattern</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Fenestrated Pattern</Concept>
                        <WitnessAxioms>
                           <Axiom>Fenestrated Pattern SubClassOf Morphologic Finding</Axiom>
                           <Axiom>Fenestrated Pattern SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Fenestrated Pattern SubClassOf Finding</Axiom>
                           <Axiom>Fenestrated Pattern SubClassOf Findings_and_Disorders_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Fenestrated Pattern</New_Terms>
            </Change>
            <Change id="163">
               <Axiom>Follicular Differentiation SubClassOf Adnexal Differentiation</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Follicular Differentiation</Concept>
                        <WitnessAxioms>
                           <Axiom>Follicular Differentiation SubClassOf Adnexal Differentiation</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Follicular Differentiation</Concept>
                        <WitnessAxioms>
                           <Axiom>Follicular Differentiation SubClassOf Finding</Axiom>
                           <Axiom>Follicular Differentiation SubClassOf Tissue Differentiation</Axiom>
                           <Axiom>Follicular Differentiation SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Follicular Differentiation SubClassOf Morphologic Finding</Axiom>
                           <Axiom>Follicular Differentiation SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Follicular Differentiation SubClassOf Epithelial Differentiation</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Follicular Differentiation</New_Terms>
            </Change>
            <Change id="164">
               <Axiom>Full Permission SubClassOf Authorization</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Full Permission</Concept>
                        <WitnessAxioms>
                           <Axiom>Full Permission SubClassOf Authorization</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Full Permission</Concept>
                        <WitnessAxioms>
                           <Axiom>Full Permission SubClassOf NCI_Kind</Axiom>
                           <Axiom>Full Permission SubClassOf Document</Axiom>
                           <Axiom>Full Permission SubClassOf NCI Administrative Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Full Permission</New_Terms>
            </Change>
            <Change id="178">
               <Axiom>Glutathione Disulfide SubClassOf Protective Agent</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Glutathione Disulfide</Concept>
                        <WitnessAxioms>
                           <Axiom>Glutathione Disulfide SubClassOf Protective Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Glutathione Disulfide</Concept>
                        <WitnessAxioms>
                           <Axiom>Glutathione Disulfide SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Glutathione Disulfide SubClassOf Drug or Chemical</Axiom>
                           <Axiom>Glutathione Disulfide SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                           <Axiom>Glutathione Disulfide SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Glutathione Disulfide</New_Terms>
            </Change>
            <Change id="165">
               <Axiom>Gram-Positive Rod SubClassOf Other Organism Groupings</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Gram-Positive Rod</Concept>
                        <WitnessAxioms>
                           <Axiom>Gram-Positive Rod SubClassOf Other Organism Groupings</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Gram-Positive Rod</Concept>
                        <WitnessAxioms>
                           <Axiom>Gram-Positive Rod SubClassOf Organism</Axiom>
                           <Axiom>Gram-Positive Rod SubClassOf Organism_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Gram-Positive Rod</New_Terms>
            </Change>
            <Change id="219">
               <Axiom>Homologous Gene SubClassOf Miscellaneous Molecular Biology Terms</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Homologous Gene</Concept>
                        <WitnessAxioms>
                           <Axiom>Homologous Gene SubClassOf Miscellaneous Molecular Biology Terms</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Homologous Gene</Concept>
                        <WitnessAxioms>
                           <Axiom>Homologous Gene SubClassOf NCI Administrative Concept</Axiom>
                           <Axiom>Homologous Gene SubClassOf Cancer Science</Axiom>
                           <Axiom>Homologous Gene SubClassOf NCI_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Homologous Gene</New_Terms>
            </Change>
            <Change id="166">
               <Axiom>Homologous_Gene Range: string</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Homologous_Gene</New_Terms>
            </Change>
            <Change id="167">
               <Axiom>Hypopituitarism SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Hypopituitarism</Concept>
                        <WitnessAxioms>
                           <Axiom>Hypopituitarism SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Hypopituitarism</Concept>
                        <WitnessAxioms>
                           <Axiom>Hypopituitarism SubClassOf Disorder by Site</Axiom>
                           <Axiom>Hypopituitarism SubClassOf Non-Neoplastic Disorder</Axiom>
                           <Axiom>Hypopituitarism SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Hypopituitarism SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Hypopituitarism SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                           <Axiom>Hypopituitarism SubClassOf Endocrine Disorder</Axiom>
                           <Axiom>Hypopituitarism SubClassOf Disease, Disorder or Finding</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Hypopituitarism</New_Terms>
            </Change>
            <Change id="168">
               <Axiom>Idiopathic Pneumonia Syndrome SubClassOf Pneumonia</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Idiopathic Pneumonia Syndrome</Concept>
                        <WitnessAxioms>
                           <Axiom>Idiopathic Pneumonia Syndrome SubClassOf Pneumonia</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Idiopathic Pneumonia Syndrome</Concept>
                        <WitnessAxioms>
                           <Axiom>Idiopathic Pneumonia Syndrome SubClassOf Respiratory Disorder</Axiom>
                           <Axiom>Idiopathic Pneumonia Syndrome SubClassOf Respiratory and Thoracic Disorder</Axiom>
                           <Axiom>Idiopathic Pneumonia Syndrome SubClassOf Thoracic Disorder</Axiom>
                           <Axiom>Idiopathic Pneumonia Syndrome SubClassOf Disorder by Site</Axiom>
                           <Axiom>Idiopathic Pneumonia Syndrome SubClassOf Lung Disorder</Axiom>
                           <Axiom>Idiopathic Pneumonia Syndrome SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Idiopathic Pneumonia Syndrome SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Idiopathic Pneumonia Syndrome SubClassOf Non-Neoplastic Lung Disorder</Axiom>
                           <Axiom>Idiopathic Pneumonia Syndrome SubClassOf Non-Neoplastic Disorder</Axiom>
                           <Axiom>Idiopathic Pneumonia Syndrome SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                           <Axiom>Idiopathic Pneumonia Syndrome SubClassOf Non-Neoplastic Thoracic Disorder</Axiom>
                           <Axiom>Idiopathic Pneumonia Syndrome SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Idiopathic Pneumonia Syndrome SubClassOf Non-Neoplastic Respiratory Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Idiopathic Pneumonia Syndrome</New_Terms>
            </Change>
            <Change id="169">
               <Axiom>Intraoral Appliance SubClassOf Medical Device</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Intraoral Appliance</Concept>
                        <WitnessAxioms>
                           <Axiom>Intraoral Appliance SubClassOf Medical Device</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Intraoral Appliance</Concept>
                        <WitnessAxioms>
                           <Axiom>Intraoral Appliance SubClassOf Equipment_Kind</Axiom>
                           <Axiom>Intraoral Appliance SubClassOf Diagnostic, Therapeutic, and Research Equipment</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Intraoral Appliance</New_Terms>
            </Change>
            <Change id="170">
               <Axiom>Manual SubClassOf Document</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Manual</Concept>
                        <WitnessAxioms>
                           <Axiom>Manual SubClassOf Document</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Manual</Concept>
                        <WitnessAxioms>
                           <Axiom>Manual SubClassOf NCI_Kind</Axiom>
                           <Axiom>Manual SubClassOf NCI Administrative Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Manual</New_Terms>
            </Change>
            <Change id="171">
               <Axiom>Message SubClassOf Document</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Message</Concept>
                        <WitnessAxioms>
                           <Axiom>Message SubClassOf Document</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Message</Concept>
                        <WitnessAxioms>
                           <Axiom>Message SubClassOf NCI_Kind</Axiom>
                           <Axiom>Message SubClassOf NCI Administrative Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Message</New_Terms>
            </Change>
            <Change id="172">
               <Axiom>Mood Alteration SubClassOf Psychiatric Disorder</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Mood Alteration</Concept>
                        <WitnessAxioms>
                           <Axiom>Mood Alteration SubClassOf Psychiatric Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Mood Alteration</Concept>
                        <WitnessAxioms>
                           <Axiom>Mood Alteration SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Mood Alteration SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Mood Alteration SubClassOf Disease, Disorder or Finding</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Mood Alteration</New_Terms>
            </Change>
            <Change id="220">
               <Axiom>NSC Number SubClassOf Code</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>NSC Number</Concept>
                        <WitnessAxioms>
                           <Axiom>NSC Number SubClassOf Code</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>NSC Number</Concept>
                        <WitnessAxioms>
                           <Axiom>NSC Number SubClassOf Conceptual Entity</Axiom>
                           <Axiom>NSC Number SubClassOf NCI_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>NSC Number</New_Terms>
            </Change>
            <Change id="173">
               <Axiom>NSC_Code Range: string</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>NSC_Code</New_Terms>
            </Change>
            <Change id="174">
               <Axiom>National Marrow Donor Program SubClassOf Professional Organization or Group</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>National Marrow Donor Program</Concept>
                        <WitnessAxioms>
                           <Axiom>National Marrow Donor Program SubClassOf Professional Organization or Group</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>National Marrow Donor Program</Concept>
                        <WitnessAxioms>
                           <Axiom>National Marrow Donor Program SubClassOf Group</Axiom>
                           <Axiom>National Marrow Donor Program SubClassOf Conceptual Entity</Axiom>
                           <Axiom>National Marrow Donor Program SubClassOf Population Group</Axiom>
                           <Axiom>National Marrow Donor Program SubClassOf NCI_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>National Marrow Donor Program</New_Terms>
            </Change>
            <Change id="175">
               <Axiom>Nested Diagnostic Context SubClassOf Document</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Nested Diagnostic Context</Concept>
                        <WitnessAxioms>
                           <Axiom>Nested Diagnostic Context SubClassOf Document</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Nested Diagnostic Context</Concept>
                        <WitnessAxioms>
                           <Axiom>Nested Diagnostic Context SubClassOf NCI_Kind</Axiom>
                           <Axiom>Nested Diagnostic Context SubClassOf NCI Administrative Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Nested Diagnostic Context</New_Terms>
            </Change>
            <Change id="176">
               <Axiom>Non-carious Tissue Change SubClassOf Oral Cavity Finding</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Non-carious Tissue Change</Concept>
                        <WitnessAxioms>
                           <Axiom>Non-carious Tissue Change SubClassOf Oral Cavity Finding</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Non-carious Tissue Change</Concept>
                        <WitnessAxioms>
                           <Axiom>Non-carious Tissue Change SubClassOf Finding</Axiom>
                           <Axiom>Non-carious Tissue Change SubClassOf Finding by Site or System</Axiom>
                           <Axiom>Non-carious Tissue Change SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Non-carious Tissue Change SubClassOf Head and Neck Finding</Axiom>
                           <Axiom>Non-carious Tissue Change SubClassOf Disease, Disorder or Finding</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Non-carious Tissue Change</New_Terms>
            </Change>
            <Change id="177">
               <Axiom>Object Attribute SubClassOf Property or Attribute</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Object Attribute</Concept>
                        <WitnessAxioms>
                           <Axiom>Object Attribute SubClassOf Property or Attribute</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Object Attribute</Concept>
                        <WitnessAxioms>
                           <Axiom>Object Attribute SubClassOf Properties_or_Attributes_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Object Attribute</New_Terms>
            </Change>
            <Change id="180">
               <Axiom>Periodontal Pocket SubClassOf Non-Neoplastic Dental Disorder</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Periodontal Pocket</Concept>
                        <WitnessAxioms>
                           <Axiom>Periodontal Pocket SubClassOf Non-Neoplastic Dental Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Periodontal Pocket</Concept>
                        <WitnessAxioms>
                           <Axiom>Periodontal Pocket SubClassOf Non-Neoplastic Oral Cavity Disorder</Axiom>
                           <Axiom>Periodontal Pocket SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                           <Axiom>Periodontal Pocket SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Periodontal Pocket SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Periodontal Pocket SubClassOf Oral Cavity Disorder</Axiom>
                           <Axiom>Periodontal Pocket SubClassOf Non-Neoplastic Disorder</Axiom>
                           <Axiom>Periodontal Pocket SubClassOf Non-Neoplastic Oral Disorder</Axiom>
                           <Axiom>Periodontal Pocket SubClassOf Head and Neck Disorder</Axiom>
                           <Axiom>Periodontal Pocket SubClassOf Dental Disorder</Axiom>
                           <Axiom>Periodontal Pocket SubClassOf Oral Disorder</Axiom>
                           <Axiom>Periodontal Pocket SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Periodontal Pocket SubClassOf Non-Neoplastic Head and Neck Disorder</Axiom>
                           <Axiom>Periodontal Pocket SubClassOf Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Periodontal Pocket</New_Terms>
            </Change>
            <Change id="181">
               <Axiom>Periodontal Probing SubClassOf Dental Procedure</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Periodontal Probing</Concept>
                        <WitnessAxioms>
                           <Axiom>Periodontal Probing SubClassOf Dental Procedure</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Periodontal Probing</Concept>
                        <WitnessAxioms>
                           <Axiom>Periodontal Probing SubClassOf Procedure</Axiom>
                           <Axiom>Periodontal Probing SubClassOf Clinical or Research Activity</Axiom>
                           <Axiom>Periodontal Probing SubClassOf Activity</Axiom>
                           <Axiom>Periodontal Probing SubClassOf Activity_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Periodontal Probing</New_Terms>
            </Change>
            <Change id="182">
               <Axiom>Pharyngeal/Respiratory Flora SubClassOf Other Organism Groupings</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Pharyngeal/Respiratory Flora</Concept>
                        <WitnessAxioms>
                           <Axiom>Pharyngeal/Respiratory Flora SubClassOf Other Organism Groupings</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Pharyngeal/Respiratory Flora</Concept>
                        <WitnessAxioms>
                           <Axiom>Pharyngeal/Respiratory Flora SubClassOf Organism_Kind</Axiom>
                           <Axiom>Pharyngeal/Respiratory Flora SubClassOf Organism</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Pharyngeal/Respiratory Flora</New_Terms>
            </Change>
            <Change id="183">
               <Axiom>Poly (ADP-Ribose) Polymerase Inhibitor SubClassOf Enzyme Inhibitor</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Poly (ADP-Ribose) Polymerase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>Poly (ADP-Ribose) Polymerase Inhibitor SubClassOf Enzyme Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Poly (ADP-Ribose) Polymerase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>Poly (ADP-Ribose) Polymerase Inhibitor SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                           <Axiom>Poly (ADP-Ribose) Polymerase Inhibitor SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Poly (ADP-Ribose) Polymerase Inhibitor SubClassOf Drug or Chemical</Axiom>
                           <Axiom>Poly (ADP-Ribose) Polymerase Inhibitor SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Poly (ADP-Ribose) Polymerase Inhibitor</New_Terms>
            </Change>
            <Change id="184">
               <Axiom>Posterior Foramen Magnum SubClassOf Anatomic_Structure_Is_Physical_Part_Of some Foramen Magnum</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Posterior Foramen Magnum</Concept>
                        <WitnessAxioms>
                           <Axiom>Posterior Foramen Magnum SubClassOf Anatomy_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Posterior Foramen Magnum</New_Terms>
            </Change>
            <Change id="185">
               <Axiom>Posterior Foramen Magnum SubClassOf Skeletal System Part</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Posterior Foramen Magnum</Concept>
                        <WitnessAxioms>
                           <Axiom>Posterior Foramen Magnum SubClassOf Skeletal System Part</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Posterior Foramen Magnum</Concept>
                        <WitnessAxioms>
                           <Axiom>Posterior Foramen Magnum SubClassOf Body Part</Axiom>
                           <Axiom>Posterior Foramen Magnum SubClassOf Musculoskeletal System Part</Axiom>
                           <Axiom>Posterior Foramen Magnum SubClassOf Anatomy_Kind</Axiom>
                           <Axiom>Posterior Foramen Magnum SubClassOf Anatomic Structure, System, or Substance</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Posterior Foramen Magnum</New_Terms>
            </Change>
            <Change id="179">
               <Axiom>Practice-Based Research Collaborative in Evidence-Based Dentistry SubClassOf Professional Organization or Group</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Practice-Based Research Collaborative in Evidence-Based Dentistry</Concept>
                        <WitnessAxioms>
                           <Axiom>Practice-Based Research Collaborative in Evidence-Based Dentistry SubClassOf Professional Organization or Group</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Practice-Based Research Collaborative in Evidence-Based Dentistry</Concept>
                        <WitnessAxioms>
                           <Axiom>Practice-Based Research Collaborative in Evidence-Based Dentistry SubClassOf Population Group</Axiom>
                           <Axiom>Practice-Based Research Collaborative in Evidence-Based Dentistry SubClassOf Group</Axiom>
                           <Axiom>Practice-Based Research Collaborative in Evidence-Based Dentistry SubClassOf NCI_Kind</Axiom>
                           <Axiom>Practice-Based Research Collaborative in Evidence-Based Dentistry SubClassOf Conceptual Entity</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Practice-Based Research Collaborative in Evidence-Based Dentistry</New_Terms>
            </Change>
            <Change id="186">
               <Axiom>Premature Ovarian Failure SubClassOf Ovarian Non-Neoplastic Disorder</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Premature Ovarian Failure</Concept>
                        <WitnessAxioms>
                           <Axiom>Premature Ovarian Failure SubClassOf Ovarian Non-Neoplastic Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Premature Ovarian Failure</Concept>
                        <WitnessAxioms>
                           <Axiom>Premature Ovarian Failure SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Premature Ovarian Failure SubClassOf Reproductive System Disorder</Axiom>
                           <Axiom>Premature Ovarian Failure SubClassOf Non-Neoplastic Reproductive System Disorder</Axiom>
                           <Axiom>Premature Ovarian Failure SubClassOf Female Non-Neoplastic Reproductive System Disorder</Axiom>
                           <Axiom>Premature Ovarian Failure SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Premature Ovarian Failure SubClassOf Disorder by Site</Axiom>
                           <Axiom>Premature Ovarian Failure SubClassOf Non-Neoplastic Disorder</Axiom>
                           <Axiom>Premature Ovarian Failure SubClassOf Female Reproductive System Disorder</Axiom>
                           <Axiom>Premature Ovarian Failure SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                           <Axiom>Premature Ovarian Failure SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Premature Ovarian Failure SubClassOf Ovarian Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Premature Ovarian Failure</New_Terms>
            </Change>
            <Change id="187">
               <Axiom>Primary Adrenal Insufficiency SubClassOf Addison's Disease</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Primary Adrenal Insufficiency</Concept>
                        <WitnessAxioms>
                           <Axiom>Primary Adrenal Insufficiency SubClassOf Addison's Disease</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Primary Adrenal Insufficiency</Concept>
                        <WitnessAxioms>
                           <Axiom>Primary Adrenal Insufficiency SubClassOf Peritoneal and Retroperitoneal Disorder</Axiom>
                           <Axiom>Primary Adrenal Insufficiency SubClassOf Non-Neoplastic Disorder</Axiom>
                           <Axiom>Primary Adrenal Insufficiency SubClassOf Non-Neoplastic Retroperitoneal Disorder</Axiom>
                           <Axiom>Primary Adrenal Insufficiency SubClassOf Endocrine Disorder</Axiom>
                           <Axiom>Primary Adrenal Insufficiency SubClassOf Non-Neoplastic Peritoneal and Retroperitoneal Disorder</Axiom>
                           <Axiom>Primary Adrenal Insufficiency SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Primary Adrenal Insufficiency SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                           <Axiom>Primary Adrenal Insufficiency SubClassOf Adrenal Gland Insufficiency</Axiom>
                           <Axiom>Primary Adrenal Insufficiency SubClassOf Adrenal Gland Disorder</Axiom>
                           <Axiom>Primary Adrenal Insufficiency SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                           <Axiom>Primary Adrenal Insufficiency SubClassOf Non-Neoplastic Adrenal Gland Disorder</Axiom>
                           <Axiom>Primary Adrenal Insufficiency SubClassOf Adrenal Cortical Insufficiency</Axiom>
                           <Axiom>Primary Adrenal Insufficiency SubClassOf Disorder by Site</Axiom>
                           <Axiom>Primary Adrenal Insufficiency SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Primary Adrenal Insufficiency SubClassOf Retroperitoneal Disorder</Axiom>
                           <Axiom>Primary Adrenal Insufficiency SubClassOf Findings_and_Disorders_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Primary Adrenal Insufficiency</New_Terms>
            </Change>
            <Change id="189">
               <Axiom>Pulpectomy SubClassOf Dental Procedure</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Pulpectomy</Concept>
                        <WitnessAxioms>
                           <Axiom>Pulpectomy SubClassOf Dental Procedure</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Pulpectomy</Concept>
                        <WitnessAxioms>
                           <Axiom>Pulpectomy SubClassOf Activity_Kind</Axiom>
                           <Axiom>Pulpectomy SubClassOf Clinical or Research Activity</Axiom>
                           <Axiom>Pulpectomy SubClassOf Activity</Axiom>
                           <Axiom>Pulpectomy SubClassOf Procedure</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Pulpectomy</New_Terms>
            </Change>
            <Change id="190">
               <Axiom>Pulpotomy SubClassOf Dental Procedure</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Pulpotomy</Concept>
                        <WitnessAxioms>
                           <Axiom>Pulpotomy SubClassOf Dental Procedure</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Pulpotomy</Concept>
                        <WitnessAxioms>
                           <Axiom>Pulpotomy SubClassOf Activity_Kind</Axiom>
                           <Axiom>Pulpotomy SubClassOf Procedure</Axiom>
                           <Axiom>Pulpotomy SubClassOf Clinical or Research Activity</Axiom>
                           <Axiom>Pulpotomy SubClassOf Activity</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Pulpotomy</New_Terms>
            </Change>
            <Change id="191">
               <Axiom>Pyridoxine SubClassOf Miscellaneous Chemoprotective Agent</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Pyridoxine</Concept>
                        <WitnessAxioms>
                           <Axiom>Pyridoxine SubClassOf Miscellaneous Chemoprotective Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Pyridoxine</Concept>
                        <WitnessAxioms>
                           <Axiom>Pyridoxine SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Pyridoxine SubClassOf Protective Agent</Axiom>
                           <Axiom>Pyridoxine SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                           <Axiom>Pyridoxine SubClassOf Drug or Chemical</Axiom>
                           <Axiom>Pyridoxine SubClassOf Chemoprotective Agent</Axiom>
                           <Axiom>Pyridoxine SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Pyridoxine</New_Terms>
            </Change>
            <Change id="192">
               <Axiom>Pyridoxine SubClassOf Vitamin B6</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Pyridoxine</Concept>
                        <WitnessAxioms>
                           <Axiom>Pyridoxine SubClassOf Vitamin B6</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Pyridoxine</Concept>
                        <WitnessAxioms>
                           <Axiom>Pyridoxine SubClassOf B Vitamin</Axiom>
                           <Axiom>Pyridoxine SubClassOf Nutrient</Axiom>
                           <Axiom>Pyridoxine SubClassOf Nutritional Supplement</Axiom>
                           <Axiom>Pyridoxine SubClassOf Water-Soluble Vitamin</Axiom>
                           <Axiom>Pyridoxine SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                           <Axiom>Pyridoxine SubClassOf Vitamin</Axiom>
                           <Axiom>Pyridoxine SubClassOf Drug or Chemical</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Pyridoxine</New_Terms>
            </Change>
            <Change id="193">
               <Axiom>Read Permission SubClassOf Authorization</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Read Permission</Concept>
                        <WitnessAxioms>
                           <Axiom>Read Permission SubClassOf Authorization</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Read Permission</Concept>
                        <WitnessAxioms>
                           <Axiom>Read Permission SubClassOf Document</Axiom>
                           <Axiom>Read Permission SubClassOf NCI Administrative Concept</Axiom>
                           <Axiom>Read Permission SubClassOf NCI_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Read Permission</New_Terms>
            </Change>
            <Change id="194">
               <Axiom>Recombinant Parathyroid Hormone SubClassOf Therapeutic Hormone</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recombinant Parathyroid Hormone</Concept>
                        <WitnessAxioms>
                           <Axiom>Recombinant Parathyroid Hormone SubClassOf Therapeutic Hormone</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recombinant Parathyroid Hormone</Concept>
                        <WitnessAxioms>
                           <Axiom>Recombinant Parathyroid Hormone SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Recombinant Parathyroid Hormone SubClassOf Drug or Chemical</Axiom>
                           <Axiom>Recombinant Parathyroid Hormone SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                           <Axiom>Recombinant Parathyroid Hormone SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Recombinant Parathyroid Hormone</New_Terms>
            </Change>
            <Change id="195">
               <Axiom>Restorative Material SubClassOf Dental Material</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Restorative Material</Concept>
                        <WitnessAxioms>
                           <Axiom>Restorative Material SubClassOf Dental Material</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Restorative Material</Concept>
                        <WitnessAxioms>
                           <Axiom>Restorative Material SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                           <Axiom>Restorative Material SubClassOf Biomaterial</Axiom>
                           <Axiom>Restorative Material SubClassOf Drug or Chemical</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Restorative Material</New_Terms>
            </Change>
            <Change id="196">
               <Axiom>Retinopathy SubClassOf Non-Neoplastic Retinal Disorder</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Retinopathy</Concept>
                        <WitnessAxioms>
                           <Axiom>Retinopathy SubClassOf Non-Neoplastic Retinal Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Retinopathy</Concept>
                        <WitnessAxioms>
                           <Axiom>Retinopathy SubClassOf Retinal Disorder</Axiom>
                           <Axiom>Retinopathy SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Retinopathy SubClassOf Disorder by Site</Axiom>
                           <Axiom>Retinopathy SubClassOf Eye Disorder</Axiom>
                           <Axiom>Retinopathy SubClassOf Non-Neoplastic Eye Disorder</Axiom>
                           <Axiom>Retinopathy SubClassOf Non-Neoplastic Disorder</Axiom>
                           <Axiom>Retinopathy SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Retinopathy SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Retinopathy SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Retinopathy</New_Terms>
            </Change>
            <Change id="197">
               <Axiom>Ring Dosing Unit SubClassOf Potency Unit</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Ring Dosing Unit</Concept>
                        <WitnessAxioms>
                           <Axiom>Ring Dosing Unit SubClassOf Potency Unit</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Ring Dosing Unit</Concept>
                        <WitnessAxioms>
                           <Axiom>Ring Dosing Unit SubClassOf Properties_or_Attributes_Kind</Axiom>
                           <Axiom>Ring Dosing Unit SubClassOf Property or Attribute</Axiom>
                           <Axiom>Ring Dosing Unit SubClassOf Unit by Category</Axiom>
                           <Axiom>Ring Dosing Unit SubClassOf Unit of Measure</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Ring Dosing Unit</New_Terms>
            </Change>
            <Change id="198">
               <Axiom>SEER Summary Staging Manual 2000 SubClassOf Document</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>SEER Summary Staging Manual 2000</Concept>
                        <WitnessAxioms>
                           <Axiom>SEER Summary Staging Manual 2000 SubClassOf Document</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>SEER Summary Staging Manual 2000</Concept>
                        <WitnessAxioms>
                           <Axiom>SEER Summary Staging Manual 2000 SubClassOf NCI Administrative Concept</Axiom>
                           <Axiom>SEER Summary Staging Manual 2000 SubClassOf NCI_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>SEER Summary Staging Manual 2000</New_Terms>
            </Change>
            <Change id="199">
               <Axiom>Secondary Adrenal Insufficiency SubClassOf Addison's Disease</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Secondary Adrenal Insufficiency</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Adrenal Insufficiency SubClassOf Addison's Disease</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Secondary Adrenal Insufficiency</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Adrenal Insufficiency SubClassOf Non-Neoplastic Peritoneal and Retroperitoneal Disorder</Axiom>
                           <Axiom>Secondary Adrenal Insufficiency SubClassOf Adrenal Cortical Insufficiency</Axiom>
                           <Axiom>Secondary Adrenal Insufficiency SubClassOf Adrenal Gland Insufficiency</Axiom>
                           <Axiom>Secondary Adrenal Insufficiency SubClassOf Adrenal Gland Disorder</Axiom>
                           <Axiom>Secondary Adrenal Insufficiency SubClassOf Peritoneal and Retroperitoneal Disorder</Axiom>
                           <Axiom>Secondary Adrenal Insufficiency SubClassOf Endocrine Disorder</Axiom>
                           <Axiom>Secondary Adrenal Insufficiency SubClassOf Non-Neoplastic Retroperitoneal Disorder</Axiom>
                           <Axiom>Secondary Adrenal Insufficiency SubClassOf Non-Neoplastic Disorder</Axiom>
                           <Axiom>Secondary Adrenal Insufficiency SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                           <Axiom>Secondary Adrenal Insufficiency SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Secondary Adrenal Insufficiency SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Secondary Adrenal Insufficiency SubClassOf Disorder by Site</Axiom>
                           <Axiom>Secondary Adrenal Insufficiency SubClassOf Non-Neoplastic Adrenal Gland Disorder</Axiom>
                           <Axiom>Secondary Adrenal Insufficiency SubClassOf Non-Neoplastic Endocrine Disorder</Axiom>
                           <Axiom>Secondary Adrenal Insufficiency SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Secondary Adrenal Insufficiency SubClassOf Retroperitoneal Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Secondary Adrenal Insufficiency</New_Terms>
            </Change>
            <Change id="200">
               <Axiom>Session SubClassOf Conceptual Entity</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Session</Concept>
                        <WitnessAxioms>
                           <Axiom>Session SubClassOf Conceptual Entity</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Session</Concept>
                        <WitnessAxioms>
                           <Axiom>Session SubClassOf NCI_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Session</New_Terms>
            </Change>
            <Change id="201">
               <Axiom>Shadow Cells Present SubClassOf Abnormal Cells Present</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Shadow Cells Present</Concept>
                        <WitnessAxioms>
                           <Axiom>Shadow Cells Present SubClassOf Abnormal Cells Present</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Shadow Cells Present</Concept>
                        <WitnessAxioms>
                           <Axiom>Shadow Cells Present SubClassOf Morphologic Finding</Axiom>
                           <Axiom>Shadow Cells Present SubClassOf Finding</Axiom>
                           <Axiom>Shadow Cells Present SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Shadow Cells Present SubClassOf Disease, Disorder or Finding</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Shadow Cells Present</New_Terms>
            </Change>
            <Change id="202">
               <Axiom>Staphylococcus SubClassOf Bacteria</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Staphylococcus</Concept>
                        <WitnessAxioms>
                           <Axiom>Staphylococcus SubClassOf Bacteria</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Coagulase-Positive Staphylococcus</Concept>
                        <WitnessAxioms>
                           <Axiom>Coagulase-Positive Staphylococcus SubClassOf Organism</Axiom>
                           <Axiom>Coagulase-Positive Staphylococcus SubClassOf Organism_Kind</Axiom>
                           <Axiom>Coagulase-Positive Staphylococcus SubClassOf Bacteria</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Staphylococcus</New_Terms>
            </Change>
            <Change id="203">
               <Axiom>Stem Cell Mobilization Therapy SubClassOf Intervention</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Stem Cell Mobilization Therapy</Concept>
                        <WitnessAxioms>
                           <Axiom>Stem Cell Mobilization Therapy SubClassOf Intervention</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Stem Cell Mobilization Therapy</Concept>
                        <WitnessAxioms>
                           <Axiom>Stem Cell Mobilization Therapy SubClassOf Procedure</Axiom>
                           <Axiom>Stem Cell Mobilization Therapy SubClassOf Clinical or Research Activity</Axiom>
                           <Axiom>Stem Cell Mobilization Therapy SubClassOf Activity</Axiom>
                           <Axiom>Stem Cell Mobilization Therapy SubClassOf Activity_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Stem Cell Mobilization Therapy</New_Terms>
            </Change>
            <Change id="204">
               <Axiom>Summary Staging Guide 1977 SubClassOf Document</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Summary Staging Guide 1977</Concept>
                        <WitnessAxioms>
                           <Axiom>Summary Staging Guide 1977 SubClassOf Document</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Summary Staging Guide 1977</Concept>
                        <WitnessAxioms>
                           <Axiom>Summary Staging Guide 1977 SubClassOf NCI_Kind</Axiom>
                           <Axiom>Summary Staging Guide 1977 SubClassOf NCI Administrative Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Summary Staging Guide 1977</New_Terms>
            </Change>
            <Change id="205">
               <Axiom>Synonym Range: string</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Synonym</New_Terms>
            </Change>
            <Change id="221">
               <Axiom>Synonym SubClassOf Document</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Synonym</Concept>
                        <WitnessAxioms>
                           <Axiom>Synonym SubClassOf Document</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Synonym</Concept>
                        <WitnessAxioms>
                           <Axiom>Synonym SubClassOf NCI_Kind</Axiom>
                           <Axiom>Synonym SubClassOf NCI Administrative Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Synonym</New_Terms>
            </Change>
            <Change id="188">
               <Axiom>Thread SubClassOf Computer Program</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Thread</Concept>
                        <WitnessAxioms>
                           <Axiom>Thread SubClassOf Computer Program</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Thread</Concept>
                        <WitnessAxioms>
                           <Axiom>Thread SubClassOf Diagnostic, Therapeutic, and Research Equipment</Axiom>
                           <Axiom>Thread SubClassOf Equipment_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Thread</New_Terms>
            </Change>
            <Change id="206">
               <Axiom>Thrombotic Microangiopathy SubClassOf Coagulation Disorder</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Thrombotic Microangiopathy</Concept>
                        <WitnessAxioms>
                           <Axiom>Thrombotic Microangiopathy SubClassOf Coagulation Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Thrombotic Microangiopathy</Concept>
                        <WitnessAxioms>
                           <Axiom>Thrombotic Microangiopathy SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Thrombotic Microangiopathy SubClassOf Non-Neoplastic Disorder</Axiom>
                           <Axiom>Thrombotic Microangiopathy SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                           <Axiom>Thrombotic Microangiopathy SubClassOf Hematopoietic and Lymphoid System Disorder</Axiom>
                           <Axiom>Thrombotic Microangiopathy SubClassOf Disorder by Site</Axiom>
                           <Axiom>Thrombotic Microangiopathy SubClassOf Hematologic and Lymphocytic Disorder</Axiom>
                           <Axiom>Thrombotic Microangiopathy SubClassOf Non-Neoplastic Hematologic and Lymphocytic Disorder</Axiom>
                           <Axiom>Thrombotic Microangiopathy SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Thrombotic Microangiopathy SubClassOf Diseases and Disorders</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Thrombotic Microangiopathy</New_Terms>
            </Change>
            <Change id="207">
               <Axiom>Tooth Crowding SubClassOf Oral Cavity Finding</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Tooth Crowding</Concept>
                        <WitnessAxioms>
                           <Axiom>Tooth Crowding SubClassOf Oral Cavity Finding</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Tooth Crowding</Concept>
                        <WitnessAxioms>
                           <Axiom>Tooth Crowding SubClassOf Finding by Site or System</Axiom>
                           <Axiom>Tooth Crowding SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Tooth Crowding SubClassOf Head and Neck Finding</Axiom>
                           <Axiom>Tooth Crowding SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Tooth Crowding SubClassOf Finding</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Tooth Crowding</New_Terms>
            </Change>
            <Change id="208">
               <Axiom>Trichoblastic Differentiation SubClassOf Follicular Differentiation</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Trichoblastic Differentiation</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichoblastic Differentiation SubClassOf Follicular Differentiation</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Follicular Differentiation</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichoblastic Differentiation SubClassOf Follicular Differentiation</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Trichoblastic Differentiation</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichoblastic Differentiation SubClassOf Adnexal Differentiation</Axiom>
                           <Axiom>Trichoblastic Differentiation SubClassOf Finding</Axiom>
                           <Axiom>Trichoblastic Differentiation SubClassOf Tissue Differentiation</Axiom>
                           <Axiom>Trichoblastic Differentiation SubClassOf Epithelial Differentiation</Axiom>
                           <Axiom>Trichoblastic Differentiation SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Trichoblastic Differentiation SubClassOf Morphologic Finding</Axiom>
                           <Axiom>Trichoblastic Differentiation SubClassOf Findings_and_Disorders_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Follicular Differentiation, Trichoblastic Differentiation</New_Terms>
            </Change>
            <Change id="209">
               <Axiom>Tricholemmal Differentiation SubClassOf Follicular Differentiation</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Tricholemmal Differentiation</Concept>
                        <WitnessAxioms>
                           <Axiom>Tricholemmal Differentiation SubClassOf Follicular Differentiation</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Follicular Differentiation</Concept>
                        <WitnessAxioms>
                           <Axiom>Tricholemmal Differentiation SubClassOf Follicular Differentiation</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Tricholemmal Differentiation</Concept>
                        <WitnessAxioms>
                           <Axiom>Tricholemmal Differentiation SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Tricholemmal Differentiation SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Tricholemmal Differentiation SubClassOf Adnexal Differentiation</Axiom>
                           <Axiom>Tricholemmal Differentiation SubClassOf Tissue Differentiation</Axiom>
                           <Axiom>Tricholemmal Differentiation SubClassOf Morphologic Finding</Axiom>
                           <Axiom>Tricholemmal Differentiation SubClassOf Finding</Axiom>
                           <Axiom>Tricholemmal Differentiation SubClassOf Epithelial Differentiation</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Follicular Differentiation, Tricholemmal Differentiation</New_Terms>
            </Change>
            <Change id="210">
               <Axiom>Write Permission SubClassOf Authorization</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Write Permission</Concept>
                        <WitnessAxioms>
                           <Axiom>Write Permission SubClassOf Authorization</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Write Permission</Concept>
                        <WitnessAxioms>
                           <Axiom>Write Permission SubClassOf NCI Administrative Concept</Axiom>
                           <Axiom>Write Permission SubClassOf NCI_Kind</Axiom>
                           <Axiom>Write Permission SubClassOf Document</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Write Permission</New_Terms>
            </Change>
         </NewDescription>
         <PureAddition id="padd" size="218">
            <Change id="436">
               <Axiom>18F-FHBG SubClassOf Radioconjugate</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>18F-FHBG</Concept>
                        <WitnessAxioms>
                           <Axiom>18F-FHBG SubClassOf Radioconjugate</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>18F-FHBG</Concept>
                        <WitnessAxioms>
                           <Axiom>18F-FHBG SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>18F-FHBG SubClassOf Radiopharmaceutical Compound</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="437">
               <Axiom>18F-Fluoroazomycin Arabinoside SubClassOf Radioconjugate</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>18F-Fluoroazomycin Arabinoside</Concept>
                        <WitnessAxioms>
                           <Axiom>18F-Fluoroazomycin Arabinoside SubClassOf Radioconjugate</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>18F-Fluoroazomycin Arabinoside</Concept>
                        <WitnessAxioms>
                           <Axiom>18F-Fluoroazomycin Arabinoside SubClassOf Radiopharmaceutical Compound</Axiom>
                           <Axiom>18F-Fluoroazomycin Arabinoside SubClassOf Pharmacologic Substance</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="438">
               <Axiom>2-Diethylaminoethanol SubClassOf Reagent</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>2-Diethylaminoethanol</Concept>
                        <WitnessAxioms>
                           <Axiom>2-Diethylaminoethanol SubClassOf Reagent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="439">
               <Axiom>4-((5-((Cyclopropylamino)Carbonyl)-2-Methylphenyl)Amino)-5-Methyl-N-Propylpyrrolo(2,1-F)(1,2,4)Triazine-6-Carboxamide Hydrochloride SubClassOf Reagent</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>4-((5-((Cyclopropylamino)Carbonyl)-2-Methylphenyl)Amino)-5-Methyl-N-Propylpyrrolo(2,1-F)(1,2,4)Triazine-6-Carboxamide Hydrochloride</Concept>
                        <WitnessAxioms>
                           <Axiom>4-((5-((Cyclopropylamino)Carbonyl)-2-Methylphenyl)Amino)-5-Methyl-N-Propylpyrrolo(2,1-F)(1,2,4)Triazine-6-Carboxamide Hydrochloride SubClassOf Reagent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="223">
               <Axiom>Adenoid Cystic Skin Carcinoma EquivalentTo Adenoid Cystic Carcinoma and Sweat Gland Carcinoma</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="224">
               <Axiom>Adenovirus Encoding Rat HER-2/neu SubClassOf Adenovirus Vaccine</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Adenovirus Encoding Rat HER-2/neu</Concept>
                        <WitnessAxioms>
                           <Axiom>Adenovirus Encoding Rat HER-2/neu SubClassOf Adenovirus Vaccine</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Adenovirus Encoding Rat HER-2/neu</Concept>
                        <WitnessAxioms>
                           <Axiom>Adenovirus Encoding Rat HER-2/neu SubClassOf Vaccine</Axiom>
                           <Axiom>Adenovirus Encoding Rat HER-2/neu SubClassOf Recombinant Viral Vaccine</Axiom>
                           <Axiom>Adenovirus Encoding Rat HER-2/neu SubClassOf Biological Response Modifier</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="225">
               <Axiom>Adenovirus Encoding Rat HER-2/neu SubClassOf Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="226">
               <Axiom>Adenovirus Encoding Rat HER-2/neu SubClassOf Chemical_Or_Drug_Has_Mechanism_Of_Action some Gene Expression Alteration</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="227">
               <Axiom>Adenovirus Encoding Rat HER-2/neu SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="228">
               <Axiom>Adenovirus Encoding Rat HER-2/neu SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="345">
               <Axiom>Adrenal Cortex Mixed Cell Adenoma EquivalentTo Adrenal Cortex Adenoma and Mixed Neoplasm</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Adrenal Cortex Mixed Cell Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Adrenal Cortex Mixed Cell Adenoma SubClassOf Mixed Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="231">
               <Axiom>Aluminum Stearate SubClassOf Reagent</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Aluminum Stearate</Concept>
                        <WitnessAxioms>
                           <Axiom>Aluminum Stearate SubClassOf Reagent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="233">
               <Axiom>Ameloblastic Carcinoma Derived From Odontogenic Cyst EquivalentTo Ameloblastic Carcinoma and Secondary Carcinoma and (Disease_Has_Finding only Odontogenic Cyst)</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Ameloblastic Carcinoma Derived From Odontogenic Cyst</Concept>
                        <WitnessAxioms>
                           <Axiom>Ameloblastic Carcinoma Derived From Odontogenic Cyst SubClassOf Secondary Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Secondary Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Ameloblastic Carcinoma Derived From Odontogenic Cyst SubClassOf Secondary Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Ameloblastic Carcinoma Derived From Odontogenic Cyst</Concept>
                        <WitnessAxioms>
                           <Axiom>Ameloblastic Carcinoma Derived From Odontogenic Cyst SubClassOf Secondary Malignant Neoplasm</Axiom>
                           <Axiom>Ameloblastic Carcinoma Derived From Odontogenic Cyst SubClassOf Secondary Neoplasm</Axiom>
                           <Axiom>Ameloblastic Carcinoma Derived From Odontogenic Cyst SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="232">
               <Axiom>Ameloblastic Carcinoma-Secondary Type (Dedifferentiated) EquivalentTo Ameloblastic Carcinoma and Secondary Carcinoma and (Disease_Has_Associated_Disease only Ameloblastoma)</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Ameloblastic Carcinoma-Secondary Type (Dedifferentiated)</Concept>
                        <WitnessAxioms>
                           <Axiom>Ameloblastic Carcinoma-Secondary Type (Dedifferentiated) SubClassOf Secondary Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Secondary Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Ameloblastic Carcinoma-Secondary Type (Dedifferentiated) SubClassOf Secondary Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral</Concept>
                        <WitnessAxioms>
                           <Axiom>Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral SubClassOf Secondary Malignant Neoplasm</Axiom>
                           <Axiom>Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral SubClassOf Secondary Carcinoma</Axiom>
                           <Axiom>Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral SubClassOf Secondary Neoplasm</Axiom>
                           <Axiom>Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Secondary Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral SubClassOf Secondary Carcinoma</Axiom>
                           <Axiom>Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous SubClassOf Secondary Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="235">
               <Axiom>Amphetamine Aspartate SubClassOf CNS Stimulant</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Amphetamine Aspartate</Concept>
                        <WitnessAxioms>
                           <Axiom>Amphetamine Aspartate SubClassOf CNS Stimulant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="236">
               <Axiom>Amphetamine SubClassOf Adrenergic Agent</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Amphetamine</Concept>
                        <WitnessAxioms>
                           <Axiom>Amphetamine SubClassOf Adrenergic Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Amphetamine</Concept>
                        <WitnessAxioms>
                           <Axiom>Amphetamine SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Amphetamine SubClassOf Adjuvant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="237">
               <Axiom>Amphetamine SubClassOf CNS Stimulant</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Amphetamine</Concept>
                        <WitnessAxioms>
                           <Axiom>Amphetamine SubClassOf CNS Stimulant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Amphetamine</Concept>
                        <WitnessAxioms>
                           <Axiom>Amphetamine SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Amphetamine SubClassOf Adjuvant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="234">
               <Axiom>Amphetamine Sulfate SubClassOf CNS Stimulant</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Amphetamine Sulfate</Concept>
                        <WitnessAxioms>
                           <Axiom>Amphetamine Sulfate SubClassOf CNS Stimulant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="238">
               <Axiom>Anaplastic Oligodendroglioma EquivalentTo Anaplastic Malignant Neoplasm and Malignant Glioma and Oligodendroglial Tumor and (Disease_May_Have_Abnormal_Cell some Neoplastic Multinucleated Giant Cell) and (Disease_May_Have_Cytogenetic_Abnormality some CDKN2A Gene Deletion) and (Disease_May_Have_Cytogenetic_Abnormality some Double Minutes) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Finding some Extensive Necrosis) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Microvascular Proliferation) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Increased Cellularity Present) and (Disease_Is_Grade only Grade 3)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Anaplastic Oligodendroglioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Anaplastic Oligodendroglioma SubClassOf Anaplastic Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Anaplastic Oligodendroglioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Anaplastic Oligodendroglioma SubClassOf Neoplasm by Special Category</Axiom>
                           <Axiom>Anaplastic Oligodendroglioma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="240">
               <Axiom>Anti-CD137 Monoclonal Antibody SubClassOf Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some B-Lymphocyte</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="241">
               <Axiom>Anti-CD137 Monoclonal Antibody SubClassOf Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="242">
               <Axiom>Anti-CD137 Monoclonal Antibody SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Antibody-Dependent Cellular Cytotoxicity</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="243">
               <Axiom>Anti-CD19/Anti-CD3 Bispecific Monoclonal Antibody SubClassOf Chemical_Or_Drug_Has_Mechanism_Of_Action some Antigen Binding</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="244">
               <Axiom>Anti-CD19/Anti-CD3 Bispecific Monoclonal Antibody SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="245">
               <Axiom>Anti-Mesothelin Monoclonal Antibody SubClassOf Chemical_Or_Drug_Affects_Gene_Product some Mesothelin</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="246">
               <Axiom>Anti-Mesothelin Monoclonal Antibody SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Antibody-Dependent Cellular Cytotoxicity</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="247">
               <Axiom>Anti-Mesothelin Monoclonal Antibody SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="248">
               <Axiom>Arginine Hydrochloride SubClassOf Nutritional Supplement</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Arginine Hydrochloride</Concept>
                        <WitnessAxioms>
                           <Axiom>Arginine Hydrochloride SubClassOf Nutritional Supplement</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="249">
               <Axiom>Arginine SubClassOf Essential Amino Acid</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Arginine</Concept>
                        <WitnessAxioms>
                           <Axiom>Arginine SubClassOf Essential Amino Acid</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Arginine</Concept>
                        <WitnessAxioms>
                           <Axiom>Arginine SubClassOf Nutritional Supplement</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="250">
               <Axiom>Benign Breast Eccrine Spiradenoma EquivalentTo Benign Breast Neoplasm and Spiradenoma</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Benign Breast Eccrine Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="251">
               <Axiom>Benign Eccrine Spiradenoma SubClassOf Retired Concept</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Benign Eccrine Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Eccrine Spiradenoma SubClassOf Retired Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Benign Eccrine Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Eccrine Spiradenoma SubClassOf Retired_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="252">
               <Axiom>Benign Epithelioma SubClassOf Retired Concept</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Benign Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Epithelioma SubClassOf Retired Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Benign Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Epithelioma SubClassOf Retired_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="253">
               <Axiom>Benign Palate Neoplasm EquivalentTo Palate Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Connective and Soft Tissue Cell) and (Disease_Excludes_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Primary_Anatomic_Site only Palate)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="254">
               <Axiom>Benign Reproductive System Neoplasm EquivalentTo Reproductive System Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Excludes_Abnormal_Cell only Adenocarcinoma Cell with Intracytoplasmic Mucin) and (Disease_Excludes_Abnormal_Cell only Serous Adenocarcinoma Cell) and (Disease_Has_Primary_Anatomic_Site only Reproductive System)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="255">
               <Axiom>Benign Retroperitoneal Neoplasm EquivalentTo Retroperitoneal Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Connective and Soft Tissue Cell) and (Disease_Excludes_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Primary_Anatomic_Site only Retroperitoneum)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="257">
               <Axiom>Bilateral Carcinoma EquivalentTo Bilateral Malignant Neoplasm and Carcinoma</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Bilateral Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Bilateral Carcinoma SubClassOf Bilateral Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Bilateral Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Bilateral Carcinoma SubClassOf Neoplasm by Special Category</Axiom>
                           <Axiom>Bilateral Carcinoma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="258">
               <Axiom>Bilateral Retinoblastoma EquivalentTo Bilateral Malignant Neoplasm and Retinoblastoma</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Bilateral Retinoblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Bilateral Retinoblastoma SubClassOf Bilateral Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Bilateral Retinoblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Bilateral Retinoblastoma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Bilateral Retinoblastoma SubClassOf Neoplasm by Special Category</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="259">
               <Axiom>Borderline Ovarian Serous Tumor EquivalentTo Borderline Ovarian Surface Epithelial-Stromal Tumor and Ovarian Papillary Tumor and Ovarian Serous Tumor and (Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS2 Gene Amplification) and (Disease_Excludes_Finding only Atypical Glandular Epithelium Resembling the Normal Endometrium Present)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Borderline Ovarian Serous Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Borderline Ovarian Serous Tumor SubClassOf Ovarian Papillary Tumor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Borderline Ovarian Serous Adenofibroma</Concept>
                        <WitnessAxioms>
                           <Axiom>Borderline Ovarian Serous Adenofibroma SubClassOf Ovarian Papillary Tumor</Axiom>
                           <Axiom>Borderline Ovarian Serous Adenofibroma SubClassOf Papillary Epithelial Neoplasm</Axiom>
                           <Axiom>Borderline Ovarian Serous Adenofibroma SubClassOf Papillary Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="260">
               <Axiom>Breast Carcinoma Metastatic to the Skin EquivalentTo Carcinoma Metastatic to the Skin and Stage IV Breast Cancer</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Breast Carcinoma Metastatic to the Skin</Concept>
                        <WitnessAxioms>
                           <Axiom>Breast Carcinoma Metastatic to the Skin SubClassOf Carcinoma Metastatic to the Skin</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Carcinoma Metastatic to the Skin</Concept>
                        <WitnessAxioms>
                           <Axiom>Breast Carcinoma Metastatic to the Skin SubClassOf Carcinoma Metastatic to the Skin</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Breast Carcinoma Metastatic to the Skin</Concept>
                        <WitnessAxioms>
                           <Axiom>Breast Carcinoma Metastatic to the Skin SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="261">
               <Axiom>CNF2024 SubClassOf Geldanamycin Analogue</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>CNF2024</Concept>
                        <WitnessAxioms>
                           <Axiom>CNF2024 SubClassOf Geldanamycin Analogue</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>CNF2024</Concept>
                        <WitnessAxioms>
                           <Axiom>CNF2024 SubClassOf Antineoplastic Antibiotic</Axiom>
                           <Axiom>CNF2024 SubClassOf Ansamycin Antineoplastic Antibiotic</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="262">
               <Axiom>CRS-100 SubClassOf Vaccine Adjuvant</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>CRS-100</Concept>
                        <WitnessAxioms>
                           <Axiom>CRS-100 SubClassOf Vaccine Adjuvant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="263">
               <Axiom>CS-1008 SubClassOf Chemical_Or_Drug_Affects_Gene_Product some Tumor Necrosis Factor Receptor Superfamily, Member 10B</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="264">
               <Axiom>CS-1008 SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Antibody-Dependent Cellular Cytotoxicity</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="265">
               <Axiom>Cancer Other SubClassOf Malignant Neoplasm</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Cancer Other</Concept>
                        <WitnessAxioms>
                           <Axiom>Cancer Other SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="342">
               <Axiom>Carcinoma Metastatic to the Skin EquivalentTo Epithelial Skin Neoplasm and Metastatic Malignant Neoplasm to the Skin and Metastatic Carcinoma and (Disease_Excludes_Primary_Anatomic_Site only Skin)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Carcinoma Metastatic to the Skin</Concept>
                        <WitnessAxioms>
                           <Axiom>Carcinoma Metastatic to the Skin SubClassOf Metastatic Carcinoma</Axiom>
                           <Axiom>Carcinoma Metastatic to the Skin SubClassOf Metastatic Malignant Neoplasm to the Skin</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Breast Carcinoma Metastatic to the Skin</Concept>
                        <WitnessAxioms>
                           <Axiom>Breast Carcinoma Metastatic to the Skin SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="266">
               <Axiom>Catumaxomab SubClassOf Chemical_Or_Drug_Affects_Gene_Product some Tumor-Associated Calcium Signal Transducer 2</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="267">
               <Axiom>Catumaxomab SubClassOf Chemical_Or_Drug_Has_Mechanism_Of_Action some Antigen Binding</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="268">
               <Axiom>Catumaxomab SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="269">
               <Axiom>Cervical Squamotransitional Carcinoma EquivalentTo Cervical Papillary Squamous Cell Carcinoma and (Disease_May_Have_Abnormal_Cell some Malignant Transitional Cell)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Cervical Squamotransitional Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Cervical Squamotransitional Carcinoma SubClassOf Cervical Papillary Squamous Cell Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Cervical Squamotransitional Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Cervical Squamotransitional Carcinoma SubClassOf Papillary Neoplasm</Axiom>
                           <Axiom>Cervical Squamotransitional Carcinoma SubClassOf Papillary Squamous Cell Carcinoma</Axiom>
                           <Axiom>Cervical Squamotransitional Carcinoma SubClassOf Papillary Carcinoma</Axiom>
                           <Axiom>Cervical Squamotransitional Carcinoma SubClassOf Papillary Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="270">
               <Axiom>Cervical Warty Carcinoma EquivalentTo Cervical Papillary Squamous Cell Carcinoma and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Exophytic Papillary Lesion)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Cervical Warty Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Cervical Warty Carcinoma SubClassOf Cervical Papillary Squamous Cell Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Cervical Warty Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Cervical Warty Carcinoma SubClassOf Papillary Carcinoma</Axiom>
                           <Axiom>Cervical Warty Carcinoma SubClassOf Papillary Epithelial Neoplasm</Axiom>
                           <Axiom>Cervical Warty Carcinoma SubClassOf Papillary Squamous Cell Carcinoma</Axiom>
                           <Axiom>Cervical Warty Carcinoma SubClassOf Papillary Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="271">
               <Axiom>Childhood Brain Neoplasm EquivalentTo Brain Neoplasm and Childhood Intracranial Neoplasm</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Childhood Brain Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Childhood Brain Neoplasm SubClassOf Childhood Intracranial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Childhood Intracranial Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Childhood Brain Neoplasm SubClassOf Childhood Intracranial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Childhood Choroid Plexus Papilloma</Concept>
                        <WitnessAxioms>
                           <Axiom>Childhood Choroid Plexus Papilloma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Childhood Intracranial Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Childhood Optic Nerve Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Infratentorial Ependymoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Infratentorial Ependymoblastoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Brain Germ Cell Tumor SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Cerebellar Neoplasm SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Cerebellar Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Brain Stem Glioma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Supratentorial Neoplasm SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Benign Childhood Supratentorial Neoplasm SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Cerebral Ependymoblastoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Atypical Teratoid/Rhabdoid Tumor SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Choroid Plexus Neoplasm SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Visual Pathway Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Infratentorial Neoplasm SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Supratentorial Ependymoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Visual Pathway Glioma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Brain Germinoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Brain Stem Glioma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Brain Stem Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Brain Neoplasm SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Desmoplastic Infantile Ganglioglioma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Choroid Plexus Papilloma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Cerebral Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Optic Nerve Glioma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Cerebellar Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Cerebral Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Medulloblastoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Brain Anaplastic Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Desmoplastic Infantile Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Visual Pathway Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Cerebral Ependymoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Cerebral Diffuse Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Supratentorial Ependymoblastoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Benign Childhood Brain Neoplasm SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Brain Stem Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Visual Pathway Glioma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Childhood Brain Stem Neoplasm SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Benign Childhood Cerebral Neoplasm SubClassOf Childhood Intracranial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="272">
               <Axiom>Childhood Glioblastoma EquivalentTo Childhood Astrocytic Tumor and Glioblastoma and Malignant Childhood Central Nervous System Neoplasm and ((((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression)))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Childhood Glioblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Childhood Glioblastoma SubClassOf Malignant Childhood Central Nervous System Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Childhood Glioblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Childhood Glioblastoma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Childhood Glioblastoma SubClassOf Malignant Childhood Neoplasm</Axiom>
                           <Axiom>Childhood Glioblastoma SubClassOf Anaplastic Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="273">
               <Axiom>Cholangiolocellular Carcinoma EquivalentTo Intrahepatic Cholangiocarcinoma and (Disease_Excludes_Primary_Anatomic_Site only Exocrine System) and (Disease_Has_Finding only Tubular Pattern)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="274">
               <Axiom>Cigarette SubClassOf CNS Stimulant</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Cigarette</Concept>
                        <WitnessAxioms>
                           <Axiom>Cigarette SubClassOf CNS Stimulant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Cigarette</Concept>
                        <WitnessAxioms>
                           <Axiom>Cigarette SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Cigarette SubClassOf Adjuvant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="275">
               <Axiom>Classic Type Trichoepithelioma SubClassOf Epithelial Neoplasm (Antiquated)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Classic Type Trichoepithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Epithelial Neoplasm (Antiquated)</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Classic Type Trichoepithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Neoplasm by Obsolete Classification</Axiom>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Neoplasm by Special Category</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="277">
               <Axiom>Cold Sore SubClassOf Non-Neoplastic Oral Cavity Disorder</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Cold Sore</Concept>
                        <WitnessAxioms>
                           <Axiom>Cold Sore SubClassOf Non-Neoplastic Oral Cavity Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Cold Sore</Concept>
                        <WitnessAxioms>
                           <Axiom>Cold Sore SubClassOf Head and Neck Disorder</Axiom>
                           <Axiom>Cold Sore SubClassOf Non-Neoplastic Oral Disorder</Axiom>
                           <Axiom>Cold Sore SubClassOf Non-Neoplastic Head and Neck Disorder</Axiom>
                           <Axiom>Cold Sore SubClassOf Oral Disorder</Axiom>
                           <Axiom>Cold Sore SubClassOf Oral Cavity Disorder</Axiom>
                           <Axiom>Cold Sore SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                           <Axiom>Cold Sore SubClassOf Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="278">
               <Axiom>Collection Facilitator SubClassOf Clinical Study Element</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Collection Facilitator</Concept>
                        <WitnessAxioms>
                           <Axiom>Collection Facilitator SubClassOf Clinical Study Element</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Collection Facilitator</Concept>
                        <WitnessAxioms>
                           <Axiom>Collection Facilitator SubClassOf NCI_Kind</Axiom>
                           <Axiom>Collection Facilitator SubClassOf Conceptual Entity</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="279">
               <Axiom>Combined Lung Carcinoma EquivalentTo High Grade Lung Neuroendocrine Neoplasm and Lung Carcinoma and Malignant Mixed Neoplasm and Neuroendocrine Carcinoma and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemoptysis)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Combined Lung Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Combined Lung Carcinoma SubClassOf Malignant Mixed Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Combined Small Cell and Squamous Cell Lung Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Combined Small Cell and Squamous Cell Lung Carcinoma SubClassOf Mixed Neoplasm</Axiom>
                           <Axiom>Combined Small Cell and Squamous Cell Lung Carcinoma SubClassOf Malignant Mixed Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="280">
               <Axiom>Condyloma Acuminatum EquivalentTo Verrucous Lesion and (Disease_Excludes_Finding only Pushing Tumor Margins Present)</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Condyloma Acuminatum</Concept>
                        <WitnessAxioms>
                           <Axiom>Condyloma Acuminatum SubClassOf Verrucous Lesion</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Verrucous Lesion</Concept>
                        <WitnessAxioms>
                           <Axiom>Condyloma Acuminatum SubClassOf Verrucous Lesion</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Urethral Condyloma Acuminatum</Concept>
                        <WitnessAxioms>
                           <Axiom>Urethral Condyloma Acuminatum SubClassOf Verrucous Lesion</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="281">
               <Axiom>Conventional Osteosarcoma EquivalentTo Anaplastic Malignant Neoplasm and Primary Bone Osteosarcoma and (Disease_May_Have_Cytogenetic_Abnormality some Double Minutes) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1) and (Disease_May_Have_Cytogenetic_Abnormality some Homogeneously Staining Region) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Lytic Bone Lesion) and (Disease_May_Have_Finding some Osteosclerotic Lesion) and (Disease_May_Have_Finding some Pain) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_May_Have_Molecular_Abnormality some RB1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some FOS Gene Amplification) and (Disease_Has_Finding only Cellular Pleomorphism) and (Disease_Has_Finding only High Grade Lesion) and (Disease_Has_Finding only Osteoid Formation) and (Disease_Has_Finding only Vascular Channel Formation) and (Disease_Has_Normal_Tissue_Origin only Medullary Bone)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Conventional Osteosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Conventional Osteosarcoma SubClassOf Anaplastic Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Osteoblastic Osteosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Osteoblastic Osteosarcoma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Osteoblastic Osteosarcoma SubClassOf Anaplastic Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="282">
               <Axiom>Cryoablation SubClassOf Retired Concept</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Cryoablation</Concept>
                        <WitnessAxioms>
                           <Axiom>Cryoablation SubClassOf Retired Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Cryoablation</Concept>
                        <WitnessAxioms>
                           <Axiom>Cryoablation SubClassOf Retired_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="283">
               <Axiom>Cryosurgery SubClassOf Ablation</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Cryosurgery</Concept>
                        <WitnessAxioms>
                           <Axiom>Cryosurgery SubClassOf Ablation</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="284">
               <Axiom>Cyanogen Bromide SubClassOf Reagent</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Cyanogen Bromide</Concept>
                        <WitnessAxioms>
                           <Axiom>Cyanogen Bromide SubClassOf Reagent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Cyanogen Bromide</Concept>
                        <WitnessAxioms>
                           <Axiom>Cyanogen Bromide SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="285">
               <Axiom>Cylindroma EquivalentTo Benign Sweat Gland Neoplasm and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Multinodular Pattern)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Cylindroma</Concept>
                        <WitnessAxioms>
                           <Axiom>Cylindroma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Cylindroma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Cylindroma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Cylindroma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Cylindroma SubClassOf Benign Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="286">
               <Axiom>Cystadenoma EquivalentTo Cystic Neoplasm and Glandular Cell Neoplasm and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Glandular Cell) and (Disease_Has_Normal_Tissue_Origin only Glandular Epithelium)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Cystadenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Cystadenoma SubClassOf Glandular Cell Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Salivary Gland Cystadenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Salivary Gland Cystadenoma SubClassOf Glandular Cell Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="287">
               <Axiom>DLC1 Gene SubClassOf Gene_Plays_Role_In_Process some Cytoskeletal Modeling</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="288">
               <Axiom>Defensins SubClassOf Immunostimulant</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Defensins</Concept>
                        <WitnessAxioms>
                           <Axiom>Defensins SubClassOf Immunostimulant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Defensins</Concept>
                        <WitnessAxioms>
                           <Axiom>Defensins SubClassOf Biological Response Modifier</Axiom>
                           <Axiom>Defensins SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Defensins SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="289">
               <Axiom>Dental Explorer SubClassOf Medical Device</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Dental Explorer</Concept>
                        <WitnessAxioms>
                           <Axiom>Dental Explorer SubClassOf Medical Device</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="290">
               <Axiom>Dermal Involvement SubClassOf Cutaneous Involvement</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Dermal Involvement</Concept>
                        <WitnessAxioms>
                           <Axiom>Dermal Involvement SubClassOf Cutaneous Involvement</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="291">
               <Axiom>Desmoplastic Trichoepithelioma EquivalentTo Trichoblastoma and (Disease_Has_Finding only Desmoplastic Stroma Formation)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Desmoplastic Trichoepithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Desmoplastic Trichoepithelioma SubClassOf Trichoblastoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Desmoplastic Trichoepithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Desmoplastic Trichoepithelioma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Desmoplastic Trichoepithelioma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="292">
               <Axiom>Dextroamphetamine SubClassOf Adrenergic Agent</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Dextroamphetamine</Concept>
                        <WitnessAxioms>
                           <Axiom>Dextroamphetamine SubClassOf Adrenergic Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="294">
               <Axiom>ECO-4601 SubClassOf Signal Transduction Inhibitor</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>ECO-4601</Concept>
                        <WitnessAxioms>
                           <Axiom>ECO-4601 SubClassOf Signal Transduction Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>ECO-4601</Concept>
                        <WitnessAxioms>
                           <Axiom>ECO-4601 SubClassOf Antineoplastic Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="295">
               <Axiom>Eccrine Acrospiroma SubClassOf Retired Concept</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Eccrine Acrospiroma</Concept>
                        <WitnessAxioms>
                           <Axiom>Eccrine Acrospiroma SubClassOf Retired Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Eccrine Acrospiroma</Concept>
                        <WitnessAxioms>
                           <Axiom>Eccrine Acrospiroma SubClassOf Retired_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="297">
               <Axiom>Eccrine Porocarcinoma EquivalentTo Eccrine Carcinoma and (Disease_May_Have_Finding some Papular Lesion) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Finding only Dermal Involvement) and (Disease_Has_Finding only Epidermal Involvement) and (Disease_Has_Finding only Invasive Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="299">
               <Axiom>Environment-Related Malignant Neoplasm SubClassOf Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Environment-Related Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Environment-Related Malignant Neoplasm SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Solar Radiation-Related Skin Squamous Cell Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Solar Radiation-Related Skin Squamous Cell Carcinoma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="300">
               <Axiom>Epidermal Involvement SubClassOf Cutaneous Involvement</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Epidermal Involvement</Concept>
                        <WitnessAxioms>
                           <Axiom>Epidermal Involvement SubClassOf Cutaneous Involvement</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="301">
               <Axiom>Epidermolysis Verruciformis SubClassOf Non-Neoplastic Skin Disorder</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Epidermolysis Verruciformis</Concept>
                        <WitnessAxioms>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Non-Neoplastic Skin Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Epidermolysis Verruciformis</Concept>
                        <WitnessAxioms>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Non-Neoplastic Disorder</Axiom>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="302">
               <Axiom>Epithelioma SubClassOf Retired Concept</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Epithelioma SubClassOf Retired Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Epithelioma SubClassOf Retired_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="230">
               <Axiom>Ethanol SubClassOf Sedative and Hypnotic</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Ethanol</Concept>
                        <WitnessAxioms>
                           <Axiom>Ethanol SubClassOf Sedative and Hypnotic</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Ethanol</Concept>
                        <WitnessAxioms>
                           <Axiom>Ethanol SubClassOf Adjuvant</Axiom>
                           <Axiom>Ethanol SubClassOf Pharmacologic Substance</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="303">
               <Axiom>Extension SubClassOf Action</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Extension</Concept>
                        <WitnessAxioms>
                           <Axiom>Extension SubClassOf Action</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Extension</Concept>
                        <WitnessAxioms>
                           <Axiom>Extension SubClassOf Activity_Kind</Axiom>
                           <Axiom>Extension SubClassOf Activity</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="304">
               <Axiom>FGFR1OP Gene SubClassOf Gene_Plays_Role_In_Process some Cell Motility</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="305">
               <Axiom>Fluoride SubClassOf Ion</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Fluoride</Concept>
                        <WitnessAxioms>
                           <Axiom>Fluoride SubClassOf Ion</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="293">
               <Axiom>Folate-FITC SubClassOf Vaccine</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Folate-FITC</Concept>
                        <WitnessAxioms>
                           <Axiom>Folate-FITC SubClassOf Vaccine</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Folate-FITC</Concept>
                        <WitnessAxioms>
                           <Axiom>Folate-FITC SubClassOf Biological Agent</Axiom>
                           <Axiom>Folate-FITC SubClassOf Biological Response Modifier</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="306">
               <Axiom>Gastric Tubular Adenocarcinoma EquivalentTo Sporadic Gastric Adenocarcinoma and (Disease_Excludes_Primary_Anatomic_Site only Exocrine System)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="307">
               <Axiom>Glioblastoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytic Tumor and Malignant Glioma and (Disease_May_Have_Abnormal_Cell some Fibrillary Neoplastic Astrocyte) and (Disease_May_Have_Abnormal_Cell some Gemistocytic Neoplastic Astrocyte) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q25-26)) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Poorly Differentiated Neoplastic Astrocyte) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Microvascular Proliferation) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 4)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Glioblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Glioblastoma SubClassOf Anaplastic Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Adult Brain Stem Gliosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Adult Brain Stem Gliosarcoma SubClassOf Anaplastic Malignant Neoplasm</Axiom>
                           <Axiom>Adult Brain Stem Gliosarcoma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="308">
               <Axiom>Glutathione SubClassOf Antioxidant</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Glutathione</Concept>
                        <WitnessAxioms>
                           <Axiom>Glutathione SubClassOf Antioxidant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Glutathione</Concept>
                        <WitnessAxioms>
                           <Axiom>Glutathione SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                           <Axiom>Glutathione SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Glutathione SubClassOf Protective Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="309">
               <Axiom>Gold SubClassOf Metal</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Gold</Concept>
                        <WitnessAxioms>
                           <Axiom>Gold SubClassOf Metal</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="310">
               <Axiom>HMGN1 Gene SubClassOf Gene_Plays_Role_In_Process some Chromatin Remodeling</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="311">
               <Axiom>HMGN2 Gene SubClassOf Gene_Plays_Role_In_Process some Chromatin Remodeling</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="312">
               <Axiom>HMGN4 Gene SubClassOf Gene_Plays_Role_In_Process some Chromatin Remodeling</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="313">
               <Axiom>Heptanoic Acid SubClassOf Carboxylic Acids</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Heptanoic Acid</Concept>
                        <WitnessAxioms>
                           <Axiom>Heptanoic Acid SubClassOf Carboxylic Acids</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Heptanoic Acid</Concept>
                        <WitnessAxioms>
                           <Axiom>Heptanoic Acid SubClassOf Organic Oxoacids</Axiom>
                           <Axiom>Heptanoic Acid SubClassOf Organic Chemical</Axiom>
                           <Axiom>Heptanoic Acid SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="314">
               <Axiom>Heroin SubClassOf Opiate</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Heroin</Concept>
                        <WitnessAxioms>
                           <Axiom>Heroin SubClassOf Opiate</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Heroin</Concept>
                        <WitnessAxioms>
                           <Axiom>Heroin SubClassOf Analgesic Agent</Axiom>
                           <Axiom>Heroin SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Heroin SubClassOf Opioid</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="276">
               <Axiom>Hidradenocarcinoma EquivalentTo Clear Cell Adenocarcinoma and Sweat Gland Carcinoma and (Disease_May_Have_Finding some Necrotic Change) and (Disease_May_Have_Finding some Nodular Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="315">
               <Axiom>Hidradenoma EquivalentTo Sweat Gland Adenoma and (Disease_May_Have_Finding some Apocrine Differentiation) and (Disease_May_Have_Finding some Eccrine Differentiation)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Nodular Hidradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Nodular Hidradenoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Nodular Hidradenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="362">
               <Axiom>Hidradenoma Papilliferum EquivalentTo Benign Sweat Gland Neoplasm and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Papillary Pattern)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Hidradenoma Papilliferum</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidradenoma Papilliferum SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Hidradenoma Papilliferum SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="316">
               <Axiom>Iatrogenic Kaposi's Sarcoma EquivalentTo Kaposi's Sarcoma and Therapy Related Malignant Neoplasm</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Iatrogenic Kaposi's Sarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Iatrogenic Kaposi's Sarcoma SubClassOf Therapy Related Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Therapy Related Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Iatrogenic Kaposi's Sarcoma SubClassOf Therapy Related Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Iatrogenic Kaposi's Sarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Iatrogenic Kaposi's Sarcoma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Iatrogenic Kaposi's Sarcoma SubClassOf Therapy-Related Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="317">
               <Axiom>Infiltrating Papillary Adenocarcinoma EquivalentTo Invasive Carcinoma and Papillary Adenocarcinoma</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Infiltrating Papillary Adenocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Infiltrating Papillary Adenocarcinoma SubClassOf Invasive Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Infiltrating Papillary Adenocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Infiltrating Papillary Adenocarcinoma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Infiltrating Papillary Adenocarcinoma SubClassOf Invasive Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="318">
               <Axiom>Intraductal Papillary Mucinous Neoplasm of the Biliary Tract SubClassOf Disease_Has_Finding only Intraductal Lesion</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="319">
               <Axiom>Intraepidermal Epithelioma of Jadassohn SubClassOf Epithelial Neoplasm (Antiquated)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Intraepidermal Epithelioma of Jadassohn</Concept>
                        <WitnessAxioms>
                           <Axiom>Intraepidermal Epithelioma of Jadassohn SubClassOf Epithelial Neoplasm (Antiquated)</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Intraepidermal Epithelioma of Jadassohn</Concept>
                        <WitnessAxioms>
                           <Axiom>Intraepidermal Epithelioma of Jadassohn SubClassOf Neoplasm by Obsolete Classification</Axiom>
                           <Axiom>Intraepidermal Epithelioma of Jadassohn SubClassOf Neoplasm by Special Category</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="320">
               <Axiom>Invasive Mixed Breast Carcinoma EquivalentTo Invasive Breast Carcinoma and Malignant Mixed Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Invasive Mixed Breast Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Invasive Mixed Breast Carcinoma SubClassOf Malignant Mixed Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Invasive Mixed Breast Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Invasive Mixed Breast Carcinoma SubClassOf Mixed Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="321">
               <Axiom>Isotope SubClassOf Element</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Isotope</Concept>
                        <WitnessAxioms>
                           <Axiom>Isotope SubClassOf Element</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Ruthenium 106</Concept>
                        <WitnessAxioms>
                           <Axiom>Ruthenium 106 SubClassOf Element</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="322">
               <Axiom>KW-0761 SubClassOf Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some T-Lymphocyte</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="323">
               <Axiom>Laryngopharynx SubClassOf Retired Concept</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Laryngopharynx</Concept>
                        <WitnessAxioms>
                           <Axiom>Laryngopharynx SubClassOf Retired Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Laryngopharynx</Concept>
                        <WitnessAxioms>
                           <Axiom>Laryngopharynx SubClassOf Retired_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="324">
               <Axiom>Levomenthol SubClassOf Anesthetic Agent</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Levomenthol</Concept>
                        <WitnessAxioms>
                           <Axiom>Levomenthol SubClassOf Anesthetic Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Levomenthol</Concept>
                        <WitnessAxioms>
                           <Axiom>Levomenthol SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Levomenthol SubClassOf Adjuvant Analgesic</Axiom>
                           <Axiom>Levomenthol SubClassOf Analgesic Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="325">
               <Axiom>Lithium Carbonate SubClassOf Antipsychotic Agent</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Lithium Carbonate</Concept>
                        <WitnessAxioms>
                           <Axiom>Lithium Carbonate SubClassOf Antipsychotic Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Lithium Carbonate</Concept>
                        <WitnessAxioms>
                           <Axiom>Lithium Carbonate SubClassOf Adjuvant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="326">
               <Axiom>Lithium Citrate SubClassOf Antipsychotic Agent</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Lithium Citrate</Concept>
                        <WitnessAxioms>
                           <Axiom>Lithium Citrate SubClassOf Antipsychotic Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Lithium Citrate</Concept>
                        <WitnessAxioms>
                           <Axiom>Lithium Citrate SubClassOf Adjuvant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="327">
               <Axiom>Localized Carcinoma EquivalentTo Carcinoma and Localized Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Localized Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Localized Carcinoma SubClassOf Localized Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Localized Unresectable Adult Hepatocellular Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Localized Unresectable Adult Hepatocellular Carcinoma SubClassOf Localized Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="328">
               <Axiom>MC1R Gene SubClassOf Gene_Plays_Role_In_Process some Receptor Signaling</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="329">
               <Axiom>MGCD0103 SubClassOf Chemical_Or_Drug_Affects_Gene_Product some Histone Deacetylase</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="330">
               <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Recombinant Viral Vaccine</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>MSCV-MGMT(P140K) Vaccine</Concept>
                        <WitnessAxioms>
                           <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Recombinant Viral Vaccine</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>MSCV-MGMT(P140K) Vaccine</Concept>
                        <WitnessAxioms>
                           <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Vaccine</Axiom>
                           <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Biological Response Modifier</Axiom>
                           <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Biological Agent</Axiom>
                           <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="332">
               <Axiom>Malignant Epithelioma SubClassOf Retired Concept</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Malignant Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Malignant Epithelioma SubClassOf Retired Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Malignant Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Malignant Epithelioma SubClassOf Retired_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="333">
               <Axiom>Malignant Proliferating Pilar Tumor EquivalentTo Malignant Outer Hair Sheath and Infundibulum Neoplasm and (Disease_May_Have_Finding some Cord-Like Pattern) and (Disease_May_Have_Finding some Nested Pattern) and (Disease_Excludes_Finding only Lobular Pattern) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Desmoplastic Stroma Formation) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue) and (Disease_Has_Primary_Anatomic_Site only Pilar Sheath)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="334">
               <Axiom>Marijuana SubClassOf Opioid</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Marijuana</Concept>
                        <WitnessAxioms>
                           <Axiom>Marijuana SubClassOf Opioid</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="335">
               <Axiom>Metastasizing Ameloblastoma EquivalentTo Ameloblastoma and Metastatic Neoplasm</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastasizing Ameloblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastasizing Ameloblastoma SubClassOf Metastatic Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="336">
               <Axiom>Metastatic Childhood Soft Tissue Sarcoma EquivalentTo Childhood Soft Tissue Sarcoma and Metastatic Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Childhood Soft Tissue Sarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Childhood Soft Tissue Sarcoma SubClassOf Metastatic Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Childhood Soft Tissue Sarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Childhood Soft Tissue Sarcoma SubClassOf Metastatic Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="337">
               <Axiom>Metastatic Chondrosarcoma EquivalentTo Chondrosarcoma and Metastatic Malignant Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q15-qter) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7p13-pter) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 18p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 4) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q24-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(11p13-pter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q25)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q21-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(1p13-22)) and (Disease_May_Have_Cytogenetic_Abnormality some del(1p36)) and (Disease_May_Have_Cytogenetic_Abnormality some del(22q13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(5q13-31)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q22-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(9p22-pter))</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Chondrosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Chondrosarcoma SubClassOf Metastatic Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Chondrosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Chondrosarcoma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Metastatic Chondrosarcoma SubClassOf Metastatic Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="338">
               <Axiom>Metastatic Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Metastatic Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor SubClassOf Metastatic Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Extraosseous Ewing's Sarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Extraosseous Ewing's Sarcoma SubClassOf Metastatic Neoplasm</Axiom>
                           <Axiom>Metastatic Extraosseous Ewing's Sarcoma SubClassOf Metastatic Malignant Neoplasm</Axiom>
                           <Axiom>Metastatic Extraosseous Ewing's Sarcoma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="409">
               <Axiom>Metastatic Hodgkin's Lymphoma to Cerebral Hemisphere EquivalentTo Hodgkin's Lymphoma and Secondary Malignant Neoplasm and (Disease_Has_Metastatic_Anatomic_Site only Cerebral Hemisphere)</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Metastatic Hodgkin's Lymphoma to Cerebral Hemisphere</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Hodgkin's Lymphoma to Cerebral Hemisphere SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Secondary Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Hodgkin's Lymphoma to Cerebral Hemisphere SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Hodgkin's Lymphoma to Cerebral Hemisphere</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Hodgkin's Lymphoma to Cerebral Hemisphere SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Metastatic Hodgkin's Lymphoma to Cerebral Hemisphere SubClassOf Secondary Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="339">
               <Axiom>Metastatic Melanoma EquivalentTo Melanoma and Metastatic Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Melanoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Melanoma SubClassOf Metastatic Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Melanoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Melanoma SubClassOf Metastatic Neoplasm</Axiom>
                           <Axiom>Metastatic Melanoma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="340">
               <Axiom>Metastatic Osteosarcoma EquivalentTo Metastatic Malignant Neoplasm and Osteosarcoma</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Osteosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Osteosarcoma SubClassOf Metastatic Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Osteosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Osteosarcoma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Metastatic Osteosarcoma SubClassOf Metastatic Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="341">
               <Axiom>Metastatic Signet Ring Cell Breast Carcinoma EquivalentTo Metastatic Adenocarcinoma and Signet Ring Cell Breast Carcinoma</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Signet Ring Cell Breast Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Signet Ring Cell Breast Carcinoma SubClassOf Metastatic Adenocarcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Signet Ring Cell Breast Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Signet Ring Cell Breast Carcinoma SubClassOf Metastatic Malignant Neoplasm</Axiom>
                           <Axiom>Metastatic Signet Ring Cell Breast Carcinoma SubClassOf Metastatic Neoplasm</Axiom>
                           <Axiom>Metastatic Signet Ring Cell Breast Carcinoma SubClassOf Metastatic Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="343">
               <Axiom>Methaqualone SubClassOf Sedative and Hypnotic</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Methaqualone</Concept>
                        <WitnessAxioms>
                           <Axiom>Methaqualone SubClassOf Sedative and Hypnotic</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Methaqualone</Concept>
                        <WitnessAxioms>
                           <Axiom>Methaqualone SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Methaqualone SubClassOf Adjuvant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="344">
               <Axiom>Microcystic Adnexal Carcinoma EquivalentTo Sweat Gland Carcinoma and (Disease_Has_Finding only Low Grade Lesion) and (Disease_Has_Finding only Microcystic Change) and (Disease_May_Have_Finding only Desmoplastic Stroma Formation)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="346">
               <Axiom>Mixed Glioma EquivalentTo Central Nervous System Neoplasm and Mixed Neoplasm and Neuroglial Tumor and (Disease_Has_Primary_Anatomic_Site only Central Nervous System)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Mixed Glioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Mixed Glioma SubClassOf Mixed Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Mixed Astrocytoma-Ependymoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Mixed Astrocytoma-Ependymoma SubClassOf Mixed Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="347">
               <Axiom>Mucoepidermoid Skin Carcinoma EquivalentTo Mucoepidermoid Carcinoma and Sweat Gland Carcinoma</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="348">
               <Axiom>Muramyl Dipeptide SubClassOf Immunostimulant</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Muramyl Dipeptide</Concept>
                        <WitnessAxioms>
                           <Axiom>Muramyl Dipeptide SubClassOf Immunostimulant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Muramyl Dipeptide</Concept>
                        <WitnessAxioms>
                           <Axiom>Muramyl Dipeptide SubClassOf Biological Response Modifier</Axiom>
                           <Axiom>Muramyl Dipeptide SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Muramyl Dipeptide SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="349">
               <Axiom>NY-ESO-1 Plasmid DNA Vaccine SubClassOf Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="350">
               <Axiom>NY-ESO-1 Plasmid DNA Vaccine SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="351">
               <Axiom>NY-ESO-1 Plasmid DNA Vaccine SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="352">
               <Axiom>Neuroendocrine Carcinoma of the Skin EquivalentTo Infrequent Neoplasm and Malignant Dermal Neoplasm and Neuroendocrine Carcinoma and Skin Carcinoma and (Disease_May_Have_Finding some Diffuse Pattern) and (Disease_May_Have_Finding some Nodular Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Small Round Cell) and (Disease_Has_Finding only Cytoplasmic Membrane-Bound Granules Present) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Single Cell Necrosis)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Neuroendocrine Carcinoma of the Skin</Concept>
                        <WitnessAxioms>
                           <Axiom>Neuroendocrine Carcinoma of the Skin SubClassOf Malignant Dermal Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Neuroendocrine Carcinoma of the Skin</Concept>
                        <WitnessAxioms>
                           <Axiom>Neuroendocrine Carcinoma of the Skin SubClassOf Dermal Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="354">
               <Axiom>Nicotine Gum SubClassOf CNS Stimulant</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Nicotine Gum</Concept>
                        <WitnessAxioms>
                           <Axiom>Nicotine Gum SubClassOf CNS Stimulant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Nicotine Gum</Concept>
                        <WitnessAxioms>
                           <Axiom>Nicotine Gum SubClassOf Adjuvant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="355">
               <Axiom>Nicotine Gum SubClassOf Cholinergic Agonist</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Nicotine Gum</Concept>
                        <WitnessAxioms>
                           <Axiom>Nicotine Gum SubClassOf Cholinergic Agonist</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Nicotine Gum</Concept>
                        <WitnessAxioms>
                           <Axiom>Nicotine Gum SubClassOf Adjuvant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="353">
               <Axiom>Nicotine SubClassOf CNS Stimulant</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Nicotine</Concept>
                        <WitnessAxioms>
                           <Axiom>Nicotine SubClassOf CNS Stimulant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="356">
               <Axiom>Nitrogen Dioxide SubClassOf Pollutant</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Nitrogen Dioxide</Concept>
                        <WitnessAxioms>
                           <Axiom>Nitrogen Dioxide SubClassOf Pollutant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Nitrogen Dioxide</Concept>
                        <WitnessAxioms>
                           <Axiom>Nitrogen Dioxide SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                           <Axiom>Nitrogen Dioxide SubClassOf Industrial Product</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="357">
               <Axiom>Ovarian Mixed Epithelial Tumor EquivalentTo Mixed Neoplasm and Ovarian Surface Epithelial-Stromal Tumor and (Disease_May_Have_Abnormal_Cell some Neoplastic Epithelial Cell with Intracytoplasmic Mucin) and (Disease_May_Have_Abnormal_Cell some Neoplastic Serous Epithelial Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Transitional Cell) and (Disease_May_Have_Finding some Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present) and (Disease_May_Have_Molecular_Abnormality some KRAS2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Ovarian Mixed Epithelial Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Ovarian Mixed Epithelial Tumor SubClassOf Mixed Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Malignant Ovarian Mixed Epithelial Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Malignant Ovarian Mixed Epithelial Tumor SubClassOf Mixed Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="358">
               <Axiom>Pancreatic Intraductal Papillary-Mucinous Neoplasm EquivalentTo Pancreatic Exocrine Neoplasm and Glandular Cell Neoplasm and (Disease_May_Have_Associated_Disease some Diabetes Mellitus) and (Disease_May_Have_Associated_Disease some Pancreatitis) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 18q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Finding some Abdominal Pain) and (Disease_May_Have_Finding some Jaundice) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Mucoid Stroma Formation) and (Disease_Has_Finding only Papillary Pattern) and (Disease_Has_Primary_Anatomic_Site only Exocrine Pancreas)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Pancreatic Intraductal Papillary-Mucinous Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Pancreatic Intraductal Papillary-Mucinous Neoplasm SubClassOf Glandular Cell Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Pancreatic Intraductal Papillary-Mucinous Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Pancreatic Intraductal Papillary-Mucinous Adenoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Pancreatic Intraductal Papillary-Mucinous Adenoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Pancreatic Intraductal Papillary-Mucinous Adenoma SubClassOf Glandular Cell Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="359">
               <Axiom>Pancreatic Polypeptide SubClassOf Hormone</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Pancreatic Polypeptide</Concept>
                        <WitnessAxioms>
                           <Axiom>Pancreatic Polypeptide SubClassOf Hormone</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Pancreatic Polypeptide</Concept>
                        <WitnessAxioms>
                           <Axiom>Pancreatic Polypeptide SubClassOf Physiology-Regulatory Factor</Axiom>
                           <Axiom>Pancreatic Polypeptide SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="360">
               <Axiom>Papillary Cystadenoma EquivalentTo Cystadenoma and Papillary Cystic Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Papillary Cystadenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Papillary Cystadenoma SubClassOf Papillary Cystic Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Papillary Serous Cystadenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Papillary Serous Cystadenoma SubClassOf Papillary Epithelial Neoplasm</Axiom>
                           <Axiom>Papillary Serous Cystadenoma SubClassOf Papillary Neoplasm</Axiom>
                           <Axiom>Papillary Serous Cystadenoma SubClassOf Papillary Cystic Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="361">
               <Axiom>Papillary Eccrine Adenoma SubClassOf Epithelial Neoplasm (Antiquated)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Papillary Eccrine Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Epithelial Neoplasm (Antiquated)</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Papillary Eccrine Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Neoplasm by Special Category</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Neoplasm by Obsolete Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="296">
               <Axiom>Papillary Eccrine Carcinoma EquivalentTo Eccrine Carcinoma and Papillary Adenocarcinoma and (Disease_Has_Finding only Papillary Pattern) and (Disease_Has_Primary_Anatomic_Site only Extremity Part)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Papillary Eccrine Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Papillary Eccrine Carcinoma SubClassOf Papillary Adenocarcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Digital Papillary Eccrine Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Digital Papillary Eccrine Carcinoma SubClassOf Papillary Adenocarcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="363">
               <Axiom>Papillary Renal Cell Carcinoma EquivalentTo Papillary Carcinoma and Renal Cell Carcinoma and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7) and (Disease_May_Have_Finding some Cystic Change) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_May_Have_Finding some Tubular Pattern)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Papillary Renal Cell Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Papillary Renal Cell Carcinoma SubClassOf Papillary Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Hereditary Papillary Renal Cell Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hereditary Papillary Renal Cell Carcinoma SubClassOf Papillary Carcinoma</Axiom>
                           <Axiom>Hereditary Papillary Renal Cell Carcinoma SubClassOf Papillary Neoplasm</Axiom>
                           <Axiom>Hereditary Papillary Renal Cell Carcinoma SubClassOf Papillary Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="365">
               <Axiom>Phencyclidine SubClassOf Adjuvant Analgesic</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Phencyclidine</Concept>
                        <WitnessAxioms>
                           <Axiom>Phencyclidine SubClassOf Adjuvant Analgesic</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Phencyclidine</Concept>
                        <WitnessAxioms>
                           <Axiom>Phencyclidine SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Phencyclidine SubClassOf Analgesic Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="366">
               <Axiom>Position Delta SubClassOf Retired Concept</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Position Delta</Concept>
                        <WitnessAxioms>
                           <Axiom>Position Delta SubClassOf Retired Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Position Delta</Concept>
                        <WitnessAxioms>
                           <Axiom>Position Delta SubClassOf Retired_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="367">
               <Axiom>Presymptomatic Cancer SubClassOf Clinical Course of Disease</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Presymptomatic Cancer</Concept>
                        <WitnessAxioms>
                           <Axiom>Presymptomatic Cancer SubClassOf Clinical Course of Disease</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Presymptomatic Cancer</Concept>
                        <WitnessAxioms>
                           <Axiom>Presymptomatic Cancer SubClassOf Finding</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="229">
               <Axiom>Primary Cutaneous Mucinous Carcinoma EquivalentTo Mucinous Adenocarcinoma and Sweat Gland Carcinoma and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Finding only Mucoid Stroma Formation)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="369">
               <Axiom>Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor EquivalentTo Primary Intraosseous Squamous Cell Carcinoma and Secondary Carcinoma and (Disease_Has_Associated_Disease only Keratocystic Odontogenic Tumor)</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor SubClassOf Secondary Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Secondary Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor SubClassOf Secondary Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor SubClassOf Secondary Malignant Neoplasm</Axiom>
                           <Axiom>Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor SubClassOf Secondary Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="368">
               <Axiom>Primary Intraosseous Squamous Cell Carcinoma Derived From Odontogenic Cyst EquivalentTo Primary Intraosseous Squamous Cell Carcinoma and Secondary Carcinoma and (Disease_Has_Finding only Odontogenic Cyst)</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Primary Intraosseous Squamous Cell Carcinoma Derived From Odontogenic Cyst</Concept>
                        <WitnessAxioms>
                           <Axiom>Primary Intraosseous Squamous Cell Carcinoma Derived From Odontogenic Cyst SubClassOf Secondary Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Secondary Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Primary Intraosseous Squamous Cell Carcinoma Derived From Odontogenic Cyst SubClassOf Secondary Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Primary Intraosseous Squamous Cell Carcinoma Derived From Odontogenic Cyst</Concept>
                        <WitnessAxioms>
                           <Axiom>Primary Intraosseous Squamous Cell Carcinoma Derived From Odontogenic Cyst SubClassOf Secondary Neoplasm</Axiom>
                           <Axiom>Primary Intraosseous Squamous Cell Carcinoma Derived From Odontogenic Cyst SubClassOf Secondary Malignant Neoplasm</Axiom>
                           <Axiom>Primary Intraosseous Squamous Cell Carcinoma Derived From Odontogenic Cyst SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="370">
               <Axiom>Propionic Acid SubClassOf Reagent</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Propionic Acid</Concept>
                        <WitnessAxioms>
                           <Axiom>Propionic Acid SubClassOf Reagent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="371">
               <Axiom>Prostate Ductal Adenocarcinoma, Papillary Pattern EquivalentTo Infiltrating Papillary Adenocarcinoma and Prostate Ductal Adenocarcinoma and Well Differentiated Prostate Adenocarcinoma</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Prostate Ductal Adenocarcinoma, Papillary Pattern</Concept>
                        <WitnessAxioms>
                           <Axiom>Prostate Ductal Adenocarcinoma, Papillary Pattern SubClassOf Infiltrating Papillary Adenocarcinoma</Axiom>
                           <Axiom>Prostate Ductal Adenocarcinoma, Papillary Pattern SubClassOf Well Differentiated Prostate Adenocarcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Infiltrating Papillary Adenocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Prostate Ductal Adenocarcinoma, Papillary Pattern SubClassOf Infiltrating Papillary Adenocarcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Prostate Ductal Adenocarcinoma, Papillary Pattern</Concept>
                        <WitnessAxioms>
                           <Axiom>Prostate Ductal Adenocarcinoma, Papillary Pattern SubClassOf Papillary Neoplasm</Axiom>
                           <Axiom>Prostate Ductal Adenocarcinoma, Papillary Pattern SubClassOf Papillary Adenocarcinoma</Axiom>
                           <Axiom>Prostate Ductal Adenocarcinoma, Papillary Pattern SubClassOf Papillary Carcinoma</Axiom>
                           <Axiom>Prostate Ductal Adenocarcinoma, Papillary Pattern SubClassOf Papillary Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="372">
               <Axiom>Psilocybin SubClassOf Alkaloid</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Psilocybin</Concept>
                        <WitnessAxioms>
                           <Axiom>Psilocybin SubClassOf Alkaloid</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Psilocybin</Concept>
                        <WitnessAxioms>
                           <Axiom>Psilocybin SubClassOf Organic Chemical</Axiom>
                           <Axiom>Psilocybin SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="373">
               <Axiom>Pyridoxine Hydrochloride SubClassOf Vitamin B6</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Pyridoxine Hydrochloride</Concept>
                        <WitnessAxioms>
                           <Axiom>Pyridoxine Hydrochloride SubClassOf Vitamin B6</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="374">
               <Axiom>Quantitation SubClassOf Action</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Quantitation</Concept>
                        <WitnessAxioms>
                           <Axiom>Quantitation SubClassOf Action</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Quantitation</Concept>
                        <WitnessAxioms>
                           <Axiom>Quantitation SubClassOf Activity</Axiom>
                           <Axiom>Quantitation SubClassOf Activity_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="375">
               <Axiom>Radiation-Related Malignant Neoplasm EquivalentTo Malignant Neoplasm and Radiation-Related Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Radiation-Related Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Radiation-Related Malignant Neoplasm SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Ionizing Radiation-Related Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Ionizing Radiation-Related Malignant Neoplasm SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="376">
               <Axiom>Recombinant Human Interleukin-21 SubClassOf Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some B-Lymphocyte</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="377">
               <Axiom>Recombinant Human Interleukin-21 SubClassOf Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Dendritic Cell</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="378">
               <Axiom>Recombinant Human Interleukin-21 SubClassOf Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Natural Killer Cell</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="379">
               <Axiom>Recurrent Carcinoma EquivalentTo Carcinoma and Recurrent Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Carcinoma SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Lip and Oral Cavity Cancer</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Lip and Oral Cavity Cancer SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Lip and Oral Cavity Cancer SubClassOf Neoplasm by Special Category</Axiom>
                           <Axiom>Recurrent Lip and Oral Cavity Cancer SubClassOf Recurrent Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Lip and Oral Cavity Cancer SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="380">
               <Axiom>Recurrent Childhood Central Nervous System Neoplasm EquivalentTo Childhood Central Nervous System Neoplasm and Recurrent Neoplasm</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Childhood Central Nervous System Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Childhood Central Nervous System Neoplasm SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Recurrent Childhood Ependymoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Childhood Ependymoma SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Childhood Intracranial Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Childhood Optic Nerve Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Medulloblastoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Visual Pathway Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Brain Stem Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Visual Pathway Glioma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Brain Stem Glioma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Cerebellar Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Cerebral Astrocytoma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Optic Nerve Glioma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="381">
               <Axiom>Recurrent Childhood Hepatocellular Carcinoma EquivalentTo Childhood Hepatocellular Carcinoma and Recurrent Childhood Liver Cancer and Recurrent Hepatocellular Carcinoma</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Childhood Hepatocellular Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Childhood Hepatocellular Carcinoma SubClassOf Recurrent Hepatocellular Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Recurrent Childhood Hepatocellular Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Childhood Hepatocellular Carcinoma SubClassOf Recurrent Gastrointestinal System Cancer</Axiom>
                           <Axiom>Recurrent Childhood Hepatocellular Carcinoma SubClassOf Recurrent Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Hepatocellular Carcinoma SubClassOf Recurrent Liver Cancer</Axiom>
                           <Axiom>Recurrent Childhood Hepatocellular Carcinoma SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Recurrent Gastrointestinal System Cancer</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Childhood Hepatocellular Carcinoma SubClassOf Recurrent Gastrointestinal System Cancer</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="382">
               <Axiom>Recurrent Childhood Liver Cancer EquivalentTo Childhood Liver Cancer and Recurrent Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Childhood Liver Cancer</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Childhood Liver Cancer SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Hepatoblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Hepatoblastoma SubClassOf Recurrent Neoplasm</Axiom>
                           <Axiom>Recurrent Hepatoblastoma SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="383">
               <Axiom>Recurrent Childhood Malignant Germ Cell Neoplasm EquivalentTo Malignant Childhood Germ Cell Tumor and Recurrent Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Childhood Malignant Germ Cell Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Childhood Malignant Germ Cell Neoplasm SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Childhood Malignant Germ Cell Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Childhood Malignant Germ Cell Neoplasm SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="384">
               <Axiom>Recurrent Childhood Soft Tissue Sarcoma EquivalentTo Childhood Soft Tissue Sarcoma and Recurrent Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Childhood Soft Tissue Sarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Childhood Soft Tissue Sarcoma SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Childhood Soft Tissue Sarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Childhood Soft Tissue Sarcoma SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="385">
               <Axiom>Recurrent Cholangiocarcinoma EquivalentTo Cholangiocarcinoma and Recurrent Gastrointestinal System Cancer</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Cholangiocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Cholangiocarcinoma SubClassOf Recurrent Gastrointestinal System Cancer</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Cholangiocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Cholangiocarcinoma SubClassOf Recurrent Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Cholangiocarcinoma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Cholangiocarcinoma SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="386">
               <Axiom>Recurrent Chondrosarcoma EquivalentTo Chondrosarcoma and Recurrent Malignant Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q15-qter) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7p13-pter) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 18p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 4) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q24-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(11p13-pter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q25)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q21-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(1p13-22)) and (Disease_May_Have_Cytogenetic_Abnormality some del(1p36)) and (Disease_May_Have_Cytogenetic_Abnormality some del(22q13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(5q13-31)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q22-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(9p22-pter))</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Chondrosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Chondrosarcoma SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Chondrosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Chondrosarcoma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Chondrosarcoma SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="387">
               <Axiom>Recurrent Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Recurrent Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Bone Ewing's Sarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Bone Ewing's Sarcoma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Bone Ewing's Sarcoma SubClassOf Recurrent Neoplasm</Axiom>
                           <Axiom>Recurrent Bone Ewing's Sarcoma SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="388">
               <Axiom>Recurrent Extrahepatic Bile Duct Carcinoma EquivalentTo Extrahepatic Bile Duct Carcinoma and Recurrent Gastrointestinal System Cancer</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Extrahepatic Bile Duct Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Extrahepatic Bile Duct Carcinoma SubClassOf Recurrent Gastrointestinal System Cancer</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Extrahepatic Bile Duct Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Extrahepatic Bile Duct Carcinoma SubClassOf Recurrent Neoplasm</Axiom>
                           <Axiom>Recurrent Extrahepatic Bile Duct Carcinoma SubClassOf Neoplasm by Special Category</Axiom>
                           <Axiom>Recurrent Extrahepatic Bile Duct Carcinoma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Extrahepatic Bile Duct Carcinoma SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="404">
               <Axiom>Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Recurrent Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Hematologic Malignancy</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Hematologic Malignancy SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Childhood Lymphoblastic Lymphoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Childhood Lymphoblastic Lymphoma SubClassOf Recurrent Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Childhood Lymphoblastic Lymphoma SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="389">
               <Axiom>Recurrent Kaposi Sarcoma EquivalentTo Kaposi's Sarcoma and Recurrent Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Kaposi Sarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Kaposi Sarcoma SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Kaposi Sarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Kaposi Sarcoma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Kaposi Sarcoma SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="390">
               <Axiom>Recurrent Malignant Duodenal Neoplasm EquivalentTo Malignant Duodenal Neoplasm and Recurrent Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Malignant Duodenal Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Malignant Duodenal Neoplasm SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Duodenal Cancer</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Duodenal Cancer SubClassOf Recurrent Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Duodenal Cancer SubClassOf Neoplasm by Special Category</Axiom>
                           <Axiom>Recurrent Duodenal Cancer SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Duodenal Cancer SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="391">
               <Axiom>Recurrent Malignant Gastric Neoplasm EquivalentTo Malignant Gastric Neoplasm and Recurrent Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Malignant Gastric Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Malignant Gastric Neoplasm SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Malignant Gastric Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Malignant Gastric Neoplasm SubClassOf Recurrent Neoplasm</Axiom>
                           <Axiom>Recurrent Malignant Gastric Neoplasm SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Malignant Gastric Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="392">
               <Axiom>Recurrent Malignant Hypopharyngeal Neoplasm EquivalentTo Malignant Hypopharyngeal Neoplasm and Recurrent Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Malignant Hypopharyngeal Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Malignant Hypopharyngeal Neoplasm SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Hypopharyngeal Squamous Cell Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Hypopharyngeal Squamous Cell Carcinoma SubClassOf Recurrent Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Hypopharyngeal Squamous Cell Carcinoma SubClassOf Recurrent Neoplasm</Axiom>
                           <Axiom>Recurrent Hypopharyngeal Squamous Cell Carcinoma SubClassOf Neoplasm by Special Category</Axiom>
                           <Axiom>Recurrent Hypopharyngeal Squamous Cell Carcinoma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="393">
               <Axiom>Recurrent Malignant Nasopharyngeal Neoplasm EquivalentTo Malignant Nasopharyngeal Neoplasm and Recurrent Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Malignant Nasopharyngeal Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Malignant Nasopharyngeal Neoplasm SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Nasopharyngeal Cancer</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Nasopharyngeal Cancer SubClassOf Recurrent Neoplasm</Axiom>
                           <Axiom>Recurrent Nasopharyngeal Cancer SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Nasopharyngeal Cancer SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="394">
               <Axiom>Recurrent Malignant Neoplasm of Salivary Gland EquivalentTo Malignant Salivary Gland Neoplasm and Recurrent Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Malignant Neoplasm of Salivary Gland</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Malignant Neoplasm of Salivary Gland SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Salivary Gland Cancer</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Salivary Gland Cancer SubClassOf Recurrent Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Salivary Gland Cancer SubClassOf Recurrent Neoplasm</Axiom>
                           <Axiom>Recurrent Salivary Gland Cancer SubClassOf Neoplasm by Special Category</Axiom>
                           <Axiom>Recurrent Salivary Gland Cancer SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="395">
               <Axiom>Recurrent Malignant Oral Neoplasm EquivalentTo Malignant Oral Neoplasm and Recurrent Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Malignant Oral Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Malignant Oral Neoplasm SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Lip and Oral Cavity Cancer</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Lip and Oral Cavity Cancer SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Lip and Oral Cavity Cancer SubClassOf Neoplasm by Special Category</Axiom>
                           <Axiom>Recurrent Lip and Oral Cavity Cancer SubClassOf Recurrent Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Lip and Oral Cavity Cancer SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="396">
               <Axiom>Recurrent Melanoma EquivalentTo Melanoma and Recurrent Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Melanoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Melanoma SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Uveal Melanoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Uveal Melanoma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Uveal Melanoma SubClassOf Recurrent Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Uveal Melanoma SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="397">
               <Axiom>Recurrent Nevus EquivalentTo Benign Melanocytic Skin Nevus and Recurrent Neoplasm</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Nevus</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Nevus SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="398">
               <Axiom>Recurrent Osteosarcoma EquivalentTo Osteosarcoma and Recurrent Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Osteosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Osteosarcoma SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Osteosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Osteosarcoma SubClassOf Recurrent Neoplasm</Axiom>
                           <Axiom>Recurrent Osteosarcoma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="399">
               <Axiom>Recurrent Ovarian Germ Cell Tumor EquivalentTo Malignant Ovarian Germ Cell Tumor and Recurrent Malignant Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some i(12p)) and (Disease_May_Have_Finding some Abdominal Mass) and (Disease_May_Have_Finding some Abdominal Pain)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Ovarian Germ Cell Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Ovarian Germ Cell Tumor SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Ovarian Germ Cell Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Ovarian Germ Cell Tumor SubClassOf Recurrent Neoplasm</Axiom>
                           <Axiom>Recurrent Ovarian Germ Cell Tumor SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="400">
               <Axiom>Recurrent Primitive Neuroectodermal Tumor EquivalentTo Primitive Neuroectodermal Tumor and Recurrent Malignant Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Neuroectodermal Cell)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Primitive Neuroectodermal Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Primitive Neuroectodermal Tumor SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Peripheral Primitive Neuroectodermal Tumor of Bone</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Peripheral Primitive Neuroectodermal Tumor of Bone SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Peripheral Primitive Neuroectodermal Tumor of Bone SubClassOf Recurrent Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Peripheral Primitive Neuroectodermal Tumor of Bone SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="402">
               <Axiom>Recurrent Renal Wilms Tumor EquivalentTo Recurrent Malignant Neoplasm and Renal Wilms Tumor and (Disease_May_Have_Molecular_Abnormality some WT1 Gene Inactivation)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Renal Wilms Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Renal Wilms Tumor SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Renal Wilms Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Renal Wilms Tumor SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Renal Wilms Tumor SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="401">
               <Axiom>Recurrent Rhabdomyosarcoma EquivalentTo Recurrent Malignant Neoplasm and Rhabdomyosarcoma</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Rhabdomyosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Rhabdomyosarcoma SubClassOf Recurrent Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Rhabdomyosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Rhabdomyosarcoma SubClassOf Recurrent Neoplasm</Axiom>
                           <Axiom>Recurrent Rhabdomyosarcoma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="403">
               <Axiom>Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Refractory Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Refractory Hematologic Malignancy</Concept>
                        <WitnessAxioms>
                           <Axiom>Refractory Hematologic Malignancy SubClassOf Refractory Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Refractory Small Lymphocytic Lymphoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Refractory Small Lymphocytic Lymphoma SubClassOf Refractory Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="405">
               <Axiom>Resin Modified Glass Ionomer Liner SubClassOf Dental Liner</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Resin Modified Glass Ionomer Liner</Concept>
                        <WitnessAxioms>
                           <Axiom>Resin Modified Glass Ionomer Liner SubClassOf Dental Liner</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="222">
               <Axiom>SOD1 Inhibitor ATN-224 SubClassOf Chemical_Or_Drug_Affects_Gene_Product some Superoxide Dismutase [Cu-Zn]</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="406">
               <Axiom>Sarcomatoid Carcinoma EquivalentTo Anaplastic Malignant Neoplasm and Carcinoma and (Disease_Has_Abnormal_Cell only Malignant Epithelial Spindle Cell) and (Disease_Has_Finding only Poorly Differentiated Lesion)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Sarcomatoid Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Sarcomatoid Carcinoma SubClassOf Anaplastic Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Thymic Sarcomatoid Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Thymic Sarcomatoid Carcinoma SubClassOf Anaplastic Malignant Neoplasm</Axiom>
                           <Axiom>Thymic Sarcomatoid Carcinoma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Thymic Sarcomatoid Carcinoma SubClassOf Neoplasm by Special Category</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="407">
               <Axiom>Secondary Acute Myeloid Leukemia EquivalentTo Acute Myeloid Leukemia and Secondary Malignant Neoplasm and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloid Blast) and (Disease_Has_Finding only Immature Myeloid Cells Increased in Bone Marrow)</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Secondary Acute Myeloid Leukemia</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Acute Myeloid Leukemia SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Secondary Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Acute Myeloid Leukemia SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Acute Myeloid Leukemia with Multilineage Dysplasia following Myelodysplastic Syndrome</Concept>
                        <WitnessAxioms>
                           <Axiom>Acute Myeloid Leukemia with Multilineage Dysplasia following Myelodysplastic Syndrome SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Acute Myeloid Leukemia with Multilineage Dysplasia following Myelodysplastic Syndrome SubClassOf Secondary Malignant Neoplasm</Axiom>
                           <Axiom>Acute Myeloid Leukemia with Multilineage Dysplasia following Myelodysplastic Syndrome SubClassOf Secondary Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="408">
               <Axiom>Secondary Carcinoma EquivalentTo Carcinoma and Secondary Malignant Neoplasm</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Secondary Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Carcinoma SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Secondary Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Carcinoma SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral</Concept>
                        <WitnessAxioms>
                           <Axiom>Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral SubClassOf Secondary Malignant Neoplasm</Axiom>
                           <Axiom>Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral SubClassOf Secondary Neoplasm</Axiom>
                           <Axiom>Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="410">
               <Axiom>Secondary Chondrosarcoma EquivalentTo Bone Sarcoma and Chondrosarcoma and Secondary Malignant Neoplasm and (Disease_May_Have_Associated_Disease some Enchondroma) and (Disease_May_Have_Associated_Disease some Enchondromatosis) and (Disease_May_Have_Associated_Disease some Maffucci Syndrome) and (Disease_May_Have_Associated_Disease some Osteochondroma) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q15-qter) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7p13-pter) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 18p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 4) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q24-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(11p13-pter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q25)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q21-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(1p13-22)) and (Disease_May_Have_Cytogenetic_Abnormality some del(1p36)) and (Disease_May_Have_Cytogenetic_Abnormality some del(22q13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(5q13-31)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q22-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(9p22-pter))</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Secondary Chondrosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Chondrosarcoma SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Secondary Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Chondrosarcoma SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Secondary Chondrosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Chondrosarcoma SubClassOf Secondary Neoplasm</Axiom>
                           <Axiom>Secondary Chondrosarcoma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="411">
               <Axiom>Secondary Glioblastoma EquivalentTo Glioblastoma and Secondary Malignant Neoplasm and ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression)) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Secondary Glioblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Glioblastoma SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Secondary Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Glioblastoma SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Secondary Glioblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Glioblastoma SubClassOf Anaplastic Malignant Neoplasm</Axiom>
                           <Axiom>Secondary Glioblastoma SubClassOf Secondary Neoplasm</Axiom>
                           <Axiom>Secondary Glioblastoma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="412">
               <Axiom>Secondary Myelodysplastic Syndrome EquivalentTo Myelodysplastic Syndrome and Secondary Malignant Neoplasm</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Secondary Myelodysplastic Syndrome</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Myelodysplastic Syndrome SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Secondary Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Myelodysplastic Syndrome SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Epipodophyllotoxin-Related Myelodysplastic Syndrome</Concept>
                        <WitnessAxioms>
                           <Axiom>Epipodophyllotoxin-Related Myelodysplastic Syndrome SubClassOf Secondary Neoplasm</Axiom>
                           <Axiom>Epipodophyllotoxin-Related Myelodysplastic Syndrome SubClassOf Secondary Malignant Neoplasm</Axiom>
                           <Axiom>Epipodophyllotoxin-Related Myelodysplastic Syndrome SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="413">
               <Axiom>Secondary Osteosarcoma EquivalentTo Bone Osteosarcoma and Secondary Malignant Neoplasm and (Disease_May_Have_Finding some Lytic Bone Lesion) and (Disease_May_Have_Finding some Osteosclerotic Lesion) and (Disease_May_Have_Finding some Pain) and (Disease_Has_Finding only High Grade Lesion) and (Disease_Has_Finding only Osteoid Formation)</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Secondary Osteosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Osteosarcoma SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Secondary Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Osteosarcoma SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Radiation-Related Osteosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Radiation-Related Osteosarcoma SubClassOf Secondary Neoplasm</Axiom>
                           <Axiom>Radiation-Related Osteosarcoma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Radiation-Related Osteosarcoma SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="239">
               <Axiom>Secondary Supratentorial Anaplastic Astrocytoma EquivalentTo Anaplastic Astrocytoma and Malignant Supratentorial Neoplasm and Secondary Malignant Neoplasm and (Disease_Has_Primary_Anatomic_Site only Supratentorial Brain)</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Secondary Supratentorial Anaplastic Astrocytoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Supratentorial Anaplastic Astrocytoma SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Secondary Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Supratentorial Anaplastic Astrocytoma SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Secondary Supratentorial Anaplastic Astrocytoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Secondary Supratentorial Anaplastic Astrocytoma SubClassOf Secondary Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="414">
               <Axiom>Sodium Carbonate SubClassOf Electrolyte Replacement Agent</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Sodium Carbonate</Concept>
                        <WitnessAxioms>
                           <Axiom>Sodium Carbonate SubClassOf Electrolyte Replacement Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Sodium Carbonate</Concept>
                        <WitnessAxioms>
                           <Axiom>Sodium Carbonate SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Sodium Carbonate SubClassOf Adjuvant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="415">
               <Axiom>Solar Lentigo SubClassOf Non-Neoplastic Skin Disorder</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Solar Lentigo</Concept>
                        <WitnessAxioms>
                           <Axiom>Solar Lentigo SubClassOf Non-Neoplastic Skin Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Solar Lentigo</Concept>
                        <WitnessAxioms>
                           <Axiom>Solar Lentigo SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                           <Axiom>Solar Lentigo SubClassOf Non-Neoplastic Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="416">
               <Axiom>Sorafenib SubClassOf Tyrosine Kinase Inhibitor</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Sorafenib</Concept>
                        <WitnessAxioms>
                           <Axiom>Sorafenib SubClassOf Tyrosine Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="331">
               <Axiom>Spiradenocarcinoma EquivalentTo Sweat Gland Carcinoma and (Disease_May_Have_Finding some Eccrine Differentiation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Spiradenocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Spiradenocarcinoma SubClassOf Sweat Gland Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Spiradenocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Spiradenocarcinoma SubClassOf Adnexal Carcinoma</Axiom>
                           <Axiom>Spiradenocarcinoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Spiradenocarcinoma SubClassOf Carcinoma</Axiom>
                           <Axiom>Spiradenocarcinoma SubClassOf Adenocarcinoma</Axiom>
                           <Axiom>Spiradenocarcinoma SubClassOf Skin Carcinoma</Axiom>
                           <Axiom>Spiradenocarcinoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Spiradenocarcinoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Spiradenocarcinoma SubClassOf Glandular Cell Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="298">
               <Axiom>Spiradenoma EquivalentTo Benign Sweat Gland Neoplasm and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Nodular Pattern)</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Spiradenoma SubClassOf Benign Sweat Gland Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Sweat Gland Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Spiradenoma SubClassOf Benign Sweat Gland Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Benign Breast Eccrine Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="417">
               <Axiom>Squamous Cell Epithelioma SubClassOf Retired Concept</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Squamous Cell Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Retired Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Squamous Cell Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Retired_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="418">
               <Axiom>Stage 0a Urethral Cancer EquivalentTo Papillary Transitional Cell Carcinoma and Stage 0 Urethral Cancer and (Disease_Is_Stage only Stage 0a)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Stage 0a Urethral Cancer</Concept>
                        <WitnessAxioms>
                           <Axiom>Stage 0a Urethral Cancer SubClassOf Papillary Transitional Cell Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Stage 0a Urethral Cancer</Concept>
                        <WitnessAxioms>
                           <Axiom>Stage 0a Urethral Cancer SubClassOf Transitional Cell Carcinoma</Axiom>
                           <Axiom>Stage 0a Urethral Cancer SubClassOf Papillary Neoplasm</Axiom>
                           <Axiom>Stage 0a Urethral Cancer SubClassOf Papillary Carcinoma</Axiom>
                           <Axiom>Stage 0a Urethral Cancer SubClassOf Papillary Epithelial Neoplasm</Axiom>
                           <Axiom>Stage 0a Urethral Cancer SubClassOf Transitional Cell Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="419">
               <Axiom>Stilbene Aldehyde SubClassOf Reagent</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Stilbene Aldehyde</Concept>
                        <WitnessAxioms>
                           <Axiom>Stilbene Aldehyde SubClassOf Reagent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="420">
               <Axiom>Succinic Acid SubClassOf Carboxylic Acids</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Succinic Acid</Concept>
                        <WitnessAxioms>
                           <Axiom>Succinic Acid SubClassOf Carboxylic Acids</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Succinic Acid</Concept>
                        <WitnessAxioms>
                           <Axiom>Succinic Acid SubClassOf Organic Oxoacids</Axiom>
                           <Axiom>Succinic Acid SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                           <Axiom>Succinic Acid SubClassOf Organic Chemical</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="426">
               <Axiom>Sweat Gland Tubular Carcinoma EquivalentTo Sweat Gland Carcinoma and (Disease_May_Have_Finding some Aggressive Clinical Course) and (Disease_May_Have_Finding some Apocrine Differentiation) and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Finding only Tubular Pattern)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="421">
               <Axiom>Syringadenoma SubClassOf Retired Concept</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Syringadenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringadenoma SubClassOf Retired Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Syringadenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringadenoma SubClassOf Retired_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="364">
               <Axiom>Syringocystadenoma Papilliferum EquivalentTo Sweat Gland Adenoma and (Disease_May_Have_Associated_Disease some Organoid Nevus) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Papillary Pattern) and (Disease_Has_Finding only Plasmacytic Infiltrate)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Syringocystadenoma Papilliferum</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringocystadenoma Papilliferum SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Syringocystadenoma Papilliferum SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="422">
               <Axiom>Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome EquivalentTo Myeloid Neoplasm and Secondary Malignant Neoplasm and Therapy Related Malignant Neoplasm and (Disease_Has_Finding only Ineffective Hematopoiesis)</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome</Concept>
                        <WitnessAxioms>
                           <Axiom>Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Secondary Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome SubClassOf Secondary Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Epipodophyllotoxin-Related Myelodysplastic Syndrome</Concept>
                        <WitnessAxioms>
                           <Axiom>Epipodophyllotoxin-Related Myelodysplastic Syndrome SubClassOf Secondary Neoplasm</Axiom>
                           <Axiom>Epipodophyllotoxin-Related Myelodysplastic Syndrome SubClassOf Secondary Malignant Neoplasm</Axiom>
                           <Axiom>Epipodophyllotoxin-Related Myelodysplastic Syndrome SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="423">
               <Axiom>Tobacco SubClassOf CNS Stimulant</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Tobacco</Concept>
                        <WitnessAxioms>
                           <Axiom>Tobacco SubClassOf CNS Stimulant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Smokeless Tobacco</Concept>
                        <WitnessAxioms>
                           <Axiom>Smokeless Tobacco SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Smokeless Tobacco SubClassOf Adjuvant</Axiom>
                           <Axiom>Smokeless Tobacco SubClassOf CNS Stimulant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="424">
               <Axiom>Trichoepithelioma SubClassOf Retired Concept</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Trichoepithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichoepithelioma SubClassOf Retired Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Trichoepithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichoepithelioma SubClassOf Retired_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="425">
               <Axiom>Trichofolliculoma SubClassOf Skin Appendage Hamartoma</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Trichofolliculoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichofolliculoma SubClassOf Skin Appendage Hamartoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Trichofolliculoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichofolliculoma SubClassOf Non-Neoplastic Disorder</Axiom>
                           <Axiom>Trichofolliculoma SubClassOf Non-Neoplastic Skin Disorder</Axiom>
                           <Axiom>Trichofolliculoma SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                           <Axiom>Trichofolliculoma SubClassOf Hamartoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="427">
               <Axiom>Tubular Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Invasive Breast Carcinoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 11q ATM Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p FHIT Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8p) and (Disease_May_Have_Finding some Calcification) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Excludes_Finding only High Mitotic Activity) and (Disease_Excludes_Finding only Nuclear Pleomorphism) and (Disease_Excludes_Primary_Anatomic_Site only Exocrine System)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="428">
               <Axiom>Tumor Specific Peptide SubClassOf Tumor Antigen</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Tumor Specific Peptide</Concept>
                        <WitnessAxioms>
                           <Axiom>Tumor Specific Peptide SubClassOf Tumor Antigen</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Carcinoembryonic Antigen Peptide 1</Concept>
                        <WitnessAxioms>
                           <Axiom>Carcinoembryonic Antigen Peptide 1 SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Carcinoembryonic Antigen Peptide 1 SubClassOf Tumor Antigen</Axiom>
                           <Axiom>Carcinoembryonic Antigen Peptide 1 SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                           <Axiom>Carcinoembryonic Antigen Peptide 1 SubClassOf Biological Agent</Axiom>
                           <Axiom>Carcinoembryonic Antigen Peptide 1 SubClassOf Antigen</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="429">
               <Axiom>Vaginal Warty Carcinoma EquivalentTo Human Papilloma Virus-Related Squamous Cell Carcinoma and Papillary Squamous Cell Carcinoma and Vaginal Squamous Cell Carcinoma and (Disease_May_Have_Finding some Postcoital Bleeding) and (Disease_May_Have_Finding some Vaginal Hemorrhage) and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Exophytic Papillary Lesion)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Vaginal Warty Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Vaginal Warty Carcinoma SubClassOf Papillary Squamous Cell Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Vaginal Warty Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Vaginal Warty Carcinoma SubClassOf Papillary Carcinoma</Axiom>
                           <Axiom>Vaginal Warty Carcinoma SubClassOf Papillary Epithelial Neoplasm</Axiom>
                           <Axiom>Vaginal Warty Carcinoma SubClassOf Papillary Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="430">
               <Axiom>Vascular SubClassOf Anatomy Qualifier</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Vascular</Concept>
                        <WitnessAxioms>
                           <Axiom>Vascular SubClassOf Anatomy Qualifier</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="431">
               <Axiom>Verrucous Carcinoma EquivalentTo Papillary Squamous Cell Carcinoma and (Disease_Excludes_Finding only Koilocytotic Atypia) and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Endophytic Tumor Growth) and (Disease_Has_Finding only Exophytic Papillary Lesion) and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Finding only Mild Cytologic Atypia) and (Disease_Has_Finding only Pushing Tumor Margins Present) and (Disease_Has_Finding only Well Differentiated Lesion)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Verrucous Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Verrucous Carcinoma SubClassOf Papillary Squamous Cell Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Plantar Verrucous Skin Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Plantar Verrucous Skin Carcinoma SubClassOf Papillary Squamous Cell Carcinoma</Axiom>
                           <Axiom>Plantar Verrucous Skin Carcinoma SubClassOf Papillary Epithelial Neoplasm</Axiom>
                           <Axiom>Plantar Verrucous Skin Carcinoma SubClassOf Papillary Neoplasm</Axiom>
                           <Axiom>Plantar Verrucous Skin Carcinoma SubClassOf Papillary Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="432">
               <Axiom>Verrucous Carcinoma of the Penis EquivalentTo Papillary Carcinoma of the Penis and Verrucous Carcinoma</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Verrucous Carcinoma of the Penis</Concept>
                        <WitnessAxioms>
                           <Axiom>Verrucous Carcinoma of the Penis SubClassOf Papillary Carcinoma of the Penis</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Verrucous Carcinoma of the Penis</Concept>
                        <WitnessAxioms>
                           <Axiom>Verrucous Carcinoma of the Penis SubClassOf Neoplasm by Special Category</Axiom>
                           <Axiom>Verrucous Carcinoma of the Penis SubClassOf Papillary Carcinoma</Axiom>
                           <Axiom>Verrucous Carcinoma of the Penis SubClassOf Papillary Epithelial Neoplasm</Axiom>
                           <Axiom>Verrucous Carcinoma of the Penis SubClassOf Papillary Neoplasm</Axiom>
                           <Axiom>Verrucous Carcinoma of the Penis SubClassOf Papillary Squamous Cell Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="256">
               <Axiom>Verrucous Lesion EquivalentTo Squamous Cell Neoplasm and (Disease_Excludes_Finding only Endophytic Tumor Growth) and (Disease_Has_Associated_Disease only Human Papilloma Virus Infection) and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Exophytic Papillary Lesion) and (Disease_Has_Finding only Papillary Pattern) and (Disease_Has_Normal_Cell_Origin only Squamous Cell) and (Disease_Has_Normal_Tissue_Origin only Squamous Epithelium)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Verrucous Lesion</Concept>
                        <WitnessAxioms>
                           <Axiom>Verrucous Lesion SubClassOf Squamous Cell Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Verruca Plantaris</Concept>
                        <WitnessAxioms>
                           <Axiom>Verruca Plantaris SubClassOf Squamous Cell Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="433">
               <Axiom>Vulvar Clear Cell Hidradenocarcinoma EquivalentTo Hidradenocarcinoma and Malignant Vulvar Sweat Gland Neoplasm and Vulvar Adenocarcinoma</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Vulvar Clear Cell Hidradenocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Vulvar Clear Cell Hidradenocarcinoma SubClassOf Hidradenocarcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="434">
               <Axiom>Vulvar Warty Carcinoma EquivalentTo Human Papilloma Virus-Related Vulvar Squamous Cell Carcinoma and Papillary Squamous Cell Carcinoma and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Exophytic Papillary Lesion)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Vulvar Warty Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Vulvar Warty Carcinoma SubClassOf Papillary Squamous Cell Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Vulvar Warty Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Vulvar Warty Carcinoma SubClassOf Papillary Carcinoma</Axiom>
                           <Axiom>Vulvar Warty Carcinoma SubClassOf Papillary Epithelial Neoplasm</Axiom>
                           <Axiom>Vulvar Warty Carcinoma SubClassOf Papillary Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="435">
               <Axiom>Warty Carcinoma of the Penis EquivalentTo Human Papilloma Virus-Related Penile Squamous Cell Carcinoma and Papillary Carcinoma of the Penis and (Disease_Has_Finding only Acanthosis)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Warty Carcinoma of the Penis</Concept>
                        <WitnessAxioms>
                           <Axiom>Warty Carcinoma of the Penis SubClassOf Papillary Carcinoma of the Penis</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Warty Carcinoma of the Penis</Concept>
                        <WitnessAxioms>
                           <Axiom>Warty Carcinoma of the Penis SubClassOf Papillary Carcinoma</Axiom>
                           <Axiom>Warty Carcinoma of the Penis SubClassOf Papillary Epithelial Neoplasm</Axiom>
                           <Axiom>Warty Carcinoma of the Penis SubClassOf Papillary Neoplasm</Axiom>
                           <Axiom>Warty Carcinoma of the Penis SubClassOf Papillary Squamous Cell Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
         </PureAddition>
         <PureAdditionWithNewTerms id="paddnt" size="30">
            <Change id="440">
               <Axiom>ABT-888 SubClassOf Poly (ADP-Ribose) Polymerase Inhibitor</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>ABT-888</Concept>
                        <WitnessAxioms>
                           <Axiom>ABT-888 SubClassOf Poly (ADP-Ribose) Polymerase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Poly (ADP-Ribose) Polymerase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>ABT-888 SubClassOf Poly (ADP-Ribose) Polymerase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Poly (ADP-Ribose) Polymerase Inhibitor</New_Terms>
            </Change>
            <Change id="446">
               <Axiom>Agent Combination Indexed in Open Clinical Trials SubClassOf Agent Combination</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Agent Combination Indexed in Open Clinical Trials</Concept>
                        <WitnessAxioms>
                           <Axiom>Agent Combination Indexed in Open Clinical Trials SubClassOf Agent Combination</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Agent Combination</Concept>
                        <WitnessAxioms>
                           <Axiom>Agent Combination Indexed in Open Clinical Trials SubClassOf Agent Combination</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Cisplatin/Cyclophosphamide/Vindesine</Concept>
                        <WitnessAxioms>
                           <Axiom>Cisplatin/Cyclophosphamide/Vindesine SubClassOf Agent Combination</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Agent Combination</Concept>
                        <WitnessAxioms>
                           <Axiom>Carboplatin/Docetaxel/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Dalteparin/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Filgrastim/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Monoclonal Antibody Lym-1 SubClassOf Agent Combination</Axiom>
                           <Axiom>Flutamide/Triptorelin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Mitolactol SubClassOf Agent Combination</Axiom>
                           <Axiom>Fowlpox Virus Vaccine/gp100 Antigen/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Fluorouracil/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Tirapazamine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Melphalan/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Carboplatin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Dexamethasone/Leucovorin Calcium/Mercaptopurine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Filgrastim/Ifosfamide/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Isotretinoin/Monoclonal antibody Ch14.18/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Paclitaxel/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Dexamethasone/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Temozolomide/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Daunorubicin/Dexamethasone/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Fowlpox-CEA-TRICOM Vaccine/Fowlpox-Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Prednisolone/Procarbazine/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Arsenic trioxide/Ascorbic acid SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Methotrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Antineoplaston A10/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Dexamethasone/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Mechlorethamine/Prednisone/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-3/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Estramustine/Ketoconazole/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/cyclophosphamide/cytarabine/daunorubicin/dexamethasone/methotrexate/thioguanine/vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Epirubicin/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Interleukin-2/Montanide ISA-51/Tumor Infiltrating Lymphocytes SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Hydroxyurea/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/cyclophosphamide/cytarabine/daunorubicin/methotrexate/prednisone/vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fowlpox-CEA-TRICOM Vaccine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Lymphocytes/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Methotrexate/Pegaspargase/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Filgrastim/Prednisone/Rituximab/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Paclitaxel/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Erlotinib/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bortezomib/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Leucovorin Calcium/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Tariquidar/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Sargramostim/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Etoposide/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>BAY 12-9566/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Fowlpox-CEA-TRICOM Vaccine/Sargramostim/Vaccinia-CEA-TRICOM Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Capecitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Floxuridine/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Daunorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/Tipifarnib SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Ciprofloxacin/Cisplatin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyproterone/Luteinizing Hormone-Releasing Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Irinotecan/Leucovorin Calcium/SU5416 SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Fludarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Leucovorin Calcium/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dexrazoxane/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Fluorouracil/Hydroxyurea/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Toremifene SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Docetaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody/gp100 antigen/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Cytarabine/Daunorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Flavopiridol SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-thymocyte Globulin/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Irinotecan/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Multivitamins/Soy Protein Isolate SubClassOf Agent Combination</Axiom>
                           <Axiom>Keyhole Limpet Hemocyanin/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Pegaspargase SubClassOf Agent Combination</Axiom>
                           <Axiom>Melphalan/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Daunorubicin/Pegaspargase/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bicalutamide/Buserelin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Daunorubicin/Dexamethasone/Methotrexate/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Irinotecan/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-thymocyte globulin/fludarabine/melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Daunorubicin/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Ifosfamide/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Mitoxantrone/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Etoposide/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Dactinomycin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Isotretinoin/Monoclonal Antibody Ch14.18 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Sargramostim/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Dexamethasone/Etoposide/Ifosfamide/Methotrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Erlotinib/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Flutamide/Leuprolide SubClassOf Agent Combination</Axiom>
                           <Axiom>Leucovorin Calcium/Mercaptopurine/Methotrexate/Prednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Dacarbazine/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Daunorubicin/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Isotretinoin/Monoclonal antibody Ch14.18 SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Methotrexate/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Lobradimil SubClassOf Agent Combination</Axiom>
                           <Axiom>Oxaliplatin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Prednisolone/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Paclitaxel/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Tacrolimus SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Daunorubicin/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Mercaptopurine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/IM-862/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Flavopiridol/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cetuximab/Fluorouracil/Irinotecan/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Losoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Leucovorin Calcium/Methotrexate/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Doxorubicin/Prednisone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Daunorubicin/Dexamethasone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Mycophenolate Mofetil SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Mercaptopurine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-Thymocyte Globulin/Cyclophosphamide/Fludarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Hydrocortisone/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Bortezomib/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Decitabine/FR901228 SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/cytarabine/daunorubicin/dexamethasone/methotrexate/prednisolone/vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Ifosfamide/Prednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Ad5CMV-p53 gene/Docetaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Paclitaxel/PSC 833 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Lomustine/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cetuximab/Cisplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Goserelin/Nilutamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Paclitaxel/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vinblastine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/Pemetrexed Disodium SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Diethylstilbestrol/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Interferon Alfa/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Epirubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Idoxuridine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Prednisone/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Efaproxiral SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/dexamethasone/methotrexate/pegaspargase/vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Mercaptopurine/Methotrexate/Thioguanine/Vincristine/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/MART-1 Antigen/Sargramostim/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody/gp100 antigen/MART-1 antigen/Montanide ISA-51/tyrosinase peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Bicalutamide/Leuprolide SubClassOf Agent Combination</Axiom>
                           <Axiom>Buserelin/Cyproterone SubClassOf Agent Combination</Axiom>
                           <Axiom>QS21/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Floxuridine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone/Etoposide/Imatinib Mesylate/Mercaptopurine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bortezomib/Carboplatin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dacarbazine/Interferon Alfa/interleukin-2/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/O6-Benzylguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Methotrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Iodine I 131 Tositumomab/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>interleukin-2/Monoclonal Antibody OKT3 SubClassOf Agent Combination</Axiom>
                           <Axiom>Allogeneic lymphocytes/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Etoposide/Prednisone/Procarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Cisplatin/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Etoposide/Ifosfamide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Piroxicam SubClassOf Agent Combination</Axiom>
                           <Axiom>Isotretinoin/Temozolomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Filgrastim/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Rituximab/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Floxuridine/Leucovorin Calcium/SCH-58500 SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/Irinotecan/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Lomustine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Leucovorin Calcium/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Cytarabine/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Cyclophosphamide/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Epirubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Dexamethasone/Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dactinomycin/Doxorubicin/Filgrastim/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Doxorubicin/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone/Etoposide/Mercaptopurine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dexamethasone/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Imatinib mesylate SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Mitomycin/Triazinate SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Carboplatin/Filgrastim/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Doxorubicin/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Fludarabine/Isotretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Trimetrexate Glucuronate SubClassOf Agent Combination</Axiom>
                           <Axiom>Rituximab/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cytarabine/Etoposide/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Tirapazamine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>EGFR Antisense DNA/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide Phosphate/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>MART-1 antigen/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Interleukin-2/Tumor Necrosis Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Didanosine/Doxorubicin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Methotrexate/Sirolimus SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cisplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Cyclophosphamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Dactinomycin/Ifosfamide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Dendritic Cells/Fowlpox-CEA-TRICOM Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone/Doxorubicin/Rituximab/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Paclitaxel/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Mercaptopurine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Strontium Chloride Sr 89 SubClassOf Agent Combination</Axiom>
                           <Axiom>Leuprolide/Nilutamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Doxorubicin/Etoposide/Mechlorethamine/Prednisone/Vinblastine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Ifosfamide/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Fludarabine/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Daunorubicin/Dexamethasone/Imatinib Mesylate/Methotrexate/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Rituximab/Yttrium Y 90 ibritumomab tiuxetan SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/L-Leucovorin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Rituximab/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>EGFR Antisense DNA/Keyhole Limpet Hemocyanin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Dacarbazine/Doxorubicin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Tirapazamine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Dexamethasone/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Epirubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Temozolomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Dacarbazine/Hydroxyurea/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Eflornithine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fludarabine/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Milodistim/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Fludarabine/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cisplatin/Filgrastim/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Dendritic Cells/Autologous Tumor Cell Vaccine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Ketoconazole SubClassOf Agent Combination</Axiom>
                           <Axiom>Octreotide Pamoate/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Etoposide/Mitoxantrone/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin HCl Liposome/VX-853 SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Dexamethasone/Etoposide/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-thymocyte globulin/Cyclophosphamide/Fludarabine/methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Lycopene/Multivitamins SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Filgrastim/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-thymocyte globulin/Cyclosporine SubClassOf Agent Combination</Axiom>
                           <Axiom>Flavopiridol/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Lymphokine-Activated Killer Cells SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Ifosfamide/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Idarubicin/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyproterone/Goserelin SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/Docetaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Indomethacin/Zinc Sulfate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Leucovorin Calcium/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Mercaptopurine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Lymphocytes/gp100 Antigen/Interleukin-2/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Fluorouracil/Leucovorin Calcium/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bortezomib/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Tariquidar SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Ifosfamide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Ifosfamide/Imatinib Mesylate/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Fludarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Buthionine Sulfoximine/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Filgrastim/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Etoposide/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Interleukin-2/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Doxorubicin/Quinine/Verapamil/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dactinomycin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexrazoxane/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Dexamethasone/Doxorubicin/methotrexate/thioguanine/vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>O6-benzylguanine/Temozolomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Floxuridine/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Leucovorin Calcium/Mercaptopurine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Interleukin-2 Liposome/Polyvalent Melanoma Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Melatonin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Filgrastim/Idarubicin/Interleukin-6 SubClassOf Agent Combination</Axiom>
                           <Axiom>Montanide ISA-51/PR1 leukemia peptide vaccine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Prednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cisplatin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Gefitinib SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Filgrastim/Trastuzumab/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Etoposide/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Tretinoin Liposome SubClassOf Agent Combination</Axiom>
                           <Axiom>Dactinomycin/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-thymocyte Globulin/Cyclophosphamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Sulindac/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Daunorubicin/Dexamethasone/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Gamma/Interleukin-1-Beta/Interleukin-2/Sargramostim/Tumor Necrosis Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Monoclonal Antibody Ch14.18 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Etoposide/Fluorouracil/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Buserelin/Nilutamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Docetaxel/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Interferon Gamma/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Doxorubicin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Bryostatin 1/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Docetaxel/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Hydrocortisone/Leucovorin Calcium/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Dexamethasone/Etoposide/Filgrastim/Ifosfamide/Leucovorin Calcium/Methotrexate/Rituximab/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Temozolomide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carbogen/Niacinamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Mercaptopurine/Methotrexate/Teniposide/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Mercaptopurine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Dexamethasone SubClassOf Agent Combination</Axiom>
                           <Axiom>Prednisone/Tacrolimus SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Calcium Gluconate/Cholecalciferol/Zoledronate SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Filgrastim/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Paclitaxel/Tirapazamine SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Prednisone/Rituximab/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Etoposide/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-CD3 x Anti-HER-2-Neu Bispecific Monoclonal Antibody/Autologous Lymphocytes/Interleukin-2/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>QS21/TF(c)-KLH Conjugate Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Dexamethasone/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Leucovorin Calcium/Mercaptopurine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Alemtuzumab/Fludarabine/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Docetaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Imatinib Mesylate/Mercaptopurine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Mercaptopurine/Methotrexate/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Flutamide/Goserelin SubClassOf Agent Combination</Axiom>
                           <Axiom>Irinotecan/UCN-01 SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Mycophenolate Mofetil/Tacrolimus SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/UCN-01 SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Bismuth Bi213 Monoclonal Antibody M195/Cytarabine/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Daunorubicin/Dexamethasone/Leucovorin Calcium/Methotrexate/Thioguanine/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/irinotecan/leucovorin calcium/oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Epirubicin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Pemetrexed Disodium SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Interferon Alfa/Melphalan/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Monoclonal Antibody 3F8/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Mitomycin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Dexamethasone/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cytarabine/Dexamethasone SubClassOf Agent Combination</Axiom>
                           <Axiom>Mercaptopurine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Bromocriptine/Flutamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Dexamethasone/Etoposide/Ifosfamide/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexrazoxane/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Lymphocytes/Interleukin-2/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Daunorubicin/Methotrexate/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Tumor Cell Vaccine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cisplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-Thymocyte Globulin/Busulfan/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Fludarabine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Temozolomide/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Estramustine/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cisplatin/Dacarbazine/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluoxymesterone/Mitolactol/Prednisone/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Irinotecan/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Prednisone/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Methylprednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Docetaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Epirubicin/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Gemcitabine/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Leucovorin Calcium/Mercaptopurine/Methotrexate/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Isotretinoin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Prednisone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dipyridamole/Fluorouracil/PALA SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Filgrastim/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dactinomycin/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Cyclophosphamide/Anti-Thymocyte Globulin SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Tumor Infiltrating Lymphocytes SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Docetaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Carboplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/cytarabine/daunorubicin/methotrexate/prednisone/vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Granisetron SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Dacarbazine/Hydroxyurea SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Bicalutamide/Goserelin/Mitoxantrone/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Floxuridine/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>GM2-KLH Vaccine/QS21 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Safingol SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Erlotinib SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Gemcitabine/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Erlotinib/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Buserelin/Flutamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Filgrastim/Leucovorin Calcium/Methotrexate/Rituximab/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Mercaptopurine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Lomustine/Temozolomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Estramustine/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Imatinib Mesylate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Calcitriol/Dexamethasone SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Ad5CMV-p53 gene/Cisplatin/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Ranpirnase SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Hydrocortisone/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine SubClassOf Agent Combination</Axiom>
                           <Axiom>Imatinib Mesylate/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Estramustine/Strontium Chloride Sr 89/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Alemtuzumab/Cyclophosphamide/Fludarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fludarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bryostatin 1/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Tumor Cell Vaccine/Keyhole Limpet Hemocyanin/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Mercaptopurine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bicalutamide/Goserelin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Pentostatin/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Etoposide/Lomustine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>BCG/Cyclophosphamide/Doxorubicin/Tegafur SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Fludarabine/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-2/MART-1 Antigen/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Antineoplaston A10/Antineoplaston AS2-1 SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Melphalan/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Estramustine SubClassOf Agent Combination</Axiom>
                           <Axiom>Ethinyl Estradiol/Norgestrel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-thymocyte globulin/Cyclophosphamide/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cetuximab/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Goserelin/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Dexamethasone/Prednisolone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Goserelin/Raloxifene SubClassOf Agent Combination</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Agent Combination</New_Terms>
            </Change>
            <Change id="460">
               <Axiom>Agent Combination Not Indexed in Open Clinical Trials SubClassOf Agent Combination</Axiom>
               <ConceptChanges size="6">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Agent Combination Not Indexed in Open Clinical Trials</Concept>
                        <WitnessAxioms>
                           <Axiom>Agent Combination Not Indexed in Open Clinical Trials SubClassOf Agent Combination</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Agent Combination</Concept>
                        <WitnessAxioms>
                           <Axiom>Agent Combination Not Indexed in Open Clinical Trials SubClassOf Agent Combination</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="4">
                     <Specialisation>
                        <Concept>Docetaxel/Doxorubicin HCl Liposome</Concept>
                        <WitnessAxioms>
                           <Axiom>Docetaxel/Doxorubicin HCl Liposome SubClassOf Agent Combination</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Specialisation>
                        <Concept>Cyclophosphamide/Doxorubicin/Vinblastine</Concept>
                        <WitnessAxioms>
                           <Axiom>Cyclophosphamide/Doxorubicin/Vinblastine SubClassOf Agent Combination</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Specialisation>
                        <Concept>Carmustine/Cyclophosphamide/Etoposide/Filgrastim</Concept>
                        <WitnessAxioms>
                           <Axiom>Carmustine/Cyclophosphamide/Etoposide/Filgrastim SubClassOf Agent Combination</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Agent Combination</Concept>
                        <WitnessAxioms>
                           <Axiom>Interleukin-1-Alpha/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fludarabine/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Dendritic Cells/MAGE-3/Melan-A/Survivin Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Doxorubicin/Prednisone/Procarbazine/Vinblastine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Interleukin-1-Alpha SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Methotrexate/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Gefitinib/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Mechlorethamine/Prednisone/Procarbazine/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Doxorubicin/Methotrexate/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Methylprednisolone/Mitoxantrone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Daunorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>RAS Peptide Cancer Vaccine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Epirubicin/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>BMS-275291/Carboplatin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/GTI-2040 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Methotrexate/Sargramostim/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>ALVAC-CEA Vaccine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Ixabepilone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cimetidine/Tumor Infiltrating Lymphocytes SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Diethylstilbestrol/Fluorouracil/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Gemcitabine/Interferon Alfa/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Melan-A/Na17.A2 Antigen/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Mitomycin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dacarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin/Rhumab-Vegf SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Thymidine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Megestrol SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Doxorubicin/Ifosfamide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Monoclonal antibody 11D10 anti-idiotype vaccine/Monoclonal antibody 3H1 anti-idiotype vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Tamoxifen/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>CI-980/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Etoposide/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Etoposide/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Azacytidine/Cytarabine/Daunorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Doxorubicin/Etoposide/Prednisolone/Procarbazine/Vinblastine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Dactinomycin/Mercaptopurine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Melphalan/Methylprednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Dacarbazine/Doxorubicin/Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Montanide ISA-51/Sargramostim/Tetanus Peptide Melanoma Vaccine/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>MAGE-3/PADRE 965.10 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Azacytidine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/DPPE SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Levamisole SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Estradiol/Norethindrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexrazoxane/Doxorubicin/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>Sargramostim/Vaccinia-MUC-1 Vaccine/Vaccinia-TRICOM Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Dexamethasone/Doxorubicin/Mercaptopurine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bryostatin 1/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Etoposide/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Cyclophosphamide/Etoposide/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Fowlpox-PSA Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Cisplatin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Fluorouracil/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Arsenic trioxide/Dexamethasone SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Gamma/Monoclonal Antibody CC49 SubClassOf Agent Combination</Axiom>
                           <Axiom>Histamine Dihydrochloride/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Ascorbic acid/Selenium/Vitamin E SubClassOf Agent Combination</Axiom>
                           <Axiom>APC8015/Bevacizumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Methylprednisolone/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-Thymocyte Globulin/Busulfan/Cyclophosphamide/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Hydroxyurea SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Methotrexate/Procarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dactinomycin/Tumor Necrosis Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Vaccinia-Tyrosinase Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone/Doxorubicin/Quinine/Verapamil/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Ifosfamide/Milodistim SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cisplatin/Doxorubicin/Methotrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclosporine/Dipyridamole/Etoposide/Prochlorperazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Captopril/Tissue Plasminogen Activator SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Melphalan/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cytarabine/Hydroxyurea SubClassOf Agent Combination</Axiom>
                           <Axiom>Montanide ISA-51/Peptide 946 melanoma vaccine/Tetanus peptide melanoma vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dextromethorphan/Morphine SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Lomustine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Piroxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Ifosfamide/Mesna/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dacarbazine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Amphotericin B/Flucytosine SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/ISIS 2503 SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Sargramostim/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dacarbazine/Interferon Alfa/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Mercaptopurine/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amiodarone/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Dexamethasone/Ifosfamide/Methotrexate/Teniposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/PEG-Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Paclitaxel/Quinine SubClassOf Agent Combination</Axiom>
                           <Axiom>PEG-Interferon Alfa-2b/Temozolomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Epratuzumab/Prednisone/Rituximab/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Melphalan/Misonidazole SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboxypeptidase-G2/Leucovorin Calcium/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Interleukin-2/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin HCl Liposome/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Mitoxantrone/Thiotepa/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Lomustine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Mitomycin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/PS-341 SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Interleukin-2/Leucovorin Calcium/Lymphokine-Activated Killer Cells SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Satraplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Flt3 Ligand/gp100 Antigen/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Estramustine/Exisulind SubClassOf Agent Combination</Axiom>
                           <Axiom>Montanide ISA-51/Tyrosinase-related protein-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Epirubicin/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Allovectin-7/Dacarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Ondansetron SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Tipifarnib SubClassOf Agent Combination</Axiom>
                           <Axiom>Gefitinib/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cisplatin/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Ciprofloxacin/Melphalan/Pentoxifylline/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Temozolomide/ZD 1839 SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Etoposide/Mitotane/Tariquidar/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Carmustine/Cyclophosphamide/Cytarabine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Doxorubicin/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Floxuridine/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Ranpirnase/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>R115777/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Interferon Alfa/Leucovorin Calcium/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Lomustine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Prednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Daunorubicin/Methotrexate/Nelarabine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bortezomib/Carboplatin/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-12/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dacarbazine/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Epoetin Alfa/Iron SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Gefitinib SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Cytarabine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Erlotinib SubClassOf Agent Combination</Axiom>
                           <Axiom>Incomplete Freund's Adjuvant/Sargramostim/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Prochlorperazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Octreotide SubClassOf Agent Combination</Axiom>
                           <Axiom>Dactinomycin/Etoposide/Ifosfamide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Dexamethasone/Epirubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bortezomib/Dexamethasone SubClassOf Agent Combination</Axiom>
                           <Axiom>Bismuth Subcitrate/Metronidazole/Omeprazole/Tetracycline SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Prednisone/Vinblastine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Doxorubicin/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Dexamethasone/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Nitrocamptothecin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Doxorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Doxorubicin/Etoposide/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/MAGE-12 Peptide Vaccine/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Beta-Glucan/Monoclonal Antibody 3F8 SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Etoposide/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Dipyridamole/Fluorouracil/Leucovorin Calcium/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Doxorubicin Hydrochloride Liposome SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Exisulind SubClassOf Agent Combination</Axiom>
                           <Axiom>Bortezomib/Carboplatin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Prednisone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Tumor Necrosis Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Cyclophosphamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Epirubicin/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Interferon Alfa/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Zalcitabine/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Dexamethasone/Etoposide/Ifosfamide/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Etoposide/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Marimastat/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Herceptin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Methylprednisolone/Rasburicase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Estramustine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Zorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dactinomycin/Doxorubicin/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Hydrocortisone/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Interleukin-2/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Interleukin-2/Tumor Necrosis Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Filgrastim/Fludarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Interleukin-3/Prednisone/Vincristine/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-thymocyte globulin/melphalan/methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Floxuridine/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Pirarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>MUC-1 Antigen/SB AS-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fazarabine/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Methylprednisolone/Pixantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cisplatin/Cyclophosphamide/Etoposide/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Ifosfamide/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Vincristine/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cisplatin/Cyclophosphamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Exemestane/Goserelin SubClassOf Agent Combination</Axiom>
                           <Axiom>Keyhole Limpet Hemocyanin/MUC-1 Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Paclitaxel/Suramin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Yttrium Y 90 Monoclonal Antibody Lym-1 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Mechlorethamine/Prednisone/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Decitabine/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Dexamethasone/Etoposide/Idarubicin/Ifosfamide/Methotrexate/Pegaspargase/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Doxorubicin/Prednisone/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/UCN-01 SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Cisplatin/Etoposide/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Methotrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Progesterone SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Prednisone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bryostatin 1/Cladribine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Etoposide/Filgrastim/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin HCl Liposome/PSC 833 SubClassOf Agent Combination</Axiom>
                           <Axiom>SU5416/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/GTI-2040 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Floxuridine SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/interleukin-2/MART-1 Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>Fowlpox Virus Vaccine/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>BMS-214662/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Monoclonal Antibody 11D10 Anti-Idiotype Vaccine/Monoclonal Antibody GD2 Anti-Idiotype Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-thymocyte globulin/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Leucovorin Calcium/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Mercaptopurine/Methotrexate/Prednisone/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Lomustine/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Etanidazole SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Lomustine/Mechlorethamine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Monoclonal Antibody HuG1-M195 SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cisplatin/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Floxuridine/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>BMS-214662/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Doxorubicin/Lomustine/Streptozocin SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Doxorubicin/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Doxorubicin/Etoposide/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cetuximab/Docetaxel/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/9-cis-Retinoic Acid SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Doxorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Tretinoin/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Floxuridine/Leucovorin Calcium/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cisplatin/Cyclophosphamide/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Fluorouracil/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fowlpox-PSA-TRICOM Vaccine/Fowlpox-Sargramostim Vaccine/Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Mercaptopurine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Paclitaxel/Beta-Lapachone SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Celecoxib/Gemcitabine/Zileuton SubClassOf Agent Combination</Axiom>
                           <Axiom>Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Ifosfamide/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Etoposide/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Paclitaxel/SCH-58500 SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Procarbazine/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Ifosfamide/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>16.88/88BV59 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Gemcitabine/Paclitaxel/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Mitoxantrone/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Doxorubicin/Prednisone/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Apolizumab/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cladribine/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Flt3 Ligand/gp100 Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Aminocamptothecin/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexverapamil/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Dexamethasone/Etoposide/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Ciprofloxacin/Cisplatin/Cyclophosphamide/Etoposide/Pentoxifylline SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Semustine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cetuximab/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Ifosfamide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/Mistletoe SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Interleukin-1-Alpha SubClassOf Agent Combination</Axiom>
                           <Axiom>Everolimus/Gefitinib SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Piritrexim SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Etoposide/Lomustine SubClassOf Agent Combination</Axiom>
                           <Axiom>IDEC-Y2B8 Monoclonal Antibody/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cisplatin/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Bispecific Antibody 520C9XH22/Interferon Gamma SubClassOf Agent Combination</Axiom>
                           <Axiom>Floxuridine/Streptozocin SubClassOf Agent Combination</Axiom>
                           <Axiom>Megestrol/Omega-3 Fatty acids SubClassOf Agent Combination</Axiom>
                           <Axiom>IDEC-In2B8/Rituximab/Yttrium Y 90 Ibritumomab Tiuxetan SubClassOf Agent Combination</Axiom>
                           <Axiom>Aminopterin/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Vaccinia-MUC-1 Vaccine/Vaccinia-TRICOM Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Etoposide Phosphate/Sodium Thiosulfate SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Prednisolone/Rituximab/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Arsenic Trioxide/Imatinib Mesylate SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Mycophenolate Mofetil/Tacrolimus SubClassOf Agent Combination</Axiom>
                           <Axiom>Lomustine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Selenium/vitamin E SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Cyclosporine/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Topotecan/ZD9331 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone/Doxorubicin/Leucovorin Calcium/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Azacitidine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone/Tamoxifen/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Etoposide/Interleukin-3 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Epoetin alfa/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/SU5416 SubClassOf Agent Combination</Axiom>
                           <Axiom>Fowlpox-PSA-TRICOM Vaccine/Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Daunorubicin/Methotrexate/Prednisone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Methotrexate/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>L-744,832/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Coenzyme Q10/Vitamin E SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Dacarbazine/Doxorubicin/Mechlorethamine/Prednisone/Procarbazine/Vinblastine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Ketoconazole/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Methotrexate/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Tumor Cell Vaccine/BCG SubClassOf Agent Combination</Axiom>
                           <Axiom>Paclitaxel/VX-710 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Etoposide/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Interferon Alfa/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Etoposide Phosphate SubClassOf Agent Combination</Axiom>
                           <Axiom>Idarubicin/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Idarubicin/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bupropion/Nicotine SubClassOf Agent Combination</Axiom>
                           <Axiom>Pentoxifylline/Suramin/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>IDEC-In2B8/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dactinomycin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Monoclonal Antibody 17-1A SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Cyclophosphamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Epirubicin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Estramustine/Vitaxin-2/Zoledronate SubClassOf Agent Combination</Axiom>
                           <Axiom>Amsacrine/Cyclophosphamide/Hydroxyurea SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Melphalan/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Epirubicin/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Lonafarnib SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Mercaptopurine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Ixabepilone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Dexamethasone/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Paclitaxel/Pegfilgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Pixantrone/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etanidazole SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fludarabine/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Alum adjuvant/gp100 antigen/Interleukin-12/MART-1 antigen/Montanide ISA-51/tyrosinase peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Montanide ISA-51/Sargramostim/von Hippel-Lindau peptide vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Gamma/Levamisole SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Mercaptopurine/Methotrexate/Prednisolone/Teniposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Methotrexate/Prednisone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyproterone/Leuprolide SubClassOf Agent Combination</Axiom>
                           <Axiom>Bortezomib/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Pegaspargase/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Imatinib Mesylate/Leucovorin Calcium/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Paclitaxel/PSC 833 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Irinotecan/SU5416 SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Idarubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Paclitaxel/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Temozolomide/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Milodistim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Homoharringtonine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Etoposide/Hydroxyurea SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Milodistim/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dianhydrogalactitol/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Semustine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Etoposide/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Cyclophosphamide/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Cyclophosphamide/Doxorubicin/Fluorouracil/Fluoxymesterone/Methotrexate/Prednisone/Tamoxifen/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Mitoxantrone/Paclitaxel/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Doxorubicin/Interferon Alfa/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/UCN-01 SubClassOf Agent Combination</Axiom>
                           <Axiom>BMS-275291/Zoledronate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Pyrazoloacridine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Bleomycin/Epirubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone/Doxorubicin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Indomethacin/Interleukin-2/Tumor Infiltrating Lymphocytes SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Interferon Alfa/Leucovorin Calcium/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Cytarabine/Etoposide Phosphate/Rituximab/Sodium Thiosulfate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Hydroxyurea SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Hydroxyurea/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/EL625/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Fludarabine/Prednisone/Rituximab/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cytarabine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Gemcitabine/LY293111 SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Cytarabine/Doxorubicin/Etoposide/Methotrexate/Prednisone/Sargramostim/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Filgrastim/Ifosfamide/Interleukin-6 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Doxorubicin/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Ciprofloxacin/Pentoxifylline SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Goserelin/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Dactinomycin/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Interleukin-2/Lymphokine-Activated Killer Cells SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Etoposide/Mafosfamide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/cytarabine/prednisolone/vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Melphalan/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Melanoma Helper Peptide Vaccine/Montanide ISA-51/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Geldanamycin Analogue SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Pyrazoloacridine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>DX-8951f/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Fluorouracil/Folinic Acid SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Epirubicin/Etoposide/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Fludarabine/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Muramyl Tripeptide Phosphatidylethanolamine Liposome SubClassOf Agent Combination</Axiom>
                           <Axiom>Exemestane/Raloxifene SubClassOf Agent Combination</Axiom>
                           <Axiom>Hydroxyurea/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclosporine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Prednisone/Rasburicase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluoxymesterone/Mitolactol/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cetuximab/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Cytarabine/Etoposide/Rituximab/Sodium Thiosulfate SubClassOf Agent Combination</Axiom>
                           <Axiom>gp209-2M Antigen/Interleukin-2/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>Palivizumab/Ribavirin SubClassOf Agent Combination</Axiom>
                           <Axiom>Floxuridine/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Calcitriol/Zoledronate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cisplatin/Dacarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Filgrastim/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Carboplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>AFP Gene Hepatocellular Carcinoma Vaccine/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Gamma/Interleukin-2/Tumor Infiltrating Lymphocytes SubClassOf Agent Combination</Axiom>
                           <Axiom>R115777/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Metronidazole SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Melphalan/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Epoetin Alfa/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Goserelin SubClassOf Agent Combination</Axiom>
                           <Axiom>Fenretinide/Vitamin A SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/Soblidotin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/interleukin-2/Tumor Infiltrating Lymphocytes SubClassOf Agent Combination</Axiom>
                           <Axiom>Epirubicin/Bleomycin/Vinblastine/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Hydroxyurea/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Cisplatin/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-thymocyte globulin/methylprednisolone/tacrolimus SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Gemcitabine/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Hexamethylene Bisacetamide/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Tumor Cell Vaccine/CD40-Ligand/Interleukin-2 Gene SubClassOf Agent Combination</Axiom>
                           <Axiom>Keyhole Limpet Hemocyanin/Polysialic Acid/QS21 SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Interferon Alfa/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Dexniguldipine/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Carboplatin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Floxuridine/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Edrecolomab/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine/R-Verapamil SubClassOf Agent Combination</Axiom>
                           <Axiom>Pentostatin/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Oxaliplatin/ZD 1839 SubClassOf Agent Combination</Axiom>
                           <Axiom>Edatrexate/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Dipyridamole/Etoposide/Ketoconazole/Metronidazole/Quinidine/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Fluorouracil/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Aspirin/Clopidogrel Bisulfate SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Tirapazamine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Irinotecan/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Oxaliplatin/PTK787 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Methylprednisolone/Rituximab/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Omeprazole/Porfimer Sodium SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Idarubicin/Interleukin-3 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cisplatin/Cyclophosphamide/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Streptozocin SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Mitoxantrone/PSC 833 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/10-EdAM SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>interleukin-6/sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Carboplatin/Cisplatin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Doxorubicin/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Floxuridine/Leucovorin Calcium/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Neovastat/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Gentamicin/Piperacillin/Vancomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>ABT-510/Carboplatin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Flutamide/Goserelin/Suramin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Mercaptopurine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Cetuximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/L-Leucovorin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Doxorubicin/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Floxuridine/Hydroxyurea/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>CD40-Ligand/flt3 Ligand SubClassOf Agent Combination</Axiom>
                           <Axiom>Incomplete Freund's Adjuvant/Sargramostim/Tyrosinase Related Protein-1 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Mitomycin/Triazinate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Epoetin Alfa/Fluorouracil/Hydroxyurea/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Thymidine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fowlpox-CEA-TRICOM Vaccine/Vaccinia-CEA-TRICOM Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Irinotecan/Phenobarbital SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Epirubicin/Toremifene SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Etoposide/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Cyclophosphamide/Cytarabine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Interleukin-2/MART-1 Antigen/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Mitoxantrone/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Dexamethasone/Doxorubicin/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/OXi-104 SubClassOf Agent Combination</Axiom>
                           <Axiom>Daclizumab/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Methotrexate/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Etoposide/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cisplatin/Interferon Alfa/interleukin-2/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Dipyridamole/Etoposide/Ketoconazole/Metronidazole/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Ixabepilone/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Fluorouracil/Procarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Octreotide Pamoate/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Fludarabine/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Dexamethasone SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Idoxuridine/Leucovorin Calcium/PALA SubClassOf Agent Combination</Axiom>
                           <Axiom>Dipyridamole/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Dexamethasone/Etoposide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Filgrastim/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Incomplete Freund's Adjuvant/Interleukin-2/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Ritonavir/Stavudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Atamestane/Toremifene SubClassOf Agent Combination</Axiom>
                           <Axiom>Decitabine/Valproic Acid SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Ifosfamide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Amsacrine/Cytarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Merbarone SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Ifosfamide/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluoxymesterone/Mitolactol/Mitoxantrone/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Interleukin-4/Tumor Infiltrating Lymphocytes SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Semustine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Prednisone/UCN-01 SubClassOf Agent Combination</Axiom>
                           <Axiom>Mercaptopurine/Methotrexate/Methylprednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Etoposide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>QS21/Tn(c)-KLH Conjugate Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Raltitrexed SubClassOf Agent Combination</Axiom>
                           <Axiom>KSA-KLH Conjugate Vaccine/QS21 SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Irinotecan/Leucovorin Calcium/Monoclonal Antibody ABX-EGF SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/PALA SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexverapamil/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Diaziquone SubClassOf Agent Combination</Axiom>
                           <Axiom>Fludarabine/Octreotide SubClassOf Agent Combination</Axiom>
                           <Axiom>Clofarabine/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Ifosfamide/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Lomustine/Procarbazine/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Floxuridine/Leucovorin Calcium/PALA SubClassOf Agent Combination</Axiom>
                           <Axiom>Etanidazole/Melphalan/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Etoposide/Mercaptopurine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Dexverapamil/Etoposide/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Irinotecan/LY231514 SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Ifosfamide/Methotrexate/Procarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Interleukin-6 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Dexamethasone/Gemcitabine/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/RSR13 SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Mercaptopurine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Fluorouracil/Hydroxyurea/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Methotrexate/Prednisone/Vincristine/Zorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Interleukin-12/Montanide ISA-51/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dacarbazine/Doxorubicin/Mitomycin/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Folic Acid/Lometrexol SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Fludarabine/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Gefitinib/Temozolomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Thiotepa/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Leuprolide/Testosterone SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Dexrazoxane/Doxorubicin/Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Monoclonal Antibody R24 SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Quinidine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Interleukin-3 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Methylprednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>AG337/Cisplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Gemcitabine/Tipifarnib SubClassOf Agent Combination</Axiom>
                           <Axiom>Bryostatin 1/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Interleukin-2/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Estramustine/Mitoxantrone/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Bropirimine/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Sargramostim/Tumor Necrosis Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Ifosfamide/Sargramostim/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexrazoxane/Doxorubicin/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Goserelin/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Adenovirus 5-CD40-L Vector/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Epirubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Cetuximab/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Mechlorethamine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Ifosfamide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Fludarabine/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dacarbazine/Interferon Alfa/interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Gallium Nitrate SubClassOf Agent Combination</Axiom>
                           <Axiom>70-kD Heat-Shock Protein/MUC-1 Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Etoposide/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Calcium Citrate/Cholecalciferol/Zoledronate SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Carboplatin/Fluorouracil/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Methotrexate/Teniposide/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Amikacin/Ceftriaxone SubClassOf Agent Combination</Axiom>
                           <Axiom>Bcr-Abl Peptide Vaccine/QS21 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/Virulizin SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Interferon Alfa/Leucovorin Calcium/Raltitrexed SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Dendritic Cells/CD40-Ligand SubClassOf Agent Combination</Axiom>
                           <Axiom>Thalidomide/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Deoxycytidine SubClassOf Agent Combination</Axiom>
                           <Axiom>Montanide ISA-51/Multi-Epitope Melanoma Peptide Vaccine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>ALVAC-CEA-B7.1 vaccine/Fluorouracil/Irinotecan/Leucovorin calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Monoclonal Antibody CC49/Pentetic Acid SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Mitoguazone/Mitoxantrone/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/VNP40101M SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Doxorubicin/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>interleukin-2/Monoclonal Antibody OKT3/pentoxifylline SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Melphalan/Misonidazole/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Interferon Alfa/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Dexrazoxane/Doxorubicin/Etoposide/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Fluorouracil/Leucovorin Calcium/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Detoxpc/Lung Tumor Associated Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>Exemestane/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Eflornithine/Mitoguazone SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cisplatin/Monoclonal Antibody R24 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Dexamethasone/Mercaptopurine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/NY-ESO-B/QS21/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Ascorbic acid/Selenium SubClassOf Agent Combination</Axiom>
                           <Axiom>Peptide 946 Melanoma Vaccine/QS21 SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/LY317615 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Methotrexate/Pamidronate Disodium SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Doxorubicin/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Geldanamycin Analogue (AAG)/Imatinib Mesylate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Paclitaxel/ZD 1839 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Doxorubicin/Interferon Alfa/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Methotrexate/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Epirubicin/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Ifosfamide/Lomustine/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Phenylbutyrate/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-12/PSA Prostate Cancer Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Filgrastim/XR9576 SubClassOf Agent Combination</Axiom>
                           <Axiom>Daunorubicin/Dexamethasone/Ifosfamide/Methotrexate/Thioguanine/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>MUC-1 KLH Vaccine/QS21 SubClassOf Agent Combination</Axiom>
                           <Axiom>Lomustine/Prednisone/Procarbazine/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboxyamidotriazole/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Ifosfamide/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Paclitaxel/Yttrium Y 90 Monoclonal Antibody CC49 SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Tumor Necrosis Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Trifluoperazine/Verapamil/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Temozolomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Isotretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Azacitidine/Cytarabine/Daunorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Dexamethasone/Mercaptopurine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Floxuridine/Gemcitabine/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Fludarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Filgrastim/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Ifosfamide/Lomustine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Doxorubicin/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Ifosfamide/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-12/Paclitaxel/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Beta/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Sargramostim/Telomerase: 540-548 Peptide Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Topotecan/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Leucovorin Calcium/Mercaptopurine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Doxorubicin/Methotrexate/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Gamma/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Exemestane SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cyclophosphamide/Mitoxantrone/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Gefitinib/Irinotecan/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cisplatin/Cyclophosphamide/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Triazinate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Methotrexate/Procarbazine/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Semustine SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Dactinomycin/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>GM2-KLH Vaccine/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Zinc Oxide SubClassOf Agent Combination</Axiom>
                           <Axiom>Azacitidine/Carboplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Lomustine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Flavopiridol/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Mesna SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Doxorubicin/Melphalan/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Dactinomycin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Doxorubicin/Mechlorethamine/Prednisone/Procarbazine/Vinblastine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/DPPE SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Filgrastim/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Hydroxyurea SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin Hydrochloride Liposome/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>NY-ESO-1 peptide vaccine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Celecoxib/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Mercaptopurine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Floxuridine/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dacarbazine/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Pemetrexed Disodium SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Methotrexate/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>PSC 833/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dronabinol/Megestrol SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Filgrastim/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12 SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Pegylated Recombinant Human Megakaryocyte Growth and Development Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-12/Montanide ISA-51/Tyrosinase-Related Protein-1 SubClassOf Agent Combination</Axiom>
                           <Axiom>Erlotinib/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Ifosfamide/Mesna SubClassOf Agent Combination</Axiom>
                           <Axiom>Exemestane/Triptorelin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Interferon Gamma SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Mycophenolate Mofetil/Tacrolimus SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Dexamethasone/Etoposide/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Mercaptopurine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Docetaxel/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Dexamethasone/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Fluorouracil/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>CRL 1005/gp100 Antigen/Incomplete Freund's Adjuvant/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Flavopiridol/Imatinib Mesylate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Doxorubicin/Triazinate SubClassOf Agent Combination</Axiom>
                           <Axiom>AN-9/Docetaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Eflornithine/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/cytarabine/daunorubicin/dexamethasone/methotrexate/prednisolone/vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine/QS21 SubClassOf Agent Combination</Axiom>
                           <Axiom>Ethynyluracil/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Dactinomycin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Triapine SubClassOf Agent Combination</Axiom>
                           <Axiom>Ad5CMV-p53 Gene/Docetaxel/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/UCN-01 SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Staphylococcal Enterotoxin B SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Carmustine/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Methotrexate/Prednisone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Methotrexate/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Oxaliplatin/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Methotrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/MART-1 Antigen/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Fluorouracil/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/dexrazoxane/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Carmustine/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Mitoguazone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Filgrastim/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Interleukin-11/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Lomustine/Mitolactol/Procarbazine/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Diaziquone/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Diaziquone/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Azacitidine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Etoposide/Filgrastim/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Paclitaxel/PS-341 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Fluorouracil/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Mitoxantrone/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Doxorubicin/Ifosfamide/SU5416 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Detox-B Adjuvant/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Monoclonal Antibody 14G2A SubClassOf Agent Combination</Axiom>
                           <Axiom>rV-B7.1 Vaccine/Vaccinia-Prostate-Specific-Antigen Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Incomplete Freund's Adjuvant/Peptide 946 Melanoma Vaccine/Tetanus Peptide Melanoma Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/SU5416 SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Doxorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Pentostatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Interferon Alfa/Melphalan/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/G17DT SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Bleomycin/Cisplatin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Methotrexate/Pegaspargase/Prednisone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Caffeine/Cisplatin/Cytarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Interleukin-2/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Lymphocytes/Fludarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Etoposide/Procarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Flu Matrix/gp100 Antigen/Keyhole Limpet Hemocyanin/MAGE-3 /MART-1 Antigen/NY-ESO-B/QS21/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/L-Leucovorin/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Leuprolide/Methotrexate/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Tamoxifen/Tipifarnib SubClassOf Agent Combination</Axiom>
                           <Axiom>Flutamide/Hydrocortisone/Suramin SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Gallium Nitrate/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Doxorubicin/Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cisplatin/Etoposide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Amsacrine/Cyclophosphamide/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Eniluracil/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Keyhole Limpet Hemocyanin/QS21/Sialyl Tn Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Doxorubicin/Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Hypericum perforatum SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Cyclophosphamide/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/NG-Monomethyl-L-Arginine SubClassOf Agent Combination</Axiom>
                           <Axiom>Acyclovir/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Etoposide/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Eniluracil/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytochlor/Tetrahydrouridine SubClassOf Agent Combination</Axiom>
                           <Axiom>Epirubicin/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>BMS-247550/Carboplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Metoclopramide/Midazolam SubClassOf Agent Combination</Axiom>
                           <Axiom>Amsacrine/Carmustine/Cytarabine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Lomustine/Temozolomide/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Decitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fludarabine/Hydroxyurea SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Interleukin-1-Alpha SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Doxorubicin/Thalidomide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Montanide ISA-51/Tyrosinase peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Monoclonal Antibody Anti-Avb3 Integrin SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Cladribine SubClassOf Agent Combination</Axiom>
                           <Axiom>Leflunomide/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cimetidine/Cyclophosphamide/Indomethacin/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Filgrastim/Fluorouracil/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Mercaptopurine/Methotrexate/Prednisone/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Prednisone/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>O6-Benzylguanine/Polifeprosan 20 With Carmustine Implant SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Filgrastim/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Daunorubicin Liposomal/SU5416 SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Octreotide SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Fluorouracil-Uracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>ALVAC-CEA-B7.1 Vaccine/Tetanus Toxoid SubClassOf Agent Combination</Axiom>
                           <Axiom>Tamoxifen/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Monoclonal Antibody Hu1D10 SubClassOf Agent Combination</Axiom>
                           <Axiom>DC-Chol Liposomes/EGFR Antisense DNA SubClassOf Agent Combination</Axiom>
                           <Axiom>Dipyridamole/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Pefloxacin/Penicillin V SubClassOf Agent Combination</Axiom>
                           <Axiom>Nimodipine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Lomustine/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexrazoxane/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Polyglutamate Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Monoclonal Antibody CC49 SubClassOf Agent Combination</Axiom>
                           <Axiom>Lomustine/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Irinotecan/Leucovorin Calcium/ZD 1839 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Dexamethasone/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>BCG/NY-ESO-1 Peptide Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Triapine/Cisplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Doxorubicin/Tegafur SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Etoposide/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Melphalan/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Methotrexate/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Cyclophosphamide/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Monoclonal Antibody 11D10 Anti-Idiotype Vaccine/Monoclonal Antibody GD2 Anti-Idiotype Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Melanoma Helper Peptide Vaccine/Montanide ISA-51/Multi-Epitope Melanoma Peptide Vaccine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Edrecolomab/Fluorouracil/Levamisole SubClassOf Agent Combination</Axiom>
                           <Axiom>QS21/RAS peptide cancer vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Melphalan/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Mitomycin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Methotrexate/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Mitoxantrone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Epoetin Alfa/Interleukin-3 SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Melphalan/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cytarabine/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Mitolactol SubClassOf Agent Combination</Axiom>
                           <Axiom>Montanide ISA-51/NY-ESO-1 Peptide Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Interleukin-1-Beta SubClassOf Agent Combination</Axiom>
                           <Axiom>Edrecolomab/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Dexamethasone/Etoposide/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Cyclophosphamide/Decitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>PEG-Interferon Alfa-2b/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluoxymesterone/Thiotepa/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Epirubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Daunorubicin/Dexamethasone/Ifosfamide/Mercaptopurine/Methotrexate/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Etoposide/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Tiazofurin SubClassOf Agent Combination</Axiom>
                           <Axiom>BCG/Bropirimine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Doxorubicin/Lomustine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Estramustine/Paclitaxel/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Methotrexate/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Methotrexate/Prednisone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>CI-994/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Suramin/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cisplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Fowlpox-PSA Vaccine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Interleukin-3 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Dipyridamole/Etoposide/Ketoconazole/Metronidazole/Quinidine/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Ifosfamide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Monoclonal Antibody 3622W94/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Mercaptopurine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Prednisone/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Eflornithine/Lomustine/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Dendritic Cells/Tetanus Toxoid SubClassOf Agent Combination</Axiom>
                           <Axiom>CpG 7909/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Hydroxyurea SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Aminoglutethimide/Bicalutamide/Hydrocortisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Methotrexate/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cisplatin/Cyclophosphamide/Cytarabine/Hydroxyurea/Methylprednisolone/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Clofarabine/Cytarabine/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Monoclonal antibody Ch14.18/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Dexamethasone/Doxorubicin/Melphalan/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Pegaspargase SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Doxorubicin/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Leuprolide/Suramin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Mercaptopurine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Flutamide/Isotretinoin/Leuprolide SubClassOf Agent Combination</Axiom>
                           <Axiom>MAGE-10.A2/Melan-A/NY-ESO-1 peptide vaccine/Tyrosinase peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/filgrastim/Ifosfamide/Mesna SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Mitomycin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Fluorouracil/Interferon Alfa/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Etoposide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dacarbazine/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Calcium Gluconate/Cholecalciferol SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Sargramostim/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Flu Matrix/gp100 Antigen/MAGE-3.1/MART-1 Antigen/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Estramustine/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Epirubicin/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Erlotinib/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Irinotecan/Raltitrexed SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluoxymesterone/Mitolactol/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Ifosfamide/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Leucovorin Calcium/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Leucovorin Calcium/Trimetrexate Glucuronate SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Ras Peptide Cancer Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Etoposide/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Epirubicin/Fluorouracil/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Acetaminophen/Acetylcysteine/Carmustine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Montanide ISA-51/Tyrosinase-Related Protein-1 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Interleukin-2/Tumor Infiltrating Lymphocytes SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Incomplete Freund's Adjuvant/Interleukin-12/Tyrosinase Related Protein-1 SubClassOf Agent Combination</Axiom>
                           <Axiom>Mitoxantrone/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/Tipifarnib SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Filgrastim/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>CCI-779/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Prednisone/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Estramustine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Methotrexate/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Mitoxantrone/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Isotretinoin/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Mitotane SubClassOf Agent Combination</Axiom>
                           <Axiom>Flavopiridol/irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Methotrexate/Methylprednisolone/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Etoposide/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Ethiodized Oil SubClassOf Agent Combination</Axiom>
                           <Axiom>Daunorubicin/Methylprednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Filgrastim/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin HCl Liposome/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Mercaptopurine/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin Hydrochloride Liposome/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/IM-862 SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Methotrexate/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Adenovirus 5-Tumor Necrosis Factor Alpha/Capecitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Motexafin Gadolinium SubClassOf Agent Combination</Axiom>
                           <Axiom>Floxuridine/Fluorouracil/Interferon Alfa/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Dactinomycin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Melphalan/Prednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Lomustine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Lymphocytes/Fluorouracil/Interferon Alfa/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/ZD6474 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Ifosfamide/Mitomycin/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Bryostatin 1/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Fludarabine/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Interleukin-2/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Etoposide/Ifosfamide/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Mitolactol SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Mitomycin/Tegafur SubClassOf Agent Combination</Axiom>
                           <Axiom>Dactinomycin/Doxorubicin/Etoposide/Ifosfamide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Mitomycin/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Corticotropin/Cyclophosphamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Fluorouracil/Irinotecan/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Mitoxantrone/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dacarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Tipifarnib/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Daunorubicin/Dexamethasone SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Hydroxyurea SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Cytarabine/Doxorubicin/Etoposide/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>AG3340/Carboplatin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Daunorubicin/Etoposide/Prednisone/Teniposide/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Neovastat/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Estramustine/Filgrastim/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Lomustine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Hydrocortisone/Suramin SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Interleukin-12 SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Interferon alpha/Interleukin-2/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Etoposide/Leucovorin calcium/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bortezomib/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Paclitaxel/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Monoclonal Antibody 14G2A/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>CCI-779/Letrozole SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Chlorambucil/Cisplatin/Cyclophosphamide/Dactinomycin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Irinotecan/SU5416 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dimesna/Docetaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Doxorubicin/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Idarubicin/Leucovorin calcium/methotrexate/methylprednisolone/vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Hydrazine Sulfate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/Triapine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Methotrexate/Prednisone/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Doxorubicin/Mercaptopurine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Doxorubicin/Methotrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Monoclonal Antibody 3F8 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclosporine/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Leucovorin Calcium/Tegafur/Uracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Epirubicin/Folinic Acid/Fluorouracil/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Dexamethasone/Doxorubicin/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Etoposide/Ifosfamide/Methotrexate/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Poly ICLC SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cytarabine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Filgrastim/Mercaptopurine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Estramustine/Etoposide/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Lamivudine/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Flavopiridol/Fludarabine/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Paclitaxel/Suramin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Mercaptopurine/Methotrexate/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Methotrexate/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Isotretinoin/Vitamin E SubClassOf Agent Combination</Axiom>
                           <Axiom>Mechlorethamine/Prednisone/Procarbazine/Sargramostim/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Interferon Alfa/MART-1 Antigen/Montanide ISA-51/Sargramostim/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Oxaliplatin/ZD6126 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Geldanamycin Analogue/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Idarubicin/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Ifosfamide/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Donepezil/Vitamin E SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluoxetine/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Fluorouracil/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>GPI-0100/MUC-2-Globo H-KLH Conjugate Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/MAGE-3/MART-1 Antigen/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Montanide ISA-51/von Hippel-Lindau peptide vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Filgrastim/Interleukin-6/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Filgrastim/Paclitaxel/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Thioguanine/Tiazofurin SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-12/Montanide ISA-51/Tyrosinase Related Protein-1 SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Interleukin-4 SubClassOf Agent Combination</Axiom>
                           <Axiom>Flavone Acetic Acid/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Paclitaxel/R101933 SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dianhydrogalactitol/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/Carboplatin/Epirubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Dacarbazine/Doxorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Doxorubicin/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Filgrastim/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Epratuzumab/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Gemcitabine/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cyclophosphamide/Doxorubicin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/QS21/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Interleukin-1-Beta SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dexamethasone/Doxorubicin/Floxuridine/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/filgrastim/Paclitaxel/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>gp209-2M Antigen/Heat Shock Protein 70/OVA Bip Peptide/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dacarbazine/Interferon-alpha/Tamoxifen/Tumor Infiltrating Lymphocytes SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil-Uracil/Gemcitabine/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Erlotinib/Paclitaxel/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Raltitrexed SubClassOf Agent Combination</Axiom>
                           <Axiom>Incomplete Freund's Adjuvant/Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin Hcl Liposome/Gemcitabine/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/Monoclonal Antibody HER2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Estramustine/Hydrocortisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Idarubicin/Recombinant Human Thrombopoietin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Dexamethasone/Leucovorin Calcium/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Montanide ISA-51/Peptide 946 melanoma vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Fludarabine/Pixantrone/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cytarabine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Daunorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cladribine/Cytarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Doxorubicin/Filgrastim/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Methotrexate/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Hydroxyurea/Idoxuridine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Levamisole SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Lomustine/Methotrexate/Methylprednisolone/Procarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Vinorelbine/Zosuquidar Trihydrochloride SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Mitomycin/Streptozocin SubClassOf Agent Combination</Axiom>
                           <Axiom>Tamoxifen/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Vaccine-Sensitized Draining Lymph Node Cells SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Methotrexate/Tamoxifen/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Topotecan/UCN-01 SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-12/Montanide ISA-51/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Etoposide/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Cytarabine/Doxorubicin/Etoposide/Filgrastim/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Flavopiridol SubClassOf Agent Combination</Axiom>
                           <Axiom>Estramustine/Mitoxantrone/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Temozolomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Fludarabine/Thalidomide/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Monoclonal Antibody R24/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Dexrazoxane/Doxorubicin/Mercaptopurine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Fluorouracil/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Tamoxifen/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fowlpox-Tyrosinase Vaccine/Interleukin-2/Vaccinia-Tyrosinase Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Prednisone/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Etoposide/Sodium Thiosulfate SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Doxorubicin/Vincristine/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Interferon Alfa/PALA SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cisplatin/Interferon Alfa/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Lonafarnib/Paclitaxel/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Prednisone/Sargramostim/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Interleukin-11 SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Vincristine/VX-710 SubClassOf Agent Combination</Axiom>
                           <Axiom>Imatinib Mesylate/PEG-Interferon Alfa-2a SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/P-30 Protein SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/MAGE-3.1/MART-1 Antigen/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Bryostatin 1/Interleukin-2/Ionomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Methylprednisolone/Pixantrone/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Rifampin/Tetracycline SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Prednisone/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-12/MART-1 Antigen/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Filgrastim/Methylprednisolone/Monoclonal Antibody Okt3 SubClassOf Agent Combination</Axiom>
                           <Axiom>Azacytidine/Carboplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Mitoxantrone/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Oxaliplatin/ZD 1839 SubClassOf Agent Combination</Axiom>
                           <Axiom>Daunorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Dexamethasone/Lomustine/Methotrexate/Procarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Dexamethasone/Idarubicin/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Epoetin Alfa/Etoposide/Filgrastim/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Irinotecan/Temozolomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Methotrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Prednisolone/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Methylprednisolone/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>CC-5013/Dexamethasone SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Dendritic Cells/Indinavir SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Mitoxantrone/Monoclonal Antibody Hug1-M195 SubClassOf Agent Combination</Axiom>
                           <Axiom>Montanide ISA-51/Peptide 946-tetanus peptide conjugate melanoma vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Hydroxyurea/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxol/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide Phosphate/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Infliximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Lymphokine-Activated Killer Cells SubClassOf Agent Combination</Axiom>
                           <Axiom>Cetuximab/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bortezomib/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Clarithromycin/Omeprazole/Tinidazole SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Didanosine/Doxorubicin/Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Leucovorin Calcium/Mercaptopurine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>E7070/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Ritonavir SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cisplatin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Filgrastim/Fluorouracil/Hydroxyurea SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Oblimersen/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Flutamide/Leuprolide/Suramin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Dexamethasone/Mercaptopurine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/cytarabine/dexamethasone/vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Paclitaxel/Tirapazamine SubClassOf Agent Combination</Axiom>
                           <Axiom>Flu Matrix/gp100 Antigen/Keyhole Limpet Hemocyanin/MAGE-3/MART-1 Antigen/NY-ESO-B/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Leucovorin Calcium/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Cytarabine/Daunorubicin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Edatrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Methotrexate/Muramyl Tripeptide Phosphatidylethanolamine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Doxorubicin/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Diaziquone/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>IDEC-114 Monoclonal Antibody/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Mercaptopurine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Ifosfamide/Mesna/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Leuprolide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Yttrium Y 90 Monoclonal Antibody M170 SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Interleukin-2/Isotretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Filgrastim/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Piritrexim SubClassOf Agent Combination</Axiom>
                           <Axiom>BMS-188797/Carboplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cisplatin/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Lomustine SubClassOf Agent Combination</Axiom>
                           <Axiom>Medroxyprogesterone/Mitomycin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Flutamide/Ketoconazole/Leuprolide SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Leucovorin Calcium/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Interleukin-3/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dacarbazine/Interleukin-2/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/VX-710 SubClassOf Agent Combination</Axiom>
                           <Axiom>Human Papillomavirus 16/18 L1 Virus-Like Particle/AS04 Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Biomed 101/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Bexarotene/Cisplatin/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cisplatin/Cytarabine/Dexamethasone/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Ifosfamide/Mercaptopurine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Doxorubicin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Epirubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Lomustine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dimesna/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Vincristine/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Ifosfamide/Interferon Alfa/Pentostatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Edatrexate/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Dacarbazine/Lomustine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-Thymocyte Globulin/Busulfan/Melphalan/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Doxorubicin/Hydroxyurea/Lomustine/Methotrexate/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Letrozole/Tipifarnib SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Ifosfamide/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Marimastat SubClassOf Agent Combination</Axiom>
                           <Axiom>Allogeneic Lymphocytes/Cyclosporine SubClassOf Agent Combination</Axiom>
                           <Axiom>Melphalan/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Fluorouracil/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Beta/Interferon Gamma SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Lutetium Lu 177 Monoclonal Antibody CC49/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Sulindac/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Ciprofloxacin/Cisplatin/Etoposide/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Monoclonal Antibody 3622W94 SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Mitoxantrone/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Pentoxifylline SubClassOf Agent Combination</Axiom>
                           <Axiom>BCG/Dacarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>cBR96-Doxorubicin Immunoconjugate/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Monoclonal Antibody HER2/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Etoposide/Gemtuzumab Ozogamicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Ifosfamide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Flavopiridol SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Rebeccamycin Analogue SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Flt3 Ligand/Milodistim/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Hydrocortisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Irinotecan/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Fluorouracil/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Filgrastim/Interleukin-6/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Clodronate/Mitoxantrone/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Paclitaxel/Cisplatin/Topotecan/G-CSF SubClassOf Agent Combination</Axiom>
                           <Axiom>Bispecific Antibody MDX447/Lymphokine-Activated Killer Cells SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Mitoxantrone/Prednisone/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/eflornithine/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Daunorubicin/Dexamethasone/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Filgrastim/Interleukin-6 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Menogaril SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Methotrexate/Sargramostim/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Suramin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Dexamethasone/Etoposide/Idarubicin/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Cyclophosphamide/Diaziquone SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Melphalan/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Idarubicin/Methylprednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Lovastatin/Sulindac SubClassOf Agent Combination</Axiom>
                           <Axiom>Fludarabine/UCN-01 SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Tetanus Peptide Melanoma Vaccine/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Maxamine/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Lomustine/Mitolactol/Procarbazine/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Pentamidine/Sargramostim/Vincristine/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Daunorubicin/Dexamethasone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Hydroxyurea/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Vitaxin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Irinotecan/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Sargramostim/Vaccinia-CEA-TRICOM Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Daunorubicin/Pegaspargase/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Beta Carotene/Vitamin A SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Gemcitabine/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Doxorubicin/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/PALA SubClassOf Agent Combination</Axiom>
                           <Axiom>Mitoxantrone/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Filgrastim/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Epoetin Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Epirubicin/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Montanide ISA-51/Multi-Epitope Melanoma Peptide Vaccine/Sargramostim/Tetanus Peptide Melanoma Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Filgrastim/Paclitaxel/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cisplatin/Docetaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>GEM 231/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Ifosfamide/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Etoposide/Prednisolone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Leucovorin Calcium/Mercaptopurine/Methotrexate/Pegaspargase/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Stem Cell Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Mercaptopurine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Methotrexate/Prednisone/Thiotepa/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/Docetaxel/Tipifarnib SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin Hcl Liposome/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>interleukin-3/interleukin-6 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Ifosfamide/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amsacrine/Cytarabine/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexrazoxane/Doxorubicin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Etoposide/Hydroxyurea SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Doxorubicin/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Dexamethasone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Dactinomycin/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Melphalan/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Leflunomide/Mitoxantrone/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Doxorubicin/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Leucovorin Calcium/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Etoposide/Ifosfamide/Yttrium Y 90 Humanized Epratuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Flt3 Ligand/gp100 Antigen/MART-1 Antigen/Tyrosinase SubClassOf Agent Combination</Axiom>
                           <Axiom>Oblimersen/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>BCG/Interferon alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Pegylated Interferon Alfa/Temozolomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Ketoconazole SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Carboplatin/Epirubicin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Etoposide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>HER-2-neu peptide vaccine/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Prednisone/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Etoposide/Methotrexate/Prednisolone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Raltitrexed SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Hydroxyurea/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Incomplete Freund's Adjuvant/MART-1 Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>BCG/Monoclonal Antibody BEC2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cytarabine/Doxorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Fluorouracil/Leucovorin Calcium/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>p53 Adenovirus/SCH 66336 SubClassOf Agent Combination</Axiom>
                           <Axiom>Mitolactol/Mitoxantrone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Doxorubicin/Methotrexate/Methylprednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Vitamin E/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Epirubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Prednisone/Procarbazine/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Edatrexate/Filgrastim/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Paclitaxel/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Edatrexate/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Dexamethasone/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Novobiocin SubClassOf Agent Combination</Axiom>
                           <Axiom>Levamisole/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Mitoxantrone/Tretinoin Liposome SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Prednisone/Sargramostim/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Flavopiridol/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Doxorubicin/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Daunorubicin/Milodistim/Pegaspargase/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-11/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cladribine/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Melphalan/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Mechlorethamine/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Oxaliplatin/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Beclomethasone/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Mitomycin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/ISIS 3521/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>EP-2101/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>Montanide ISA-51/PSA prostate cancer vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Melphalan/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Methotrexate/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Etoposide/Mesna SubClassOf Agent Combination</Axiom>
                           <Axiom>Monoclonal Antibody HER2/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/Lonafarnib SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Methotrexate/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dactinomycin/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Cyclophosphamide/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Daunorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/cyclophosphamide/cytarabine/daunorubicin/dexamethasone/leucovorin calcium/mercaptopurine/methotrexate/thioguanine/vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Interleukin-2/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Paclitaxel/Prinomastat SubClassOf Agent Combination</Axiom>
                           <Axiom>Indinavir/Lamivudine/Stavudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Interleukin-1-Alpha SubClassOf Agent Combination</Axiom>
                           <Axiom>BCG/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>506U78/Mercaptopurine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Docetaxel/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Bicalutamide/Triptorelin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Daunorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Cytarabine/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Poly ICLC SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Ifosfamide/Muramyl Tripeptide Phosphatidylethanolamine Liposome SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/MART-1 Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>Lomustine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Ifosfamide/Mesna/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/S-1 SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Trimetrexate Glucuronate SubClassOf Agent Combination</Axiom>
                           <Axiom>Detox/Keyhole Limpet Hemocyanin/Sialyl Tn Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>Allopurinol/Fluorouracil/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Interleukin-6/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorodihydroxypyridine/Potassium Oxonate/Tegafur SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Etoposide/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Erlotinib/Fluorouracil/Leucovorin Calcium/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>HLA-A1, A2, B35-Restricted Survivin Peptides/Montanide ISA-51 Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Fluoxymesterone/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Amsacrine/Cytarabine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cisplatin/Cytarabine/Dexamethasone SubClassOf Agent Combination</Axiom>
                           <Axiom>BCG/Polyvalent Melanoma Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Methotrexate/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim-Fetal Liver Tyrosine Kinase-3 Fusion Protein/gp100 Antigen/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Gamma/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Fowlpox Virus Vaccine/Interleukin-2/Vaccinia-Tyrosinase Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Interferon Alfa/Interferon Gamma/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Dipyridamole/Etoposide/Ketoconazole/Metronidazole SubClassOf Agent Combination</Axiom>
                           <Axiom>Irinotecan/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Semustine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-3/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Interferon Alfa/Interleukin-2/Isotretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Methotrexate/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Cisplatin/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Lomustine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Peptide 946 Melanoma Vaccine/QS21/Tetanus Peptide Melanoma Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Buserelin/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Fludarabine/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Daclizumab/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Levamisole SubClassOf Agent Combination</Axiom>
                           <Axiom>Montanide ISA-51/p53 peptide vaccine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Estramustine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Dexamethasone/Doxorubicin/Etoposide/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Nolatrexed Dihydrochloride/Cisplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Etoposide/Mercaptopurine/Methotrexate/Prednisolone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Fludarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Methotrexate/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Selenium SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Carcinoembryonic Antigen Peptide 1-6D/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Mechlorethamine/Methotrexate/Prednisone/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Macrophage Colony-Stimulating Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Gallium Nitrate/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>BCG/Cyclophosphamide/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>GW572016/Letrozole SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Penclomedine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Floxuridine/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Doxorubicin/Prednisone/Quinine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Pegaspargase SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Squalamine Lactate SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Doxorubicin/Etoposide/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Etoposide/PSC 833 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Streptozocin SubClassOf Agent Combination</Axiom>
                           <Axiom>Aminoglutethimide/Suramin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cytarabine/Dexamethasone/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin Hcl Liposome/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Interferon Gamma SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide Phosphate/Melphalan/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Thiotepa/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Sirolimus SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Procarbazine/Rituximab/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/interleukin-2/Paclitaxel/Tumor Infiltrating Lymphocytes SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Monoclonal Antibody 3F8 SubClassOf Agent Combination</Axiom>
                           <Axiom>Incomplete Freund's Adjuvant/Interleukin-2/Tyrosinase-Related Protein-1 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dacarbazine/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Bortezomib/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Methotrexate/Procarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-1-Beta/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Monoclonal Antibody Anti-Tac SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Prednisone/Procarbazine/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexrazoxane/Doxorubicin/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>interleukin-2/Monoclonal Antibody OKT3/Tumor Necrosis Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Daunorubicin/Etoposide/Prednisone/Teniposide/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Dexamethasone/Methotrexate/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Iodine I 125/Polifeprosan 20 With Carmustine Implant SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cisplatin/Floxuridine SubClassOf Agent Combination</Axiom>
                           <Axiom>Immune Globulin/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Montanide ISA-51/Von Hippel-Lindau Peptide Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Epirubicin/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Incomplete Freund's Adjuvant/Interleukin-2/Von Hippel-Lindau Peptide Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Cytarabine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Mechlorethamine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Ifosfamide/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Interleukin-3/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cetuximab/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bortezomib/Fludarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Ifosfamide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Doxorubicin/Prednisone/Teniposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Melphalan/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/cyclophosphamide/cytarabine/daunorubicin/thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Aminoglutethimide/Danazol/Medroxyprogesterone/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Amsacrine/Decitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Quinidine/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Aminoglutethimide/Hydrocortisone/Suramin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Mitoguazone/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Lomustine/Melphalan/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Pegaspargase/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Mercaptopurine/Methotrexate/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/PS-341 SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/Celecoxib/Gefitinib SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Ifosfamide/Methotrexate/Muramyl Tripeptide Phosphatidylethanolamine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Lomustine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Paclitaxel/ZD-6474 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/SU5416 SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Lomustine/Methotrexate/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Mitoxantrone/Prednisone/Prinomastat SubClassOf Agent Combination</Axiom>
                           <Axiom>Fludarabine/Pentostatin SubClassOf Agent Combination</Axiom>
                           <Axiom>HER-2-Neu Peptide Vaccine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Prednisolone/Rituximab/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Doxorubicin Hcl Liposome/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Etoposide/Mitotane/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Ifosfamide/Methotrexate/Mitoguazone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Dexamethasone/Etoposide/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Cisplatin/Cyclophosphamide/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Epirubicin/Methotrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Idoxuridine/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Lomustine/Methotrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Monoclonal Antibody C225/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Fulvestrant/Gefitinib SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Oblimersen/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Gemtuzumab Ozogamicin/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Sargramostim/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Cyclophosphamide/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Milodistim SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Mitoxantrone/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexverapamil/Doxorubicin/Etoposide/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Calcium Citrate/Cholecalciferol SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/Ixabepilone SubClassOf Agent Combination</Axiom>
                           <Axiom>Amoxicillin/Clarithromycin/Omeprazole SubClassOf Agent Combination</Axiom>
                           <Axiom>Incomplete Freund's Adjuvant/Sargramostim/Von Hippel-Lindau Peptide Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Monoclonal Antibody ABX-EGF/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/RMP-7 SubClassOf Agent Combination</Axiom>
                           <Axiom>Indomethacin/Interleukin-2/Lymphokine-Activated Killer Cells SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Octreotide Pamoate SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Imatinib Mesylate SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Dendritic Cells/Candida Albicans Skin Test Reagent/CD40-Ligand/gp100 Antigen/Interferon Gamma/Interleukin-4/MART-1 Antigen/Sargramostim/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Benznidazole/Lomustine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bispecific Antibody 520C9XH22/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Trifluoperazine/Verapamil SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/MART-1 Antigen/Montanide ISA-51/Sargramostim/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Gefitinib/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Probenecid/10-Propargyl-10-Deazaaminopterin SubClassOf Agent Combination</Axiom>
                           <Axiom>Prednisone/Satraplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Aminoglutethimide/Hydrocortisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclosporine/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Razoxane/Semustine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Interferon alfa/Interleukin-2/Lymphokine-Activated Killer Cells SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Pegaspargase/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cytarabine/Etoposide/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Amsacrine/Cytarabine/Daunorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Interleukin-12/MART-1 Antigen/Montanide ISA-51/Sargramostim/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/cytarabine/mercaptopurine/methotrexate/prednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Ethacrynic Acid/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>D1/3-MAGE-3 Fusion Protein/SB-AS02B Adjuvant SubClassOf Agent Combination</Axiom>
                           <Axiom>Floxuridine/Octreotide/Streptozocin SubClassOf Agent Combination</Axiom>
                           <Axiom>Alum adjuvant/Monoclonal antibody 4B5 anti-idiotype vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Etoposide/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Methotrexate/PALA/Triacetyluridine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Doxorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Interleukin-3 SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Tariquidar SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Cytarabine/Etoposide/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Etoposide/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cisplatin/Dacarbazine/Interleukin-2/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Ifosfamide/Paclitaxel/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Iodine I 131 Tositumomab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cladribine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Interleukin-12/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>BMS-182751/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Fenretinide/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Mercaptopurine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Prednisone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Epoetin Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Ifosfamide/Etanidazole SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Melan-A/NA17-A Antigen/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Flavopiridol/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>UFT/Leucovorin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Doxorubicin/Misonidazole SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Lamivudine/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Methotrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Daunorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Folic Acid/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Piperacillin/Tazobactam/Vancomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/Sargramostim/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Temozolomide/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Gemtuzumab Ozogamicin/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Doxorubicin/Mechlorethamine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Etoposide/Methotrexate/Methylprednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Ifosfamide/Interleukin-3 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Dexamethasone/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Beclomethasone/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Dexniguldipine/Doxorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cytarabine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Daunorubicin/Prednisone/Teniposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Hydroxychloroquine/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Eflornithine/Triamcinolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Imatinib Mesylate/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>IM-862/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Methotrexate/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Mitomycin/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Dexamethasone/Etoposide/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Oblimersen/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>MUC-2-KLH Vaccine/QS21 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/ZD 1839 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Epirubicin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/cytarabine/daunorubicin/methotrexate/prednisolone/vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Virulizin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Idarubicin/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Pentoxifylline SubClassOf Agent Combination</Axiom>
                           <Axiom>506U78/Asparaginase/Daunorubicin/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Dendritic Cells/CMV pp65 Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxol/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Keyhole Limpet Hemocyanin/Polysialic Acid SubClassOf Agent Combination</Axiom>
                           <Axiom>Bryostatin 1/Fludarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxifluridine/L-Leucovorin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyproterone/Triptorelin SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/DJ-927 SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Floxuridine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cisplatin/Cyclophosphamide/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Interferon Alfa/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Irinotecan/Pemetrexed Disodium SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cytarabine/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-2/MART-1 Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Shark Cartilage/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/PS-341 SubClassOf Agent Combination</Axiom>
                           <Axiom>BMS-182751/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Montanide ISA-51/Tyrosinase-Related Protein-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Monoclonal antibody 4B5 anti-idiotype vaccine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>3-AP/Cisplatin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Edatrexate/Filgrastim/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Fludarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Rituximab/Temozolomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Prednisone/Teniposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Fluorouracil/Hydroxyurea SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Etoposide/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Hydroxyurea SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Fluorouracil/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Gemcitabine/Zileuton SubClassOf Agent Combination</Axiom>
                           <Axiom>Cetuximab/Fluorouracil/Leucovorin Calcium/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Fluorouracil/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Interleukin-6/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cisplatin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Aminoglutethimide/Danazol/Hydrocortisone/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Fluoxymesterone/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Dexamethasone/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Dacarbazine/Doxorubicin/Mechlorethamine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Floxuridine/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Fludarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Dexamethasone/Methotrexate/Mitoxantrone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/MART-1 Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>CpG 7909/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Amphotericin B/Colistin Sulfate/Tobramycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Maxamine/Interferon Alpha SubClassOf Agent Combination</Axiom>
                           <Axiom>Mechlorethamine/Methotrexate/Prednisone/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Flutamide/Toremifene SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Fludarabine/Triapine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dipyridamole/Fluorouracil/Leucovorin Calcium/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Monoclonal Antibody 17-1A/sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cytarabine/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Interleukin-6 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Interferon Alfa/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Lymphocytes/gp100 Antigen/Interleukin-12/MAGE-3/Melan-A/NA17-A Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Fowlpox-PSA Vaccine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Gemcitabine/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Etoposide/Methotrexate/Prednisone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Gefitinib/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Daunorubicin/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Montanide ISA-51/Telomerase: 540-548 Peptide Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Idarubicin/Ifosfamide/Methotrexate/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Melphalan/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluoxymesterone/Tamoxifen/Thiotepa/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/interleukin-12 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Uracil/Tegafur/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dacarbazine/Interleukin-2/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Lutetium Lu 177 Monoclonal Antibody CC49/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Epoetin Alfa/Interleukin-6/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dexamethasone/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cisplatin/Dacarbazine/Interferon Alfa/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Ifosfamide/Mesna/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin HCl Liposome/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin HCl Liposome/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cisplatin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Prednisolone/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Nimodipine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Paclitaxel/Yttrium Y 90 Monoclonal Antibody Lym-1 SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Ifosfamide/Methotrexate/Muramyl Tripeptide Phosphatidylethanolamine Liposome SubClassOf Agent Combination</Axiom>
                           <Axiom>Daunorubicin/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>9-cis-Retinoic Acid/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Dexamethasone/Etoposide/Methotrexate/Pegaspargase/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>BCG/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Dexamethasone/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexrazoxane/Doxorubicin/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine/QS21 SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Filgrastim/Mercaptopurine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate/Sargramostim/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Beta/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/Ixabepilone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Fluorouracil/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Mercaptopurine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amoxicillin-Clavulanate Potassium/Ciprofloxacin SubClassOf Agent Combination</Axiom>
                           <Axiom>Idarubicin/Tretinoin Liposome SubClassOf Agent Combination</Axiom>
                           <Axiom>Irinotecan/Octreotide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Dexamethasone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Cyclosporine/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Procarbazine/Semustine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/MART-1 Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Tegafur/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Cyclophosphamide/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Gamma/Melphalan/Tumor Necrosis Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Mitoxantrone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Brequinar/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Mechlorethamine/Prednisone/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Idoxuridine/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Hydrazine Sulfate SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Doxorubicin/Vincristine/zalcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin Hcl Liposome/ZD0473 SubClassOf Agent Combination</Axiom>
                           <Axiom>Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/NY-ESO-B/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/PS-341 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Temozolomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Dexamethasone/Etoposide Phosphate/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Hydroxyurea/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Mercaptopurine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Cyclophosphamide/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/ONYX-015 SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Cyclophosphamide/Interferon Alfa/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fowlpox-PSA-TRICOM Vaccine/Sargramostim/Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Dacarbazine/Thymidine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dacarbazine/Interferon Alfa/Interleukin-2/Tamoxifen/Tumor Infiltrating Lymphocytes SubClassOf Agent Combination</Axiom>
                           <Axiom>Bryostatin 1/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Flavopiridol/Fluorouracil/Irinotecan/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amsacrine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Mitomycin/Tretinoin/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Melphalan/Procarbazine/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Oltipraz/Vitamin A SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Dendritic Cells/Keyhole Limpet Hemocyanin/MAGE-3/Melan-A/Survivin Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>MUC-2-Globo H-KLH Conjugate Vaccine/QS21 SubClassOf Agent Combination</Axiom>
                           <Axiom>AUT-OV-ALVAC-hB7.1/Interferon Gamma SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Methylprednisolone/Mycophenolate Mofetil SubClassOf Agent Combination</Axiom>
                           <Axiom>Dianhydrogalactitol/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Idarubicin/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Hydroxyurea/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Pentostatin/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-1-Alpha/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Mitomycin/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Filgrastim/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Detox-B Adjuvant/Keyhole Limpet Hemocyanin/Sialyl Tn Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Montanide ISA-51/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Cyclophosphamide/Doxorubicin/Etoposide/Ifosfamide/Vinblastine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Prednisone/Vincristine/Zorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Epoetin Alfa/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Melphalan/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Leucovorin Calcium/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>ImmTher/Indomethacin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Mitomycin/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Filgrastim/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Dactinomycin/Idarubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Erlotinib SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Cisplatin/Cyclophosphamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Doxorubicin/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Allogeneic Lymphocytes/Interleukin-2/MOv-Gamma Chimeric Receptor Gene SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Gallium Nitrate/Hydroxyurea SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Doxorubicin/Streptozocin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemtuzumab Ozogamicin/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Rituximab/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Levamisole/Monoclonal Antibody 17-1A SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Epirubicin/Fluorouracil/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Sargramostim/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexverapamil/Doxorubicin/Etoposide/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Cisplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>BAY 12-9566/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Doxorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Exisulind/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Mitoguazone/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Gamma/Voriconazole SubClassOf Agent Combination</Axiom>
                           <Axiom>BCG/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Doxorubicin HCl Liposome SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Gemcitabine/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Doxorubicin/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Tumor Cell Vaccine/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Triacetyluridine SubClassOf Agent Combination</Axiom>
                           <Axiom>LY335979/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Bexarotene SubClassOf Agent Combination</Axiom>
                           <Axiom>Melphalan/Prednisone/Wobe-Mugos E SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexrazoxane/Doxorubicin/Filgrastim/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Dipyridamole/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Detox-B Adjuvant/Verteporfin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Dacarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>BCG/Isoniazid SubClassOf Agent Combination</Axiom>
                           <Axiom>Amiodarone/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Daunorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Mercaptopurine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Hydralazine/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dacarbazine/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cytarabine/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone/Filgrastim/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Biostim/Doxorubicin/Etoposide/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Fludarabine/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>MAGE-3/SB AS-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Doxorubicin/Prednisolone/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Doxorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Paclitaxel/SU5416 SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Mercaptopurine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Fluorouracil/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Ifosfamide/Cyclophosphamide/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/SCH 66336 SubClassOf Agent Combination</Axiom>
                           <Axiom>Ancitabine Hydrochloride/Daunorubicin/Mercaptopurine/Prednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Dexamethasone/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Ifosfamide/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Tumor Necrosis Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Rv-B7.1 Vaccine/Sargramostim/Vaccinia-Prostate-Specific Antigen Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Prednisone/Sargramostim/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Mercaptopurine/Prednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cisplatin-epinephrine/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Methylprednisolone/Mycophenolate Mofetil/Tacrolimus SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Etoposide/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Filgrastim/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin Hcl Liposome/Interleukin-12 SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Doxorubicin/Lomustine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Doxorubicin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/SU5416 SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Doxorubicin/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Thiotepa/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Conjugated Estrogens/Medroxyprogesterone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Floxuridine/Fluorouracil/Leucovorin Calcium/Levamisole SubClassOf Agent Combination</Axiom>
                           <Axiom>Melphalan/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/Celecoxib/ZD 1839 SubClassOf Agent Combination</Axiom>
                           <Axiom>Marijuana/Morphine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bacitracin/Clotrimazole/Gentamicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Montanide ISA-51/Sargramostim/Tyrosinase-Related Protein-1 SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Carboplatin/Cyclophosphamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dactinomycin/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/TLK286 SubClassOf Agent Combination</Axiom>
                           <Axiom>Conjugated Estrogens/Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Mercaptopurine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>L-778,123/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Daunorubicin/Methotrexate/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Estramustine/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Ketoconazole/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Allogeneic Lymphocytes/MOv-Gamma Chimeric Receptor Gene SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/PSC 833 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Montanide ISA-51/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Triacetyluridine SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Lymphocytes/Fluorouracil/Pegylated Interferon Alfa/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Epirubicin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/p53 Peptide Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Tirapazamine SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/UCN-01 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Prednisone/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Estradiol/Goserelin/Thiotepa/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Filgrastim/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Incomplete Freund's Adjuvant/Sargramostim/Tyrosinase-Related Protein-1 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclosporine/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-3/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Octreotide/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Filgrastim/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>Nilutamide/Triptorelin SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Semustine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Floxuridine/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/SCH 66336 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Interleukin-2/Monoclonal Antibody OKT3/Tumor Necrosis Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Keyhole Limpet Hemocyanin/MUC-1 Antigen/QS21 SubClassOf Agent Combination</Axiom>
                           <Axiom>DHA-Paclitaxel/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/R115777 SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Carboplatin/Cyclophosphamide/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Tirapazamine/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Gefitinib SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Mercaptopurine/Methotrexate/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Thiotepa/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Denileukin Diftitox/Dexamethasone SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Prednisone/Procarbazine/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Sulindac SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Ifosfamide/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Tamoxifen/Triptorelin SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Tipifarnib/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Edotecarin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Eflornithine/Piroxicam SubClassOf Agent Combination</Axiom>
                           <Axiom>Azacytidine/Cyclophosphamide/Cytarabine/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Dexamethasone/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Dactinomycin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Hydroxychloroquine/Prednisone/Tacrolimus SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Hydroxyurea/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cordycepin/Pentostatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Estramustine/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclosporine/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Edatrexate/Mitomycin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Filgrastim/Pyrazoloacridine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Lomustine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Gamma/Tumor Necrosis Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Indomethacin/Interleukin-1-Alpha/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Megestrol/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Adenovirus-L523S Vaccine/L523S DNA Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amiodarone/Doxorubicin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Aminoglutethimide/Leuprolide SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Dacarbazine/Dactinomycin/Doxorubicin/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Interleukin-2/Lymphokine-Activated Killer Cells SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Daunorubicin/Prednisolone/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>MAGE-12 peptide vaccine/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Mitoxantrone/Prednimustine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Ifosfamide/Muramyl Tripeptide Phosphatidylethanolamine SubClassOf Agent Combination</Axiom>
                           <Axiom>ALVAC-CEA-B7.1 vaccine/Fluorouracil/Irinotecan/Leucovorin calcium/Tetanus toxoid SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/SU5416 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Detox/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Isotretinoin/Vitamin E SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Methotrexate/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Amikacin/Ceftazidime SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Daunorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide Phosphate/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Mercaptopurine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Ifosfamide/Methotrexate/Prednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Interferon Alfa/interleukin-2/Tumor Infiltrating Lymphocytes SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Cytarabine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/UCN-01 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Pegaspargase SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Ifosfamide/Leucovorin Calcium/Methotrexate/Prednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Ciprofloxacin/Dexamethasone/Pentoxifylline SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Etoposide/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Clofarabine/Cytarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin HCl Liposome/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Pegaspargase/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Ifosfamide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Doxorubicin HCl Liposome SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Ifosfamide/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Lymphokine-Activated Killer Cells/Monoclonal Antibody R24 SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Losoxantrone/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Daunorubicin/Imatinib Mesylate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Etoposide/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Lomustine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Daunorubicin/Dexamethasone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Incomplete Freund's Adjuvant/Interleukin-2/Tyrosinase Related Protein-1 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Hydroxyurea/Pentoxifylline SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Cyclophosphamide/Cytarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Hydroxyurea SubClassOf Agent Combination</Axiom>
                           <Axiom>Aspirin/Folic acid SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Tumor Necrosis Factor Receptor IgG Chimera SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Daunorubicin/Dexamethasone/Etoposide/Methotrexate/Thiotepa/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carcinoembryonic Antigen Peptide 1-6D/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Piroxantrone/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Mitomycin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Interleukin-2/Temozolomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Calcium Carbonate/Cholecalciferol/Risedronate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Cytarabine/Daunorubicin/Hydroxyurea/Methotrexate/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Mitomycin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Doxorubicin/Methotrexate/Prednisone/Rituximab/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Docetaxel/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Disulfiram/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Methylmercaptopurine Riboside/PALA SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Doxorubicin/PSC 833/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Etoposide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-thymocyte globulin/Cyclophosphamide/Cytarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bortezomib/Carboplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Epoetin Alfa/Etoposide/Filgrastim/Ifosfamide/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Ifosfamide/Interleukin-1-Alpha SubClassOf Agent Combination</Axiom>
                           <Axiom>Ganciclovir/Interleukin-2/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Trimetrexate Glucuronate SubClassOf Agent Combination</Axiom>
                           <Axiom>Floxuridine/Interferon Alfa/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cisplatin/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Erlotinib SubClassOf Agent Combination</Axiom>
                           <Axiom>Indium In 111 Monoclonal Antibody Bre-3/Yttrium Y 90 Monoclonal Antibody Bre-3 SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Phenylbutyrate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Interleukin-1-Alpha/Methylene Blue SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Cyclophosphamide/Dactinomycin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Detoxpc/Interleukin-2/RAS Peptide Cancer Vaccine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>9-cis-Retinoic Acid/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Cisplatin/Cyclophosphamide/Misonidazole SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Methylmercaptopurine Riboside/PALA SubClassOf Agent Combination</Axiom>
                           <Axiom>Edetate Calcium Disodium/Interferon Alfa/Monoclonal Antibody CC49 SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Filgrastim/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Gemcitabine/Prinomastat SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Idarubicin/Imatinib Mesylate/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Pentoxifylline/vitamin E SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Etoposide/Thiotepa/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Calcitriol/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Doxorubicin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Gemtuzumab Ozogamicin/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Etoposide/Quinidine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Novobiocin SubClassOf Agent Combination</Axiom>
                           <Axiom>Lomustine/Procarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amsacrine/Cytarabine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Etoposide/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>BCG/Monoclonal Antibody 105AD7 Anti-idiotype Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Idarubicin/Methylprednisolone/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Carboplatin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Isotretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Detox-B Adjuvant/RAS Peptide Cancer Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Doxorubicin/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bryostatin 1/Cisplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Calcium Carbonate/Cholecalciferol/Zoledronate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cytarabine/Etoposide/Ifosfamide/Methotrexate/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Docetaxel/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Methotrexate/PALA SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Doxorubicin/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Aspirin/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Mitoxantrone/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Triazinate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Flavopiridol/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Fluoxymesterone/Methotrexate/Prednisone/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Ciprofloxacin/Dexamethasone/Pentoxifylline SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Methotrexate/Prednisone/Thiotepa/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Methotrexate/Mitolactol/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Doxorubicin/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Mitoxantrone/PSC 833 SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Levamisole/L-Leucovorin SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-Thymocyte Globulin/Methotrexate/Mycophenolate Mofetil/Tacrolimus SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Metoclopramide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Etoposide/Interleukin-2/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Lomustine/Methotrexate/Procarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>gp209-2M Antigen/Incomplete Freund's Adjuvant/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Filgrastim/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Carmustine/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>MAGE-10.A2/Melan-A/NY-ESO-1 peptide vaccine/Sargramostim/tyrosinase peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Promegapoietin SubClassOf Agent Combination</Axiom>
                           <Axiom>Calcium Carbonate/Cholecalciferol/Conjugated Estrogens/Risedronate SubClassOf Agent Combination</Axiom>
                           <Axiom>CT-1501R/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fenretinide/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Lomustine/Mitoxantrone/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Paclitaxel/Shark Cartilage SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Dexamethasone/Doxorubicin/Mercaptopurine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Idarubicin/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Filgrastim/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/GTI-2040 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Irinotecan/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>3-AP/Fludarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Interferon Alfa/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>KSA Glycoprotein/QS21 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Paclitaxel/Yttrium Y 90 Monoclonal Antibody M170 SubClassOf Agent Combination</Axiom>
                           <Axiom>Indomethacin/Interleukin-1-Alpha SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Epoetin Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Prednisolone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Marimastat SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Dexamethasone/Doxorubicin/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Daunorubicin/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Idarubicin/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Estramustine/Ixabepilone SubClassOf Agent Combination</Axiom>
                           <Axiom>Sargramostim/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Interleukin-1-Beta SubClassOf Agent Combination</Axiom>
                           <Axiom>CpG 7909/Dacarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Selenium/Soy Protein Isolate/Vitamin E SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Doxorubicin/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Dacarbazine/Doxorubicin/Lomustine/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Mitoxantrone/Prednisone/YM598 SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Dexamethasone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Mercaptopurine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Dacarbazine/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin Hcl Liposome/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Daunorubicin/dexamethasone/methotrexate/vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Busulfan/Melphalan/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Verapamil SubClassOf Agent Combination</Axiom>
                           <Axiom>Pentamidine/Trimetrexate Glucuronate SubClassOf Agent Combination</Axiom>
                           <Axiom>Dapsone/Trimetrexate Glucuronate SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Doxorubicin/Mercaptopurine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cisplatin/Fluorouracil/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Ethinyl Estradiol/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Cytarabine/Doxorubicin/Methotrexate/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Ifosfamide/Muramyl Tripeptide Phosphatidylethanolamine Liposome SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Melphalan/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Letrozole/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Edatrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Interferon Alfa/interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Arsenic trioxide/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Methotrexate/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dactinomycin/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/DN-101 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Interleukin-3/Leucovorin Calcium/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Oblimersen/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Interferon Alfa/Tretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Montanide ISA-51/Tyrosinase-Related Protein-1 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Cytarabine/Etoposide/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Cyclophosphamide/Doxorubicin/Fluorouracil/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluoxymesterone/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Edatrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fludarabine/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Interleukin-1-Beta SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone/Idarubicin/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Carboplatin/Etoposide/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Etoposide/Thioguanine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/iodine I 131 Monoclonal Antibody Anti-B1 SubClassOf Agent Combination</Axiom>
                           <Axiom>Human Chorionic Gonadotropin/Staphage Lysate SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Gefitinib/Leucovorin Calcium/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/Cyclophosphamide/Epirubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Lomustine/Prednisone/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Docetaxel/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Etoposide/Filgrastim/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Doxorubicin/Verapamil/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Epoetin Alfa/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/PSC 833 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin Liposomal SubClassOf Agent Combination</Axiom>
                           <Axiom>Alemtuzumab/Fludarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Azacitidine/Phenylbutyrate SubClassOf Agent Combination</Axiom>
                           <Axiom>Bexarotene/Carboplatin/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Boronophenylalanine-Fructose Complex/Sodium Borocaptate SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Isotretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Celecoxib/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Doxorubicin/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Paclitaxel/Prinomastat SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Doxorubicin HCl Liposome/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Methotrexate/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Hydrocortisone/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Lomustine/Prednisone/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Homoharringtonine/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Epirubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Interferon Alfa/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Imatinib Mesylate/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/LY231514 SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Daunorubicin/Methotrexate/Prednisone/Teniposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Flutamide/Leuprolide/Somatuline/Suramin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bromocriptine/Flutamide/Leuprolide SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Cyclophosphamide/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Mitomycin/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Dendritic Cells/Carcinoembryonic Antigen Peptide 1-6D/CMV Pp65 Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Doxorubicin/Fluoxymesterone/Methotrexate/Mitolactol/Prednisone/Tamoxifen/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Prednisone/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/SU5416 SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Dactinomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Fluoxymesterone/Thiotepa/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Mercaptopurine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>HLA-A2, A3-Restricted FGF-5 Peptides/Montanide ISA-51 Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Monoclonal Antibody C225 SubClassOf Agent Combination</Axiom>
                           <Axiom>Hydrocortisone/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Decitabine/Imatinib Mesylate SubClassOf Agent Combination</Axiom>
                           <Axiom>Trastuzumab/ZD 1839 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Gemcitabine/ZD 1839 SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluoxymesterone/Mitolactol/Tamoxifen/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Mercaptopurine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluoxymesterone/Methotrexate/Mitolactol/Tamoxifen/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>P-30 Protein/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-12/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Carboplatin/Cyclophosphamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Mitomycin C/Cisplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Mechlorethamine/Prednisone/Procarbazine/Vinblastine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Daunorubicin/Dexamethasone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Lurtotecan Liposome SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Filgrastim/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Capecitabine/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Mercaptopurine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>AG3340/Mitoxantrone/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Patent Blue V Dye/Technetium Tc 99m Sulfur Colloid SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Interferon Alfa/interleukin-2/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Erlotinib/Temozolomide SubClassOf Agent Combination</Axiom>
                           <Axiom>HER-2-neu, CEA Peptides, GM-CSF, Montanide ISA-51 Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Interleukin-2/Monoclonal Antibody R24 SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Beta/Isotretinoin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Idarubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Mercaptopurine/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Flavopiridol/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Pegfilgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Epirubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Cyclophosphamide/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Paclitaxel/Pegfilgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Ifosfamide/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Semustine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Pirarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Epirubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Folic Acid/Lometrexol/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Alum Adjuvant/Monoclonal Antibody 105AD7 Anti-Idiotype Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Ifosfamide/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Leucovorin Calcium/Milodistim SubClassOf Agent Combination</Axiom>
                           <Axiom>ALVAC-hB7.1/Canarypox-hIL-12 Melanoma Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/PALA/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>AG-858/Imatinib Mesylate SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Carmustine/Etoposide/Methotrexate/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Alemtuzumab/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Mitoxantrone/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexrazoxane/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Doxorubicin/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Toremifene SubClassOf Agent Combination</Axiom>
                           <Axiom>Calcium Carbonate/Cholecalciferol/Conjugated Estrogens SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Tamoxifen/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Pentostatin/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Prinomastat/Temozolomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Methotrexate/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-thymocyte globulin/thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cisplatin/Cyclophosphamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Methotrexate/Muramyl Tripeptide Phosphatidylethanolamine Liposome SubClassOf Agent Combination</Axiom>
                           <Axiom>Hydrocortisone/Ketoconazole SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Etoposide/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Acetaminophen/Acetylcysteine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bortezomib/Docetaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Busulfan/Ciprofloxacin/Cyclophosphamide/Pentoxifylline SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dactinomycin/Irinotecan/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Filgrastim/Methotrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Irinotecan/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Didanosine/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Doxorubicin/Mercaptopurine SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Montanide ISA-51/Sargramostim/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Fenretinide/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Exisulind SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Leuprolide/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Calcitriol/Carboplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bryostatin 1/Cytarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/Celecoxib/Irinotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Pyrazoloacridine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/PEG-Interferon Alfa-2b SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Idoxuridine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Interleukin-1-Alpha SubClassOf Agent Combination</Axiom>
                           <Axiom>Autologous Lymphocytes/gp100 Antigen/Interleukin-2/Interleukin-12/MAGE-3/Melan-A/NA17-A Antigen SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Ethacrynic Acid SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Dacarbazine/Hydroxyurea/Lomustine/Methylprednisolone/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Daunorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Filgrastim/Ifosfamide/Interleukin-3/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cyclophosphamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Dexamethasone/Ifosfamide/Leucovorin Calcium/Methotrexate/Teniposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Etoposide/Ifosfamide/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Fluorouracil/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Epirubicin/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Doxorubicin/Ifosfamide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Doxorubicin/Fluorouracil/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bortezomib/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cladribine/Cyclophosphamide/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Ifosfamide/Mesna SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Etoposide/Ifosfamide/Methotrexate/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Oblimersen/Prednisone/Rituximab/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Edatrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Monoclonal Antibody HER2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Phenylbutyrate/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Imatinib Mesylate/Pegaspargase/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Monoclonal Antibody CC49/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Interferon Alfa/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Mitoxantrone/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Lomustine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Floxuridine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Zorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Decitabine/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Lomustine/Procarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Gefitinib/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Prednisone/Vincristine/Zorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Ketoconazole/Metronidazole SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Interferon Alfa/Leucovorin Calcium/Mitoxantrone/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Dexamethasone/Idarubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Lomustine SubClassOf Agent Combination</Axiom>
                           <Axiom>Finasteride/Flutamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Calcium Carbonate/Cholecalciferol SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dactinomycin/Doxorubicin/Hydroxyurea/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dihydro-5-Azacytidine SubClassOf Agent Combination</Axiom>
                           <Axiom>Aminoglutethimide/Megestrol SubClassOf Agent Combination</Axiom>
                           <Axiom>Irinotecan/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Anastrozole/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Ifosfamide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Streptozocin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cetuximab/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Dacarbazine/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/Paclitaxel/Trastuzumab SubClassOf Agent Combination</Axiom>
                           <Axiom>Estramustine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Interferon Alfa/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Medroxyprogesterone/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Bicalutamide/Exemestane SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Methotrexate/Thiotepa/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/MART-1 Antigen/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>cBR96-Doxorubicin Immunoconjugate/Docetaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Mutant p53 peptide pulsed dendritic cell vaccine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/HPV-16 E7(12-20) Peptide Vaccine/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dexamethasone/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Filgrastim/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>Eflornithine/Sulindac SubClassOf Agent Combination</Axiom>
                           <Axiom>Acivicin/Aminosyn SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Trimetrexate Glucuronate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Medroxyprogesterone/Quinine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Methylprednisolone SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Epirubicin/Monoclonal Antibody HER2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Amsacrine/Azacitidine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone/Doxorubicin/Verapamil/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Doxorubicin/Lomustine/Mechlorethamine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Trastuzumab/Vinorelbine SubClassOf Agent Combination</Axiom>
                           <Axiom>BMS-247550/Estramustine SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Mercaptopurine/Methotrexate/Pentostatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cytarabine/Dexamethasone/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Paclitaxel/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Semustine/Streptozocin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Homoharringtonine/Interferon Alfa SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Cisplatin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Edatrexate/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Tretinoin Liposome SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Docetaxel/Estramustine SubClassOf Agent Combination</Axiom>
                           <Axiom>Flutamide/Ketoconazole SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Epirubicin/Filgrastim/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Melphalan/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Docetaxel/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Montanide ISA-51/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Losoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Epirubicin/Pegfilgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Somatuline/Suramin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Daunorubicin/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Interferon Beta SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Thiotepa/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Prednisone/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Flt3 Ligand/gp100 Antigen/Incomplete Freund's Adjuvant/MART-1 Antigen/Tyrosinase SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Diethyldithiocarbamate SubClassOf Agent Combination</Axiom>
                           <Axiom>Penicillamine/Pyridoxine SubClassOf Agent Combination</Axiom>
                           <Axiom>Daunorubicin/Hydroxyurea SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Trifluoperazine/Vinblastine/Verapamil SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-human chorionic gonadotropin vaccine/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Anastrozole/Fulvestrant SubClassOf Agent Combination</Axiom>
                           <Axiom>Irinotecan/Thalidomide SubClassOf Agent Combination</Axiom>
                           <Axiom>Incomplete Freund's Adjuvant/Interleukin-12/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Filgrastim/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Interferon Alfa/Leucovorin Calcium/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bortezomib/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Mitomycin/Streptozocin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Lomustine/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Teniposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Interferon Alfa/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Ifosfamide/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Anastrozole/Gefitinib SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclosporine/Interferon Alfa/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Etoposide/Filgrastim/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Idarubicin/Lomustine SubClassOf Agent Combination</Axiom>
                           <Axiom>Chinese Herbs/Cyclophosphamide/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Mitoxantrone/Pegaspargase/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Gusperimus/Monoclonal Antibody L6 SubClassOf Agent Combination</Axiom>
                           <Axiom>Gallium Nitrate/Ifosfamide/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Cyclophosphamide/Fluorouracil/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Ifosfamide/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Dacarbazine/Interferon Alfa/Lomustine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/MS-209 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Milodistim/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Paclitaxel/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Theratope STn-KLH Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Devil's Foot/Jambul SubClassOf Agent Combination</Axiom>
                           <Axiom>Leuprolide/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Zosuquidar Trihydrochloride SubClassOf Agent Combination</Axiom>
                           <Axiom>Anastrozole/Celecoxib SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Doxorubicin/Etoposide/Mechlorethamine/Vinblastine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Gemtuzumab Ozogamicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Dexamethasone/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Filgrastim SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Leucovorin Calcium/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Incomplete Freund's Adjuvant/Von Hippel-Lindau Peptide Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cisplatin/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Etoposide/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Arginine butyrate/Ganciclovir SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Carboplatin/Cyclophosphamide/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Filgrastim/Ifosfamide/Interleukin-3 SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Erlotinib SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Ifosfamide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Prednisone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Cyclophosphamide/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Etoposide/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Epoetin Alfa/Filgrastim/Flt3 Ligand/Interleukin-3/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dacarbazine/Dactinomycin/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interleukin-2/Monoclonal Antibody Ch14.18/Monoclonal Antibody R24 SubClassOf Agent Combination</Axiom>
                           <Axiom>Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Etoposide/Ifosfamide/Pegaspargase/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Doxorubicin/Filgrastim/Methotrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Ifosfamide/Topotecan SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Etoposide/Mitoxantrone/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Sargramostim SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cisplatin/Dacarbazine/Interferon Alfa/interleukin-2/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Fowlpox-Sargramostim Vaccine/Fowlpox-TRICOM Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Fluorouracil/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Cyclophosphamide/Cytarabine/Hydroxyurea/Lomustine/Methylprednisolone/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Azacitidine/Cyclophosphamide/Cytarabine/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Paclitaxel/PS-341 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cyclosporine/Fludarabine/Methylprednisolone/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Diethyldithiocarbamate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Melphalan/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboxyamidotriazole/Ketoconazole SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Docetaxel/Doxorubicin/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Imatinib Mesylate SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Procarbazine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Allovectin-7/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Melphalan/Tumor Necrosis Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Fluorouracil/Streptozocin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Incomplete Freund's Adjuvant/Peptide 946 Melanoma Vaccine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Etoposide/Mitoxantrone/Prednisolone/Rituximab/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Fluorouracil/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Capecitabine/Fluorouracil/Leucovorin Calcium/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Altretamine/Cisplatin/Cyclophosphamide/Fluorouracil SubClassOf Agent Combination</Axiom>
                           <Axiom>Deoxyspergualin/Monoclonal Antibody L6 SubClassOf Agent Combination</Axiom>
                           <Axiom>Methotrexate/Prednisone/Procarbazine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexverapamil/Doxorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Dexamethasone/Floxuridine/Mitomycin SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Interleukin-2/Monoclonal Antibody R24 SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/GEM 231 SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Etoposide/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Docetaxel/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Fluoxymesterone/Interferon Alfa/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Thiotepa/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Methotrexate/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Etoposide/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Chlorambucil/Fludarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Trifluoperazine/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Ampligen/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Methylprednisolone/Rituximab SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Interleukin-2/Lymphokine-Activated Killer Cells SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Methotrexate/Prednisolone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Doxorubicin/Mercaptopurine/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/R101933 SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Mitomycin/Vindesine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Interleukin-2/Monoclonal Antibody OKT3 SubClassOf Agent Combination</Axiom>
                           <Axiom>Idarubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Doxorubicin/Ifosfamide/Mesna SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Gamma/Macrophage Colony-Stimulating Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Fluorouracil/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Bevacizumab/Docetaxel/Estramustine SubClassOf Agent Combination</Axiom>
                           <Axiom>Estradiol/Zoledronate SubClassOf Agent Combination</Axiom>
                           <Axiom>Biostim/Melphalan/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Fluoxymesterone/Methotrexate/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Gemcitabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Amifostine/Carboplatin/Cisplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Gemcitabine/Suramin SubClassOf Agent Combination</Axiom>
                           <Axiom>E7(86-93) Lipopeptide/HPV-16 E7(12-20) Peptide Vaccine/Montanide ISA-51 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Dexamethasone/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Etoposide/Mercaptopurine/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Epirubicin/Gemcitabine/Paclitaxel SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Melphalan/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>CRL 1005/gp100 Antigen/Montanide ISA-51/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Thymalfasin/Dacarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Dacarbazine/Interleukin-2 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Gemcitabine/ISIS 3521 SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Fluorouracil/Goserelin/Methotrexate/Tamoxifen SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Filgrastim/Thiotepa SubClassOf Agent Combination</Axiom>
                           <Axiom>Alendronate Sodium/Ketoconazole SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Perflubron SubClassOf Agent Combination</Axiom>
                           <Axiom>Montanide ISA-51/Sargramostim/Tyrosinase peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cyclosporine/Cytarabine/Daunorubicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Isotretinoin/Procarbazine SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Gamma/Interleukin-2/Melphalan/Tumor Necrosis Factor SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cytarabine/Gemtuzumab ozogamicin SubClassOf Agent Combination</Axiom>
                           <Axiom>Eniluracil/Fluorouracil/Oxaliplatin SubClassOf Agent Combination</Axiom>
                           <Axiom>Asparaginase/Cyclophosphamide/Daunorubicin/Filgrastim/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Methotrexate/Pegaspargase/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Mercaptopurine/Methotrexate/Nelarabine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Fluorouracil/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Irinotecan/Oblimersen SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Cytarabine/Doxorubicin/Methotrexate/Prednisone/Thioguanine/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Octreotide/Prednisone SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Doxorubicin/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cytarabine/Dexamethasone/Etoposide/Melphalan SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Dacarbazine/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>gp100 Antigen/Incomplete Freund's Adjuvant/MART-1 Antigen/Tyrosinase Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Doxorubicin/Semustine/Streptozocin SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carboplatin/Mitoxantrone SubClassOf Agent Combination</Axiom>
                           <Axiom>Carmustine/Cyclophosphamide/Melphalan/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Carcinoembryonic Antigen Peptide 1/Hepatitis B Antigen Peptide SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Suramin SubClassOf Agent Combination</Axiom>
                           <Axiom>Interferon Alfa/Sargramostim/Zidovudine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Toremifene SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cisplatin/Methotrexate SubClassOf Agent Combination</Axiom>
                           <Axiom>Dimethylbusulfan/Etoposide SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Methotrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cytarabine/Daunorubicin/Pegaspargase/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Allogeneic Lymphocytes/Cyclosporine/Sirolimus SubClassOf Agent Combination</Axiom>
                           <Axiom>Docetaxel/Filgrastim/XR9576 SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Cyclophosphamide/Cytarabine/Doxorubicin/Methotrexate/Prednisone/Vincristine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cisplatin/Ifosfamide SubClassOf Agent Combination</Axiom>
                           <Axiom>Celecoxib/Fluorouracil/Irinotecan/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                           <Axiom>Bleomycin/Methotrexate/Vinblastine SubClassOf Agent Combination</Axiom>
                           <Axiom>Cyclophosphamide/Doxorubicin/Filgrastim/Fluorouracil/Leucovorin Calcium SubClassOf Agent Combination</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Agent Combination</New_Terms>
            </Change>
            <Change id="442">
               <Axiom>Amalgam SubClassOf Restorative Material</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Amalgam</Concept>
                        <WitnessAxioms>
                           <Axiom>Amalgam SubClassOf Restorative Material</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Restorative Material</Concept>
                        <WitnessAxioms>
                           <Axiom>Amalgam SubClassOf Restorative Material</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Restorative Material</New_Terms>
            </Change>
            <Change id="441">
               <Axiom>Aurora Kinase Inhibitor AZD1152 SubClassOf Aurora Kinase Inhibitor</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Aurora Kinase Inhibitor AZD1152</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor AZD1152 SubClassOf Aurora Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Aurora Kinase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor AZD1152 SubClassOf Aurora Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Aurora Kinase Inhibitor</New_Terms>
            </Change>
            <Change id="456">
               <Axiom>Aurora Kinase Inhibitor MK-0457 SubClassOf Aurora Kinase Inhibitor</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Aurora Kinase Inhibitor MK-0457</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor MK-0457 SubClassOf Aurora Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Aurora Kinase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor MK-0457 SubClassOf Aurora Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Aurora Kinase Inhibitor</New_Terms>
            </Change>
            <Change id="457">
               <Axiom>Aurora Kinase Inhibitor MLN8054 SubClassOf Aurora Kinase Inhibitor</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Aurora Kinase Inhibitor MLN8054</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor MLN8054 SubClassOf Aurora Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Aurora Kinase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor MLN8054 SubClassOf Aurora Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Aurora Kinase Inhibitor</New_Terms>
            </Change>
            <Change id="443">
               <Axiom>BSI-201 SubClassOf Poly (ADP-Ribose) Polymerase Inhibitor</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>BSI-201</Concept>
                        <WitnessAxioms>
                           <Axiom>BSI-201 SubClassOf Poly (ADP-Ribose) Polymerase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Poly (ADP-Ribose) Polymerase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>BSI-201 SubClassOf Poly (ADP-Ribose) Polymerase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Poly (ADP-Ribose) Polymerase Inhibitor</New_Terms>
            </Change>
            <Change id="444">
               <Axiom>Bowen Disease of the Skin EquivalentTo Skin Squamous Cell Carcinoma In Situ and (Disease_May_Have_Finding some Skin Patch) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Finding only Parakeratosis) and (Disease_Has_Finding only Windblown Appearance of Atypical Keratinocytes)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Bowen Disease of the Skin</Concept>
                        <WitnessAxioms>
                           <Axiom>Bowen Disease of the Skin SubClassOf Skin Squamous Cell Carcinoma In Situ</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Bowen Disease of the Skin</Concept>
                        <WitnessAxioms>
                           <Axiom>Bowen Disease of the Skin SubClassOf Cellular Precursor of Cancer</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Skin Disorder</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Common Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Carcinoma In Situ</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Stage 0 Skin Cancer</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Neoplasm by Special Category</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Cancer-Related Condition</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf High Grade Intraepithelial Neoplasia</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Skin Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Carcinoma</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Squamous Cell Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Squamous Cell Carcinoma</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Malignant Skin Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Common Carcinoma</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Skin Squamous Cell Carcinoma</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Disorder by Site</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Skin Carcinoma</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Neoplasm by Site</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Precancerous Condition</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Intraepithelial Neoplasia</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Bowen Disease of the Skin</New_Terms>
            </Change>
            <Change id="445">
               <Axiom>Capillary Leak Syndrome SubClassOf Disease_Has_Primary_Anatomic_Site only Capillary</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Capillary Leak Syndrome</New_Terms>
            </Change>
            <Change id="447">
               <Axiom>Deprecated Concept SubClassOf Concept Status</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Deprecated Concept</Concept>
                        <WitnessAxioms>
                           <Axiom>Deprecated Concept SubClassOf Concept Status</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Concept Status</Concept>
                        <WitnessAxioms>
                           <Axiom>Deprecated Concept SubClassOf Concept Status</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Concept Status</New_Terms>
            </Change>
            <Change id="448">
               <Axiom>Diabetic Retinopathy SubClassOf Retinopathy</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Diabetic Retinopathy</Concept>
                        <WitnessAxioms>
                           <Axiom>Diabetic Retinopathy SubClassOf Retinopathy</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Retinopathy</Concept>
                        <WitnessAxioms>
                           <Axiom>Diabetic Retinopathy SubClassOf Retinopathy</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Non-Proliferative Diabetic Retinopathy</Concept>
                        <WitnessAxioms>
                           <Axiom>Non-Proliferative Diabetic Retinopathy SubClassOf Retinopathy</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Retinopathy</Concept>
                        <WitnessAxioms>
                           <Axiom>Non-Proliferative Diabetic Retinopathy SubClassOf Retinopathy</Axiom>
                           <Axiom>Background Diabetic Retinopathy SubClassOf Retinopathy</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Retinopathy</New_Terms>
            </Change>
            <Change id="449">
               <Axiom>Flowable Composite SubClassOf Restorative Material</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Flowable Composite</Concept>
                        <WitnessAxioms>
                           <Axiom>Flowable Composite SubClassOf Restorative Material</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Restorative Material</Concept>
                        <WitnessAxioms>
                           <Axiom>Flowable Composite SubClassOf Restorative Material</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Restorative Material</New_Terms>
            </Change>
            <Change id="450">
               <Axiom>Header Concept SubClassOf Concept Status</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Header Concept</Concept>
                        <WitnessAxioms>
                           <Axiom>Header Concept SubClassOf Concept Status</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Concept Status</Concept>
                        <WitnessAxioms>
                           <Axiom>Header Concept SubClassOf Concept Status</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Concept Status</New_Terms>
            </Change>
            <Change id="451">
               <Axiom>Hybrid Composite SubClassOf Restorative Material</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Hybrid Composite</Concept>
                        <WitnessAxioms>
                           <Axiom>Hybrid Composite SubClassOf Restorative Material</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Restorative Material</Concept>
                        <WitnessAxioms>
                           <Axiom>Hybrid Composite SubClassOf Restorative Material</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Restorative Material</New_Terms>
            </Change>
            <Change id="452">
               <Axiom>Hypertensive Retinopathy SubClassOf Retinopathy</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Hypertensive Retinopathy</Concept>
                        <WitnessAxioms>
                           <Axiom>Hypertensive Retinopathy SubClassOf Retinopathy</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Retinopathy</Concept>
                        <WitnessAxioms>
                           <Axiom>Hypertensive Retinopathy SubClassOf Retinopathy</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Retinopathy</New_Terms>
            </Change>
            <Change id="453">
               <Axiom>Hypoxanthine SubClassOf Poly (ADP-Ribose) Polymerase Inhibitor</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Hypoxanthine</Concept>
                        <WitnessAxioms>
                           <Axiom>Hypoxanthine SubClassOf Poly (ADP-Ribose) Polymerase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Poly (ADP-Ribose) Polymerase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>Hypoxanthine SubClassOf Poly (ADP-Ribose) Polymerase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Hypoxanthine</Concept>
                        <WitnessAxioms>
                           <Axiom>Hypoxanthine SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Hypoxanthine SubClassOf Enzyme Inhibitor</Axiom>
                           <Axiom>Hypoxanthine SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Poly (ADP-Ribose) Polymerase Inhibitor</New_Terms>
            </Change>
            <Change id="454">
               <Axiom>INO-1001 SubClassOf Poly (ADP-Ribose) Polymerase Inhibitor</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>INO-1001</Concept>
                        <WitnessAxioms>
                           <Axiom>INO-1001 SubClassOf Poly (ADP-Ribose) Polymerase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Poly (ADP-Ribose) Polymerase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>INO-1001 SubClassOf Poly (ADP-Ribose) Polymerase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Poly (ADP-Ribose) Polymerase Inhibitor</New_Terms>
            </Change>
            <Change id="458">
               <Axiom>Medical Device Component Or Accessory Terminology FDA CDRH SubClassOf FDA Center For Devices and Radiological Health Terminology</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Medical Device Component Or Accessory Terminology FDA CDRH</Concept>
                        <WitnessAxioms>
                           <Axiom>Medical Device Component Or Accessory Terminology FDA CDRH SubClassOf FDA Center For Devices and Radiological Health Terminology</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>FDA Center For Devices and Radiological Health Terminology</Concept>
                        <WitnessAxioms>
                           <Axiom>Medical Device Component Or Accessory Terminology FDA CDRH SubClassOf FDA Center For Devices and Radiological Health Terminology</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>FDA Center For Devices and Radiological Health Terminology</New_Terms>
            </Change>
            <Change id="459">
               <Axiom>Medical Device Problem Codes FDA CDRH SubClassOf FDA Center For Devices and Radiological Health Terminology</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Medical Device Problem Codes FDA CDRH</Concept>
                        <WitnessAxioms>
                           <Axiom>Medical Device Problem Codes FDA CDRH SubClassOf FDA Center For Devices and Radiological Health Terminology</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>FDA Center For Devices and Radiological Health Terminology</Concept>
                        <WitnessAxioms>
                           <Axiom>Medical Device Problem Codes FDA CDRH SubClassOf FDA Center For Devices and Radiological Health Terminology</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>FDA Center For Devices and Radiological Health Terminology</New_Terms>
            </Change>
            <Change id="461">
               <Axiom>Obsolete Concept SubClassOf Concept Status</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Obsolete Concept</Concept>
                        <WitnessAxioms>
                           <Axiom>Obsolete Concept SubClassOf Concept Status</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Concept Status</Concept>
                        <WitnessAxioms>
                           <Axiom>Obsolete Concept SubClassOf Concept Status</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Concept Status</New_Terms>
            </Change>
            <Change id="462">
               <Axiom>PHA-739358 SubClassOf Aurora Kinase Inhibitor</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>PHA-739358</Concept>
                        <WitnessAxioms>
                           <Axiom>PHA-739358 SubClassOf Aurora Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Aurora Kinase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>PHA-739358 SubClassOf Aurora Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Aurora Kinase Inhibitor</New_Terms>
            </Change>
            <Change id="463">
               <Axiom>Patient Problem Codes FDA CDRH SubClassOf FDA Center For Devices and Radiological Health Terminology</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Patient Problem Codes FDA CDRH</Concept>
                        <WitnessAxioms>
                           <Axiom>Patient Problem Codes FDA CDRH SubClassOf FDA Center For Devices and Radiological Health Terminology</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>FDA Center For Devices and Radiological Health Terminology</Concept>
                        <WitnessAxioms>
                           <Axiom>Patient Problem Codes FDA CDRH SubClassOf FDA Center For Devices and Radiological Health Terminology</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>FDA Center For Devices and Radiological Health Terminology</New_Terms>
            </Change>
            <Change id="464">
               <Axiom>Porcelain Veneer SubClassOf Restorative Material</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Porcelain Veneer</Concept>
                        <WitnessAxioms>
                           <Axiom>Porcelain Veneer SubClassOf Restorative Material</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Restorative Material</Concept>
                        <WitnessAxioms>
                           <Axiom>Porcelain Veneer SubClassOf Restorative Material</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Restorative Material</New_Terms>
            </Change>
            <Change id="465">
               <Axiom>Provisional Concept SubClassOf Concept Status</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Provisional Concept</Concept>
                        <WitnessAxioms>
                           <Axiom>Provisional Concept SubClassOf Concept Status</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Concept Status</Concept>
                        <WitnessAxioms>
                           <Axiom>Provisional Concept SubClassOf Concept Status</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Concept Status</New_Terms>
            </Change>
            <Change id="466">
               <Axiom>Resin-Based Composite SubClassOf Restorative Material</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Resin-Based Composite</Concept>
                        <WitnessAxioms>
                           <Axiom>Resin-Based Composite SubClassOf Restorative Material</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Restorative Material</Concept>
                        <WitnessAxioms>
                           <Axiom>Resin-Based Composite SubClassOf Restorative Material</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Restorative Material</New_Terms>
            </Change>
            <Change id="467">
               <Axiom>Staphylococcus aureus SubClassOf Coagulase-Positive Staphylococcus</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Staphylococcus aureus</Concept>
                        <WitnessAxioms>
                           <Axiom>Staphylococcus aureus SubClassOf Coagulase-Positive Staphylococcus</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Coagulase-Positive Staphylococcus</Concept>
                        <WitnessAxioms>
                           <Axiom>Staphylococcus aureus SubClassOf Coagulase-Positive Staphylococcus</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Staphylococcus aureus</Concept>
                        <WitnessAxioms>
                           <Axiom>Staphylococcus aureus SubClassOf Staphylococcus</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Staphylococcus</Concept>
                        <WitnessAxioms>
                           <Axiom>Staphylococcus aureus SubClassOf Staphylococcus</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Coagulase-Positive Staphylococcus</New_Terms>
            </Change>
            <Change id="468">
               <Axiom>Trichofolliculoma SubClassOf Disease_Has_Finding only Follicular Differentiation</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Follicular Differentiation</New_Terms>
            </Change>
            <Change id="469">
               <Axiom>UMLS Cross-Reference Concept SubClassOf Concept Status</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>UMLS Cross-Reference Concept</Concept>
                        <WitnessAxioms>
                           <Axiom>UMLS Cross-Reference Concept SubClassOf Concept Status</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Concept Status</Concept>
                        <WitnessAxioms>
                           <Axiom>UMLS Cross-Reference Concept SubClassOf Concept Status</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <New_Terms>Concept Status</New_Terms>
            </Change>
            <Change id="455">
               <Axiom>Warty Dyskeratoma EquivalentTo Acanthoma and (Disease_Has_Finding only Acantholysis) and (Disease_Has_Finding only Dyskeratosis) and (Disease_Has_Normal_Cell_Origin only Keratinocyte)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Warty Dyskeratoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Warty Dyskeratoma SubClassOf Acanthoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Warty Dyskeratoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Warty Dyskeratoma SubClassOf Neoplasm</Axiom>
                           <Axiom>Warty Dyskeratoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Warty Dyskeratoma SubClassOf Benign Skin Neoplasm</Axiom>
                           <Axiom>Warty Dyskeratoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Warty Dyskeratoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Warty Dyskeratoma SubClassOf Skin Neoplasm</Axiom>
                           <Axiom>Warty Dyskeratoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Warty Dyskeratoma SubClassOf Neoplasm by Site</Axiom>
                           <Axiom>Warty Dyskeratoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <New_Terms>Dyskeratosis</New_Terms>
            </Change>
         </PureAdditionWithNewTerms>
         <NewModifiedDefinition id="stequiv" size="79">
            <Change id="470">
               <Axiom>ALK-Positive Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and ((((Disease_May_Have_Cytogenetic_Abnormality some inv(2)(p23q35)) and (Disease_May_Have_Molecular_Abnormality some ATIC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q35)) and (Disease_May_Have_Molecular_Abnormality some ALO17-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(p23;q11)) and (Disease_May_Have_Molecular_Abnormality some MYH9-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;3)(p23;q21)) and (Disease_May_Have_Molecular_Abnormality some TFG-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;5)(p23;q35)) and (Disease_May_Have_Molecular_Abnormality some NPM-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(X;2)(q11-12;p23)) and (Disease_May_Have_Molecular_Abnormality some MSN-ALK Fusion Protein Expression)))) and (Disease_May_Have_Abnormal_Cell some Doughnut Cell) and (Disease_May_Have_Abnormal_Cell some Hodgkin's-Like Cell) and (Disease_May_Have_Abnormal_Cell some Reed-Sternberg-Like Cell) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Abnormal_Cell only Hallmark Cell) and (Disease_Has_Molecular_Abnormality only Rearrangement of 2p23) and (Disease_Has_Normal_Cell_Origin only Activated Mature Cytotoxic T-Lymphocyte)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>ALK-Positive Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and (Disease_May_Have_Abnormal_Cell some Doughnut Cell) and (Disease_May_Have_Abnormal_Cell some Hodgkin's-Like Cell) and (Disease_May_Have_Abnormal_Cell some Reed-Sternberg-Like Cell) and (Disease_May_Have_Cytogenetic_Abnormality some inv(2)(p23q35)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q35)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(p23;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;3)(p23;q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;5)(p23;q35)) and (Disease_May_Have_Cytogenetic_Abnormality some t(X;2)(q11-12;p23)) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Molecular_Abnormality some ALO17-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some ATIC-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MSN-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MYH9-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some NPM-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TFG-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Hallmark Cell) and (Disease_Has_Molecular_Abnormality only Rearrangement of 2p23) and (Disease_Has_Normal_Cell_Origin only Activated Mature Cytotoxic T-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="471">
               <Axiom>Accelerated Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and ((((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression)))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Basophilia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Finding only Accelerated Phase of Disease) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Splenomegaly)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Accelerated Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Basophilia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Finding only Accelerated Phase of Disease) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Splenomegaly)</Axiom>
               </Source>
            </Change>
            <Change id="500">
               <Axiom>Activated B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and ((((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma)))) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Molecular_Abnormality only BCL2 Gene mRNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD44 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Increased NFkappaB Pathway Activation) and (Disease_Has_Molecular_Abnormality only PKCbeta1 Messenger RNA Overexpression) and (Disease_Has_Normal_Cell_Origin only Activated B-Lymphocyte)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Activated B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Molecular_Abnormality only BCL2 Gene mRNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD44 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Increased NFkappaB Pathway Activation) and (Disease_Has_Molecular_Abnormality only PKCbeta1 Messenger RNA Overexpression) and (Disease_Has_Normal_Cell_Origin only Activated B-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="472">
               <Axiom>Acute Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and Leukemic Phase of Lymphoma and ((((Disease_May_Have_Associated_Disease some Opportunistic Infection) and (Disease_May_Have_Associated_Disease some T-Cell Immunodeficiency)) or ((Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Osteoclastic Activity Present)) or ((Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Finding only Pautrier-Like Microabscess Present)) or ((Disease_Has_Finding only Bone Marrow Involvement) and (Disease_Has_Finding only Peripheral Blood Involvement) and (Disease_Has_Finding only White Blood Cell Count Increased)))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Medium-Sized to Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Small T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Polylobated T-Lymphocyte) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lactate Dehydrogenase Increased) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Lymphadenopathy)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Acute Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and Leukemic Phase of Lymphoma and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Medium-Sized to Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Small T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Polylobated T-Lymphocyte) and (Disease_May_Have_Associated_Disease some Opportunistic Infection) and (Disease_May_Have_Associated_Disease some T-Cell Immunodeficiency) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lactate Dehydrogenase Increased) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Osteoclastic Activity Present) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Finding only Bone Marrow Involvement) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Finding only Pautrier-Like Microabscess Present) and (Disease_Has_Finding only Peripheral Blood Involvement) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
               </Source>
            </Change>
            <Change id="473">
               <Axiom>Acute Monoblastic Leukemia and Acute Monocytic Leukemia EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and ((((Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;V)(p11;v)) and (Disease_May_Have_Molecular_Abnormality some MOZ-V Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(V;11)(v;q23)) and (Disease_May_Have_Molecular_Abnormality some V-MLL Fusion Protein Expression)))) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;22)(p11;q13)) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Acute Monoblastic Leukemia and Acute Monocytic Leukemia EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;22)(p11;q13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;V)(p11;v)) and (Disease_May_Have_Cytogenetic_Abnormality some t(V;11)(v;q23)) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MOZ-V Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some V-MLL Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation)</Axiom>
               </Source>
            </Change>
            <Change id="474">
               <Axiom>Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities EquivalentTo Acute Myeloid Leukemia with Recurrent Genetic Abnormalities and ((((Disease_May_Have_Cytogenetic_Abnormality some t(10;11)(p11;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF10 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q23;p13.1)) and (Disease_May_Have_Molecular_Abnormality some MLL-EEN Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ELL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ENL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF9 Fusion Protein Expression)))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Neutrophilic Precursor) and (Disease_May_Have_Finding some Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_May_Have_Finding some Disseminated Intravascular Coagulation) and (Disease_May_Have_Finding some Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Therapy-Related Toxicity) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Immature Myeloid Cells Increased in Bone Marrow) and (Disease_Has_Normal_Cell_Origin only Multipotent Bone Marrow Stem Cell)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities EquivalentTo Acute Myeloid Leukemia with Recurrent Genetic Abnormalities and (Disease_May_Have_Abnormal_Cell some Neoplastic Neutrophilic Precursor) and (Disease_May_Have_Cytogenetic_Abnormality some t(10;11)(p11;q23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q23;p13.1)) and (Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;11)(q21;q23)) and (Disease_May_Have_Finding some Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_May_Have_Finding some Disseminated Intravascular Coagulation) and (Disease_May_Have_Finding some Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Therapy-Related Toxicity) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some MLL-AF10 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-AF9 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-EEN Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ELL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ENL Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Immature Myeloid Cells Increased in Bone Marrow) and (Disease_Has_Normal_Cell_Origin only Multipotent Bone Marrow Stem Cell)</Axiom>
               </Source>
            </Change>
            <Change id="475">
               <Axiom>Acute Myeloid Leukemia with Maturation EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and ((((Disease_May_Have_Cytogenetic_Abnormality some del(12p11p13)) and (Disease_May_Have_Finding some Bone Marrow Basophilia)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(6;9)(p23;q34)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some DEK-CAN Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Finding some Hemophagocytosis)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;21)(q22;q22)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some AML1-ETO Fusion Protein Expression)))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast with Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast without Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Bone Marrow Dysplasia Present) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Molecular_Abnormality some CEBPA Gene Mutation) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Acute Myeloid Leukemia with Maturation EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast with Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast without Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Cytogenetic_Abnormality some del(12p11p13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(6;9)(p23;q34)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;21)(q22;q22)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Bone Marrow Basophilia) and (Disease_May_Have_Finding some Bone Marrow Dysplasia Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Hemophagocytosis) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some AML1-ETO Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some CEBPA Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some DEK-CAN Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation)</Axiom>
               </Source>
            </Change>
            <Change id="476">
               <Axiom>Acute Myeloid Leukemia with Multilineage Dysplasia EquivalentTo Acute Myeloid Leukemia and ((((Disease_May_Have_Cytogenetic_Abnormality some ins(3;3)) and (Disease_May_Have_Finding some Thrombocytosis)) or ((Disease_May_Have_Cytogenetic_Abnormality some inv(3)(q21q26.2)) and (Disease_May_Have_Finding some Thrombocytosis)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;3)(q21;q26.2)) and (Disease_May_Have_Finding some Thrombocytosis)))) and (Disease_May_Have_Abnormal_Cell some Large Multinucleated Erythroid Cell) and (Disease_May_Have_Abnormal_Cell some Megaloblast) and (Disease_May_Have_Abnormal_Cell some Micromegakaryocyte) and (Disease_May_Have_Abnormal_Cell some Monolobed Megakaryocyte) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Abnormal_Cell some Ringed Sideroblast) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 21) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 11q ATM Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 5q) and (Disease_May_Have_Cytogenetic_Abnormality some del(20)(q11)) and (Disease_May_Have_Cytogenetic_Abnormality some del(7)(q11;q36)) and (Disease_May_Have_Cytogenetic_Abnormality some t(3;5)(q25;q34)) and (Disease_May_Have_Finding some Granulocytopenia) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Pancytopenia) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines) and (Disease_Has_Finding only Ineffective Hematopoiesis) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Acute Myeloid Leukemia with Multilineage Dysplasia EquivalentTo Acute Myeloid Leukemia and (Disease_May_Have_Abnormal_Cell some Large Multinucleated Erythroid Cell) and (Disease_May_Have_Abnormal_Cell some Megaloblast) and (Disease_May_Have_Abnormal_Cell some Micromegakaryocyte) and (Disease_May_Have_Abnormal_Cell some Monolobed Megakaryocyte) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Abnormal_Cell some Ringed Sideroblast) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 21) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 11q ATM Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 5q) and (Disease_May_Have_Cytogenetic_Abnormality some del(20)(q11)) and (Disease_May_Have_Cytogenetic_Abnormality some del(7)(q11;q36)) and (Disease_May_Have_Cytogenetic_Abnormality some ins(3;3)) and (Disease_May_Have_Cytogenetic_Abnormality some inv(3)(q21q26.2)) and (Disease_May_Have_Cytogenetic_Abnormality some t(3;3)(q21;q26.2)) and (Disease_May_Have_Cytogenetic_Abnormality some t(3;5)(q25;q34)) and (Disease_May_Have_Finding some Granulocytopenia) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Pancytopenia) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines) and (Disease_Has_Finding only Ineffective Hematopoiesis) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells)</Axiom>
               </Source>
            </Change>
            <Change id="477">
               <Axiom>Acute Myelomonocytic Leukemia with Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and ((((Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)))) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Abnormal Eosinophil) and (Disease_Has_Finding only Abnormal Eosinophilic Granules Present) and (Disease_Has_Finding only Bone Marrow Eosinophilia)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Acute Myelomonocytic Leukemia with Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Abnormal Eosinophil) and (Disease_Has_Finding only Abnormal Eosinophilic Granules Present) and (Disease_Has_Finding only Bone Marrow Eosinophilia)</Axiom>
               </Source>
            </Change>
            <Change id="478">
               <Axiom>Acute Myelomonocytic Leukemia without Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and ((((Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Finding some Hemophagocytosis)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(V;11)(v;q23)) and (Disease_May_Have_Molecular_Abnormality some V-MLL Fusion Protein Expression)))) and (Disease_May_Have_Cytogenetic_Abnormality some t(6;9)(p23;q34)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_Excludes_Abnormal_Cell only Abnormal Eosinophil)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Acute Myelomonocytic Leukemia without Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some t(6;9)(p23;q34)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(V;11)(v;q23)) and (Disease_May_Have_Finding some Hemophagocytosis) and (Disease_May_Have_Molecular_Abnormality some V-MLL Fusion Protein Expression) and (Disease_Excludes_Abnormal_Cell only Abnormal Eosinophil)</Axiom>
               </Source>
            </Change>
            <Change id="479">
               <Axiom>Adult Brain Stem Gliosarcoma EquivalentTo Adult Astrocytic Tumor and Adult Brain Stem Glioma and Gliosarcoma and Malignant Adult Brain Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Adult Brain Stem Gliosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Adult Brain Stem Gliosarcoma SubClassOf Malignant Adult Brain Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Adult Brain Stem Gliosarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Adult Brain Stem Gliosarcoma SubClassOf Anaplastic Malignant Neoplasm</Axiom>
                           <Axiom>Adult Brain Stem Gliosarcoma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Adult Brain Stem Gliosarcoma EquivalentTo Adult Astrocytic Tumor and Adult Brain Stem Glioma and Gliosarcoma</Axiom>
               </Source>
            </Change>
            <Change id="480">
               <Axiom>Adult Glioblastoma EquivalentTo Adult Astrocytic Tumor and Glioblastoma and ((((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression)))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Adult Spinal Cord Glioblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Adult Spinal Cord Glioblastoma SubClassOf Anaplastic Malignant Neoplasm</Axiom>
                           <Axiom>Adult Spinal Cord Glioblastoma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Adult Glioblastoma EquivalentTo Adult Astrocytic Tumor and Glioblastoma and (Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
               </Source>
            </Change>
            <Change id="481">
               <Axiom>Advanced Favorable Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Excludes_Finding only Localized Disease) and (Disease_Has_Finding only Extensive Stage Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Advanced Favorable Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Excludes_Finding only Localized Disease)</Axiom>
               </Source>
            </Change>
            <Change id="482">
               <Axiom>Advanced Unfavorable Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Excludes_Finding only Localized Disease) and (Disease_Has_Finding only Extensive Stage Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Advanced Unfavorable Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Excludes_Finding only Localized Disease)</Axiom>
               </Source>
            </Change>
            <Change id="484">
               <Axiom>Alveolar Rhabdomyosarcoma EquivalentTo Rhabdomyosarcoma and Sarcoma Differentiation Score 3 and ((((Disease_May_Have_Cytogenetic_Abnormality some t(1;13)(q36;q14)) and (Disease_May_Have_Molecular_Abnormality some PAX3-FKHR Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;13)(q35;q14)) and (Disease_May_Have_Molecular_Abnormality some PAX7-FKHR Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;2)(q35;p23)) and (Disease_May_Have_Molecular_Abnormality some PAX3-NCOA1 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(X;2)(q13;q35)) and (Disease_May_Have_Molecular_Abnormality some PAX3-AFX Fusion Protein Expression)))) and (Disease_Excludes_Finding only Well-Circumscribed Lesion) and (Disease_Has_Abnormal_Cell only Round Cell with Primitive Myoblastic Differentiation)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Alveolar Rhabdomyosarcoma EquivalentTo Rhabdomyosarcoma and Sarcoma Differentiation Score 3 and (Disease_May_Have_Cytogenetic_Abnormality some t(1;13)(q36;q14)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;13)(q35;q14)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;2)(q35;p23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(X;2)(q13;q35)) and (Disease_May_Have_Molecular_Abnormality some PAX3-AFX Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some PAX3-FKHR Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some PAX3-NCOA1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some PAX7-FKHR Fusion Protein Expression) and (Disease_Excludes_Finding only Well-Circumscribed Lesion) and (Disease_Has_Abnormal_Cell only Round Cell with Primitive Myoblastic Differentiation)</Axiom>
               </Source>
            </Change>
            <Change id="487">
               <Axiom>Anaplastic (Malignant) Meningioma EquivalentTo Anaplastic Malignant Neoplasm and Grade III Meningioma and Malignant Neoplasm of the Meninges and (Disease_May_Have_Finding some High Mitotic Activity) and (Disease_Has_Finding only Malignant Cellular Infiltrate)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Anaplastic (Malignant) Meningioma EquivalentTo Anaplastic Malignant Neoplasm and Grade III Meningioma and Malignant Neoplasm of the Meninges and (Disease_May_Have_Finding some High Mitotic Activity) and (Disease_Has_Finding only Anaplastic Lesion) and (Disease_Has_Finding only Malignant Cellular Infiltrate)</Axiom>
               </Source>
            </Change>
            <Change id="485">
               <Axiom>Anaplastic Astrocytoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytoma and Malignant Glioma and (Disease_May_Have_Cytogenetic_Abnormality some CDKN2A Gene Deletion) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Motor Manifestations) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Finding some Sensory Manifestations) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some RB1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Excludes_Finding only Microvascular Proliferation) and (Disease_Excludes_Finding only Necrotic Change) and (Disease_Has_Abnormal_Cell only Anaplastic Astrocyte) and (Disease_Has_Finding only Increased Cellularity Present) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 3)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Anaplastic Astrocytoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytoma and Malignant Glioma and (Disease_May_Have_Cytogenetic_Abnormality some CDKN2A Gene Deletion) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Motor Manifestations) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Finding some Sensory Manifestations) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some RB1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Excludes_Finding only Microvascular Proliferation) and (Disease_Excludes_Finding only Necrotic Change) and (Disease_Has_Abnormal_Cell only Anaplastic Astrocyte) and (Disease_Has_Finding only Anaplastic Lesion) and (Disease_Has_Finding only Increased Cellularity Present) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 3)</Axiom>
               </Source>
            </Change>
            <Change id="486">
               <Axiom>Anaplastic Ependymoma EquivalentTo Anaplastic Malignant Neoplasm and Ependymal Tumor and Malignant Glioma and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Microvascular Proliferation) and (Disease_May_Have_Finding some Nausea) and (Disease_May_Have_Finding some Pseudopalisading Necrosis) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Finding some Vomiting) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Increased Cellularity Present) and (Disease_Has_Finding only Perivascular Pseudorosette Formation) and (Disease_Is_Grade only Grade 3)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Anaplastic Ependymoma EquivalentTo Anaplastic Malignant Neoplasm and Ependymal Tumor and Malignant Glioma and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Microvascular Proliferation) and (Disease_May_Have_Finding some Nausea) and (Disease_May_Have_Finding some Pseudopalisading Necrosis) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Finding some Vomiting) and (Disease_Has_Finding only Anaplastic Lesion) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Increased Cellularity Present) and (Disease_Has_Finding only Perivascular Pseudorosette Formation) and (Disease_Is_Grade only Grade 3)</Axiom>
               </Source>
            </Change>
            <Change id="488">
               <Axiom>Atypical Chronic Myeloid Leukemia EquivalentTo Myelodysplastic/Myeloproliferative Disease and ((((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(p24;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-JAK2 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(q34;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-ABL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(p24;q11)) and (Disease_May_Have_Molecular_Abnormality some BCR-JAK2 Fusion Protein Expression)))) and (Disease_May_Have_Abnormal_Cell some Dysplastic Erythroid Precursor) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_Has_Abnormal_Cell only Dysplastic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Dysplastic Neutrophil) and (Disease_Has_Finding only Bone Marrow Dysplasia Present) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Increased) and (Disease_Has_Finding only Neutrophilia) and (Disease_Has_Finding only White Blood Cell Count Increased) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Myeloid Stem Cell)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Atypical Chronic Myeloid Leukemia EquivalentTo Myelodysplastic/Myeloproliferative Disease and (Disease_May_Have_Abnormal_Cell some Dysplastic Erythroid Precursor) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(p24;p13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(q34;p13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(p24;q11)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Molecular_Abnormality some BCR-JAK2 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TEL-ABL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TEL-JAK2 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Dysplastic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Dysplastic Neutrophil) and (Disease_Has_Finding only Bone Marrow Dysplasia Present) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Increased) and (Disease_Has_Finding only Neutrophilia) and (Disease_Has_Finding only White Blood Cell Count Increased) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Myeloid Stem Cell)</Axiom>
               </Source>
            </Change>
            <Change id="489">
               <Axiom>Benign Sebaceous Neoplasm EquivalentTo Benign Epithelial Skin Neoplasm and Benign Skin Appendage Neoplasm and Sebaceous Gland Neoplasm</Axiom>
               <ConceptChanges size="3">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Benign Sebaceous Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Sebaceous Neoplasm SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Epithelial Skin Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Sebaceous Neoplasm SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Sebaceous Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Sebaceous Adenoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Sebaceous Adenoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Benign Sebaceous Neoplasm EquivalentTo Benign Skin Appendage Neoplasm and Sebaceous Gland Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="490">
               <Axiom>Blast Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and ((((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression)))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Abnormal_Cell only Neoplastic Blast) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Blast Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Neoplastic Blast) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
               </Source>
            </Change>
            <Change id="491">
               <Axiom>Borderline Ovarian Serous Surface Papillary Tumor EquivalentTo Borderline Ovarian Serous Tumor and (Disease_May_Have_Finding some Psammoma Body Formation)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Borderline Ovarian Serous Surface Papillary Tumor EquivalentTo Borderline Ovarian Serous Tumor and Ovarian Papillary Tumor and (Disease_May_Have_Finding some Psammoma Body Formation)</Axiom>
               </Source>
            </Change>
            <Change id="492">
               <Axiom>Brain Glioblastoma EquivalentTo Glioblastoma and ((((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression)))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Cerebral Glioblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Cerebral Glioblastoma SubClassOf Anaplastic Malignant Neoplasm</Axiom>
                           <Axiom>Cerebral Glioblastoma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Brain Glioblastoma EquivalentTo Glioblastoma and (Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
               </Source>
            </Change>
            <Change id="493">
               <Axiom>Carcinoma ex Eccrine Spiradenoma EquivalentTo Spiradenocarcinoma and (Disease_Has_Associated_Disease only Spiradenoma) and (Disease_Has_Finding only Secondary Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Carcinoma ex Eccrine Spiradenoma EquivalentTo Eccrine Carcinoma and Spiradenocarcinoma and (Disease_Has_Associated_Disease only Spiradenoma) and (Disease_Has_Finding only Secondary Lesion)</Axiom>
               </Source>
            </Change>
            <Change id="494">
               <Axiom>Cervical Mullerian Papilloma EquivalentTo Benign Cervical Neoplasm and Cervical Glandular Neoplasm and Papilloma and (Disease_May_Have_Finding some Squamous Metaplasia) and (Disease_Has_Normal_Tissue_Origin only Cervix Epithelium)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Cervical Mullerian Papilloma EquivalentTo Benign Cervical Neoplasm and Cervical Glandular Neoplasm and Papilloma and (Disease_May_Have_Finding some Squamous Metaplasia) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell with Intracytoplasmic Mucin) and (Disease_Has_Normal_Tissue_Origin only Cervix Epithelium)</Axiom>
               </Source>
            </Change>
            <Change id="495">
               <Axiom>Childhood Brain Meningioma EquivalentTo Childhood Intracranial Neoplasm and Childhood Meningioma and Intracranial Meningioma and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Childhood Brain Meningioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Childhood Brain Meningioma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Childhood Intracranial Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Childhood Brain Meningioma SubClassOf Childhood Intracranial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Childhood Brain Meningioma EquivalentTo Childhood Meningioma and Intracranial Meningioma and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
               </Source>
            </Change>
            <Change id="496">
               <Axiom>Chordoma EquivalentTo Notochordal Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 20) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 4) and (Disease_Has_Abnormal_Cell only Physaliphorous Cell) and (Disease_Has_Finding only Lobulated Growth Pattern) and (Disease_Has_Finding only Myxoid Stroma Formation) and (Disease_Has_Finding only Slow Growing Mass) and (Disease_Has_Finding only Solitary Mass)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Chordoma EquivalentTo Notochordal Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 20) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 4) and (Disease_Has_Abnormal_Cell only Physaliphorous Cell) and (Disease_Has_Finding only Lobulated Growth Pattern) and (Disease_Has_Finding only Lytic Bone Lesion) and (Disease_Has_Finding only Myxoid Stroma Formation) and (Disease_Has_Finding only Slow Growing Mass) and (Disease_Has_Finding only Solitary Mass)</Axiom>
               </Source>
            </Change>
            <Change id="497">
               <Axiom>Chronic Eosinophilic Leukemia EquivalentTo Chronic Leukemia and Chronic Myeloproliferative Disorder and ((((Disease_May_Have_Cytogenetic_Abnormality some t(1;4)(q44;q12)) and (Disease_May_Have_Molecular_Abnormality some FIP1L1-PDGFRalpha Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;13)(p11;q11)) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell)) or ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression)))) and (Disease_May_Have_Associated_Disease some Endomyocardial Fibrosis) and (Disease_May_Have_Associated_Disease some Eosinophilic Endomyocardial Disease) and (Disease_May_Have_Associated_Disease some Neuropathy) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some del(4)(q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(6;8)(q27;p11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;9)(p11;q32-34)) and (Disease_May_Have_Finding some Charcot-Leyden Crystals Formation) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_Has_Finding only Blasts Under 20 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Monoclonal Eosinophils Present) and (Disease_Has_Finding only Eosinophilia) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Chronic Eosinophilic Leukemia EquivalentTo Chronic Leukemia and Chronic Myeloproliferative Disorder and (Disease_May_Have_Associated_Disease some Endomyocardial Fibrosis) and (Disease_May_Have_Associated_Disease some Eosinophilic Endomyocardial Disease) and (Disease_May_Have_Associated_Disease some Neuropathy) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some del(4)(q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;4)(q44;q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(6;8)(q27;p11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;13)(p11;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;9)(p11;q32-34)) and (Disease_May_Have_Finding some Charcot-Leyden Crystals Formation) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Molecular_Abnormality some FIP1L1-PDGFRalpha Fusion Protein Expression) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell) and (Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression) and (Disease_Has_Finding only Blasts Under 20 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Monoclonal Eosinophils Present) and (Disease_Has_Finding only Eosinophilia) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
               </Source>
            </Change>
            <Change id="498">
               <Axiom>Classical Hodgkin's Lymphoma EquivalentTo Hodgkin's Lymphoma and ((((Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Mature B-Lymphocyte at the Germinal Center Stage of Differentiation)) or ((Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Peripheral (Post-Thymic) T-Lymphocyte)))) and (Disease_May_Have_Abnormal_Cell some Mummified Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 2p) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9p) and (Disease_May_Have_Finding some CD15-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some CD30-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some Colony-Stimulating Factor Overexpression) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Interleukin-10 Overexpression) and (Disease_May_Have_Finding some Interleukin-13 Overexpression) and (Disease_May_Have_Finding some Interleukin-2 Overexpression) and (Disease_May_Have_Finding some Interleukin-5 Overexpression) and (Disease_May_Have_Finding some Interleukin-6 Overexpression) and (Disease_May_Have_Finding some Interleukin-7 Overexpression) and (Disease_May_Have_Finding some Interleukin-9 Overexpression) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Lymphotoxin-Alpha Overexpression) and (Disease_May_Have_Finding some Night Sweating) and (Disease_May_Have_Finding some Transforming Growth Factor-Beta Overexpression) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some Apoptotic Pathway Deregulation) and (Disease_Has_Abnormal_Cell only Classical Reed-Sternberg Cell) and (Disease_Has_Abnormal_Cell only Hodgkin's Cell)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Classical Hodgkin's Lymphoma EquivalentTo Hodgkin's Lymphoma and (Disease_May_Have_Abnormal_Cell some Mummified Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 2p) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9p) and (Disease_May_Have_Finding some CD15-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some CD30-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some Colony-Stimulating Factor Overexpression) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Interleukin-10 Overexpression) and (Disease_May_Have_Finding some Interleukin-13 Overexpression) and (Disease_May_Have_Finding some Interleukin-2 Overexpression) and (Disease_May_Have_Finding some Interleukin-5 Overexpression) and (Disease_May_Have_Finding some Interleukin-6 Overexpression) and (Disease_May_Have_Finding some Interleukin-7 Overexpression) and (Disease_May_Have_Finding some Interleukin-9 Overexpression) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Lymphotoxin-Alpha Overexpression) and (Disease_May_Have_Finding some Night Sweating) and (Disease_May_Have_Finding some Transforming Growth Factor-Beta Overexpression) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some Apoptotic Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Mature B-Lymphocyte at the Germinal Center Stage of Differentiation) and (Disease_May_Have_Normal_Cell_Origin some Peripheral (Post-Thymic) T-Lymphocyte) and (Disease_Has_Abnormal_Cell only Classical Reed-Sternberg Cell) and (Disease_Has_Abnormal_Cell only Hodgkin's Cell)</Axiom>
               </Source>
            </Change>
            <Change id="483">
               <Axiom>Digital Papillary Eccrine Carcinoma EquivalentTo Papillary Eccrine Carcinoma and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Finding only Aggressive Clinical Course) and (Disease_Has_Finding only Micropapillary Pattern) and (Disease_Has_Primary_Anatomic_Site only Digit)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Digital Papillary Eccrine Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Digital Papillary Eccrine Carcinoma SubClassOf Papillary Adenocarcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Digital Papillary Eccrine Carcinoma EquivalentTo Papillary Eccrine Carcinoma and (Disease_Has_Finding only Aggressive Clinical Course) and (Disease_Has_Finding only Micropapillary Pattern) and (Disease_Has_Primary_Anatomic_Site only Digit)</Axiom>
               </Source>
            </Change>
            <Change id="501">
               <Axiom>Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Embryonal Neoplasm and ((((Disease_May_Have_Cytogenetic_Abnormality some inv(22q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;22)(p36.1;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ZSG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(11;22) (q24;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-FL1 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;21)(p11;q22)) and (Disease_May_Have_Molecular_Abnormality some FUS-ERG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(17;22)(q21;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-E1AF Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(21;22)(q22;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ERG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(q33;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-FEV Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(7;22)(p22;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ETV1 Fusion Protein Expression)))) and (Disease_May_Have_Abnormal_Cell some Malignant Small Round Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Homer Wright Rosette Formation) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Primitive Round to Oval Cell) and (Disease_Has_Normal_Tissue_Origin only Neural Crest)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Bone Ewing's Sarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Bone Ewing's Sarcoma SubClassOf Metastatic Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Embryonal Neoplasm and (Disease_May_Have_Abnormal_Cell some Malignant Small Round Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some inv(22q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;22) (q24;q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(16;21)(p11;q22)) and (Disease_May_Have_Cytogenetic_Abnormality some t(17;22)(q21;q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;22)(p36.1;q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(21;22)(q22;q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(q33;q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;22)(p22;q12)) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Homer Wright Rosette Formation) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_May_Have_Molecular_Abnormality some EWS-E1AF Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some EWS-ERG Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some EWS-ETV1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some EWS-FEV Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some EWS-FL1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some EWS-ZSG Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some FUS-ERG Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Primitive Round to Oval Cell) and (Disease_Has_Normal_Tissue_Origin only Neural Crest)</Axiom>
               </Source>
            </Change>
            <Change id="502">
               <Axiom>Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone EquivalentTo Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Malignant Bone Neoplasm and (Disease_May_Have_Finding some Pain) and (Disease_Has_Primary_Anatomic_Site only Bone)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Bone Ewing's Sarcoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Bone Ewing's Sarcoma SubClassOf Metastatic Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone EquivalentTo Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Malignant Bone Neoplasm and (Disease_May_Have_Finding some Pain) and (Disease_Has_Finding only Lytic Bone Lesion) and (Disease_Has_Primary_Anatomic_Site only Bone)</Axiom>
               </Source>
            </Change>
            <Change id="519">
               <Axiom>Extraskeletal Myxoid Chondrosarcoma EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Soft Tissue Sarcoma and ((((Disease_May_Have_Cytogenetic_Abnormality some t(3;9)(q11-12;q22)) and (Disease_May_Have_Molecular_Abnormality some TFG-NR4A3 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;15)(q22;q21)) and (Disease_May_Have_Molecular_Abnormality some TCF12-NR4A3 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;17)(q22;q11)) and (Disease_May_Have_Molecular_Abnormality some RBP56-NR4A3 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q22-31;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-NR4A3 Fusion Protein Expression)))) and (Disease_May_Have_Finding some Cord-Like Pattern) and (Disease_May_Have_Finding some Cribriform Pattern) and (Disease_May_Have_Finding some Cystic Change) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Spindle Cell Pattern) and (Disease_Has_Abnormal_Cell only Malignant Cell with Eosinophilic Cytoplasm) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Extraosseous Lesion) and (Disease_Has_Finding only Multinodular Pattern) and (Disease_Has_Finding only Myxoid Stroma Formation)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Extraskeletal Myxoid Chondrosarcoma EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Soft Tissue Sarcoma and (Disease_May_Have_Cytogenetic_Abnormality some t(3;9)(q11-12;q22)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;15)(q22;q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;17)(q22;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q22-31;q12)) and (Disease_May_Have_Finding some Cord-Like Pattern) and (Disease_May_Have_Finding some Cribriform Pattern) and (Disease_May_Have_Finding some Cystic Change) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Spindle Cell Pattern) and (Disease_May_Have_Molecular_Abnormality some EWS-NR4A3 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some RBP56-NR4A3 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TCF12-NR4A3 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TFG-NR4A3 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Malignant Cell with Eosinophilic Cytoplasm) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Extraosseous Lesion) and (Disease_Has_Finding only Multinodular Pattern) and (Disease_Has_Finding only Myxoid Stroma Formation)</Axiom>
               </Source>
            </Change>
            <Change id="503">
               <Axiom>Fibrofolliculoma EquivalentTo Benign Pilar-Associated Mesenchyme Neoplasm and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Distortion of the Hair Follicle)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Fibrofolliculoma EquivalentTo Benign Pilar-Associated Mesenchyme Neoplasm and (Disease_Has_Finding only Distortion of the Hair Follicle)</Axiom>
               </Source>
            </Change>
            <Change id="499">
               <Axiom>Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Diffuse Large B-Cell Lymphoma by Gene Expression Profile and ((((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma)))) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Molecular_Abnormality only A-myb Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Has_Molecular_Abnormality only BCL-6 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD10 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only LMO2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only REL Gene Amplification) and (Disease_Has_Normal_Cell_Origin only Germinal Center B-Lymphocyte)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Molecular_Abnormality only A-myb Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Has_Molecular_Abnormality only BCL-6 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD10 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only LMO2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only REL Gene Amplification) and (Disease_Has_Normal_Cell_Origin only Germinal Center B-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="504">
               <Axiom>Hereditary Thyroid Gland Medullary Carcinoma EquivalentTo Hereditary Malignant Neoplasm and Thyroid Gland Medullary Carcinoma and (Disease_Has_Associated_Disease only Neoplastic C-Cell Hyperplasia) and (Disease_Has_Molecular_Abnormality only RET Gene Mutation)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Hereditary Thyroid Gland Medullary Carcinoma EquivalentTo Bilateral Carcinoma and Hereditary Malignant Neoplasm and Thyroid Gland Medullary Carcinoma and (Disease_Has_Associated_Disease only Neoplastic C-Cell Hyperplasia) and (Disease_Has_Molecular_Abnormality only RET Gene Mutation)</Axiom>
               </Source>
            </Change>
            <Change id="505">
               <Axiom>Hodgkin's Lymphoma EquivalentTo Common Hematopoietic Neoplasm and Lymphoma and (Disease_Has_Abnormal_Cell only Reed-Sternberg Cell) and (Disease_Has_Normal_Cell_Origin only Mature Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Lymphoid Tissue)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Hodgkin's Lymphoma EquivalentTo Common Hematopoietic Neoplasm and Lymphoma and (Disease_Has_Abnormal_Cell only Neoplastic Large Lymphocyte) and (Disease_Has_Abnormal_Cell only Reed-Sternberg Cell) and (Disease_Has_Associated_Anatomic_Site only Lymphatic System) and (Disease_Has_Normal_Cell_Origin only Mature Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Lymphoid Tissue)</Axiom>
               </Source>
            </Change>
            <Change id="506">
               <Axiom>Indolent Myeloma EquivalentTo Osteolytic Neoplasm and Plasma Cell Myeloma and ((Disease_Excludes_Finding only Bone Pain) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Pathologic Fracture) and (Disease_Has_Finding only Lytic Metastatic Bone Lesion)) and (Disease_Has_Finding only Monoclonal Paraproteinemia) and (Disease_Has_Finding only Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Stable Disease)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Indolent Myeloma</Concept>
                        <WitnessAxioms>
                           <Axiom>Indolent Myeloma SubClassOf Osteolytic Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Indolent Myeloma EquivalentTo Plasma Cell Myeloma and (Disease_Excludes_Finding only Bone Pain) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Pathologic Fracture) and (Disease_Has_Finding only Lytic Metastatic Bone Lesion) and (Disease_Has_Finding only Monoclonal Paraproteinemia) and (Disease_Has_Finding only Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Stable Disease)</Axiom>
               </Source>
            </Change>
            <Change id="507">
               <Axiom>Infectious Mononucleosis EquivalentTo Benign Lymphoproliferative Disorder and Epstein-Barr Virus Infection and ((((Disease_May_Have_Finding some Splenic Rupture) and (Disease_Has_Finding only Splenomegaly)) or ((Disease_Has_Finding only Atypical Lymphocytes Present in Peripheral Blood) and (Disease_Has_Finding only Diffuse Immunoblastic Proliferation) and (Disease_Has_Finding only Polymorphic Cellular Infiltrate)))) and (Disease_May_Have_Associated_Disease some Acute Hepatitis) and (Disease_Excludes_Molecular_Abnormality only Clonal Antigen Receptor Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Finding only Fever) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only EBV-Specific Cytotoxic T-Lymphocyte)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Infectious Mononucleosis EquivalentTo Benign Lymphoproliferative Disorder and Epstein-Barr Virus Infection and (Disease_May_Have_Associated_Disease some Acute Hepatitis) and (Disease_May_Have_Finding some Splenic Rupture) and (Disease_Excludes_Molecular_Abnormality only Clonal Antigen Receptor Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Finding only Atypical Lymphocytes Present in Peripheral Blood) and (Disease_Has_Finding only Diffuse Immunoblastic Proliferation) and (Disease_Has_Finding only Fever) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Finding only Polymorphic Cellular Infiltrate) and (Disease_Has_Finding only Splenomegaly) and (Disease_Has_Normal_Cell_Origin only EBV-Specific Cytotoxic T-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="508">
               <Axiom>Inflammatory Myofibroblastic Tumor EquivalentTo Intermediate Fibrocytic Neoplasm and ((((Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression)))) and (Disease_May_Have_Abnormal_Cell some Ganglion-Like Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Stellate Cell) and (Disease_May_Have_Finding some Well-Circumscribed Lesion) and (Disease_May_Have_Finding some Fascicular Pattern) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Multinodular Lesion) and (Disease_May_Have_Finding some Myxoid Background) and (Disease_May_Have_Finding some Pain) and (Disease_Has_Abnormal_Cell only Neoplastic Spindle-Shaped Myofibroblast) and (Disease_Has_Finding only Eosinophilic Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Inflammatory Myofibroblastic Tumor EquivalentTo Intermediate Fibrocytic Neoplasm and (Disease_May_Have_Abnormal_Cell some Ganglion-Like Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Stellate Cell) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Finding some Well-Circumscribed Lesion) and (Disease_May_Have_Finding some Fascicular Pattern) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Multinodular Lesion) and (Disease_May_Have_Finding some Myxoid Background) and (Disease_May_Have_Finding some Pain) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Neoplastic Spindle-Shaped Myofibroblast) and (Disease_Has_Finding only Eosinophilic Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate)</Axiom>
               </Source>
            </Change>
            <Change id="509">
               <Axiom>Kaposi's Sarcoma Related to Immunosuppressive Treatment EquivalentTo Iatrogenic Kaposi's Sarcoma and (Disease_Has_Finding only Drug Toxicity)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Kaposi's Sarcoma Related to Immunosuppressive Treatment</Concept>
                        <WitnessAxioms>
                           <Axiom>Kaposi's Sarcoma Related to Immunosuppressive Treatment SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Kaposi's Sarcoma Related to Immunosuppressive Treatment EquivalentTo Iatrogenic Kaposi's Sarcoma and Therapy Related Malignant Neoplasm and (Disease_Has_Finding only Drug Toxicity)</Axiom>
               </Source>
            </Change>
            <Change id="510">
               <Axiom>Lung Mixed Squamous and Glandular Papilloma EquivalentTo Mixed Neoplasm and Lung Papilloma and (Disease_May_Have_Finding some Squamous Cell Atypia) and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Squamous Cell) and (Disease_Has_Finding only Mixed Neoplastic Glandular and Squamous Cell Population) and (Disease_Has_Normal_Cell_Origin only Bronchial Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Bronchial Epithelium) and (Disease_Has_Primary_Anatomic_Site only Bronchus)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Lung Mixed Squamous and Glandular Papilloma</Concept>
                        <WitnessAxioms>
                           <Axiom>Lung Mixed Squamous and Glandular Papilloma SubClassOf Mixed Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Lung Mixed Squamous and Glandular Papilloma EquivalentTo Lung Papilloma and (Disease_May_Have_Finding some Squamous Cell Atypia) and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Squamous Cell) and (Disease_Has_Finding only Mixed Neoplastic Glandular and Squamous Cell Population) and (Disease_Has_Normal_Cell_Origin only Bronchial Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Bronchial Epithelium) and (Disease_Has_Primary_Anatomic_Site only Bronchus)</Axiom>
               </Source>
            </Change>
            <Change id="511">
               <Axiom>Lung Mucinous Cystadenocarcinoma EquivalentTo Lung Mucinous Adenocarcinoma and Mucinous Cystadenocarcinoma and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Cystic Change)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Lung Mucinous Cystadenocarcinoma EquivalentTo Lung Mucinous Adenocarcinoma and Mucinous Cystadenocarcinoma and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Partially Encapsulated Mass)</Axiom>
               </Source>
            </Change>
            <Change id="512">
               <Axiom>Lymphomatoid Papulosis EquivalentTo Cutaneous Mature T-Cell and NK-Cell Neoplasm and Cutaneous Precancerous Condition and T-Cell Proliferation of Uncertain Malignant Potential and ((((Disease_May_Have_Associated_Disease some Anaplastic Large Cell Lymphoma) and (Disease_May_Have_Associated_Disease some Hodgkin's Lymphoma) and (Disease_May_Have_Associated_Disease some Mycosis Fungoides)) or ((Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Complete Spontaneous Regression) and (Disease_Has_Finding only Cutaneous Involvement)))) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Activated Skin-Homing T-Lymphocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Lymphomatoid Papulosis EquivalentTo Cutaneous Mature T-Cell and NK-Cell Neoplasm and Cutaneous Precancerous Condition and T-Cell Proliferation of Uncertain Malignant Potential and (Disease_May_Have_Associated_Disease some Anaplastic Large Cell Lymphoma) and (Disease_May_Have_Associated_Disease some Hodgkin's Lymphoma) and (Disease_May_Have_Associated_Disease some Mycosis Fungoides) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Complete Spontaneous Regression) and (Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Normal_Cell_Origin only Activated Skin-Homing T-Lymphocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
               </Source>
            </Change>
            <Change id="513">
               <Axiom>Malignant Glomus Tumor EquivalentTo Glomus Tumor and Malignant Pericytic Neoplasm and ((((Disease_May_Have_Finding some Deep Lesion) and (Disease_May_Have_Finding some Lesion with Diameter Greater than 2cm)) or ((Disease_May_Have_Finding some Marked Nuclear Atypia Present) and (Disease_May_Have_Finding some Mitotic Activity)))) and (Disease_May_Have_Finding some Atypical Mitotic Figures) and (Disease_Has_Abnormal_Cell only Malignant Glomus Cell)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Malignant Glomus Tumor EquivalentTo Glomus Tumor and Malignant Pericytic Neoplasm and (Disease_May_Have_Finding some Atypical Mitotic Figures) and (Disease_May_Have_Finding some Deep Lesion) and (Disease_May_Have_Finding some Lesion with Diameter Greater than 2cm) and (Disease_May_Have_Finding some Marked Nuclear Atypia Present) and (Disease_May_Have_Finding some Mitotic Activity) and (Disease_Has_Abnormal_Cell only Malignant Glomus Cell)</Axiom>
               </Source>
            </Change>
            <Change id="514">
               <Axiom>Malignant Ovarian Mixed Epithelial Tumor EquivalentTo Malignant Mixed Neoplasm and Malignant Ovarian Surface Epithelial-Stromal Tumor and Ovarian Mixed Epithelial Tumor and (Disease_May_Have_Abnormal_Cell some Malignant Transitional Cell) and (Disease_May_Have_Abnormal_Cell some Adenocarcinoma Cell with Intracytoplasmic Mucin) and (Disease_May_Have_Abnormal_Cell some Serous Adenocarcinoma Cell) and (Disease_May_Have_Finding some Ascites) and (Disease_May_Have_Finding some Malignant Glandular Epithelium Resembling the Normal Endometrium Present) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Malignant Ovarian Mixed Epithelial Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Malignant Ovarian Mixed Epithelial Tumor SubClassOf Malignant Mixed Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Malignant Ovarian Mixed Epithelial Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Malignant Ovarian Mixed Epithelial Tumor SubClassOf Mixed Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Malignant Ovarian Mixed Epithelial Tumor EquivalentTo Malignant Ovarian Surface Epithelial-Stromal Tumor and Ovarian Mixed Epithelial Tumor and (Disease_May_Have_Abnormal_Cell some Malignant Transitional Cell) and (Disease_May_Have_Abnormal_Cell some Adenocarcinoma Cell with Intracytoplasmic Mucin) and (Disease_May_Have_Abnormal_Cell some Serous Adenocarcinoma Cell) and (Disease_May_Have_Finding some Ascites) and (Disease_May_Have_Finding some Malignant Glandular Epithelium Resembling the Normal Endometrium Present) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)</Axiom>
               </Source>
            </Change>
            <Change id="515">
               <Axiom>Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type EquivalentTo Metastatic Carcinoma and Ovarian Small Cell Carcinoma, Hypercalcemic Type and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type SubClassOf Metastatic Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type</Concept>
                        <WitnessAxioms>
                           <Axiom>Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type SubClassOf Metastatic Malignant Neoplasm</Axiom>
                           <Axiom>Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type SubClassOf Metastatic Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type EquivalentTo Ovarian Small Cell Carcinoma, Hypercalcemic Type and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
               </Source>
            </Change>
            <Change id="516">
               <Axiom>Mixed Lobular and Ductal Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Malignant Mixed Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Molecular_Abnormality some CDH1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some Loss of E-cadherin Expression)) and (Disease_Has_Abnormal_Cell only Ductal Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Lobular Carcinoma Cell) and (Disease_Has_Associated_Disease only Ductal Breast Carcinoma) and (Disease_Has_Associated_Disease only Lobular Breast Carcinoma) and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Mixed Lobular and Ductal Breast Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Mixed Lobular and Ductal Breast Carcinoma SubClassOf Malignant Mixed Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Intraductal and Lobular Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Intraductal and Lobular Carcinoma SubClassOf Malignant Mixed Neoplasm</Axiom>
                           <Axiom>Intraductal and Lobular Carcinoma SubClassOf Mixed Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Mixed Lobular and Ductal Breast Carcinoma EquivalentTo Breast Adenocarcinoma and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Molecular_Abnormality some CDH1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some Loss of E-cadherin Expression) and (Disease_Has_Abnormal_Cell only Ductal Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Lobular Carcinoma Cell) and (Disease_Has_Associated_Disease only Ductal Breast Carcinoma) and (Disease_Has_Associated_Disease only Lobular Breast Carcinoma) and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit)</Axiom>
               </Source>
            </Change>
            <Change id="517">
               <Axiom>Monoblastic Sarcoma EquivalentTo Myeloid Sarcoma and ((((Disease_May_Have_Cytogenetic_Abnormality some t(10;11)(p11;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF10 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q23;p13.1)) and (Disease_May_Have_Molecular_Abnormality some MLL-EEN Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ELL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ENL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF9 Fusion Protein Expression)))) and (Disease_Excludes_Abnormal_Cell only Neoplastic Granulocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Monoblastic Sarcoma EquivalentTo Myeloid Sarcoma and (Disease_May_Have_Cytogenetic_Abnormality some t(10;11)(p11;q23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q23;p13.1)) and (Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF10 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-AF9 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-EEN Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ELL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ENL Fusion Protein Expression) and (Disease_Excludes_Abnormal_Cell only Neoplastic Granulocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast)</Axiom>
               </Source>
            </Change>
            <Change id="518">
               <Axiom>Mycosis Fungoides EquivalentTo Cutaneous T-Cell Non-Hodgkin's Lymphoma and Indolent Non-Hodgkin's Lymphoma and Mycosis Fungoides and Sezary Syndrome and ((((Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate)) or ((Disease_May_Have_Finding some Progressive Disease) and (Disease_May_Have_Molecular_Abnormality some CDKN2A Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation)))) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Dermatopathic Lymphadenopathy) and (Disease_May_Have_Finding some Scaly Skin Eruption) and (Disease_May_Have_Finding some Skin Patch) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Has_Abnormal_Cell only Cerebriform Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Mycosis Fungoides EquivalentTo Cutaneous T-Cell Non-Hodgkin's Lymphoma and Indolent Non-Hodgkin's Lymphoma and Mycosis Fungoides and Sezary Syndrome and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Dermatopathic Lymphadenopathy) and (Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Progressive Disease) and (Disease_May_Have_Finding some Scaly Skin Eruption) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_May_Have_Finding some Skin Patch) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_May_Have_Molecular_Abnormality some CDKN2A Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Cerebriform Lymphocyte) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="520">
               <Axiom>Myxoid/Round Cell Liposarcoma EquivalentTo Liposarcoma and ((((Disease_May_Have_Cytogenetic_Abnormality some t(12;16)(q13;p11)) and (Disease_May_Have_Molecular_Abnormality some FUS-DDIT3 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(12;22)(q13;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-DDIT3 Fusion Protein Expression)))) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13q) and (Disease_Has_Abnormal_Cell only Primitive Mesenchymal Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Myxoid/Round Cell Liposarcoma EquivalentTo Liposarcoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some t(12;16)(q13;p11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(12;22)(q13;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-DDIT3 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some FUS-DDIT3 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Primitive Mesenchymal Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
               </Source>
            </Change>
            <Change id="522">
               <Axiom>O(6)-Benzylguanine EquivalentTo O6-Alkylguanine-DNA Alkyltransferase Inhibitor and (Chemical_Or_Drug_Affects_Gene_Product some Alkyltransferase and Aryltransferase) and (Chemical_Or_Drug_Has_Mechanism_Of_Action some Enzyme Inhibition) and (Chemical_Or_Drug_Has_Physiologic_Effect some DNA Repair Inhibition)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>O(6)-Benzylguanine EquivalentTo Chemo Immunostimulant Adjuvant and O6-Alkylguanine-DNA Alkyltransferase Inhibitor and (Chemical_Or_Drug_Affects_Gene_Product some Alkyltransferase and Aryltransferase) and (Chemical_Or_Drug_Has_Mechanism_Of_Action some Enzyme Inhibition) and (Chemical_Or_Drug_Has_Physiologic_Effect some DNA Repair Inhibition)</Axiom>
               </Source>
            </Change>
            <Change id="523">
               <Axiom>Ovarian Serous Surface Papillary Adenocarcinoma EquivalentTo Ovarian Papillary Tumor and Ovarian Serous Adenocarcinoma and Serous Surface Papillary Carcinoma</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Ovarian Serous Surface Papillary Adenocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Ovarian Serous Surface Papillary Adenocarcinoma SubClassOf Serous Surface Papillary Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Ovarian Serous Surface Papillary Adenocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Ovarian Serous Surface Papillary Adenocarcinoma SubClassOf Papillary Adenocarcinoma</Axiom>
                           <Axiom>Ovarian Serous Surface Papillary Adenocarcinoma SubClassOf Papillary Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Ovarian Serous Surface Papillary Adenocarcinoma EquivalentTo Ovarian Papillary Tumor and Ovarian Serous Adenocarcinoma</Axiom>
               </Source>
            </Change>
            <Change id="548">
               <Axiom>Paget's Disease of the Vulva EquivalentTo Extramammary Paget's Disease and Malignant Vulvar Sweat Gland Neoplasm and Sweat Gland Carcinoma and Vulvar Adenocarcinoma and (Disease_May_Have_Finding some Eczema)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Paget's Disease of the Vulva</Concept>
                        <WitnessAxioms>
                           <Axiom>Paget's Disease of the Vulva SubClassOf Sweat Gland Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Paget's Disease of the Vulva</Concept>
                        <WitnessAxioms>
                           <Axiom>Paget's Disease of the Vulva SubClassOf Adnexal Carcinoma</Axiom>
                           <Axiom>Paget's Disease of the Vulva SubClassOf Skin Carcinoma</Axiom>
                           <Axiom>Paget's Disease of the Vulva SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Paget's Disease of the Vulva EquivalentTo Extramammary Paget's Disease and Malignant Vulvar Sweat Gland Neoplasm and Vulvar Adenocarcinoma and (Disease_May_Have_Finding some Eczema)</Axiom>
               </Source>
            </Change>
            <Change id="526">
               <Axiom>Pancreatic Borderline Intraductal Papillary-Mucinous Neoplasm EquivalentTo Borderline Exocrine Pancreatic Neoplasm and Pancreatic Intraductal Papillary-Mucinous Neoplasm and Papillary Epithelial Neoplasm and (Disease_Excludes_Finding only Severe Dysplasia) and (Disease_Has_Finding only Moderate Dysplasia)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Pancreatic Borderline Intraductal Papillary-Mucinous Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Pancreatic Borderline Intraductal Papillary-Mucinous Neoplasm SubClassOf Papillary Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Pancreatic Borderline Intraductal Papillary-Mucinous Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Pancreatic Borderline Intraductal Papillary-Mucinous Neoplasm SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Pancreatic Borderline Intraductal Papillary-Mucinous Neoplasm SubClassOf Glandular Cell Neoplasm</Axiom>
                           <Axiom>Pancreatic Borderline Intraductal Papillary-Mucinous Neoplasm SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Pancreatic Borderline Intraductal Papillary-Mucinous Neoplasm SubClassOf Papillary Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Pancreatic Borderline Intraductal Papillary-Mucinous Neoplasm EquivalentTo Borderline Exocrine Pancreatic Neoplasm and Pancreatic Intraductal Papillary-Mucinous Neoplasm and (Disease_Excludes_Finding only Severe Dysplasia) and (Disease_Has_Finding only Moderate Dysplasia)</Axiom>
               </Source>
            </Change>
            <Change id="527">
               <Axiom>Pancreatic Borderline Mucinous Cystic Neoplasm EquivalentTo Borderline Exocrine Pancreatic Neoplasm and Pancreatic Mucinous Cystic Neoplasm and (Disease_Has_Finding only Cellular Pseudostratification) and (Disease_Has_Finding only Mitotic Activity)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Pancreatic Borderline Mucinous Cystic Neoplasm EquivalentTo Borderline Exocrine Pancreatic Neoplasm and Pancreatic Mucinous Cystic Neoplasm and (Disease_Has_Finding only Cellular Pseudostratification) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Papillary Pattern)</Axiom>
               </Source>
            </Change>
            <Change id="524">
               <Axiom>Pancreatic Intraductal Papillary-Mucinous Adenoma EquivalentTo Adenoma and Pancreatic Intraductal Papillary-Mucinous Neoplasm and (Disease_May_Have_Finding some Mild Dysplasia) and (Disease_Excludes_Finding only Moderate Dysplasia) and (Disease_Excludes_Finding only Severe Dysplasia)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Pancreatic Intraductal Papillary-Mucinous Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Pancreatic Intraductal Papillary-Mucinous Adenoma SubClassOf Adenoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Pancreatic Intraductal Papillary-Mucinous Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Pancreatic Intraductal Papillary-Mucinous Adenoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Pancreatic Intraductal Papillary-Mucinous Adenoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Pancreatic Intraductal Papillary-Mucinous Adenoma SubClassOf Glandular Cell Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Pancreatic Intraductal Papillary-Mucinous Adenoma EquivalentTo Pancreatic Intraductal Papillary-Mucinous Neoplasm and (Disease_May_Have_Finding some Mild Dysplasia) and (Disease_Excludes_Finding only Moderate Dysplasia) and (Disease_Excludes_Finding only Severe Dysplasia)</Axiom>
               </Source>
            </Change>
            <Change id="525">
               <Axiom>Pancreatic Intraductal Papillary-Mucinous Carcinoma EquivalentTo Pancreatic Ductal Adenocarcinoma and Pancreatic Intraductal Papillary-Mucinous Neoplasm and Papillary Carcinoma and (Disease_Has_Finding only Severe Dysplasia)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Pancreatic Intraductal Papillary-Mucinous Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Pancreatic Intraductal Papillary-Mucinous Carcinoma SubClassOf Papillary Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Pancreatic Intraductal Papillary-Mucinous Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Pancreatic Intraductal Papillary-Mucinous Carcinoma SubClassOf Papillary Neoplasm</Axiom>
                           <Axiom>Pancreatic Intraductal Papillary-Mucinous Carcinoma SubClassOf Papillary Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Pancreatic Intraductal Papillary-Mucinous Carcinoma EquivalentTo Pancreatic Ductal Adenocarcinoma and Pancreatic Intraductal Papillary-Mucinous Neoplasm and (Disease_Has_Finding only Severe Dysplasia)</Axiom>
               </Source>
            </Change>
            <Change id="528">
               <Axiom>Penile Bowenoid Papulosis EquivalentTo Bowenoid Papulosis and Penile Neoplasm and (Disease_Has_Primary_Anatomic_Site only Penis)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Penile Bowenoid Papulosis EquivalentTo Bowenoid Papulosis and Penile Neoplasm and (Disease_May_Have_Associated_Disease some Human Papilloma Virus Infection) and (Disease_Has_Primary_Anatomic_Site only Penis)</Axiom>
               </Source>
            </Change>
            <Change id="529">
               <Axiom>Pilomatrical Carcinoma EquivalentTo Adnexal Carcinoma and Malignant Germinative Follicular Epithelium Neoplasm and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Finding only Desmoplastic Stroma Formation) and (Disease_Has_Finding only Geographic Necrosis) and (Disease_Has_Finding only Invasive Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Pilomatrical Carcinoma EquivalentTo Adnexal Carcinoma and Malignant Germinative Follicular Epithelium Neoplasm and (Disease_Has_Finding only Desmoplastic Stroma Formation) and (Disease_Has_Finding only Geographic Necrosis) and (Disease_Has_Finding only Invasive Lesion)</Axiom>
               </Source>
            </Change>
            <Change id="530">
               <Axiom>Precursor B-Lymphoblastic Lymphoma/Leukemia EquivalentTo B-Cell Neoplasm and Precursor Lymphoblastic Lymphoma/Leukemia and ((((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Coarse Azurophilic Granules Present) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(1;19)(q23;p13.3)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some E2A-PBX1 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression)))) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;v)(q23;v)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_Excludes_Normal_Cell_Origin only Mature B-Lymphocyte) and (Disease_Has_Abnormal_Cell only Neoplastic B-Lymphoblast) and (Disease_Has_Normal_Cell_Origin only Precursor B-Lymphoblast)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Precursor B-Lymphoblastic Lymphoma/Leukemia EquivalentTo B-Cell Neoplasm and Precursor Lymphoblastic Lymphoma/Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;v)(q23;v)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;19)(q23;p13.3)) and (Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Coarse Azurophilic Granules Present) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some E2A-PBX1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_Excludes_Normal_Cell_Origin only Mature B-Lymphocyte) and (Disease_Has_Abnormal_Cell only Neoplastic B-Lymphoblast) and (Disease_Has_Normal_Cell_Origin only Precursor B-Lymphoblast)</Axiom>
               </Source>
            </Change>
            <Change id="521">
               <Axiom>Primitive Neuroectodermal Tumor EquivalentTo Embryonal Neoplasm and Neuroepithelial Neoplasm and (Disease_Has_Finding only Neuroectodermal Differentiation) and (Disease_Has_Normal_Cell_Origin only Neuroectodermal Cell) and (Disease_Has_Normal_Tissue_Origin only Neuroectoderm)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Primitive Neuroectodermal Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Primitive Neuroectodermal Tumor SubClassOf Embryonal Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Neuroblastic Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Neuroblastic Tumor SubClassOf Embryonal Neoplasm</Axiom>
                           <Axiom>Neuroblastic Tumor SubClassOf Neoplasm by Special Category</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Primitive Neuroectodermal Tumor EquivalentTo Neuroepithelial Neoplasm and (Disease_Has_Finding only Neuroectodermal Differentiation) and (Disease_Has_Normal_Cell_Origin only Neuroectodermal Cell) and (Disease_Has_Normal_Tissue_Origin only Neuroectoderm)</Axiom>
               </Source>
            </Change>
            <Change id="531">
               <Axiom>Recurrent Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Recurrent Hematologic Malignancy and ((((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture)))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Recurrent Plasma Cell Myeloma</Concept>
                        <WitnessAxioms>
                           <Axiom>Recurrent Plasma Cell Myeloma SubClassOf Recurrent Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Plasma Cell Myeloma SubClassOf Malignant Neoplasm</Axiom>
                           <Axiom>Recurrent Plasma Cell Myeloma SubClassOf Recurrent Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Recurrent Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Recurrent Hematologic Malignancy and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               </Source>
            </Change>
            <Change id="532">
               <Axiom>Refractory Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Refractory Plasma Cell Neoplasm and ((((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture)))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Refractory Plasma Cell Myeloma</Concept>
                        <WitnessAxioms>
                           <Axiom>Refractory Plasma Cell Myeloma SubClassOf Refractory Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Refractory Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Refractory Plasma Cell Neoplasm and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Has_Finding only Refractory Disease)</Axiom>
               </Source>
            </Change>
            <Change id="533">
               <Axiom>Sebaceoma EquivalentTo Benign Sebaceous Neoplasm and (Disease_Excludes_Finding only Compartmentalized Pattern) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Papular Lesion)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Sebaceoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Sebaceoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Sebaceoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Sebaceoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Sebaceoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Sebaceoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Sebaceoma EquivalentTo Benign Sebaceous Neoplasm and (Disease_Excludes_Finding only Compartmentalized Pattern) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
               </Source>
            </Change>
            <Change id="534">
               <Axiom>Sebaceous Carcinoma EquivalentTo Adenocarcinoma and Adnexal Carcinoma and Malignant Sebaceous Neoplasm and (Disease_May_Have_Finding some Slow Growing Painless Mass)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Sebaceous Carcinoma EquivalentTo Adenocarcinoma and Adnexal Carcinoma and Malignant Sebaceous Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="535">
               <Axiom>Sezary Syndrome EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Leukemic Phase of Lymphoma and Mycosis Fungoides and Sezary Syndrome and ((((Disease_May_Have_Abnormal_Cell some Lutzner Cell) and (Disease_May_Have_Abnormal_Cell some Sezary Cell) and (Disease_Has_Finding only Peripheral Blood Involvement)) or ((Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate)))) and (Disease_May_Have_Associated_Disease some Erythroderma) and (Disease_May_Have_Finding some Alopecia) and (Disease_May_Have_Finding some Hyperkeratosis) and (Disease_May_Have_Finding some Pruritus) and (Disease_Has_Abnormal_Cell only Sezary Cell) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Associated_Anatomic_Site only Skin) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Sezary Syndrome EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Leukemic Phase of Lymphoma and Mycosis Fungoides and Sezary Syndrome and (Disease_May_Have_Abnormal_Cell some Lutzner Cell) and (Disease_May_Have_Abnormal_Cell some Sezary Cell) and (Disease_May_Have_Associated_Disease some Erythroderma) and (Disease_May_Have_Finding some Alopecia) and (Disease_May_Have_Finding some Hyperkeratosis) and (Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Pruritus) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Abnormal_Cell only Sezary Cell) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Associated_Anatomic_Site only Skin) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Finding only Peripheral Blood Involvement) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="536">
               <Axiom>Skin Squamous Cell Carcinoma EquivalentTo Common Carcinoma and Skin Carcinoma and Squamous Cell Carcinoma and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Normal_Tissue_Origin only Epidermis)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Bowen Disease of the Skin</Concept>
                        <WitnessAxioms>
                           <Axiom>Bowen Disease of the Skin SubClassOf Common Carcinoma</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Disorder by Site</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Skin Carcinoma</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Neoplasm by Site</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Common Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Skin Disorder</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Neoplasm by Special Category</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Skin Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Carcinoma</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Squamous Cell Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Squamous Cell Carcinoma</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Malignant Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Skin Squamous Cell Carcinoma EquivalentTo Common Carcinoma and Skin Carcinoma and Squamous Cell Carcinoma and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Normal_Tissue_Origin only Epidermis)</Axiom>
               </Source>
            </Change>
            <Change id="537">
               <Axiom>Skin Squamous Cell Carcinoma In Situ EquivalentTo Skin Squamous Cell Carcinoma and Stage 0 Skin Cancer and (Disease_May_Have_Finding some Erythema) and (Disease_May_Have_Finding some Scaly Skin Eruption)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Bowen Disease of the Skin</Concept>
                        <WitnessAxioms>
                           <Axiom>Bowen Disease of the Skin SubClassOf Cellular Precursor of Cancer</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Skin Disorder</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Common Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Carcinoma In Situ</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Stage 0 Skin Cancer</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Neoplasm by Special Category</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Cancer-Related Condition</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf High Grade Intraepithelial Neoplasia</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Skin Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Carcinoma</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Squamous Cell Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Squamous Cell Carcinoma</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Malignant Skin Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Common Carcinoma</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Skin Squamous Cell Carcinoma</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Disorder by Site</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Skin Carcinoma</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Neoplasm by Site</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Precancerous Condition</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Intraepithelial Neoplasia</Axiom>
                           <Axiom>Bowen Disease of the Skin SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Skin Squamous Cell Carcinoma In Situ EquivalentTo Skin Squamous Cell Carcinoma and Stage 0 Skin Cancer and (Disease_May_Have_Finding some Erythema) and (Disease_May_Have_Finding some Scaly Skin Eruption) and (Disease_May_Have_Finding some Skin Patch) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Finding only Parakeratosis) and (Disease_Has_Finding only Windblown Appearance of Atypical Keratinocytes)</Axiom>
               </Source>
            </Change>
            <Change id="538">
               <Axiom>Small Cell Osteosarcoma EquivalentTo Primary Bone Osteosarcoma and Small Cell Sarcoma and (Disease_May_Have_Finding some Pain) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_Has_Abnormal_Cell only Malignant Small Osteoblast) and (Disease_Has_Finding only Osteoid Formation) and (Disease_Has_Normal_Tissue_Origin only Medullary Bone)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Small Cell Osteosarcoma EquivalentTo Primary Bone Osteosarcoma and Small Cell Sarcoma and (Disease_May_Have_Finding some Pain) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_Has_Abnormal_Cell only Malignant Small Osteoblast) and (Disease_Has_Finding only Lytic Bone Lesion) and (Disease_Has_Finding only Osteoid Formation) and (Disease_Has_Normal_Tissue_Origin only Medullary Bone)</Axiom>
               </Source>
            </Change>
            <Change id="539">
               <Axiom>Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma EquivalentTo Papillary Transitional Cell Carcinoma and Papillary Urothelial Neoplasm and Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma and (Disease_Is_Stage only Stage 0a)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="1">
                     <Specialisation>
                        <Concept>Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma SubClassOf Papillary Transitional Cell Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </DirectChanges>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Stage 0a Ureter Urothelial Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Stage 0a Ureter Urothelial Carcinoma SubClassOf Papillary Transitional Cell Carcinoma</Axiom>
                           <Axiom>Stage 0a Ureter Urothelial Carcinoma SubClassOf Papillary Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma EquivalentTo Papillary Urothelial Neoplasm and Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma and (Disease_Is_Stage only Stage 0a)</Axiom>
               </Source>
            </Change>
            <Change id="541">
               <Axiom>Stage I Multiple Myeloma EquivalentTo Plasma Cell Myeloma and ((((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Solitary Lytic Metastatic Bone Lesion) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Pathologic Fracture)))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage I)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Stage I Multiple Myeloma EquivalentTo Plasma Cell Myeloma and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Finding some Solitary Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Pathologic Fracture) and (Disease_Is_Stage only Stage I)</Axiom>
               </Source>
            </Change>
            <Change id="540">
               <Axiom>Stage III Multiple Myeloma EquivalentTo Plasma Cell Myeloma and ((((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture)))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage III)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Stage III Multiple Myeloma EquivalentTo Plasma Cell Myeloma and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage III)</Axiom>
               </Source>
            </Change>
            <Change id="542">
               <Axiom>Superficial Epithelioma with Sebaceous Differentiation EquivalentTo Benign Sebaceous Neoplasm and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Anastomosing Cells Connected to the Basal Layer of the Epidermis Present)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Superficial Epithelioma with Sebaceous Differentiation</Concept>
                        <WitnessAxioms>
                           <Axiom>Superficial Epithelioma with Sebaceous Differentiation SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Superficial Epithelioma with Sebaceous Differentiation SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Superficial Epithelioma with Sebaceous Differentiation SubClassOf Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Superficial Epithelioma with Sebaceous Differentiation EquivalentTo Benign Sebaceous Neoplasm and Epithelioma and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Anastomosing Cells Connected to the Basal Layer of the Epidermis Present)</Axiom>
               </Source>
            </Change>
            <Change id="543">
               <Axiom>Telangiectatic Osteosarcoma EquivalentTo Primary Bone Osteosarcoma and (Disease_May_Have_Finding some Pain) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Large Spaces Filled with Blood Present) and (Disease_Has_Finding only Osteoid Formation) and (Disease_Has_Normal_Tissue_Origin only Medullary Bone)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Telangiectatic Osteosarcoma EquivalentTo Primary Bone Osteosarcoma and (Disease_May_Have_Finding some Pain) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Large Spaces Filled with Blood Present) and (Disease_Has_Finding only Lytic Bone Lesion) and (Disease_Has_Finding only Osteoid Formation) and (Disease_Has_Normal_Tissue_Origin only Medullary Bone)</Axiom>
               </Source>
            </Change>
            <Change id="544">
               <Axiom>Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation EquivalentTo Thyroid Gland Carcinoma and ((((Disease_May_Have_Abnormal_Cell some Adenocarcinoma Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Epithelial Spindle Cell) and (Disease_May_Have_Finding some Monophasic Pattern)) or ((Disease_May_Have_Finding some Biphasic Pattern) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Spindle Cell)))) and (Disease_Excludes_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Lobulated Growth Pattern) and (Disease_Has_Finding only Slow Growing Mass)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation EquivalentTo Thyroid Gland Carcinoma and (Disease_May_Have_Abnormal_Cell some Adenocarcinoma Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Epithelial Spindle Cell) and (Disease_May_Have_Finding some Biphasic Pattern) and (Disease_May_Have_Finding some Monophasic Pattern) and (Disease_Excludes_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Spindle Cell) and (Disease_Has_Finding only Lobulated Growth Pattern) and (Disease_Has_Finding only Slow Growing Mass)</Axiom>
               </Source>
            </Change>
            <Change id="545">
               <Axiom>Trichodiscoma EquivalentTo Benign Pilar-Associated Mesenchyme Neoplasm and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Capillary Sized Vascular Channel Formation) and (Disease_Has_Finding only Dermal Nodule) and (Disease_Has_Finding only Elastin Fibers Present)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Trichodiscoma EquivalentTo Benign Pilar-Associated Mesenchyme Neoplasm and (Disease_Has_Finding only Capillary Sized Vascular Channel Formation) and (Disease_Has_Finding only Dermal Nodule) and (Disease_Has_Finding only Elastin Fibers Present)</Axiom>
               </Source>
            </Change>
            <Change id="546">
               <Axiom>Type 3 Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and ((((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma)))) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Excludes_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Excludes_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only REL Gene Amplification)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Type 3 Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Excludes_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Excludes_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only REL Gene Amplification)</Axiom>
               </Source>
            </Change>
            <Change id="547">
               <Axiom>Vaginal Mullerian Papilloma EquivalentTo Benign Vaginal Neoplasm and Papilloma and Vaginal Glandular Neoplasm</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Vaginal Mullerian Papilloma EquivalentTo Benign Vaginal Neoplasm and Papilloma and Vaginal Glandular Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell with Intracytoplasmic Mucin)</Axiom>
               </Source>
            </Change>
         </NewModifiedDefinition>
         <NewModifiedDefinitionWithNewTerms id="stequivnt" size="1">
            <Change id="549">
               <Axiom>Aflatoxins-Related Hepatocellular Carcinoma EquivalentTo Environment-Related Malignant Neoplasm and Hepatocellular Carcinoma and (Disease_Has_Finding only Aflatoxins Toxicity)</Axiom>
               <ConceptChanges size="1">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="1">
                     <Specialisation>
                        <Concept>Aflatoxins-Related Hepatocellular Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Aflatoxins-Related Hepatocellular Carcinoma SubClassOf Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Aflatoxins-Related Hepatocellular Carcinoma EquivalentTo Environment-Related Malignant Neoplasm and Hepatocellular Carcinoma</Axiom>
               </Source>
               <New_Terms>Aflatoxins Toxicity</New_Terms>
            </Change>
         </NewModifiedDefinitionWithNewTerms>
      </Effectual>
      <Ineffectual id="ineffadds" size="164">
         <AddedRedundancy id="ared" size="1">
            <Change id="550">
               <Axiom>CS-1008 SubClassOf Chemical_Or_Drug_Has_Mechanism_Of_Action some Antigen Binding</Axiom>
               <Source>
                  <Axiom shared="true">CS-1008 SubClassOf Monoclonal Antibody</Axiom>
                  <Axiom shared="true">Monoclonal Antibody SubClassOf Chemical_Or_Drug_Has_Mechanism_Of_Action some Antigen Binding</Axiom>
               </Source>
            </Change>
         </AddedRedundancy>
         <AddedRewrite id="arws" size="114">
            <AddedCompleteRewrite id="arw" size="114">
               <Change id="609">
                  <Axiom>Acute Monocytic Leukemia EquivalentTo Acute Monoblastic Leukemia and Acute Monocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Finding some Hemophagocytosis)) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Neoplastic Promonocytes in Bone Marrow Markedly Increased)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Monocytic Leukemia EquivalentTo Acute Monoblastic Leukemia and Acute Monocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Finding some Hemophagocytosis) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Neoplastic Promonocytes in Bone Marrow Markedly Increased)</Axiom>
                  </Source>
               </Change>
               <Change id="551">
                  <Axiom>Acute Myeloid Leukemia with inv(16)(p13;q22) EquivalentTo Acute Myeloid Leukemia with Abnormal Marrow Eosinophils and ((Disease_Has_Cytogenetic_Abnormality only inv(16)(p13;q22)) and (Disease_Has_Molecular_Abnormality only CBFbeta-MYH11 Fusion Protein Expression)) and (Disease_May_Have_Finding some Favorable Clinical Outcome)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Myeloid Leukemia with inv(16)(p13;q22) EquivalentTo Acute Myeloid Leukemia with Abnormal Marrow Eosinophils and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Cytogenetic_Abnormality only inv(16)(p13;q22)) and (Disease_Has_Molecular_Abnormality only CBFbeta-MYH11 Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="552">
                  <Axiom>Acute Myeloid Leukemia with t(16;16)(p13;q22) EquivalentTo Acute Myeloid Leukemia with Abnormal Marrow Eosinophils and ((Disease_Has_Cytogenetic_Abnormality only t(16;16)(p13;q22)) and (Disease_Has_Molecular_Abnormality only CBFbeta-MYH11 Fusion Protein Expression)) and (Disease_May_Have_Finding some Favorable Clinical Outcome)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Myeloid Leukemia with t(16;16)(p13;q22) EquivalentTo Acute Myeloid Leukemia with Abnormal Marrow Eosinophils and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Cytogenetic_Abnormality only t(16;16)(p13;q22)) and (Disease_Has_Molecular_Abnormality only CBFbeta-MYH11 Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="553">
                  <Axiom>Acute Myeloid Leukemia with t(8;21)(q22;q22)(AML1(CBFa)/ETO) EquivalentTo Acute Myeloid Leukemia with Recurrent Genetic Abnormalities and ((Disease_Has_Cytogenetic_Abnormality only t(8;21)(q22;q22)) and (Disease_Has_Molecular_Abnormality only AML1-ETO Fusion Protein Expression)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast with Abundant Basophilic Cytoplasm) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Predominant Neutrophil Differentiation)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Myeloid Leukemia with t(8;21)(q22;q22)(AML1(CBFa)/ETO) EquivalentTo Acute Myeloid Leukemia with Recurrent Genetic Abnormalities and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast with Abundant Basophilic Cytoplasm) and (Disease_Has_Cytogenetic_Abnormality only t(8;21)(q22;q22)) and (Disease_Has_Molecular_Abnormality only AML1-ETO Fusion Protein Expression) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Predominant Neutrophil Differentiation)</Axiom>
                  </Source>
               </Change>
               <Change id="554">
                  <Axiom>Acute Promyelocytic Leukemia with t(11;17)(q13;q21) EquivalentTo Acute Promyelocytic Leukemia with Variant Translocations and ((Disease_Has_Cytogenetic_Abnormality only t(11;17)(q13;q21)) and (Disease_Has_Molecular_Abnormality only NuMA-RARalpha Fusion Protein Expression))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Promyelocytic Leukemia with t(11;17)(q13;q21) EquivalentTo Acute Promyelocytic Leukemia with Variant Translocations and (Disease_Has_Cytogenetic_Abnormality only t(11;17)(q13;q21)) and (Disease_Has_Molecular_Abnormality only NuMA-RARalpha Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="555">
                  <Axiom>Acute Promyelocytic Leukemia with t(11;17)(q23;q21) EquivalentTo Acute Promyelocytic Leukemia with Variant Translocations and ((Disease_Has_Cytogenetic_Abnormality only t(11;17)(q23;q21)) and (Disease_Has_Molecular_Abnormality only PLZF-RARalpha Fusion Protein Expression))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Promyelocytic Leukemia with t(11;17)(q23;q21) EquivalentTo Acute Promyelocytic Leukemia with Variant Translocations and (Disease_Has_Cytogenetic_Abnormality only t(11;17)(q23;q21)) and (Disease_Has_Molecular_Abnormality only PLZF-RARalpha Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="556">
                  <Axiom>Acute Promyelocytic Leukemia with t(15;17)(q22;q12)(PML/RARa) EquivalentTo Acute Promyelocytic Leukemia and ((Disease_Has_Cytogenetic_Abnormality only t(15;17)(q22;q12)) and (Disease_Has_Molecular_Abnormality only PML-RARalpha Fusion Protein Expression)) and (Disease_May_Have_Abnormal_Cell some Faggot Cell) and (Disease_May_Have_Finding some Disseminated Intravascular Coagulation) and (Disease_May_Have_Finding some Favorable Clinical Outcome)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Promyelocytic Leukemia with t(15;17)(q22;q12)(PML/RARa) EquivalentTo Acute Promyelocytic Leukemia and (Disease_May_Have_Abnormal_Cell some Faggot Cell) and (Disease_May_Have_Finding some Disseminated Intravascular Coagulation) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Cytogenetic_Abnormality only t(15;17)(q22;q12)) and (Disease_Has_Molecular_Abnormality only PML-RARalpha Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="557">
                  <Axiom>Acute Promyelocytic Leukemia with t(17;17)(q11;q11) EquivalentTo Acute Promyelocytic Leukemia with Variant Translocations and ((Disease_Has_Cytogenetic_Abnormality only t(17;17)(q11;q11)) and (Disease_Has_Molecular_Abnormality only STAT5-RARalpha Fusion Protein Expression))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Promyelocytic Leukemia with t(17;17)(q11;q11) EquivalentTo Acute Promyelocytic Leukemia with Variant Translocations and (Disease_Has_Cytogenetic_Abnormality only t(17;17)(q11;q11)) and (Disease_Has_Molecular_Abnormality only STAT5-RARalpha Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="558">
                  <Axiom>Acute Promyelocytic Leukemia with t(5;17)(q32;q12) EquivalentTo Acute Promyelocytic Leukemia with Variant Translocations and ((Disease_Has_Cytogenetic_Abnormality only t(5;17)(q32;q12)) and (Disease_Has_Molecular_Abnormality only NPM-RARalpha Fusion Protein Expression))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Promyelocytic Leukemia with t(5;17)(q32;q12) EquivalentTo Acute Promyelocytic Leukemia with Variant Translocations and (Disease_Has_Cytogenetic_Abnormality only t(5;17)(q32;q12)) and (Disease_Has_Molecular_Abnormality only NPM-RARalpha Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="559">
                  <Axiom>Adenocarcinoma of the Gastroesophageal Junction EquivalentTo Adenocarcinoma and Malignant Gastrointestinal Neoplasm and ((Disease_May_Have_Associated_Disease some Gastroesophageal Reflux Disease) and (Disease_May_Have_Finding some Intestinal Metaplasia)) and (Disease_May_Have_Finding some Abdominal Pain) and (Disease_May_Have_Finding some Dysphagia) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Primary_Anatomic_Site only Gastroesophageal Junction)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Adenocarcinoma of the Gastroesophageal Junction EquivalentTo Adenocarcinoma and Malignant Gastrointestinal Neoplasm and (Disease_May_Have_Associated_Disease some Gastroesophageal Reflux Disease) and (Disease_May_Have_Finding some Abdominal Pain) and (Disease_May_Have_Finding some Dysphagia) and (Disease_May_Have_Finding some Intestinal Metaplasia) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Primary_Anatomic_Site only Gastroesophageal Junction)</Axiom>
                  </Source>
               </Change>
               <Change id="560">
                  <Axiom>Adult Type Ovarian Granulosa Cell Tumor EquivalentTo Ovarian Granulosa Cell Tumor and ((Disease_May_Have_Finding some Call Exner Bodies Present) and (Disease_May_Have_Finding some Microfollicular Structures Present)) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some Tetrasomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Finding some Gyriform Trabecular Pattern) and (Disease_May_Have_Finding some Insular Pattern) and (Disease_May_Have_Finding some Macrofollicular Structures Present) and (Disease_May_Have_Finding some Menstrual Disorder) and (Disease_May_Have_Finding some Postmenopausal Hemorrhage) and (Disease_May_Have_Finding some Solid Growth Pattern)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Adult Type Ovarian Granulosa Cell Tumor EquivalentTo Ovarian Granulosa Cell Tumor and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some Tetrasomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Finding some Call Exner Bodies Present) and (Disease_May_Have_Finding some Gyriform Trabecular Pattern) and (Disease_May_Have_Finding some Insular Pattern) and (Disease_May_Have_Finding some Macrofollicular Structures Present) and (Disease_May_Have_Finding some Menstrual Disorder) and (Disease_May_Have_Finding some Microfollicular Structures Present) and (Disease_May_Have_Finding some Postmenopausal Hemorrhage) and (Disease_May_Have_Finding some Solid Growth Pattern)</Axiom>
                  </Source>
               </Change>
               <Change id="661">
                  <Axiom>Adult Type Testicular Granulosa Cell Tumor EquivalentTo Testicular Granulosa Cell Tumor and ((Disease_May_Have_Finding some Call Exner Bodies Present) and (Disease_May_Have_Finding some Microfollicular Structures Present)) and (Disease_Has_Finding some Adulthood Lesion) and (Disease_May_Have_Associated_Disease some Gynecomastia) and (Disease_May_Have_Finding some Gyriform Trabecular Pattern) and (Disease_May_Have_Finding some Insular Pattern) and (Disease_May_Have_Finding some Macrofollicular Structures Present) and (Disease_May_Have_Finding some Solid Growth Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Adult Type Testicular Granulosa Cell Tumor EquivalentTo Testicular Granulosa Cell Tumor and (Disease_Has_Finding some Adulthood Lesion) and (Disease_May_Have_Associated_Disease some Gynecomastia) and (Disease_May_Have_Finding some Call Exner Bodies Present) and (Disease_May_Have_Finding some Gyriform Trabecular Pattern) and (Disease_May_Have_Finding some Insular Pattern) and (Disease_May_Have_Finding some Macrofollicular Structures Present) and (Disease_May_Have_Finding some Microfollicular Structures Present) and (Disease_May_Have_Finding some Solid Growth Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="561">
                  <Axiom>Aleukemic Lymphocytic Leukemia EquivalentTo Aleukemic Lymphoid Leukemia and Chronic Lymphocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Aleukemic Lymphocytic Leukemia EquivalentTo Aleukemic Lymphoid Leukemia and Chronic Lymphocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)</Axiom>
                  </Source>
               </Change>
               <Change id="562">
                  <Axiom>Alveolar Soft Part Sarcoma EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Sarcoma Differentiation Score 3 and Sarcoma NCI Grade 3 and Soft Tissue Sarcoma and ((Disease_May_Have_Cytogenetic_Abnormality some ASPL-TFE3 Fusion Protein Expression) and (Disease_May_Have_Cytogenetic_Abnormality some Unbalanced Translocation) and (Disease_May_Have_Cytogenetic_Abnormality some t(X;17)(p11.2;q25))) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Malignant Epithelioid Cell) and (Disease_Has_Finding only Crystal Formation) and (Disease_Has_Finding only Organoid Pattern) and (Disease_Has_Finding only Pseudoalveolar Pattern)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Alveolar Soft Part Sarcoma EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Sarcoma Differentiation Score 3 and Sarcoma NCI Grade 3 and Soft Tissue Sarcoma and (Disease_May_Have_Cytogenetic_Abnormality some ASPL-TFE3 Fusion Protein Expression) and (Disease_May_Have_Cytogenetic_Abnormality some Unbalanced Translocation) and (Disease_May_Have_Cytogenetic_Abnormality some t(X;17)(p11.2;q25)) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Malignant Epithelioid Cell) and (Disease_Has_Finding only Crystal Formation) and (Disease_Has_Finding only Organoid Pattern) and (Disease_Has_Finding only Pseudoalveolar Pattern)</Axiom>
                  </Source>
               </Change>
               <Change id="563">
                  <Axiom>Angiomatoid Fibrous Histiocytoma EquivalentTo Intermediate Soft Tissue Neoplasm and Soft Tissue Neoplasm of Uncertain Differentiation and ((Disease_May_Have_Cytogenetic_Abnormality some t(12;16)(q13;p11)) and (Disease_May_Have_Molecular_Abnormality some FUS-ATF1 Fusion Protein Expression)) and (Disease_May_Have_Abnormal_Cell some Neoplastic Epithelioid Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Spindle Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Hemorrhagic Change) and (Disease_Has_Finding only Hemosiderin Deposition) and (Disease_Has_Finding only Pseudoangiomatoid Space Formation) and (Disease_Has_Finding only Subcutaneous Involvement)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Angiomatoid Fibrous Histiocytoma EquivalentTo Intermediate Soft Tissue Neoplasm and Soft Tissue Neoplasm of Uncertain Differentiation and (Disease_May_Have_Abnormal_Cell some Neoplastic Epithelioid Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Spindle Cell) and (Disease_May_Have_Cytogenetic_Abnormality some t(12;16)(q13;p11)) and (Disease_May_Have_Molecular_Abnormality some FUS-ATF1 Fusion Protein Expression) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Hemorrhagic Change) and (Disease_Has_Finding only Hemosiderin Deposition) and (Disease_Has_Finding only Pseudoangiomatoid Space Formation) and (Disease_Has_Finding only Subcutaneous Involvement)</Axiom>
                  </Source>
               </Change>
               <Change id="564">
                  <Axiom>Bronchial Mucosa-Associated Lymphoid Tissue Lymphoma EquivalentTo Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue and Lung Mature B-Cell Neoplasm and Lung Non-Hodgkin's Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(11;18)(q21;q21)) and (Disease_May_Have_Molecular_Abnormality some AP12-MLT Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;14)(p22;q32)) and (Disease_Has_Normal_Tissue_Origin only Bronchus-Associated Lymphoid Tissue) and (Disease_Has_Primary_Anatomic_Site only Bronchus)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Bronchial Mucosa-Associated Lymphoid Tissue Lymphoma EquivalentTo Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue and Lung Mature B-Cell Neoplasm and Lung Non-Hodgkin's Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some t(11;18)(q21;q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;14)(p22;q32)) and (Disease_May_Have_Molecular_Abnormality some AP12-MLT Fusion Protein Expression) and (Disease_Has_Normal_Tissue_Origin only Bronchus-Associated Lymphoid Tissue) and (Disease_Has_Primary_Anatomic_Site only Bronchus)</Axiom>
                  </Source>
               </Change>
               <Change id="566">
                  <Axiom>Cellular Congenital Mesoblastic Nephroma EquivalentTo Congenital Mesoblastic Nephroma and ((Disease_May_Have_Cytogenetic_Abnormality some Trisomy 11) and (Disease_May_Have_Cytogenetic_Abnormality some t(12;15)(p13;q26)) and (Disease_May_Have_Molecular_Abnormality some ETV6-NTRK3 Fusion Protein Expression)) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Increased Cellularity Present)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Cellular Congenital Mesoblastic Nephroma EquivalentTo Congenital Mesoblastic Nephroma and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 11) and (Disease_May_Have_Cytogenetic_Abnormality some t(12;15)(p13;q26)) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_May_Have_Molecular_Abnormality some ETV6-NTRK3 Fusion Protein Expression) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Increased Cellularity Present)</Axiom>
                  </Source>
               </Change>
               <Change id="565">
                  <Axiom>Childhood Acute Megakaryoblastic Leukemia EquivalentTo Acute Megakaryoblastic Leukemia and Childhood Acute Myeloid Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(1;22)(p13;q13)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some OTT-MAL Fusion Protein Expression))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Childhood Acute Megakaryoblastic Leukemia EquivalentTo Acute Megakaryoblastic Leukemia and Childhood Acute Myeloid Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some t(1;22)(p13;q13)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some OTT-MAL Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="567">
                  <Axiom>Childhood Chronic Myelogenous Leukemia EquivalentTo Childhood Leukemia and Chronic Myelogenous Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Childhood Chronic Myelogenous Leukemia EquivalentTo Childhood Leukemia and Chronic Myelogenous Leukemia and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="569">
                  <Axiom>Childhood Precursor B-Lymphoblastic Leukemia EquivalentTo Childhood Acute Lymphoblastic Leukemia and Precursor B-Lymphoblastic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(12;21)(p13;q22)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some TEL-AML1 Fusion Protein Expression))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Childhood Precursor B-Lymphoblastic Leukemia EquivalentTo Childhood Acute Lymphoblastic Leukemia and Precursor B-Lymphoblastic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some t(12;21)(p13;q22)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some TEL-AML1 Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="570">
                  <Axiom>Childhood Precursor B-Lymphoblastic Lymphoma EquivalentTo Childhood Lymphoblastic Lymphoma and Precursor B-Lymphoblastic Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(12;21)(p13;q22)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some TEL-AML1 Fusion Protein Expression))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Childhood Precursor B-Lymphoblastic Lymphoma EquivalentTo Childhood Lymphoblastic Lymphoma and Precursor B-Lymphoblastic Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some t(12;21)(p13;q22)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some TEL-AML1 Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="571">
                  <Axiom>Chronic Idiopathic Myelofibrosis EquivalentTo Chronic Myeloproliferative Disorder and Myelofibrosis and ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Partial Trisomy 1q) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_Has_Finding only Granulocytes Increased in Bone Marrow) and (Disease_Has_Finding only Megakaryocytes Increased in Bone Marrow) and (Disease_Has_Finding only Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Chronic Idiopathic Myelofibrosis EquivalentTo Chronic Myeloproliferative Disorder and Myelofibrosis and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Partial Trisomy 1q) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression) and (Disease_Has_Finding only Granulocytes Increased in Bone Marrow) and (Disease_Has_Finding only Megakaryocytes Increased in Bone Marrow) and (Disease_Has_Finding only Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells)</Axiom>
                  </Source>
               </Change>
               <Change id="572">
                  <Axiom>Chronic Idiopathic Myelofibrosis, Fibrotic Stage EquivalentTo Chronic Idiopathic Myelofibrosis and ((Disease_Has_Finding only Extramedullary Hematopoiesis) and (Disease_Has_Finding only Hepatomegaly) and (Disease_Has_Finding only Splenomegaly)) and (Disease_Has_Finding some Nucleated Red Blood Cells Present) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Hypocellular Bone Marrow) and (Disease_May_Have_Finding some Leukopenia) and (Disease_May_Have_Finding some Low Grade Fever) and (Disease_May_Have_Finding some Night Sweating) and (Disease_May_Have_Finding some Osteosclerosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Abnormal_Cell only Hyperchromatic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Large Atypical Platelet) and (Disease_Has_Abnormal_Cell only Tear-Drop Red Blood Cell) and (Disease_Has_Associated_Disease only Anemia) and (Disease_Has_Finding only Leukoerythroblastosis) and (Disease_Has_Finding only Marked Bone Marrow Fibrosis) and (Disease_Has_Finding only Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Myeloblasts Under 10 Percent of Peripheral Blood White Cells) and (Disease_Has_Finding only Poikilocytosis)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Chronic Idiopathic Myelofibrosis, Fibrotic Stage EquivalentTo Chronic Idiopathic Myelofibrosis and (Disease_Has_Finding some Nucleated Red Blood Cells Present) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Hypocellular Bone Marrow) and (Disease_May_Have_Finding some Leukopenia) and (Disease_May_Have_Finding some Low Grade Fever) and (Disease_May_Have_Finding some Night Sweating) and (Disease_May_Have_Finding some Osteosclerosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Abnormal_Cell only Hyperchromatic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Large Atypical Platelet) and (Disease_Has_Abnormal_Cell only Tear-Drop Red Blood Cell) and (Disease_Has_Associated_Disease only Anemia) and (Disease_Has_Finding only Extramedullary Hematopoiesis) and (Disease_Has_Finding only Hepatomegaly) and (Disease_Has_Finding only Leukoerythroblastosis) and (Disease_Has_Finding only Marked Bone Marrow Fibrosis) and (Disease_Has_Finding only Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Myeloblasts Under 10 Percent of Peripheral Blood White Cells) and (Disease_Has_Finding only Poikilocytosis) and (Disease_Has_Finding only Splenomegaly)</Axiom>
                  </Source>
               </Change>
               <Change id="573">
                  <Axiom>Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation EquivalentTo Chronic Lymphocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Has_Abnormal_Cell only Lymphoplasmacytoid Cell)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation EquivalentTo Chronic Lymphocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Lymphoplasmacytoid Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="574">
                  <Axiom>Chronic Myelomonocytic Leukemia with Eosinophilia EquivalentTo Chronic Myelomonocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(5;12)(q31;p12)) and (Disease_May_Have_Molecular_Abnormality some TEL-PDGFbeta Receptor Fusion Protein Expression)) and (Disease_Has_Finding only Eosinophilia)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Chronic Myelomonocytic Leukemia with Eosinophilia EquivalentTo Chronic Myelomonocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some t(5;12)(q31;p12)) and (Disease_May_Have_Molecular_Abnormality some TEL-PDGFbeta Receptor Fusion Protein Expression) and (Disease_Has_Finding only Eosinophilia)</Axiom>
                  </Source>
               </Change>
               <Change id="575">
                  <Axiom>Chronic Myeloproliferative Disease, Unclassifiable EquivalentTo Chronic Myeloproliferative Disorder and ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression)) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Cytopenia) and (Disease_May_Have_Finding some Erythroid Hyperplasia) and (Disease_May_Have_Finding some Granulocytes Increased in Bone Marrow) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Megakaryocytes Increased in Bone Marrow) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Chronic Myeloproliferative Disease, Unclassifiable EquivalentTo Chronic Myeloproliferative Disorder and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Cytopenia) and (Disease_May_Have_Finding some Erythroid Hyperplasia) and (Disease_May_Have_Finding some Granulocytes Increased in Bone Marrow) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Megakaryocytes Increased in Bone Marrow) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell) and (Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="576">
                  <Axiom>Chronic Neutrophilic Leukemia EquivalentTo Chronic Leukemia and Chronic Myeloproliferative Disorder and ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression)) and (Disease_May_Have_Abnormal_Cell some Toxic Neutrophil) and (Disease_May_Have_Associated_Disease some Plasma Cell Myeloma) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 11q ATM Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_Excludes_Abnormal_Cell only Dysplastic Granulocyte) and (Disease_Has_Abnormal_Cell only Segmented Neutrophil) and (Disease_Has_Finding only Granulocytes Increased in Bone Marrow) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Under 10 Percent) and (Disease_Has_Finding only Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Neutrophilia) and (Disease_Has_Finding only Splenomegaly)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Chronic Neutrophilic Leukemia EquivalentTo Chronic Leukemia and Chronic Myeloproliferative Disorder and (Disease_May_Have_Abnormal_Cell some Toxic Neutrophil) and (Disease_May_Have_Associated_Disease some Plasma Cell Myeloma) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 11q ATM Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_Excludes_Abnormal_Cell only Dysplastic Granulocyte) and (Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Segmented Neutrophil) and (Disease_Has_Finding only Granulocytes Increased in Bone Marrow) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Under 10 Percent) and (Disease_Has_Finding only Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Neutrophilia) and (Disease_Has_Finding only Splenomegaly)</Axiom>
                  </Source>
               </Change>
               <Change id="577">
                  <Axiom>Chronic Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Leukemia and Chronic Myelogenous Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) and (Disease_May_Have_Abnormal_Cell some Pseudo-Gaucher Cell) and (Disease_May_Have_Abnormal_Cell some Sea-Blue Histiocyte) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Reticulin Fibrosis of the Bone Marrow) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_Has_Abnormal_Cell only Hypolobated Megakaryocyte) and (Disease_Has_Abnormal_Cell only Segmented Neutrophil) and (Disease_Has_Finding only Basophilia) and (Disease_Has_Finding only Chronic Phase of Disease) and (Disease_Has_Finding only Granulocytes Increased in Bone Marrow) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Myeloblasts Under 2 Percent of Peripheral Blood White Cells) and (Disease_Has_Finding only Splenomegaly) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Chronic Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Leukemia and Chronic Myelogenous Leukemia and (Disease_May_Have_Abnormal_Cell some Pseudo-Gaucher Cell) and (Disease_May_Have_Abnormal_Cell some Sea-Blue Histiocyte) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Reticulin Fibrosis of the Bone Marrow) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Hypolobated Megakaryocyte) and (Disease_Has_Abnormal_Cell only Segmented Neutrophil) and (Disease_Has_Finding only Basophilia) and (Disease_Has_Finding only Chronic Phase of Disease) and (Disease_Has_Finding only Granulocytes Increased in Bone Marrow) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Myeloblasts Under 2 Percent of Peripheral Blood White Cells) and (Disease_Has_Finding only Splenomegaly) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
                  </Source>
               </Change>
               <Change id="579">
                  <Axiom>Clear Cell Sarcoma of Soft Tissue EquivalentTo Neoplasm of Uncertain Histogenesis and Soft Tissue Sarcoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(12;22)(q13;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ATF1 Fusion Protein Expression)) and (Disease_May_Have_Abnormal_Cell some Malignant Spindle Cell) and (Disease_May_Have_Abnormal_Cell some Wreath-Like Multinucleated Giant Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Finding some Melanosomes Present) and (Disease_May_Have_Finding some Slow Growing Mass) and (Disease_Has_Abnormal_Cell only Malignant Polygonal Cell with Eosinophilic Cytoplasm) and (Disease_Has_Finding only Fascicular Pattern) and (Disease_Has_Finding only Nested Pattern)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Clear Cell Sarcoma of Soft Tissue EquivalentTo Neoplasm of Uncertain Histogenesis and Soft Tissue Sarcoma and (Disease_May_Have_Abnormal_Cell some Malignant Spindle Cell) and (Disease_May_Have_Abnormal_Cell some Wreath-Like Multinucleated Giant Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some t(12;22)(q13;q12)) and (Disease_May_Have_Finding some Melanosomes Present) and (Disease_May_Have_Finding some Slow Growing Mass) and (Disease_May_Have_Molecular_Abnormality some EWS-ATF1 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Malignant Polygonal Cell with Eosinophilic Cytoplasm) and (Disease_Has_Finding only Fascicular Pattern) and (Disease_Has_Finding only Nested Pattern)</Axiom>
                  </Source>
               </Change>
               <Change id="568">
                  <Axiom>Congenital Mesoblastic Nephroma EquivalentTo Childhood Renal Neoplasm and Embryonal Neoplasm and Malignant Renal Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some t(12;15)(p13;q26)) and (Disease_May_Have_Molecular_Abnormality some ETV6-NTRK3 Fusion Protein Expression)) and (Disease_Has_Abnormal_Cell only Malignant Fibroblast) and (Disease_Has_Finding only Low Grade Lesion) and (Disease_Has_Primary_Anatomic_Site only Kidney)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Congenital Mesoblastic Nephroma EquivalentTo Childhood Renal Neoplasm and Embryonal Neoplasm and Malignant Renal Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some t(12;15)(p13;q26)) and (Disease_May_Have_Molecular_Abnormality some ETV6-NTRK3 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Malignant Fibroblast) and (Disease_Has_Finding only Low Grade Lesion) and (Disease_Has_Primary_Anatomic_Site only Kidney)</Axiom>
                  </Source>
               </Change>
               <Change id="578">
                  <Axiom>Conventional Lipoma EquivalentTo Lipoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(3;12)(q27-28;q13-15)) and (Disease_May_Have_Molecular_Abnormality some HMGIC-LPP Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;12)(p32-34;q13-15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;12)(p22-24;q13-15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;12)(q35-37;q13-15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(5;12)(q33;q13-15)) and (Disease_May_Have_Finding some Painless Mass) and (Disease_Excludes_Abnormal_Cell only Neoplastic Lipoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Mature Adipocyte) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Conventional Lipoma EquivalentTo Lipoma and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;12)(p32-34;q13-15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;12)(p22-24;q13-15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;12)(q35-37;q13-15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(3;12)(q27-28;q13-15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(5;12)(q33;q13-15)) and (Disease_May_Have_Finding some Painless Mass) and (Disease_May_Have_Molecular_Abnormality some HMGIC-LPP Fusion Protein Expression) and (Disease_Excludes_Abnormal_Cell only Neoplastic Lipoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Mature Adipocyte) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="580">
                  <Axiom>Cutaneous Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and Cutaneous Mature B-Cell Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Cutaneous Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and Cutaneous Mature B-Cell Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)</Axiom>
                  </Source>
               </Change>
               <Change id="581">
                  <Axiom>Cutaneous Gamma/Delta T-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Cutaneous T-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Finding some Rimming of Adipose Tissue Cells Present) and (Disease_May_Have_Finding some Subcutaneous Involvement)) and (Disease_May_Have_Associated_Disease some Hemophagocytic Syndrome) and (Disease_May_Have_Finding some Angioinvasion) and (Disease_May_Have_Finding some CD56-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some CD8-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some Dermal Involvement) and (Disease_May_Have_Finding some Epidermotropic Lymphocytic Infiltrate) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Excludes_Finding only CD4-Positive Neoplastic Cells Present) and (Disease_Has_Abnormal_Cell only Neoplastic Medium-Sized to Large T-Lymphocyte) and (Disease_Has_Molecular_Abnormality only Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Activated Mature Gamma/Delta T-Lymphocyte with a Cytotoxic Phenotype)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Cutaneous Gamma/Delta T-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Cutaneous T-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Associated_Disease some Hemophagocytic Syndrome) and (Disease_May_Have_Finding some Angioinvasion) and (Disease_May_Have_Finding some CD56-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some CD8-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some Dermal Involvement) and (Disease_May_Have_Finding some Epidermotropic Lymphocytic Infiltrate) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_May_Have_Finding some Rimming of Adipose Tissue Cells Present) and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_May_Have_Finding some Subcutaneous Involvement) and (Disease_Excludes_Finding only CD4-Positive Neoplastic Cells Present) and (Disease_Has_Abnormal_Cell only Neoplastic Medium-Sized to Large T-Lymphocyte) and (Disease_Has_Molecular_Abnormality only Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Activated Mature Gamma/Delta T-Lymphocyte with a Cytotoxic Phenotype)</Axiom>
                  </Source>
               </Change>
               <Change id="582">
                  <Axiom>Dermatofibrosarcoma Protuberans EquivalentTo Cutaneous Fibrohistiocytic Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some t(17;22)(q22;q13)) and (Disease_May_Have_Molecular_Abnormality some COL1A1-PDGFbeta Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Supernumerary Circular Chromosome) and (Disease_Excludes_Finding only Well-Circumscribed Lesion) and (Disease_Has_Abnormal_Cell only Neoplastic Spindle-Shaped Fibrohistiocytic Cell) and (Disease_Has_Finding only Invasive Lesion) and (Disease_Has_Finding only Multinodular Mass) and (Disease_Has_Finding only Storiform Growth Pattern)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Dermatofibrosarcoma Protuberans EquivalentTo Cutaneous Fibrohistiocytic Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Supernumerary Circular Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(17;22)(q22;q13)) and (Disease_May_Have_Molecular_Abnormality some COL1A1-PDGFbeta Fusion Protein Expression) and (Disease_Excludes_Finding only Well-Circumscribed Lesion) and (Disease_Has_Abnormal_Cell only Neoplastic Spindle-Shaped Fibrohistiocytic Cell) and (Disease_Has_Finding only Invasive Lesion) and (Disease_Has_Finding only Multinodular Mass) and (Disease_Has_Finding only Storiform Growth Pattern)</Axiom>
                  </Source>
               </Change>
               <Change id="583">
                  <Axiom>Desmoplastic Small Round Cell Tumor EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Small Cell Sarcoma and Soft Tissue Sarcoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(11;22)(p13;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-WT1 Fusion Protein Expression)) and (Disease_May_Have_Finding some Abdominal Mass) and (Disease_May_Have_Finding some Ascites) and (Disease_May_Have_Finding some High Mitotic Activity) and (Disease_May_Have_Finding some Pain) and (Disease_May_Have_Finding some Tumor Cell Necrosis) and (Disease_Has_Abnormal_Cell only Malignant Small Round Cell) and (Disease_Has_Finding only Desmoplastic Stroma Formation)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Desmoplastic Small Round Cell Tumor EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Small Cell Sarcoma and Soft Tissue Sarcoma and (Disease_May_Have_Cytogenetic_Abnormality some t(11;22)(p13;q12)) and (Disease_May_Have_Finding some Abdominal Mass) and (Disease_May_Have_Finding some Ascites) and (Disease_May_Have_Finding some High Mitotic Activity) and (Disease_May_Have_Finding some Pain) and (Disease_May_Have_Finding some Tumor Cell Necrosis) and (Disease_May_Have_Molecular_Abnormality some EWS-WT1 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Malignant Small Round Cell) and (Disease_Has_Finding only Desmoplastic Stroma Formation)</Axiom>
                  </Source>
               </Change>
               <Change id="584">
                  <Axiom>Ductal Breast Carcinoma EquivalentTo Breast Adenocarcinoma and ((Disease_Excludes_Molecular_Abnormality only CDH1 Gene Inactivation) and (Disease_Excludes_Molecular_Abnormality only Loss of E-cadherin Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 17q22-q24) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 20q13) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome Xq) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 22q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8p) and (Disease_May_Have_Finding some Calcification) and (Disease_May_Have_Molecular_Abnormality some CCND1 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Messenger RNA Overexpression) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some c-erbB2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some ERBB2 Protein Overexpression) and (Disease_Has_Abnormal_Cell only Ductal Carcinoma Cell) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Ductal Breast Carcinoma EquivalentTo Breast Adenocarcinoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 17q22-q24) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 20q13) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome Xq) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 22q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8p) and (Disease_May_Have_Finding some Calcification) and (Disease_May_Have_Molecular_Abnormality some CCND1 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Messenger RNA Overexpression) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some c-erbB2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some ERBB2 Protein Overexpression) and (Disease_Excludes_Molecular_Abnormality only CDH1 Gene Inactivation) and (Disease_Excludes_Molecular_Abnormality only Loss of E-cadherin Expression) and (Disease_Has_Abnormal_Cell only Ductal Carcinoma Cell) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit)</Axiom>
                  </Source>
               </Change>
               <Change id="585">
                  <Axiom>Dysgerminoma EquivalentTo Malignant Germ Cell Tumor and ((Disease_May_Have_Molecular_Abnormality some C-KIT Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression)) and (Disease_Excludes_Abnormal_Cell only Neoplastic Sex Cord-Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Primitive Germ Cell) and (Disease_Has_Finding only Chronic Inflammatory Infiltrate) and (Disease_Has_Finding only Fibrous Septa Present) and (Disease_Has_Normal_Cell_Origin only Germ Cell) and (Disease_Has_Normal_Tissue_Origin only Germinal Layer)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Dysgerminoma EquivalentTo Malignant Germ Cell Tumor and (Disease_May_Have_Molecular_Abnormality some C-KIT Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression) and (Disease_Excludes_Abnormal_Cell only Neoplastic Sex Cord-Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Primitive Germ Cell) and (Disease_Has_Finding only Chronic Inflammatory Infiltrate) and (Disease_Has_Finding only Fibrous Septa Present) and (Disease_Has_Normal_Cell_Origin only Germ Cell) and (Disease_Has_Normal_Tissue_Origin only Germinal Layer)</Axiom>
                  </Source>
               </Change>
               <Change id="586">
                  <Axiom>Essential Thrombocythemia EquivalentTo Chronic Myeloproliferative Disorder and Megakaryocytic Neoplasm and ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression)) and (Disease_May_Have_Associated_Disease some Thrombosis) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Excludes_Abnormal_Cell only Tear-Drop Red Blood Cell) and (Disease_Excludes_Finding only Bone Marrow Dysplasia Present) and (Disease_Excludes_Finding only Bone Marrow Fibrosis) and (Disease_Excludes_Finding only Increased Red Cell Mass) and (Disease_Excludes_Finding only Leukoerythroblastosis) and (Disease_Has_Abnormal_Cell only Giant Megakaryocyte) and (Disease_Has_Abnormal_Cell only Giant Platelet) and (Disease_Has_Abnormal_Cell only Large Atypical Platelet) and (Disease_Has_Abnormal_Cell only Large Megakaryocyte) and (Disease_Has_Finding only Chronic Clinical Course) and (Disease_Has_Finding only Megakaryocytes Increased in Bone Marrow) and (Disease_Has_Finding only Thrombocytosis) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Variable Lineage Potential)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Essential Thrombocythemia EquivalentTo Chronic Myeloproliferative Disorder and Megakaryocytic Neoplasm and (Disease_May_Have_Associated_Disease some Thrombosis) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Excludes_Abnormal_Cell only Tear-Drop Red Blood Cell) and (Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Finding only Bone Marrow Dysplasia Present) and (Disease_Excludes_Finding only Bone Marrow Fibrosis) and (Disease_Excludes_Finding only Increased Red Cell Mass) and (Disease_Excludes_Finding only Leukoerythroblastosis) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Giant Megakaryocyte) and (Disease_Has_Abnormal_Cell only Giant Platelet) and (Disease_Has_Abnormal_Cell only Large Atypical Platelet) and (Disease_Has_Abnormal_Cell only Large Megakaryocyte) and (Disease_Has_Finding only Chronic Clinical Course) and (Disease_Has_Finding only Megakaryocytes Increased in Bone Marrow) and (Disease_Has_Finding only Thrombocytosis) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Variable Lineage Potential)</Axiom>
                  </Source>
               </Change>
               <Change id="587">
                  <Axiom>Follicular Bronchitis/Bronchiolitis EquivalentTo Benign Lymphoproliferative Disorder and Non-Neoplastic Lung Disorder and ((Disease_May_Have_Finding some Lymphoplasmacytic Infiltrate) and (Disease_May_Have_Finding some Reactive Germinal Centers Present) and (Disease_Excludes_Finding only Lymphoepithelial Lesion) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Nodular Pattern) and (Disease_Has_Finding only Peribronchial and Lobular Septal Involvement Only)) and (Disease_May_Have_Associated_Disease some Immunodeficiency Syndrome) and (Disease_May_Have_Associated_Disease some Rheumatologic Disorder) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Associated_Anatomic_Site only Lung) and (Disease_Has_Normal_Cell_Origin only Mature Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Bronchus-Associated Lymphoid Tissue)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Follicular Bronchitis/Bronchiolitis EquivalentTo Benign Lymphoproliferative Disorder and Non-Neoplastic Lung Disorder and (Disease_May_Have_Associated_Disease some Immunodeficiency Syndrome) and (Disease_May_Have_Associated_Disease some Rheumatologic Disorder) and (Disease_May_Have_Finding some Lymphoplasmacytic Infiltrate) and (Disease_May_Have_Finding some Reactive Germinal Centers Present) and (Disease_Excludes_Finding only Lymphoepithelial Lesion) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Associated_Anatomic_Site only Lung) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Nodular Pattern) and (Disease_Has_Finding only Peribronchial and Lobular Septal Involvement Only) and (Disease_Has_Normal_Cell_Origin only Mature Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Bronchus-Associated Lymphoid Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="588">
                  <Axiom>Gastric Gastrointestinal Stromal Tumor EquivalentTo Gastric Soft Tissue Neoplasm and Gastrointestinal Stromal Tumor of the Gastrointestinal Tract and ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Gastric Gastrointestinal Stromal Tumor EquivalentTo Gastric Soft Tissue Neoplasm and Gastrointestinal Stromal Tumor of the Gastrointestinal Tract and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression)</Axiom>
                  </Source>
               </Change>
               <Change id="589">
                  <Axiom>Gastric Mucosa-Associated Lymphoid Tissue Lymphoma EquivalentTo Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue and Gastric Non-Hodgkin's Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(11;18)(q21;q21)) and (Disease_May_Have_Molecular_Abnormality some AP12-MLT Fusion Protein Expression)) and (Disease_May_Have_Associated_Disease some Hepatitis C) and (Disease_Has_Normal_Tissue_Origin only Gut-Associated Lymphoid Tissue) and (Disease_Has_Primary_Anatomic_Site only Stomach)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Gastric Mucosa-Associated Lymphoid Tissue Lymphoma EquivalentTo Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue and Gastric Non-Hodgkin's Lymphoma and (Disease_May_Have_Associated_Disease some Hepatitis C) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;18)(q21;q21)) and (Disease_May_Have_Molecular_Abnormality some AP12-MLT Fusion Protein Expression) and (Disease_Has_Normal_Tissue_Origin only Gut-Associated Lymphoid Tissue) and (Disease_Has_Primary_Anatomic_Site only Stomach)</Axiom>
                  </Source>
               </Change>
               <Change id="590">
                  <Axiom>Gastrointestinal Autonomic Nerve Tumor EquivalentTo Autonomic Nervous System Neoplasm and Gastrointestinal Neuroendocrine Neoplasm and ((Disease_May_Have_Molecular_Abnormality some C-KIT Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression)) and (Disease_May_Have_Abnormal_Cell some Neoplastic Epithelioid Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Spindle Cell)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Gastrointestinal Autonomic Nerve Tumor EquivalentTo Autonomic Nervous System Neoplasm and Gastrointestinal Neuroendocrine Neoplasm and (Disease_May_Have_Abnormal_Cell some Neoplastic Epithelioid Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Spindle Cell) and (Disease_May_Have_Molecular_Abnormality some C-KIT Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression)</Axiom>
                  </Source>
               </Change>
               <Change id="591">
                  <Axiom>Gastrointestinal Stromal Tumor EquivalentTo Stromal Neoplasm and ((Disease_May_Have_Molecular_Abnormality some C-KIT Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression)) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 22) and (Disease_Has_Normal_Cell_Origin only Interstitial Cell of Cajal)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Gastrointestinal Stromal Tumor EquivalentTo Stromal Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 22) and (Disease_May_Have_Molecular_Abnormality some C-KIT Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression) and (Disease_Has_Normal_Cell_Origin only Interstitial Cell of Cajal)</Axiom>
                  </Source>
               </Change>
               <Change id="592">
                  <Axiom>Giant Cell Glioblastoma EquivalentTo Glioblastoma and Malignant Giant Cell Neoplasm and ((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Abnormal_Cell only Giant Astrocyte)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Giant Cell Glioblastoma EquivalentTo Glioblastoma and Malignant Giant Cell Neoplasm and (Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Abnormal_Cell only Giant Astrocyte)</Axiom>
                  </Source>
               </Change>
               <Change id="593">
                  <Axiom>Glomus Tumor of Uncertain Malignant Potential EquivalentTo Glomus Tumor and ((Disease_May_Have_Finding some High Mitotic Activity) and (Disease_May_Have_Finding some Superficial Lesion)) and (Disease_May_Have_Finding some Deep Lesion) and (Disease_May_Have_Finding some Lesion with Diameter Greater than 2cm) and (Disease_Has_Finding only Borderline Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Glomus Tumor of Uncertain Malignant Potential EquivalentTo Glomus Tumor and (Disease_May_Have_Finding some Deep Lesion) and (Disease_May_Have_Finding some High Mitotic Activity) and (Disease_May_Have_Finding some Lesion with Diameter Greater than 2cm) and (Disease_May_Have_Finding some Superficial Lesion) and (Disease_Has_Finding only Borderline Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="594">
                  <Axiom>Hereditary Paraganglioma-Pheochromocytoma Syndrome EquivalentTo Endocrine Syndrome and Hereditary Neoplastic Syndrome and ((Disease_May_Have_Molecular_Abnormality some SDHB Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some SDHC Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some SDHD Gene Mutation) and (Disease_Has_Molecular_Abnormality only Mitochondrial Complex II Gene Mutation)) and (Disease_Has_Associated_Disease only Paraganglioma)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Hereditary Paraganglioma-Pheochromocytoma Syndrome EquivalentTo Endocrine Syndrome and Hereditary Neoplastic Syndrome and (Disease_May_Have_Molecular_Abnormality some SDHB Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some SDHC Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some SDHD Gene Mutation) and (Disease_Has_Associated_Disease only Paraganglioma) and (Disease_Has_Molecular_Abnormality only Mitochondrial Complex II Gene Mutation)</Axiom>
                  </Source>
               </Change>
               <Change id="595">
                  <Axiom>Infantile Fibrosarcoma EquivalentTo Childhood Fibrosarcoma and Conventional Fibrosarcoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(12;15)(p13;q26)) and (Disease_May_Have_Molecular_Abnormality some ETV6-NTRK3 Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 17) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 20) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 11) and (Disease_May_Have_Finding some Favorable Clinical Outcome)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Infantile Fibrosarcoma EquivalentTo Childhood Fibrosarcoma and Conventional Fibrosarcoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 17) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 20) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 11) and (Disease_May_Have_Cytogenetic_Abnormality some t(12;15)(p13;q26)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some ETV6-NTRK3 Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="596">
                  <Axiom>Interdigitating Dendritic Cell Sarcoma/Tumor EquivalentTo Histiocytic and Dendritic Cell Neoplasms and ((Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Paracortical Involvement with Residual Follicles Present)) and (Disease_May_Have_Finding some Asymptomatic Mass) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Night Sweating) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Excludes_Finding only Birbeck Granules Present) and (Disease_Excludes_Finding only CD1a-Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only CD21-Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only CD35-Positive Neoplastic Cells Present) and (Disease_Has_Abnormal_Cell only Neoplastic Interdigitating Dendritic Cell) and (Disease_Has_Finding only S-100-Positive Neoplastic Cells Present) and (Disease_Has_Finding only Storiform Growth Pattern) and (Disease_Has_Finding only Whorling Growth Pattern) and (Disease_Has_Normal_Cell_Origin only Interdigitating Dendritic Cell) and (Disease_Has_Normal_Tissue_Origin only Interfollicular Area of the Lymph Node)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Interdigitating Dendritic Cell Sarcoma/Tumor EquivalentTo Histiocytic and Dendritic Cell Neoplasms and (Disease_May_Have_Finding some Asymptomatic Mass) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Night Sweating) and (Disease_May_Have_Finding some Paracortical Involvement with Residual Follicles Present) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Excludes_Finding only Birbeck Granules Present) and (Disease_Excludes_Finding only CD1a-Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only CD21-Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only CD35-Positive Neoplastic Cells Present) and (Disease_Has_Abnormal_Cell only Neoplastic Interdigitating Dendritic Cell) and (Disease_Has_Finding only S-100-Positive Neoplastic Cells Present) and (Disease_Has_Finding only Storiform Growth Pattern) and (Disease_Has_Finding only Whorling Growth Pattern) and (Disease_Has_Normal_Cell_Origin only Interdigitating Dendritic Cell) and (Disease_Has_Normal_Tissue_Origin only Interfollicular Area of the Lymph Node)</Axiom>
                  </Source>
               </Change>
               <Change id="597">
                  <Axiom>Juvenile Myelomonocytic Leukemia EquivalentTo Myelodysplastic/Myeloproliferative Disease and ((Disease_May_Have_Associated_Disease some Neurofibromatosis Type 1) and (Disease_May_Have_Finding some Cafe Au Lait Patch)) and (Disease_May_Have_Associated_Disease some Bronchitis) and (Disease_May_Have_Associated_Disease some Noonan Syndrome) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Finding some Absence of Bone Marrow Dysplasia) and (Disease_May_Have_Finding some Elevated Serum Lysozyme) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemoglobin F Increased) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_May_Have_Finding some Nucleated Red Blood Cells Present) and (Disease_May_Have_Finding some Polyclonal Hypergammaglobulinemia) and (Disease_May_Have_Finding some Skin Rash) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell) and (Disease_Excludes_Finding only Auer Rods Present) and (Disease_Has_Associated_Disease only Anemia) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Increased) and (Disease_Has_Finding only Monocytosis) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Juvenile Myelomonocytic Leukemia EquivalentTo Myelodysplastic/Myeloproliferative Disease and (Disease_May_Have_Associated_Disease some Bronchitis) and (Disease_May_Have_Associated_Disease some Neurofibromatosis Type 1) and (Disease_May_Have_Associated_Disease some Noonan Syndrome) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Finding some Absence of Bone Marrow Dysplasia) and (Disease_May_Have_Finding some Cafe Au Lait Patch) and (Disease_May_Have_Finding some Elevated Serum Lysozyme) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemoglobin F Increased) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_May_Have_Finding some Nucleated Red Blood Cells Present) and (Disease_May_Have_Finding some Polyclonal Hypergammaglobulinemia) and (Disease_May_Have_Finding some Skin Rash) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell) and (Disease_Excludes_Finding only Auer Rods Present) and (Disease_Has_Associated_Disease only Anemia) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Increased) and (Disease_Has_Finding only Monocytosis) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
                  </Source>
               </Change>
               <Change id="598">
                  <Axiom>Lipoblastoma EquivalentTo Benign Lipomatous Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some Rearrangement of 8q11-13) and (Disease_May_Have_Molecular_Abnormality some COL1A2-PLAG1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some HAS2-PLAG1 Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_Has_Abnormal_Cell only Neoplastic Lipoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Mature Adipocyte) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Localized Disease) and (Disease_Has_Finding only Slow Growing Painless Mass)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lipoblastoma EquivalentTo Benign Lipomatous Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Rearrangement of 8q11-13) and (Disease_May_Have_Molecular_Abnormality some COL1A2-PLAG1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some HAS2-PLAG1 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Neoplastic Lipoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Mature Adipocyte) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Localized Disease) and (Disease_Has_Finding only Slow Growing Painless Mass)</Axiom>
                  </Source>
               </Change>
               <Change id="599">
                  <Axiom>Lipoblastomatosis EquivalentTo Benign Lipomatous Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some Rearrangement of 8q11-13) and (Disease_May_Have_Molecular_Abnormality some COL1A2-PLAG1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some HAS2-PLAG1 Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_Excludes_Finding only Localized Disease) and (Disease_Has_Abnormal_Cell only Neoplastic Lipoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Mature Adipocyte) and (Disease_Has_Finding only Multifocal Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lipoblastomatosis EquivalentTo Benign Lipomatous Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Rearrangement of 8q11-13) and (Disease_May_Have_Molecular_Abnormality some COL1A2-PLAG1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some HAS2-PLAG1 Fusion Protein Expression) and (Disease_Excludes_Finding only Localized Disease) and (Disease_Has_Abnormal_Cell only Neoplastic Lipoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Mature Adipocyte) and (Disease_Has_Finding only Multifocal Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="600">
                  <Axiom>Lipoma EquivalentTo Benign Lipomatous Neoplasm and ((Disease_Excludes_Cytogenetic_Abnormality only Rearrangement of 8q11-13) and (Disease_Excludes_Molecular_Abnormality only COL1A2-PLAG1 Fusion Protein Expression) and (Disease_Excludes_Molecular_Abnormality only HAS2-PLAG1 Fusion Protein Expression)) and (Disease_Has_Finding only Localized Disease)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lipoma EquivalentTo Benign Lipomatous Neoplasm and (Disease_Excludes_Cytogenetic_Abnormality only Rearrangement of 8q11-13) and (Disease_Excludes_Molecular_Abnormality only COL1A2-PLAG1 Fusion Protein Expression) and (Disease_Excludes_Molecular_Abnormality only HAS2-PLAG1 Fusion Protein Expression) and (Disease_Has_Finding only Localized Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="601">
                  <Axiom>Lobular Neoplasia EquivalentTo Breast Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Molecular_Abnormality some CDH1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some Loss of E-cadherin Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 22q) and (Disease_May_Have_Finding some Monomorphic Cellular Infiltrate) and (Disease_May_Have_Finding some Multifocal Lesion) and (Disease_Excludes_Finding only Breast Lump) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Absence of Invasion) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lobular Neoplasia EquivalentTo Breast Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 22q) and (Disease_May_Have_Finding some Monomorphic Cellular Infiltrate) and (Disease_May_Have_Finding some Multifocal Lesion) and (Disease_May_Have_Molecular_Abnormality some CDH1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some Loss of E-cadherin Expression) and (Disease_Excludes_Finding only Breast Lump) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Absence of Invasion) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                  </Source>
               </Change>
               <Change id="602">
                  <Axiom>Low Grade Fibromyxoid Sarcoma EquivalentTo Soft Tissue Fibrosarcoma and ((Disease_May_Have_Molecular_Abnormality some FUS-CREB3L1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some FUS-CREB3L2 Fusion Protein Expression) and (Disease_Has_Cytogenetic_Abnormality only Balanced Chromosomal Translocation) and (Disease_Has_Cytogenetic_Abnormality only t(7;16)(q32-34;p11))) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Mild Cytologic Atypia) and (Disease_Excludes_Finding only Nuclear Pleomorphism) and (Disease_Has_Abnormal_Cell only Malignant Spindle-Shaped Fibroblast) and (Disease_Has_Finding only Fibrotic Stroma Formation) and (Disease_Has_Finding only Low Grade Lesion) and (Disease_Has_Finding only Myxoid Stroma Formation) and (Disease_Has_Finding only Whorling Growth Pattern)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Low Grade Fibromyxoid Sarcoma EquivalentTo Soft Tissue Fibrosarcoma and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Mild Cytologic Atypia) and (Disease_May_Have_Molecular_Abnormality some FUS-CREB3L1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some FUS-CREB3L2 Fusion Protein Expression) and (Disease_Excludes_Finding only Nuclear Pleomorphism) and (Disease_Has_Abnormal_Cell only Malignant Spindle-Shaped Fibroblast) and (Disease_Has_Cytogenetic_Abnormality only Balanced Chromosomal Translocation) and (Disease_Has_Cytogenetic_Abnormality only t(7;16)(q32-34;p11)) and (Disease_Has_Finding only Fibrotic Stroma Formation) and (Disease_Has_Finding only Low Grade Lesion) and (Disease_Has_Finding only Myxoid Stroma Formation) and (Disease_Has_Finding only Whorling Growth Pattern)</Axiom>
                  </Source>
               </Change>
               <Change id="603">
                  <Axiom>Lymphocytic Interstitial Pneumonia SubClassOf (Disease_May_Have_Finding some Lymphoplasmacytic Infiltrate) and (Disease_May_Have_Finding some Reactive Germinal Centers Present) and (Disease_Excludes_Finding only Lymphoepithelial Lesion) and (Disease_Excludes_Finding only Peribronchial and Lobular Septal Involvement Only) and (Disease_Has_Finding only Diffuse Cellular Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lymphocytic Interstitial Pneumonia SubClassOf Disease_Excludes_Finding only Lymphoepithelial Lesion</Axiom>
                     <Axiom ineffectual="true">Lymphocytic Interstitial Pneumonia SubClassOf Disease_Has_Finding only Lymphocytic Infiltrate</Axiom>
                     <Axiom ineffectual="true">Lymphocytic Interstitial Pneumonia SubClassOf Disease_May_Have_Finding some Lymphoplasmacytic Infiltrate</Axiom>
                     <Axiom ineffectual="true">Lymphocytic Interstitial Pneumonia SubClassOf Disease_Excludes_Finding only Peribronchial and Lobular Septal Involvement Only</Axiom>
                     <Axiom ineffectual="true">Lymphocytic Interstitial Pneumonia SubClassOf Disease_Has_Finding only Diffuse Cellular Infiltrate</Axiom>
                     <Axiom ineffectual="true">Lymphocytic Interstitial Pneumonia SubClassOf Disease_May_Have_Finding some Reactive Germinal Centers Present</Axiom>
                  </Source>
               </Change>
               <Change id="604">
                  <Axiom>Lymphomatous Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and ((Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Osteoclastic Activity Present)) and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Medium-Sized to Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Small T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Polylobated T-Lymphocyte) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Finding only Negative Peripheral Blood)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lymphomatous Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Medium-Sized to Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Small T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Polylobated T-Lymphocyte) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Osteoclastic Activity Present) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Finding only Negative Peripheral Blood)</Axiom>
                  </Source>
               </Change>
               <Change id="605">
                  <Axiom>Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia EquivalentTo Indolent Non-Hodgkin's Lymphoma and Mature B-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Finding some Cryoglobulinemia) and (Disease_May_Have_Finding some Hyperviscosity) and (Disease_May_Have_Finding some Monoclonal Gammopathy)) and (Disease_May_Have_Associated_Disease some Autoimmune Disease) and (Disease_May_Have_Associated_Disease some Hepatitis C) and (Disease_May_Have_Associated_Disease some Neuropathy) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;14)(p13;q32)) and (Disease_May_Have_Finding some Diarrhea) and (Disease_May_Have_Finding some Dutcher Body) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Abnormal_Cell only Lymphoplasmacytoid Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Plasma Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Small B-Lymphocyte) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Finding only Lymphoplasmacytic Infiltrate) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Peripheral B-Lymphocyte)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia EquivalentTo Indolent Non-Hodgkin's Lymphoma and Mature B-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Associated_Disease some Autoimmune Disease) and (Disease_May_Have_Associated_Disease some Hepatitis C) and (Disease_May_Have_Associated_Disease some Neuropathy) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;14)(p13;q32)) and (Disease_May_Have_Finding some Cryoglobulinemia) and (Disease_May_Have_Finding some Diarrhea) and (Disease_May_Have_Finding some Dutcher Body) and (Disease_May_Have_Finding some Hyperviscosity) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Monoclonal Gammopathy) and (Disease_Has_Abnormal_Cell only Lymphoplasmacytoid Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Plasma Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Small B-Lymphocyte) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Finding only Lymphoplasmacytic Infiltrate) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Peripheral B-Lymphocyte)</Axiom>
                  </Source>
               </Change>
               <Change id="606">
                  <Axiom>Mantle Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Mature B-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Molecular_Abnormality some Clonal CCND1 Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Abnormal_Cell only Neoplastic Small to Medium-Sized B-Lymphocyte Resembling a Centrocyte) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Peripheral B-Lymphocyte of Inner Mantle Zone) and (Disease_Has_Normal_Tissue_Origin only Mantle Zone)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Mantle Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Mature B-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Molecular_Abnormality some Clonal CCND1 Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Has_Abnormal_Cell only Neoplastic Small to Medium-Sized B-Lymphocyte Resembling a Centrocyte) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Peripheral B-Lymphocyte of Inner Mantle Zone) and (Disease_Has_Normal_Tissue_Origin only Mantle Zone)</Axiom>
                  </Source>
               </Change>
               <Change id="607">
                  <Axiom>Meningeal Chronic Myelogenous Leukemia EquivalentTo Central Nervous System Leukemia and Chronic Myelogenous Leukemia and Malignant Neoplasm of the Meninges and ((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Meningeal Chronic Myelogenous Leukemia EquivalentTo Central Nervous System Leukemia and Chronic Myelogenous Leukemia and Malignant Neoplasm of the Meninges and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                  </Source>
               </Change>
               <Change id="608">
                  <Axiom>Methotrexate-Associated Lymphoproliferative Disorder EquivalentTo Lymphoma and ((Disease_May_Have_Associated_Disease some Dermatomyositis) and (Disease_May_Have_Associated_Disease some Psoriasis) and (Disease_May_Have_Associated_Disease some Rheumatoid Arthritis) and (Disease_Has_Associated_Disease only Autoimmune Disease)) and (Disease_May_Have_Associated_Disease some Epstein-Barr Virus Infection) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Lymphadenopathy)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Methotrexate-Associated Lymphoproliferative Disorder EquivalentTo Lymphoma and (Disease_May_Have_Associated_Disease some Dermatomyositis) and (Disease_May_Have_Associated_Disease some Epstein-Barr Virus Infection) and (Disease_May_Have_Associated_Disease some Psoriasis) and (Disease_May_Have_Associated_Disease some Rheumatoid Arthritis) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Associated_Disease only Autoimmune Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="610">
                  <Axiom>Myelodysplastic/Myeloproliferative Disease EquivalentTo Myeloid Neoplasm and ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Ineffective Hematopoiesis) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_Has_Finding only Blasts Under 20 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Blasts Under 20 Percent of Peripheral Blood White Cells)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Myelodysplastic/Myeloproliferative Disease EquivalentTo Myeloid Neoplasm and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Ineffective Hematopoiesis) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression) and (Disease_Has_Finding only Blasts Under 20 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Blasts Under 20 Percent of Peripheral Blood White Cells)</Axiom>
                  </Source>
               </Change>
               <Change id="611">
                  <Axiom>Nasal Cavity Non-Hodgkin's Lymphoma EquivalentTo Nasal Cavity Lymphoma and Non-Hodgkin's Lymphoma and ((Disease_May_Have_Associated_Disease some Nasal Type Extranodal NK/T-Cell Lymphoma) and (Disease_May_Have_Finding some Nasal Cavity Lethal Midline Granuloma)) and (Disease_May_Have_Finding some Epistaxis)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Nasal Cavity Non-Hodgkin's Lymphoma EquivalentTo Nasal Cavity Lymphoma and Non-Hodgkin's Lymphoma and (Disease_May_Have_Associated_Disease some Nasal Type Extranodal NK/T-Cell Lymphoma) and (Disease_May_Have_Finding some Epistaxis) and (Disease_May_Have_Finding some Nasal Cavity Lethal Midline Granuloma)</Axiom>
                  </Source>
               </Change>
               <Change id="612">
                  <Axiom>Nodular Lymphoid Hyperplasia of Lung EquivalentTo Benign Lymphoproliferative Disorder and Non-Neoplastic Lung Disorder and ((Disease_May_Have_Finding some Russell Body) and (Disease_Excludes_Finding only Lymphoepithelial Lesion) and (Disease_Excludes_Finding only Peribronchial and Lobular Septal Involvement Only) and (Disease_Has_Finding only Lymphoplasmacytic Infiltrate) and (Disease_Has_Finding only Nodular Pattern) and (Disease_Has_Finding only Reactive Germinal Centers Present)) and (Disease_May_Have_Finding some Chest Pain) and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Solitary Nodule) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Associated_Anatomic_Site only Lung) and (Disease_Has_Normal_Cell_Origin only Mature Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Bronchus-Associated Lymphoid Tissue)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Nodular Lymphoid Hyperplasia of Lung EquivalentTo Benign Lymphoproliferative Disorder and Non-Neoplastic Lung Disorder and (Disease_May_Have_Finding some Chest Pain) and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Russell Body) and (Disease_May_Have_Finding some Solitary Nodule) and (Disease_Excludes_Finding only Lymphoepithelial Lesion) and (Disease_Excludes_Finding only Peribronchial and Lobular Septal Involvement Only) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Associated_Anatomic_Site only Lung) and (Disease_Has_Finding only Lymphoplasmacytic Infiltrate) and (Disease_Has_Finding only Nodular Pattern) and (Disease_Has_Finding only Reactive Germinal Centers Present) and (Disease_Has_Normal_Cell_Origin only Mature Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Bronchus-Associated Lymphoid Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="613">
                  <Axiom>Non-Hereditary Conventional (Clear Cell) Renal Cell Carcinoma EquivalentTo Conventional (Clear Cell) Renal Cell Carcinoma and ((Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) and (Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some VHL Gene Inactivation) and (Disease_Has_Cytogenetic_Abnormality only Loss of Chromosome 3) and (Disease_Has_Finding only Non-Hereditary Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Non-Hereditary Conventional (Clear Cell) Renal Cell Carcinoma EquivalentTo Conventional (Clear Cell) Renal Cell Carcinoma and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some VHL Gene Inactivation) and (Disease_Has_Cytogenetic_Abnormality only Loss of Chromosome 3) and (Disease_Has_Finding only Non-Hereditary Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="614">
                  <Axiom>Non-Secretory Myeloma EquivalentTo Plasma Cell Myeloma and ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture)) and (Disease_Excludes_Finding only Monoclonal Paraproteinemia)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Non-Secretory Myeloma EquivalentTo Plasma Cell Myeloma and (Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_Excludes_Finding only Monoclonal Paraproteinemia)</Axiom>
                  </Source>
               </Change>
               <Change id="615">
                  <Axiom>Parathyroid Gland Carcinoma EquivalentTo Adenocarcinoma and Malignant Endocrine Neoplasm and Malignant Parathyroid Gland Neoplasm and Neck Carcinoma and ((Disease_May_Have_Molecular_Abnormality some CCND1 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)) and (Disease_May_Have_Abnormal_Cell some Malignant Parathyroid Gland Chief Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Parathyroid Gland Clear Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Parathyroid Gland Oncocyte) and (Disease_May_Have_Associated_Disease some Primary Hyperparathyroidism) and (Disease_May_Have_Finding some Broad Fibrous Bands Formation) and (Disease_May_Have_Finding some Capsular Invasion) and (Disease_May_Have_Finding some Hemosiderin Deposition) and (Disease_May_Have_Finding some Mitotic Activity) and (Disease_May_Have_Finding some Neck Mass) and (Disease_May_Have_Finding some Perineurial Invasion) and (Disease_May_Have_Finding some Solid Growth Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_May_Have_Finding some Tumor Vascular Invasion) and (Disease_May_Have_Molecular_Abnormality some Aneuploidy) and (Disease_May_Have_Molecular_Abnormality some HRPT2 Gene Mutation) and (Disease_Has_Abnormal_Cell only Malignant Parathyroid Gland Cell) and (Disease_Has_Normal_Cell_Origin only Parathyroid Gland Parenchymal Cell) and (Disease_Has_Normal_Tissue_Origin only Parathyroid Gland Epithelial Tissue) and (Disease_Has_Primary_Anatomic_Site only Parathyroid Gland)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Parathyroid Gland Carcinoma EquivalentTo Adenocarcinoma and Malignant Endocrine Neoplasm and Malignant Parathyroid Gland Neoplasm and Neck Carcinoma and (Disease_May_Have_Abnormal_Cell some Malignant Parathyroid Gland Chief Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Parathyroid Gland Clear Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Parathyroid Gland Oncocyte) and (Disease_May_Have_Associated_Disease some Primary Hyperparathyroidism) and (Disease_May_Have_Finding some Broad Fibrous Bands Formation) and (Disease_May_Have_Finding some Capsular Invasion) and (Disease_May_Have_Finding some Hemosiderin Deposition) and (Disease_May_Have_Finding some Mitotic Activity) and (Disease_May_Have_Finding some Neck Mass) and (Disease_May_Have_Finding some Perineurial Invasion) and (Disease_May_Have_Finding some Solid Growth Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_May_Have_Finding some Tumor Vascular Invasion) and (Disease_May_Have_Molecular_Abnormality some Aneuploidy) and (Disease_May_Have_Molecular_Abnormality some CCND1 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some HRPT2 Gene Mutation) and (Disease_Has_Abnormal_Cell only Malignant Parathyroid Gland Cell) and (Disease_Has_Normal_Cell_Origin only Parathyroid Gland Parenchymal Cell) and (Disease_Has_Normal_Tissue_Origin only Parathyroid Gland Epithelial Tissue) and (Disease_Has_Primary_Anatomic_Site only Parathyroid Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="617">
                  <Axiom>Philadelphia Chromosome Positive Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and Philadelphia-Positive Myelogenous Leukemia and ((Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Has_Cytogenetic_Abnormality only t(9;22)(q34;q11))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Molecular_Abnormality some JAK-STAT Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some JUN Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some MYC Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some P13K-AKT Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some RAS-RAF Pathway Deregulation)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Philadelphia Chromosome Positive Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and Philadelphia-Positive Myelogenous Leukemia and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Molecular_Abnormality some JAK-STAT Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some JUN Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some MYC Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some P13K-AKT Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some RAS-RAF Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Has_Cytogenetic_Abnormality only t(9;22)(q34;q11))</Axiom>
                  </Source>
               </Change>
               <Change id="618">
                  <Axiom>Philadelphia Positive Precursor Lymphoblastic Leukemia EquivalentTo Precursor Lymphoblastic Leukemia and ((Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_Has_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Has_Cytogenetic_Abnormality only t(9;22)(q34;q11))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Coarse Azurophilic Granules Present) and (Disease_May_Have_Finding some Extensive Bone Marrow and Blood Involvement) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Associated_Disease only Precursor B-Lymphoblastic Leukemia)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Philadelphia Positive Precursor Lymphoblastic Leukemia EquivalentTo Precursor Lymphoblastic Leukemia and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Coarse Azurophilic Granules Present) and (Disease_May_Have_Finding some Extensive Bone Marrow and Blood Involvement) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_Has_Associated_Disease only Precursor B-Lymphoblastic Leukemia) and (Disease_Has_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Has_Cytogenetic_Abnormality only t(9;22)(q34;q11))</Axiom>
                  </Source>
               </Change>
               <Change id="616">
                  <Axiom>Philadelphia-Positive Myelogenous Leukemia EquivalentTo Myeloid Leukemia and ((Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Has_Cytogenetic_Abnormality only t(9;22)(q34;q11)))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Philadelphia-Positive Myelogenous Leukemia EquivalentTo Myeloid Leukemia and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Has_Cytogenetic_Abnormality only t(9;22)(q34;q11))</Axiom>
                  </Source>
               </Change>
               <Change id="619">
                  <Axiom>Polycythemia Vera EquivalentTo Chronic Myeloproliferative Disorder and Erythroid Neoplasm and Polycythemia and ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_Has_Normal_Cell_Origin only Multipotent Bone Marrow Stem Cell)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Polycythemia Vera EquivalentTo Chronic Myeloproliferative Disorder and Erythroid Neoplasm and Polycythemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression) and (Disease_Has_Normal_Cell_Origin only Multipotent Bone Marrow Stem Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="620">
                  <Axiom>Polycythemia Vera, Polycythemic Stage EquivalentTo Polycythemia Vera and ((Disease_Has_Finding only Erythroid Hyperplasia) and (Disease_Has_Finding only Increased Red Cell Mass)) and (Disease_May_Have_Associated_Disease some Cerebrovascular Accident) and (Disease_May_Have_Associated_Disease some Gout) and (Disease_May_Have_Associated_Disease some Myocardial Infarction) and (Disease_May_Have_Associated_Disease some Thrombophlebitis) and (Disease_May_Have_Finding some Basophilia) and (Disease_May_Have_Finding some Dizziness) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Neutrophilia) and (Disease_May_Have_Finding some Paresthesia) and (Disease_May_Have_Finding some Pruritus) and (Disease_May_Have_Finding some Reticulin Fibrosis of the Bone Marrow) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_Excludes_Abnormal_Cell only Hyperchromatic Megakaryocyte) and (Disease_Excludes_Abnormal_Cell only Tear-Drop Red Blood Cell) and (Disease_Excludes_Finding only Leukoerythroblastosis) and (Disease_Excludes_Finding only Osteosclerosis) and (Disease_Excludes_Finding only Poikilocytosis) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Polycythemia Vera, Polycythemic Stage EquivalentTo Polycythemia Vera and (Disease_May_Have_Associated_Disease some Cerebrovascular Accident) and (Disease_May_Have_Associated_Disease some Gout) and (Disease_May_Have_Associated_Disease some Myocardial Infarction) and (Disease_May_Have_Associated_Disease some Thrombophlebitis) and (Disease_May_Have_Finding some Basophilia) and (Disease_May_Have_Finding some Dizziness) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Neutrophilia) and (Disease_May_Have_Finding some Paresthesia) and (Disease_May_Have_Finding some Pruritus) and (Disease_May_Have_Finding some Reticulin Fibrosis of the Bone Marrow) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_Excludes_Abnormal_Cell only Hyperchromatic Megakaryocyte) and (Disease_Excludes_Abnormal_Cell only Tear-Drop Red Blood Cell) and (Disease_Excludes_Finding only Leukoerythroblastosis) and (Disease_Excludes_Finding only Osteosclerosis) and (Disease_Excludes_Finding only Poikilocytosis) and (Disease_Has_Finding only Erythroid Hyperplasia) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Increased Red Cell Mass)</Axiom>
                  </Source>
               </Change>
               <Change id="621">
                  <Axiom>Polycythemia Vera, Post-Polycythemic Myelofibrosis and Myeloid Metaplasia Stage EquivalentTo Polycythemia Vera and ((Disease_Has_Finding only Extramedullary Hematopoiesis) and (Disease_Has_Finding only Hepatomegaly) and (Disease_Has_Finding only Splenomegaly)) and (Disease_May_Have_Finding some Osteosclerosis) and (Disease_Excludes_Finding only Increased Red Cell Mass) and (Disease_Has_Abnormal_Cell only Hyperchromatic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Tear-Drop Red Blood Cell) and (Disease_Has_Finding only Bone Marrow Fibrosis) and (Disease_Has_Finding only Leukoerythroblastosis) and (Disease_Has_Finding only Poikilocytosis)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Polycythemia Vera, Post-Polycythemic Myelofibrosis and Myeloid Metaplasia Stage EquivalentTo Polycythemia Vera and (Disease_May_Have_Finding some Osteosclerosis) and (Disease_Excludes_Finding only Increased Red Cell Mass) and (Disease_Has_Abnormal_Cell only Hyperchromatic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Tear-Drop Red Blood Cell) and (Disease_Has_Finding only Bone Marrow Fibrosis) and (Disease_Has_Finding only Extramedullary Hematopoiesis) and (Disease_Has_Finding only Hepatomegaly) and (Disease_Has_Finding only Leukoerythroblastosis) and (Disease_Has_Finding only Poikilocytosis) and (Disease_Has_Finding only Splenomegaly)</Axiom>
                  </Source>
               </Change>
               <Change id="623">
                  <Axiom>Precursor T-Lymphoblastic Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Precursor Lymphoblastic Lymphoma and Precursor T-Lymphoblastic Lymphoma/Leukemia and T-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Starry Sky Pattern)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphoblasts 25 Percent or Less of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Skin Nodule)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Precursor T-Lymphoblastic Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Precursor Lymphoblastic Lymphoma and Precursor T-Lymphoblastic Lymphoma/Leukemia and T-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Lymphoblasts 25 Percent or Less of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Starry Sky Pattern)</Axiom>
                  </Source>
               </Change>
               <Change id="622">
                  <Axiom>Precursor T-Lymphoblastic Lymphoma/Leukemia EquivalentTo Precursor Lymphoblastic Lymphoma/Leukemia and T-Cell and NK-Cell Neoplasm and ((Disease_May_Have_Finding some High Mitotic Activity) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Starry Sky Pattern)) and (Disease_May_Have_Cytogenetic_Abnormality some del(9p21p22)) and (Disease_May_Have_Cytogenetic_Abnormality some inv(14)(q11;q32.1)) and (Disease_May_Have_Cytogenetic_Abnormality some t(10;14)(q24;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(p13;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(p15;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;14)(q11;q32)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;14)(p32;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;7)(p33;q35)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;10)(q34;q24)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;14)(q35;q32.1)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;19)(q34;q13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;9)(q34;q32)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;9)(q34;q34.3)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;13)(p11;q11)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Malignant Pleural Effusion) and (Disease_May_Have_Molecular_Abnormality some NOTCH1 Gene Mutation) and (Disease_Excludes_Normal_Cell_Origin only Peripheral (Post-Thymic) T-Lymphocyte) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphoblast) and (Disease_Has_Normal_Cell_Origin only Precursor T-Lymphoblast)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Precursor T-Lymphoblastic Lymphoma/Leukemia EquivalentTo Precursor Lymphoblastic Lymphoma/Leukemia and T-Cell and NK-Cell Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some del(9p21p22)) and (Disease_May_Have_Cytogenetic_Abnormality some inv(14)(q11;q32.1)) and (Disease_May_Have_Cytogenetic_Abnormality some t(10;14)(q24;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(p13;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(p15;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;14)(q11;q32)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;14)(p32;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;7)(p33;q35)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;10)(q34;q24)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;14)(q35;q32.1)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;19)(q34;q13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;9)(q34;q32)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;9)(q34;q34.3)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;13)(p11;q11)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some High Mitotic Activity) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Malignant Pleural Effusion) and (Disease_May_Have_Finding some Starry Sky Pattern) and (Disease_May_Have_Molecular_Abnormality some NOTCH1 Gene Mutation) and (Disease_Excludes_Normal_Cell_Origin only Peripheral (Post-Thymic) T-Lymphocyte) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphoblast) and (Disease_Has_Normal_Cell_Origin only Precursor T-Lymphoblast)</Axiom>
                  </Source>
               </Change>
               <Change id="624">
                  <Axiom>Primary Glioblastoma EquivalentTo Glioblastoma and ((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_Has_Finding only Primary Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Primary Glioblastoma EquivalentTo Glioblastoma and (Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_Has_Finding only Primary Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="625">
                  <Axiom>Pulmonary Lymphomatoid Granulomatosis EquivalentTo Lung Mature B-Cell Neoplasm and Lymphomatoid Granulomatosis and ((Disease_May_Have_Finding some Chest Pain) and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Pulmonary Mass)) and (Disease_Has_Finding only Premalignant Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Pulmonary Lymphomatoid Granulomatosis EquivalentTo Lung Mature B-Cell Neoplasm and Lymphomatoid Granulomatosis and (Disease_May_Have_Finding some Chest Pain) and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Pulmonary Mass) and (Disease_Has_Finding only Premalignant Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="626">
                  <Axiom>RAEB-2 EquivalentTo Refractory Anemia with Excess Blasts and ((Disease_May_Have_Finding some Myeloblasts 5-19 Percent of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">RAEB-2 EquivalentTo Refractory Anemia with Excess Blasts and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Myeloblasts 5-19 Percent of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)</Axiom>
                  </Source>
               </Change>
               <Change id="627">
                  <Axiom>Recurrent Small Lymphocytic Lymphoma EquivalentTo Recurrent B-Cell Non-Hodgkin's Lymphoma and Small Lymphocytic Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Recurrent Small Lymphocytic Lymphoma EquivalentTo Recurrent B-Cell Non-Hodgkin's Lymphoma and Small Lymphocytic Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)</Axiom>
                  </Source>
               </Change>
               <Change id="628">
                  <Axiom>Refractory Small Lymphocytic Lymphoma EquivalentTo Refractory Mature B-Cell Non-Hodgkin's Lymphoma and Small Lymphocytic Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Refractory Small Lymphocytic Lymphoma EquivalentTo Refractory Mature B-Cell Non-Hodgkin's Lymphoma and Small Lymphocytic Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)</Axiom>
                  </Source>
               </Change>
               <Change id="629">
                  <Axiom>Renal Cell Carcinoma Associated with inv(X)(p11;q12) EquivalentTo Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions and ((Disease_Has_Cytogenetic_Abnormality only inv(X)(p11;q12)) and (Disease_Has_Molecular_Abnormality only NONO-TFE3 Fusion Protein Expression))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Renal Cell Carcinoma Associated with inv(X)(p11;q12) EquivalentTo Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions and (Disease_Has_Cytogenetic_Abnormality only inv(X)(p11;q12)) and (Disease_Has_Molecular_Abnormality only NONO-TFE3 Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="631">
                  <Axiom>Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34) EquivalentTo Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions and ((Disease_Has_Cytogenetic_Abnormality only t(X;1)(p11.2;p34)) and (Disease_Has_Molecular_Abnormality only PSF-TFE3 Fusion Protein Expression))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34) EquivalentTo Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions and (Disease_Has_Cytogenetic_Abnormality only t(X;1)(p11.2;p34)) and (Disease_Has_Molecular_Abnormality only PSF-TFE3 Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="632">
                  <Axiom>Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21) EquivalentTo Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions and ((Disease_Has_Cytogenetic_Abnormality only t(X;1)(p11.2;q21)) and (Disease_Has_Molecular_Abnormality only PRCC-TFE3 Fusion Protein Expression)) and (Disease_May_Have_Finding some Psammoma Body Formation)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21) EquivalentTo Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_Has_Cytogenetic_Abnormality only t(X;1)(p11.2;q21)) and (Disease_Has_Molecular_Abnormality only PRCC-TFE3 Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="630">
                  <Axiom>Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25) EquivalentTo Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions and ((Disease_Has_Cytogenetic_Abnormality only Balanced Chromosomal Translocation) and (Disease_Has_Cytogenetic_Abnormality only t(X;17)(p11.2;q25)) and (Disease_Has_Molecular_Abnormality only ASPL-TFE3 Fusion Protein Expression)) and (Disease_Has_Finding only Psammoma Body Formation)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25) EquivalentTo Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions and (Disease_Has_Cytogenetic_Abnormality only Balanced Chromosomal Translocation) and (Disease_Has_Cytogenetic_Abnormality only t(X;17)(p11.2;q25)) and (Disease_Has_Finding only Psammoma Body Formation) and (Disease_Has_Molecular_Abnormality only ASPL-TFE3 Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="633">
                  <Axiom>Rhabdoid Tumor EquivalentTo Embryonal Neoplasm and Malignant Childhood Neoplasm and ((Disease_Has_Finding only Intermediate Filaments Present) and (Disease_Has_Finding only Intracytoplasmic Eosinophilic Inclusion)) and (Disease_May_Have_Abnormal_Cell some Non-Neoplastic Osteoclast-Like Giant Cell) and (Disease_May_Have_Finding some Aggressive Clinical Course) and (Disease_May_Have_Finding some High Mitotic Activity) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Malignant Cell with Large Nucleus and Abundant Eosinophilic Cytoplasm) and (Disease_Is_Grade only Grade 4)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Rhabdoid Tumor EquivalentTo Embryonal Neoplasm and Malignant Childhood Neoplasm and (Disease_May_Have_Abnormal_Cell some Non-Neoplastic Osteoclast-Like Giant Cell) and (Disease_May_Have_Finding some Aggressive Clinical Course) and (Disease_May_Have_Finding some High Mitotic Activity) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Malignant Cell with Large Nucleus and Abundant Eosinophilic Cytoplasm) and (Disease_Has_Finding only Intermediate Filaments Present) and (Disease_Has_Finding only Intracytoplasmic Eosinophilic Inclusion) and (Disease_Is_Grade only Grade 4)</Axiom>
                  </Source>
               </Change>
               <Change id="635">
                  <Axiom>Salivary Gland Mucoepidermoid Carcinoma EquivalentTo Mucoepidermoid Carcinoma and Salivary Gland Carcinoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q14-21;p12-13)) and (Disease_May_Have_Molecular_Abnormality some MECT1-MAML2 Fusion Protein Expression))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Salivary Gland Mucoepidermoid Carcinoma EquivalentTo Mucoepidermoid Carcinoma and Salivary Gland Carcinoma and (Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q14-21;p12-13)) and (Disease_May_Have_Molecular_Abnormality some MECT1-MAML2 Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="636">
                  <Axiom>Secretory Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Invasive Breast Carcinoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(12;15)(p13;q26)) and (Disease_May_Have_Molecular_Abnormality some ETV6-NTRK3 Fusion Protein Expression)) and (Disease_May_Have_Finding some Well-Circumscribed Lesion) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell with Abundant Pale Staining Cytoplasm) and (Disease_Has_Finding only Intracytoplasmic and Extracytoplasmic Eosinophilic Material Present) and (Disease_Is_Grade only Low Grade)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Secretory Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Invasive Breast Carcinoma and (Disease_May_Have_Cytogenetic_Abnormality some t(12;15)(p13;q26)) and (Disease_May_Have_Finding some Well-Circumscribed Lesion) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some ETV6-NTRK3 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell with Abundant Pale Staining Cytoplasm) and (Disease_Has_Finding only Intracytoplasmic and Extracytoplasmic Eosinophilic Material Present) and (Disease_Is_Grade only Low Grade)</Axiom>
                  </Source>
               </Change>
               <Change id="637">
                  <Axiom>Seminoma EquivalentTo Malignant Germ Cell Tumor and ((Disease_May_Have_Molecular_Abnormality some C-KIT Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression)) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Necrotic Change)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Seminoma EquivalentTo Malignant Germ Cell Tumor and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_May_Have_Molecular_Abnormality some C-KIT Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression)</Axiom>
                  </Source>
               </Change>
               <Change id="634">
                  <Axiom>Sinus Histiocytosis with Massive Lymphadenopathy EquivalentTo Non-Neoplastic Hematologic and Lymphocytic Disorder and ((Disease_Has_Finding only Emperipolesis) and (Disease_Has_Finding only Massive Sinusoidal Histiocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate)) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_Has_Abnormal_Cell only Atypical Histiocyte) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Associated_Anatomic_Site only Lymphatic System) and (Disease_Has_Finding only Cervical Lymphadenopathy) and (Disease_Has_Finding only Fever) and (Disease_Has_Finding only Polyclonal Hypergammaglobulinemia) and (Disease_Has_Normal_Cell_Origin only Histiocyte) and (Disease_Has_Normal_Tissue_Origin only Hematopoietic Tissue) and (Disease_Has_Normal_Tissue_Origin only Lymphoid Tissue)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Sinus Histiocytosis with Massive Lymphadenopathy EquivalentTo Non-Neoplastic Hematologic and Lymphocytic Disorder and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_Has_Abnormal_Cell only Atypical Histiocyte) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Associated_Anatomic_Site only Lymphatic System) and (Disease_Has_Finding only Cervical Lymphadenopathy) and (Disease_Has_Finding only Emperipolesis) and (Disease_Has_Finding only Fever) and (Disease_Has_Finding only Massive Sinusoidal Histiocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate) and (Disease_Has_Finding only Polyclonal Hypergammaglobulinemia) and (Disease_Has_Normal_Cell_Origin only Histiocyte) and (Disease_Has_Normal_Tissue_Origin only Hematopoietic Tissue) and (Disease_Has_Normal_Tissue_Origin only Lymphoid Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="638">
                  <Axiom>Small Cell Variant Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and ((Disease_May_Have_Abnormal_Cell some Flower-Like T-Lymphocyte) and (Disease_May_Have_Finding some Peripheral Blood Involvement)) and (Disease_May_Have_Abnormal_Cell some Doughnut Cell) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Abnormal_Cell only Hallmark Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Small to Medium-Sized T-Lymphocyte with Irregular Nucleus) and (Disease_Has_Normal_Cell_Origin only Activated Mature Cytotoxic T-Lymphocyte)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Small Cell Variant Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and (Disease_May_Have_Abnormal_Cell some Doughnut Cell) and (Disease_May_Have_Abnormal_Cell some Flower-Like T-Lymphocyte) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Peripheral Blood Involvement) and (Disease_Has_Abnormal_Cell only Hallmark Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Small to Medium-Sized T-Lymphocyte with Irregular Nucleus) and (Disease_Has_Normal_Cell_Origin only Activated Mature Cytotoxic T-Lymphocyte)</Axiom>
                  </Source>
               </Change>
               <Change id="639">
                  <Axiom>Small Intestinal Enteropathy-Type T-Cell Lymphoma EquivalentTo Enteropathy-type T-Cell Lymphoma and Small Intestinal Non-Hodgkin's Lymphoma and ((Disease_May_Have_Associated_Disease some Celiac Disease) and (Disease_May_Have_Associated_Disease some Malabsorption Syndrome) and (Disease_May_Have_Finding some Villous Atrophy)) and (Disease_May_Have_Finding some Abdominal Pain) and (Disease_May_Have_Finding some Intestinal Perforation) and (Disease_May_Have_Finding some Intestinal Ulcerated Mass) and (Disease_Has_Normal_Cell_Origin only Intraepithelial T-Lymphocyte of the Intestine) and (Disease_Has_Primary_Anatomic_Site only Small Intestine)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Small Intestinal Enteropathy-Type T-Cell Lymphoma EquivalentTo Enteropathy-type T-Cell Lymphoma and Small Intestinal Non-Hodgkin's Lymphoma and (Disease_May_Have_Associated_Disease some Celiac Disease) and (Disease_May_Have_Associated_Disease some Malabsorption Syndrome) and (Disease_May_Have_Finding some Abdominal Pain) and (Disease_May_Have_Finding some Intestinal Perforation) and (Disease_May_Have_Finding some Intestinal Ulcerated Mass) and (Disease_May_Have_Finding some Villous Atrophy) and (Disease_Has_Normal_Cell_Origin only Intraepithelial T-Lymphocyte of the Intestine) and (Disease_Has_Primary_Anatomic_Site only Small Intestine)</Axiom>
                  </Source>
               </Change>
               <Change id="640">
                  <Axiom>Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma EquivalentTo Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue and Small Intestinal Non-Hodgkin's Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(11;18)(q21;q21)) and (Disease_May_Have_Molecular_Abnormality some AP12-MLT Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;14)(p22;q32)) and (Disease_Has_Normal_Tissue_Origin only Gut-Associated Lymphoid Tissue) and (Disease_Has_Normal_Tissue_Origin only Small Intestinal Mucosa)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma EquivalentTo Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue and Small Intestinal Non-Hodgkin's Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some t(11;18)(q21;q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;14)(p22;q32)) and (Disease_May_Have_Molecular_Abnormality some AP12-MLT Fusion Protein Expression) and (Disease_Has_Normal_Tissue_Origin only Gut-Associated Lymphoid Tissue) and (Disease_Has_Normal_Tissue_Origin only Small Intestinal Mucosa)</Axiom>
                  </Source>
               </Change>
               <Change id="641">
                  <Axiom>Small Lymphocytic Lymphoma with Plasmacytoid Differentiation EquivalentTo Small Lymphocytic Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Has_Abnormal_Cell only Lymphoplasmacytoid Cell)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Small Lymphocytic Lymphoma with Plasmacytoid Differentiation EquivalentTo Small Lymphocytic Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Lymphoplasmacytoid Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="642">
                  <Axiom>Smoldering Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and Leukemic Phase of Lymphoma and ((Disease_May_Have_Finding some Cutaneous Involvement) and (Disease_May_Have_Finding some Skin Rash)) and (Disease_May_Have_Abnormal_Cell some Neoplastic Small T-Lymphocyte) and (Disease_Has_Finding only Peripheral Blood Involvement)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Smoldering Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and Leukemic Phase of Lymphoma and (Disease_May_Have_Abnormal_Cell some Neoplastic Small T-Lymphocyte) and (Disease_May_Have_Finding some Cutaneous Involvement) and (Disease_May_Have_Finding some Skin Rash) and (Disease_Has_Finding only Peripheral Blood Involvement)</Axiom>
                  </Source>
               </Change>
               <Change id="643">
                  <Axiom>Smoldering Myeloma EquivalentTo Plasma Cell Myeloma and ((Disease_Excludes_Finding only Bone Pain) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Lytic Metastatic Bone Lesion) and (Disease_Excludes_Finding only Pathologic Fracture)) and (Disease_Has_Finding only Monoclonal Paraproteinemia) and (Disease_Has_Finding only Neoplastic Plasma Cells Between 10 and 30 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Stable Disease)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Smoldering Myeloma EquivalentTo Plasma Cell Myeloma and (Disease_Excludes_Finding only Bone Pain) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Lytic Metastatic Bone Lesion) and (Disease_Excludes_Finding only Pathologic Fracture) and (Disease_Has_Finding only Monoclonal Paraproteinemia) and (Disease_Has_Finding only Neoplastic Plasma Cells Between 10 and 30 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Stable Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="644">
                  <Axiom>Splenic Manifestation of Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and Splenic Manifestation of Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Splenic Manifestation of Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and Splenic Manifestation of Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)</Axiom>
                  </Source>
               </Change>
               <Change id="645">
                  <Axiom>Splenic Manifestation of Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and Splenic Manifestation of Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Splenic Manifestation of Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and Splenic Manifestation of Leukemia and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                  </Source>
               </Change>
               <Change id="646">
                  <Axiom>Splenic Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Associated_Anatomic_Site only Spleen)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Splenic Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Has_Associated_Anatomic_Site only Spleen)</Axiom>
                  </Source>
               </Change>
               <Change id="647">
                  <Axiom>Sporadic Papillary Renal Cell Carcinoma EquivalentTo Papillary Renal Cell Carcinoma and ((Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 16) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 20) and (Disease_May_Have_Finding some Progressive Disease)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Tetrasomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 17) and (Disease_Has_Finding only Non-Hereditary Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Sporadic Papillary Renal Cell Carcinoma EquivalentTo Papillary Renal Cell Carcinoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Tetrasomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 16) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 17) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 20) and (Disease_May_Have_Finding some Progressive Disease) and (Disease_Has_Finding only Non-Hereditary Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="648">
                  <Axiom>Stage 0 Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage 0)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage 0 Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage 0)</Axiom>
                  </Source>
               </Change>
               <Change id="656">
                  <Axiom>Stage I Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage I)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage I Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage I)</Axiom>
                  </Source>
               </Change>
               <Change id="657">
                  <Axiom>Stage I Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and Stage I B-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage I)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage I Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and Stage I B-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage I)</Axiom>
                  </Source>
               </Change>
               <Change id="651">
                  <Axiom>Stage II Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage II)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage II Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage II)</Axiom>
                  </Source>
               </Change>
               <Change id="652">
                  <Axiom>Stage II Multiple Myeloma EquivalentTo Plasma Cell Myeloma and ((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage II)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage II Multiple Myeloma EquivalentTo Plasma Cell Myeloma and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage II)</Axiom>
                  </Source>
               </Change>
               <Change id="653">
                  <Axiom>Stage II Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and Stage II B-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage II)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage II Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and Stage II B-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage II)</Axiom>
                  </Source>
               </Change>
               <Change id="649">
                  <Axiom>Stage III Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage III)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage III Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage III)</Axiom>
                  </Source>
               </Change>
               <Change id="650">
                  <Axiom>Stage III Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and Stage III B-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage III)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage III Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and Stage III B-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage III)</Axiom>
                  </Source>
               </Change>
               <Change id="654">
                  <Axiom>Stage IV Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage IV)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage IV Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage IV)</Axiom>
                  </Source>
               </Change>
               <Change id="655">
                  <Axiom>Stage IV Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and Stage IV B-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage IV)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage IV Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and Stage IV B-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage IV)</Axiom>
                  </Source>
               </Change>
               <Change id="658">
                  <Axiom>Subcutaneous Panniculitis-Like T-Cell Lymphoma EquivalentTo Cutaneous T-Cell Non-Hodgkin's Lymphoma and Indolent Non-Hodgkin's Lymphoma and ((Disease_Excludes_Finding only Dermal Involvement) and (Disease_Excludes_Finding only Epidermotropic Lymphocytic Infiltrate) and (Disease_Has_Finding only Rimming of Adipose Tissue Cells Present) and (Disease_Has_Finding only Subcutaneous Involvement) and (Disease_Has_Finding only Subcutaneous Nodule)) and (Disease_May_Have_Abnormal_Cell some Neoplastic Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Neoplastic Small T-Lymphocyte) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Karyorrhexis) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_May_Have_Finding some Weight Loss) and (Disease_Excludes_Finding only CD4-Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only CD56-Positive Neoplastic Cells Present) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only CD8-Positive Neoplastic Cells Present) and (Disease_Has_Molecular_Abnormality only Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_Has_Molecular_Abnormality only Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Cytotoxic T-Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Subcutis)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Subcutaneous Panniculitis-Like T-Cell Lymphoma EquivalentTo Cutaneous T-Cell Non-Hodgkin's Lymphoma and Indolent Non-Hodgkin's Lymphoma and (Disease_May_Have_Abnormal_Cell some Neoplastic Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Neoplastic Small T-Lymphocyte) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Karyorrhexis) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_May_Have_Finding some Weight Loss) and (Disease_Excludes_Finding only CD4-Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only CD56-Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Dermal Involvement) and (Disease_Excludes_Finding only Epidermotropic Lymphocytic Infiltrate) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only CD8-Positive Neoplastic Cells Present) and (Disease_Has_Finding only Rimming of Adipose Tissue Cells Present) and (Disease_Has_Finding only Subcutaneous Involvement) and (Disease_Has_Finding only Subcutaneous Nodule) and (Disease_Has_Molecular_Abnormality only Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_Has_Molecular_Abnormality only Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Cytotoxic T-Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Subcutis)</Axiom>
                  </Source>
               </Change>
               <Change id="659">
                  <Axiom>Synovial Sarcoma EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Sarcoma NCI Grade 3 and Soft Tissue Sarcoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(X;18)(p11;q11)) and (Disease_May_Have_Molecular_Abnormality some SS18-SSX1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some SS18-SSX2 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some SS18-SSX4 Fusion Protein Expression))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Synovial Sarcoma EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Sarcoma NCI Grade 3 and Soft Tissue Sarcoma and (Disease_May_Have_Cytogenetic_Abnormality some t(X;18)(p11;q11)) and (Disease_May_Have_Molecular_Abnormality some SS18-SSX1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some SS18-SSX2 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some SS18-SSX4 Fusion Protein Expression)</Axiom>
                  </Source>
               </Change>
               <Change id="660">
                  <Axiom>Systemic Mastocytosis EquivalentTo Mast Cell Neoplasm and ((Disease_May_Have_Molecular_Abnormality some C-KIT Somatic Point Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression)) and (Disease_May_Have_Finding some Serum Total Tryptase Levels Increased)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Systemic Mastocytosis EquivalentTo Mast Cell Neoplasm and (Disease_May_Have_Finding some Serum Total Tryptase Levels Increased) and (Disease_May_Have_Molecular_Abnormality some C-KIT Somatic Point Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression)</Axiom>
                  </Source>
               </Change>
               <Change id="662">
                  <Axiom>Unspecified Peripheral T-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Associated_Disease some Hemophagocytic Syndrome) and (Disease_May_Have_Finding some Hemophagocytosis)) and (Disease_May_Have_Abnormal_Cell some Neoplastic T-Lymphocyte with Clear Cytoplasm) and (Disease_May_Have_Abnormal_Cell some Reed-Sternberg-Like Cell) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Polymorphic Cellular Infiltrate) and (Disease_May_Have_Finding some Pruritus) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Peripheral (Post-Thymic) T-Lymphocyte)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Unspecified Peripheral T-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Abnormal_Cell some Neoplastic T-Lymphocyte with Clear Cytoplasm) and (Disease_May_Have_Abnormal_Cell some Reed-Sternberg-Like Cell) and (Disease_May_Have_Associated_Disease some Hemophagocytic Syndrome) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Hemophagocytosis) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Polymorphic Cellular Infiltrate) and (Disease_May_Have_Finding some Pruritus) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Peripheral (Post-Thymic) T-Lymphocyte)</Axiom>
                  </Source>
               </Change>
               <Change id="663">
                  <Axiom>Uterine Corpus Endometrial Stromal Neoplasm EquivalentTo Endometrial Stromal Neoplasm and Uterine Corpus Soft Tissue Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some t(7;17)(p15;q21)) and (Disease_May_Have_Molecular_Abnormality some JAZF1-JJAZ1 Fusion Protein Expression)) and (Disease_Has_Normal_Cell_Origin only Endometrial Stromal Cell)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Uterine Corpus Endometrial Stromal Neoplasm EquivalentTo Endometrial Stromal Neoplasm and Uterine Corpus Soft Tissue Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some t(7;17)(p15;q21)) and (Disease_May_Have_Molecular_Abnormality some JAZF1-JJAZ1 Fusion Protein Expression) and (Disease_Has_Normal_Cell_Origin only Endometrial Stromal Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="664">
                  <Axiom>Uveal Melanoma EquivalentTo Malignant Uveal Neoplasm and Ocular Melanoma and ((Disease_May_Have_Cytogenetic_Abnormality some Monosomy 3) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) and (Disease_Has_Primary_Anatomic_Site only Uvea)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Uveal Melanoma EquivalentTo Malignant Uveal Neoplasm and Ocular Melanoma and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 3) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Primary_Anatomic_Site only Uvea)</Axiom>
                  </Source>
               </Change>
            </AddedCompleteRewrite>
            <AddedPartialRewrite id="aprw" size="0"/>
         </AddedRewrite>
         <AddedProspectiveRedundancy id="apred" size="49">
            <AddedReshuffleProspectiveRedundancy id="aavred" size="19">
               <Change id="665">
                  <Axiom>Benign Metastasizing Leiomyoma of the Uterine Corpus EquivalentTo Metastatic Benign Neoplasm and Uterine Corpus Leiomyoma</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Metastatic Neoplasm SubClassOf Disease_Has_Finding only Metastatic Lesion</Axiom>
                     <Axiom ineffectual="true">Benign Metastasizing Leiomyoma of the Uterine Corpus EquivalentTo Metastatic Benign Neoplasm and Uterine Corpus Leiomyoma and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                     <Axiom shared="true">Metastatic Benign Neoplasm EquivalentTo Benign Neoplasm and Metastatic Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="667">
                  <Axiom>External Auditory Canal Ceruminous Adenoma EquivalentTo Apocrine Adenoma and Benign External Ear Neoplasm and Ceruminous Neoplasm</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Benign Skin Appendage Neoplasm SubClassOf Benign Skin Neoplasm</Axiom>
                     <Axiom ineffectual="true">Benign Apocrine Neoplasm SubClassOf Benign Sweat Gland Neoplasm</Axiom>
                     <Axiom ineffectual="true">Benign Skin Neoplasm SubClassOf Disease_Excludes_Finding only Invasive Lesion</Axiom>
                     <Axiom ineffectual="true">Apocrine Adenoma SubClassOf Benign Apocrine Neoplasm</Axiom>
                     <Axiom ineffectual="true">Benign Sweat Gland Neoplasm SubClassOf Benign Skin Appendage Neoplasm</Axiom>
                     <Axiom ineffectual="true">External Auditory Canal Ceruminous Adenoma EquivalentTo Apocrine Adenoma and Benign External Ear Neoplasm and Ceruminous Neoplasm and (Disease_Excludes_Finding only Invasive Lesion)</Axiom>
                  </Source>
                  <Source>
                     <Axiom ineffectual="true">Benign Skin Appendage Neoplasm SubClassOf Benign Skin Neoplasm</Axiom>
                     <Axiom ineffectual="true">Benign Skin Neoplasm SubClassOf Disease_Excludes_Finding only Invasive Lesion</Axiom>
                     <Axiom ineffectual="true">Apocrine Adenoma SubClassOf Sweat Gland Adenoma</Axiom>
                     <Axiom ineffectual="true">External Auditory Canal Ceruminous Adenoma EquivalentTo Apocrine Adenoma and Benign External Ear Neoplasm and Ceruminous Neoplasm and (Disease_Excludes_Finding only Invasive Lesion)</Axiom>
                     <Axiom ineffectual="true">Sweat Gland Adenoma SubClassOf Skin Appendage Adenoma</Axiom>
                     <Axiom ineffectual="true">Skin Appendage Adenoma SubClassOf Benign Skin Appendage Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="666">
                  <Axiom>Lung Papillary Adenoma EquivalentTo Lung Adenoma and Papillary Epithelial Neoplasm</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lung Papillary Adenoma EquivalentTo Lung Adenoma and Papillary Epithelial Neoplasm and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                     <Axiom ineffectual="true">Papillary Neoplasm SubClassOf Disease_Has_Finding only Papillary Pattern</Axiom>
                     <Axiom ineffectual="true">Papillary Epithelial Neoplasm SubClassOf Papillary Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="668">
                  <Axiom>Metastatic Carcinoma to the Bone EquivalentTo Metastatic Carcinoma and Metastatic Malignant Neoplasm to the Bone</Axiom>
                  <Source>
                     <Axiom shared="true">Metastatic Malignant Neoplasm to the Bone EquivalentTo Malignant Bone Neoplasm and Metastatic Malignant Neoplasm and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_Has_Metastatic_Anatomic_Site only Bone)</Axiom>
                     <Axiom ineffectual="true">Metastatic Carcinoma to the Bone EquivalentTo Metastatic Carcinoma and Metastatic Malignant Neoplasm to the Bone and (Disease_Has_Metastatic_Anatomic_Site only Bone)</Axiom>
                  </Source>
               </Change>
               <Change id="669">
                  <Axiom>Metastatic Malignant Neoplasm EquivalentTo Malignant Neoplasm and Metastatic Neoplasm</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Metastatic Neoplasm SubClassOf Disease_Has_Finding only Metastatic Lesion</Axiom>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm EquivalentTo Malignant Neoplasm and Metastatic Neoplasm and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="671">
                  <Axiom>Metastatic Malignant Neoplasm to the Colon EquivalentTo Malignant Colon Neoplasm and Metastatic Malignant Neoplasm to the Large Intestine and (Disease_Has_Metastatic_Anatomic_Site only Colon)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm to the Colon EquivalentTo Malignant Colon Neoplasm and Metastatic Malignant Neoplasm to the Large Intestine and (Disease_Has_Finding only Metastatic Lesion) and (Disease_Has_Metastatic_Anatomic_Site only Colon)</Axiom>
                     <Axiom shared="true">Metastatic Malignant Neoplasm to the Large Intestine EquivalentTo Malignant Colorectal Neoplasm and Metastatic Malignant Neoplasm and (Disease_Has_Metastatic_Anatomic_Site only Large Intestine)</Axiom>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm EquivalentTo Malignant Neoplasm and Metastatic Neoplasm and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="670">
                  <Axiom>Metastatic Malignant Neoplasm to the Ovary EquivalentTo Malignant Ovarian Neoplasm and Metastatic Malignant Neoplasm and (Disease_Has_Metastatic_Anatomic_Site only Ovary)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm to the Ovary EquivalentTo Malignant Ovarian Neoplasm and Metastatic Malignant Neoplasm and (Disease_Has_Finding only Metastatic Lesion) and (Disease_Has_Metastatic_Anatomic_Site only Ovary)</Axiom>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm EquivalentTo Malignant Neoplasm and Metastatic Neoplasm and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="672">
                  <Axiom>Non-Metastatic Extraskeletal Osteosarcoma EquivalentTo Extraskeletal Osteosarcoma and Non-Metastatic Neoplasm</Axiom>
                  <Source>
                     <Axiom shared="true">Non-Metastatic Neoplasm SubClassOf Disease_Excludes_Finding only Metastatic Lesion</Axiom>
                     <Axiom ineffectual="true">Non-Metastatic Extraskeletal Osteosarcoma EquivalentTo Extraskeletal Osteosarcoma and Non-Metastatic Neoplasm and (Disease_Excludes_Finding only Metastatic Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="673">
                  <Axiom>Papilloma EquivalentTo Benign Epithelial Neoplasm and Papillary Epithelial Neoplasm and (Disease_Excludes_Finding only Diffuse Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Papilloma EquivalentTo Benign Epithelial Neoplasm and Papillary Epithelial Neoplasm and (Disease_Excludes_Finding only Diffuse Lesion) and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                     <Axiom ineffectual="true">Papillary Neoplasm SubClassOf Disease_Has_Finding only Papillary Pattern</Axiom>
                     <Axiom ineffectual="true">Papillary Epithelial Neoplasm SubClassOf Papillary Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="674">
                  <Axiom>Radiation-Related Neoplasm EquivalentTo Neoplasm by Cause and Radiation-Related Disorder</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Radiation-Related Neoplasm EquivalentTo Neoplasm by Cause and Radiation-Related Disorder and (Disease_Has_Abnormal_Cell only Neoplastic Cell)</Axiom>
                     <Axiom shared="true">Neoplasm by Cause SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom shared="true">Neoplasm by Special Category SubClassOf Neoplasm</Axiom>
                     <Axiom shared="true">Neoplasm SubClassOf Disease_Has_Abnormal_Cell only Neoplastic Cell</Axiom>
                  </Source>
               </Change>
               <Change id="675">
                  <Axiom>Recurrent Adult Burkitt's Lymphoma EquivalentTo Adult Burkitt's Lymphoma and Recurrent Aggressive Adult Non-Hodgkin's Lymphoma and Recurrent Burkitt's Lymphoma</Axiom>
                  <Source>
                     <Axiom shared="true">Recurrent Adult Non-Hodgkin's Lymphoma EquivalentTo Adult Non-Hodgkin's Lymphoma and Recurrent Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom ineffectual="true">Recurrent Adult Burkitt's Lymphoma EquivalentTo Adult Burkitt's Lymphoma and Recurrent Aggressive Adult Non-Hodgkin's Lymphoma and Recurrent Burkitt's Lymphoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom shared="true">Recurrent Aggressive Adult Non-Hodgkin's Lymphoma EquivalentTo Aggressive Adult Non-Hodgkin's Lymphoma and Recurrent Adult Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom ineffectual="true">Recurrent Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Recurrent Hematologic Malignancy and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
                  <Source>
                     <Axiom ineffectual="true">Recurrent Adult Burkitt's Lymphoma EquivalentTo Adult Burkitt's Lymphoma and Recurrent Aggressive Adult Non-Hodgkin's Lymphoma and Recurrent Burkitt's Lymphoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom shared="true">Recurrent Burkitt's Lymphoma EquivalentTo Burkitt's Lymphoma and Recurrent B-Cell Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom ineffectual="true">Recurrent B-Cell Non-Hodgkin's Lymphoma EquivalentTo B-Cell Non-Hodgkin's Lymphoma and Recurrent Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="676">
                  <Axiom>Recurrent Adult Immunoblastic Lymphoma EquivalentTo Adult Immunoblastic Lymphoma and Recurrent Adult Non-Hodgkin's Lymphoma and Recurrent Diffuse Large B-Cell Lymphoma</Axiom>
                  <Source>
                     <Axiom shared="true">Recurrent Adult Non-Hodgkin's Lymphoma EquivalentTo Adult Non-Hodgkin's Lymphoma and Recurrent Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom ineffectual="true">Recurrent Adult Immunoblastic Lymphoma EquivalentTo Adult Immunoblastic Lymphoma and Recurrent Adult Non-Hodgkin's Lymphoma and Recurrent Diffuse Large B-Cell Lymphoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Recurrent Hematologic Malignancy and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Recurrent Diffuse Large B-Cell Lymphoma EquivalentTo Diffuse Large B-Cell Lymphoma and Recurrent B-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Finding some Lymphadenopathy)</Axiom>
                     <Axiom ineffectual="true">Recurrent Adult Immunoblastic Lymphoma EquivalentTo Adult Immunoblastic Lymphoma and Recurrent Adult Non-Hodgkin's Lymphoma and Recurrent Diffuse Large B-Cell Lymphoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent B-Cell Non-Hodgkin's Lymphoma EquivalentTo B-Cell Non-Hodgkin's Lymphoma and Recurrent Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="677">
                  <Axiom>Recurrent Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and Recurrent Aggressive Adult Non-Hodgkin's Lymphoma and Recurrent Mature T- and NK-Cell Non-Hodgkin's Lymphoma</Axiom>
                  <Source>
                     <Axiom shared="true">Recurrent T-Cell Non-Hodgkin's Lymphoma EquivalentTo Recurrent Non-Hodgkin's Lymphoma and T-Cell Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom shared="true">Recurrent Mature T- and NK-Cell Non-Hodgkin's Lymphoma EquivalentTo Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma and Recurrent T-Cell Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom ineffectual="true">Recurrent Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and Recurrent Aggressive Adult Non-Hodgkin's Lymphoma and Recurrent Mature T- and NK-Cell Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Recurrent Hematologic Malignancy and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Recurrent Adult Non-Hodgkin's Lymphoma EquivalentTo Adult Non-Hodgkin's Lymphoma and Recurrent Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom ineffectual="true">Recurrent Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and Recurrent Aggressive Adult Non-Hodgkin's Lymphoma and Recurrent Mature T- and NK-Cell Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Recurrent Hematologic Malignancy and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom shared="true">Recurrent Aggressive Adult Non-Hodgkin's Lymphoma EquivalentTo Aggressive Adult Non-Hodgkin's Lymphoma and Recurrent Adult Non-Hodgkin's Lymphoma</Axiom>
                  </Source>
               </Change>
               <Change id="678">
                  <Axiom>Recurrent B-Cell Non-Hodgkin's Lymphoma EquivalentTo B-Cell Non-Hodgkin's Lymphoma and Recurrent Non-Hodgkin's Lymphoma</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Recurrent B-Cell Non-Hodgkin's Lymphoma EquivalentTo B-Cell Non-Hodgkin's Lymphoma and Recurrent Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Recurrent Hematologic Malignancy and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="679">
                  <Axiom>Recurrent Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia EquivalentTo Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia and Recurrent B-Cell Non-Hodgkin's Lymphoma</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Recurrent Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia EquivalentTo Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia and Recurrent B-Cell Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent B-Cell Non-Hodgkin's Lymphoma EquivalentTo B-Cell Non-Hodgkin's Lymphoma and Recurrent Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="680">
                  <Axiom>Refractory Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and Refractory Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Refractory T-Cell Non-Hodgkin's Lymphoma EquivalentTo Refractory Non-Hodgkin's Lymphoma and T-Cell Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom ineffectual="true">Refractory Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and Refractory Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom shared="true">Refractory Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma EquivalentTo Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma and Refractory T-Cell Non-Hodgkin's Lymphoma</Axiom>
                  </Source>
               </Change>
               <Change id="681">
                  <Axiom>Refractory Angioimmunoblastic T-cell Lymphoma EquivalentTo Angioimmunoblastic T-Cell Lymphoma and Refractory Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Refractory T-Cell Non-Hodgkin's Lymphoma EquivalentTo Refractory Non-Hodgkin's Lymphoma and T-Cell Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom ineffectual="true">Refractory Angioimmunoblastic T-cell Lymphoma EquivalentTo Angioimmunoblastic T-Cell Lymphoma and Refractory Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom shared="true">Refractory Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma EquivalentTo Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma and Refractory T-Cell Non-Hodgkin's Lymphoma</Axiom>
                  </Source>
               </Change>
               <Change id="682">
                  <Axiom>Refractory B-Cell Non-Hodgkin's Lymphoma EquivalentTo B-Cell Non-Hodgkin's Lymphoma and Refractory Non-Hodgkin's Lymphoma</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Refractory B-Cell Non-Hodgkin's Lymphoma EquivalentTo B-Cell Non-Hodgkin's Lymphoma and Refractory Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom ineffectual="true">Refractory Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Refractory Hematologic Malignancy and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="683">
                  <Axiom>Refractory T-Cell Non-Hodgkin's Lymphoma EquivalentTo Refractory Non-Hodgkin's Lymphoma and T-Cell Non-Hodgkin's Lymphoma</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Refractory T-Cell Non-Hodgkin's Lymphoma EquivalentTo Refractory Non-Hodgkin's Lymphoma and T-Cell Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom ineffectual="true">Refractory Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Refractory Hematologic Malignancy and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  </Source>
               </Change>
            </AddedReshuffleProspectiveRedundancy>
            <AddedNewProspectiveRedundancy id="anpred" size="30">
               <Change id="684">
                  <Axiom>Bilateral Breast Carcinoma EquivalentTo Bilateral Carcinoma and Breast Carcinoma and (Disease_Has_Finding only Bilateral Mass)</Axiom>
                  <Source>
                     <Axiom effectual="true">Bilateral Carcinoma EquivalentTo Carcinoma and (Disease_Has_Finding only Bilateral Mass)</Axiom>
                     <Axiom effectual="true">Bilateral Breast Carcinoma EquivalentTo Bilateral Carcinoma and Breast Carcinoma</Axiom>
                  </Source>
               </Change>
               <Change id="685">
                  <Axiom>DLC1 Gene SubClassOf Gene_Plays_Role_In_Process some Cell Growth Regulation</Axiom>
                  <Source>
                     <Axiom effectual="true">DLC1 Gene SubClassOf Gene_Plays_Role_In_Process some Regulation of Cell Shape</Axiom>
                     <Axiom shared="true">Regulation of Cell Shape SubClassOf Cell Growth Regulation</Axiom>
                  </Source>
               </Change>
               <Change id="686">
                  <Axiom>ECO-4601 SubClassOf Enzyme Inhibitor</Axiom>
                  <Source>
                     <Axiom shared="true">Protein Kinase Inhibitor SubClassOf Enzyme Inhibitor</Axiom>
                     <Axiom shared="true">Mitogen-Activated Protein Kinase Inhibitor SubClassOf Protein Kinase Inhibitor</Axiom>
                     <Axiom effectual="true">ECO-4601 SubClassOf Mitogen-Activated Protein Kinase Inhibitor</Axiom>
                  </Source>
               </Change>
               <Change id="687">
                  <Axiom>Lactic Acid, L- SubClassOf Industrial Product</Axiom>
                  <Source>
                     <Axiom effectual="true">Lactic Acid, L- SubClassOf Pharmaceutical Excipient</Axiom>
                     <Axiom shared="true">Industrial Aid SubClassOf Industrial Product</Axiom>
                     <Axiom shared="true">Pharmaceutical Excipient SubClassOf Industrial Aid</Axiom>
                  </Source>
               </Change>
               <Change id="688">
                  <Axiom>MS-275 SubClassOf (((Chemical_Or_Drug_Affects_Gene_Product some Histone Deacetylase) and (Chemical_Or_Drug_Has_Mechanism_Of_Action some Enzyme Inhibition) and (Chemical_Or_Drug_Has_Physiologic_Effect some Cell Cycle Inhibition) and (Chemical_Or_Drug_Has_Physiologic_Effect some Cell Differentiation Induction) and (Chemical_Or_Drug_Has_Physiologic_Effect some Chromatin Structure Alteration) and (Chemical_Or_Drug_Has_Physiologic_Effect some Gene Expression Alteration)) or ((Chemical_Or_Drug_Has_Mechanism_Of_Action some Free Radical Formation) and (Chemical_Or_Drug_Has_Physiologic_Effect some Apoptosis) and (Chemical_Or_Drug_Has_Physiologic_Effect some Mitochondrial Damage)))</Axiom>
                  <Source>
                     <Axiom effectual="true">MS-275 SubClassOf Chemical_Or_Drug_Has_Mechanism_Of_Action some Enzyme Inhibition</Axiom>
                     <Axiom effectual="true">MS-275 SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Gene Expression Alteration</Axiom>
                     <Axiom effectual="true">MS-275 SubClassOf Chemical_Or_Drug_Affects_Gene_Product some Histone Deacetylase</Axiom>
                     <Axiom effectual="true">MS-275 SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Cell Differentiation Induction</Axiom>
                     <Axiom effectual="true">MS-275 SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Cell Cycle Inhibition</Axiom>
                     <Axiom effectual="true">MS-275 SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Chromatin Structure Alteration</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">MS-275 SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Mitochondrial Damage</Axiom>
                     <Axiom effectual="true">MS-275 SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Apoptosis</Axiom>
                     <Axiom effectual="true">MS-275 SubClassOf Chemical_Or_Drug_Has_Mechanism_Of_Action some Free Radical Formation</Axiom>
                  </Source>
               </Change>
               <Change id="689">
                  <Axiom>Magnesium Stearate SubClassOf Industrial Product</Axiom>
                  <Source>
                     <Axiom effectual="true">Magnesium Stearate SubClassOf Lubricant Excipient</Axiom>
                     <Axiom shared="true">Industrial Aid SubClassOf Industrial Product</Axiom>
                     <Axiom shared="true">Pharmaceutical Excipient SubClassOf Industrial Aid</Axiom>
                     <Axiom shared="true">Lubricant Excipient SubClassOf Pharmaceutical Excipient</Axiom>
                  </Source>
               </Change>
               <Change id="690">
                  <Axiom>Metachronous Wilms Tumor SubClassOf Disease_May_Have_Molecular_Abnormality some WT1 Gene Inactivation</Axiom>
                  <Source>
                     <Axiom effectual="true">Metachronous Wilms Tumor EquivalentTo Metachronous Malignant Neoplasm and Renal Wilms Tumor and (Disease_May_Have_Molecular_Abnormality some WT1 Gene Inactivation) and (Disease_Has_Finding only Bilateral Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="691">
                  <Axiom>Metachronous Wilms Tumor SubClassOf Metachronous Malignant Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Metachronous Wilms Tumor EquivalentTo Metachronous Malignant Neoplasm and Renal Wilms Tumor and (Disease_May_Have_Molecular_Abnormality some WT1 Gene Inactivation) and (Disease_Has_Finding only Bilateral Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="692">
                  <Axiom>Metachronous Wilms Tumor SubClassOf Renal Wilms Tumor</Axiom>
                  <Source>
                     <Axiom effectual="true">Metachronous Wilms Tumor EquivalentTo Metachronous Malignant Neoplasm and Renal Wilms Tumor and (Disease_May_Have_Molecular_Abnormality some WT1 Gene Inactivation) and (Disease_Has_Finding only Bilateral Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="693">
                  <Axiom>Metastatic Extraskeletal Osteosarcoma EquivalentTo Extraskeletal Osteosarcoma and Metastatic Osteosarcoma</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Metastatic Extraskeletal Osteosarcoma EquivalentTo Extraskeletal Osteosarcoma and Metastatic Osteosarcoma and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                     <Axiom effectual="true">Metastatic Osteosarcoma EquivalentTo Osteosarcoma and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="694">
                  <Axiom>Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone EquivalentTo Metastatic Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Peripheral Primitive Neuroectodermal Tumor of Bone</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone EquivalentTo Metastatic Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Peripheral Primitive Neuroectodermal Tumor of Bone and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                     <Axiom effectual="true">Metastatic Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="695">
                  <Axiom>Ovarian Papillary Cystadenoma EquivalentTo Ovarian Papillary Tumor and Ovarian Serous Cystadenoma and Papillary Serous Cystadenoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Cystadenoma EquivalentTo Cystic Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Glandular Cell) and (Disease_Has_Normal_Tissue_Origin only Glandular Epithelium)</Axiom>
                     <Axiom ineffectual="true">Ovarian Papillary Cystadenoma EquivalentTo Ovarian Papillary Tumor and Ovarian Serous Cystadenoma and Papillary Cystic Neoplasm and Papillary Serous Cystadenoma</Axiom>
                     <Axiom shared="true">Papillary Serous Cystadenoma EquivalentTo Papillary Cystadenoma and Serous Cystadenoma</Axiom>
                     <Axiom ineffectual="true">Papillary Cystadenoma EquivalentTo Cystadenoma and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                     <Axiom shared="true">Ovarian Papillary Tumor EquivalentTo Ovarian Surface Epithelial-Stromal Tumor and Papillary Epithelial Neoplasm</Axiom>
                     <Axiom shared="true">Papillary Cystic Neoplasm EquivalentTo Cystic Neoplasm and Papillary Epithelial Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Cystadenoma EquivalentTo Cystic Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Glandular Cell) and (Disease_Has_Normal_Tissue_Origin only Glandular Epithelium)</Axiom>
                     <Axiom ineffectual="true">Ovarian Papillary Cystadenoma EquivalentTo Ovarian Papillary Tumor and Ovarian Serous Cystadenoma and Papillary Cystic Neoplasm and Papillary Serous Cystadenoma</Axiom>
                     <Axiom shared="true">Ovarian Serous Cystadenoma EquivalentTo Benign Ovarian Serous Tumor and Ovarian Cystadenoma and Serous Cystadenoma</Axiom>
                     <Axiom shared="true">Serous Cystadenoma EquivalentTo Cystadenoma and Serous Neoplasm and (Disease_Has_Finding only Cysts Containing Proteinaceous Fluid Present)</Axiom>
                     <Axiom shared="true">Ovarian Papillary Tumor EquivalentTo Ovarian Surface Epithelial-Stromal Tumor and Papillary Epithelial Neoplasm</Axiom>
                     <Axiom shared="true">Papillary Cystic Neoplasm EquivalentTo Cystic Neoplasm and Papillary Epithelial Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Cystadenoma EquivalentTo Cystic Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Glandular Cell) and (Disease_Has_Normal_Tissue_Origin only Glandular Epithelium)</Axiom>
                     <Axiom ineffectual="true">Ovarian Papillary Cystadenoma EquivalentTo Ovarian Papillary Tumor and Ovarian Serous Cystadenoma and Papillary Cystic Neoplasm and Papillary Serous Cystadenoma</Axiom>
                     <Axiom shared="true">Ovarian Serous Cystadenoma EquivalentTo Benign Ovarian Serous Tumor and Ovarian Cystadenoma and Serous Cystadenoma</Axiom>
                     <Axiom shared="true">Ovarian Papillary Tumor EquivalentTo Ovarian Surface Epithelial-Stromal Tumor and Papillary Epithelial Neoplasm</Axiom>
                     <Axiom shared="true">Ovarian Cystadenoma EquivalentTo Benign Ovarian Surface Epithelial-Stromal Tumor and Cystadenoma</Axiom>
                     <Axiom shared="true">Papillary Cystic Neoplasm EquivalentTo Cystic Neoplasm and Papillary Epithelial Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Cystadenoma EquivalentTo Cystic Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Glandular Cell) and (Disease_Has_Normal_Tissue_Origin only Glandular Epithelium)</Axiom>
                     <Axiom ineffectual="true">Ovarian Papillary Cystadenoma EquivalentTo Ovarian Papillary Tumor and Ovarian Serous Cystadenoma and Papillary Cystic Neoplasm and Papillary Serous Cystadenoma</Axiom>
                     <Axiom shared="true">Papillary Serous Cystadenoma EquivalentTo Papillary Cystadenoma and Serous Cystadenoma</Axiom>
                     <Axiom shared="true">Serous Cystadenoma EquivalentTo Cystadenoma and Serous Neoplasm and (Disease_Has_Finding only Cysts Containing Proteinaceous Fluid Present)</Axiom>
                     <Axiom shared="true">Ovarian Papillary Tumor EquivalentTo Ovarian Surface Epithelial-Stromal Tumor and Papillary Epithelial Neoplasm</Axiom>
                     <Axiom shared="true">Papillary Cystic Neoplasm EquivalentTo Cystic Neoplasm and Papillary Epithelial Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="696">
                  <Axiom>Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia SubClassOf (((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(p24;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-JAK2 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(q34;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-ABL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(p24;q11)) and (Disease_May_Have_Molecular_Abnormality some BCR-JAK2 Fusion Protein Expression)))</Axiom>
                  <Source>
                     <Axiom effectual="true">Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia SubClassOf Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(p24;p13)</Axiom>
                     <Axiom effectual="true">Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia SubClassOf Disease_May_Have_Molecular_Abnormality some TEL-JAK2 Fusion Protein Expression</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia SubClassOf Disease_May_Have_Molecular_Abnormality some BCR-JAK2 Fusion Protein Expression</Axiom>
                     <Axiom effectual="true">Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia SubClassOf Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(p24;q11)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia SubClassOf Disease_May_Have_Molecular_Abnormality some TEL-ABL Fusion Protein Expression</Axiom>
                     <Axiom effectual="true">Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia SubClassOf Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(q34;p13)</Axiom>
                  </Source>
               </Change>
               <Change id="697">
                  <Axiom>Promethazine Hydrochloride SubClassOf Phenothiazine</Axiom>
                  <Source>
                     <Axiom shared="true">Promethazine SubClassOf Phenothiazine</Axiom>
                     <Axiom effectual="true">Promethazine Hydrochloride SubClassOf Promethazine</Axiom>
                  </Source>
               </Change>
               <Change id="698">
                  <Axiom>Recurrent Adult Acute Myeloid Leukemia EquivalentTo Adult Acute Myeloid Leukemia and Recurrent Hematologic Malignancy</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Recurrent Adult Acute Myeloid Leukemia EquivalentTo Adult Acute Myeloid Leukemia and Recurrent Hematologic Malignancy and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="699">
                  <Axiom>Recurrent Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and Recurrent Hematologic Malignancy and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Recurrent Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and Recurrent Hematologic Malignancy and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="713">
                  <Axiom>Recurrent Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and Recurrent Hematologic Malignancy and ((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and Recurrent Hematologic Malignancy and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Recurrent Disease) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
                  </Source>
               </Change>
               <Change id="700">
                  <Axiom>Recurrent Extraskeletal Osteosarcoma EquivalentTo Extraskeletal Osteosarcoma and Recurrent Osteosarcoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Osteosarcoma EquivalentTo Osteosarcoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Extraskeletal Osteosarcoma EquivalentTo Extraskeletal Osteosarcoma and Recurrent Osteosarcoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="701">
                  <Axiom>Recurrent Hodgkin's Lymphoma EquivalentTo Hodgkin's Lymphoma and Recurrent Hematologic Malignancy</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Recurrent Hodgkin's Lymphoma EquivalentTo Hodgkin's Lymphoma and Recurrent Hematologic Malignancy and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="702">
                  <Axiom>Recurrent Lymphomatoid Granulomatosis EquivalentTo Lymphomatoid Granulomatosis and Recurrent Hematologic Malignancy and (Disease_Has_Finding only Angiocentric Pattern) and (Disease_Has_Finding only Angiodestructive Pattern)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Recurrent Lymphomatoid Granulomatosis EquivalentTo Lymphomatoid Granulomatosis and Recurrent Hematologic Malignancy and (Disease_Has_Finding only Angiocentric Pattern) and (Disease_Has_Finding only Angiodestructive Pattern) and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="703">
                  <Axiom>Recurrent Neuroblastoma EquivalentTo Neuroblastoma and Recurrent Primitive Neuroectodermal Tumor and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 17q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 11q ATM Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some NMYC Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some MYC Gene Amplification)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Primitive Neuroectodermal Tumor EquivalentTo Primitive Neuroectodermal Tumor and (Disease_Has_Abnormal_Cell only Malignant Neuroectodermal Cell) and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Neuroblastoma EquivalentTo Neuroblastoma and Recurrent Primitive Neuroectodermal Tumor and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 17q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 11q ATM Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some NMYC Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some MYC Gene Amplification) and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="704">
                  <Axiom>Recurrent Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Recurrent Hematologic Malignancy</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Recurrent Hematologic Malignancy and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="705">
                  <Axiom>Recurrent Precursor T-Lymphoblastic Lymphoma/Leukemia EquivalentTo Precursor T-Lymphoblastic Lymphoma/Leukemia and Recurrent Hematologic Malignancy</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Recurrent Precursor T-Lymphoblastic Lymphoma/Leukemia EquivalentTo Precursor T-Lymphoblastic Lymphoma/Leukemia and Recurrent Hematologic Malignancy and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="706">
                  <Axiom>Refractory Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and Refractory Hematologic Malignancy and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Refractory Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and Refractory Hematologic Malignancy and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom effectual="true">Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="707">
                  <Axiom>Refractory Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and Refractory Hematologic Malignancy and ((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Refractory Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and Refractory Hematologic Malignancy and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Refractory Disease) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
                     <Axiom effectual="true">Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="708">
                  <Axiom>Refractory Hodgkin's Disease Lymphocyte Predominance Type SubClassOf Lymphocyte Predominant Type Hodgkin's Disease</Axiom>
                  <Source>
                     <Axiom effectual="true">Refractory Hodgkin's Disease Lymphocyte Predominance Type EquivalentTo Lymphocyte Predominant Type Hodgkin's Disease and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="709">
                  <Axiom>Refractory Hodgkin's Lymphoma EquivalentTo Hodgkin's Lymphoma and Refractory Hematologic Malignancy</Axiom>
                  <Source>
                     <Axiom effectual="true">Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom ineffectual="true">Refractory Hodgkin's Lymphoma EquivalentTo Hodgkin's Lymphoma and Refractory Hematologic Malignancy and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="710">
                  <Axiom>Refractory Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Refractory Hematologic Malignancy</Axiom>
                  <Source>
                     <Axiom effectual="true">Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom ineffectual="true">Refractory Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Refractory Hematologic Malignancy and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="711">
                  <Axiom>Refractory Plasma Cell Neoplasm EquivalentTo Plasma Cell Neoplasm and Refractory Hematologic Malignancy</Axiom>
                  <Source>
                     <Axiom effectual="true">Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom ineffectual="true">Refractory Plasma Cell Neoplasm EquivalentTo Plasma Cell Neoplasm and Refractory Hematologic Malignancy and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="712">
                  <Axiom>Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia EquivalentTo Precursor T-Lymphoblastic Lymphoma/Leukemia and Refractory Hematologic Malignancy</Axiom>
                  <Source>
                     <Axiom effectual="true">Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom ineffectual="true">Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia EquivalentTo Precursor T-Lymphoblastic Lymphoma/Leukemia and Refractory Hematologic Malignancy and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  </Source>
               </Change>
            </AddedNewProspectiveRedundancy>
         </AddedProspectiveRedundancy>
      </Ineffectual>
   </Additions>
   <Removals id="rems" size="740">
      <Effectual id="effrems" size="281">
         <Weakening id="wk" size="2">
            <Change id="714">
               <Axiom>Metachronous Wilms Tumor EquivalentTo Metachronous Malignant Neoplasm and Renal Wilms Tumor and (Disease_May_Have_Molecular_Abnormality some WT1 Gene Inactivation) and (Disease_Has_Finding only Bilateral Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Metachronous Wilms Tumor SubClassOf Metachronous Malignant Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="715">
               <Axiom>Refractory Hodgkin's Disease Lymphocyte Predominance Type EquivalentTo Lymphocyte Predominant Type Hodgkin's Disease and (Disease_Has_Finding only Refractory Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Refractory Hodgkin's Disease Lymphocyte Predominance Type SubClassOf Lymphocyte Predominant Type Hodgkin's Disease</Axiom>
               </Source>
            </Change>
         </Weakening>
         <WeakeningWithRetiredTerms id="wkrt" size="0"/>
         <RetiredDescription id="retdesc" size="8">
            <Change id="716">
               <Axiom>Concept_Status SubClassOf Status</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Concept_Status</Concept>
                        <WitnessAxioms>
                           <Axiom>Concept_Status SubClassOf Status</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Status</Concept>
                        <WitnessAxioms>
                           <Axiom>Concept_Status SubClassOf Status</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Concept_Status</Concept>
                        <WitnessAxioms>
                           <Axiom>Concept_Status SubClassOf Property or Attribute</Axiom>
                           <Axiom>Concept_Status SubClassOf Properties_or_Attributes_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Property or Attribute</Concept>
                        <WitnessAxioms>
                           <Axiom>Concept_Status SubClassOf Property or Attribute</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Retired_Terms>Concept_Status</Retired_Terms>
            </Change>
            <Change id="717">
               <Axiom>Homologous_Gene SubClassOf Miscellaneous Molecular Biology Terms</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Homologous_Gene</Concept>
                        <WitnessAxioms>
                           <Axiom>Homologous_Gene SubClassOf Miscellaneous Molecular Biology Terms</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Miscellaneous Molecular Biology Terms</Concept>
                        <WitnessAxioms>
                           <Axiom>Homologous_Gene SubClassOf Miscellaneous Molecular Biology Terms</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Homologous_Gene</Concept>
                        <WitnessAxioms>
                           <Axiom>Homologous_Gene SubClassOf Cancer Science</Axiom>
                           <Axiom>Homologous_Gene SubClassOf NCI_Kind</Axiom>
                           <Axiom>Homologous_Gene SubClassOf NCI Administrative Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>NCI Administrative Concept</Concept>
                        <WitnessAxioms>
                           <Axiom>Homologous_Gene SubClassOf NCI Administrative Concept</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Retired_Terms>Homologous_Gene</Retired_Terms>
            </Change>
            <Change id="718">
               <Axiom>NSC_Code SubClassOf Code</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>NSC_Code</Concept>
                        <WitnessAxioms>
                           <Axiom>NSC_Code SubClassOf Code</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Code</Concept>
                        <WitnessAxioms>
                           <Axiom>NSC_Code SubClassOf Code</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>NSC_Code</Concept>
                        <WitnessAxioms>
                           <Axiom>NSC_Code SubClassOf Conceptual Entity</Axiom>
                           <Axiom>NSC_Code SubClassOf NCI_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>NCI_Kind</Concept>
                        <WitnessAxioms>
                           <Axiom>NSC_Code SubClassOf NCI_Kind</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Retired_Terms>NSC_Code</Retired_Terms>
            </Change>
            <Change id="719">
               <Axiom>Synonym SubClassOf Document</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Synonym</Concept>
                        <WitnessAxioms>
                           <Axiom>Synonym SubClassOf Document</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Document</Concept>
                        <WitnessAxioms>
                           <Axiom>Synonym SubClassOf Document</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Synonym</Concept>
                        <WitnessAxioms>
                           <Axiom>Synonym SubClassOf NCI_Kind</Axiom>
                           <Axiom>Synonym SubClassOf NCI Administrative Concept</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>NCI Administrative Concept</Concept>
                        <WitnessAxioms>
                           <Axiom>Synonym SubClassOf NCI Administrative Concept</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Retired_Terms>Synonym</Retired_Terms>
            </Change>
            <Change id="720">
               <Axiom>dConcept_Status Range: string</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Retired_Terms>dConcept_Status</Retired_Terms>
            </Change>
            <Change id="721">
               <Axiom>dHomologous_Gene Range: string</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Retired_Terms>dHomologous_Gene</Retired_Terms>
            </Change>
            <Change id="722">
               <Axiom>dNSC_Code Range: string</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Retired_Terms>dNSC_Code</Retired_Terms>
            </Change>
            <Change id="723">
               <Axiom>dSynonym Range: string</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Retired_Terms>dSynonym</Retired_Terms>
            </Change>
         </RetiredDescription>
         <PureRemoval id="prem" size="201">
            <Change id="921">
               <Axiom>18F-FHBG SubClassOf Reagent</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>18F-FHBG</Concept>
                        <WitnessAxioms>
                           <Axiom>18F-FHBG SubClassOf Reagent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Reagent</Concept>
                        <WitnessAxioms>
                           <Axiom>18F-FHBG SubClassOf Reagent</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="922">
               <Axiom>18F-Fluoroazomycin Arabinoside SubClassOf Diagnostic Reagent</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>18F-Fluoroazomycin Arabinoside</Concept>
                        <WitnessAxioms>
                           <Axiom>18F-Fluoroazomycin Arabinoside SubClassOf Diagnostic Reagent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Diagnostic Reagent</Concept>
                        <WitnessAxioms>
                           <Axiom>18F-Fluoroazomycin Arabinoside SubClassOf Diagnostic Reagent</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>18F-Fluoroazomycin Arabinoside</Concept>
                        <WitnessAxioms>
                           <Axiom>18F-Fluoroazomycin Arabinoside SubClassOf Reagent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Reagent</Concept>
                        <WitnessAxioms>
                           <Axiom>18F-Fluoroazomycin Arabinoside SubClassOf Reagent</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="923">
               <Axiom>2-Diethylaminoethanol SubClassOf Industrial Aid</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>2-Diethylaminoethanol</Concept>
                        <WitnessAxioms>
                           <Axiom>2-Diethylaminoethanol SubClassOf Industrial Aid</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Industrial Aid</Concept>
                        <WitnessAxioms>
                           <Axiom>2-Diethylaminoethanol SubClassOf Industrial Aid</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>2-Diethylaminoethanol</Concept>
                        <WitnessAxioms>
                           <Axiom>2-Diethylaminoethanol SubClassOf Industrial Product</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Industrial Product</Concept>
                        <WitnessAxioms>
                           <Axiom>2-Diethylaminoethanol SubClassOf Industrial Product</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="924">
               <Axiom>4-((5-((Cyclopropylamino)Carbonyl)-2-Methylphenyl)Amino)-5-Methyl-N-Propylpyrrolo(2,1-F)(1,2,4)Triazine-6-Carboxamide Hydrochloride SubClassOf Pharmaceutical Excipient</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>4-((5-((Cyclopropylamino)Carbonyl)-2-Methylphenyl)Amino)-5-Methyl-N-Propylpyrrolo(2,1-F)(1,2,4)Triazine-6-Carboxamide Hydrochloride</Concept>
                        <WitnessAxioms>
                           <Axiom>4-((5-((Cyclopropylamino)Carbonyl)-2-Methylphenyl)Amino)-5-Methyl-N-Propylpyrrolo(2,1-F)(1,2,4)Triazine-6-Carboxamide Hydrochloride SubClassOf Pharmaceutical Excipient</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Pharmaceutical Excipient</Concept>
                        <WitnessAxioms>
                           <Axiom>4-((5-((Cyclopropylamino)Carbonyl)-2-Methylphenyl)Amino)-5-Methyl-N-Propylpyrrolo(2,1-F)(1,2,4)Triazine-6-Carboxamide Hydrochloride SubClassOf Pharmaceutical Excipient</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>4-((5-((Cyclopropylamino)Carbonyl)-2-Methylphenyl)Amino)-5-Methyl-N-Propylpyrrolo(2,1-F)(1,2,4)Triazine-6-Carboxamide Hydrochloride</Concept>
                        <WitnessAxioms>
                           <Axiom>4-((5-((Cyclopropylamino)Carbonyl)-2-Methylphenyl)Amino)-5-Methyl-N-Propylpyrrolo(2,1-F)(1,2,4)Triazine-6-Carboxamide Hydrochloride SubClassOf Industrial Product</Axiom>
                           <Axiom>4-((5-((Cyclopropylamino)Carbonyl)-2-Methylphenyl)Amino)-5-Methyl-N-Propylpyrrolo(2,1-F)(1,2,4)Triazine-6-Carboxamide Hydrochloride SubClassOf Industrial Aid</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Industrial Product</Concept>
                        <WitnessAxioms>
                           <Axiom>4-((5-((Cyclopropylamino)Carbonyl)-2-Methylphenyl)Amino)-5-Methyl-N-Propylpyrrolo(2,1-F)(1,2,4)Triazine-6-Carboxamide Hydrochloride SubClassOf Industrial Product</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="726">
               <Axiom>Adenoid Cystic Skin Carcinoma EquivalentTo Adenoid Cystic Carcinoma and Eccrine Carcinoma</Axiom>
               <ConceptChanges size="5">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Adenoid Cystic Skin Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Adenoid Cystic Skin Carcinoma SubClassOf Eccrine Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Eccrine Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Adenoid Cystic Skin Carcinoma SubClassOf Eccrine Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="3">
                     <Specialisation>
                        <Concept>Adenoid Cystic Skin Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Adenoid Cystic Skin Carcinoma SubClassOf Malignant Eccrine Neoplasm</Axiom>
                           <Axiom>Adenoid Cystic Skin Carcinoma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Malignant Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Adenoid Cystic Skin Carcinoma SubClassOf Malignant Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Adenoid Cystic Skin Carcinoma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="727">
               <Axiom>Adenovirus Encoding Rat HER-2/neu SubClassOf Gene Transfer or Gene Delivery Agent</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Adenovirus Encoding Rat HER-2/neu</Concept>
                        <WitnessAxioms>
                           <Axiom>Adenovirus Encoding Rat HER-2/neu SubClassOf Gene Transfer or Gene Delivery Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Gene Transfer or Gene Delivery Agent</Concept>
                        <WitnessAxioms>
                           <Axiom>Adenovirus Encoding Rat HER-2/neu SubClassOf Gene Transfer or Gene Delivery Agent</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="730">
               <Axiom>Aluminum Stearate SubClassOf Pharmaceutical Excipient</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Aluminum Stearate</Concept>
                        <WitnessAxioms>
                           <Axiom>Aluminum Stearate SubClassOf Pharmaceutical Excipient</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Pharmaceutical Excipient</Concept>
                        <WitnessAxioms>
                           <Axiom>Aluminum Stearate SubClassOf Pharmaceutical Excipient</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Aluminum Stearate</Concept>
                        <WitnessAxioms>
                           <Axiom>Aluminum Stearate SubClassOf Industrial Product</Axiom>
                           <Axiom>Aluminum Stearate SubClassOf Industrial Aid</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Industrial Product</Concept>
                        <WitnessAxioms>
                           <Axiom>Aluminum Stearate SubClassOf Industrial Product</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="732">
               <Axiom>Ameloblastic Carcinoma Derived From Odontogenic Cyst EquivalentTo Ameloblastic Carcinoma and (Disease_Has_Finding only Odontogenic Cyst) and (Disease_Has_Finding only Secondary Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="731">
               <Axiom>Ameloblastic Carcinoma-Secondary Type (Dedifferentiated) EquivalentTo Ameloblastic Carcinoma and (Disease_Has_Associated_Disease only Ameloblastoma) and (Disease_Has_Finding only Secondary Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="734">
               <Axiom>Amphetamine Aspartate SubClassOf Substance of Abuse</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Amphetamine Aspartate</Concept>
                        <WitnessAxioms>
                           <Axiom>Amphetamine Aspartate SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Substance of Abuse</Concept>
                        <WitnessAxioms>
                           <Axiom>Amphetamine Aspartate SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="735">
               <Axiom>Amphetamine SubClassOf Substance of Abuse</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Amphetamine</Concept>
                        <WitnessAxioms>
                           <Axiom>Amphetamine SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Substance of Abuse</Concept>
                        <WitnessAxioms>
                           <Axiom>Amphetamine SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="733">
               <Axiom>Amphetamine Sulfate SubClassOf Substance of Abuse</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Amphetamine Sulfate</Concept>
                        <WitnessAxioms>
                           <Axiom>Amphetamine Sulfate SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Substance of Abuse</Concept>
                        <WitnessAxioms>
                           <Axiom>Amphetamine Sulfate SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="736">
               <Axiom>Anaplastic Oligodendroglioma EquivalentTo Malignant Glioma and Oligodendroglial Tumor and (Disease_May_Have_Abnormal_Cell some Neoplastic Multinucleated Giant Cell) and (Disease_May_Have_Cytogenetic_Abnormality some CDKN2A Gene Deletion) and (Disease_May_Have_Cytogenetic_Abnormality some Double Minutes) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 19q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Finding some Extensive Necrosis) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Microvascular Proliferation) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Finding only Anaplastic Lesion) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Increased Cellularity Present) and (Disease_Is_Grade only Grade 3)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="737">
               <Axiom>Arginine Hydrochloride SubClassOf Non-Essential Amino Acid</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Arginine Hydrochloride</Concept>
                        <WitnessAxioms>
                           <Axiom>Arginine Hydrochloride SubClassOf Non-Essential Amino Acid</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Non-Essential Amino Acid</Concept>
                        <WitnessAxioms>
                           <Axiom>Arginine Hydrochloride SubClassOf Non-Essential Amino Acid</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Arginine Hydrochloride</Concept>
                        <WitnessAxioms>
                           <Axiom>Arginine Hydrochloride SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                           <Axiom>Arginine Hydrochloride SubClassOf Amino Acid</Axiom>
                           <Axiom>Arginine Hydrochloride SubClassOf Amino Acid, Peptide, or Protein</Axiom>
                           <Axiom>Arginine Hydrochloride SubClassOf Organic Chemical</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Amino Acid, Peptide, or Protein</Concept>
                        <WitnessAxioms>
                           <Axiom>Arginine Hydrochloride SubClassOf Amino Acid, Peptide, or Protein</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="738">
               <Axiom>Arginine SubClassOf Non-Essential Amino Acid</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Arginine</Concept>
                        <WitnessAxioms>
                           <Axiom>Arginine SubClassOf Non-Essential Amino Acid</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Non-Essential Amino Acid</Concept>
                        <WitnessAxioms>
                           <Axiom>Arginine SubClassOf Non-Essential Amino Acid</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="724">
               <Axiom>Aurora Kinase Inhibitor AZD1152 SubClassOf Serine Threonine Kinase Inhibitor</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Aurora Kinase Inhibitor AZD1152</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor AZD1152 SubClassOf Serine Threonine Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Serine Threonine Kinase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor AZD1152 SubClassOf Serine Threonine Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Aurora Kinase Inhibitor AZD1152</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor AZD1152 SubClassOf Protein Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Protein Kinase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor AZD1152 SubClassOf Protein Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="725">
               <Axiom>Aurora Kinase Inhibitor AZD1152 SubClassOf Signal Transduction Inhibitor</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Aurora Kinase Inhibitor AZD1152</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor AZD1152 SubClassOf Signal Transduction Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Signal Transduction Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor AZD1152 SubClassOf Signal Transduction Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Aurora Kinase Inhibitor AZD1152</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor AZD1152 SubClassOf Antineoplastic Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Antineoplastic Agent</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor AZD1152 SubClassOf Antineoplastic Agent</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="810">
               <Axiom>Aurora Kinase Inhibitor MK-0457 SubClassOf Serine Threonine Kinase Inhibitor</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Aurora Kinase Inhibitor MK-0457</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor MK-0457 SubClassOf Serine Threonine Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Serine Threonine Kinase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor MK-0457 SubClassOf Serine Threonine Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Aurora Kinase Inhibitor MK-0457</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor MK-0457 SubClassOf Protein Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Protein Kinase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor MK-0457 SubClassOf Protein Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="811">
               <Axiom>Aurora Kinase Inhibitor MK-0457 SubClassOf Signal Transduction Inhibitor</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Aurora Kinase Inhibitor MK-0457</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor MK-0457 SubClassOf Signal Transduction Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Signal Transduction Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor MK-0457 SubClassOf Signal Transduction Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Aurora Kinase Inhibitor MK-0457</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor MK-0457 SubClassOf Antineoplastic Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Antineoplastic Agent</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor MK-0457 SubClassOf Antineoplastic Agent</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="812">
               <Axiom>Aurora Kinase Inhibitor MLN8054 SubClassOf Serine Threonine Kinase Inhibitor</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Aurora Kinase Inhibitor MLN8054</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor MLN8054 SubClassOf Serine Threonine Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Serine Threonine Kinase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor MLN8054 SubClassOf Serine Threonine Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Aurora Kinase Inhibitor MLN8054</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor MLN8054 SubClassOf Protein Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Protein Kinase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>Aurora Kinase Inhibitor MLN8054 SubClassOf Protein Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="739">
               <Axiom>Benign Breast Eccrine Spiradenoma EquivalentTo Benign Breast Neoplasm and Benign Eccrine Spiradenoma</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Benign Breast Eccrine Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Benign Eccrine Spiradenoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Eccrine Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Benign Eccrine Spiradenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Benign Breast Eccrine Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Benign Eccrine Neoplasm</Axiom>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="740">
               <Axiom>Benign Eccrine Spiradenoma SubClassOf Benign Eccrine Neoplasm</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Benign Eccrine Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Eccrine Spiradenoma SubClassOf Benign Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Eccrine Spiradenoma SubClassOf Benign Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Benign Breast Eccrine Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Benign Eccrine Neoplasm</Axiom>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Disorder by Site</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Eccrine Spiradenoma SubClassOf Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="741">
               <Axiom>Benign Eccrine Spiradenoma SubClassOf Spiradenoma</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Benign Eccrine Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Eccrine Spiradenoma SubClassOf Spiradenoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Eccrine Spiradenoma SubClassOf Spiradenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Benign Breast Eccrine Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Breast Eccrine Spiradenoma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Disorder by Site</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Eccrine Spiradenoma SubClassOf Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="742">
               <Axiom>Benign Epithelioma SubClassOf Epithelioma</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Benign Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Epithelioma SubClassOf Epithelioma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Epithelioma SubClassOf Epithelioma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Benign Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Epithelioma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Benign Epithelioma SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Benign Epithelioma SubClassOf Neoplasm</Axiom>
                           <Axiom>Benign Epithelioma SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Benign Epithelioma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Benign Epithelioma SubClassOf Disease, Disorder or Finding</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Neoplasm by Morphology</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Epithelioma SubClassOf Neoplasm by Morphology</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="744">
               <Axiom>Benign Palate Neoplasm EquivalentTo Palate Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Has_Primary_Anatomic_Site only Palate)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="745">
               <Axiom>Benign Reproductive System Neoplasm EquivalentTo Reproductive System Neoplasm and (Disease_Excludes_Abnormal_Cell only Adenocarcinoma Cell) and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Primary_Anatomic_Site only Reproductive System)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="746">
               <Axiom>Benign Retroperitoneal Neoplasm EquivalentTo Retroperitoneal Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Has_Primary_Anatomic_Site only Retroperitoneum)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="748">
               <Axiom>Bilateral Carcinoma EquivalentTo Carcinoma and (Disease_Has_Finding only Bilateral Mass)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="749">
               <Axiom>Bilateral Retinoblastoma EquivalentTo Retinoblastoma and (Disease_Has_Finding only Bilateral Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="750">
               <Axiom>Breast Carcinoma Metastatic to the Skin EquivalentTo Metastatic Malignant Neoplasm to the Skin and Metastatic Carcinoma and Stage IV Breast Cancer</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="751">
               <Axiom>CNF2024 SubClassOf Enzyme Inhibitor</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>CNF2024</Concept>
                        <WitnessAxioms>
                           <Axiom>CNF2024 SubClassOf Enzyme Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Enzyme Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>CNF2024 SubClassOf Enzyme Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="752">
               <Axiom>CRS-100 SubClassOf Chemo Immunostimulant Adjuvant</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>CRS-100</Concept>
                        <WitnessAxioms>
                           <Axiom>CRS-100 SubClassOf Chemo Immunostimulant Adjuvant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Chemo Immunostimulant Adjuvant</Concept>
                        <WitnessAxioms>
                           <Axiom>CRS-100 SubClassOf Chemo Immunostimulant Adjuvant</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="753">
               <Axiom>CRS-100 SubClassOf Immunostimulant</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>CRS-100</Concept>
                        <WitnessAxioms>
                           <Axiom>CRS-100 SubClassOf Immunostimulant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Immunostimulant</Concept>
                        <WitnessAxioms>
                           <Axiom>CRS-100 SubClassOf Immunostimulant</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="832">
               <Axiom>Carcinoma Metastatic to the Skin EquivalentTo Skin Carcinoma and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Carcinoma Metastatic to the Skin</Concept>
                        <WitnessAxioms>
                           <Axiom>Carcinoma Metastatic to the Skin SubClassOf Skin Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Skin Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Carcinoma Metastatic to the Skin SubClassOf Skin Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="754">
               <Axiom>Cervical Squamotransitional Carcinoma EquivalentTo Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma and (Disease_May_Have_Abnormal_Cell some Malignant Transitional Cell) and (Disease_Has_Finding only Papillary Pattern)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="755">
               <Axiom>Cervical Warty Carcinoma EquivalentTo Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Exophytic Papillary Lesion) and (Disease_Has_Finding only Papillary Pattern)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="756">
               <Axiom>Childhood Glioblastoma EquivalentTo Childhood Astrocytic Tumor and Glioblastoma and (Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="757">
               <Axiom>Cholangiolocellular Carcinoma EquivalentTo Intrahepatic Cholangiocarcinoma and Sweat Gland Tubular Carcinoma and (Disease_Has_Finding only Tubular Pattern)</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Cholangiolocellular Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Sweat Gland Tubular Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Sweat Gland Tubular Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Sweat Gland Tubular Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Cholangiolocellular Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Sweat Gland Carcinoma</Axiom>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Malignant Sweat Gland Neoplasm</Axiom>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Skin Appendage Neoplasm</Axiom>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Malignant Skin Neoplasm</Axiom>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Skin Disorder</Axiom>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Skin Neoplasm</Axiom>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Apocrine Gland Carcinoma</Axiom>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Apocrine Neoplasm</Axiom>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Malignant Skin Appendage Neoplasm</Axiom>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Adnexal Carcinoma</Axiom>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Skin Carcinoma</Axiom>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Malignant Apocrine Neoplasm</Axiom>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Sweat Gland Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Skin Appendage Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Skin Appendage Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="758">
               <Axiom>Chromic Chloride SubClassOf Inorganic Chemical</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Chromic Chloride</Concept>
                        <WitnessAxioms>
                           <Axiom>Chromic Chloride SubClassOf Inorganic Chemical</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Inorganic Chemical</Concept>
                        <WitnessAxioms>
                           <Axiom>Chromic Chloride SubClassOf Inorganic Chemical</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Chromic Chloride</Concept>
                        <WitnessAxioms>
                           <Axiom>Chromic Chloride SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Drugs and Chemicals, Structural Classification</Concept>
                        <WitnessAxioms>
                           <Axiom>Chromic Chloride SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="759">
               <Axiom>Cigarette SubClassOf Substance of Abuse</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Cigarette</Concept>
                        <WitnessAxioms>
                           <Axiom>Cigarette SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Substance of Abuse</Concept>
                        <WitnessAxioms>
                           <Axiom>Cigarette SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="760">
               <Axiom>Classic Type Trichoepithelioma SubClassOf Trichoepithelioma</Axiom>
               <ConceptChanges size="5">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Classic Type Trichoepithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Trichoepithelioma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Trichoepithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Trichoepithelioma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="3">
                     <Specialisation>
                        <Concept>Classic Type Trichoepithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Hair Disorder</Axiom>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Skin Appendage Neoplasm</Axiom>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Benign Germinative Follicular Epithelium Neoplasm</Axiom>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Hair Follicle Neoplasm</Axiom>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Benign Skin Neoplasm</Axiom>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Benign Hair Follicle Neoplasm</Axiom>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Neoplasm by Site</Axiom>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Disorder by Site</Axiom>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Benign Skin Appendage Neoplasm</Axiom>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Germinative Follicular Epithelium Neoplasm</Axiom>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Skin Neoplasm</Axiom>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Skin Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Hair Follicle Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Hair Follicle Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Disorder by Site</Concept>
                        <WitnessAxioms>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="761">
               <Axiom>Classical Poroma SubClassOf Benign Eccrine Neoplasm</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Classical Poroma</Concept>
                        <WitnessAxioms>
                           <Axiom>Classical Poroma SubClassOf Benign Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Classical Poroma SubClassOf Benign Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Classical Poroma</Concept>
                        <WitnessAxioms>
                           <Axiom>Classical Poroma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Classical Poroma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="763">
               <Axiom>Collection Facilitator SubClassOf Pharmaceutical Product-related Substance</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Collection Facilitator</Concept>
                        <WitnessAxioms>
                           <Axiom>Collection Facilitator SubClassOf Pharmaceutical Product-related Substance</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Pharmaceutical Product-related Substance</Concept>
                        <WitnessAxioms>
                           <Axiom>Collection Facilitator SubClassOf Pharmaceutical Product-related Substance</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Collection Facilitator</Concept>
                        <WitnessAxioms>
                           <Axiom>Collection Facilitator SubClassOf Drug or Chemical</Axiom>
                           <Axiom>Collection Facilitator SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                           <Axiom>Collection Facilitator SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Chemicals_and_Drugs_Kind</Concept>
                        <WitnessAxioms>
                           <Axiom>Collection Facilitator SubClassOf Chemicals_and_Drugs_Kind</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="764">
               <Axiom>Conventional Osteosarcoma EquivalentTo Primary Bone Osteosarcoma and (Disease_May_Have_Cytogenetic_Abnormality some Double Minutes) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1) and (Disease_May_Have_Cytogenetic_Abnormality some Homogeneously Staining Region) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Lytic Bone Lesion) and (Disease_May_Have_Finding some Osteosclerotic Lesion) and (Disease_May_Have_Finding some Pain) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_May_Have_Molecular_Abnormality some RB1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some FOS Gene Amplification) and (Disease_Has_Finding only Anaplastic Lesion) and (Disease_Has_Finding only Cellular Pleomorphism) and (Disease_Has_Finding only High Grade Lesion) and (Disease_Has_Finding only Osteoid Formation) and (Disease_Has_Finding only Vascular Channel Formation) and (Disease_Has_Normal_Tissue_Origin only Medullary Bone)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="765">
               <Axiom>Cryoablation SubClassOf Ablation</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Cryoablation</Concept>
                        <WitnessAxioms>
                           <Axiom>Cryoablation SubClassOf Ablation</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Ablation</Concept>
                        <WitnessAxioms>
                           <Axiom>Cryoablation SubClassOf Ablation</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Cryoablation</Concept>
                        <WitnessAxioms>
                           <Axiom>Cryoablation SubClassOf Surgical Procedure by Method</Axiom>
                           <Axiom>Cryoablation SubClassOf Activity_Kind</Axiom>
                           <Axiom>Cryoablation SubClassOf Activity</Axiom>
                           <Axiom>Cryoablation SubClassOf Clinical or Research Activity</Axiom>
                           <Axiom>Cryoablation SubClassOf Procedure</Axiom>
                           <Axiom>Cryoablation SubClassOf Surgical Procedure</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Procedure</Concept>
                        <WitnessAxioms>
                           <Axiom>Cryoablation SubClassOf Procedure</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="766">
               <Axiom>Cyanogen Bromide SubClassOf Inorganic Chemical</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Cyanogen Bromide</Concept>
                        <WitnessAxioms>
                           <Axiom>Cyanogen Bromide SubClassOf Inorganic Chemical</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Inorganic Chemical</Concept>
                        <WitnessAxioms>
                           <Axiom>Cyanogen Bromide SubClassOf Inorganic Chemical</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Cyanogen Bromide</Concept>
                        <WitnessAxioms>
                           <Axiom>Cyanogen Bromide SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Drugs and Chemicals, Structural Classification</Concept>
                        <WitnessAxioms>
                           <Axiom>Cyanogen Bromide SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="767">
               <Axiom>Cylindroma SubClassOf Benign Eccrine Neoplasm</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Cylindroma</Concept>
                        <WitnessAxioms>
                           <Axiom>Cylindroma SubClassOf Benign Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Cylindroma SubClassOf Benign Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Cylindroma</Concept>
                        <WitnessAxioms>
                           <Axiom>Cylindroma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Turban Tumor SubClassOf Eccrine Neoplasm</Axiom>
                           <Axiom>Cylindroma SubClassOf Eccrine Neoplasm</Axiom>
                           <Axiom>Sporadic Cylindroma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="768">
               <Axiom>Cystadenoma EquivalentTo Cystic Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Glandular Cell) and (Disease_Has_Normal_Tissue_Origin only Glandular Epithelium)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="769">
               <Axiom>DLC1 Gene SubClassOf Gene_Plays_Role_In_Process some Cell Adhesion</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="770">
               <Axiom>DLC1 Gene SubClassOf Gene_Plays_Role_In_Process some Regulation of Cell Shape</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="771">
               <Axiom>Defensins SubClassOf Peptide</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Defensins</Concept>
                        <WitnessAxioms>
                           <Axiom>Defensins SubClassOf Peptide</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Peptide</Concept>
                        <WitnessAxioms>
                           <Axiom>Defensins SubClassOf Peptide</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Defensins</Concept>
                        <WitnessAxioms>
                           <Axiom>Defensins SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                           <Axiom>Defensins SubClassOf Organic Chemical</Axiom>
                           <Axiom>Defensins SubClassOf Amino Acid, Peptide, or Protein</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Amino Acid, Peptide, or Protein</Concept>
                        <WitnessAxioms>
                           <Axiom>Defensins SubClassOf Amino Acid, Peptide, or Protein</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="780">
               <Axiom>Dermal Duct Tumor SubClassOf Benign Eccrine Neoplasm</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Dermal Duct Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Dermal Duct Tumor SubClassOf Benign Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Dermal Duct Tumor SubClassOf Benign Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Dermal Duct Tumor</Concept>
                        <WitnessAxioms>
                           <Axiom>Dermal Duct Tumor SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Dermal Duct Tumor SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="772">
               <Axiom>Desmoplastic Trichoepithelioma SubClassOf Trichoepithelioma</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Desmoplastic Trichoepithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Desmoplastic Trichoepithelioma SubClassOf Trichoepithelioma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Trichoepithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Desmoplastic Trichoepithelioma SubClassOf Trichoepithelioma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="773">
               <Axiom>Dextroamphetamine SubClassOf Substance of Abuse</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Dextroamphetamine</Concept>
                        <WitnessAxioms>
                           <Axiom>Dextroamphetamine SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Substance of Abuse</Concept>
                        <WitnessAxioms>
                           <Axiom>Dextroamphetamine SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="774">
               <Axiom>Diamorphine Hydrochloride SubClassOf Substance of Abuse</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Diamorphine Hydrochloride</Concept>
                        <WitnessAxioms>
                           <Axiom>Diamorphine Hydrochloride SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Substance of Abuse</Concept>
                        <WitnessAxioms>
                           <Axiom>Diamorphine Hydrochloride SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="775">
               <Axiom>Diazepam SubClassOf Antidepressant Agent</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Diazepam</Concept>
                        <WitnessAxioms>
                           <Axiom>Diazepam SubClassOf Antidepressant Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Antidepressant Agent</Concept>
                        <WitnessAxioms>
                           <Axiom>Diazepam SubClassOf Antidepressant Agent</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="778">
               <Axiom>ECO-4601 SubClassOf Mitogen-Activated Protein Kinase Inhibitor</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>ECO-4601</Concept>
                        <WitnessAxioms>
                           <Axiom>ECO-4601 SubClassOf Mitogen-Activated Protein Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Mitogen-Activated Protein Kinase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>ECO-4601 SubClassOf Mitogen-Activated Protein Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>ECO-4601</Concept>
                        <WitnessAxioms>
                           <Axiom>ECO-4601 SubClassOf Protein Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Protein Kinase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>ECO-4601 SubClassOf Protein Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="779">
               <Axiom>Eccrine Acrospiroma SubClassOf Benign Eccrine Neoplasm</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Eccrine Acrospiroma</Concept>
                        <WitnessAxioms>
                           <Axiom>Eccrine Acrospiroma SubClassOf Benign Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Eccrine Acrospiroma SubClassOf Benign Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Eccrine Acrospiroma</Concept>
                        <WitnessAxioms>
                           <Axiom>Eccrine Acrospiroma SubClassOf Benign Skin Neoplasm</Axiom>
                           <Axiom>Eccrine Acrospiroma SubClassOf Benign Sweat Gland Neoplasm</Axiom>
                           <Axiom>Eccrine Acrospiroma SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Eccrine Acrospiroma SubClassOf Disorder by Site</Axiom>
                           <Axiom>Eccrine Acrospiroma SubClassOf Skin Appendage Neoplasm</Axiom>
                           <Axiom>Eccrine Acrospiroma SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Eccrine Acrospiroma SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Eccrine Acrospiroma SubClassOf Neoplasm by Site</Axiom>
                           <Axiom>Eccrine Acrospiroma SubClassOf Benign Skin Appendage Neoplasm</Axiom>
                           <Axiom>Eccrine Acrospiroma SubClassOf Sweat Gland Neoplasm</Axiom>
                           <Axiom>Eccrine Acrospiroma SubClassOf Skin Disorder</Axiom>
                           <Axiom>Eccrine Acrospiroma SubClassOf Neoplasm</Axiom>
                           <Axiom>Eccrine Acrospiroma SubClassOf Skin Neoplasm</Axiom>
                           <Axiom>Eccrine Acrospiroma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Disorder by Site</Concept>
                        <WitnessAxioms>
                           <Axiom>Eccrine Acrospiroma SubClassOf Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="782">
               <Axiom>Eccrine Porocarcinoma EquivalentTo Eccrine Carcinoma and (Disease_May_Have_Finding some Papular Lesion) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Has_Finding only Desmoplastic Stroma Formation) and (Disease_Has_Finding only Invasive Lesion)</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Eccrine Porocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Eccrine Porocarcinoma SubClassOf Scirrhous Adenocarcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Scirrhous Adenocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Eccrine Porocarcinoma SubClassOf Scirrhous Adenocarcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Vulvar Eccrine Porocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Vulvar Eccrine Porocarcinoma SubClassOf Scirrhous Adenocarcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Scirrhous Adenocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Vulvar Eccrine Porocarcinoma SubClassOf Scirrhous Adenocarcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="784">
               <Axiom>Environment-Related Malignant Neoplasm SubClassOf Disease_Has_Finding only Toxicity</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="785">
               <Axiom>Epidermolysis Verruciformis SubClassOf Verrucous Lesion</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Epidermolysis Verruciformis</Concept>
                        <WitnessAxioms>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Verrucous Lesion</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Verrucous Lesion</Concept>
                        <WitnessAxioms>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Verrucous Lesion</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Epidermolysis Verruciformis</Concept>
                        <WitnessAxioms>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Neoplasm by Site</Axiom>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Skin Neoplasm</Axiom>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Neoplasm</Axiom>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Benign Skin Neoplasm</Axiom>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Neoplasm by Morphology</Concept>
                        <WitnessAxioms>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Neoplasm by Morphology</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="786">
               <Axiom>Epithelioma SubClassOf Epithelial Neoplasm</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Epithelioma SubClassOf Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Epithelial Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Epithelioma SubClassOf Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Squamous Cell Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Neoplasm</Axiom>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Neoplasm by Morphology</Concept>
                        <WitnessAxioms>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Malignant Epithelioma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Epithelioma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Intraepidermal Epithelioma of Jadassohn SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Benign Epithelioma SubClassOf Neoplasm by Morphology</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="729">
               <Axiom>Ethanol SubClassOf Substance of Abuse</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Ethanol</Concept>
                        <WitnessAxioms>
                           <Axiom>Ethanol SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Substance of Abuse</Concept>
                        <WitnessAxioms>
                           <Axiom>Ethanol SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="787">
               <Axiom>Extension SubClassOf Conceptual Entity</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Extension</Concept>
                        <WitnessAxioms>
                           <Axiom>Extension SubClassOf Conceptual Entity</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Conceptual Entity</Concept>
                        <WitnessAxioms>
                           <Axiom>Extension SubClassOf Conceptual Entity</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Extension</Concept>
                        <WitnessAxioms>
                           <Axiom>Extension SubClassOf NCI_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>NCI_Kind</Concept>
                        <WitnessAxioms>
                           <Axiom>Extension SubClassOf NCI_Kind</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="788">
               <Axiom>FGFR1OP Gene SubClassOf Gene_Plays_Role_In_Process some RNA Interference</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="776">
               <Axiom>Folate-FITC SubClassOf Antineoplastic Agent</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Folate-FITC</Concept>
                        <WitnessAxioms>
                           <Axiom>Folate-FITC SubClassOf Antineoplastic Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Antineoplastic Agent</Concept>
                        <WitnessAxioms>
                           <Axiom>Folate-FITC SubClassOf Antineoplastic Agent</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="789">
               <Axiom>Gastric Tubular Adenocarcinoma EquivalentTo Sporadic Gastric Adenocarcinoma and Sweat Gland Tubular Carcinoma</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Gastric Tubular Adenocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Sweat Gland Tubular Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Sweat Gland Tubular Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Sweat Gland Tubular Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Gastric Tubular Adenocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Adnexal Carcinoma</Axiom>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Apocrine Neoplasm</Axiom>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Malignant Skin Neoplasm</Axiom>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Skin Neoplasm</Axiom>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Sweat Gland Carcinoma</Axiom>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Malignant Skin Appendage Neoplasm</Axiom>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Malignant Apocrine Neoplasm</Axiom>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Skin Disorder</Axiom>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Malignant Sweat Gland Neoplasm</Axiom>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Skin Appendage Neoplasm</Axiom>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Skin Carcinoma</Axiom>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Sweat Gland Neoplasm</Axiom>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Apocrine Gland Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Skin Appendage Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Skin Appendage Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="790">
               <Axiom>Glioblastoma EquivalentTo Astrocytic Tumor and Malignant Glioma and (Disease_May_Have_Abnormal_Cell some Fibrillary Neoplastic Astrocyte) and (Disease_May_Have_Abnormal_Cell some Gemistocytic Neoplastic Astrocyte) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q25-26)) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Poorly Differentiated Neoplastic Astrocyte) and (Disease_Has_Finding only Anaplastic Lesion) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Microvascular Proliferation) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 4)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="791">
               <Axiom>Glutathione SubClassOf Peptide</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Glutathione</Concept>
                        <WitnessAxioms>
                           <Axiom>Glutathione SubClassOf Peptide</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Peptide</Concept>
                        <WitnessAxioms>
                           <Axiom>Glutathione SubClassOf Peptide</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Glutathione</Concept>
                        <WitnessAxioms>
                           <Axiom>Glutathione SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                           <Axiom>Glutathione SubClassOf Organic Chemical</Axiom>
                           <Axiom>Glutathione SubClassOf Amino Acid, Peptide, or Protein</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Amino Acid, Peptide, or Protein</Concept>
                        <WitnessAxioms>
                           <Axiom>Glutathione SubClassOf Amino Acid, Peptide, or Protein</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="792">
               <Axiom>Heptanoic Acid SubClassOf Pharmaceutical Excipient</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Heptanoic Acid</Concept>
                        <WitnessAxioms>
                           <Axiom>Heptanoic Acid SubClassOf Pharmaceutical Excipient</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Pharmaceutical Excipient</Concept>
                        <WitnessAxioms>
                           <Axiom>Heptanoic Acid SubClassOf Pharmaceutical Excipient</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Heptanoic Acid</Concept>
                        <WitnessAxioms>
                           <Axiom>Heptanoic Acid SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                           <Axiom>Heptanoic Acid SubClassOf Industrial Aid</Axiom>
                           <Axiom>Heptanoic Acid SubClassOf Industrial Product</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Industrial Product</Concept>
                        <WitnessAxioms>
                           <Axiom>Heptanoic Acid SubClassOf Industrial Product</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="793">
               <Axiom>Heroin SubClassOf Substance of Abuse</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Heroin</Concept>
                        <WitnessAxioms>
                           <Axiom>Heroin SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Substance of Abuse</Concept>
                        <WitnessAxioms>
                           <Axiom>Heroin SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="762">
               <Axiom>Hidradenocarcinoma EquivalentTo Clear Cell Adenocarcinoma and Eccrine Carcinoma</Axiom>
               <ConceptChanges size="5">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Hidradenocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidradenocarcinoma SubClassOf Eccrine Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Eccrine Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidradenocarcinoma SubClassOf Eccrine Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="3">
                     <Specialisation>
                        <Concept>Hidradenocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidradenocarcinoma SubClassOf Eccrine Neoplasm</Axiom>
                           <Axiom>Hidradenocarcinoma SubClassOf Malignant Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Malignant Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidradenocarcinoma SubClassOf Malignant Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidradenocarcinoma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="845">
               <Axiom>Hidradenoma Papilliferum SubClassOf Hidradenoma</Axiom>
               <ConceptChanges size="6">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Hidradenoma Papilliferum</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidradenoma Papilliferum SubClassOf Hidradenoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Hidradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidradenoma Papilliferum SubClassOf Hidradenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="4">
                     <Specialisation>
                        <Concept>Hidradenoma Papilliferum</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidradenoma Papilliferum SubClassOf Adenoma</Axiom>
                           <Axiom>Hidradenoma Papilliferum SubClassOf Sweat Gland Adenoma</Axiom>
                           <Axiom>Hidradenoma Papilliferum SubClassOf Apocrine Adenoma</Axiom>
                           <Axiom>Hidradenoma Papilliferum SubClassOf Benign Apocrine Neoplasm</Axiom>
                           <Axiom>Hidradenoma Papilliferum SubClassOf Apocrine Neoplasm</Axiom>
                           <Axiom>Hidradenoma Papilliferum SubClassOf Skin Appendage Adenoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Apocrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidradenoma Papilliferum SubClassOf Benign Apocrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Skin Appendage Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidradenoma Papilliferum SubClassOf Skin Appendage Adenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidradenoma Papilliferum SubClassOf Adenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="794">
               <Axiom>Hidradenoma SubClassOf Apocrine Adenoma</Axiom>
               <ConceptChanges size="6">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Hidradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidradenoma SubClassOf Apocrine Adenoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Apocrine Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidradenoma SubClassOf Apocrine Adenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="4">
                     <Specialisation>
                        <Concept>Clear Cell Hidradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Clear Cell Hidradenoma SubClassOf Apocrine Neoplasm</Axiom>
                           <Axiom>Clear Cell Hidradenoma SubClassOf Apocrine Adenoma</Axiom>
                           <Axiom>Clear Cell Hidradenoma SubClassOf Benign Apocrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Apocrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidradenoma SubClassOf Benign Apocrine Neoplasm</Axiom>
                           <Axiom>Hidradenoma Papilliferum SubClassOf Benign Apocrine Neoplasm</Axiom>
                           <Axiom>Vulvar Nodular Hidradenoma SubClassOf Benign Apocrine Neoplasm</Axiom>
                           <Axiom>Clear Cell Hidradenoma SubClassOf Benign Apocrine Neoplasm</Axiom>
                           <Axiom>Nodular Hidradenoma SubClassOf Benign Apocrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Skin Appendage Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidradenoma Papilliferum SubClassOf Skin Appendage Adenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidradenoma Papilliferum SubClassOf Adenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="795">
               <Axiom>Hidrocystoma SubClassOf Sweat Gland Adenoma</Axiom>
               <ConceptChanges size="5">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Hidrocystoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidrocystoma SubClassOf Sweat Gland Adenoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Sweat Gland Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidrocystoma SubClassOf Sweat Gland Adenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="3">
                     <Specialisation>
                        <Concept>Hidrocystoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidrocystoma SubClassOf Skin Appendage Adenoma</Axiom>
                           <Axiom>Hidrocystoma SubClassOf Adenoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Skin Appendage Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidrocystoma SubClassOf Skin Appendage Adenoma</Axiom>
                           <Axiom>Eccrine Hidrocystoma SubClassOf Skin Appendage Adenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hidrocystoma SubClassOf Adenoma</Axiom>
                           <Axiom>Eccrine Hidrocystoma SubClassOf Adenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="796">
               <Axiom>Iatrogenic Kaposi's Sarcoma EquivalentTo Kaposi's Sarcoma and (Disease_Has_Finding only Therapy-Related Toxicity)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="797">
               <Axiom>Infiltrating Papillary Adenocarcinoma EquivalentTo Papillary Adenocarcinoma and (Disease_Has_Finding only Invasive Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="798">
               <Axiom>Intraepidermal Epithelioma of Jadassohn SubClassOf Epithelioma</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Intraepidermal Epithelioma of Jadassohn</Concept>
                        <WitnessAxioms>
                           <Axiom>Intraepidermal Epithelioma of Jadassohn SubClassOf Epithelioma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Intraepidermal Epithelioma of Jadassohn SubClassOf Epithelioma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Intraepidermal Epithelioma of Jadassohn</Concept>
                        <WitnessAxioms>
                           <Axiom>Intraepidermal Epithelioma of Jadassohn SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Intraepidermal Epithelioma of Jadassohn SubClassOf Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Neoplasm by Morphology</Concept>
                        <WitnessAxioms>
                           <Axiom>Intraepidermal Epithelioma of Jadassohn SubClassOf Neoplasm by Morphology</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="777">
               <Axiom>KLH-FITC SubClassOf Immunostimulant</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>KLH-FITC</Concept>
                        <WitnessAxioms>
                           <Axiom>KLH-FITC SubClassOf Immunostimulant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Immunostimulant</Concept>
                        <WitnessAxioms>
                           <Axiom>KLH-FITC SubClassOf Immunostimulant</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="800">
               <Axiom>Lactic Acid, L- SubClassOf Pharmaceutical Excipient</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Lactic Acid, L-</Concept>
                        <WitnessAxioms>
                           <Axiom>Lactic Acid, L- SubClassOf Pharmaceutical Excipient</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Pharmaceutical Excipient</Concept>
                        <WitnessAxioms>
                           <Axiom>Lactic Acid, L- SubClassOf Pharmaceutical Excipient</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Lactic Acid, L-</Concept>
                        <WitnessAxioms>
                           <Axiom>Lactic Acid, L- SubClassOf Industrial Aid</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Industrial Aid</Concept>
                        <WitnessAxioms>
                           <Axiom>Lactic Acid, L- SubClassOf Industrial Aid</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="801">
               <Axiom>Laryngopharynx SubClassOf Anatomic_Structure_Is_Physical_Part_Of some Pharynx</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Laryngopharynx</Concept>
                        <WitnessAxioms>
                           <Axiom>Laryngopharynx SubClassOf Anatomy_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Anatomy_Kind</Concept>
                        <WitnessAxioms>
                           <Axiom>Laryngopharynx SubClassOf Anatomy_Kind</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="802">
               <Axiom>Laryngopharynx SubClassOf Head and Neck Part</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Laryngopharynx</Concept>
                        <WitnessAxioms>
                           <Axiom>Laryngopharynx SubClassOf Head and Neck Part</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Head and Neck Part</Concept>
                        <WitnessAxioms>
                           <Axiom>Laryngopharynx SubClassOf Head and Neck Part</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Laryngopharynx</Concept>
                        <WitnessAxioms>
                           <Axiom>Laryngopharynx SubClassOf Anatomic Structure, System, or Substance</Axiom>
                           <Axiom>Laryngopharynx SubClassOf Body Part</Axiom>
                           <Axiom>Laryngopharynx SubClassOf Anatomy_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Anatomic Structure, System, or Substance</Concept>
                        <WitnessAxioms>
                           <Axiom>Laryngopharynx SubClassOf Anatomic Structure, System, or Substance</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="803">
               <Axiom>Levomenthol SubClassOf Flavor Excipient</Axiom>
               <ConceptChanges size="5">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Levomenthol</Concept>
                        <WitnessAxioms>
                           <Axiom>Levomenthol SubClassOf Flavor Excipient</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Flavor Excipient</Concept>
                        <WitnessAxioms>
                           <Axiom>Levomenthol SubClassOf Flavor Excipient</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="3">
                     <Specialisation>
                        <Concept>Levomenthol</Concept>
                        <WitnessAxioms>
                           <Axiom>Levomenthol SubClassOf Industrial Aid</Axiom>
                           <Axiom>Levomenthol SubClassOf Industrial Product</Axiom>
                           <Axiom>Levomenthol SubClassOf Pharmaceutical Excipient</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Pharmaceutical Excipient</Concept>
                        <WitnessAxioms>
                           <Axiom>Levomenthol SubClassOf Pharmaceutical Excipient</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Industrial Product</Concept>
                        <WitnessAxioms>
                           <Axiom>Levomenthol SubClassOf Industrial Product</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="804">
               <Axiom>Lithium Carbonate SubClassOf Miscellaneous Chemoprotective Agent</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Lithium Carbonate</Concept>
                        <WitnessAxioms>
                           <Axiom>Lithium Carbonate SubClassOf Miscellaneous Chemoprotective Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Miscellaneous Chemoprotective Agent</Concept>
                        <WitnessAxioms>
                           <Axiom>Lithium Carbonate SubClassOf Miscellaneous Chemoprotective Agent</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Lithium Carbonate</Concept>
                        <WitnessAxioms>
                           <Axiom>Lithium Carbonate SubClassOf Protective Agent</Axiom>
                           <Axiom>Lithium Carbonate SubClassOf Chemoprotective Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Protective Agent</Concept>
                        <WitnessAxioms>
                           <Axiom>Lithium Carbonate SubClassOf Protective Agent</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="805">
               <Axiom>Lithium Citrate SubClassOf Antidepressant Agent</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Lithium Citrate</Concept>
                        <WitnessAxioms>
                           <Axiom>Lithium Citrate SubClassOf Antidepressant Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Antidepressant Agent</Concept>
                        <WitnessAxioms>
                           <Axiom>Lithium Citrate SubClassOf Antidepressant Agent</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Lithium Citrate</Concept>
                        <WitnessAxioms>
                           <Axiom>Lithium Citrate SubClassOf Analgesic Agent</Axiom>
                           <Axiom>Lithium Citrate SubClassOf Adjuvant Analgesic</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Analgesic Agent</Concept>
                        <WitnessAxioms>
                           <Axiom>Lithium Citrate SubClassOf Analgesic Agent</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="806">
               <Axiom>Localized Carcinoma EquivalentTo Carcinoma and (Disease_Has_Finding only Localized Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="807">
               <Axiom>Locally Advanced Malignant Neoplasm SubClassOf Advanced Malignant Neoplasm</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Locally Advanced Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Locally Advanced Malignant Neoplasm SubClassOf Advanced Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Advanced Malignant Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Locally Advanced Malignant Neoplasm SubClassOf Advanced Malignant Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="808">
               <Axiom>Lytic Metastatic Bone Lesion SubClassOf Metastatic Lesion</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Lytic Metastatic Bone Lesion</Concept>
                        <WitnessAxioms>
                           <Axiom>Lytic Metastatic Bone Lesion SubClassOf Metastatic Lesion</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Metastatic Lesion</Concept>
                        <WitnessAxioms>
                           <Axiom>Lytic Metastatic Bone Lesion SubClassOf Metastatic Lesion</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Solitary Lytic Metastatic Bone Lesion</Concept>
                        <WitnessAxioms>
                           <Axiom>Solitary Lytic Metastatic Bone Lesion SubClassOf Metastatic Lesion</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Metastatic Lesion</Concept>
                        <WitnessAxioms>
                           <Axiom>Solitary Lytic Metastatic Bone Lesion SubClassOf Metastatic Lesion</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="813">
               <Axiom>MS-275 SubClassOf Chemical_Or_Drug_Affects_Gene_Product some Histone Deacetylase</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="814">
               <Axiom>MS-275 SubClassOf Chemical_Or_Drug_Has_Mechanism_Of_Action some Enzyme Inhibition</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="815">
               <Axiom>MS-275 SubClassOf Chemical_Or_Drug_Has_Mechanism_Of_Action some Free Radical Formation</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="816">
               <Axiom>MS-275 SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Apoptosis</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="817">
               <Axiom>MS-275 SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Cell Cycle Inhibition</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="818">
               <Axiom>MS-275 SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Cell Differentiation Induction</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="819">
               <Axiom>MS-275 SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Chromatin Structure Alteration</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="820">
               <Axiom>MS-275 SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Gene Expression Alteration</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="821">
               <Axiom>MS-275 SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Mitochondrial Damage</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="809">
               <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Wild Type and Mutant MGMT Vector</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>MSCV-MGMT(P140K) Vaccine</Concept>
                        <WitnessAxioms>
                           <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Wild Type and Mutant MGMT Vector</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Wild Type and Mutant MGMT Vector</Concept>
                        <WitnessAxioms>
                           <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Wild Type and Mutant MGMT Vector</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>MSCV-MGMT(P140K) Vaccine</Concept>
                        <WitnessAxioms>
                           <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Cloning Vector</Axiom>
                           <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Viral Vector</Axiom>
                           <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Retroviral Vector</Axiom>
                           <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                           <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Nucleic Acids, Nucleosides, and Nucleotides</Axiom>
                           <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Nucleic Acids</Axiom>
                           <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf DNA</Axiom>
                           <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Organic Chemical</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Retroviral Vector</Concept>
                        <WitnessAxioms>
                           <Axiom>MSCV-MGMT(P140K) Vaccine SubClassOf Retroviral Vector</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="822">
               <Axiom>Magnesium Stearate SubClassOf Lubricant Excipient</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Magnesium Stearate</Concept>
                        <WitnessAxioms>
                           <Axiom>Magnesium Stearate SubClassOf Lubricant Excipient</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Lubricant Excipient</Concept>
                        <WitnessAxioms>
                           <Axiom>Magnesium Stearate SubClassOf Lubricant Excipient</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Magnesium Stearate</Concept>
                        <WitnessAxioms>
                           <Axiom>Magnesium Stearate SubClassOf Industrial Aid</Axiom>
                           <Axiom>Magnesium Stearate SubClassOf Pharmaceutical Excipient</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Pharmaceutical Excipient</Concept>
                        <WitnessAxioms>
                           <Axiom>Magnesium Stearate SubClassOf Pharmaceutical Excipient</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="824">
               <Axiom>Malignant Epithelioma SubClassOf Epithelioma</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Malignant Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Malignant Epithelioma SubClassOf Epithelioma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Malignant Epithelioma SubClassOf Epithelioma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Malignant Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Malignant Epithelioma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Malignant Epithelioma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Malignant Epithelioma SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Malignant Epithelioma SubClassOf Neoplasm</Axiom>
                           <Axiom>Malignant Epithelioma SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Malignant Epithelioma SubClassOf Diseases and Disorders</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Neoplasm by Morphology</Concept>
                        <WitnessAxioms>
                           <Axiom>Malignant Epithelioma SubClassOf Neoplasm by Morphology</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="825">
               <Axiom>Malignant Proliferating Pilar Tumor EquivalentTo Malignant Outer Hair Sheath and Infundibulum Neoplasm and (Disease_Excludes_Finding some Lobular Pattern) and (Disease_May_Have_Finding some Cord-Like Pattern) and (Disease_May_Have_Finding some Nested Pattern) and (Disease_Has_Finding only Desmoplastic Stroma Formation) and (Disease_Has_Primary_Anatomic_Site only Pilar Sheath)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="826">
               <Axiom>Marijuana SubClassOf Antiemetic Agent</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Marijuana</Concept>
                        <WitnessAxioms>
                           <Axiom>Marijuana SubClassOf Antiemetic Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Antiemetic Agent</Concept>
                        <WitnessAxioms>
                           <Axiom>Marijuana SubClassOf Antiemetic Agent</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Marijuana</Concept>
                        <WitnessAxioms>
                           <Axiom>Marijuana SubClassOf Adjuvant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Adjuvant</Concept>
                        <WitnessAxioms>
                           <Axiom>Marijuana SubClassOf Adjuvant</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="827">
               <Axiom>Marijuana SubClassOf Substance of Abuse</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Marijuana</Concept>
                        <WitnessAxioms>
                           <Axiom>Marijuana SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Substance of Abuse</Concept>
                        <WitnessAxioms>
                           <Axiom>Marijuana SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="828">
               <Axiom>Metastatic Chondrosarcoma EquivalentTo Chondrosarcoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q15-qter) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7p13-pter) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 18p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 4) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q24-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(11p13-pter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q25)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q21-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(1p13-22)) and (Disease_May_Have_Cytogenetic_Abnormality some del(1p36)) and (Disease_May_Have_Cytogenetic_Abnormality some del(22q13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(5q13-31)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q22-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(9p22-pter)) and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="829">
               <Axiom>Metastatic Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="895">
               <Axiom>Metastatic Hodgkin's Lymphoma to Cerebral Hemisphere EquivalentTo Hodgkin's Lymphoma and (Disease_Has_Finding only Secondary Lesion) and (Disease_Has_Metastatic_Anatomic_Site only Cerebral Hemisphere)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="830">
               <Axiom>Metastatic Melanoma EquivalentTo Melanoma and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="831">
               <Axiom>Metastatic Osteosarcoma EquivalentTo Osteosarcoma and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="833">
               <Axiom>Methaqualone SubClassOf Substance of Abuse</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Methaqualone</Concept>
                        <WitnessAxioms>
                           <Axiom>Methaqualone SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Substance of Abuse</Concept>
                        <WitnessAxioms>
                           <Axiom>Methaqualone SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="834">
               <Axiom>Microcystic Adnexal Carcinoma EquivalentTo Eccrine Carcinoma and (Disease_Has_Finding only Microcystic Change) and (Disease_May_Have_Finding only Desmoplastic Stroma Formation)</Axiom>
               <ConceptChanges size="5">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Microcystic Adnexal Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Microcystic Adnexal Carcinoma SubClassOf Eccrine Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Eccrine Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Microcystic Adnexal Carcinoma SubClassOf Eccrine Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="3">
                     <Specialisation>
                        <Concept>Microcystic Adnexal Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Microcystic Adnexal Carcinoma SubClassOf Malignant Eccrine Neoplasm</Axiom>
                           <Axiom>Microcystic Adnexal Carcinoma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Malignant Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Microcystic Adnexal Carcinoma SubClassOf Malignant Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Microcystic Adnexal Carcinoma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="743">
               <Axiom>Mixed Tumor of the Skin (Chondroid Syringoma) SubClassOf Benign Eccrine Neoplasm</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Mixed Tumor of the Skin (Chondroid Syringoma)</Concept>
                        <WitnessAxioms>
                           <Axiom>Mixed Tumor of the Skin (Chondroid Syringoma) SubClassOf Benign Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Mixed Tumor of the Skin (Chondroid Syringoma) SubClassOf Benign Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Mixed Tumor of the Skin (Chondroid Syringoma)</Concept>
                        <WitnessAxioms>
                           <Axiom>Mixed Tumor of the Skin (Chondroid Syringoma) SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Mixed Tumor of the Skin (Chondroid Syringoma) SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="835">
               <Axiom>Mucoepidermoid Skin Carcinoma EquivalentTo Eccrine Carcinoma and Mucoepidermoid Carcinoma</Axiom>
               <ConceptChanges size="5">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Mucoepidermoid Skin Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Mucoepidermoid Skin Carcinoma SubClassOf Eccrine Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Eccrine Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Mucoepidermoid Skin Carcinoma SubClassOf Eccrine Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="3">
                     <Specialisation>
                        <Concept>Mucoepidermoid Skin Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Mucoepidermoid Skin Carcinoma SubClassOf Eccrine Neoplasm</Axiom>
                           <Axiom>Mucoepidermoid Skin Carcinoma SubClassOf Malignant Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Malignant Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Mucoepidermoid Skin Carcinoma SubClassOf Malignant Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Mucoepidermoid Skin Carcinoma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="836">
               <Axiom>Muramyl Dipeptide SubClassOf Peptide</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Muramyl Dipeptide</Concept>
                        <WitnessAxioms>
                           <Axiom>Muramyl Dipeptide SubClassOf Peptide</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Peptide</Concept>
                        <WitnessAxioms>
                           <Axiom>Muramyl Dipeptide SubClassOf Peptide</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Muramyl Dipeptide</Concept>
                        <WitnessAxioms>
                           <Axiom>Muramyl Dipeptide SubClassOf Organic Chemical</Axiom>
                           <Axiom>Muramyl Dipeptide SubClassOf Amino Acid, Peptide, or Protein</Axiom>
                           <Axiom>Muramyl Dipeptide SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Amino Acid, Peptide, or Protein</Concept>
                        <WitnessAxioms>
                           <Axiom>Muramyl Dipeptide SubClassOf Amino Acid, Peptide, or Protein</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="837">
               <Axiom>Nitrogen Dioxide SubClassOf Inorganic Chemical</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Nitrogen Dioxide</Concept>
                        <WitnessAxioms>
                           <Axiom>Nitrogen Dioxide SubClassOf Inorganic Chemical</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Inorganic Chemical</Concept>
                        <WitnessAxioms>
                           <Axiom>Nitrogen Dioxide SubClassOf Inorganic Chemical</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Nitrogen Dioxide</Concept>
                        <WitnessAxioms>
                           <Axiom>Nitrogen Dioxide SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Drugs and Chemicals, Structural Classification</Concept>
                        <WitnessAxioms>
                           <Axiom>Nitrogen Dioxide SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="838">
               <Axiom>Ovarian Mixed Epithelial Tumor EquivalentTo Ovarian Surface Epithelial-Stromal Tumor and (Disease_May_Have_Abnormal_Cell some Neoplastic Epithelial Cell with Intracytoplasmic Mucin) and (Disease_May_Have_Abnormal_Cell some Neoplastic Serous Epithelial Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Transitional Cell) and (Disease_May_Have_Finding some Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present) and (Disease_May_Have_Molecular_Abnormality some KRAS2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Finding only Mixed Epithelial Cell Population)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="839">
               <Axiom>PHA-739358 SubClassOf Serine Threonine Kinase Inhibitor</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>PHA-739358</Concept>
                        <WitnessAxioms>
                           <Axiom>PHA-739358 SubClassOf Serine Threonine Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Serine Threonine Kinase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>PHA-739358 SubClassOf Serine Threonine Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>PHA-739358</Concept>
                        <WitnessAxioms>
                           <Axiom>PHA-739358 SubClassOf Protein Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Protein Kinase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>PHA-739358 SubClassOf Protein Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="840">
               <Axiom>PHA-739358 SubClassOf Signal Transduction Inhibitor</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>PHA-739358</Concept>
                        <WitnessAxioms>
                           <Axiom>PHA-739358 SubClassOf Signal Transduction Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Signal Transduction Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>PHA-739358 SubClassOf Signal Transduction Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>PHA-739358</Concept>
                        <WitnessAxioms>
                           <Axiom>PHA-739358 SubClassOf Antineoplastic Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Antineoplastic Agent</Concept>
                        <WitnessAxioms>
                           <Axiom>PHA-739358 SubClassOf Antineoplastic Agent</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="841">
               <Axiom>Pancreatic Intraductal Papillary-Mucinous Neoplasm EquivalentTo Pancreatic Exocrine Neoplasm and (Disease_May_Have_Associated_Disease some Diabetes Mellitus) and (Disease_May_Have_Associated_Disease some Pancreatitis) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 18q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Finding some Abdominal Pain) and (Disease_May_Have_Finding some Jaundice) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Mucoid Stroma Formation) and (Disease_Has_Finding only Papillary Pattern) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue) and (Disease_Has_Primary_Anatomic_Site only Exocrine Pancreas)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="842">
               <Axiom>Pancreatic Polypeptide SubClassOf Peptide</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Pancreatic Polypeptide</Concept>
                        <WitnessAxioms>
                           <Axiom>Pancreatic Polypeptide SubClassOf Peptide</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Peptide</Concept>
                        <WitnessAxioms>
                           <Axiom>Pancreatic Polypeptide SubClassOf Peptide</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Pancreatic Polypeptide</Concept>
                        <WitnessAxioms>
                           <Axiom>Pancreatic Polypeptide SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                           <Axiom>Pancreatic Polypeptide SubClassOf Amino Acid, Peptide, or Protein</Axiom>
                           <Axiom>Pancreatic Polypeptide SubClassOf Organic Chemical</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Amino Acid, Peptide, or Protein</Concept>
                        <WitnessAxioms>
                           <Axiom>Pancreatic Polypeptide SubClassOf Amino Acid, Peptide, or Protein</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="843">
               <Axiom>Papillary Eccrine Adenoma SubClassOf Benign Eccrine Neoplasm</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Papillary Eccrine Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Benign Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Benign Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Papillary Eccrine Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Benign Sweat Gland Neoplasm</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Eccrine Neoplasm</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Skin Appendage Neoplasm</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Benign Skin Neoplasm</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Neoplasm by Site</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Disorder by Site</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Benign Skin Appendage Neoplasm</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Sweat Gland Neoplasm</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Skin Disorder</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Disorder by Site</Concept>
                        <WitnessAxioms>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="844">
               <Axiom>Papillary Eccrine Adenoma SubClassOf Sweat Gland Adenoma</Axiom>
               <ConceptChanges size="6">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Papillary Eccrine Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Sweat Gland Adenoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Sweat Gland Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Sweat Gland Adenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="4">
                     <Specialisation>
                        <Concept>Papillary Eccrine Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Skin Appendage Neoplasm</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Benign Skin Neoplasm</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Neoplasm by Site</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Disorder by Site</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Benign Skin Appendage Neoplasm</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Adenoma</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Skin Appendage Adenoma</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Skin Disorder</Axiom>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Skin Appendage Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Skin Appendage Adenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Disorder by Site</Concept>
                        <WitnessAxioms>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Papillary Eccrine Adenoma SubClassOf Adenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="781">
               <Axiom>Papillary Eccrine Carcinoma EquivalentTo Eccrine Carcinoma and Papillary Carcinoma and (Disease_Has_Finding only Papillary Pattern) and (Disease_Has_Primary_Anatomic_Site only Extremity Part)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="846">
               <Axiom>Papillary Renal Cell Carcinoma EquivalentTo Renal Cell Carcinoma and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 7) and (Disease_May_Have_Finding some Cystic Change) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_May_Have_Finding some Tubular Pattern) and (Disease_Has_Finding only Papillary Pattern)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="848">
               <Axiom>Phencyclidine SubClassOf Substance of Abuse</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Phencyclidine</Concept>
                        <WitnessAxioms>
                           <Axiom>Phencyclidine SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Substance of Abuse</Concept>
                        <WitnessAxioms>
                           <Axiom>Phencyclidine SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="849">
               <Axiom>Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia SubClassOf Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(p24;p13)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="850">
               <Axiom>Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia SubClassOf Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(q34;p13)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="851">
               <Axiom>Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia SubClassOf Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(p24;q11)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="852">
               <Axiom>Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia SubClassOf Disease_May_Have_Molecular_Abnormality some BCR-JAK2 Fusion Protein Expression</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="853">
               <Axiom>Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia SubClassOf Disease_May_Have_Molecular_Abnormality some TEL-ABL Fusion Protein Expression</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="854">
               <Axiom>Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia SubClassOf Disease_May_Have_Molecular_Abnormality some TEL-JAK2 Fusion Protein Expression</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="856">
               <Axiom>Pilomatricoma SubClassOf Disease_Excludes_Finding only Geographic Necrosis</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="857">
               <Axiom>Position Delta SubClassOf Delta</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Position Delta</Concept>
                        <WitnessAxioms>
                           <Axiom>Position Delta SubClassOf Delta</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Delta</Concept>
                        <WitnessAxioms>
                           <Axiom>Position Delta SubClassOf Delta</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Position Delta</Concept>
                        <WitnessAxioms>
                           <Axiom>Position Delta SubClassOf Property or Attribute</Axiom>
                           <Axiom>Position Delta SubClassOf Qualifier</Axiom>
                           <Axiom>Position Delta SubClassOf Properties_or_Attributes_Kind</Axiom>
                           <Axiom>Position Delta SubClassOf General Qualifier</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Property or Attribute</Concept>
                        <WitnessAxioms>
                           <Axiom>Position Delta SubClassOf Property or Attribute</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="858">
               <Axiom>Presymptomatic Cancer SubClassOf Neoplasm by Special Category</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Presymptomatic Cancer</Concept>
                        <WitnessAxioms>
                           <Axiom>Presymptomatic Cancer SubClassOf Neoplasm by Special Category</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Neoplasm by Special Category</Concept>
                        <WitnessAxioms>
                           <Axiom>Presymptomatic Cancer SubClassOf Neoplasm by Special Category</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Presymptomatic Cancer</Concept>
                        <WitnessAxioms>
                           <Axiom>Presymptomatic Cancer SubClassOf Neoplasm</Axiom>
                           <Axiom>Presymptomatic Cancer SubClassOf Diseases and Disorders</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Presymptomatic Cancer SubClassOf Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="728">
               <Axiom>Primary Cutaneous Mucinous Carcinoma EquivalentTo Eccrine Carcinoma and Mucinous Adenocarcinoma and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Finding only Mucoid Stroma Formation)</Axiom>
               <ConceptChanges size="5">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Primary Cutaneous Mucinous Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Primary Cutaneous Mucinous Carcinoma SubClassOf Eccrine Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Eccrine Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Primary Cutaneous Mucinous Carcinoma SubClassOf Eccrine Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="3">
                     <Specialisation>
                        <Concept>Primary Cutaneous Mucinous Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Primary Cutaneous Mucinous Carcinoma SubClassOf Malignant Eccrine Neoplasm</Axiom>
                           <Axiom>Primary Cutaneous Mucinous Carcinoma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Malignant Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Primary Cutaneous Mucinous Carcinoma SubClassOf Malignant Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Primary Cutaneous Mucinous Carcinoma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="860">
               <Axiom>Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor EquivalentTo Primary Intraosseous Squamous Cell Carcinoma and (Disease_Has_Associated_Disease only Keratocystic Odontogenic Tumor) and (Disease_Has_Finding only Secondary Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="859">
               <Axiom>Primary Intraosseous Squamous Cell Carcinoma Derived From Odontogenic Cyst EquivalentTo Primary Intraosseous Squamous Cell Carcinoma and (Disease_Has_Finding only Odontogenic Cyst) and (Disease_Has_Finding only Secondary Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="855">
               <Axiom>Proliferating Pilar Tumor SubClassOf Disease_Has_Primary_Anatomic_Site only Pilar Sheath</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="861">
               <Axiom>Promethazine Hydrochloride SubClassOf Promethazine</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Promethazine Hydrochloride</Concept>
                        <WitnessAxioms>
                           <Axiom>Promethazine Hydrochloride SubClassOf Promethazine</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Promethazine</Concept>
                        <WitnessAxioms>
                           <Axiom>Promethazine Hydrochloride SubClassOf Promethazine</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="862">
               <Axiom>Propionic Acid SubClassOf Industrial Aid</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Propionic Acid</Concept>
                        <WitnessAxioms>
                           <Axiom>Propionic Acid SubClassOf Industrial Aid</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Industrial Aid</Concept>
                        <WitnessAxioms>
                           <Axiom>Propionic Acid SubClassOf Industrial Aid</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Propionic Acid</Concept>
                        <WitnessAxioms>
                           <Axiom>Propionic Acid SubClassOf Industrial Product</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Industrial Product</Concept>
                        <WitnessAxioms>
                           <Axiom>Propionic Acid SubClassOf Industrial Product</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="863">
               <Axiom>Prostate Ductal Adenocarcinoma, Papillary Pattern EquivalentTo Prostate Ductal Adenocarcinoma and (Disease_Has_Finding only Papillary Pattern)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="864">
               <Axiom>Psilocybin SubClassOf Anxiolytic</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Psilocybin</Concept>
                        <WitnessAxioms>
                           <Axiom>Psilocybin SubClassOf Anxiolytic</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Anxiolytic</Concept>
                        <WitnessAxioms>
                           <Axiom>Psilocybin SubClassOf Anxiolytic</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Psilocybin</Concept>
                        <WitnessAxioms>
                           <Axiom>Psilocybin SubClassOf Analgesic Agent</Axiom>
                           <Axiom>Psilocybin SubClassOf Adjuvant Analgesic</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Analgesic Agent</Concept>
                        <WitnessAxioms>
                           <Axiom>Psilocybin SubClassOf Analgesic Agent</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="865">
               <Axiom>Psilocybin SubClassOf Substance of Abuse</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Psilocybin</Concept>
                        <WitnessAxioms>
                           <Axiom>Psilocybin SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Substance of Abuse</Concept>
                        <WitnessAxioms>
                           <Axiom>Psilocybin SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="866">
               <Axiom>Quantitation SubClassOf Property or Attribute</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Quantitation</Concept>
                        <WitnessAxioms>
                           <Axiom>Quantitation SubClassOf Property or Attribute</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Property or Attribute</Concept>
                        <WitnessAxioms>
                           <Axiom>Quantitation SubClassOf Property or Attribute</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Quantitation</Concept>
                        <WitnessAxioms>
                           <Axiom>Quantitation SubClassOf Properties_or_Attributes_Kind</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Properties_or_Attributes_Kind</Concept>
                        <WitnessAxioms>
                           <Axiom>Quantitation SubClassOf Properties_or_Attributes_Kind</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="867">
               <Axiom>Radiation-Related Malignant Neoplasm EquivalentTo Radiation-Related Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="868">
               <Axiom>Recurrent Carcinoma EquivalentTo Carcinoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="869">
               <Axiom>Recurrent Childhood Hepatocellular Carcinoma EquivalentTo Childhood Hepatocellular Carcinoma and Recurrent Carcinoma and Recurrent Childhood Liver Cancer</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="870">
               <Axiom>Recurrent Childhood Large Cell Lymphoma SubClassOf Disease_Has_Finding only Recurrent Disease</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="871">
               <Axiom>Recurrent Cholangiocarcinoma EquivalentTo Cholangiocarcinoma and Recurrent Carcinoma</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="872">
               <Axiom>Recurrent Chondrosarcoma EquivalentTo Chondrosarcoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q15-qter) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7p13-pter) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 18p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 4) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q24-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(11p13-pter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q25)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q21-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(1p13-22)) and (Disease_May_Have_Cytogenetic_Abnormality some del(1p36)) and (Disease_May_Have_Cytogenetic_Abnormality some del(22q13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(5q13-31)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q22-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(9p22-pter)) and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="873">
               <Axiom>Recurrent Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="874">
               <Axiom>Recurrent Extrahepatic Bile Duct Carcinoma EquivalentTo Extrahepatic Bile Duct Carcinoma and Recurrent Carcinoma</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="891">
               <Axiom>Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="875">
               <Axiom>Recurrent High Grade Adult Non-Hodgkin's Lymphoma SubClassOf Disease_Has_Finding only Recurrent Disease</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="876">
               <Axiom>Recurrent Kaposi Sarcoma EquivalentTo Kaposi's Sarcoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="877">
               <Axiom>Recurrent Low Grade Adult Non-Hodgkin's Lymphoma SubClassOf Disease_Has_Finding only Recurrent Disease</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="878">
               <Axiom>Recurrent Malignant Duodenal Neoplasm EquivalentTo Malignant Duodenal Neoplasm and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="879">
               <Axiom>Recurrent Malignant Gastric Neoplasm EquivalentTo Malignant Gastric Neoplasm and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="880">
               <Axiom>Recurrent Malignant Hypopharyngeal Neoplasm EquivalentTo Malignant Hypopharyngeal Neoplasm and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="881">
               <Axiom>Recurrent Malignant Nasopharyngeal Neoplasm EquivalentTo Malignant Nasopharyngeal Neoplasm and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="882">
               <Axiom>Recurrent Malignant Neoplasm of Salivary Gland EquivalentTo Malignant Salivary Gland Neoplasm and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="883">
               <Axiom>Recurrent Malignant Oral Neoplasm EquivalentTo Malignant Oral Neoplasm and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="884">
               <Axiom>Recurrent Melanoma EquivalentTo Melanoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="885">
               <Axiom>Recurrent Osteosarcoma EquivalentTo Osteosarcoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="886">
               <Axiom>Recurrent Ovarian Germ Cell Tumor EquivalentTo Malignant Ovarian Germ Cell Tumor and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some i(12p)) and (Disease_May_Have_Finding some Abdominal Mass) and (Disease_May_Have_Finding some Abdominal Pain) and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="887">
               <Axiom>Recurrent Primitive Neuroectodermal Tumor EquivalentTo Primitive Neuroectodermal Tumor and (Disease_Has_Abnormal_Cell only Malignant Neuroectodermal Cell) and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="889">
               <Axiom>Recurrent Renal Wilms Tumor EquivalentTo Renal Wilms Tumor and (Disease_May_Have_Molecular_Abnormality some WT1 Gene Inactivation) and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="888">
               <Axiom>Recurrent Rhabdomyosarcoma EquivalentTo Rhabdomyosarcoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="890">
               <Axiom>Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and (Disease_Has_Finding only Refractory Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="892">
               <Axiom>Sarcomatoid Carcinoma EquivalentTo Carcinoma and (Disease_Has_Abnormal_Cell only Malignant Epithelial Spindle Cell) and (Disease_Has_Finding only Anaplastic Lesion) and (Disease_Has_Finding only Poorly Differentiated Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="893">
               <Axiom>Secondary Acute Myeloid Leukemia EquivalentTo Acute Myeloid Leukemia and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloid Blast) and (Disease_Has_Finding only Immature Myeloid Cells Increased in Bone Marrow) and (Disease_Has_Finding only Secondary Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="894">
               <Axiom>Secondary Carcinoma EquivalentTo Carcinoma and Secondary Neoplasm</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="896">
               <Axiom>Secondary Chondrosarcoma EquivalentTo Bone Sarcoma and Chondrosarcoma and (Disease_May_Have_Associated_Disease some Enchondroma) and (Disease_May_Have_Associated_Disease some Enchondromatosis) and (Disease_May_Have_Associated_Disease some Maffucci Syndrome) and (Disease_May_Have_Associated_Disease some Osteochondroma) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q15-qter) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7p13-pter) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 18p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 4) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q24-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(11p13-pter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q25)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q21-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(1p13-22)) and (Disease_May_Have_Cytogenetic_Abnormality some del(1p36)) and (Disease_May_Have_Cytogenetic_Abnormality some del(22q13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(5q13-31)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q22-qter)) and (Disease_May_Have_Cytogenetic_Abnormality some del(9p22-pter)) and (Disease_Has_Finding only Secondary Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="897">
               <Axiom>Secondary Myelodysplastic Syndrome EquivalentTo Myelodysplastic Syndrome and (Disease_Excludes_Finding only Primary Lesion) and (Disease_Has_Finding only Secondary Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="898">
               <Axiom>Secondary Osteosarcoma EquivalentTo Bone Osteosarcoma and (Disease_May_Have_Finding some Lytic Bone Lesion) and (Disease_May_Have_Finding some Osteosclerotic Lesion) and (Disease_May_Have_Finding some Pain) and (Disease_Has_Finding only High Grade Lesion) and (Disease_Has_Finding only Osteoid Formation) and (Disease_Has_Finding only Secondary Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="899">
               <Axiom>Sodium Carbonate SubClassOf Essential Minor Component of Pharmaceutical Excipient</Axiom>
               <ConceptChanges size="5">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Sodium Carbonate</Concept>
                        <WitnessAxioms>
                           <Axiom>Sodium Carbonate SubClassOf Essential Minor Component of Pharmaceutical Excipient</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Essential Minor Component of Pharmaceutical Excipient</Concept>
                        <WitnessAxioms>
                           <Axiom>Sodium Carbonate SubClassOf Essential Minor Component of Pharmaceutical Excipient</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="3">
                     <Specialisation>
                        <Concept>Sodium Carbonate</Concept>
                        <WitnessAxioms>
                           <Axiom>Sodium Carbonate SubClassOf Pharmaceutical Excipient</Axiom>
                           <Axiom>Sodium Carbonate SubClassOf Industrial Aid</Axiom>
                           <Axiom>Sodium Carbonate SubClassOf Industrial Product</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Pharmaceutical Excipient</Concept>
                        <WitnessAxioms>
                           <Axiom>Sodium Carbonate SubClassOf Pharmaceutical Excipient</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Industrial Product</Concept>
                        <WitnessAxioms>
                           <Axiom>Sodium Carbonate SubClassOf Industrial Product</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="900">
               <Axiom>Solar Lentigo SubClassOf Pre-Malignant Skin Epithelial Lesion</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Solar Lentigo</Concept>
                        <WitnessAxioms>
                           <Axiom>Solar Lentigo SubClassOf Pre-Malignant Skin Epithelial Lesion</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Pre-Malignant Skin Epithelial Lesion</Concept>
                        <WitnessAxioms>
                           <Axiom>Solar Lentigo SubClassOf Pre-Malignant Skin Epithelial Lesion</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Solar Lentigo</Concept>
                        <WitnessAxioms>
                           <Axiom>Solar Lentigo SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Solar Lentigo SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Solar Lentigo SubClassOf Cutaneous Precancerous Condition</Axiom>
                           <Axiom>Solar Lentigo SubClassOf Precancerous Condition by Site</Axiom>
                           <Axiom>Solar Lentigo SubClassOf Neoplasm by Site</Axiom>
                           <Axiom>Solar Lentigo SubClassOf Precancerous Condition</Axiom>
                           <Axiom>Solar Lentigo SubClassOf Cancer-Related Condition</Axiom>
                           <Axiom>Solar Lentigo SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Solar Lentigo SubClassOf Skin Neoplasm</Axiom>
                           <Axiom>Solar Lentigo SubClassOf Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Neoplasm by Morphology</Concept>
                        <WitnessAxioms>
                           <Axiom>Solar Lentigo SubClassOf Neoplasm by Morphology</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="901">
               <Axiom>Sorafenib SubClassOf Raf Kinase Inhibitor</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Sorafenib</Concept>
                        <WitnessAxioms>
                           <Axiom>Sorafenib SubClassOf Raf Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Raf Kinase Inhibitor</Concept>
                        <WitnessAxioms>
                           <Axiom>Sorafenib SubClassOf Raf Kinase Inhibitor</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="823">
               <Axiom>Spiradenocarcinoma EquivalentTo Spiradenoma and Malignant Eccrine Neoplasm</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Spiradenocarcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Spiradenocarcinoma SubClassOf Spiradenoma</Axiom>
                           <Axiom>Spiradenocarcinoma SubClassOf Malignant Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Malignant Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Spiradenocarcinoma SubClassOf Malignant Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Carcinoma ex Eccrine Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Carcinoma ex Eccrine Spiradenoma SubClassOf Eccrine Neoplasm</Axiom>
                           <Axiom>Carcinoma ex Eccrine Spiradenoma SubClassOf Spiradenoma</Axiom>
                           <Axiom>Carcinoma ex Eccrine Spiradenoma SubClassOf Malignant Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Carcinoma ex Eccrine Spiradenoma SubClassOf Spiradenoma</Axiom>
                           <Axiom>Malignant Breast Eccrine Spiradenoma SubClassOf Spiradenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="783">
               <Axiom>Spiradenoma SubClassOf Eccrine Neoplasm</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Spiradenoma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Eccrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Spiradenoma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Carcinoma ex Eccrine Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Carcinoma ex Eccrine Spiradenoma SubClassOf Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Disorder by Site</Concept>
                        <WitnessAxioms>
                           <Axiom>Benign Eccrine Spiradenoma SubClassOf Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="902">
               <Axiom>Squamous Cell Epithelioma SubClassOf Epithelioma</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Squamous Cell Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Epithelioma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Epithelioma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Squamous Cell Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Neoplasm</Axiom>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Neoplasm by Morphology</Concept>
                        <WitnessAxioms>
                           <Axiom>Squamous Cell Epithelioma SubClassOf Neoplasm by Morphology</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="903">
               <Axiom>Stage 0a Urethral Cancer EquivalentTo Stage 0 Urethral Cancer and (Disease_Has_Finding only Papillary Pattern) and (Disease_Is_Stage only Stage 0a)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="904">
               <Axiom>Stilbene Aldehyde SubClassOf Industrial Aid</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Stilbene Aldehyde</Concept>
                        <WitnessAxioms>
                           <Axiom>Stilbene Aldehyde SubClassOf Industrial Aid</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Industrial Aid</Concept>
                        <WitnessAxioms>
                           <Axiom>Stilbene Aldehyde SubClassOf Industrial Aid</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Stilbene Aldehyde</Concept>
                        <WitnessAxioms>
                           <Axiom>Stilbene Aldehyde SubClassOf Industrial Product</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Industrial Product</Concept>
                        <WitnessAxioms>
                           <Axiom>Stilbene Aldehyde SubClassOf Industrial Product</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="905">
               <Axiom>Succinic Acid SubClassOf Flavor Excipient</Axiom>
               <ConceptChanges size="5">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Succinic Acid</Concept>
                        <WitnessAxioms>
                           <Axiom>Succinic Acid SubClassOf Flavor Excipient</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Flavor Excipient</Concept>
                        <WitnessAxioms>
                           <Axiom>Succinic Acid SubClassOf Flavor Excipient</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="3">
                     <Specialisation>
                        <Concept>Succinic Acid</Concept>
                        <WitnessAxioms>
                           <Axiom>Succinic Acid SubClassOf Pharmaceutical Excipient</Axiom>
                           <Axiom>Succinic Acid SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                           <Axiom>Succinic Acid SubClassOf Industrial Product</Axiom>
                           <Axiom>Succinic Acid SubClassOf Industrial Aid</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Pharmaceutical Excipient</Concept>
                        <WitnessAxioms>
                           <Axiom>Succinic Acid SubClassOf Pharmaceutical Excipient</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Industrial Product</Concept>
                        <WitnessAxioms>
                           <Axiom>Succinic Acid SubClassOf Industrial Product</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="910">
               <Axiom>Sweat Gland Tubular Carcinoma EquivalentTo Apocrine Gland Carcinoma and (Disease_May_Have_Finding some Aggressive Clinical Course) and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Finding only Tubular Pattern)</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Tubular Breast Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Invasive Apocrine Breast Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Apocrine Gland Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Sweat Gland Tubular Carcinoma SubClassOf Apocrine Gland Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Sweat Gland Tubular Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Sweat Gland Tubular Carcinoma SubClassOf Apocrine Neoplasm</Axiom>
                           <Axiom>Sweat Gland Tubular Carcinoma SubClassOf Malignant Apocrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Skin Appendage Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Skin Appendage Neoplasm</Axiom>
                           <Axiom>Gastric Tubular Adenocarcinoma SubClassOf Skin Appendage Neoplasm</Axiom>
                           <Axiom>Cholangiolocellular Carcinoma SubClassOf Skin Appendage Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="906">
               <Axiom>Syringadenoma SubClassOf Apocrine Adenoma</Axiom>
               <ConceptChanges size="8">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Syringadenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringadenoma SubClassOf Apocrine Adenoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Apocrine Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringadenoma SubClassOf Apocrine Adenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="6">
                     <Specialisation>
                        <Concept>Syringocystadenoma Papilliferum</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringocystadenoma Papilliferum SubClassOf Apocrine Neoplasm</Axiom>
                           <Axiom>Syringocystadenoma Papilliferum SubClassOf Apocrine Adenoma</Axiom>
                           <Axiom>Syringocystadenoma Papilliferum SubClassOf Benign Apocrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Specialisation>
                        <Concept>Syringadenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringadenoma SubClassOf Sweat Gland Neoplasm</Axiom>
                           <Axiom>Syringadenoma SubClassOf Skin Neoplasm</Axiom>
                           <Axiom>Syringadenoma SubClassOf Disorder by Site</Axiom>
                           <Axiom>Syringadenoma SubClassOf Benign Sweat Gland Neoplasm</Axiom>
                           <Axiom>Syringadenoma SubClassOf Skin Appendage Neoplasm</Axiom>
                           <Axiom>Syringadenoma SubClassOf Sweat Gland Adenoma</Axiom>
                           <Axiom>Syringadenoma SubClassOf Adenoma</Axiom>
                           <Axiom>Syringadenoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Syringadenoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Syringadenoma SubClassOf Benign Skin Neoplasm</Axiom>
                           <Axiom>Syringadenoma SubClassOf Benign Skin Appendage Neoplasm</Axiom>
                           <Axiom>Syringadenoma SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Syringadenoma SubClassOf Skin Appendage Adenoma</Axiom>
                           <Axiom>Syringadenoma SubClassOf Neoplasm</Axiom>
                           <Axiom>Syringadenoma SubClassOf Neoplasm by Site</Axiom>
                           <Axiom>Syringadenoma SubClassOf Skin Disorder</Axiom>
                           <Axiom>Syringadenoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Syringadenoma SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Syringadenoma SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Syringadenoma SubClassOf Apocrine Neoplasm</Axiom>
                           <Axiom>Syringadenoma SubClassOf Benign Apocrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Apocrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringocystadenoma Papilliferum SubClassOf Benign Apocrine Neoplasm</Axiom>
                           <Axiom>Syringadenoma SubClassOf Benign Apocrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Skin Appendage Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringadenoma SubClassOf Skin Appendage Adenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Disorder by Site</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringadenoma SubClassOf Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Adenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringadenoma SubClassOf Adenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="847">
               <Axiom>Syringocystadenoma Papilliferum SubClassOf Syringadenoma</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Syringocystadenoma Papilliferum</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringocystadenoma Papilliferum SubClassOf Syringadenoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Syringadenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringocystadenoma Papilliferum SubClassOf Syringadenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Syringocystadenoma Papilliferum</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringocystadenoma Papilliferum SubClassOf Apocrine Neoplasm</Axiom>
                           <Axiom>Syringocystadenoma Papilliferum SubClassOf Apocrine Adenoma</Axiom>
                           <Axiom>Syringocystadenoma Papilliferum SubClassOf Benign Apocrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Apocrine Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Syringocystadenoma Papilliferum SubClassOf Benign Apocrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="907">
               <Axiom>Tobacco SubClassOf Substance of Abuse</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Tobacco</Concept>
                        <WitnessAxioms>
                           <Axiom>Tobacco SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Substance of Abuse</Concept>
                        <WitnessAxioms>
                           <Axiom>Tobacco SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Smokeless Tobacco</Concept>
                        <WitnessAxioms>
                           <Axiom>Smokeless Tobacco SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Substance of Abuse</Concept>
                        <WitnessAxioms>
                           <Axiom>Chewing Tobacco SubClassOf Substance of Abuse</Axiom>
                           <Axiom>Smokeless Tobacco SubClassOf Substance of Abuse</Axiom>
                           <Axiom>Cigar SubClassOf Substance of Abuse</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="908">
               <Axiom>Trichoepithelioma SubClassOf Benign Germinative Follicular Epithelium Neoplasm</Axiom>
               <ConceptChanges size="5">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Trichoepithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichoepithelioma SubClassOf Benign Germinative Follicular Epithelium Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Germinative Follicular Epithelium Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichoepithelioma SubClassOf Benign Germinative Follicular Epithelium Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="3">
                     <Specialisation>
                        <Concept>Trichoepithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichoepithelioma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Skin Appendage Neoplasm</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Hair Disorder</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Skin Neoplasm</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Disorder by Site</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Disease, Disorder or Finding</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Benign Skin Appendage Neoplasm</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Skin Disorder</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Neoplasm by Site</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Findings_and_Disorders_Kind</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Benign Hair Follicle Neoplasm</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Germinative Follicular Epithelium Neoplasm</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Neoplasm</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Diseases and Disorders</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Hair Follicle Neoplasm</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Benign Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Hair Follicle Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Hair Follicle Neoplasm</Axiom>
                           <Axiom>Trichoepithelioma SubClassOf Hair Follicle Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Disorder by Site</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichoepithelioma SubClassOf Disorder by Site</Axiom>
                           <Axiom>Classic Type Trichoepithelioma SubClassOf Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="909">
               <Axiom>Trichofolliculoma SubClassOf Benign Germinative Follicular Epithelium Neoplasm</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Trichofolliculoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichofolliculoma SubClassOf Benign Germinative Follicular Epithelium Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Germinative Follicular Epithelium Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichofolliculoma SubClassOf Benign Germinative Follicular Epithelium Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Trichofolliculoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichofolliculoma SubClassOf Benign Skin Appendage Neoplasm</Axiom>
                           <Axiom>Trichofolliculoma SubClassOf Germinative Follicular Epithelium Neoplasm</Axiom>
                           <Axiom>Trichofolliculoma SubClassOf Benign Hair Follicle Neoplasm</Axiom>
                           <Axiom>Trichofolliculoma SubClassOf Benign Skin Neoplasm</Axiom>
                           <Axiom>Trichofolliculoma SubClassOf Epithelial Neoplasm</Axiom>
                           <Axiom>Trichofolliculoma SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Trichofolliculoma SubClassOf Neoplasm</Axiom>
                           <Axiom>Trichofolliculoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                           <Axiom>Trichofolliculoma SubClassOf Hair Follicle Neoplasm</Axiom>
                           <Axiom>Trichofolliculoma SubClassOf Hair Disorder</Axiom>
                           <Axiom>Trichofolliculoma SubClassOf Skin Appendage Neoplasm</Axiom>
                           <Axiom>Trichofolliculoma SubClassOf Neoplasm by Site</Axiom>
                           <Axiom>Trichofolliculoma SubClassOf Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Hair Follicle Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Trichofolliculoma SubClassOf Hair Follicle Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="911">
               <Axiom>Tubular Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Invasive Breast Carcinoma and Sweat Gland Tubular Carcinoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 11q ATM Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p FHIT Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8p) and (Disease_May_Have_Finding some Calcification) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Excludes_Finding only High Mitotic Activity) and (Disease_Excludes_Finding only Nuclear Pleomorphism)</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Tubular Breast Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Sweat Gland Tubular Carcinoma</Axiom>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Invasive Apocrine Breast Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Sweat Gland Tubular Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Sweat Gland Tubular Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Tubular Breast Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Sweat Gland Neoplasm</Axiom>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Skin Disorder</Axiom>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Malignant Apocrine Neoplasm</Axiom>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Apocrine Breast Carcinoma</Axiom>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Malignant Skin Neoplasm</Axiom>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Malignant Sweat Gland Neoplasm</Axiom>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Apocrine Neoplasm</Axiom>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Skin Appendage Neoplasm</Axiom>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Sweat Gland Carcinoma</Axiom>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Adnexal Carcinoma</Axiom>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Apocrine Gland Carcinoma</Axiom>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Skin Carcinoma</Axiom>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Malignant Skin Appendage Neoplasm</Axiom>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Skin Appendage Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Tubular Breast Carcinoma SubClassOf Skin Appendage Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="912">
               <Axiom>Tumor Specific Peptide SubClassOf Peptide</Axiom>
               <ConceptChanges size="5">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Tumor Specific Peptide</Concept>
                        <WitnessAxioms>
                           <Axiom>Tumor Specific Peptide SubClassOf Peptide</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Peptide</Concept>
                        <WitnessAxioms>
                           <Axiom>Tumor Specific Peptide SubClassOf Peptide</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="3">
                     <Specialisation>
                        <Concept>Tumor Specific Peptide</Concept>
                        <WitnessAxioms>
                           <Axiom>Tumor Specific Peptide SubClassOf Organic Chemical</Axiom>
                           <Axiom>Tumor Specific Peptide SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                           <Axiom>Tumor Specific Peptide SubClassOf Amino Acid, Peptide, or Protein</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Specialisation>
                        <Concept>Peptide 946</Concept>
                        <WitnessAxioms>
                           <Axiom>Peptide 946 SubClassOf Amino Acid, Peptide, or Protein</Axiom>
                           <Axiom>Peptide 946 SubClassOf Peptide</Axiom>
                           <Axiom>Peptide 946 SubClassOf Organic Chemical</Axiom>
                           <Axiom>Peptide 946 SubClassOf Drugs and Chemicals, Structural Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Peptide</Concept>
                        <WitnessAxioms>
                           <Axiom>Peptide 946 SubClassOf Peptide</Axiom>
                           <Axiom>Carcinoembryonic Antigen Peptide 1 SubClassOf Peptide</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="913">
               <Axiom>Vaginal Warty Carcinoma EquivalentTo Human Papilloma Virus-Related Squamous Cell Carcinoma and Vaginal Squamous Cell Carcinoma and (Disease_May_Have_Finding some Postcoital Bleeding) and (Disease_May_Have_Finding some Vaginal Hemorrhage) and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Exophytic Papillary Lesion) and (Disease_Has_Finding only Papillary Pattern)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="914">
               <Axiom>Vascular SubClassOf General Qualifier</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Vascular</Concept>
                        <WitnessAxioms>
                           <Axiom>Vascular SubClassOf General Qualifier</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>General Qualifier</Concept>
                        <WitnessAxioms>
                           <Axiom>Vascular SubClassOf General Qualifier</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="915">
               <Axiom>Verrucous Carcinoma EquivalentTo Squamous Cell Carcinoma and (Disease_Excludes_Finding only Koilocytotic Atypia) and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Endophytic Tumor Growth) and (Disease_Has_Finding only Exophytic Papillary Lesion) and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Finding only Mild Cytologic Atypia) and (Disease_Has_Finding only Papillary Pattern) and (Disease_Has_Finding only Pushing Tumor Margins Present) and (Disease_Has_Finding only Well Differentiated Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="747">
               <Axiom>Verrucous Lesion SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
               <ConceptChanges size="5">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Verrucous Lesion</Concept>
                        <WitnessAxioms>
                           <Axiom>Verrucous Lesion SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Benign Epithelial Skin Neoplasm</Concept>
                        <WitnessAxioms>
                           <Axiom>Verrucous Lesion SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="3">
                     <Specialisation>
                        <Concept>Epidermolysis Verruciformis</Concept>
                        <WitnessAxioms>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Neoplasm by Site</Axiom>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Skin Neoplasm</Axiom>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Neoplasm</Axiom>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Neoplasm by Morphology</Axiom>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Benign Skin Neoplasm</Axiom>
                           <Axiom>Epidermolysis Verruciformis SubClassOf Epithelial Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Specialisation>
                        <Concept>Verrucous Lesion</Concept>
                        <WitnessAxioms>
                           <Axiom>Verrucous Lesion SubClassOf Disorder by Site</Axiom>
                           <Axiom>Verrucous Lesion SubClassOf Benign Skin Neoplasm</Axiom>
                           <Axiom>Verrucous Lesion SubClassOf Skin Neoplasm</Axiom>
                           <Axiom>Verrucous Lesion SubClassOf Epithelial Skin Neoplasm</Axiom>
                           <Axiom>Verrucous Lesion SubClassOf Skin Disorder</Axiom>
                           <Axiom>Verrucous Lesion SubClassOf Neoplasm by Site</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Disorder by Site</Concept>
                        <WitnessAxioms>
                           <Axiom>Verrucous Lesion SubClassOf Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="916">
               <Axiom>Vitamin B6 SubClassOf Miscellaneous Chemoprotective Agent</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Vitamin B6</Concept>
                        <WitnessAxioms>
                           <Axiom>Vitamin B6 SubClassOf Miscellaneous Chemoprotective Agent</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Miscellaneous Chemoprotective Agent</Concept>
                        <WitnessAxioms>
                           <Axiom>Vitamin B6 SubClassOf Miscellaneous Chemoprotective Agent</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Vitamin B6</Concept>
                        <WitnessAxioms>
                           <Axiom>Vitamin B6 SubClassOf Chemoprotective Agent</Axiom>
                           <Axiom>Vitamin B6 SubClassOf Protective Agent</Axiom>
                           <Axiom>Vitamin B6 SubClassOf Pharmacologic Substance</Axiom>
                           <Axiom>Vitamin B6 SubClassOf Drugs and Chemicals, Functional Classification</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Pharmacologic Substance</Concept>
                        <WitnessAxioms>
                           <Axiom>Vitamin B6 SubClassOf Pharmacologic Substance</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
            <Change id="917">
               <Axiom>Vulvar Clear Cell Hidradenocarcinoma EquivalentTo Clear Cell Adenocarcinoma and Malignant Vulvar Sweat Gland Neoplasm and Sweat Gland Carcinoma and Vulvar Adenocarcinoma</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="918">
               <Axiom>Vulvar Trichoblastoma SubClassOf Trichoepithelioma</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Vulvar Trichoblastoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Vulvar Trichoblastoma SubClassOf Trichoepithelioma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Trichoepithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Vulvar Trichoblastoma SubClassOf Trichoepithelioma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="919">
               <Axiom>Vulvar Warty Carcinoma EquivalentTo Human Papilloma Virus-Related Vulvar Squamous Cell Carcinoma and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Exophytic Papillary Lesion) and (Disease_Has_Finding only Papillary Pattern)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="920">
               <Axiom>Warty Carcinoma of the Penis EquivalentTo Human Papilloma Virus-Related Penile Squamous Cell Carcinoma and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Exophytic Papillary Lesion) and (Disease_Has_Finding only Papillary Pattern)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
            </Change>
            <Change id="799">
               <Axiom>Warty Dyskeratoma SubClassOf Non-Neoplastic Hair Disorder</Axiom>
               <ConceptChanges size="5">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Warty Dyskeratoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Warty Dyskeratoma SubClassOf Non-Neoplastic Hair Disorder</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Non-Neoplastic Hair Disorder</Concept>
                        <WitnessAxioms>
                           <Axiom>Warty Dyskeratoma SubClassOf Non-Neoplastic Hair Disorder</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="3">
                     <Specialisation>
                        <Concept>Warty Dyskeratoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Warty Dyskeratoma SubClassOf Hair Disorder</Axiom>
                           <Axiom>Warty Dyskeratoma SubClassOf Non-Neoplastic Skin Disorder</Axiom>
                           <Axiom>Warty Dyskeratoma SubClassOf Non-Neoplastic Disorder</Axiom>
                           <Axiom>Warty Dyskeratoma SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Non-Neoplastic Disorder by Site</Concept>
                        <WitnessAxioms>
                           <Axiom>Warty Dyskeratoma SubClassOf Non-Neoplastic Disorder by Site</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                     <Generalisation>
                        <Concept>Hair Disorder</Concept>
                        <WitnessAxioms>
                           <Axiom>Warty Dyskeratoma SubClassOf Hair Disorder</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
            </Change>
         </PureRemoval>
         <PureRemovalWithRetiredTerms id="premrt" size="5">
            <Change id="925">
               <Axiom>Deprecated Concept SubClassOf Concept_Status</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Deprecated Concept</Concept>
                        <WitnessAxioms>
                           <Axiom>Deprecated Concept SubClassOf Concept_Status</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Concept_Status</Concept>
                        <WitnessAxioms>
                           <Axiom>Deprecated Concept SubClassOf Concept_Status</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Retired_Terms>Concept_Status</Retired_Terms>
            </Change>
            <Change id="926">
               <Axiom>Header Concept SubClassOf Concept_Status</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Header Concept</Concept>
                        <WitnessAxioms>
                           <Axiom>Header Concept SubClassOf Concept_Status</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Concept_Status</Concept>
                        <WitnessAxioms>
                           <Axiom>Header Concept SubClassOf Concept_Status</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Retired_Terms>Concept_Status</Retired_Terms>
            </Change>
            <Change id="927">
               <Axiom>Obsolete Concept SubClassOf Concept_Status</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Obsolete Concept</Concept>
                        <WitnessAxioms>
                           <Axiom>Obsolete Concept SubClassOf Concept_Status</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Concept_Status</Concept>
                        <WitnessAxioms>
                           <Axiom>Obsolete Concept SubClassOf Concept_Status</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Retired_Terms>Concept_Status</Retired_Terms>
            </Change>
            <Change id="928">
               <Axiom>Provisional Concept SubClassOf Concept_Status</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Provisional Concept</Concept>
                        <WitnessAxioms>
                           <Axiom>Provisional Concept SubClassOf Concept_Status</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Concept_Status</Concept>
                        <WitnessAxioms>
                           <Axiom>Provisional Concept SubClassOf Concept_Status</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Retired_Terms>Concept_Status</Retired_Terms>
            </Change>
            <Change id="929">
               <Axiom>UMLS Cross-Reference Concept SubClassOf Concept_Status</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>UMLS Cross-Reference Concept</Concept>
                        <WitnessAxioms>
                           <Axiom>UMLS Cross-Reference Concept SubClassOf Concept_Status</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Concept_Status</Concept>
                        <WitnessAxioms>
                           <Axiom>UMLS Cross-Reference Concept SubClassOf Concept_Status</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Retired_Terms>Concept_Status</Retired_Terms>
            </Change>
         </PureRemovalWithRetiredTerms>
         <RetiredModifiedDefinition id="wkequiv" size="65">
            <Change id="930">
               <Axiom>ALK-Positive Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and (Disease_May_Have_Abnormal_Cell some Doughnut Cell) and (Disease_May_Have_Abnormal_Cell some Hodgkin's-Like Cell) and (Disease_May_Have_Abnormal_Cell some Reed-Sternberg-Like Cell) and (Disease_May_Have_Cytogenetic_Abnormality some inv(2)(p23q35)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q35)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(p23;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;3)(p23;q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;5)(p23;q35)) and (Disease_May_Have_Cytogenetic_Abnormality some t(X;2)(q11-12;p23)) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Molecular_Abnormality some ALO17-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some ATIC-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MSN-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MYH9-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some NPM-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TFG-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Hallmark Cell) and (Disease_Has_Molecular_Abnormality only Rearrangement of 2p23) and (Disease_Has_Normal_Cell_Origin only Activated Mature Cytotoxic T-Lymphocyte)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>ALK-Positive Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and ((((Disease_May_Have_Cytogenetic_Abnormality some inv(2)(p23q35)) and (Disease_May_Have_Molecular_Abnormality some ATIC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q35)) and (Disease_May_Have_Molecular_Abnormality some ALO17-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(p23;q11)) and (Disease_May_Have_Molecular_Abnormality some MYH9-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;3)(p23;q21)) and (Disease_May_Have_Molecular_Abnormality some TFG-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;5)(p23;q35)) and (Disease_May_Have_Molecular_Abnormality some NPM-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(X;2)(q11-12;p23)) and (Disease_May_Have_Molecular_Abnormality some MSN-ALK Fusion Protein Expression)))) and (Disease_May_Have_Abnormal_Cell some Doughnut Cell) and (Disease_May_Have_Abnormal_Cell some Hodgkin's-Like Cell) and (Disease_May_Have_Abnormal_Cell some Reed-Sternberg-Like Cell) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Abnormal_Cell only Hallmark Cell) and (Disease_Has_Molecular_Abnormality only Rearrangement of 2p23) and (Disease_Has_Normal_Cell_Origin only Activated Mature Cytotoxic T-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="931">
               <Axiom>Accelerated Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Basophilia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Finding only Accelerated Phase of Disease) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Splenomegaly)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Accelerated Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and ((((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression)))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Basophilia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Finding only Accelerated Phase of Disease) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Splenomegaly)</Axiom>
               </Source>
            </Change>
            <Change id="956">
               <Axiom>Activated B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Molecular_Abnormality only BCL2 Gene mRNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD44 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Increased NFkappaB Pathway Activation) and (Disease_Has_Molecular_Abnormality only PKCbeta1 Messenger RNA Overexpression) and (Disease_Has_Normal_Cell_Origin only Activated B-Lymphocyte)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Activated B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and ((((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma)))) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Molecular_Abnormality only BCL2 Gene mRNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD44 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only Increased NFkappaB Pathway Activation) and (Disease_Has_Molecular_Abnormality only PKCbeta1 Messenger RNA Overexpression) and (Disease_Has_Normal_Cell_Origin only Activated B-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="932">
               <Axiom>Acute Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and Leukemic Phase of Lymphoma and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Medium-Sized to Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Small T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Polylobated T-Lymphocyte) and (Disease_May_Have_Associated_Disease some Opportunistic Infection) and (Disease_May_Have_Associated_Disease some T-Cell Immunodeficiency) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lactate Dehydrogenase Increased) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Osteoclastic Activity Present) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Finding only Bone Marrow Involvement) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Finding only Pautrier-Like Microabscess Present) and (Disease_Has_Finding only Peripheral Blood Involvement) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Acute Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and Leukemic Phase of Lymphoma and ((((Disease_May_Have_Associated_Disease some Opportunistic Infection) and (Disease_May_Have_Associated_Disease some T-Cell Immunodeficiency)) or ((Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Osteoclastic Activity Present)) or ((Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Finding only Pautrier-Like Microabscess Present)) or ((Disease_Has_Finding only Bone Marrow Involvement) and (Disease_Has_Finding only Peripheral Blood Involvement) and (Disease_Has_Finding only White Blood Cell Count Increased)))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Medium-Sized to Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Small T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Polylobated T-Lymphocyte) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lactate Dehydrogenase Increased) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Lymphadenopathy)</Axiom>
               </Source>
            </Change>
            <Change id="933">
               <Axiom>Acute Monoblastic Leukemia and Acute Monocytic Leukemia EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;22)(p11;q13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;V)(p11;v)) and (Disease_May_Have_Cytogenetic_Abnormality some t(V;11)(v;q23)) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MOZ-V Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some V-MLL Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Acute Monoblastic Leukemia and Acute Monocytic Leukemia EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and ((((Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;V)(p11;v)) and (Disease_May_Have_Molecular_Abnormality some MOZ-V Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(V;11)(v;q23)) and (Disease_May_Have_Molecular_Abnormality some V-MLL Fusion Protein Expression)))) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;22)(p11;q13)) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation)</Axiom>
               </Source>
            </Change>
            <Change id="934">
               <Axiom>Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities EquivalentTo Acute Myeloid Leukemia with Recurrent Genetic Abnormalities and (Disease_May_Have_Abnormal_Cell some Neoplastic Neutrophilic Precursor) and (Disease_May_Have_Cytogenetic_Abnormality some t(10;11)(p11;q23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q23;p13.1)) and (Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;11)(q21;q23)) and (Disease_May_Have_Finding some Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_May_Have_Finding some Disseminated Intravascular Coagulation) and (Disease_May_Have_Finding some Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Therapy-Related Toxicity) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some MLL-AF10 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-AF9 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-EEN Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ELL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ENL Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Immature Myeloid Cells Increased in Bone Marrow) and (Disease_Has_Normal_Cell_Origin only Multipotent Bone Marrow Stem Cell)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities EquivalentTo Acute Myeloid Leukemia with Recurrent Genetic Abnormalities and ((((Disease_May_Have_Cytogenetic_Abnormality some t(10;11)(p11;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF10 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q23;p13.1)) and (Disease_May_Have_Molecular_Abnormality some MLL-EEN Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ELL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ENL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF9 Fusion Protein Expression)))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Neutrophilic Precursor) and (Disease_May_Have_Finding some Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells) and (Disease_May_Have_Finding some Disseminated Intravascular Coagulation) and (Disease_May_Have_Finding some Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells) and (Disease_May_Have_Finding some Therapy-Related Toxicity) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Monocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Immature Myeloid Cells Increased in Bone Marrow) and (Disease_Has_Normal_Cell_Origin only Multipotent Bone Marrow Stem Cell)</Axiom>
               </Source>
            </Change>
            <Change id="935">
               <Axiom>Acute Myeloid Leukemia with Maturation EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast with Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast without Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Cytogenetic_Abnormality some del(12p11p13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(6;9)(p23;q34)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;21)(q22;q22)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Bone Marrow Basophilia) and (Disease_May_Have_Finding some Bone Marrow Dysplasia Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Hemophagocytosis) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some AML1-ETO Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some CEBPA Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some DEK-CAN Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Acute Myeloid Leukemia with Maturation EquivalentTo Acute Myeloid Leukemia not Otherwise Categorized and ((((Disease_May_Have_Cytogenetic_Abnormality some del(12p11p13)) and (Disease_May_Have_Finding some Bone Marrow Basophilia)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(6;9)(p23;q34)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some DEK-CAN Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Finding some Hemophagocytosis)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;21)(q22;q22)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some AML1-ETO Fusion Protein Expression)))) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast with Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neoplastic Myeloblast without Azurophilic Granules) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Bone Marrow Dysplasia Present) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Molecular_Abnormality some CEBPA Gene Mutation) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation)</Axiom>
               </Source>
            </Change>
            <Change id="936">
               <Axiom>Acute Myeloid Leukemia with Multilineage Dysplasia EquivalentTo Acute Myeloid Leukemia and (Disease_May_Have_Abnormal_Cell some Large Multinucleated Erythroid Cell) and (Disease_May_Have_Abnormal_Cell some Megaloblast) and (Disease_May_Have_Abnormal_Cell some Micromegakaryocyte) and (Disease_May_Have_Abnormal_Cell some Monolobed Megakaryocyte) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Abnormal_Cell some Ringed Sideroblast) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 21) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 11q ATM Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 5q) and (Disease_May_Have_Cytogenetic_Abnormality some del(20)(q11)) and (Disease_May_Have_Cytogenetic_Abnormality some del(7)(q11;q36)) and (Disease_May_Have_Cytogenetic_Abnormality some ins(3;3)) and (Disease_May_Have_Cytogenetic_Abnormality some inv(3)(q21q26.2)) and (Disease_May_Have_Cytogenetic_Abnormality some t(3;3)(q21;q26.2)) and (Disease_May_Have_Cytogenetic_Abnormality some t(3;5)(q25;q34)) and (Disease_May_Have_Finding some Granulocytopenia) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Pancytopenia) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines) and (Disease_Has_Finding only Ineffective Hematopoiesis) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Acute Myeloid Leukemia with Multilineage Dysplasia EquivalentTo Acute Myeloid Leukemia and ((((Disease_May_Have_Cytogenetic_Abnormality some ins(3;3)) and (Disease_May_Have_Finding some Thrombocytosis)) or ((Disease_May_Have_Cytogenetic_Abnormality some inv(3)(q21q26.2)) and (Disease_May_Have_Finding some Thrombocytosis)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;3)(q21;q26.2)) and (Disease_May_Have_Finding some Thrombocytosis)))) and (Disease_May_Have_Abnormal_Cell some Large Multinucleated Erythroid Cell) and (Disease_May_Have_Abnormal_Cell some Megaloblast) and (Disease_May_Have_Abnormal_Cell some Micromegakaryocyte) and (Disease_May_Have_Abnormal_Cell some Monolobed Megakaryocyte) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Cytoplasmic Hypogranularity) and (Disease_May_Have_Abnormal_Cell some Neutrophil with Pseudo Pelger-Huet Nucleus) and (Disease_May_Have_Abnormal_Cell some Ringed Sideroblast) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 21) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 11q ATM Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 5q) and (Disease_May_Have_Cytogenetic_Abnormality some del(20)(q11)) and (Disease_May_Have_Cytogenetic_Abnormality some del(7)(q11;q36)) and (Disease_May_Have_Cytogenetic_Abnormality some t(3;5)(q25;q34)) and (Disease_May_Have_Finding some Granulocytopenia) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Pancytopenia) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast) and (Disease_Has_Finding only Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines) and (Disease_Has_Finding only Ineffective Hematopoiesis) and (Disease_Has_Finding only Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells)</Axiom>
               </Source>
            </Change>
            <Change id="937">
               <Axiom>Acute Myelomonocytic Leukemia with Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Abnormal Eosinophil) and (Disease_Has_Finding only Abnormal Eosinophilic Granules Present) and (Disease_Has_Finding only Bone Marrow Eosinophilia)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Acute Myelomonocytic Leukemia with Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and ((((Disease_May_Have_Cytogenetic_Abnormality some inv(16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;16)(p13;q22)) and (Disease_May_Have_Molecular_Abnormality some CBFbeta-MYH11 Fusion Protein Expression)))) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Abnormal Eosinophil) and (Disease_Has_Finding only Abnormal Eosinophilic Granules Present) and (Disease_Has_Finding only Bone Marrow Eosinophilia)</Axiom>
               </Source>
            </Change>
            <Change id="938">
               <Axiom>Acute Myelomonocytic Leukemia without Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some t(6;9)(p23;q34)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(V;11)(v;q23)) and (Disease_May_Have_Finding some Hemophagocytosis) and (Disease_May_Have_Molecular_Abnormality some V-MLL Fusion Protein Expression) and (Disease_Excludes_Abnormal_Cell only Abnormal Eosinophil)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Acute Myelomonocytic Leukemia without Abnormal Eosinophils EquivalentTo Acute Myelomonocytic Leukemia and ((((Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Finding some Hemophagocytosis)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(V;11)(v;q23)) and (Disease_May_Have_Molecular_Abnormality some V-MLL Fusion Protein Expression)))) and (Disease_May_Have_Cytogenetic_Abnormality some t(6;9)(p23;q34)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;11)(p15;p15)) and (Disease_Excludes_Abnormal_Cell only Abnormal Eosinophil)</Axiom>
               </Source>
            </Change>
            <Change id="939">
               <Axiom>Adult Glioblastoma EquivalentTo Adult Astrocytic Tumor and Glioblastoma and (Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Adult Glioblastoma EquivalentTo Adult Astrocytic Tumor and Glioblastoma and ((((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression)))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
               </Source>
            </Change>
            <Change id="940">
               <Axiom>Advanced Favorable Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Excludes_Finding only Localized Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Advanced Favorable Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Excludes_Finding only Localized Disease) and (Disease_Has_Finding only Extensive Stage Lesion)</Axiom>
               </Source>
            </Change>
            <Change id="941">
               <Axiom>Advanced Unfavorable Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Excludes_Finding only Localized Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Advanced Unfavorable Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Excludes_Finding only Localized Disease) and (Disease_Has_Finding only Extensive Stage Lesion)</Axiom>
               </Source>
            </Change>
            <Change id="942">
               <Axiom>Aflatoxins-Related Hepatocellular Carcinoma EquivalentTo Environment-Related Malignant Neoplasm and Hepatocellular Carcinoma</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Aflatoxins-Related Hepatocellular Carcinoma EquivalentTo Environment-Related Malignant Neoplasm and Hepatocellular Carcinoma and (Disease_Has_Finding only Aflatoxins Toxicity)</Axiom>
               </Source>
            </Change>
            <Change id="944">
               <Axiom>Alveolar Rhabdomyosarcoma EquivalentTo Rhabdomyosarcoma and Sarcoma Differentiation Score 3 and (Disease_May_Have_Cytogenetic_Abnormality some t(1;13)(q36;q14)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;13)(q35;q14)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;2)(q35;p23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(X;2)(q13;q35)) and (Disease_May_Have_Molecular_Abnormality some PAX3-AFX Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some PAX3-FKHR Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some PAX3-NCOA1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some PAX7-FKHR Fusion Protein Expression) and (Disease_Excludes_Finding only Well-Circumscribed Lesion) and (Disease_Has_Abnormal_Cell only Round Cell with Primitive Myoblastic Differentiation)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Alveolar Rhabdomyosarcoma EquivalentTo Rhabdomyosarcoma and Sarcoma Differentiation Score 3 and ((((Disease_May_Have_Cytogenetic_Abnormality some t(1;13)(q36;q14)) and (Disease_May_Have_Molecular_Abnormality some PAX3-FKHR Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;13)(q35;q14)) and (Disease_May_Have_Molecular_Abnormality some PAX7-FKHR Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;2)(q35;p23)) and (Disease_May_Have_Molecular_Abnormality some PAX3-NCOA1 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(X;2)(q13;q35)) and (Disease_May_Have_Molecular_Abnormality some PAX3-AFX Fusion Protein Expression)))) and (Disease_Excludes_Finding only Well-Circumscribed Lesion) and (Disease_Has_Abnormal_Cell only Round Cell with Primitive Myoblastic Differentiation)</Axiom>
               </Source>
            </Change>
            <Change id="945">
               <Axiom>Atypical Chronic Myeloid Leukemia EquivalentTo Myelodysplastic/Myeloproliferative Disease and (Disease_May_Have_Abnormal_Cell some Dysplastic Erythroid Precursor) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(p24;p13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(q34;p13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(p24;q11)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Molecular_Abnormality some BCR-JAK2 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TEL-ABL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TEL-JAK2 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Dysplastic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Dysplastic Neutrophil) and (Disease_Has_Finding only Bone Marrow Dysplasia Present) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Increased) and (Disease_Has_Finding only Neutrophilia) and (Disease_Has_Finding only White Blood Cell Count Increased) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Myeloid Stem Cell)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Atypical Chronic Myeloid Leukemia EquivalentTo Myelodysplastic/Myeloproliferative Disease and ((((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(p24;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-JAK2 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;12)(q34;p13)) and (Disease_May_Have_Molecular_Abnormality some TEL-ABL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(p24;q11)) and (Disease_May_Have_Molecular_Abnormality some BCR-JAK2 Fusion Protein Expression)))) and (Disease_May_Have_Abnormal_Cell some Dysplastic Erythroid Precursor) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_Has_Abnormal_Cell only Dysplastic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Dysplastic Neutrophil) and (Disease_Has_Finding only Bone Marrow Dysplasia Present) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Increased) and (Disease_Has_Finding only Neutrophilia) and (Disease_Has_Finding only White Blood Cell Count Increased) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Myeloid Stem Cell)</Axiom>
               </Source>
            </Change>
            <Change id="946">
               <Axiom>Benign Sebaceous Neoplasm EquivalentTo Benign Skin Appendage Neoplasm and Sebaceous Gland Neoplasm</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Benign Sebaceous Neoplasm EquivalentTo Benign Epithelial Skin Neoplasm and Benign Skin Appendage Neoplasm and Sebaceous Gland Neoplasm</Axiom>
               </Source>
            </Change>
            <Change id="947">
               <Axiom>Bilateral Breast Carcinoma EquivalentTo Bilateral Carcinoma and Breast Carcinoma</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Bilateral Breast Carcinoma EquivalentTo Bilateral Carcinoma and Breast Carcinoma and (Disease_Has_Finding only Bilateral Mass)</Axiom>
               </Source>
            </Change>
            <Change id="948">
               <Axiom>Blast Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Neoplastic Blast) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Blast Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and ((((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(3;21)(q26;q22)) and (Disease_May_Have_Molecular_Abnormality some EVI1-AML1 Fusion Protein Expression)))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 8) and (Disease_May_Have_Cytogenetic_Abnormality some i(17q)) and (Disease_May_Have_Cytogenetic_Abnormality some i(19)) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Blasts 20 Percent or More of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Abnormal_Cell only Neoplastic Blast) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
               </Source>
            </Change>
            <Change id="949">
               <Axiom>Brain Glioblastoma EquivalentTo Glioblastoma and (Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Brain Glioblastoma EquivalentTo Glioblastoma and ((((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) or ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression)))) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
               </Source>
            </Change>
            <Change id="950">
               <Axiom>Carcinoma ex Eccrine Spiradenoma EquivalentTo Eccrine Carcinoma and Spiradenocarcinoma and (Disease_Has_Associated_Disease only Spiradenoma) and (Disease_Has_Finding only Secondary Lesion)</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Carcinoma ex Eccrine Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Carcinoma ex Eccrine Spiradenoma SubClassOf Eccrine Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Eccrine Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Carcinoma ex Eccrine Spiradenoma SubClassOf Eccrine Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>Carcinoma ex Eccrine Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Carcinoma ex Eccrine Spiradenoma SubClassOf Eccrine Neoplasm</Axiom>
                           <Axiom>Carcinoma ex Eccrine Spiradenoma SubClassOf Spiradenoma</Axiom>
                           <Axiom>Carcinoma ex Eccrine Spiradenoma SubClassOf Malignant Eccrine Neoplasm</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Spiradenoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Carcinoma ex Eccrine Spiradenoma SubClassOf Spiradenoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>Carcinoma ex Eccrine Spiradenoma EquivalentTo Spiradenocarcinoma and (Disease_Has_Associated_Disease only Spiradenoma) and (Disease_Has_Finding only Secondary Lesion)</Axiom>
               </Source>
            </Change>
            <Change id="951">
               <Axiom>Cervical Mullerian Papilloma EquivalentTo Benign Cervical Neoplasm and Cervical Glandular Neoplasm and Papilloma and (Disease_May_Have_Finding some Squamous Metaplasia) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell with Intracytoplasmic Mucin) and (Disease_Has_Normal_Tissue_Origin only Cervix Epithelium)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Cervical Mullerian Papilloma EquivalentTo Benign Cervical Neoplasm and Cervical Glandular Neoplasm and Papilloma and (Disease_May_Have_Finding some Squamous Metaplasia) and (Disease_Has_Normal_Tissue_Origin only Cervix Epithelium)</Axiom>
               </Source>
            </Change>
            <Change id="952">
               <Axiom>Chordoma EquivalentTo Notochordal Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 20) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 4) and (Disease_Has_Abnormal_Cell only Physaliphorous Cell) and (Disease_Has_Finding only Lobulated Growth Pattern) and (Disease_Has_Finding only Lytic Bone Lesion) and (Disease_Has_Finding only Myxoid Stroma Formation) and (Disease_Has_Finding only Slow Growing Mass) and (Disease_Has_Finding only Solitary Mass)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Chordoma EquivalentTo Notochordal Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 20) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 4) and (Disease_Has_Abnormal_Cell only Physaliphorous Cell) and (Disease_Has_Finding only Lobulated Growth Pattern) and (Disease_Has_Finding only Myxoid Stroma Formation) and (Disease_Has_Finding only Slow Growing Mass) and (Disease_Has_Finding only Solitary Mass)</Axiom>
               </Source>
            </Change>
            <Change id="953">
               <Axiom>Chronic Eosinophilic Leukemia EquivalentTo Chronic Leukemia and Chronic Myeloproliferative Disorder and (Disease_May_Have_Associated_Disease some Endomyocardial Fibrosis) and (Disease_May_Have_Associated_Disease some Eosinophilic Endomyocardial Disease) and (Disease_May_Have_Associated_Disease some Neuropathy) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some del(4)(q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;4)(q44;q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(6;8)(q27;p11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;13)(p11;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;9)(p11;q32-34)) and (Disease_May_Have_Finding some Charcot-Leyden Crystals Formation) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Molecular_Abnormality some FIP1L1-PDGFRalpha Fusion Protein Expression) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell) and (Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression) and (Disease_Has_Finding only Blasts Under 20 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Monoclonal Eosinophils Present) and (Disease_Has_Finding only Eosinophilia) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Chronic Eosinophilic Leukemia EquivalentTo Chronic Leukemia and Chronic Myeloproliferative Disorder and ((((Disease_May_Have_Cytogenetic_Abnormality some t(1;4)(q44;q12)) and (Disease_May_Have_Molecular_Abnormality some FIP1L1-PDGFRalpha Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(8;13)(p11;q11)) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell)) or ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression)))) and (Disease_May_Have_Associated_Disease some Endomyocardial Fibrosis) and (Disease_May_Have_Associated_Disease some Eosinophilic Endomyocardial Disease) and (Disease_May_Have_Associated_Disease some Neuropathy) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some del(4)(q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(6;8)(q27;p11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;9)(p11;q32-34)) and (Disease_May_Have_Finding some Charcot-Leyden Crystals Formation) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_Has_Finding only Blasts Under 20 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Monoclonal Eosinophils Present) and (Disease_Has_Finding only Eosinophilia) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
               </Source>
            </Change>
            <Change id="954">
               <Axiom>Classical Hodgkin's Lymphoma EquivalentTo Hodgkin's Lymphoma and (Disease_May_Have_Abnormal_Cell some Mummified Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 2p) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9p) and (Disease_May_Have_Finding some CD15-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some CD30-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some Colony-Stimulating Factor Overexpression) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Interleukin-10 Overexpression) and (Disease_May_Have_Finding some Interleukin-13 Overexpression) and (Disease_May_Have_Finding some Interleukin-2 Overexpression) and (Disease_May_Have_Finding some Interleukin-5 Overexpression) and (Disease_May_Have_Finding some Interleukin-6 Overexpression) and (Disease_May_Have_Finding some Interleukin-7 Overexpression) and (Disease_May_Have_Finding some Interleukin-9 Overexpression) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Lymphotoxin-Alpha Overexpression) and (Disease_May_Have_Finding some Night Sweating) and (Disease_May_Have_Finding some Transforming Growth Factor-Beta Overexpression) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some Apoptotic Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Mature B-Lymphocyte at the Germinal Center Stage of Differentiation) and (Disease_May_Have_Normal_Cell_Origin some Peripheral (Post-Thymic) T-Lymphocyte) and (Disease_Has_Abnormal_Cell only Classical Reed-Sternberg Cell) and (Disease_Has_Abnormal_Cell only Hodgkin's Cell)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Classical Hodgkin's Lymphoma EquivalentTo Hodgkin's Lymphoma and ((((Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Mature B-Lymphocyte at the Germinal Center Stage of Differentiation)) or ((Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gene Rearrangement) and (Disease_May_Have_Normal_Cell_Origin some Peripheral (Post-Thymic) T-Lymphocyte)))) and (Disease_May_Have_Abnormal_Cell some Mummified Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 2p) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9p) and (Disease_May_Have_Finding some CD15-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some CD30-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some Colony-Stimulating Factor Overexpression) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Interleukin-10 Overexpression) and (Disease_May_Have_Finding some Interleukin-13 Overexpression) and (Disease_May_Have_Finding some Interleukin-2 Overexpression) and (Disease_May_Have_Finding some Interleukin-5 Overexpression) and (Disease_May_Have_Finding some Interleukin-6 Overexpression) and (Disease_May_Have_Finding some Interleukin-7 Overexpression) and (Disease_May_Have_Finding some Interleukin-9 Overexpression) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Lymphotoxin-Alpha Overexpression) and (Disease_May_Have_Finding some Night Sweating) and (Disease_May_Have_Finding some Transforming Growth Factor-Beta Overexpression) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some Apoptotic Pathway Deregulation) and (Disease_Has_Abnormal_Cell only Classical Reed-Sternberg Cell) and (Disease_Has_Abnormal_Cell only Hodgkin's Cell)</Axiom>
               </Source>
            </Change>
            <Change id="943">
               <Axiom>Digital Papillary Eccrine Carcinoma EquivalentTo Papillary Eccrine Carcinoma and (Disease_Has_Finding only Aggressive Clinical Course) and (Disease_Has_Finding only Micropapillary Pattern) and (Disease_Has_Primary_Anatomic_Site only Digit)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Digital Papillary Eccrine Carcinoma EquivalentTo Papillary Eccrine Carcinoma and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Finding only Aggressive Clinical Course) and (Disease_Has_Finding only Micropapillary Pattern) and (Disease_Has_Primary_Anatomic_Site only Digit)</Axiom>
               </Source>
            </Change>
            <Change id="957">
               <Axiom>Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Embryonal Neoplasm and (Disease_May_Have_Abnormal_Cell some Malignant Small Round Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some inv(22q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;22) (q24;q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(16;21)(p11;q22)) and (Disease_May_Have_Cytogenetic_Abnormality some t(17;22)(q21;q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;22)(p36.1;q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(21;22)(q22;q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(q33;q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;22)(p22;q12)) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Homer Wright Rosette Formation) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_May_Have_Molecular_Abnormality some EWS-E1AF Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some EWS-ERG Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some EWS-ETV1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some EWS-FEV Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some EWS-FL1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some EWS-ZSG Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some FUS-ERG Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Primitive Round to Oval Cell) and (Disease_Has_Normal_Tissue_Origin only Neural Crest)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Embryonal Neoplasm and ((((Disease_May_Have_Cytogenetic_Abnormality some inv(22q12)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;22)(p36.1;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ZSG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(11;22) (q24;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-FL1 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(16;21)(p11;q22)) and (Disease_May_Have_Molecular_Abnormality some FUS-ERG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(17;22)(q21;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-E1AF Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(21;22)(q22;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ERG Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;22)(q33;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-FEV Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(7;22)(p22;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ETV1 Fusion Protein Expression)))) and (Disease_May_Have_Abnormal_Cell some Malignant Small Round Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Homer Wright Rosette Formation) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Primitive Round to Oval Cell) and (Disease_Has_Normal_Tissue_Origin only Neural Crest)</Axiom>
               </Source>
            </Change>
            <Change id="958">
               <Axiom>Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone EquivalentTo Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Malignant Bone Neoplasm and (Disease_May_Have_Finding some Pain) and (Disease_Has_Finding only Lytic Bone Lesion) and (Disease_Has_Primary_Anatomic_Site only Bone)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone EquivalentTo Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Malignant Bone Neoplasm and (Disease_May_Have_Finding some Pain) and (Disease_Has_Primary_Anatomic_Site only Bone)</Axiom>
               </Source>
            </Change>
            <Change id="970">
               <Axiom>Extraskeletal Myxoid Chondrosarcoma EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Soft Tissue Sarcoma and (Disease_May_Have_Cytogenetic_Abnormality some t(3;9)(q11-12;q22)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;15)(q22;q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;17)(q22;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q22-31;q12)) and (Disease_May_Have_Finding some Cord-Like Pattern) and (Disease_May_Have_Finding some Cribriform Pattern) and (Disease_May_Have_Finding some Cystic Change) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Spindle Cell Pattern) and (Disease_May_Have_Molecular_Abnormality some EWS-NR4A3 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some RBP56-NR4A3 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TCF12-NR4A3 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TFG-NR4A3 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Malignant Cell with Eosinophilic Cytoplasm) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Extraosseous Lesion) and (Disease_Has_Finding only Multinodular Pattern) and (Disease_Has_Finding only Myxoid Stroma Formation)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Extraskeletal Myxoid Chondrosarcoma EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Soft Tissue Sarcoma and ((((Disease_May_Have_Cytogenetic_Abnormality some t(3;9)(q11-12;q22)) and (Disease_May_Have_Molecular_Abnormality some TFG-NR4A3 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;15)(q22;q21)) and (Disease_May_Have_Molecular_Abnormality some TCF12-NR4A3 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;17)(q22;q11)) and (Disease_May_Have_Molecular_Abnormality some RBP56-NR4A3 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q22-31;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-NR4A3 Fusion Protein Expression)))) and (Disease_May_Have_Finding some Cord-Like Pattern) and (Disease_May_Have_Finding some Cribriform Pattern) and (Disease_May_Have_Finding some Cystic Change) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Spindle Cell Pattern) and (Disease_Has_Abnormal_Cell only Malignant Cell with Eosinophilic Cytoplasm) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Extraosseous Lesion) and (Disease_Has_Finding only Multinodular Pattern) and (Disease_Has_Finding only Myxoid Stroma Formation)</Axiom>
               </Source>
            </Change>
            <Change id="959">
               <Axiom>Fibrofolliculoma EquivalentTo Benign Pilar-Associated Mesenchyme Neoplasm and (Disease_Has_Finding only Distortion of the Hair Follicle)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Fibrofolliculoma EquivalentTo Benign Pilar-Associated Mesenchyme Neoplasm and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Distortion of the Hair Follicle)</Axiom>
               </Source>
            </Change>
            <Change id="955">
               <Axiom>Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Molecular_Abnormality only A-myb Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Has_Molecular_Abnormality only BCL-6 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD10 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only LMO2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only REL Gene Amplification) and (Disease_Has_Normal_Cell_Origin only Germinal Center B-Lymphocyte)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma EquivalentTo Diffuse Large B-Cell Lymphoma by Gene Expression Profile and ((((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma)))) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Molecular_Abnormality only A-myb Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Has_Molecular_Abnormality only BCL-6 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only CD10 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only LMO2 Messenger RNA Overexpression) and (Disease_Has_Molecular_Abnormality only REL Gene Amplification) and (Disease_Has_Normal_Cell_Origin only Germinal Center B-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="960">
               <Axiom>Hereditary Thyroid Gland Medullary Carcinoma EquivalentTo Bilateral Carcinoma and Hereditary Malignant Neoplasm and Thyroid Gland Medullary Carcinoma and (Disease_Has_Associated_Disease only Neoplastic C-Cell Hyperplasia) and (Disease_Has_Molecular_Abnormality only RET Gene Mutation)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Hereditary Thyroid Gland Medullary Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hereditary Thyroid Gland Medullary Carcinoma SubClassOf Bilateral Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Bilateral Carcinoma</Concept>
                        <WitnessAxioms>
                           <Axiom>Hereditary Thyroid Gland Medullary Carcinoma SubClassOf Bilateral Carcinoma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Hereditary Thyroid Gland Medullary Carcinoma EquivalentTo Hereditary Malignant Neoplasm and Thyroid Gland Medullary Carcinoma and (Disease_Has_Associated_Disease only Neoplastic C-Cell Hyperplasia) and (Disease_Has_Molecular_Abnormality only RET Gene Mutation)</Axiom>
               </Source>
            </Change>
            <Change id="961">
               <Axiom>Hodgkin's Lymphoma EquivalentTo Common Hematopoietic Neoplasm and Lymphoma and (Disease_Has_Abnormal_Cell only Neoplastic Large Lymphocyte) and (Disease_Has_Abnormal_Cell only Reed-Sternberg Cell) and (Disease_Has_Associated_Anatomic_Site only Lymphatic System) and (Disease_Has_Normal_Cell_Origin only Mature Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Lymphoid Tissue)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Hodgkin's Lymphoma EquivalentTo Common Hematopoietic Neoplasm and Lymphoma and (Disease_Has_Abnormal_Cell only Reed-Sternberg Cell) and (Disease_Has_Normal_Cell_Origin only Mature Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Lymphoid Tissue)</Axiom>
               </Source>
            </Change>
            <Change id="962">
               <Axiom>Infectious Mononucleosis EquivalentTo Benign Lymphoproliferative Disorder and Epstein-Barr Virus Infection and (Disease_May_Have_Associated_Disease some Acute Hepatitis) and (Disease_May_Have_Finding some Splenic Rupture) and (Disease_Excludes_Molecular_Abnormality only Clonal Antigen Receptor Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Finding only Atypical Lymphocytes Present in Peripheral Blood) and (Disease_Has_Finding only Diffuse Immunoblastic Proliferation) and (Disease_Has_Finding only Fever) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Finding only Polymorphic Cellular Infiltrate) and (Disease_Has_Finding only Splenomegaly) and (Disease_Has_Normal_Cell_Origin only EBV-Specific Cytotoxic T-Lymphocyte)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Infectious Mononucleosis EquivalentTo Benign Lymphoproliferative Disorder and Epstein-Barr Virus Infection and ((((Disease_May_Have_Finding some Splenic Rupture) and (Disease_Has_Finding only Splenomegaly)) or ((Disease_Has_Finding only Atypical Lymphocytes Present in Peripheral Blood) and (Disease_Has_Finding only Diffuse Immunoblastic Proliferation) and (Disease_Has_Finding only Polymorphic Cellular Infiltrate)))) and (Disease_May_Have_Associated_Disease some Acute Hepatitis) and (Disease_Excludes_Molecular_Abnormality only Clonal Antigen Receptor Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Finding only Fever) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only EBV-Specific Cytotoxic T-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="963">
               <Axiom>Inflammatory Myofibroblastic Tumor EquivalentTo Intermediate Fibrocytic Neoplasm and (Disease_May_Have_Abnormal_Cell some Ganglion-Like Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Stellate Cell) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Finding some Well-Circumscribed Lesion) and (Disease_May_Have_Finding some Fascicular Pattern) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Multinodular Lesion) and (Disease_May_Have_Finding some Myxoid Background) and (Disease_May_Have_Finding some Pain) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Neoplastic Spindle-Shaped Myofibroblast) and (Disease_Has_Finding only Eosinophilic Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Inflammatory Myofibroblastic Tumor EquivalentTo Intermediate Fibrocytic Neoplasm and ((((Disease_May_Have_Cytogenetic_Abnormality some t(1;2)(q25;p23)) and (Disease_May_Have_Molecular_Abnormality some TPM3-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;17)(p23;q23)) and (Disease_May_Have_Molecular_Abnormality some CLTC-ALK Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(2;19)(p23;p13)) and (Disease_May_Have_Molecular_Abnormality some TPM4-ALK Fusion Protein Expression)))) and (Disease_May_Have_Abnormal_Cell some Ganglion-Like Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Stellate Cell) and (Disease_May_Have_Finding some Well-Circumscribed Lesion) and (Disease_May_Have_Finding some Fascicular Pattern) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Multinodular Lesion) and (Disease_May_Have_Finding some Myxoid Background) and (Disease_May_Have_Finding some Pain) and (Disease_Has_Abnormal_Cell only Neoplastic Spindle-Shaped Myofibroblast) and (Disease_Has_Finding only Eosinophilic Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate)</Axiom>
               </Source>
            </Change>
            <Change id="964">
               <Axiom>Lung Mucinous Cystadenocarcinoma EquivalentTo Lung Mucinous Adenocarcinoma and Mucinous Cystadenocarcinoma and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Partially Encapsulated Mass)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Lung Mucinous Cystadenocarcinoma EquivalentTo Lung Mucinous Adenocarcinoma and Mucinous Cystadenocarcinoma and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Cystic Change)</Axiom>
               </Source>
            </Change>
            <Change id="965">
               <Axiom>Lymphomatoid Papulosis EquivalentTo Cutaneous Mature T-Cell and NK-Cell Neoplasm and Cutaneous Precancerous Condition and T-Cell Proliferation of Uncertain Malignant Potential and (Disease_May_Have_Associated_Disease some Anaplastic Large Cell Lymphoma) and (Disease_May_Have_Associated_Disease some Hodgkin's Lymphoma) and (Disease_May_Have_Associated_Disease some Mycosis Fungoides) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Complete Spontaneous Regression) and (Disease_Has_Finding only Cutaneous Involvement) and (Disease_Has_Normal_Cell_Origin only Activated Skin-Homing T-Lymphocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Lymphomatoid Papulosis EquivalentTo Cutaneous Mature T-Cell and NK-Cell Neoplasm and Cutaneous Precancerous Condition and T-Cell Proliferation of Uncertain Malignant Potential and ((((Disease_May_Have_Associated_Disease some Anaplastic Large Cell Lymphoma) and (Disease_May_Have_Associated_Disease some Hodgkin's Lymphoma) and (Disease_May_Have_Associated_Disease some Mycosis Fungoides)) or ((Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Complete Spontaneous Regression) and (Disease_Has_Finding only Cutaneous Involvement)))) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Activated Skin-Homing T-Lymphocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
               </Source>
            </Change>
            <Change id="966">
               <Axiom>Malignant Glomus Tumor EquivalentTo Glomus Tumor and Malignant Pericytic Neoplasm and (Disease_May_Have_Finding some Atypical Mitotic Figures) and (Disease_May_Have_Finding some Deep Lesion) and (Disease_May_Have_Finding some Lesion with Diameter Greater than 2cm) and (Disease_May_Have_Finding some Marked Nuclear Atypia Present) and (Disease_May_Have_Finding some Mitotic Activity) and (Disease_Has_Abnormal_Cell only Malignant Glomus Cell)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Malignant Glomus Tumor EquivalentTo Glomus Tumor and Malignant Pericytic Neoplasm and ((((Disease_May_Have_Finding some Deep Lesion) and (Disease_May_Have_Finding some Lesion with Diameter Greater than 2cm)) or ((Disease_May_Have_Finding some Marked Nuclear Atypia Present) and (Disease_May_Have_Finding some Mitotic Activity)))) and (Disease_May_Have_Finding some Atypical Mitotic Figures) and (Disease_Has_Abnormal_Cell only Malignant Glomus Cell)</Axiom>
               </Source>
            </Change>
            <Change id="967">
               <Axiom>Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type EquivalentTo Ovarian Small Cell Carcinoma, Hypercalcemic Type and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type EquivalentTo Metastatic Carcinoma and Ovarian Small Cell Carcinoma, Hypercalcemic Type and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
               </Source>
            </Change>
            <Change id="968">
               <Axiom>Monoblastic Sarcoma EquivalentTo Myeloid Sarcoma and (Disease_May_Have_Cytogenetic_Abnormality some t(10;11)(p11;q23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q23;p13.1)) and (Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF10 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-AF9 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-EEN Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ELL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ENL Fusion Protein Expression) and (Disease_Excludes_Abnormal_Cell only Neoplastic Granulocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Monoblastic Sarcoma EquivalentTo Myeloid Sarcoma and ((((Disease_May_Have_Cytogenetic_Abnormality some t(10;11)(p11;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF10 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q23;p13.1)) and (Disease_May_Have_Molecular_Abnormality some MLL-EEN Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ELL Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-ENL Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(9;11)(q21;q23)) and (Disease_May_Have_Molecular_Abnormality some MLL-AF9 Fusion Protein Expression)))) and (Disease_Excludes_Abnormal_Cell only Neoplastic Granulocyte) and (Disease_Has_Abnormal_Cell only Neoplastic Monoblast)</Axiom>
               </Source>
            </Change>
            <Change id="969">
               <Axiom>Mycosis Fungoides EquivalentTo Cutaneous T-Cell Non-Hodgkin's Lymphoma and Indolent Non-Hodgkin's Lymphoma and Mycosis Fungoides and Sezary Syndrome and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Dermatopathic Lymphadenopathy) and (Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Progressive Disease) and (Disease_May_Have_Finding some Scaly Skin Eruption) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_May_Have_Finding some Skin Patch) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_May_Have_Molecular_Abnormality some CDKN2A Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Cerebriform Lymphocyte) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Mycosis Fungoides EquivalentTo Cutaneous T-Cell Non-Hodgkin's Lymphoma and Indolent Non-Hodgkin's Lymphoma and Mycosis Fungoides and Sezary Syndrome and ((((Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate)) or ((Disease_May_Have_Finding some Progressive Disease) and (Disease_May_Have_Molecular_Abnormality some CDKN2A Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation)))) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Dermatopathic Lymphadenopathy) and (Disease_May_Have_Finding some Scaly Skin Eruption) and (Disease_May_Have_Finding some Skin Patch) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Has_Abnormal_Cell only Cerebriform Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="971">
               <Axiom>Myxoid/Round Cell Liposarcoma EquivalentTo Liposarcoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some t(12;16)(q13;p11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(12;22)(q13;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-DDIT3 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some FUS-DDIT3 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Primitive Mesenchymal Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Myxoid/Round Cell Liposarcoma EquivalentTo Liposarcoma and ((((Disease_May_Have_Cytogenetic_Abnormality some t(12;16)(q13;p11)) and (Disease_May_Have_Molecular_Abnormality some FUS-DDIT3 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(12;22)(q13;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-DDIT3 Fusion Protein Expression)))) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 13q) and (Disease_Has_Abnormal_Cell only Primitive Mesenchymal Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
               </Source>
            </Change>
            <Change id="973">
               <Axiom>O(6)-Benzylguanine EquivalentTo Chemo Immunostimulant Adjuvant and O6-Alkylguanine-DNA Alkyltransferase Inhibitor and (Chemical_Or_Drug_Affects_Gene_Product some Alkyltransferase and Aryltransferase) and (Chemical_Or_Drug_Has_Mechanism_Of_Action some Enzyme Inhibition) and (Chemical_Or_Drug_Has_Physiologic_Effect some DNA Repair Inhibition)</Axiom>
               <ConceptChanges size="4">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>O(6)-Benzylguanine</Concept>
                        <WitnessAxioms>
                           <Axiom>O(6)-Benzylguanine SubClassOf Chemo Immunostimulant Adjuvant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Chemo Immunostimulant Adjuvant</Concept>
                        <WitnessAxioms>
                           <Axiom>O(6)-Benzylguanine SubClassOf Chemo Immunostimulant Adjuvant</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="2">
                     <Specialisation>
                        <Concept>O(6)-Benzylguanine</Concept>
                        <WitnessAxioms>
                           <Axiom>O(6)-Benzylguanine SubClassOf Biological Response Modifier</Axiom>
                           <Axiom>O(6)-Benzylguanine SubClassOf Immunoadjuvant</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Biological Response Modifier</Concept>
                        <WitnessAxioms>
                           <Axiom>O(6)-Benzylguanine SubClassOf Biological Response Modifier</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </IndirectChanges>
               </ConceptChanges>
               <Source>
                  <Axiom>O(6)-Benzylguanine EquivalentTo O6-Alkylguanine-DNA Alkyltransferase Inhibitor and (Chemical_Or_Drug_Affects_Gene_Product some Alkyltransferase and Aryltransferase) and (Chemical_Or_Drug_Has_Mechanism_Of_Action some Enzyme Inhibition) and (Chemical_Or_Drug_Has_Physiologic_Effect some DNA Repair Inhibition)</Axiom>
               </Source>
            </Change>
            <Change id="974">
               <Axiom>Ovarian Serous Surface Papillary Adenocarcinoma EquivalentTo Ovarian Papillary Tumor and Ovarian Serous Adenocarcinoma</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Ovarian Serous Surface Papillary Adenocarcinoma EquivalentTo Ovarian Papillary Tumor and Ovarian Serous Adenocarcinoma and Serous Surface Papillary Carcinoma</Axiom>
               </Source>
            </Change>
            <Change id="976">
               <Axiom>Pancreatic Borderline Mucinous Cystic Neoplasm EquivalentTo Borderline Exocrine Pancreatic Neoplasm and Pancreatic Mucinous Cystic Neoplasm and (Disease_Has_Finding only Cellular Pseudostratification) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Papillary Pattern)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Pancreatic Borderline Mucinous Cystic Neoplasm EquivalentTo Borderline Exocrine Pancreatic Neoplasm and Pancreatic Mucinous Cystic Neoplasm and (Disease_Has_Finding only Cellular Pseudostratification) and (Disease_Has_Finding only Mitotic Activity)</Axiom>
               </Source>
            </Change>
            <Change id="975">
               <Axiom>Pancreatic Intraductal Papillary-Mucinous Adenoma EquivalentTo Pancreatic Intraductal Papillary-Mucinous Neoplasm and (Disease_May_Have_Finding some Mild Dysplasia) and (Disease_Excludes_Finding only Moderate Dysplasia) and (Disease_Excludes_Finding only Severe Dysplasia)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Pancreatic Intraductal Papillary-Mucinous Adenoma EquivalentTo Adenoma and Pancreatic Intraductal Papillary-Mucinous Neoplasm and (Disease_May_Have_Finding some Mild Dysplasia) and (Disease_Excludes_Finding only Moderate Dysplasia) and (Disease_Excludes_Finding only Severe Dysplasia)</Axiom>
               </Source>
            </Change>
            <Change id="977">
               <Axiom>Pilomatrical Carcinoma EquivalentTo Adnexal Carcinoma and Malignant Germinative Follicular Epithelium Neoplasm and (Disease_Has_Finding only Desmoplastic Stroma Formation) and (Disease_Has_Finding only Geographic Necrosis) and (Disease_Has_Finding only Invasive Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Pilomatrical Carcinoma EquivalentTo Adnexal Carcinoma and Malignant Germinative Follicular Epithelium Neoplasm and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Finding only Desmoplastic Stroma Formation) and (Disease_Has_Finding only Geographic Necrosis) and (Disease_Has_Finding only Invasive Lesion)</Axiom>
               </Source>
            </Change>
            <Change id="978">
               <Axiom>Precursor B-Lymphoblastic Lymphoma/Leukemia EquivalentTo B-Cell Neoplasm and Precursor Lymphoblastic Lymphoma/Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;v)(q23;v)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;19)(q23;p13.3)) and (Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Coarse Azurophilic Granules Present) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some E2A-PBX1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_Excludes_Normal_Cell_Origin only Mature B-Lymphocyte) and (Disease_Has_Abnormal_Cell only Neoplastic B-Lymphoblast) and (Disease_Has_Normal_Cell_Origin only Precursor B-Lymphoblast)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Precursor B-Lymphoblastic Lymphoma/Leukemia EquivalentTo B-Cell Neoplasm and Precursor Lymphoblastic Lymphoma/Leukemia and ((((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Coarse Azurophilic Granules Present) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(1;19)(q23;p13.3)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some E2A-PBX1 Fusion Protein Expression)) or ((Disease_May_Have_Cytogenetic_Abnormality some t(4;11)(q21;q23)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some MLL-AF4 Fusion Protein Expression)))) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;v)(q23;v)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement) and (Disease_Excludes_Normal_Cell_Origin only Mature B-Lymphocyte) and (Disease_Has_Abnormal_Cell only Neoplastic B-Lymphoblast) and (Disease_Has_Normal_Cell_Origin only Precursor B-Lymphoblast)</Axiom>
               </Source>
            </Change>
            <Change id="972">
               <Axiom>Primitive Neuroectodermal Tumor EquivalentTo Neuroepithelial Neoplasm and (Disease_Has_Finding only Neuroectodermal Differentiation) and (Disease_Has_Normal_Cell_Origin only Neuroectodermal Cell) and (Disease_Has_Normal_Tissue_Origin only Neuroectoderm)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Primitive Neuroectodermal Tumor EquivalentTo Embryonal Neoplasm and Neuroepithelial Neoplasm and (Disease_Has_Finding only Neuroectodermal Differentiation) and (Disease_Has_Normal_Cell_Origin only Neuroectodermal Cell) and (Disease_Has_Normal_Tissue_Origin only Neuroectoderm)</Axiom>
               </Source>
            </Change>
            <Change id="979">
               <Axiom>Recurrent Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Recurrent Hematologic Malignancy and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Has_Finding only Recurrent Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Recurrent Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Recurrent Hematologic Malignancy and ((((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture)))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
               </Source>
            </Change>
            <Change id="980">
               <Axiom>Refractory Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Refractory Plasma Cell Neoplasm and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Has_Finding only Refractory Disease)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Refractory Plasma Cell Myeloma EquivalentTo Plasma Cell Myeloma and Refractory Plasma Cell Neoplasm and ((((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture)))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)</Axiom>
               </Source>
            </Change>
            <Change id="981">
               <Axiom>Sebaceoma EquivalentTo Benign Sebaceous Neoplasm and (Disease_Excludes_Finding only Compartmentalized Pattern) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Sebaceoma EquivalentTo Benign Sebaceous Neoplasm and (Disease_Excludes_Finding only Compartmentalized Pattern) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Papular Lesion)</Axiom>
               </Source>
            </Change>
            <Change id="982">
               <Axiom>Sebaceous Carcinoma EquivalentTo Adenocarcinoma and Adnexal Carcinoma and Malignant Sebaceous Neoplasm</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Sebaceous Carcinoma EquivalentTo Adenocarcinoma and Adnexal Carcinoma and Malignant Sebaceous Neoplasm and (Disease_May_Have_Finding some Slow Growing Painless Mass)</Axiom>
               </Source>
            </Change>
            <Change id="983">
               <Axiom>Sezary Syndrome EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Leukemic Phase of Lymphoma and Mycosis Fungoides and Sezary Syndrome and (Disease_May_Have_Abnormal_Cell some Lutzner Cell) and (Disease_May_Have_Abnormal_Cell some Sezary Cell) and (Disease_May_Have_Associated_Disease some Erythroderma) and (Disease_May_Have_Finding some Alopecia) and (Disease_May_Have_Finding some Hyperkeratosis) and (Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Pruritus) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Abnormal_Cell only Sezary Cell) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Associated_Anatomic_Site only Skin) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Finding only Peripheral Blood Involvement) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Sezary Syndrome EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Leukemic Phase of Lymphoma and Mycosis Fungoides and Sezary Syndrome and ((((Disease_May_Have_Abnormal_Cell some Lutzner Cell) and (Disease_May_Have_Abnormal_Cell some Sezary Cell) and (Disease_Has_Finding only Peripheral Blood Involvement)) or ((Disease_May_Have_Finding some Pautrier Microabscess Present) and (Disease_May_Have_Finding some Single Cell Exocytosis) and (Disease_Has_Finding only Epidermotropic Lymphocytic Infiltrate)))) and (Disease_May_Have_Associated_Disease some Erythroderma) and (Disease_May_Have_Finding some Alopecia) and (Disease_May_Have_Finding some Hyperkeratosis) and (Disease_May_Have_Finding some Pruritus) and (Disease_Has_Abnormal_Cell only Sezary Cell) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Associated_Anatomic_Site only Skin) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Normal_Cell_Origin only Peripheral Epidermotropic T-Lymphocyte)</Axiom>
               </Source>
            </Change>
            <Change id="984">
               <Axiom>Skin Squamous Cell Carcinoma EquivalentTo Common Carcinoma and Skin Carcinoma and Squamous Cell Carcinoma and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Normal_Tissue_Origin only Epidermis)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Skin Squamous Cell Carcinoma EquivalentTo Common Carcinoma and Skin Carcinoma and Squamous Cell Carcinoma and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Normal_Tissue_Origin only Epidermis)</Axiom>
               </Source>
            </Change>
            <Change id="985">
               <Axiom>Skin Squamous Cell Carcinoma In Situ EquivalentTo Skin Squamous Cell Carcinoma and Stage 0 Skin Cancer and (Disease_May_Have_Finding some Erythema) and (Disease_May_Have_Finding some Scaly Skin Eruption) and (Disease_May_Have_Finding some Skin Patch) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Finding only Parakeratosis) and (Disease_Has_Finding only Windblown Appearance of Atypical Keratinocytes)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Skin Squamous Cell Carcinoma In Situ EquivalentTo Skin Squamous Cell Carcinoma and Stage 0 Skin Cancer and (Disease_May_Have_Finding some Erythema) and (Disease_May_Have_Finding some Scaly Skin Eruption)</Axiom>
               </Source>
            </Change>
            <Change id="986">
               <Axiom>Small Cell Osteosarcoma EquivalentTo Primary Bone Osteosarcoma and Small Cell Sarcoma and (Disease_May_Have_Finding some Pain) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_Has_Abnormal_Cell only Malignant Small Osteoblast) and (Disease_Has_Finding only Lytic Bone Lesion) and (Disease_Has_Finding only Osteoid Formation) and (Disease_Has_Normal_Tissue_Origin only Medullary Bone)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Small Cell Osteosarcoma EquivalentTo Primary Bone Osteosarcoma and Small Cell Sarcoma and (Disease_May_Have_Finding some Pain) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_Has_Abnormal_Cell only Malignant Small Osteoblast) and (Disease_Has_Finding only Osteoid Formation) and (Disease_Has_Normal_Tissue_Origin only Medullary Bone)</Axiom>
               </Source>
            </Change>
            <Change id="988">
               <Axiom>Stage I Multiple Myeloma EquivalentTo Plasma Cell Myeloma and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Finding some Solitary Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Pathologic Fracture) and (Disease_Is_Stage only Stage I)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Stage I Multiple Myeloma EquivalentTo Plasma Cell Myeloma and ((((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Solitary Lytic Metastatic Bone Lesion) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Pathologic Fracture)))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage I)</Axiom>
               </Source>
            </Change>
            <Change id="987">
               <Axiom>Stage III Multiple Myeloma EquivalentTo Plasma Cell Myeloma and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage III)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Stage III Multiple Myeloma EquivalentTo Plasma Cell Myeloma and ((((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) or ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture)))) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage III)</Axiom>
               </Source>
            </Change>
            <Change id="989">
               <Axiom>Superficial Epithelioma with Sebaceous Differentiation EquivalentTo Benign Sebaceous Neoplasm and Epithelioma and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Anastomosing Cells Connected to the Basal Layer of the Epidermis Present)</Axiom>
               <ConceptChanges size="2">
                  <DirectChanges size="2">
                     <Specialisation>
                        <Concept>Superficial Epithelioma with Sebaceous Differentiation</Concept>
                        <WitnessAxioms>
                           <Axiom>Superficial Epithelioma with Sebaceous Differentiation SubClassOf Epithelioma</Axiom>
                        </WitnessAxioms>
                     </Specialisation>
                     <Generalisation>
                        <Concept>Epithelioma</Concept>
                        <WitnessAxioms>
                           <Axiom>Superficial Epithelioma with Sebaceous Differentiation SubClassOf Epithelioma</Axiom>
                        </WitnessAxioms>
                     </Generalisation>
                  </DirectChanges>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Superficial Epithelioma with Sebaceous Differentiation EquivalentTo Benign Sebaceous Neoplasm and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Anastomosing Cells Connected to the Basal Layer of the Epidermis Present)</Axiom>
               </Source>
            </Change>
            <Change id="990">
               <Axiom>Telangiectatic Osteosarcoma EquivalentTo Primary Bone Osteosarcoma and (Disease_May_Have_Finding some Pain) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Large Spaces Filled with Blood Present) and (Disease_Has_Finding only Lytic Bone Lesion) and (Disease_Has_Finding only Osteoid Formation) and (Disease_Has_Normal_Tissue_Origin only Medullary Bone)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Telangiectatic Osteosarcoma EquivalentTo Primary Bone Osteosarcoma and (Disease_May_Have_Finding some Pain) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Large Spaces Filled with Blood Present) and (Disease_Has_Finding only Osteoid Formation) and (Disease_Has_Normal_Tissue_Origin only Medullary Bone)</Axiom>
               </Source>
            </Change>
            <Change id="991">
               <Axiom>Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation EquivalentTo Thyroid Gland Carcinoma and (Disease_May_Have_Abnormal_Cell some Adenocarcinoma Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Epithelial Spindle Cell) and (Disease_May_Have_Finding some Biphasic Pattern) and (Disease_May_Have_Finding some Monophasic Pattern) and (Disease_Excludes_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Spindle Cell) and (Disease_Has_Finding only Lobulated Growth Pattern) and (Disease_Has_Finding only Slow Growing Mass)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation EquivalentTo Thyroid Gland Carcinoma and ((((Disease_May_Have_Abnormal_Cell some Adenocarcinoma Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Epithelial Spindle Cell) and (Disease_May_Have_Finding some Monophasic Pattern)) or ((Disease_May_Have_Finding some Biphasic Pattern) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Spindle Cell)))) and (Disease_Excludes_Finding only Calcitonin Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Thyroglobulin Positive Neoplastic Cells Present) and (Disease_Has_Finding only Lobulated Growth Pattern) and (Disease_Has_Finding only Slow Growing Mass)</Axiom>
               </Source>
            </Change>
            <Change id="992">
               <Axiom>Trichodiscoma EquivalentTo Benign Pilar-Associated Mesenchyme Neoplasm and (Disease_Has_Finding only Capillary Sized Vascular Channel Formation) and (Disease_Has_Finding only Dermal Nodule) and (Disease_Has_Finding only Elastin Fibers Present)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Trichodiscoma EquivalentTo Benign Pilar-Associated Mesenchyme Neoplasm and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Capillary Sized Vascular Channel Formation) and (Disease_Has_Finding only Dermal Nodule) and (Disease_Has_Finding only Elastin Fibers Present)</Axiom>
               </Source>
            </Change>
            <Change id="993">
               <Axiom>Type 3 Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and (Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Excludes_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Excludes_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only REL Gene Amplification)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Type 3 Diffuse Large B-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma by Gene Expression Profile and ((((Disease_May_Have_Abnormal_Cell some Neoplastic B-Immunoblast) and (Disease_May_Have_Associated_Disease some Immunoblastic Lymphoma)) or ((Disease_May_Have_Abnormal_Cell some Neoplastic Centroblast) and (Disease_May_Have_Associated_Disease some Centroblastic Lymphoma)))) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Excludes_Molecular_Abnormality only BCL2 Gene Translocation) and (Disease_Excludes_Molecular_Abnormality only Cyclin D2 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only IRF4/MUM1 Messenger RNA Overexpression) and (Disease_Excludes_Molecular_Abnormality only REL Gene Amplification)</Axiom>
               </Source>
            </Change>
            <Change id="994">
               <Axiom>Vaginal Mullerian Papilloma EquivalentTo Benign Vaginal Neoplasm and Papilloma and Vaginal Glandular Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell with Intracytoplasmic Mucin)</Axiom>
               <ConceptChanges size="0">
                  <DirectChanges size="0"/>
                  <IndirectChanges size="0"/>
               </ConceptChanges>
               <Source>
                  <Axiom>Vaginal Mullerian Papilloma EquivalentTo Benign Vaginal Neoplasm and Papilloma and Vaginal Glandular Neoplasm</Axiom>
               </Source>
            </Change>
         </RetiredModifiedDefinition>
         <RetiredModifiedDefinitionWithRetiredTerms id="wkequivrt" size="0"/>
      </Effectual>
      <Ineffectual id="ineffrems" size="459">
         <RemovedRedundancy id="rred" size="2">
            <Change id="995">
               <Axiom>Periocular Meningioma SubClassOf Disease_Has_Primary_Anatomic_Site only Orbit</Axiom>
               <Source>
                  <Axiom shared="true">Intraorbital Meningioma EquivalentTo Meningioma by Site and Orbit Neoplasm and (Disease_Has_Normal_Tissue_Origin only Cerebral Meninges) and (Disease_Has_Primary_Anatomic_Site only Orbit) and (Disease_Has_Primary_Anatomic_Site only Skull)</Axiom>
                  <Axiom shared="true">Periocular Meningioma SubClassOf Intraorbital Meningioma</Axiom>
               </Source>
            </Change>
            <Change id="996">
               <Axiom>Wolff-Parkinson-White Syndrome SubClassOf Syndrome</Axiom>
               <Source>
                  <Axiom shared="true">Wolff-Parkinson-White Syndrome SubClassOf Pre-Excitation Syndrome</Axiom>
                  <Axiom shared="true">Pre-Excitation Syndrome SubClassOf Syndrome</Axiom>
               </Source>
            </Change>
         </RemovedRedundancy>
         <RemovedRewrite id="rrws" size="113">
            <RemovedCompleteRewrite id="rrw" size="113">
               <Change id="1054">
                  <Axiom>Acute Monocytic Leukemia EquivalentTo Acute Monoblastic Leukemia and Acute Monocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Finding some Hemophagocytosis) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Neoplastic Promonocytes in Bone Marrow Markedly Increased)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Monocytic Leukemia EquivalentTo Acute Monoblastic Leukemia and Acute Monocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(8;16)(p11;p13)) and (Disease_May_Have_Finding some Hemophagocytosis)) and (Disease_Has_Abnormal_Cell only Neoplastic Promonocyte) and (Disease_Has_Finding only Neoplastic Promonocytes in Bone Marrow Markedly Increased)</Axiom>
                  </Source>
               </Change>
               <Change id="997">
                  <Axiom>Acute Myeloid Leukemia with inv(16)(p13;q22) EquivalentTo Acute Myeloid Leukemia with Abnormal Marrow Eosinophils and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Cytogenetic_Abnormality only inv(16)(p13;q22)) and (Disease_Has_Molecular_Abnormality only CBFbeta-MYH11 Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Myeloid Leukemia with inv(16)(p13;q22) EquivalentTo Acute Myeloid Leukemia with Abnormal Marrow Eosinophils and ((Disease_Has_Cytogenetic_Abnormality only inv(16)(p13;q22)) and (Disease_Has_Molecular_Abnormality only CBFbeta-MYH11 Fusion Protein Expression)) and (Disease_May_Have_Finding some Favorable Clinical Outcome)</Axiom>
                  </Source>
               </Change>
               <Change id="998">
                  <Axiom>Acute Myeloid Leukemia with t(16;16)(p13;q22) EquivalentTo Acute Myeloid Leukemia with Abnormal Marrow Eosinophils and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Cytogenetic_Abnormality only t(16;16)(p13;q22)) and (Disease_Has_Molecular_Abnormality only CBFbeta-MYH11 Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Myeloid Leukemia with t(16;16)(p13;q22) EquivalentTo Acute Myeloid Leukemia with Abnormal Marrow Eosinophils and ((Disease_Has_Cytogenetic_Abnormality only t(16;16)(p13;q22)) and (Disease_Has_Molecular_Abnormality only CBFbeta-MYH11 Fusion Protein Expression)) and (Disease_May_Have_Finding some Favorable Clinical Outcome)</Axiom>
                  </Source>
               </Change>
               <Change id="999">
                  <Axiom>Acute Myeloid Leukemia with t(8;21)(q22;q22)(AML1(CBFa)/ETO) EquivalentTo Acute Myeloid Leukemia with Recurrent Genetic Abnormalities and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast with Abundant Basophilic Cytoplasm) and (Disease_Has_Cytogenetic_Abnormality only t(8;21)(q22;q22)) and (Disease_Has_Molecular_Abnormality only AML1-ETO Fusion Protein Expression) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Predominant Neutrophil Differentiation)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Myeloid Leukemia with t(8;21)(q22;q22)(AML1(CBFa)/ETO) EquivalentTo Acute Myeloid Leukemia with Recurrent Genetic Abnormalities and ((Disease_Has_Cytogenetic_Abnormality only t(8;21)(q22;q22)) and (Disease_Has_Molecular_Abnormality only AML1-ETO Fusion Protein Expression)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells) and (Disease_Has_Abnormal_Cell only Neoplastic Myeloblast with Abundant Basophilic Cytoplasm) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Predominant Neutrophil Differentiation)</Axiom>
                  </Source>
               </Change>
               <Change id="1000">
                  <Axiom>Acute Promyelocytic Leukemia with t(11;17)(q13;q21) EquivalentTo Acute Promyelocytic Leukemia with Variant Translocations and (Disease_Has_Cytogenetic_Abnormality only t(11;17)(q13;q21)) and (Disease_Has_Molecular_Abnormality only NuMA-RARalpha Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Promyelocytic Leukemia with t(11;17)(q13;q21) EquivalentTo Acute Promyelocytic Leukemia with Variant Translocations and ((Disease_Has_Cytogenetic_Abnormality only t(11;17)(q13;q21)) and (Disease_Has_Molecular_Abnormality only NuMA-RARalpha Fusion Protein Expression))</Axiom>
                  </Source>
               </Change>
               <Change id="1001">
                  <Axiom>Acute Promyelocytic Leukemia with t(11;17)(q23;q21) EquivalentTo Acute Promyelocytic Leukemia with Variant Translocations and (Disease_Has_Cytogenetic_Abnormality only t(11;17)(q23;q21)) and (Disease_Has_Molecular_Abnormality only PLZF-RARalpha Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Promyelocytic Leukemia with t(11;17)(q23;q21) EquivalentTo Acute Promyelocytic Leukemia with Variant Translocations and ((Disease_Has_Cytogenetic_Abnormality only t(11;17)(q23;q21)) and (Disease_Has_Molecular_Abnormality only PLZF-RARalpha Fusion Protein Expression))</Axiom>
                  </Source>
               </Change>
               <Change id="1002">
                  <Axiom>Acute Promyelocytic Leukemia with t(15;17)(q22;q12)(PML/RARa) EquivalentTo Acute Promyelocytic Leukemia and (Disease_May_Have_Abnormal_Cell some Faggot Cell) and (Disease_May_Have_Finding some Disseminated Intravascular Coagulation) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Cytogenetic_Abnormality only t(15;17)(q22;q12)) and (Disease_Has_Molecular_Abnormality only PML-RARalpha Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Promyelocytic Leukemia with t(15;17)(q22;q12)(PML/RARa) EquivalentTo Acute Promyelocytic Leukemia and ((Disease_Has_Cytogenetic_Abnormality only t(15;17)(q22;q12)) and (Disease_Has_Molecular_Abnormality only PML-RARalpha Fusion Protein Expression)) and (Disease_May_Have_Abnormal_Cell some Faggot Cell) and (Disease_May_Have_Finding some Disseminated Intravascular Coagulation) and (Disease_May_Have_Finding some Favorable Clinical Outcome)</Axiom>
                  </Source>
               </Change>
               <Change id="1003">
                  <Axiom>Acute Promyelocytic Leukemia with t(17;17)(q11;q11) EquivalentTo Acute Promyelocytic Leukemia with Variant Translocations and (Disease_Has_Cytogenetic_Abnormality only t(17;17)(q11;q11)) and (Disease_Has_Molecular_Abnormality only STAT5-RARalpha Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Promyelocytic Leukemia with t(17;17)(q11;q11) EquivalentTo Acute Promyelocytic Leukemia with Variant Translocations and ((Disease_Has_Cytogenetic_Abnormality only t(17;17)(q11;q11)) and (Disease_Has_Molecular_Abnormality only STAT5-RARalpha Fusion Protein Expression))</Axiom>
                  </Source>
               </Change>
               <Change id="1004">
                  <Axiom>Acute Promyelocytic Leukemia with t(5;17)(q32;q12) EquivalentTo Acute Promyelocytic Leukemia with Variant Translocations and (Disease_Has_Cytogenetic_Abnormality only t(5;17)(q32;q12)) and (Disease_Has_Molecular_Abnormality only NPM-RARalpha Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Acute Promyelocytic Leukemia with t(5;17)(q32;q12) EquivalentTo Acute Promyelocytic Leukemia with Variant Translocations and ((Disease_Has_Cytogenetic_Abnormality only t(5;17)(q32;q12)) and (Disease_Has_Molecular_Abnormality only NPM-RARalpha Fusion Protein Expression))</Axiom>
                  </Source>
               </Change>
               <Change id="1005">
                  <Axiom>Adenocarcinoma of the Gastroesophageal Junction EquivalentTo Adenocarcinoma and Malignant Gastrointestinal Neoplasm and (Disease_May_Have_Associated_Disease some Gastroesophageal Reflux Disease) and (Disease_May_Have_Finding some Abdominal Pain) and (Disease_May_Have_Finding some Dysphagia) and (Disease_May_Have_Finding some Intestinal Metaplasia) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Primary_Anatomic_Site only Gastroesophageal Junction)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Adenocarcinoma of the Gastroesophageal Junction EquivalentTo Adenocarcinoma and Malignant Gastrointestinal Neoplasm and ((Disease_May_Have_Associated_Disease some Gastroesophageal Reflux Disease) and (Disease_May_Have_Finding some Intestinal Metaplasia)) and (Disease_May_Have_Finding some Abdominal Pain) and (Disease_May_Have_Finding some Dysphagia) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Primary_Anatomic_Site only Gastroesophageal Junction)</Axiom>
                  </Source>
               </Change>
               <Change id="1006">
                  <Axiom>Adult Type Ovarian Granulosa Cell Tumor EquivalentTo Ovarian Granulosa Cell Tumor and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some Tetrasomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Finding some Call Exner Bodies Present) and (Disease_May_Have_Finding some Gyriform Trabecular Pattern) and (Disease_May_Have_Finding some Insular Pattern) and (Disease_May_Have_Finding some Macrofollicular Structures Present) and (Disease_May_Have_Finding some Menstrual Disorder) and (Disease_May_Have_Finding some Microfollicular Structures Present) and (Disease_May_Have_Finding some Postmenopausal Hemorrhage) and (Disease_May_Have_Finding some Solid Growth Pattern)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Adult Type Ovarian Granulosa Cell Tumor EquivalentTo Ovarian Granulosa Cell Tumor and ((Disease_May_Have_Finding some Call Exner Bodies Present) and (Disease_May_Have_Finding some Microfollicular Structures Present)) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some Tetrasomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Finding some Gyriform Trabecular Pattern) and (Disease_May_Have_Finding some Insular Pattern) and (Disease_May_Have_Finding some Macrofollicular Structures Present) and (Disease_May_Have_Finding some Menstrual Disorder) and (Disease_May_Have_Finding some Postmenopausal Hemorrhage) and (Disease_May_Have_Finding some Solid Growth Pattern)</Axiom>
                  </Source>
               </Change>
               <Change id="1106">
                  <Axiom>Adult Type Testicular Granulosa Cell Tumor EquivalentTo Testicular Granulosa Cell Tumor and (Disease_Has_Finding some Adulthood Lesion) and (Disease_May_Have_Associated_Disease some Gynecomastia) and (Disease_May_Have_Finding some Call Exner Bodies Present) and (Disease_May_Have_Finding some Gyriform Trabecular Pattern) and (Disease_May_Have_Finding some Insular Pattern) and (Disease_May_Have_Finding some Macrofollicular Structures Present) and (Disease_May_Have_Finding some Microfollicular Structures Present) and (Disease_May_Have_Finding some Solid Growth Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Adult Type Testicular Granulosa Cell Tumor EquivalentTo Testicular Granulosa Cell Tumor and ((Disease_May_Have_Finding some Call Exner Bodies Present) and (Disease_May_Have_Finding some Microfollicular Structures Present)) and (Disease_Has_Finding some Adulthood Lesion) and (Disease_May_Have_Associated_Disease some Gynecomastia) and (Disease_May_Have_Finding some Gyriform Trabecular Pattern) and (Disease_May_Have_Finding some Insular Pattern) and (Disease_May_Have_Finding some Macrofollicular Structures Present) and (Disease_May_Have_Finding some Solid Growth Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1007">
                  <Axiom>Aleukemic Lymphocytic Leukemia EquivalentTo Aleukemic Lymphoid Leukemia and Chronic Lymphocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Aleukemic Lymphocytic Leukemia EquivalentTo Aleukemic Lymphoid Leukemia and Chronic Lymphocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21))</Axiom>
                  </Source>
               </Change>
               <Change id="1008">
                  <Axiom>Alveolar Soft Part Sarcoma EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Sarcoma Differentiation Score 3 and Sarcoma NCI Grade 3 and Soft Tissue Sarcoma and (Disease_May_Have_Cytogenetic_Abnormality some ASPL-TFE3 Fusion Protein Expression) and (Disease_May_Have_Cytogenetic_Abnormality some Unbalanced Translocation) and (Disease_May_Have_Cytogenetic_Abnormality some t(X;17)(p11.2;q25)) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Malignant Epithelioid Cell) and (Disease_Has_Finding only Crystal Formation) and (Disease_Has_Finding only Organoid Pattern) and (Disease_Has_Finding only Pseudoalveolar Pattern)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Alveolar Soft Part Sarcoma EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Sarcoma Differentiation Score 3 and Sarcoma NCI Grade 3 and Soft Tissue Sarcoma and ((Disease_May_Have_Cytogenetic_Abnormality some ASPL-TFE3 Fusion Protein Expression) and (Disease_May_Have_Cytogenetic_Abnormality some Unbalanced Translocation) and (Disease_May_Have_Cytogenetic_Abnormality some t(X;17)(p11.2;q25))) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Malignant Epithelioid Cell) and (Disease_Has_Finding only Crystal Formation) and (Disease_Has_Finding only Organoid Pattern) and (Disease_Has_Finding only Pseudoalveolar Pattern)</Axiom>
                  </Source>
               </Change>
               <Change id="1009">
                  <Axiom>Angiomatoid Fibrous Histiocytoma EquivalentTo Intermediate Soft Tissue Neoplasm and Soft Tissue Neoplasm of Uncertain Differentiation and (Disease_May_Have_Abnormal_Cell some Neoplastic Epithelioid Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Spindle Cell) and (Disease_May_Have_Cytogenetic_Abnormality some t(12;16)(q13;p11)) and (Disease_May_Have_Molecular_Abnormality some FUS-ATF1 Fusion Protein Expression) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Hemorrhagic Change) and (Disease_Has_Finding only Hemosiderin Deposition) and (Disease_Has_Finding only Pseudoangiomatoid Space Formation) and (Disease_Has_Finding only Subcutaneous Involvement)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Angiomatoid Fibrous Histiocytoma EquivalentTo Intermediate Soft Tissue Neoplasm and Soft Tissue Neoplasm of Uncertain Differentiation and ((Disease_May_Have_Cytogenetic_Abnormality some t(12;16)(q13;p11)) and (Disease_May_Have_Molecular_Abnormality some FUS-ATF1 Fusion Protein Expression)) and (Disease_May_Have_Abnormal_Cell some Neoplastic Epithelioid Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Spindle Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Hemorrhagic Change) and (Disease_Has_Finding only Hemosiderin Deposition) and (Disease_Has_Finding only Pseudoangiomatoid Space Formation) and (Disease_Has_Finding only Subcutaneous Involvement)</Axiom>
                  </Source>
               </Change>
               <Change id="1010">
                  <Axiom>Bronchial Mucosa-Associated Lymphoid Tissue Lymphoma EquivalentTo Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue and Lung Mature B-Cell Neoplasm and Lung Non-Hodgkin's Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some t(11;18)(q21;q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;14)(p22;q32)) and (Disease_May_Have_Molecular_Abnormality some AP12-MLT Fusion Protein Expression) and (Disease_Has_Normal_Tissue_Origin only Bronchus-Associated Lymphoid Tissue) and (Disease_Has_Primary_Anatomic_Site only Bronchus)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Bronchial Mucosa-Associated Lymphoid Tissue Lymphoma EquivalentTo Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue and Lung Mature B-Cell Neoplasm and Lung Non-Hodgkin's Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(11;18)(q21;q21)) and (Disease_May_Have_Molecular_Abnormality some AP12-MLT Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;14)(p22;q32)) and (Disease_Has_Normal_Tissue_Origin only Bronchus-Associated Lymphoid Tissue) and (Disease_Has_Primary_Anatomic_Site only Bronchus)</Axiom>
                  </Source>
               </Change>
               <Change id="1012">
                  <Axiom>Cellular Congenital Mesoblastic Nephroma EquivalentTo Congenital Mesoblastic Nephroma and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 11) and (Disease_May_Have_Cytogenetic_Abnormality some t(12;15)(p13;q26)) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_May_Have_Molecular_Abnormality some ETV6-NTRK3 Fusion Protein Expression) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Increased Cellularity Present)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Cellular Congenital Mesoblastic Nephroma EquivalentTo Congenital Mesoblastic Nephroma and ((Disease_May_Have_Cytogenetic_Abnormality some Trisomy 11) and (Disease_May_Have_Cytogenetic_Abnormality some t(12;15)(p13;q26)) and (Disease_May_Have_Molecular_Abnormality some ETV6-NTRK3 Fusion Protein Expression)) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Increased Cellularity Present)</Axiom>
                  </Source>
               </Change>
               <Change id="1011">
                  <Axiom>Childhood Acute Megakaryoblastic Leukemia EquivalentTo Acute Megakaryoblastic Leukemia and Childhood Acute Myeloid Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some t(1;22)(p13;q13)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some OTT-MAL Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Childhood Acute Megakaryoblastic Leukemia EquivalentTo Acute Megakaryoblastic Leukemia and Childhood Acute Myeloid Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(1;22)(p13;q13)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some OTT-MAL Fusion Protein Expression))</Axiom>
                  </Source>
               </Change>
               <Change id="1013">
                  <Axiom>Childhood Chronic Myelogenous Leukemia EquivalentTo Childhood Leukemia and Chronic Myelogenous Leukemia and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Childhood Chronic Myelogenous Leukemia EquivalentTo Childhood Leukemia and Chronic Myelogenous Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased)</Axiom>
                  </Source>
               </Change>
               <Change id="1015">
                  <Axiom>Childhood Precursor B-Lymphoblastic Leukemia EquivalentTo Childhood Acute Lymphoblastic Leukemia and Precursor B-Lymphoblastic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some t(12;21)(p13;q22)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some TEL-AML1 Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Childhood Precursor B-Lymphoblastic Leukemia EquivalentTo Childhood Acute Lymphoblastic Leukemia and Precursor B-Lymphoblastic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(12;21)(p13;q22)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some TEL-AML1 Fusion Protein Expression))</Axiom>
                  </Source>
               </Change>
               <Change id="1016">
                  <Axiom>Childhood Precursor B-Lymphoblastic Lymphoma EquivalentTo Childhood Lymphoblastic Lymphoma and Precursor B-Lymphoblastic Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some t(12;21)(p13;q22)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some TEL-AML1 Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Childhood Precursor B-Lymphoblastic Lymphoma EquivalentTo Childhood Lymphoblastic Lymphoma and Precursor B-Lymphoblastic Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(12;21)(p13;q22)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some TEL-AML1 Fusion Protein Expression))</Axiom>
                  </Source>
               </Change>
               <Change id="1017">
                  <Axiom>Chronic Idiopathic Myelofibrosis EquivalentTo Chronic Myeloproliferative Disorder and Myelofibrosis and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Partial Trisomy 1q) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression) and (Disease_Has_Finding only Granulocytes Increased in Bone Marrow) and (Disease_Has_Finding only Megakaryocytes Increased in Bone Marrow) and (Disease_Has_Finding only Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Chronic Idiopathic Myelofibrosis EquivalentTo Chronic Myeloproliferative Disorder and Myelofibrosis and ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Partial Trisomy 1q) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_Has_Finding only Granulocytes Increased in Bone Marrow) and (Disease_Has_Finding only Megakaryocytes Increased in Bone Marrow) and (Disease_Has_Finding only Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells)</Axiom>
                  </Source>
               </Change>
               <Change id="1018">
                  <Axiom>Chronic Idiopathic Myelofibrosis, Fibrotic Stage EquivalentTo Chronic Idiopathic Myelofibrosis and (Disease_Has_Finding some Nucleated Red Blood Cells Present) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Hypocellular Bone Marrow) and (Disease_May_Have_Finding some Leukopenia) and (Disease_May_Have_Finding some Low Grade Fever) and (Disease_May_Have_Finding some Night Sweating) and (Disease_May_Have_Finding some Osteosclerosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Abnormal_Cell only Hyperchromatic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Large Atypical Platelet) and (Disease_Has_Abnormal_Cell only Tear-Drop Red Blood Cell) and (Disease_Has_Associated_Disease only Anemia) and (Disease_Has_Finding only Extramedullary Hematopoiesis) and (Disease_Has_Finding only Hepatomegaly) and (Disease_Has_Finding only Leukoerythroblastosis) and (Disease_Has_Finding only Marked Bone Marrow Fibrosis) and (Disease_Has_Finding only Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Myeloblasts Under 10 Percent of Peripheral Blood White Cells) and (Disease_Has_Finding only Poikilocytosis) and (Disease_Has_Finding only Splenomegaly)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Chronic Idiopathic Myelofibrosis, Fibrotic Stage EquivalentTo Chronic Idiopathic Myelofibrosis and ((Disease_Has_Finding only Extramedullary Hematopoiesis) and (Disease_Has_Finding only Hepatomegaly) and (Disease_Has_Finding only Splenomegaly)) and (Disease_Has_Finding some Nucleated Red Blood Cells Present) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Hypocellular Bone Marrow) and (Disease_May_Have_Finding some Leukopenia) and (Disease_May_Have_Finding some Low Grade Fever) and (Disease_May_Have_Finding some Night Sweating) and (Disease_May_Have_Finding some Osteosclerosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Abnormal_Cell only Hyperchromatic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Large Atypical Platelet) and (Disease_Has_Abnormal_Cell only Tear-Drop Red Blood Cell) and (Disease_Has_Associated_Disease only Anemia) and (Disease_Has_Finding only Leukoerythroblastosis) and (Disease_Has_Finding only Marked Bone Marrow Fibrosis) and (Disease_Has_Finding only Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Myeloblasts Under 10 Percent of Peripheral Blood White Cells) and (Disease_Has_Finding only Poikilocytosis)</Axiom>
                  </Source>
               </Change>
               <Change id="1019">
                  <Axiom>Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation EquivalentTo Chronic Lymphocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Lymphoplasmacytoid Cell)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation EquivalentTo Chronic Lymphocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Has_Abnormal_Cell only Lymphoplasmacytoid Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="1020">
                  <Axiom>Chronic Myelomonocytic Leukemia with Eosinophilia EquivalentTo Chronic Myelomonocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some t(5;12)(q31;p12)) and (Disease_May_Have_Molecular_Abnormality some TEL-PDGFbeta Receptor Fusion Protein Expression) and (Disease_Has_Finding only Eosinophilia)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Chronic Myelomonocytic Leukemia with Eosinophilia EquivalentTo Chronic Myelomonocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(5;12)(q31;p12)) and (Disease_May_Have_Molecular_Abnormality some TEL-PDGFbeta Receptor Fusion Protein Expression)) and (Disease_Has_Finding only Eosinophilia)</Axiom>
                  </Source>
               </Change>
               <Change id="1021">
                  <Axiom>Chronic Myeloproliferative Disease, Unclassifiable EquivalentTo Chronic Myeloproliferative Disorder and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Cytopenia) and (Disease_May_Have_Finding some Erythroid Hyperplasia) and (Disease_May_Have_Finding some Granulocytes Increased in Bone Marrow) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Megakaryocytes Increased in Bone Marrow) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell) and (Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Chronic Myeloproliferative Disease, Unclassifiable EquivalentTo Chronic Myeloproliferative Disorder and ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression)) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Cytopenia) and (Disease_May_Have_Finding some Erythroid Hyperplasia) and (Disease_May_Have_Finding some Granulocytes Increased in Bone Marrow) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Megakaryocytes Increased in Bone Marrow) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="1022">
                  <Axiom>Chronic Neutrophilic Leukemia EquivalentTo Chronic Leukemia and Chronic Myeloproliferative Disorder and (Disease_May_Have_Abnormal_Cell some Toxic Neutrophil) and (Disease_May_Have_Associated_Disease some Plasma Cell Myeloma) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 11q ATM Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_Excludes_Abnormal_Cell only Dysplastic Granulocyte) and (Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Segmented Neutrophil) and (Disease_Has_Finding only Granulocytes Increased in Bone Marrow) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Under 10 Percent) and (Disease_Has_Finding only Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Neutrophilia) and (Disease_Has_Finding only Splenomegaly)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Chronic Neutrophilic Leukemia EquivalentTo Chronic Leukemia and Chronic Myeloproliferative Disorder and ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression)) and (Disease_May_Have_Abnormal_Cell some Toxic Neutrophil) and (Disease_May_Have_Associated_Disease some Plasma Cell Myeloma) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 11q ATM Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_Excludes_Abnormal_Cell only Dysplastic Granulocyte) and (Disease_Has_Abnormal_Cell only Segmented Neutrophil) and (Disease_Has_Finding only Granulocytes Increased in Bone Marrow) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Under 10 Percent) and (Disease_Has_Finding only Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Neutrophilia) and (Disease_Has_Finding only Splenomegaly)</Axiom>
                  </Source>
               </Change>
               <Change id="1023">
                  <Axiom>Chronic Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Leukemia and Chronic Myelogenous Leukemia and (Disease_May_Have_Abnormal_Cell some Pseudo-Gaucher Cell) and (Disease_May_Have_Abnormal_Cell some Sea-Blue Histiocyte) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Reticulin Fibrosis of the Bone Marrow) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Hypolobated Megakaryocyte) and (Disease_Has_Abnormal_Cell only Segmented Neutrophil) and (Disease_Has_Finding only Basophilia) and (Disease_Has_Finding only Chronic Phase of Disease) and (Disease_Has_Finding only Granulocytes Increased in Bone Marrow) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Myeloblasts Under 2 Percent of Peripheral Blood White Cells) and (Disease_Has_Finding only Splenomegaly) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Chronic Phase Chronic Myelogenous Leukemia EquivalentTo Chronic Leukemia and Chronic Myelogenous Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) and (Disease_May_Have_Abnormal_Cell some Pseudo-Gaucher Cell) and (Disease_May_Have_Abnormal_Cell some Sea-Blue Histiocyte) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Reticulin Fibrosis of the Bone Marrow) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_May_Have_Finding some Weight Loss) and (Disease_Has_Abnormal_Cell only Hypolobated Megakaryocyte) and (Disease_Has_Abnormal_Cell only Segmented Neutrophil) and (Disease_Has_Finding only Basophilia) and (Disease_Has_Finding only Chronic Phase of Disease) and (Disease_Has_Finding only Granulocytes Increased in Bone Marrow) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Myeloblasts Under 2 Percent of Peripheral Blood White Cells) and (Disease_Has_Finding only Splenomegaly) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
                  </Source>
               </Change>
               <Change id="1025">
                  <Axiom>Clear Cell Sarcoma of Soft Tissue EquivalentTo Neoplasm of Uncertain Histogenesis and Soft Tissue Sarcoma and (Disease_May_Have_Abnormal_Cell some Malignant Spindle Cell) and (Disease_May_Have_Abnormal_Cell some Wreath-Like Multinucleated Giant Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some t(12;22)(q13;q12)) and (Disease_May_Have_Finding some Melanosomes Present) and (Disease_May_Have_Finding some Slow Growing Mass) and (Disease_May_Have_Molecular_Abnormality some EWS-ATF1 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Malignant Polygonal Cell with Eosinophilic Cytoplasm) and (Disease_Has_Finding only Fascicular Pattern) and (Disease_Has_Finding only Nested Pattern)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Clear Cell Sarcoma of Soft Tissue EquivalentTo Neoplasm of Uncertain Histogenesis and Soft Tissue Sarcoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(12;22)(q13;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-ATF1 Fusion Protein Expression)) and (Disease_May_Have_Abnormal_Cell some Malignant Spindle Cell) and (Disease_May_Have_Abnormal_Cell some Wreath-Like Multinucleated Giant Cell) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Finding some Melanosomes Present) and (Disease_May_Have_Finding some Slow Growing Mass) and (Disease_Has_Abnormal_Cell only Malignant Polygonal Cell with Eosinophilic Cytoplasm) and (Disease_Has_Finding only Fascicular Pattern) and (Disease_Has_Finding only Nested Pattern)</Axiom>
                  </Source>
               </Change>
               <Change id="1014">
                  <Axiom>Congenital Mesoblastic Nephroma EquivalentTo Childhood Renal Neoplasm and Embryonal Neoplasm and Malignant Renal Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some t(12;15)(p13;q26)) and (Disease_May_Have_Molecular_Abnormality some ETV6-NTRK3 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Malignant Fibroblast) and (Disease_Has_Finding only Low Grade Lesion) and (Disease_Has_Primary_Anatomic_Site only Kidney)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Congenital Mesoblastic Nephroma EquivalentTo Childhood Renal Neoplasm and Embryonal Neoplasm and Malignant Renal Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some t(12;15)(p13;q26)) and (Disease_May_Have_Molecular_Abnormality some ETV6-NTRK3 Fusion Protein Expression)) and (Disease_Has_Abnormal_Cell only Malignant Fibroblast) and (Disease_Has_Finding only Low Grade Lesion) and (Disease_Has_Primary_Anatomic_Site only Kidney)</Axiom>
                  </Source>
               </Change>
               <Change id="1024">
                  <Axiom>Conventional Lipoma EquivalentTo Lipoma and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;12)(p32-34;q13-15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;12)(p22-24;q13-15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;12)(q35-37;q13-15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(3;12)(q27-28;q13-15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(5;12)(q33;q13-15)) and (Disease_May_Have_Finding some Painless Mass) and (Disease_May_Have_Molecular_Abnormality some HMGIC-LPP Fusion Protein Expression) and (Disease_Excludes_Abnormal_Cell only Neoplastic Lipoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Mature Adipocyte) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Conventional Lipoma EquivalentTo Lipoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(3;12)(q27-28;q13-15)) and (Disease_May_Have_Molecular_Abnormality some HMGIC-LPP Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;12)(p32-34;q13-15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;12)(p22-24;q13-15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(2;12)(q35-37;q13-15)) and (Disease_May_Have_Cytogenetic_Abnormality some t(5;12)(q33;q13-15)) and (Disease_May_Have_Finding some Painless Mass) and (Disease_Excludes_Abnormal_Cell only Neoplastic Lipoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Mature Adipocyte) and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1026">
                  <Axiom>Cutaneous Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and Cutaneous Mature B-Cell Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Cutaneous Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and Cutaneous Mature B-Cell Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21))</Axiom>
                  </Source>
               </Change>
               <Change id="1027">
                  <Axiom>Cutaneous Gamma/Delta T-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Cutaneous T-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Associated_Disease some Hemophagocytic Syndrome) and (Disease_May_Have_Finding some Angioinvasion) and (Disease_May_Have_Finding some CD56-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some CD8-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some Dermal Involvement) and (Disease_May_Have_Finding some Epidermotropic Lymphocytic Infiltrate) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_May_Have_Finding some Rimming of Adipose Tissue Cells Present) and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_May_Have_Finding some Subcutaneous Involvement) and (Disease_Excludes_Finding only CD4-Positive Neoplastic Cells Present) and (Disease_Has_Abnormal_Cell only Neoplastic Medium-Sized to Large T-Lymphocyte) and (Disease_Has_Molecular_Abnormality only Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Activated Mature Gamma/Delta T-Lymphocyte with a Cytotoxic Phenotype)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Cutaneous Gamma/Delta T-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Cutaneous T-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Finding some Rimming of Adipose Tissue Cells Present) and (Disease_May_Have_Finding some Subcutaneous Involvement)) and (Disease_May_Have_Associated_Disease some Hemophagocytic Syndrome) and (Disease_May_Have_Finding some Angioinvasion) and (Disease_May_Have_Finding some CD56-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some CD8-Positive Neoplastic Cells Present) and (Disease_May_Have_Finding some Dermal Involvement) and (Disease_May_Have_Finding some Epidermotropic Lymphocytic Infiltrate) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Excludes_Finding only CD4-Positive Neoplastic Cells Present) and (Disease_Has_Abnormal_Cell only Neoplastic Medium-Sized to Large T-Lymphocyte) and (Disease_Has_Molecular_Abnormality only Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Activated Mature Gamma/Delta T-Lymphocyte with a Cytotoxic Phenotype)</Axiom>
                  </Source>
               </Change>
               <Change id="1028">
                  <Axiom>Dermatofibrosarcoma Protuberans EquivalentTo Cutaneous Fibrohistiocytic Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Supernumerary Circular Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(17;22)(q22;q13)) and (Disease_May_Have_Molecular_Abnormality some COL1A1-PDGFbeta Fusion Protein Expression) and (Disease_Excludes_Finding only Well-Circumscribed Lesion) and (Disease_Has_Abnormal_Cell only Neoplastic Spindle-Shaped Fibrohistiocytic Cell) and (Disease_Has_Finding only Invasive Lesion) and (Disease_Has_Finding only Multinodular Mass) and (Disease_Has_Finding only Storiform Growth Pattern)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Dermatofibrosarcoma Protuberans EquivalentTo Cutaneous Fibrohistiocytic Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some t(17;22)(q22;q13)) and (Disease_May_Have_Molecular_Abnormality some COL1A1-PDGFbeta Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Supernumerary Circular Chromosome) and (Disease_Excludes_Finding only Well-Circumscribed Lesion) and (Disease_Has_Abnormal_Cell only Neoplastic Spindle-Shaped Fibrohistiocytic Cell) and (Disease_Has_Finding only Invasive Lesion) and (Disease_Has_Finding only Multinodular Mass) and (Disease_Has_Finding only Storiform Growth Pattern)</Axiom>
                  </Source>
               </Change>
               <Change id="1029">
                  <Axiom>Desmoplastic Small Round Cell Tumor EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Small Cell Sarcoma and Soft Tissue Sarcoma and (Disease_May_Have_Cytogenetic_Abnormality some t(11;22)(p13;q12)) and (Disease_May_Have_Finding some Abdominal Mass) and (Disease_May_Have_Finding some Ascites) and (Disease_May_Have_Finding some High Mitotic Activity) and (Disease_May_Have_Finding some Pain) and (Disease_May_Have_Finding some Tumor Cell Necrosis) and (Disease_May_Have_Molecular_Abnormality some EWS-WT1 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Malignant Small Round Cell) and (Disease_Has_Finding only Desmoplastic Stroma Formation)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Desmoplastic Small Round Cell Tumor EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Small Cell Sarcoma and Soft Tissue Sarcoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(11;22)(p13;q12)) and (Disease_May_Have_Molecular_Abnormality some EWS-WT1 Fusion Protein Expression)) and (Disease_May_Have_Finding some Abdominal Mass) and (Disease_May_Have_Finding some Ascites) and (Disease_May_Have_Finding some High Mitotic Activity) and (Disease_May_Have_Finding some Pain) and (Disease_May_Have_Finding some Tumor Cell Necrosis) and (Disease_Has_Abnormal_Cell only Malignant Small Round Cell) and (Disease_Has_Finding only Desmoplastic Stroma Formation)</Axiom>
                  </Source>
               </Change>
               <Change id="1030">
                  <Axiom>Ductal Breast Carcinoma EquivalentTo Breast Adenocarcinoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 17q22-q24) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 20q13) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome Xq) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 22q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8p) and (Disease_May_Have_Finding some Calcification) and (Disease_May_Have_Molecular_Abnormality some CCND1 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Messenger RNA Overexpression) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some c-erbB2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some ERBB2 Protein Overexpression) and (Disease_Excludes_Molecular_Abnormality only CDH1 Gene Inactivation) and (Disease_Excludes_Molecular_Abnormality only Loss of E-cadherin Expression) and (Disease_Has_Abnormal_Cell only Ductal Carcinoma Cell) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Ductal Breast Carcinoma EquivalentTo Breast Adenocarcinoma and ((Disease_Excludes_Molecular_Abnormality only CDH1 Gene Inactivation) and (Disease_Excludes_Molecular_Abnormality only Loss of E-cadherin Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 17q22-q24) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 20q13) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome Xq) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 22q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8p) and (Disease_May_Have_Finding some Calcification) and (Disease_May_Have_Molecular_Abnormality some CCND1 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Messenger RNA Overexpression) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some c-erbB2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some ERBB2 Protein Overexpression) and (Disease_Has_Abnormal_Cell only Ductal Carcinoma Cell) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit)</Axiom>
                  </Source>
               </Change>
               <Change id="1031">
                  <Axiom>Dysgerminoma EquivalentTo Malignant Germ Cell Tumor and (Disease_May_Have_Molecular_Abnormality some C-KIT Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression) and (Disease_Excludes_Abnormal_Cell only Neoplastic Sex Cord-Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Primitive Germ Cell) and (Disease_Has_Finding only Chronic Inflammatory Infiltrate) and (Disease_Has_Finding only Fibrous Septa Present) and (Disease_Has_Normal_Cell_Origin only Germ Cell) and (Disease_Has_Normal_Tissue_Origin only Germinal Layer)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Dysgerminoma EquivalentTo Malignant Germ Cell Tumor and ((Disease_May_Have_Molecular_Abnormality some C-KIT Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression)) and (Disease_Excludes_Abnormal_Cell only Neoplastic Sex Cord-Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Primitive Germ Cell) and (Disease_Has_Finding only Chronic Inflammatory Infiltrate) and (Disease_Has_Finding only Fibrous Septa Present) and (Disease_Has_Normal_Cell_Origin only Germ Cell) and (Disease_Has_Normal_Tissue_Origin only Germinal Layer)</Axiom>
                  </Source>
               </Change>
               <Change id="1032">
                  <Axiom>Essential Thrombocythemia EquivalentTo Chronic Myeloproliferative Disorder and Megakaryocytic Neoplasm and (Disease_May_Have_Associated_Disease some Thrombosis) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Excludes_Abnormal_Cell only Tear-Drop Red Blood Cell) and (Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Finding only Bone Marrow Dysplasia Present) and (Disease_Excludes_Finding only Bone Marrow Fibrosis) and (Disease_Excludes_Finding only Increased Red Cell Mass) and (Disease_Excludes_Finding only Leukoerythroblastosis) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Giant Megakaryocyte) and (Disease_Has_Abnormal_Cell only Giant Platelet) and (Disease_Has_Abnormal_Cell only Large Atypical Platelet) and (Disease_Has_Abnormal_Cell only Large Megakaryocyte) and (Disease_Has_Finding only Chronic Clinical Course) and (Disease_Has_Finding only Megakaryocytes Increased in Bone Marrow) and (Disease_Has_Finding only Thrombocytosis) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Variable Lineage Potential)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Essential Thrombocythemia EquivalentTo Chronic Myeloproliferative Disorder and Megakaryocytic Neoplasm and ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression)) and (Disease_May_Have_Associated_Disease some Thrombosis) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Hypercellular Bone Marrow) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Excludes_Abnormal_Cell only Tear-Drop Red Blood Cell) and (Disease_Excludes_Finding only Bone Marrow Dysplasia Present) and (Disease_Excludes_Finding only Bone Marrow Fibrosis) and (Disease_Excludes_Finding only Increased Red Cell Mass) and (Disease_Excludes_Finding only Leukoerythroblastosis) and (Disease_Has_Abnormal_Cell only Giant Megakaryocyte) and (Disease_Has_Abnormal_Cell only Giant Platelet) and (Disease_Has_Abnormal_Cell only Large Atypical Platelet) and (Disease_Has_Abnormal_Cell only Large Megakaryocyte) and (Disease_Has_Finding only Chronic Clinical Course) and (Disease_Has_Finding only Megakaryocytes Increased in Bone Marrow) and (Disease_Has_Finding only Thrombocytosis) and (Disease_Has_Normal_Cell_Origin only Bone Marrow Stem Cell with Variable Lineage Potential)</Axiom>
                  </Source>
               </Change>
               <Change id="1033">
                  <Axiom>Follicular Bronchitis/Bronchiolitis EquivalentTo Benign Lymphoproliferative Disorder and Non-Neoplastic Lung Disorder and (Disease_May_Have_Associated_Disease some Immunodeficiency Syndrome) and (Disease_May_Have_Associated_Disease some Rheumatologic Disorder) and (Disease_May_Have_Finding some Lymphoplasmacytic Infiltrate) and (Disease_May_Have_Finding some Reactive Germinal Centers Present) and (Disease_Excludes_Finding only Lymphoepithelial Lesion) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Associated_Anatomic_Site only Lung) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Nodular Pattern) and (Disease_Has_Finding only Peribronchial and Lobular Septal Involvement Only) and (Disease_Has_Normal_Cell_Origin only Mature Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Bronchus-Associated Lymphoid Tissue)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Follicular Bronchitis/Bronchiolitis EquivalentTo Benign Lymphoproliferative Disorder and Non-Neoplastic Lung Disorder and ((Disease_May_Have_Finding some Lymphoplasmacytic Infiltrate) and (Disease_May_Have_Finding some Reactive Germinal Centers Present) and (Disease_Excludes_Finding only Lymphoepithelial Lesion) and (Disease_Has_Finding only Lymphocytic Infiltrate) and (Disease_Has_Finding only Nodular Pattern) and (Disease_Has_Finding only Peribronchial and Lobular Septal Involvement Only)) and (Disease_May_Have_Associated_Disease some Immunodeficiency Syndrome) and (Disease_May_Have_Associated_Disease some Rheumatologic Disorder) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Associated_Anatomic_Site only Lung) and (Disease_Has_Normal_Cell_Origin only Mature Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Bronchus-Associated Lymphoid Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="1034">
                  <Axiom>Gastric Gastrointestinal Stromal Tumor EquivalentTo Gastric Soft Tissue Neoplasm and Gastrointestinal Stromal Tumor of the Gastrointestinal Tract and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Gastric Gastrointestinal Stromal Tumor EquivalentTo Gastric Soft Tissue Neoplasm and Gastrointestinal Stromal Tumor of the Gastrointestinal Tract and ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression))</Axiom>
                  </Source>
               </Change>
               <Change id="1035">
                  <Axiom>Gastric Mucosa-Associated Lymphoid Tissue Lymphoma EquivalentTo Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue and Gastric Non-Hodgkin's Lymphoma and (Disease_May_Have_Associated_Disease some Hepatitis C) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;18)(q21;q21)) and (Disease_May_Have_Molecular_Abnormality some AP12-MLT Fusion Protein Expression) and (Disease_Has_Normal_Tissue_Origin only Gut-Associated Lymphoid Tissue) and (Disease_Has_Primary_Anatomic_Site only Stomach)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Gastric Mucosa-Associated Lymphoid Tissue Lymphoma EquivalentTo Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue and Gastric Non-Hodgkin's Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(11;18)(q21;q21)) and (Disease_May_Have_Molecular_Abnormality some AP12-MLT Fusion Protein Expression)) and (Disease_May_Have_Associated_Disease some Hepatitis C) and (Disease_Has_Normal_Tissue_Origin only Gut-Associated Lymphoid Tissue) and (Disease_Has_Primary_Anatomic_Site only Stomach)</Axiom>
                  </Source>
               </Change>
               <Change id="1036">
                  <Axiom>Gastrointestinal Autonomic Nerve Tumor EquivalentTo Autonomic Nervous System Neoplasm and Gastrointestinal Neuroendocrine Neoplasm and (Disease_May_Have_Abnormal_Cell some Neoplastic Epithelioid Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Spindle Cell) and (Disease_May_Have_Molecular_Abnormality some C-KIT Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Gastrointestinal Autonomic Nerve Tumor EquivalentTo Autonomic Nervous System Neoplasm and Gastrointestinal Neuroendocrine Neoplasm and ((Disease_May_Have_Molecular_Abnormality some C-KIT Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression)) and (Disease_May_Have_Abnormal_Cell some Neoplastic Epithelioid Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Spindle Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="1037">
                  <Axiom>Gastrointestinal Stromal Tumor EquivalentTo Stromal Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 22) and (Disease_May_Have_Molecular_Abnormality some C-KIT Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression) and (Disease_Has_Normal_Cell_Origin only Interstitial Cell of Cajal)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Gastrointestinal Stromal Tumor EquivalentTo Stromal Neoplasm and ((Disease_May_Have_Molecular_Abnormality some C-KIT Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression)) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 22) and (Disease_Has_Normal_Cell_Origin only Interstitial Cell of Cajal)</Axiom>
                  </Source>
               </Change>
               <Change id="1038">
                  <Axiom>Giant Cell Glioblastoma EquivalentTo Glioblastoma and Malignant Giant Cell Neoplasm and (Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Abnormal_Cell only Giant Astrocyte)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Giant Cell Glioblastoma EquivalentTo Glioblastoma and Malignant Giant Cell Neoplasm and ((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Abnormal_Cell only Giant Astrocyte)</Axiom>
                  </Source>
               </Change>
               <Change id="1039">
                  <Axiom>Glomus Tumor of Uncertain Malignant Potential EquivalentTo Glomus Tumor and (Disease_May_Have_Finding some Deep Lesion) and (Disease_May_Have_Finding some High Mitotic Activity) and (Disease_May_Have_Finding some Lesion with Diameter Greater than 2cm) and (Disease_May_Have_Finding some Superficial Lesion) and (Disease_Has_Finding only Borderline Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Glomus Tumor of Uncertain Malignant Potential EquivalentTo Glomus Tumor and ((Disease_May_Have_Finding some High Mitotic Activity) and (Disease_May_Have_Finding some Superficial Lesion)) and (Disease_May_Have_Finding some Deep Lesion) and (Disease_May_Have_Finding some Lesion with Diameter Greater than 2cm) and (Disease_Has_Finding only Borderline Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1040">
                  <Axiom>Hereditary Paraganglioma-Pheochromocytoma Syndrome EquivalentTo Endocrine Syndrome and Hereditary Neoplastic Syndrome and (Disease_May_Have_Molecular_Abnormality some SDHB Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some SDHC Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some SDHD Gene Mutation) and (Disease_Has_Associated_Disease only Paraganglioma) and (Disease_Has_Molecular_Abnormality only Mitochondrial Complex II Gene Mutation)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Hereditary Paraganglioma-Pheochromocytoma Syndrome EquivalentTo Endocrine Syndrome and Hereditary Neoplastic Syndrome and ((Disease_May_Have_Molecular_Abnormality some SDHB Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some SDHC Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some SDHD Gene Mutation) and (Disease_Has_Molecular_Abnormality only Mitochondrial Complex II Gene Mutation)) and (Disease_Has_Associated_Disease only Paraganglioma)</Axiom>
                  </Source>
               </Change>
               <Change id="1041">
                  <Axiom>Infantile Fibrosarcoma EquivalentTo Childhood Fibrosarcoma and Conventional Fibrosarcoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 17) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 20) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 11) and (Disease_May_Have_Cytogenetic_Abnormality some t(12;15)(p13;q26)) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some ETV6-NTRK3 Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Infantile Fibrosarcoma EquivalentTo Childhood Fibrosarcoma and Conventional Fibrosarcoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(12;15)(p13;q26)) and (Disease_May_Have_Molecular_Abnormality some ETV6-NTRK3 Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 17) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 20) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 11) and (Disease_May_Have_Finding some Favorable Clinical Outcome)</Axiom>
                  </Source>
               </Change>
               <Change id="1042">
                  <Axiom>Interdigitating Dendritic Cell Sarcoma/Tumor EquivalentTo Histiocytic and Dendritic Cell Neoplasms and (Disease_May_Have_Finding some Asymptomatic Mass) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Night Sweating) and (Disease_May_Have_Finding some Paracortical Involvement with Residual Follicles Present) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Excludes_Finding only Birbeck Granules Present) and (Disease_Excludes_Finding only CD1a-Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only CD21-Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only CD35-Positive Neoplastic Cells Present) and (Disease_Has_Abnormal_Cell only Neoplastic Interdigitating Dendritic Cell) and (Disease_Has_Finding only S-100-Positive Neoplastic Cells Present) and (Disease_Has_Finding only Storiform Growth Pattern) and (Disease_Has_Finding only Whorling Growth Pattern) and (Disease_Has_Normal_Cell_Origin only Interdigitating Dendritic Cell) and (Disease_Has_Normal_Tissue_Origin only Interfollicular Area of the Lymph Node)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Interdigitating Dendritic Cell Sarcoma/Tumor EquivalentTo Histiocytic and Dendritic Cell Neoplasms and ((Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Paracortical Involvement with Residual Follicles Present)) and (Disease_May_Have_Finding some Asymptomatic Mass) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Night Sweating) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Excludes_Finding only Birbeck Granules Present) and (Disease_Excludes_Finding only CD1a-Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only CD21-Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only CD35-Positive Neoplastic Cells Present) and (Disease_Has_Abnormal_Cell only Neoplastic Interdigitating Dendritic Cell) and (Disease_Has_Finding only S-100-Positive Neoplastic Cells Present) and (Disease_Has_Finding only Storiform Growth Pattern) and (Disease_Has_Finding only Whorling Growth Pattern) and (Disease_Has_Normal_Cell_Origin only Interdigitating Dendritic Cell) and (Disease_Has_Normal_Tissue_Origin only Interfollicular Area of the Lymph Node)</Axiom>
                  </Source>
               </Change>
               <Change id="1043">
                  <Axiom>Juvenile Myelomonocytic Leukemia EquivalentTo Myelodysplastic/Myeloproliferative Disease and (Disease_May_Have_Associated_Disease some Bronchitis) and (Disease_May_Have_Associated_Disease some Neurofibromatosis Type 1) and (Disease_May_Have_Associated_Disease some Noonan Syndrome) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Finding some Absence of Bone Marrow Dysplasia) and (Disease_May_Have_Finding some Cafe Au Lait Patch) and (Disease_May_Have_Finding some Elevated Serum Lysozyme) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemoglobin F Increased) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_May_Have_Finding some Nucleated Red Blood Cells Present) and (Disease_May_Have_Finding some Polyclonal Hypergammaglobulinemia) and (Disease_May_Have_Finding some Skin Rash) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell) and (Disease_Excludes_Finding only Auer Rods Present) and (Disease_Has_Associated_Disease only Anemia) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Increased) and (Disease_Has_Finding only Monocytosis) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Juvenile Myelomonocytic Leukemia EquivalentTo Myelodysplastic/Myeloproliferative Disease and ((Disease_May_Have_Associated_Disease some Neurofibromatosis Type 1) and (Disease_May_Have_Finding some Cafe Au Lait Patch)) and (Disease_May_Have_Associated_Disease some Bronchitis) and (Disease_May_Have_Associated_Disease some Noonan Syndrome) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 7) and (Disease_May_Have_Finding some Absence of Bone Marrow Dysplasia) and (Disease_May_Have_Finding some Elevated Serum Lysozyme) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemoglobin F Increased) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_May_Have_Finding some Nucleated Red Blood Cells Present) and (Disease_May_Have_Finding some Polyclonal Hypergammaglobulinemia) and (Disease_May_Have_Finding some Skin Rash) and (Disease_May_Have_Finding some Thrombocytopenia) and (Disease_May_Have_Normal_Cell_Origin some Multipotent Bone Marrow Stem Cell) and (Disease_May_Have_Normal_Cell_Origin some Pluripotent Bone Marrow Stem Cell) and (Disease_Excludes_Finding only Auer Rods Present) and (Disease_Has_Associated_Disease only Anemia) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Immature Granulocytes in Peripheral Blood Increased) and (Disease_Has_Finding only Monocytosis) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
                  </Source>
               </Change>
               <Change id="1044">
                  <Axiom>Lipoblastoma EquivalentTo Benign Lipomatous Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Rearrangement of 8q11-13) and (Disease_May_Have_Molecular_Abnormality some COL1A2-PLAG1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some HAS2-PLAG1 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Neoplastic Lipoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Mature Adipocyte) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Localized Disease) and (Disease_Has_Finding only Slow Growing Painless Mass)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lipoblastoma EquivalentTo Benign Lipomatous Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some Rearrangement of 8q11-13) and (Disease_May_Have_Molecular_Abnormality some COL1A2-PLAG1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some HAS2-PLAG1 Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_Has_Abnormal_Cell only Neoplastic Lipoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Mature Adipocyte) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Finding only Localized Disease) and (Disease_Has_Finding only Slow Growing Painless Mass)</Axiom>
                  </Source>
               </Change>
               <Change id="1045">
                  <Axiom>Lipoblastomatosis EquivalentTo Benign Lipomatous Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Rearrangement of 8q11-13) and (Disease_May_Have_Molecular_Abnormality some COL1A2-PLAG1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some HAS2-PLAG1 Fusion Protein Expression) and (Disease_Excludes_Finding only Localized Disease) and (Disease_Has_Abnormal_Cell only Neoplastic Lipoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Mature Adipocyte) and (Disease_Has_Finding only Multifocal Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lipoblastomatosis EquivalentTo Benign Lipomatous Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some Rearrangement of 8q11-13) and (Disease_May_Have_Molecular_Abnormality some COL1A2-PLAG1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some HAS2-PLAG1 Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_Excludes_Finding only Localized Disease) and (Disease_Has_Abnormal_Cell only Neoplastic Lipoblast) and (Disease_Has_Abnormal_Cell only Neoplastic Mature Adipocyte) and (Disease_Has_Finding only Multifocal Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1046">
                  <Axiom>Lipoma EquivalentTo Benign Lipomatous Neoplasm and (Disease_Excludes_Cytogenetic_Abnormality only Rearrangement of 8q11-13) and (Disease_Excludes_Molecular_Abnormality only COL1A2-PLAG1 Fusion Protein Expression) and (Disease_Excludes_Molecular_Abnormality only HAS2-PLAG1 Fusion Protein Expression) and (Disease_Has_Finding only Localized Disease)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lipoma EquivalentTo Benign Lipomatous Neoplasm and ((Disease_Excludes_Cytogenetic_Abnormality only Rearrangement of 8q11-13) and (Disease_Excludes_Molecular_Abnormality only COL1A2-PLAG1 Fusion Protein Expression) and (Disease_Excludes_Molecular_Abnormality only HAS2-PLAG1 Fusion Protein Expression)) and (Disease_Has_Finding only Localized Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1047">
                  <Axiom>Lobular Neoplasia EquivalentTo Breast Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 22q) and (Disease_May_Have_Finding some Monomorphic Cellular Infiltrate) and (Disease_May_Have_Finding some Multifocal Lesion) and (Disease_May_Have_Molecular_Abnormality some CDH1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some Loss of E-cadherin Expression) and (Disease_Excludes_Finding only Breast Lump) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Absence of Invasion) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lobular Neoplasia EquivalentTo Breast Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Molecular_Abnormality some CDH1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some Loss of E-cadherin Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 6q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 22q) and (Disease_May_Have_Finding some Monomorphic Cellular Infiltrate) and (Disease_May_Have_Finding some Multifocal Lesion) and (Disease_Excludes_Finding only Breast Lump) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Absence of Invasion) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                  </Source>
               </Change>
               <Change id="1048">
                  <Axiom>Low Grade Fibromyxoid Sarcoma EquivalentTo Soft Tissue Fibrosarcoma and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Mild Cytologic Atypia) and (Disease_May_Have_Molecular_Abnormality some FUS-CREB3L1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some FUS-CREB3L2 Fusion Protein Expression) and (Disease_Excludes_Finding only Nuclear Pleomorphism) and (Disease_Has_Abnormal_Cell only Malignant Spindle-Shaped Fibroblast) and (Disease_Has_Cytogenetic_Abnormality only Balanced Chromosomal Translocation) and (Disease_Has_Cytogenetic_Abnormality only t(7;16)(q32-34;p11)) and (Disease_Has_Finding only Fibrotic Stroma Formation) and (Disease_Has_Finding only Low Grade Lesion) and (Disease_Has_Finding only Myxoid Stroma Formation) and (Disease_Has_Finding only Whorling Growth Pattern)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Low Grade Fibromyxoid Sarcoma EquivalentTo Soft Tissue Fibrosarcoma and ((Disease_May_Have_Molecular_Abnormality some FUS-CREB3L1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some FUS-CREB3L2 Fusion Protein Expression) and (Disease_Has_Cytogenetic_Abnormality only Balanced Chromosomal Translocation) and (Disease_Has_Cytogenetic_Abnormality only t(7;16)(q32-34;p11))) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Finding some Mild Cytologic Atypia) and (Disease_Excludes_Finding only Nuclear Pleomorphism) and (Disease_Has_Abnormal_Cell only Malignant Spindle-Shaped Fibroblast) and (Disease_Has_Finding only Fibrotic Stroma Formation) and (Disease_Has_Finding only Low Grade Lesion) and (Disease_Has_Finding only Myxoid Stroma Formation) and (Disease_Has_Finding only Whorling Growth Pattern)</Axiom>
                  </Source>
               </Change>
               <Change id="1049">
                  <Axiom>Lymphomatous Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Medium-Sized to Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Small T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Polylobated T-Lymphocyte) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Osteoclastic Activity Present) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Finding only Negative Peripheral Blood)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lymphomatous Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and ((Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Osteoclastic Activity Present)) and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Medium-Sized to Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Small T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Polylobated T-Lymphocyte) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only Lymphadenopathy) and (Disease_Has_Finding only Negative Peripheral Blood)</Axiom>
                  </Source>
               </Change>
               <Change id="1050">
                  <Axiom>Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia EquivalentTo Indolent Non-Hodgkin's Lymphoma and Mature B-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Associated_Disease some Autoimmune Disease) and (Disease_May_Have_Associated_Disease some Hepatitis C) and (Disease_May_Have_Associated_Disease some Neuropathy) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;14)(p13;q32)) and (Disease_May_Have_Finding some Cryoglobulinemia) and (Disease_May_Have_Finding some Diarrhea) and (Disease_May_Have_Finding some Dutcher Body) and (Disease_May_Have_Finding some Hyperviscosity) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Monoclonal Gammopathy) and (Disease_Has_Abnormal_Cell only Lymphoplasmacytoid Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Plasma Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Small B-Lymphocyte) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Finding only Lymphoplasmacytic Infiltrate) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Peripheral B-Lymphocyte)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia EquivalentTo Indolent Non-Hodgkin's Lymphoma and Mature B-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Finding some Cryoglobulinemia) and (Disease_May_Have_Finding some Hyperviscosity) and (Disease_May_Have_Finding some Monoclonal Gammopathy)) and (Disease_May_Have_Associated_Disease some Autoimmune Disease) and (Disease_May_Have_Associated_Disease some Hepatitis C) and (Disease_May_Have_Associated_Disease some Neuropathy) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;14)(p13;q32)) and (Disease_May_Have_Finding some Diarrhea) and (Disease_May_Have_Finding some Dutcher Body) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Abnormal_Cell only Lymphoplasmacytoid Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Plasma Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Small B-Lymphocyte) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Finding only Lymphoplasmacytic Infiltrate) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Peripheral B-Lymphocyte)</Axiom>
                  </Source>
               </Change>
               <Change id="1051">
                  <Axiom>Mantle Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Mature B-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Molecular_Abnormality some Clonal CCND1 Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Has_Abnormal_Cell only Neoplastic Small to Medium-Sized B-Lymphocyte Resembling a Centrocyte) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Peripheral B-Lymphocyte of Inner Mantle Zone) and (Disease_Has_Normal_Tissue_Origin only Mantle Zone)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Mantle Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Mature B-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Molecular_Abnormality some Clonal CCND1 Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17p) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Abnormal_Cell only Neoplastic Small to Medium-Sized B-Lymphocyte Resembling a Centrocyte) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Heavy Chain Gene Rearrangement) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Peripheral B-Lymphocyte of Inner Mantle Zone) and (Disease_Has_Normal_Tissue_Origin only Mantle Zone)</Axiom>
                  </Source>
               </Change>
               <Change id="1052">
                  <Axiom>Meningeal Chronic Myelogenous Leukemia EquivalentTo Central Nervous System Leukemia and Chronic Myelogenous Leukemia and Malignant Neoplasm of the Meninges and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Meningeal Chronic Myelogenous Leukemia EquivalentTo Central Nervous System Leukemia and Chronic Myelogenous Leukemia and Malignant Neoplasm of the Meninges and ((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                  </Source>
               </Change>
               <Change id="1053">
                  <Axiom>Methotrexate-Associated Lymphoproliferative Disorder EquivalentTo Lymphoma and (Disease_May_Have_Associated_Disease some Dermatomyositis) and (Disease_May_Have_Associated_Disease some Epstein-Barr Virus Infection) and (Disease_May_Have_Associated_Disease some Psoriasis) and (Disease_May_Have_Associated_Disease some Rheumatoid Arthritis) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Associated_Disease only Autoimmune Disease)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Methotrexate-Associated Lymphoproliferative Disorder EquivalentTo Lymphoma and ((Disease_May_Have_Associated_Disease some Dermatomyositis) and (Disease_May_Have_Associated_Disease some Psoriasis) and (Disease_May_Have_Associated_Disease some Rheumatoid Arthritis) and (Disease_Has_Associated_Disease only Autoimmune Disease)) and (Disease_May_Have_Associated_Disease some Epstein-Barr Virus Infection) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Lymphadenopathy)</Axiom>
                  </Source>
               </Change>
               <Change id="1055">
                  <Axiom>Myelodysplastic/Myeloproliferative Disease EquivalentTo Myeloid Neoplasm and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Ineffective Hematopoiesis) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression) and (Disease_Has_Finding only Blasts Under 20 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Blasts Under 20 Percent of Peripheral Blood White Cells)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Myelodysplastic/Myeloproliferative Disease EquivalentTo Myeloid Neoplasm and ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Ineffective Hematopoiesis) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Molecular_Abnormality some NRAS Gene Mutation) and (Disease_Has_Finding only Blasts Under 20 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Blasts Under 20 Percent of Peripheral Blood White Cells)</Axiom>
                  </Source>
               </Change>
               <Change id="1056">
                  <Axiom>Nasal Cavity Non-Hodgkin's Lymphoma EquivalentTo Nasal Cavity Lymphoma and Non-Hodgkin's Lymphoma and (Disease_May_Have_Associated_Disease some Nasal Type Extranodal NK/T-Cell Lymphoma) and (Disease_May_Have_Finding some Epistaxis) and (Disease_May_Have_Finding some Nasal Cavity Lethal Midline Granuloma)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Nasal Cavity Non-Hodgkin's Lymphoma EquivalentTo Nasal Cavity Lymphoma and Non-Hodgkin's Lymphoma and ((Disease_May_Have_Associated_Disease some Nasal Type Extranodal NK/T-Cell Lymphoma) and (Disease_May_Have_Finding some Nasal Cavity Lethal Midline Granuloma)) and (Disease_May_Have_Finding some Epistaxis)</Axiom>
                  </Source>
               </Change>
               <Change id="1057">
                  <Axiom>Nodular Lymphoid Hyperplasia of Lung EquivalentTo Benign Lymphoproliferative Disorder and Non-Neoplastic Lung Disorder and (Disease_May_Have_Finding some Chest Pain) and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Russell Body) and (Disease_May_Have_Finding some Solitary Nodule) and (Disease_Excludes_Finding only Lymphoepithelial Lesion) and (Disease_Excludes_Finding only Peribronchial and Lobular Septal Involvement Only) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Associated_Anatomic_Site only Lung) and (Disease_Has_Finding only Lymphoplasmacytic Infiltrate) and (Disease_Has_Finding only Nodular Pattern) and (Disease_Has_Finding only Reactive Germinal Centers Present) and (Disease_Has_Normal_Cell_Origin only Mature Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Bronchus-Associated Lymphoid Tissue)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Nodular Lymphoid Hyperplasia of Lung EquivalentTo Benign Lymphoproliferative Disorder and Non-Neoplastic Lung Disorder and ((Disease_May_Have_Finding some Russell Body) and (Disease_Excludes_Finding only Lymphoepithelial Lesion) and (Disease_Excludes_Finding only Peribronchial and Lobular Septal Involvement Only) and (Disease_Has_Finding only Lymphoplasmacytic Infiltrate) and (Disease_Has_Finding only Nodular Pattern) and (Disease_Has_Finding only Reactive Germinal Centers Present)) and (Disease_May_Have_Finding some Chest Pain) and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Solitary Nodule) and (Disease_Has_Abnormal_Cell only Reactive Lymphocyte) and (Disease_Has_Associated_Anatomic_Site only Lung) and (Disease_Has_Normal_Cell_Origin only Mature Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Bronchus-Associated Lymphoid Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="1058">
                  <Axiom>Non-Hereditary Conventional (Clear Cell) Renal Cell Carcinoma EquivalentTo Conventional (Clear Cell) Renal Cell Carcinoma and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some VHL Gene Inactivation) and (Disease_Has_Cytogenetic_Abnormality only Loss of Chromosome 3) and (Disease_Has_Finding only Non-Hereditary Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Non-Hereditary Conventional (Clear Cell) Renal Cell Carcinoma EquivalentTo Conventional (Clear Cell) Renal Cell Carcinoma and ((Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) and (Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some VHL Gene Inactivation) and (Disease_Has_Cytogenetic_Abnormality only Loss of Chromosome 3) and (Disease_Has_Finding only Non-Hereditary Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1059">
                  <Axiom>Non-Secretory Myeloma EquivalentTo Plasma Cell Myeloma and (Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_Excludes_Finding only Monoclonal Paraproteinemia)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Non-Secretory Myeloma EquivalentTo Plasma Cell Myeloma and ((Disease_May_Have_Finding some Bone Pain) and (Disease_May_Have_Finding some Hypercalcemia) and (Disease_May_Have_Finding some Lytic Metastatic Bone Lesion) and (Disease_May_Have_Finding some Pathologic Fracture)) and (Disease_Excludes_Finding only Monoclonal Paraproteinemia)</Axiom>
                  </Source>
               </Change>
               <Change id="1060">
                  <Axiom>Parathyroid Gland Carcinoma EquivalentTo Adenocarcinoma and Malignant Endocrine Neoplasm and Malignant Parathyroid Gland Neoplasm and Neck Carcinoma and (Disease_May_Have_Abnormal_Cell some Malignant Parathyroid Gland Chief Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Parathyroid Gland Clear Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Parathyroid Gland Oncocyte) and (Disease_May_Have_Associated_Disease some Primary Hyperparathyroidism) and (Disease_May_Have_Finding some Broad Fibrous Bands Formation) and (Disease_May_Have_Finding some Capsular Invasion) and (Disease_May_Have_Finding some Hemosiderin Deposition) and (Disease_May_Have_Finding some Mitotic Activity) and (Disease_May_Have_Finding some Neck Mass) and (Disease_May_Have_Finding some Perineurial Invasion) and (Disease_May_Have_Finding some Solid Growth Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_May_Have_Finding some Tumor Vascular Invasion) and (Disease_May_Have_Molecular_Abnormality some Aneuploidy) and (Disease_May_Have_Molecular_Abnormality some CCND1 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some HRPT2 Gene Mutation) and (Disease_Has_Abnormal_Cell only Malignant Parathyroid Gland Cell) and (Disease_Has_Normal_Cell_Origin only Parathyroid Gland Parenchymal Cell) and (Disease_Has_Normal_Tissue_Origin only Parathyroid Gland Epithelial Tissue) and (Disease_Has_Primary_Anatomic_Site only Parathyroid Gland)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Parathyroid Gland Carcinoma EquivalentTo Adenocarcinoma and Malignant Endocrine Neoplasm and Malignant Parathyroid Gland Neoplasm and Neck Carcinoma and ((Disease_May_Have_Molecular_Abnormality some CCND1 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression)) and (Disease_May_Have_Abnormal_Cell some Malignant Parathyroid Gland Chief Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Parathyroid Gland Clear Cell) and (Disease_May_Have_Abnormal_Cell some Malignant Parathyroid Gland Oncocyte) and (Disease_May_Have_Associated_Disease some Primary Hyperparathyroidism) and (Disease_May_Have_Finding some Broad Fibrous Bands Formation) and (Disease_May_Have_Finding some Capsular Invasion) and (Disease_May_Have_Finding some Hemosiderin Deposition) and (Disease_May_Have_Finding some Mitotic Activity) and (Disease_May_Have_Finding some Neck Mass) and (Disease_May_Have_Finding some Perineurial Invasion) and (Disease_May_Have_Finding some Solid Growth Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_May_Have_Finding some Tumor Vascular Invasion) and (Disease_May_Have_Molecular_Abnormality some Aneuploidy) and (Disease_May_Have_Molecular_Abnormality some HRPT2 Gene Mutation) and (Disease_Has_Abnormal_Cell only Malignant Parathyroid Gland Cell) and (Disease_Has_Normal_Cell_Origin only Parathyroid Gland Parenchymal Cell) and (Disease_Has_Normal_Tissue_Origin only Parathyroid Gland Epithelial Tissue) and (Disease_Has_Primary_Anatomic_Site only Parathyroid Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1062">
                  <Axiom>Philadelphia Chromosome Positive Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and Philadelphia-Positive Myelogenous Leukemia and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Molecular_Abnormality some JAK-STAT Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some JUN Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some MYC Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some P13K-AKT Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some RAS-RAF Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Has_Cytogenetic_Abnormality only t(9;22)(q34;q11))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Philadelphia Chromosome Positive Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and Philadelphia-Positive Myelogenous Leukemia and ((Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Has_Cytogenetic_Abnormality only t(9;22)(q34;q11))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Molecular_Abnormality some JAK-STAT Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some JUN Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some MYC Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some P13K-AKT Pathway Deregulation) and (Disease_May_Have_Molecular_Abnormality some RAS-RAF Pathway Deregulation)</Axiom>
                  </Source>
               </Change>
               <Change id="1063">
                  <Axiom>Philadelphia Positive Precursor Lymphoblastic Leukemia EquivalentTo Precursor Lymphoblastic Leukemia and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Coarse Azurophilic Granules Present) and (Disease_May_Have_Finding some Extensive Bone Marrow and Blood Involvement) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_Has_Associated_Disease only Precursor B-Lymphoblastic Leukemia) and (Disease_Has_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Has_Cytogenetic_Abnormality only t(9;22)(q34;q11))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Philadelphia Positive Precursor Lymphoblastic Leukemia EquivalentTo Precursor Lymphoblastic Leukemia and ((Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_Has_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Has_Cytogenetic_Abnormality only t(9;22)(q34;q11))) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Coarse Azurophilic Granules Present) and (Disease_May_Have_Finding some Extensive Bone Marrow and Blood Involvement) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Associated_Disease only Precursor B-Lymphoblastic Leukemia)</Axiom>
                  </Source>
               </Change>
               <Change id="1061">
                  <Axiom>Philadelphia-Positive Myelogenous Leukemia EquivalentTo Myeloid Leukemia and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Has_Cytogenetic_Abnormality only t(9;22)(q34;q11))</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Philadelphia-Positive Myelogenous Leukemia EquivalentTo Myeloid Leukemia and ((Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Has_Cytogenetic_Abnormality only t(9;22)(q34;q11)))</Axiom>
                  </Source>
               </Change>
               <Change id="1064">
                  <Axiom>Polycythemia Vera EquivalentTo Chronic Myeloproliferative Disorder and Erythroid Neoplasm and Polycythemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression) and (Disease_Has_Normal_Cell_Origin only Multipotent Bone Marrow Stem Cell)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Polycythemia Vera EquivalentTo Chronic Myeloproliferative Disorder and Erythroid Neoplasm and Polycythemia and ((Disease_Excludes_Cytogenetic_Abnormality only Philadelphia Chromosome) and (Disease_Excludes_Cytogenetic_Abnormality only t(9;22)(q34;q11)) and (Disease_Excludes_Molecular_Abnormality only BCR-ABL1 Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 20q) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Hemorrhage) and (Disease_Has_Normal_Cell_Origin only Multipotent Bone Marrow Stem Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="1065">
                  <Axiom>Polycythemia Vera, Polycythemic Stage EquivalentTo Polycythemia Vera and (Disease_May_Have_Associated_Disease some Cerebrovascular Accident) and (Disease_May_Have_Associated_Disease some Gout) and (Disease_May_Have_Associated_Disease some Myocardial Infarction) and (Disease_May_Have_Associated_Disease some Thrombophlebitis) and (Disease_May_Have_Finding some Basophilia) and (Disease_May_Have_Finding some Dizziness) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Neutrophilia) and (Disease_May_Have_Finding some Paresthesia) and (Disease_May_Have_Finding some Pruritus) and (Disease_May_Have_Finding some Reticulin Fibrosis of the Bone Marrow) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_Excludes_Abnormal_Cell only Hyperchromatic Megakaryocyte) and (Disease_Excludes_Abnormal_Cell only Tear-Drop Red Blood Cell) and (Disease_Excludes_Finding only Leukoerythroblastosis) and (Disease_Excludes_Finding only Osteosclerosis) and (Disease_Excludes_Finding only Poikilocytosis) and (Disease_Has_Finding only Erythroid Hyperplasia) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Increased Red Cell Mass)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Polycythemia Vera, Polycythemic Stage EquivalentTo Polycythemia Vera and ((Disease_Has_Finding only Erythroid Hyperplasia) and (Disease_Has_Finding only Increased Red Cell Mass)) and (Disease_May_Have_Associated_Disease some Cerebrovascular Accident) and (Disease_May_Have_Associated_Disease some Gout) and (Disease_May_Have_Associated_Disease some Myocardial Infarction) and (Disease_May_Have_Associated_Disease some Thrombophlebitis) and (Disease_May_Have_Finding some Basophilia) and (Disease_May_Have_Finding some Dizziness) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Neutrophilia) and (Disease_May_Have_Finding some Paresthesia) and (Disease_May_Have_Finding some Pruritus) and (Disease_May_Have_Finding some Reticulin Fibrosis of the Bone Marrow) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Finding some Thrombocytosis) and (Disease_Excludes_Abnormal_Cell only Hyperchromatic Megakaryocyte) and (Disease_Excludes_Abnormal_Cell only Tear-Drop Red Blood Cell) and (Disease_Excludes_Finding only Leukoerythroblastosis) and (Disease_Excludes_Finding only Osteosclerosis) and (Disease_Excludes_Finding only Poikilocytosis) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                  </Source>
               </Change>
               <Change id="1066">
                  <Axiom>Polycythemia Vera, Post-Polycythemic Myelofibrosis and Myeloid Metaplasia Stage EquivalentTo Polycythemia Vera and (Disease_May_Have_Finding some Osteosclerosis) and (Disease_Excludes_Finding only Increased Red Cell Mass) and (Disease_Has_Abnormal_Cell only Hyperchromatic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Tear-Drop Red Blood Cell) and (Disease_Has_Finding only Bone Marrow Fibrosis) and (Disease_Has_Finding only Extramedullary Hematopoiesis) and (Disease_Has_Finding only Hepatomegaly) and (Disease_Has_Finding only Leukoerythroblastosis) and (Disease_Has_Finding only Poikilocytosis) and (Disease_Has_Finding only Splenomegaly)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Polycythemia Vera, Post-Polycythemic Myelofibrosis and Myeloid Metaplasia Stage EquivalentTo Polycythemia Vera and ((Disease_Has_Finding only Extramedullary Hematopoiesis) and (Disease_Has_Finding only Hepatomegaly) and (Disease_Has_Finding only Splenomegaly)) and (Disease_May_Have_Finding some Osteosclerosis) and (Disease_Excludes_Finding only Increased Red Cell Mass) and (Disease_Has_Abnormal_Cell only Hyperchromatic Megakaryocyte) and (Disease_Has_Abnormal_Cell only Tear-Drop Red Blood Cell) and (Disease_Has_Finding only Bone Marrow Fibrosis) and (Disease_Has_Finding only Leukoerythroblastosis) and (Disease_Has_Finding only Poikilocytosis)</Axiom>
                  </Source>
               </Change>
               <Change id="1068">
                  <Axiom>Precursor T-Lymphoblastic Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Precursor Lymphoblastic Lymphoma and Precursor T-Lymphoblastic Lymphoma/Leukemia and T-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Lymphoblasts 25 Percent or Less of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Starry Sky Pattern)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Precursor T-Lymphoblastic Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Precursor Lymphoblastic Lymphoma and Precursor T-Lymphoblastic Lymphoma/Leukemia and T-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Starry Sky Pattern)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphoblasts 25 Percent or Less of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Skin Nodule)</Axiom>
                  </Source>
               </Change>
               <Change id="1067">
                  <Axiom>Precursor T-Lymphoblastic Lymphoma/Leukemia EquivalentTo Precursor Lymphoblastic Lymphoma/Leukemia and T-Cell and NK-Cell Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some del(9p21p22)) and (Disease_May_Have_Cytogenetic_Abnormality some inv(14)(q11;q32.1)) and (Disease_May_Have_Cytogenetic_Abnormality some t(10;14)(q24;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(p13;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(p15;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;14)(q11;q32)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;14)(p32;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;7)(p33;q35)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;10)(q34;q24)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;14)(q35;q32.1)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;19)(q34;q13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;9)(q34;q32)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;9)(q34;q34.3)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;13)(p11;q11)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some High Mitotic Activity) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Malignant Pleural Effusion) and (Disease_May_Have_Finding some Starry Sky Pattern) and (Disease_May_Have_Molecular_Abnormality some NOTCH1 Gene Mutation) and (Disease_Excludes_Normal_Cell_Origin only Peripheral (Post-Thymic) T-Lymphocyte) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphoblast) and (Disease_Has_Normal_Cell_Origin only Precursor T-Lymphoblast)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Precursor T-Lymphoblastic Lymphoma/Leukemia EquivalentTo Precursor Lymphoblastic Lymphoma/Leukemia and T-Cell and NK-Cell Neoplasm and ((Disease_May_Have_Finding some High Mitotic Activity) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Starry Sky Pattern)) and (Disease_May_Have_Cytogenetic_Abnormality some del(9p21p22)) and (Disease_May_Have_Cytogenetic_Abnormality some inv(14)(q11;q32.1)) and (Disease_May_Have_Cytogenetic_Abnormality some t(10;14)(q24;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(p13;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(p15;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;14)(q11;q32)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;14)(p32;q11)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;7)(p33;q35)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;10)(q34;q24)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;14)(q35;q32.1)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;19)(q34;q13)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;9)(q34;q32)) and (Disease_May_Have_Cytogenetic_Abnormality some t(7;9)(q34;q34.3)) and (Disease_May_Have_Cytogenetic_Abnormality some t(8;13)(p11;q11)) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Malignant Pleural Effusion) and (Disease_May_Have_Molecular_Abnormality some NOTCH1 Gene Mutation) and (Disease_Excludes_Normal_Cell_Origin only Peripheral (Post-Thymic) T-Lymphocyte) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphoblast) and (Disease_Has_Normal_Cell_Origin only Precursor T-Lymphoblast)</Axiom>
                  </Source>
               </Change>
               <Change id="1069">
                  <Axiom>Primary Glioblastoma EquivalentTo Glioblastoma and (Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_Has_Finding only Primary Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Primary Glioblastoma EquivalentTo Glioblastoma and ((Disease_May_Have_Molecular_Abnormality some EGFR Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some EGFR Protein Overexpression)) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_Has_Finding only Primary Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1070">
                  <Axiom>Pulmonary Lymphomatoid Granulomatosis EquivalentTo Lung Mature B-Cell Neoplasm and Lymphomatoid Granulomatosis and (Disease_May_Have_Finding some Chest Pain) and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Pulmonary Mass) and (Disease_Has_Finding only Premalignant Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Pulmonary Lymphomatoid Granulomatosis EquivalentTo Lung Mature B-Cell Neoplasm and Lymphomatoid Granulomatosis and ((Disease_May_Have_Finding some Chest Pain) and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Pulmonary Mass)) and (Disease_Has_Finding only Premalignant Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1071">
                  <Axiom>RAEB-2 EquivalentTo Refractory Anemia with Excess Blasts and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Myeloblasts 5-19 Percent of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">RAEB-2 EquivalentTo Refractory Anemia with Excess Blasts and ((Disease_May_Have_Finding some Myeloblasts 5-19 Percent of Peripheral Blood White Cells) and (Disease_May_Have_Finding some Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells)) and (Disease_May_Have_Finding some Auer Rods Present) and (Disease_May_Have_Finding some Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)</Axiom>
                  </Source>
               </Change>
               <Change id="1072">
                  <Axiom>Recurrent Small Lymphocytic Lymphoma EquivalentTo Recurrent B-Cell Non-Hodgkin's Lymphoma and Small Lymphocytic Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Recurrent Small Lymphocytic Lymphoma EquivalentTo Recurrent B-Cell Non-Hodgkin's Lymphoma and Small Lymphocytic Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21))</Axiom>
                  </Source>
               </Change>
               <Change id="1073">
                  <Axiom>Refractory Small Lymphocytic Lymphoma EquivalentTo Refractory Mature B-Cell Non-Hodgkin's Lymphoma and Small Lymphocytic Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Refractory Small Lymphocytic Lymphoma EquivalentTo Refractory Mature B-Cell Non-Hodgkin's Lymphoma and Small Lymphocytic Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21))</Axiom>
                  </Source>
               </Change>
               <Change id="1074">
                  <Axiom>Renal Cell Carcinoma Associated with inv(X)(p11;q12) EquivalentTo Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions and (Disease_Has_Cytogenetic_Abnormality only inv(X)(p11;q12)) and (Disease_Has_Molecular_Abnormality only NONO-TFE3 Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Renal Cell Carcinoma Associated with inv(X)(p11;q12) EquivalentTo Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions and ((Disease_Has_Cytogenetic_Abnormality only inv(X)(p11;q12)) and (Disease_Has_Molecular_Abnormality only NONO-TFE3 Fusion Protein Expression))</Axiom>
                  </Source>
               </Change>
               <Change id="1076">
                  <Axiom>Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34) EquivalentTo Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions and (Disease_Has_Cytogenetic_Abnormality only t(X;1)(p11.2;p34)) and (Disease_Has_Molecular_Abnormality only PSF-TFE3 Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34) EquivalentTo Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions and ((Disease_Has_Cytogenetic_Abnormality only t(X;1)(p11.2;p34)) and (Disease_Has_Molecular_Abnormality only PSF-TFE3 Fusion Protein Expression))</Axiom>
                  </Source>
               </Change>
               <Change id="1077">
                  <Axiom>Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21) EquivalentTo Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions and (Disease_May_Have_Finding some Psammoma Body Formation) and (Disease_Has_Cytogenetic_Abnormality only t(X;1)(p11.2;q21)) and (Disease_Has_Molecular_Abnormality only PRCC-TFE3 Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21) EquivalentTo Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions and ((Disease_Has_Cytogenetic_Abnormality only t(X;1)(p11.2;q21)) and (Disease_Has_Molecular_Abnormality only PRCC-TFE3 Fusion Protein Expression)) and (Disease_May_Have_Finding some Psammoma Body Formation)</Axiom>
                  </Source>
               </Change>
               <Change id="1075">
                  <Axiom>Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25) EquivalentTo Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions and (Disease_Has_Cytogenetic_Abnormality only Balanced Chromosomal Translocation) and (Disease_Has_Cytogenetic_Abnormality only t(X;17)(p11.2;q25)) and (Disease_Has_Finding only Psammoma Body Formation) and (Disease_Has_Molecular_Abnormality only ASPL-TFE3 Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25) EquivalentTo Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions and ((Disease_Has_Cytogenetic_Abnormality only Balanced Chromosomal Translocation) and (Disease_Has_Cytogenetic_Abnormality only t(X;17)(p11.2;q25)) and (Disease_Has_Molecular_Abnormality only ASPL-TFE3 Fusion Protein Expression)) and (Disease_Has_Finding only Psammoma Body Formation)</Axiom>
                  </Source>
               </Change>
               <Change id="1078">
                  <Axiom>Rhabdoid Tumor EquivalentTo Embryonal Neoplasm and Malignant Childhood Neoplasm and (Disease_May_Have_Abnormal_Cell some Non-Neoplastic Osteoclast-Like Giant Cell) and (Disease_May_Have_Finding some Aggressive Clinical Course) and (Disease_May_Have_Finding some High Mitotic Activity) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Malignant Cell with Large Nucleus and Abundant Eosinophilic Cytoplasm) and (Disease_Has_Finding only Intermediate Filaments Present) and (Disease_Has_Finding only Intracytoplasmic Eosinophilic Inclusion) and (Disease_Is_Grade only Grade 4)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Rhabdoid Tumor EquivalentTo Embryonal Neoplasm and Malignant Childhood Neoplasm and ((Disease_Has_Finding only Intermediate Filaments Present) and (Disease_Has_Finding only Intracytoplasmic Eosinophilic Inclusion)) and (Disease_May_Have_Abnormal_Cell some Non-Neoplastic Osteoclast-Like Giant Cell) and (Disease_May_Have_Finding some Aggressive Clinical Course) and (Disease_May_Have_Finding some High Mitotic Activity) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_Has_Abnormal_Cell only Malignant Cell with Large Nucleus and Abundant Eosinophilic Cytoplasm) and (Disease_Is_Grade only Grade 4)</Axiom>
                  </Source>
               </Change>
               <Change id="1080">
                  <Axiom>Salivary Gland Mucoepidermoid Carcinoma EquivalentTo Mucoepidermoid Carcinoma and Salivary Gland Carcinoma and (Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q14-21;p12-13)) and (Disease_May_Have_Molecular_Abnormality some MECT1-MAML2 Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Salivary Gland Mucoepidermoid Carcinoma EquivalentTo Mucoepidermoid Carcinoma and Salivary Gland Carcinoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(11;19)(q14-21;p12-13)) and (Disease_May_Have_Molecular_Abnormality some MECT1-MAML2 Fusion Protein Expression))</Axiom>
                  </Source>
               </Change>
               <Change id="1081">
                  <Axiom>Secretory Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Invasive Breast Carcinoma and (Disease_May_Have_Cytogenetic_Abnormality some t(12;15)(p13;q26)) and (Disease_May_Have_Finding some Well-Circumscribed Lesion) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some ETV6-NTRK3 Fusion Protein Expression) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell with Abundant Pale Staining Cytoplasm) and (Disease_Has_Finding only Intracytoplasmic and Extracytoplasmic Eosinophilic Material Present) and (Disease_Is_Grade only Low Grade)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Secretory Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Invasive Breast Carcinoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(12;15)(p13;q26)) and (Disease_May_Have_Molecular_Abnormality some ETV6-NTRK3 Fusion Protein Expression)) and (Disease_May_Have_Finding some Well-Circumscribed Lesion) and (Disease_May_Have_Finding some Favorable Clinical Outcome) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell with Abundant Pale Staining Cytoplasm) and (Disease_Has_Finding only Intracytoplasmic and Extracytoplasmic Eosinophilic Material Present) and (Disease_Is_Grade only Low Grade)</Axiom>
                  </Source>
               </Change>
               <Change id="1082">
                  <Axiom>Seminoma EquivalentTo Malignant Germ Cell Tumor and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_May_Have_Molecular_Abnormality some C-KIT Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Seminoma EquivalentTo Malignant Germ Cell Tumor and ((Disease_May_Have_Molecular_Abnormality some C-KIT Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression)) and (Disease_May_Have_Finding some Hemorrhagic Change) and (Disease_May_Have_Finding some Necrotic Change)</Axiom>
                  </Source>
               </Change>
               <Change id="1079">
                  <Axiom>Sinus Histiocytosis with Massive Lymphadenopathy EquivalentTo Non-Neoplastic Hematologic and Lymphocytic Disorder and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_Has_Abnormal_Cell only Atypical Histiocyte) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Associated_Anatomic_Site only Lymphatic System) and (Disease_Has_Finding only Cervical Lymphadenopathy) and (Disease_Has_Finding only Emperipolesis) and (Disease_Has_Finding only Fever) and (Disease_Has_Finding only Massive Sinusoidal Histiocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate) and (Disease_Has_Finding only Polyclonal Hypergammaglobulinemia) and (Disease_Has_Normal_Cell_Origin only Histiocyte) and (Disease_Has_Normal_Tissue_Origin only Hematopoietic Tissue) and (Disease_Has_Normal_Tissue_Origin only Lymphoid Tissue)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Sinus Histiocytosis with Massive Lymphadenopathy EquivalentTo Non-Neoplastic Hematologic and Lymphocytic Disorder and ((Disease_Has_Finding only Emperipolesis) and (Disease_Has_Finding only Massive Sinusoidal Histiocytic Infiltrate) and (Disease_Has_Finding only Plasmacytic Infiltrate)) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Indolent Clinical Course) and (Disease_Has_Abnormal_Cell only Atypical Histiocyte) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Associated_Anatomic_Site only Lymphatic System) and (Disease_Has_Finding only Cervical Lymphadenopathy) and (Disease_Has_Finding only Fever) and (Disease_Has_Finding only Polyclonal Hypergammaglobulinemia) and (Disease_Has_Normal_Cell_Origin only Histiocyte) and (Disease_Has_Normal_Tissue_Origin only Hematopoietic Tissue) and (Disease_Has_Normal_Tissue_Origin only Lymphoid Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="1083">
                  <Axiom>Small Cell Variant Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and (Disease_May_Have_Abnormal_Cell some Doughnut Cell) and (Disease_May_Have_Abnormal_Cell some Flower-Like T-Lymphocyte) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Peripheral Blood Involvement) and (Disease_Has_Abnormal_Cell only Hallmark Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Small to Medium-Sized T-Lymphocyte with Irregular Nucleus) and (Disease_Has_Normal_Cell_Origin only Activated Mature Cytotoxic T-Lymphocyte)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Small Cell Variant Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and ((Disease_May_Have_Abnormal_Cell some Flower-Like T-Lymphocyte) and (Disease_May_Have_Finding some Peripheral Blood Involvement)) and (Disease_May_Have_Abnormal_Cell some Doughnut Cell) and (Disease_May_Have_Finding some Extranodal Disease) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_Has_Abnormal_Cell only Hallmark Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Small to Medium-Sized T-Lymphocyte with Irregular Nucleus) and (Disease_Has_Normal_Cell_Origin only Activated Mature Cytotoxic T-Lymphocyte)</Axiom>
                  </Source>
               </Change>
               <Change id="1084">
                  <Axiom>Small Intestinal Enteropathy-Type T-Cell Lymphoma EquivalentTo Enteropathy-type T-Cell Lymphoma and Small Intestinal Non-Hodgkin's Lymphoma and (Disease_May_Have_Associated_Disease some Celiac Disease) and (Disease_May_Have_Associated_Disease some Malabsorption Syndrome) and (Disease_May_Have_Finding some Abdominal Pain) and (Disease_May_Have_Finding some Intestinal Perforation) and (Disease_May_Have_Finding some Intestinal Ulcerated Mass) and (Disease_May_Have_Finding some Villous Atrophy) and (Disease_Has_Normal_Cell_Origin only Intraepithelial T-Lymphocyte of the Intestine) and (Disease_Has_Primary_Anatomic_Site only Small Intestine)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Small Intestinal Enteropathy-Type T-Cell Lymphoma EquivalentTo Enteropathy-type T-Cell Lymphoma and Small Intestinal Non-Hodgkin's Lymphoma and ((Disease_May_Have_Associated_Disease some Celiac Disease) and (Disease_May_Have_Associated_Disease some Malabsorption Syndrome) and (Disease_May_Have_Finding some Villous Atrophy)) and (Disease_May_Have_Finding some Abdominal Pain) and (Disease_May_Have_Finding some Intestinal Perforation) and (Disease_May_Have_Finding some Intestinal Ulcerated Mass) and (Disease_Has_Normal_Cell_Origin only Intraepithelial T-Lymphocyte of the Intestine) and (Disease_Has_Primary_Anatomic_Site only Small Intestine)</Axiom>
                  </Source>
               </Change>
               <Change id="1085">
                  <Axiom>Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma EquivalentTo Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue and Small Intestinal Non-Hodgkin's Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some t(11;18)(q21;q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;14)(p22;q32)) and (Disease_May_Have_Molecular_Abnormality some AP12-MLT Fusion Protein Expression) and (Disease_Has_Normal_Tissue_Origin only Gut-Associated Lymphoid Tissue) and (Disease_Has_Normal_Tissue_Origin only Small Intestinal Mucosa)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma EquivalentTo Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue and Small Intestinal Non-Hodgkin's Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(11;18)(q21;q21)) and (Disease_May_Have_Molecular_Abnormality some AP12-MLT Fusion Protein Expression)) and (Disease_May_Have_Cytogenetic_Abnormality some t(1;14)(p22;q32)) and (Disease_Has_Normal_Tissue_Origin only Gut-Associated Lymphoid Tissue) and (Disease_Has_Normal_Tissue_Origin only Small Intestinal Mucosa)</Axiom>
                  </Source>
               </Change>
               <Change id="1086">
                  <Axiom>Small Lymphocytic Lymphoma with Plasmacytoid Differentiation EquivalentTo Small Lymphocytic Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Lymphoplasmacytoid Cell)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Small Lymphocytic Lymphoma with Plasmacytoid Differentiation EquivalentTo Small Lymphocytic Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Has_Abnormal_Cell only Lymphoplasmacytoid Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="1087">
                  <Axiom>Smoldering Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and Leukemic Phase of Lymphoma and (Disease_May_Have_Abnormal_Cell some Neoplastic Small T-Lymphocyte) and (Disease_May_Have_Finding some Cutaneous Involvement) and (Disease_May_Have_Finding some Skin Rash) and (Disease_Has_Finding only Peripheral Blood Involvement)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Smoldering Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and Leukemic Phase of Lymphoma and ((Disease_May_Have_Finding some Cutaneous Involvement) and (Disease_May_Have_Finding some Skin Rash)) and (Disease_May_Have_Abnormal_Cell some Neoplastic Small T-Lymphocyte) and (Disease_Has_Finding only Peripheral Blood Involvement)</Axiom>
                  </Source>
               </Change>
               <Change id="1088">
                  <Axiom>Smoldering Myeloma EquivalentTo Plasma Cell Myeloma and (Disease_Excludes_Finding only Bone Pain) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Lytic Metastatic Bone Lesion) and (Disease_Excludes_Finding only Pathologic Fracture) and (Disease_Has_Finding only Monoclonal Paraproteinemia) and (Disease_Has_Finding only Neoplastic Plasma Cells Between 10 and 30 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Stable Disease)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Smoldering Myeloma EquivalentTo Plasma Cell Myeloma and ((Disease_Excludes_Finding only Bone Pain) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Lytic Metastatic Bone Lesion) and (Disease_Excludes_Finding only Pathologic Fracture)) and (Disease_Has_Finding only Monoclonal Paraproteinemia) and (Disease_Has_Finding only Neoplastic Plasma Cells Between 10 and 30 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Stable Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1089">
                  <Axiom>Splenic Manifestation of Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and Splenic Manifestation of Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Splenic Manifestation of Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and Splenic Manifestation of Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21))</Axiom>
                  </Source>
               </Change>
               <Change id="1090">
                  <Axiom>Splenic Manifestation of Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and Splenic Manifestation of Leukemia and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Splenic Manifestation of Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and Splenic Manifestation of Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Finding some White Blood Cell Count Increased) and (Disease_Has_Finding only Hypercellular Bone Marrow)</Axiom>
                  </Source>
               </Change>
               <Change id="1091">
                  <Axiom>Splenic Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Has_Associated_Anatomic_Site only Spleen)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Splenic Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_Has_Associated_Anatomic_Site only Spleen)</Axiom>
                  </Source>
               </Change>
               <Change id="1092">
                  <Axiom>Sporadic Papillary Renal Cell Carcinoma EquivalentTo Papillary Renal Cell Carcinoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Tetrasomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 16) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 17) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 20) and (Disease_May_Have_Finding some Progressive Disease) and (Disease_Has_Finding only Non-Hereditary Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Sporadic Papillary Renal Cell Carcinoma EquivalentTo Papillary Renal Cell Carcinoma and ((Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 16) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 20) and (Disease_May_Have_Finding some Progressive Disease)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome Y) and (Disease_May_Have_Cytogenetic_Abnormality some Tetrasomy 7) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 17) and (Disease_Has_Finding only Non-Hereditary Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1093">
                  <Axiom>Stage 0 Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage 0)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage 0 Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage 0)</Axiom>
                  </Source>
               </Change>
               <Change id="1101">
                  <Axiom>Stage I Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage I)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage I Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage I)</Axiom>
                  </Source>
               </Change>
               <Change id="1102">
                  <Axiom>Stage I Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and Stage I B-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage I)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage I Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and Stage I B-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage I)</Axiom>
                  </Source>
               </Change>
               <Change id="1096">
                  <Axiom>Stage II Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage II)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage II Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage II)</Axiom>
                  </Source>
               </Change>
               <Change id="1097">
                  <Axiom>Stage II Multiple Myeloma EquivalentTo Plasma Cell Myeloma and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage II)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage II Multiple Myeloma EquivalentTo Plasma Cell Myeloma and ((Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) and (Disease_May_Have_Abnormal_Cell some Anaplastic Plasma Cell) and (Disease_May_Have_Abnormal_Cell some Flame Cell) and (Disease_May_Have_Abnormal_Cell some Mott Cell) and (Disease_May_Have_Abnormal_Cell some Plasmablast) and (Disease_May_Have_Abnormal_Cell some Pleomorphic Plasma Cell) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Associated_Disease some Renal Failure) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 11) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 19) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 3) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 5) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome X) and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 13) and (Disease_May_Have_Cytogenetic_Abnormality some t(11;14)(q13;q32)) and (Disease_May_Have_Finding some Monoclonal Paraproteinemia) and (Disease_May_Have_Molecular_Abnormality some Cyclin D1 Protein Overexpression) and (Disease_Is_Stage only Stage II)</Axiom>
                  </Source>
               </Change>
               <Change id="1098">
                  <Axiom>Stage II Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and Stage II B-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage II)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage II Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and Stage II B-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage II)</Axiom>
                  </Source>
               </Change>
               <Change id="1094">
                  <Axiom>Stage III Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage III)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage III Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage III)</Axiom>
                  </Source>
               </Change>
               <Change id="1095">
                  <Axiom>Stage III Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and Stage III B-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage III)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage III Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and Stage III B-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage III)</Axiom>
                  </Source>
               </Change>
               <Change id="1099">
                  <Axiom>Stage IV Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage IV)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage IV Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage IV)</Axiom>
                  </Source>
               </Change>
               <Change id="1100">
                  <Axiom>Stage IV Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and Stage IV B-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Is_Stage only Stage IV)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Stage IV Small Lymphocytic Lymphoma EquivalentTo Small Lymphocytic Lymphoma and Stage IV B-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_Is_Stage only Stage IV)</Axiom>
                  </Source>
               </Change>
               <Change id="1103">
                  <Axiom>Subcutaneous Panniculitis-Like T-Cell Lymphoma EquivalentTo Cutaneous T-Cell Non-Hodgkin's Lymphoma and Indolent Non-Hodgkin's Lymphoma and (Disease_May_Have_Abnormal_Cell some Neoplastic Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Neoplastic Small T-Lymphocyte) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Karyorrhexis) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_May_Have_Finding some Weight Loss) and (Disease_Excludes_Finding only CD4-Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only CD56-Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only Dermal Involvement) and (Disease_Excludes_Finding only Epidermotropic Lymphocytic Infiltrate) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only CD8-Positive Neoplastic Cells Present) and (Disease_Has_Finding only Rimming of Adipose Tissue Cells Present) and (Disease_Has_Finding only Subcutaneous Involvement) and (Disease_Has_Finding only Subcutaneous Nodule) and (Disease_Has_Molecular_Abnormality only Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_Has_Molecular_Abnormality only Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Cytotoxic T-Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Subcutis)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Subcutaneous Panniculitis-Like T-Cell Lymphoma EquivalentTo Cutaneous T-Cell Non-Hodgkin's Lymphoma and Indolent Non-Hodgkin's Lymphoma and ((Disease_Excludes_Finding only Dermal Involvement) and (Disease_Excludes_Finding only Epidermotropic Lymphocytic Infiltrate) and (Disease_Has_Finding only Rimming of Adipose Tissue Cells Present) and (Disease_Has_Finding only Subcutaneous Involvement) and (Disease_Has_Finding only Subcutaneous Nodule)) and (Disease_May_Have_Abnormal_Cell some Neoplastic Large T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Neoplastic Medium-Sized T-Lymphocyte) and (Disease_May_Have_Abnormal_Cell some Neoplastic Small T-Lymphocyte) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Karyorrhexis) and (Disease_May_Have_Finding some Necrotic Change) and (Disease_May_Have_Finding some Weight Loss) and (Disease_Excludes_Finding only CD4-Positive Neoplastic Cells Present) and (Disease_Excludes_Finding only CD56-Positive Neoplastic Cells Present) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Finding only CD8-Positive Neoplastic Cells Present) and (Disease_Has_Molecular_Abnormality only Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_Has_Molecular_Abnormality only Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Cytotoxic T-Lymphocyte) and (Disease_Has_Normal_Tissue_Origin only Subcutis)</Axiom>
                  </Source>
               </Change>
               <Change id="1104">
                  <Axiom>Synovial Sarcoma EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Sarcoma NCI Grade 3 and Soft Tissue Sarcoma and (Disease_May_Have_Cytogenetic_Abnormality some t(X;18)(p11;q11)) and (Disease_May_Have_Molecular_Abnormality some SS18-SSX1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some SS18-SSX2 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some SS18-SSX4 Fusion Protein Expression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Synovial Sarcoma EquivalentTo Malignant Soft Tissue Neoplasm of Uncertain Differentiation and Sarcoma NCI Grade 3 and Soft Tissue Sarcoma and ((Disease_May_Have_Cytogenetic_Abnormality some t(X;18)(p11;q11)) and (Disease_May_Have_Molecular_Abnormality some SS18-SSX1 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some SS18-SSX2 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some SS18-SSX4 Fusion Protein Expression))</Axiom>
                  </Source>
               </Change>
               <Change id="1105">
                  <Axiom>Systemic Mastocytosis EquivalentTo Mast Cell Neoplasm and (Disease_May_Have_Finding some Serum Total Tryptase Levels Increased) and (Disease_May_Have_Molecular_Abnormality some C-KIT Somatic Point Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Systemic Mastocytosis EquivalentTo Mast Cell Neoplasm and ((Disease_May_Have_Molecular_Abnormality some C-KIT Somatic Point Mutation) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression)) and (Disease_May_Have_Finding some Serum Total Tryptase Levels Increased)</Axiom>
                  </Source>
               </Change>
               <Change id="1107">
                  <Axiom>Unspecified Peripheral T-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Abnormal_Cell some Neoplastic T-Lymphocyte with Clear Cytoplasm) and (Disease_May_Have_Abnormal_Cell some Reed-Sternberg-Like Cell) and (Disease_May_Have_Associated_Disease some Hemophagocytic Syndrome) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Hemophagocytosis) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Polymorphic Cellular Infiltrate) and (Disease_May_Have_Finding some Pruritus) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Peripheral (Post-Thymic) T-Lymphocyte)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Unspecified Peripheral T-Cell Lymphoma EquivalentTo Aggressive Non-Hodgkin's Lymphoma and Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma and ((Disease_May_Have_Associated_Disease some Hemophagocytic Syndrome) and (Disease_May_Have_Finding some Hemophagocytosis)) and (Disease_May_Have_Abnormal_Cell some Neoplastic T-Lymphocyte with Clear Cytoplasm) and (Disease_May_Have_Abnormal_Cell some Reed-Sternberg-Like Cell) and (Disease_May_Have_Finding some Eosinophilia) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Lymphadenopathy) and (Disease_May_Have_Finding some Polymorphic Cellular Infiltrate) and (Disease_May_Have_Finding some Pruritus) and (Disease_May_Have_Finding some Splenomegaly) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Beta Chain Gene Rearrangement) and (Disease_May_Have_Molecular_Abnormality some Clonal T-Cell Receptor Gamma Chain Gene Rearrangement) and (Disease_Has_Abnormal_Cell only Neoplastic T-Lymphocyte) and (Disease_Has_Normal_Cell_Origin only Peripheral (Post-Thymic) T-Lymphocyte)</Axiom>
                  </Source>
               </Change>
               <Change id="1108">
                  <Axiom>Uterine Corpus Endometrial Stromal Neoplasm EquivalentTo Endometrial Stromal Neoplasm and Uterine Corpus Soft Tissue Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some t(7;17)(p15;q21)) and (Disease_May_Have_Molecular_Abnormality some JAZF1-JJAZ1 Fusion Protein Expression) and (Disease_Has_Normal_Cell_Origin only Endometrial Stromal Cell)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Uterine Corpus Endometrial Stromal Neoplasm EquivalentTo Endometrial Stromal Neoplasm and Uterine Corpus Soft Tissue Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some t(7;17)(p15;q21)) and (Disease_May_Have_Molecular_Abnormality some JAZF1-JJAZ1 Fusion Protein Expression)) and (Disease_Has_Normal_Cell_Origin only Endometrial Stromal Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="1109">
                  <Axiom>Uveal Melanoma EquivalentTo Malignant Uveal Neoplasm and Ocular Melanoma and (Disease_May_Have_Cytogenetic_Abnormality some Monosomy 3) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_Has_Primary_Anatomic_Site only Uvea)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Uveal Melanoma EquivalentTo Malignant Uveal Neoplasm and Ocular Melanoma and ((Disease_May_Have_Cytogenetic_Abnormality some Monosomy 3) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)) and (Disease_Has_Primary_Anatomic_Site only Uvea)</Axiom>
                  </Source>
               </Change>
            </RemovedCompleteRewrite>
            <RemovedPartialRewrite id="rprw" size="0"/>
         </RemovedRewrite>
         <RemovedProspectiveRedundancy id="rpred" size="344">
            <RemovedReshuffleProspectiveRedundancy id="ravred" size="9">
               <Change id="1110">
                  <Axiom>Lymphocytic Interstitial Pneumonia SubClassOf Disease_Excludes_Finding only Lymphoepithelial Lesion</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lymphocytic Interstitial Pneumonia SubClassOf (Disease_May_Have_Finding some Lymphoplasmacytic Infiltrate) and (Disease_May_Have_Finding some Reactive Germinal Centers Present) and (Disease_Excludes_Finding only Lymphoepithelial Lesion) and (Disease_Excludes_Finding only Peribronchial and Lobular Septal Involvement Only) and (Disease_Has_Finding only Diffuse Cellular Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate)</Axiom>
                  </Source>
               </Change>
               <Change id="1111">
                  <Axiom>Lymphocytic Interstitial Pneumonia SubClassOf Disease_Excludes_Finding only Peribronchial and Lobular Septal Involvement Only</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lymphocytic Interstitial Pneumonia SubClassOf (Disease_May_Have_Finding some Lymphoplasmacytic Infiltrate) and (Disease_May_Have_Finding some Reactive Germinal Centers Present) and (Disease_Excludes_Finding only Lymphoepithelial Lesion) and (Disease_Excludes_Finding only Peribronchial and Lobular Septal Involvement Only) and (Disease_Has_Finding only Diffuse Cellular Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate)</Axiom>
                  </Source>
               </Change>
               <Change id="1112">
                  <Axiom>Lymphocytic Interstitial Pneumonia SubClassOf Disease_Has_Finding only Diffuse Cellular Infiltrate</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lymphocytic Interstitial Pneumonia SubClassOf (Disease_May_Have_Finding some Lymphoplasmacytic Infiltrate) and (Disease_May_Have_Finding some Reactive Germinal Centers Present) and (Disease_Excludes_Finding only Lymphoepithelial Lesion) and (Disease_Excludes_Finding only Peribronchial and Lobular Septal Involvement Only) and (Disease_Has_Finding only Diffuse Cellular Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate)</Axiom>
                  </Source>
               </Change>
               <Change id="1113">
                  <Axiom>Lymphocytic Interstitial Pneumonia SubClassOf Disease_Has_Finding only Lymphocytic Infiltrate</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lymphocytic Interstitial Pneumonia SubClassOf (Disease_May_Have_Finding some Lymphoplasmacytic Infiltrate) and (Disease_May_Have_Finding some Reactive Germinal Centers Present) and (Disease_Excludes_Finding only Lymphoepithelial Lesion) and (Disease_Excludes_Finding only Peribronchial and Lobular Septal Involvement Only) and (Disease_Has_Finding only Diffuse Cellular Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate)</Axiom>
                  </Source>
               </Change>
               <Change id="1114">
                  <Axiom>Lymphocytic Interstitial Pneumonia SubClassOf Disease_May_Have_Finding some Lymphoplasmacytic Infiltrate</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lymphocytic Interstitial Pneumonia SubClassOf (Disease_May_Have_Finding some Lymphoplasmacytic Infiltrate) and (Disease_May_Have_Finding some Reactive Germinal Centers Present) and (Disease_Excludes_Finding only Lymphoepithelial Lesion) and (Disease_Excludes_Finding only Peribronchial and Lobular Septal Involvement Only) and (Disease_Has_Finding only Diffuse Cellular Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate)</Axiom>
                  </Source>
               </Change>
               <Change id="1115">
                  <Axiom>Lymphocytic Interstitial Pneumonia SubClassOf Disease_May_Have_Finding some Reactive Germinal Centers Present</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Lymphocytic Interstitial Pneumonia SubClassOf (Disease_May_Have_Finding some Lymphoplasmacytic Infiltrate) and (Disease_May_Have_Finding some Reactive Germinal Centers Present) and (Disease_Excludes_Finding only Lymphoepithelial Lesion) and (Disease_Excludes_Finding only Peribronchial and Lobular Septal Involvement Only) and (Disease_Has_Finding only Diffuse Cellular Infiltrate) and (Disease_Has_Finding only Lymphocytic Infiltrate)</Axiom>
                  </Source>
               </Change>
               <Change id="1116">
                  <Axiom>Metastatic Carcinoma to the Bone EquivalentTo Metastatic Carcinoma and Metastatic Malignant Neoplasm to the Bone and (Disease_Has_Metastatic_Anatomic_Site only Bone)</Axiom>
                  <Source>
                     <Axiom shared="true">Metastatic Malignant Neoplasm to the Bone EquivalentTo Malignant Bone Neoplasm and Metastatic Malignant Neoplasm and (Disease_May_Have_Finding some Pathologic Fracture) and (Disease_Has_Metastatic_Anatomic_Site only Bone)</Axiom>
                     <Axiom ineffectual="true">Metastatic Carcinoma to the Bone EquivalentTo Metastatic Carcinoma and Metastatic Malignant Neoplasm to the Bone</Axiom>
                  </Source>
               </Change>
               <Change id="1117">
                  <Axiom>Non-Metastatic Extraskeletal Osteosarcoma EquivalentTo Extraskeletal Osteosarcoma and Non-Metastatic Neoplasm and (Disease_Excludes_Finding only Metastatic Lesion)</Axiom>
                  <Source>
                     <Axiom shared="true">Non-Metastatic Neoplasm SubClassOf Disease_Excludes_Finding only Metastatic Lesion</Axiom>
                     <Axiom ineffectual="true">Non-Metastatic Extraskeletal Osteosarcoma EquivalentTo Extraskeletal Osteosarcoma and Non-Metastatic Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1118">
                  <Axiom>Radiation-Related Neoplasm EquivalentTo Neoplasm by Cause and Radiation-Related Disorder and (Disease_Has_Abnormal_Cell only Neoplastic Cell)</Axiom>
                  <Source>
                     <Axiom shared="true">Neoplasm by Cause SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom ineffectual="true">Radiation-Related Neoplasm EquivalentTo Neoplasm by Cause and Radiation-Related Disorder</Axiom>
                     <Axiom shared="true">Neoplasm by Special Category SubClassOf Neoplasm</Axiom>
                     <Axiom shared="true">Neoplasm SubClassOf Disease_Has_Abnormal_Cell only Neoplastic Cell</Axiom>
                  </Source>
               </Change>
            </RemovedReshuffleProspectiveRedundancy>
            <RemovedNewProspectiveRedundancy id="rnpred" size="335">
               <Change id="1119">
                  <Axiom>ABT-888 SubClassOf Enzyme Inhibitor</Axiom>
                  <Source>
                     <Axiom effectual="true">ABT-888 SubClassOf Poly (ADP-Ribose) Polymerase Inhibitor</Axiom>
                     <Axiom effectual="true">Poly (ADP-Ribose) Polymerase Inhibitor SubClassOf Enzyme Inhibitor</Axiom>
                  </Source>
               </Change>
               <Change id="1120">
                  <Axiom>Acantholytic Acanthoma SubClassOf Acanthoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Acantholytic Acanthoma EquivalentTo Acanthoma and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Acantholysis) and (Disease_Has_Normal_Cell_Origin only Keratinocyte)</Axiom>
                  </Source>
               </Change>
               <Change id="1121">
                  <Axiom>Acantholytic Acanthoma SubClassOf Disease_Has_Finding only Acantholysis</Axiom>
                  <Source>
                     <Axiom effectual="true">Acantholytic Acanthoma EquivalentTo Acanthoma and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Acantholysis) and (Disease_Has_Normal_Cell_Origin only Keratinocyte)</Axiom>
                  </Source>
               </Change>
               <Change id="1122">
                  <Axiom>Acanthoma SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Acanthoma EquivalentTo Benign Epithelial Skin Neoplasm and (Disease_Excludes_Primary_Anatomic_Site only Hair Follicle Infundibulum) and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte)</Axiom>
                  </Source>
               </Change>
               <Change id="1123">
                  <Axiom>Actinic (Solar) Keratosis SubClassOf Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte</Axiom>
                  <Source>
                     <Axiom effectual="true">Actinic (Solar) Keratosis EquivalentTo Pre-Malignant Skin Epithelial Lesion and (Disease_May_Have_Finding some Parakeratosis) and (Disease_Has_Finding only Hyperkeratosis)</Axiom>
                     <Axiom effectual="true">Pre-Malignant Skin Epithelial Lesion EquivalentTo Cutaneous Precancerous Condition and Epithelial Skin Neoplasm and (Disease_Excludes_Finding only Malignant Cellular Infiltrate) and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte) and (Disease_Has_Finding only Absence of Invasion) and (Disease_Has_Finding only Atypia) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Normal_Tissue_Origin only Epidermis) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1124">
                  <Axiom>Actinic (Solar) Keratosis SubClassOf Disease_Has_Normal_Cell_Origin only Keratinocyte</Axiom>
                  <Source>
                     <Axiom effectual="true">Actinic (Solar) Keratosis EquivalentTo Pre-Malignant Skin Epithelial Lesion and (Disease_May_Have_Finding some Parakeratosis) and (Disease_Has_Finding only Hyperkeratosis)</Axiom>
                     <Axiom effectual="true">Pre-Malignant Skin Epithelial Lesion EquivalentTo Cutaneous Precancerous Condition and Epithelial Skin Neoplasm and (Disease_Excludes_Finding only Malignant Cellular Infiltrate) and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte) and (Disease_Has_Finding only Absence of Invasion) and (Disease_Has_Finding only Atypia) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Normal_Tissue_Origin only Epidermis) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1125">
                  <Axiom>Actinic (Solar) Keratosis SubClassOf Disease_Has_Normal_Tissue_Origin only Epidermis</Axiom>
                  <Source>
                     <Axiom effectual="true">Actinic (Solar) Keratosis EquivalentTo Pre-Malignant Skin Epithelial Lesion and (Disease_May_Have_Finding some Parakeratosis) and (Disease_Has_Finding only Hyperkeratosis)</Axiom>
                     <Axiom effectual="true">Pre-Malignant Skin Epithelial Lesion EquivalentTo Cutaneous Precancerous Condition and Epithelial Skin Neoplasm and (Disease_Excludes_Finding only Malignant Cellular Infiltrate) and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte) and (Disease_Has_Finding only Absence of Invasion) and (Disease_Has_Finding only Atypia) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Normal_Tissue_Origin only Epidermis) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1126">
                  <Axiom>Actinic (Solar) Keratosis SubClassOf Pre-Malignant Skin Epithelial Lesion</Axiom>
                  <Source>
                     <Axiom effectual="true">Actinic (Solar) Keratosis EquivalentTo Pre-Malignant Skin Epithelial Lesion and (Disease_May_Have_Finding some Parakeratosis) and (Disease_Has_Finding only Hyperkeratosis)</Axiom>
                  </Source>
               </Change>
               <Change id="1313">
                  <Axiom>Adrenal Cortex Mixed Cell Adenoma EquivalentTo Adrenal Cortex Adenoma and (Disease_Has_Finding only Mixed Cellular Population)</Axiom>
                  <Source>
                     <Axiom shared="true">Adenoma SubClassOf Epithelial Neoplasm</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Adrenal Cortex Adenoma EquivalentTo Adenoma and Benign Adrenal Cortex Neoplasm and Benign Endocrine Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Adrenal Cortical Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Adrenal Cortical Cell)</Axiom>
                     <Axiom effectual="true">Adrenal Cortex Mixed Cell Adenoma EquivalentTo Adrenal Cortex Adenoma and Mixed Neoplasm</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Adrenal Cortex Adenoma EquivalentTo Adenoma and Benign Adrenal Cortex Neoplasm and Benign Endocrine Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Adrenal Cortical Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Adrenal Cortical Cell)</Axiom>
                     <Axiom effectual="true">Adrenal Cortex Mixed Cell Adenoma EquivalentTo Adrenal Cortex Adenoma and Mixed Neoplasm</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Benign Endocrine Neoplasm EquivalentTo Benign Epithelial Neoplasm and Endocrine Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Endocrine Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Endocrine Neoplasm EquivalentTo Endocrine Disorder and Epithelial Neoplasm and Neoplasm by Site and (Disease_Has_Abnormal_Cell only Neoplastic Endocrine Cell)</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Adenoma SubClassOf Epithelial Neoplasm</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Adrenal Cortex Adenoma EquivalentTo Adenoma and Benign Adrenal Cortex Neoplasm and Benign Endocrine Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Adrenal Cortical Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Adrenal Cortical Cell)</Axiom>
                     <Axiom shared="true">Adrenal Gland Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Adrenal Cortical Cell SubClassOf Endocrine Cell</Axiom>
                     <Axiom effectual="true">Adrenal Cortex Mixed Cell Adenoma EquivalentTo Adrenal Cortex Adenoma and Mixed Neoplasm</Axiom>
                     <Axiom shared="true">Endocrine Cell SubClassOf Secretory Cell</Axiom>
                     <Axiom shared="true">Secretory Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Benign Adrenal Gland Neoplasm EquivalentTo Adrenal Gland Neoplasm and Benign Retroperitoneal Neoplasm and (Disease_Has_Normal_Tissue_Origin only Adrenal Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Adrenal Gland)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Benign Adrenal Cortex Neoplasm EquivalentTo Adrenal Cortex Neoplasm and Benign Adrenal Gland Neoplasm and (Disease_Has_Normal_Tissue_Origin only Adrenal Cortex)</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Adenoma SubClassOf Epithelial Neoplasm</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Adrenal Cortex Adenoma EquivalentTo Adenoma and Benign Adrenal Cortex Neoplasm and Benign Endocrine Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Adrenal Cortical Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Adrenal Cortical Cell)</Axiom>
                     <Axiom shared="true">Adrenal Cortical Cell SubClassOf Endocrine Cell</Axiom>
                     <Axiom effectual="true">Adrenal Cortex Mixed Cell Adenoma EquivalentTo Adrenal Cortex Adenoma and Mixed Neoplasm</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Endocrine Cell SubClassOf Secretory Cell</Axiom>
                     <Axiom shared="true">Secretory Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Adenoma SubClassOf Epithelial Neoplasm</Axiom>
                     <Axiom shared="true">Adrenal Cortex SubClassOf Adrenal Gland Tissue</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Adrenal Cortex Adenoma EquivalentTo Adenoma and Benign Adrenal Cortex Neoplasm and Benign Endocrine Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Adrenal Cortical Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Adrenal Cortical Cell)</Axiom>
                     <Axiom shared="true">Adrenal Gland Tissue SubClassOf Tissue</Axiom>
                     <Axiom effectual="true">Adrenal Cortex Mixed Cell Adenoma EquivalentTo Adrenal Cortex Adenoma and Mixed Neoplasm</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Benign Adrenal Cortex Neoplasm EquivalentTo Adrenal Cortex Neoplasm and Benign Adrenal Gland Neoplasm and (Disease_Has_Normal_Tissue_Origin only Adrenal Cortex)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Adrenal Cortex Adenoma EquivalentTo Adenoma and Benign Adrenal Cortex Neoplasm and Benign Endocrine Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Adrenal Cortical Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Adrenal Cortical Cell)</Axiom>
                     <Axiom shared="true">Adrenal Gland Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Benign Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Excludes_Finding only Borderline Lesion)</Axiom>
                     <Axiom effectual="true">Adrenal Cortex Mixed Cell Adenoma EquivalentTo Adrenal Cortex Adenoma and Mixed Neoplasm</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Benign Adrenal Gland Neoplasm EquivalentTo Adrenal Gland Neoplasm and Benign Retroperitoneal Neoplasm and (Disease_Has_Normal_Tissue_Origin only Adrenal Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Adrenal Gland)</Axiom>
                     <Axiom shared="true">Benign Endocrine Neoplasm EquivalentTo Benign Epithelial Neoplasm and Endocrine Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Endocrine Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Benign Adrenal Cortex Neoplasm EquivalentTo Adrenal Cortex Neoplasm and Benign Adrenal Gland Neoplasm and (Disease_Has_Normal_Tissue_Origin only Adrenal Cortex)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Adrenal Cortex Adenoma EquivalentTo Adenoma and Benign Adrenal Cortex Neoplasm and Benign Endocrine Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Adrenal Cortical Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Adrenal Cortical Cell)</Axiom>
                     <Axiom shared="true">Adrenal Cortical Cell SubClassOf Endocrine Cell</Axiom>
                     <Axiom effectual="true">Adrenal Cortex Mixed Cell Adenoma EquivalentTo Adrenal Cortex Adenoma and Mixed Neoplasm</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Endocrine Cell SubClassOf Secretory Cell</Axiom>
                     <Axiom shared="true">Secretory Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Benign Endocrine Neoplasm EquivalentTo Benign Epithelial Neoplasm and Endocrine Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Endocrine Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Endocrine Neoplasm EquivalentTo Endocrine Disorder and Epithelial Neoplasm and Neoplasm by Site and (Disease_Has_Abnormal_Cell only Neoplastic Endocrine Cell)</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Adenoma SubClassOf Epithelial Neoplasm</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Adrenal Cortex Adenoma EquivalentTo Adenoma and Benign Adrenal Cortex Neoplasm and Benign Endocrine Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Adrenal Cortical Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Adrenal Cortical Cell)</Axiom>
                     <Axiom shared="true">Adrenal Gland Tissue SubClassOf Tissue</Axiom>
                     <Axiom effectual="true">Adrenal Cortex Mixed Cell Adenoma EquivalentTo Adrenal Cortex Adenoma and Mixed Neoplasm</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Benign Adrenal Gland Neoplasm EquivalentTo Adrenal Gland Neoplasm and Benign Retroperitoneal Neoplasm and (Disease_Has_Normal_Tissue_Origin only Adrenal Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Adrenal Gland)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Benign Adrenal Cortex Neoplasm EquivalentTo Adrenal Cortex Neoplasm and Benign Adrenal Gland Neoplasm and (Disease_Has_Normal_Tissue_Origin only Adrenal Cortex)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Adrenal Cortex Adenoma EquivalentTo Adenoma and Benign Adrenal Cortex Neoplasm and Benign Endocrine Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Adrenal Cortical Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Adrenal Cortical Cell)</Axiom>
                     <Axiom shared="true">Benign Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Excludes_Finding only Borderline Lesion)</Axiom>
                     <Axiom effectual="true">Adrenal Cortex Mixed Cell Adenoma EquivalentTo Adrenal Cortex Adenoma and Mixed Neoplasm</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Benign Endocrine Neoplasm EquivalentTo Benign Epithelial Neoplasm and Endocrine Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Endocrine Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Adrenal Cortex Adenoma EquivalentTo Adenoma and Benign Adrenal Cortex Neoplasm and Benign Endocrine Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Finding some Encapsulated Mass) and (Disease_Excludes_Finding only Capsular Invasion) and (Disease_Excludes_Finding only Tumor Vascular Invasion) and (Disease_Has_Abnormal_Cell only Neoplastic Adrenal Cortical Cell) and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Adrenal Cortical Cell)</Axiom>
                     <Axiom shared="true">Adrenal Gland Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Adrenal Cortical Cell SubClassOf Endocrine Cell</Axiom>
                     <Axiom shared="true">Benign Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Excludes_Finding only Borderline Lesion)</Axiom>
                     <Axiom shared="true">Benign Adrenal Gland Neoplasm EquivalentTo Adrenal Gland Neoplasm and Benign Retroperitoneal Neoplasm and (Disease_Has_Normal_Tissue_Origin only Adrenal Gland Tissue) and (Disease_Has_Primary_Anatomic_Site only Adrenal Gland)</Axiom>
                     <Axiom shared="true">Benign Endocrine Neoplasm EquivalentTo Benign Epithelial Neoplasm and Endocrine Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Endocrine Cell)</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom effectual="true">Adrenal Cortex Mixed Cell Adenoma EquivalentTo Adrenal Cortex Adenoma and Mixed Neoplasm</Axiom>
                     <Axiom shared="true">Endocrine Cell SubClassOf Secretory Cell</Axiom>
                     <Axiom shared="true">Secretory Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Benign Adrenal Cortex Neoplasm EquivalentTo Adrenal Cortex Neoplasm and Benign Adrenal Gland Neoplasm and (Disease_Has_Normal_Tissue_Origin only Adrenal Cortex)</Axiom>
                  </Source>
               </Change>
               <Change id="1127">
                  <Axiom>Adult Brain Oligodendroglioma SubClassOf Adult Oligodendroglioma</Axiom>
                  <Source>
                     <Axiom effectual="true">Adult Brain Oligodendroglioma EquivalentTo Adult Oligodendroglioma and Brain Oligodendroglioma</Axiom>
                  </Source>
               </Change>
               <Change id="1128">
                  <Axiom>Adult Brain Oligodendroglioma SubClassOf Brain Oligodendroglioma</Axiom>
                  <Source>
                     <Axiom effectual="true">Adult Brain Oligodendroglioma EquivalentTo Adult Oligodendroglioma and Brain Oligodendroglioma</Axiom>
                  </Source>
               </Change>
               <Change id="1129">
                  <Axiom>Adult Brain Oligodendroglioma SubClassOf Disease_Has_Primary_Anatomic_Site only Brain</Axiom>
                  <Source>
                     <Axiom effectual="true">Adult Brain Oligodendroglioma EquivalentTo Adult Oligodendroglioma and Brain Oligodendroglioma</Axiom>
                     <Axiom shared="true">Brain Oligodendroglioma EquivalentTo Oligodendroglioma and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
                  </Source>
               </Change>
               <Change id="1130">
                  <Axiom>Adult Brain Stem Gliosarcoma EquivalentTo Adult Astrocytic Tumor and Adult Brain Stem Glioma and Gliosarcoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Anaplastic Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Anaplastic Lesion)</Axiom>
                     <Axiom shared="true">Adult Brain Stem Glioma EquivalentTo Adult Brain Stem Neoplasm and Brain Stem Glioma</Axiom>
                     <Axiom shared="true">Malignant Adult Brain Neoplasm EquivalentTo Adult Brain Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom shared="true">Malignant Neoplasm SubClassOf Disease_Has_Abnormal_Cell only Malignant Cell</Axiom>
                     <Axiom shared="true">Adult Brain Stem Neoplasm EquivalentTo Adult Brain Neoplasm and Brain Stem Neoplasm</Axiom>
                     <Axiom shared="true">Gliosarcoma EquivalentTo Glioblastoma and (Disease_May_Have_Finding some Herringbone Growth Pattern) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Finding only Biphasic Pattern) and (Disease_Has_Finding only Glial Differentiation) and (Disease_Has_Finding only Mesenchymal Differentiation)</Axiom>
                     <Axiom effectual="true">Glioblastoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytic Tumor and Malignant Glioma and (Disease_May_Have_Abnormal_Cell some Fibrillary Neoplastic Astrocyte) and (Disease_May_Have_Abnormal_Cell some Gemistocytic Neoplastic Astrocyte) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q25-26)) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Poorly Differentiated Neoplastic Astrocyte) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Microvascular Proliferation) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 4)</Axiom>
                     <Axiom effectual="true">Adult Brain Stem Gliosarcoma EquivalentTo Adult Astrocytic Tumor and Adult Brain Stem Glioma and Gliosarcoma and Malignant Adult Brain Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Adult Brain Neoplasm EquivalentTo Adult Intracranial Neoplasm and Brain Neoplasm</Axiom>
                     <Axiom effectual="true">Anaplastic Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Anaplastic Lesion)</Axiom>
                     <Axiom shared="true">Brain Stem Neoplasm EquivalentTo Infratentorial Neoplasm and (Disease_Has_Associated_Anatomic_Site only Brain Stem)</Axiom>
                     <Axiom shared="true">Primary Brain Stem Neoplasm EquivalentTo Brain Stem Neoplasm and Primary Brain Neoplasm and (Disease_Has_Primary_Anatomic_Site only Brain Stem)</Axiom>
                     <Axiom effectual="true">Glioblastoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytic Tumor and Malignant Glioma and (Disease_May_Have_Abnormal_Cell some Fibrillary Neoplastic Astrocyte) and (Disease_May_Have_Abnormal_Cell some Gemistocytic Neoplastic Astrocyte) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q25-26)) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Poorly Differentiated Neoplastic Astrocyte) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Microvascular Proliferation) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 4)</Axiom>
                     <Axiom effectual="true">Adult Brain Stem Gliosarcoma EquivalentTo Adult Astrocytic Tumor and Adult Brain Stem Glioma and Gliosarcoma and Malignant Adult Brain Neoplasm</Axiom>
                     <Axiom shared="true">Brain Neoplasm EquivalentTo Intracranial Neoplasm and (Disease_Has_Associated_Anatomic_Site only Brain)</Axiom>
                     <Axiom shared="true">Infratentorial Neoplasm EquivalentTo Brain Neoplasm and (Disease_Has_Associated_Anatomic_Site only Infratentorial Brain)</Axiom>
                     <Axiom shared="true">Adult Brain Stem Glioma EquivalentTo Adult Brain Stem Neoplasm and Brain Stem Glioma</Axiom>
                     <Axiom shared="true">Malignant Adult Brain Neoplasm EquivalentTo Adult Brain Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom shared="true">Malignant Neoplasm SubClassOf Disease_Has_Abnormal_Cell only Malignant Cell</Axiom>
                     <Axiom shared="true">Gliosarcoma EquivalentTo Glioblastoma and (Disease_May_Have_Finding some Herringbone Growth Pattern) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Finding only Biphasic Pattern) and (Disease_Has_Finding only Glial Differentiation) and (Disease_Has_Finding only Mesenchymal Differentiation)</Axiom>
                     <Axiom shared="true">Adult Intracranial Neoplasm EquivalentTo Adult Central Nervous System Neoplasm and Intracranial Neoplasm</Axiom>
                     <Axiom shared="true">Adult Astrocytic Tumor EquivalentTo Adult Central Nervous System Neoplasm and Astrocytic Tumor</Axiom>
                     <Axiom shared="true">Brain Stem Glioma EquivalentTo Neuroglial Tumor and Primary Brain Stem Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Adult Brain Neoplasm EquivalentTo Adult Intracranial Neoplasm and Brain Neoplasm</Axiom>
                     <Axiom effectual="true">Anaplastic Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Anaplastic Lesion)</Axiom>
                     <Axiom shared="true">Primary Brain Stem Neoplasm EquivalentTo Brain Stem Neoplasm and Primary Brain Neoplasm and (Disease_Has_Primary_Anatomic_Site only Brain Stem)</Axiom>
                     <Axiom effectual="true">Glioblastoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytic Tumor and Malignant Glioma and (Disease_May_Have_Abnormal_Cell some Fibrillary Neoplastic Astrocyte) and (Disease_May_Have_Abnormal_Cell some Gemistocytic Neoplastic Astrocyte) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q25-26)) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Poorly Differentiated Neoplastic Astrocyte) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Microvascular Proliferation) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 4)</Axiom>
                     <Axiom effectual="true">Adult Brain Stem Gliosarcoma EquivalentTo Adult Astrocytic Tumor and Adult Brain Stem Glioma and Gliosarcoma and Malignant Adult Brain Neoplasm</Axiom>
                     <Axiom shared="true">Primary Brain Neoplasm EquivalentTo Brain Neoplasm and (Disease_Has_Finding only Primary Lesion) and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
                     <Axiom shared="true">Brain Neoplasm EquivalentTo Intracranial Neoplasm and (Disease_Has_Associated_Anatomic_Site only Brain)</Axiom>
                     <Axiom shared="true">Adult Brain Stem Glioma EquivalentTo Adult Brain Stem Neoplasm and Brain Stem Glioma</Axiom>
                     <Axiom shared="true">Malignant Adult Brain Neoplasm EquivalentTo Adult Brain Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom shared="true">Malignant Neoplasm SubClassOf Disease_Has_Abnormal_Cell only Malignant Cell</Axiom>
                     <Axiom shared="true">Gliosarcoma EquivalentTo Glioblastoma and (Disease_May_Have_Finding some Herringbone Growth Pattern) and (Disease_May_Have_Molecular_Abnormality some MDM2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Finding only Biphasic Pattern) and (Disease_Has_Finding only Glial Differentiation) and (Disease_Has_Finding only Mesenchymal Differentiation)</Axiom>
                     <Axiom shared="true">Adult Intracranial Neoplasm EquivalentTo Adult Central Nervous System Neoplasm and Intracranial Neoplasm</Axiom>
                     <Axiom shared="true">Adult Astrocytic Tumor EquivalentTo Adult Central Nervous System Neoplasm and Astrocytic Tumor</Axiom>
                     <Axiom shared="true">Brain Stem Glioma EquivalentTo Neuroglial Tumor and Primary Brain Stem Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1131">
                  <Axiom>Advanced Malignant Neoplasm SubClassOf Metastatic Malignant Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Advanced Malignant Neoplasm EquivalentTo Metastatic Malignant Neoplasm and (Disease_Has_Finding only Extensive Stage Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1201">
                  <Axiom>Agent Combination Indexed in Open Clinical Trials SubClassOf Chemotherapy Regimen or Agent Combination</Axiom>
                  <Source>
                     <Axiom effectual="true">Agent Combination Indexed in Open Clinical Trials SubClassOf Agent Combination</Axiom>
                     <Axiom effectual="true">Agent Combination SubClassOf Chemotherapy Regimen or Agent Combination</Axiom>
                  </Source>
               </Change>
               <Change id="1330">
                  <Axiom>Agent Combination Not Indexed in Open Clinical Trials SubClassOf Chemotherapy Regimen or Agent Combination</Axiom>
                  <Source>
                     <Axiom effectual="true">Agent Combination SubClassOf Chemotherapy Regimen or Agent Combination</Axiom>
                     <Axiom effectual="true">Agent Combination Not Indexed in Open Clinical Trials SubClassOf Agent Combination</Axiom>
                  </Source>
               </Change>
               <Change id="1132">
                  <Axiom>Aggravated Malignant Neoplasm SubClassOf Disease_Has_Finding only Aggravated Disease</Axiom>
                  <Source>
                     <Axiom effectual="true">Aggravated Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Aggravated Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1133">
                  <Axiom>Aggravated Malignant Neoplasm SubClassOf Malignant Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Aggravated Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Aggravated Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1134">
                  <Axiom>Amalgam SubClassOf Dental Material</Axiom>
                  <Source>
                     <Axiom effectual="true">Restorative Material SubClassOf Dental Material</Axiom>
                     <Axiom effectual="true">Amalgam SubClassOf Restorative Material</Axiom>
                  </Source>
               </Change>
               <Change id="1137">
                  <Axiom>Anaplastic (Malignant) Meningioma EquivalentTo Anaplastic Malignant Neoplasm and Grade III Meningioma and Malignant Neoplasm of the Meninges and (Disease_May_Have_Finding some High Mitotic Activity) and (Disease_Has_Finding only Anaplastic Lesion) and (Disease_Has_Finding only Malignant Cellular Infiltrate)</Axiom>
                  <Source>
                     <Axiom effectual="true">Anaplastic Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Anaplastic Lesion)</Axiom>
                     <Axiom effectual="true">Anaplastic (Malignant) Meningioma EquivalentTo Anaplastic Malignant Neoplasm and Grade III Meningioma and Malignant Neoplasm of the Meninges and (Disease_May_Have_Finding some High Mitotic Activity) and (Disease_Has_Finding only Malignant Cellular Infiltrate)</Axiom>
                  </Source>
               </Change>
               <Change id="1135">
                  <Axiom>Anaplastic Astrocytoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytoma and Malignant Glioma and (Disease_May_Have_Cytogenetic_Abnormality some CDKN2A Gene Deletion) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Motor Manifestations) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Finding some Sensory Manifestations) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some RB1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Excludes_Finding only Microvascular Proliferation) and (Disease_Excludes_Finding only Necrotic Change) and (Disease_Has_Abnormal_Cell only Anaplastic Astrocyte) and (Disease_Has_Finding only Anaplastic Lesion) and (Disease_Has_Finding only Increased Cellularity Present) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 3)</Axiom>
                  <Source>
                     <Axiom effectual="true">Anaplastic Astrocytoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytoma and Malignant Glioma and (Disease_May_Have_Cytogenetic_Abnormality some CDKN2A Gene Deletion) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Motor Manifestations) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Finding some Sensory Manifestations) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some RB1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Excludes_Finding only Microvascular Proliferation) and (Disease_Excludes_Finding only Necrotic Change) and (Disease_Has_Abnormal_Cell only Anaplastic Astrocyte) and (Disease_Has_Finding only Increased Cellularity Present) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 3)</Axiom>
                     <Axiom effectual="true">Anaplastic Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Anaplastic Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1136">
                  <Axiom>Anaplastic Ependymoma EquivalentTo Anaplastic Malignant Neoplasm and Ependymal Tumor and Malignant Glioma and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Microvascular Proliferation) and (Disease_May_Have_Finding some Nausea) and (Disease_May_Have_Finding some Pseudopalisading Necrosis) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Finding some Vomiting) and (Disease_Has_Finding only Anaplastic Lesion) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Increased Cellularity Present) and (Disease_Has_Finding only Perivascular Pseudorosette Formation) and (Disease_Is_Grade only Grade 3)</Axiom>
                  <Source>
                     <Axiom effectual="true">Anaplastic Ependymoma EquivalentTo Anaplastic Malignant Neoplasm and Ependymal Tumor and Malignant Glioma and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Microvascular Proliferation) and (Disease_May_Have_Finding some Nausea) and (Disease_May_Have_Finding some Pseudopalisading Necrosis) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome) and (Disease_May_Have_Finding some Vomiting) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Increased Cellularity Present) and (Disease_Has_Finding only Perivascular Pseudorosette Formation) and (Disease_Is_Grade only Grade 3)</Axiom>
                     <Axiom effectual="true">Anaplastic Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Anaplastic Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1138">
                  <Axiom>Anaplastic Malignant Neoplasm SubClassOf Malignant Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Anaplastic Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Anaplastic Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1140">
                  <Axiom>Anterior Foramen Magnum Meningioma SubClassOf Foramen Magnum Meningioma</Axiom>
                  <Source>
                     <Axiom effectual="true">Anterior Foramen Magnum Meningioma EquivalentTo Foramen Magnum Meningioma and (Disease_Has_Primary_Anatomic_Site only Anterior Foramen Magnum)</Axiom>
                  </Source>
               </Change>
               <Change id="1141">
                  <Axiom>Anterior Visual Pathway Meningioma SubClassOf Visual Pathway Meningioma</Axiom>
                  <Source>
                     <Axiom effectual="true">Anterior Visual Pathway Meningioma EquivalentTo Visual Pathway Meningioma and (Disease_Has_Primary_Anatomic_Site only Anterior Visual Pathway)</Axiom>
                  </Source>
               </Change>
               <Change id="1142">
                  <Axiom>Anti-Mesothelin Monoclonal Antibody SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some Immune Cell Activation</Axiom>
                  <Source>
                     <Axiom shared="true">T-Cell Activation SubClassOf Lymphocyte Activation</Axiom>
                     <Axiom shared="true">Lymphocyte Activation SubClassOf Immune Cell Activation</Axiom>
                     <Axiom effectual="true">Anti-Mesothelin Monoclonal Antibody SubClassOf Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation</Axiom>
                  </Source>
               </Change>
               <Change id="1143">
                  <Axiom>Apocrine Adenoma SubClassOf Benign Apocrine Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Apocrine Adenoma EquivalentTo Benign Apocrine Neoplasm and Sweat Gland Adenoma</Axiom>
                  </Source>
               </Change>
               <Change id="1144">
                  <Axiom>Apocrine Adenoma SubClassOf Sweat Gland Adenoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Apocrine Adenoma EquivalentTo Benign Apocrine Neoplasm and Sweat Gland Adenoma</Axiom>
                  </Source>
               </Change>
               <Change id="1145">
                  <Axiom>Apocrine Hidrocystoma SubClassOf Apocrine Adenoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Apocrine Hidrocystoma EquivalentTo Apocrine Adenoma and Hidrocystoma</Axiom>
                  </Source>
               </Change>
               <Change id="1146">
                  <Axiom>Apocrine Hidrocystoma SubClassOf Hidrocystoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Apocrine Hidrocystoma EquivalentTo Apocrine Adenoma and Hidrocystoma</Axiom>
                  </Source>
               </Change>
               <Change id="1147">
                  <Axiom>Apocrine Neoplasm SubClassOf Disease_Has_Abnormal_Cell only Neoplastic Apocrine Cell</Axiom>
                  <Source>
                     <Axiom effectual="true">Apocrine Neoplasm EquivalentTo Sweat Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Apocrine Cell) and (Disease_Has_Finding only Apocrine Differentiation) and (Disease_Has_Normal_Cell_Origin only Apocrine Cell) and (Disease_Has_Primary_Anatomic_Site only Apocrine Sweat Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1148">
                  <Axiom>Apocrine Neoplasm SubClassOf Disease_Has_Finding only Apocrine Differentiation</Axiom>
                  <Source>
                     <Axiom effectual="true">Apocrine Neoplasm EquivalentTo Sweat Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Apocrine Cell) and (Disease_Has_Finding only Apocrine Differentiation) and (Disease_Has_Normal_Cell_Origin only Apocrine Cell) and (Disease_Has_Primary_Anatomic_Site only Apocrine Sweat Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1149">
                  <Axiom>Apocrine Neoplasm SubClassOf Disease_Has_Normal_Cell_Origin only Apocrine Cell</Axiom>
                  <Source>
                     <Axiom effectual="true">Apocrine Neoplasm EquivalentTo Sweat Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Apocrine Cell) and (Disease_Has_Finding only Apocrine Differentiation) and (Disease_Has_Normal_Cell_Origin only Apocrine Cell) and (Disease_Has_Primary_Anatomic_Site only Apocrine Sweat Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1150">
                  <Axiom>Apocrine Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Apocrine Sweat Gland</Axiom>
                  <Source>
                     <Axiom effectual="true">Apocrine Neoplasm EquivalentTo Sweat Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Apocrine Cell) and (Disease_Has_Finding only Apocrine Differentiation) and (Disease_Has_Normal_Cell_Origin only Apocrine Cell) and (Disease_Has_Primary_Anatomic_Site only Apocrine Sweat Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1151">
                  <Axiom>Apocrine Neoplasm SubClassOf Sweat Gland Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Apocrine Neoplasm EquivalentTo Sweat Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Apocrine Cell) and (Disease_Has_Finding only Apocrine Differentiation) and (Disease_Has_Normal_Cell_Origin only Apocrine Cell) and (Disease_Has_Primary_Anatomic_Site only Apocrine Sweat Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1152">
                  <Axiom>Asbestos-Related Malignant Neoplasm SubClassOf Disease_Has_Finding only Asbestos Exposure</Axiom>
                  <Source>
                     <Axiom effectual="true">Asbestos-Related Malignant Neoplasm EquivalentTo Occupational Malignant Neoplasm and (Disease_Has_Finding only Asbestos Exposure)</Axiom>
                  </Source>
               </Change>
               <Change id="1153">
                  <Axiom>Asbestos-Related Malignant Neoplasm SubClassOf Occupational Malignant Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Asbestos-Related Malignant Neoplasm EquivalentTo Occupational Malignant Neoplasm and (Disease_Has_Finding only Asbestos Exposure)</Axiom>
                  </Source>
               </Change>
               <Change id="1154">
                  <Axiom>BSI-201 SubClassOf Enzyme Inhibitor</Axiom>
                  <Source>
                     <Axiom effectual="true">BSI-201 SubClassOf Poly (ADP-Ribose) Polymerase Inhibitor</Axiom>
                     <Axiom effectual="true">Poly (ADP-Ribose) Polymerase Inhibitor SubClassOf Enzyme Inhibitor</Axiom>
                  </Source>
               </Change>
               <Change id="1155">
                  <Axiom>Benign Apocrine Neoplasm SubClassOf Apocrine Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Apocrine Neoplasm EquivalentTo Apocrine Neoplasm and Benign Sweat Gland Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1156">
                  <Axiom>Benign Apocrine Neoplasm SubClassOf Benign Sweat Gland Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Apocrine Neoplasm EquivalentTo Apocrine Neoplasm and Benign Sweat Gland Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1157">
                  <Axiom>Benign Childhood Central Nervous System Neoplasm SubClassOf Childhood Central Nervous System Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Childhood Central Nervous System Neoplasm EquivalentTo Childhood Central Nervous System Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell with Large Nucleus and Abundant Eosinophilic Cytoplasm) and (Disease_Excludes_Abnormal_Cell only Malignant Neuroectodermal Cell) and (Disease_Excludes_Abnormal_Cell only Melanoma Cell) and (Disease_Excludes_Abnormal_Cell only Neoplastic Ependymal Cell) and (Disease_Excludes_Abnormal_Cell only Neoplastic Germ Cell) and (Disease_Excludes_Abnormal_Cell only Neoplastic Oligodendrocyte-Like Cell) and (Disease_Excludes_Abnormal_Cell only Neoplastic Oligodendrocyte) and (Disease_Excludes_Finding only Anaplastic Lesion) and (Disease_Has_Primary_Anatomic_Site only Central Nervous System)</Axiom>
                  </Source>
               </Change>
               <Change id="1158">
                  <Axiom>Benign Childhood Central Nervous System Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Central Nervous System</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Childhood Central Nervous System Neoplasm EquivalentTo Childhood Central Nervous System Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell with Large Nucleus and Abundant Eosinophilic Cytoplasm) and (Disease_Excludes_Abnormal_Cell only Malignant Neuroectodermal Cell) and (Disease_Excludes_Abnormal_Cell only Melanoma Cell) and (Disease_Excludes_Abnormal_Cell only Neoplastic Ependymal Cell) and (Disease_Excludes_Abnormal_Cell only Neoplastic Germ Cell) and (Disease_Excludes_Abnormal_Cell only Neoplastic Oligodendrocyte-Like Cell) and (Disease_Excludes_Abnormal_Cell only Neoplastic Oligodendrocyte) and (Disease_Excludes_Finding only Anaplastic Lesion) and (Disease_Has_Primary_Anatomic_Site only Central Nervous System)</Axiom>
                  </Source>
               </Change>
               <Change id="1159">
                  <Axiom>Benign Dermal Neoplasm SubClassOf Benign Skin Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Dermal Neoplasm EquivalentTo Benign Skin Neoplasm and Dermal Neoplasm and (Disease_Has_Normal_Tissue_Origin only Dermis)</Axiom>
                  </Source>
               </Change>
               <Change id="1160">
                  <Axiom>Benign Dermal Neoplasm SubClassOf Dermal Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Dermal Neoplasm EquivalentTo Benign Skin Neoplasm and Dermal Neoplasm and (Disease_Has_Normal_Tissue_Origin only Dermis)</Axiom>
                  </Source>
               </Change>
               <Change id="1161">
                  <Axiom>Benign Dermal Neoplasm SubClassOf Disease_Has_Normal_Tissue_Origin only Dermis</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Dermal Neoplasm EquivalentTo Benign Skin Neoplasm and Dermal Neoplasm and (Disease_Has_Normal_Tissue_Origin only Dermis)</Axiom>
                  </Source>
               </Change>
               <Change id="1162">
                  <Axiom>Benign Eccrine Neoplasm SubClassOf Benign Sweat Gland Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Eccrine Neoplasm EquivalentTo Benign Sweat Gland Neoplasm and Eccrine Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1163">
                  <Axiom>Benign Eccrine Neoplasm SubClassOf Eccrine Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Eccrine Neoplasm EquivalentTo Benign Sweat Gland Neoplasm and Eccrine Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1164">
                  <Axiom>Benign Epithelial Skin Neoplasm SubClassOf Benign Skin Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Epithelial Skin Neoplasm EquivalentTo Benign Epithelial Neoplasm and Benign Skin Neoplasm and Epithelial Skin Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1165">
                  <Axiom>Benign Epithelial Skin Neoplasm SubClassOf Epithelial Skin Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Epithelial Skin Neoplasm EquivalentTo Benign Epithelial Neoplasm and Benign Skin Neoplasm and Epithelial Skin Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1166">
                  <Axiom>Benign Germinative Follicular Epithelium Neoplasm SubClassOf Benign Epithelial Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Germinative Follicular Epithelium Neoplasm EquivalentTo Benign Epithelial Skin Neoplasm and Benign Hair Follicle Neoplasm and Germinative Follicular Epithelium Neoplasm</Axiom>
                     <Axiom effectual="true">Benign Epithelial Skin Neoplasm EquivalentTo Benign Epithelial Neoplasm and Benign Skin Neoplasm and Epithelial Skin Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1167">
                  <Axiom>Benign Germinative Follicular Epithelium Neoplasm SubClassOf Benign Hair Follicle Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Germinative Follicular Epithelium Neoplasm EquivalentTo Benign Epithelial Skin Neoplasm and Benign Hair Follicle Neoplasm and Germinative Follicular Epithelium Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1168">
                  <Axiom>Benign Germinative Follicular Epithelium Neoplasm SubClassOf Germinative Follicular Epithelium Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Germinative Follicular Epithelium Neoplasm EquivalentTo Benign Epithelial Skin Neoplasm and Benign Hair Follicle Neoplasm and Germinative Follicular Epithelium Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1169">
                  <Axiom>Benign Hair Follicle Neoplasm SubClassOf Benign Skin Appendage Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Hair Follicle Neoplasm EquivalentTo Benign Skin Appendage Neoplasm and Hair Follicle Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1170">
                  <Axiom>Benign Hair Follicle Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Hair Follicle</Axiom>
                  <Source>
                     <Axiom effectual="true">Hair Follicle Neoplasm EquivalentTo Hair Disorder and Skin Appendage Neoplasm and (Disease_Has_Primary_Anatomic_Site only Hair Follicle)</Axiom>
                     <Axiom effectual="true">Benign Hair Follicle Neoplasm EquivalentTo Benign Skin Appendage Neoplasm and Hair Follicle Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1171">
                  <Axiom>Benign Hair Follicle Neoplasm SubClassOf Hair Follicle Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Hair Follicle Neoplasm EquivalentTo Benign Skin Appendage Neoplasm and Hair Follicle Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1172">
                  <Axiom>Benign Metastasizing Leiomyoma of the Uterine Corpus EquivalentTo Metastatic Benign Neoplasm and Uterine Corpus Leiomyoma and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Benign Metastasizing Leiomyoma of the Uterine Corpus EquivalentTo Metastatic Benign Neoplasm and Uterine Corpus Leiomyoma</Axiom>
                     <Axiom effectual="true">Metastatic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                     <Axiom shared="true">Metastatic Benign Neoplasm EquivalentTo Benign Neoplasm and Metastatic Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1173">
                  <Axiom>Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm SubClassOf Benign Hair Follicle Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm EquivalentTo Benign Hair Follicle Neoplasm and Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1174">
                  <Axiom>Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm SubClassOf Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm EquivalentTo Benign Hair Follicle Neoplasm and Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1176">
                  <Axiom>Benign Outer Hair Sheath and Infundibulum Neoplasm SubClassOf Benign Hair Follicle Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Outer Hair Sheath and Infundibulum Neoplasm EquivalentTo Benign Epithelial Skin Neoplasm and Benign Hair Follicle Neoplasm and Outer Hair Sheath and Infundibulum Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1177">
                  <Axiom>Benign Outer Hair Sheath and Infundibulum Neoplasm SubClassOf Outer Hair Sheath and Infundibulum Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Outer Hair Sheath and Infundibulum Neoplasm EquivalentTo Benign Epithelial Skin Neoplasm and Benign Hair Follicle Neoplasm and Outer Hair Sheath and Infundibulum Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1178">
                  <Axiom>Benign Placental Neoplasm SubClassOf Disease_Excludes_Abnormal_Cell only Malignant Cell</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Placental Neoplasm EquivalentTo Placental Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Excludes_Finding only Human Chorionic Gonadotropin Positive Neoplastic Cells Present) and (Disease_Has_Primary_Anatomic_Site only Placenta)</Axiom>
                  </Source>
               </Change>
               <Change id="1179">
                  <Axiom>Benign Placental Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Placenta</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Placental Neoplasm EquivalentTo Placental Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Excludes_Finding only Human Chorionic Gonadotropin Positive Neoplastic Cells Present) and (Disease_Has_Primary_Anatomic_Site only Placenta)</Axiom>
                  </Source>
               </Change>
               <Change id="1180">
                  <Axiom>Benign Placental Neoplasm SubClassOf Placental Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Placental Neoplasm EquivalentTo Placental Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Excludes_Finding only Human Chorionic Gonadotropin Positive Neoplastic Cells Present) and (Disease_Has_Primary_Anatomic_Site only Placenta)</Axiom>
                  </Source>
               </Change>
               <Change id="1181">
                  <Axiom>Benign Skin Appendage Neoplasm SubClassOf Benign Skin Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Skin Appendage Neoplasm EquivalentTo Benign Skin Neoplasm and Skin Appendage Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1182">
                  <Axiom>Benign Skin Appendage Neoplasm SubClassOf Skin Appendage Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Skin Appendage Neoplasm EquivalentTo Benign Skin Neoplasm and Skin Appendage Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1183">
                  <Axiom>Benign Skin Neoplasm SubClassOf Disease_Excludes_Abnormal_Cell only Malignant Cell</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Skin Neoplasm EquivalentTo Skin Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Excludes_Finding only Dysplasia) and (Disease_Excludes_Finding only Invasive Lesion) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1184">
                  <Axiom>Benign Skin Neoplasm SubClassOf Disease_Excludes_Finding only Invasive Lesion</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Skin Neoplasm EquivalentTo Skin Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Excludes_Finding only Dysplasia) and (Disease_Excludes_Finding only Invasive Lesion) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1185">
                  <Axiom>Benign Skin Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Skin</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Skin Neoplasm EquivalentTo Skin Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Excludes_Finding only Dysplasia) and (Disease_Excludes_Finding only Invasive Lesion) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1186">
                  <Axiom>Benign Skin Neoplasm SubClassOf Skin Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Skin Neoplasm EquivalentTo Skin Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Excludes_Finding only Dysplasia) and (Disease_Excludes_Finding only Invasive Lesion) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1187">
                  <Axiom>Benign Sweat Gland Neoplasm SubClassOf Benign Skin Appendage Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Sweat Gland Neoplasm EquivalentTo Benign Epithelial Skin Neoplasm and Benign Skin Appendage Neoplasm and Sweat Gland Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1188">
                  <Axiom>Benign Sweat Gland Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Sweat Gland</Axiom>
                  <Source>
                     <Axiom effectual="true">Sweat Gland Neoplasm EquivalentTo Skin Appendage Neoplasm and (Disease_Has_Primary_Anatomic_Site only Sweat Gland)</Axiom>
                     <Axiom effectual="true">Benign Sweat Gland Neoplasm EquivalentTo Benign Epithelial Skin Neoplasm and Benign Skin Appendage Neoplasm and Sweat Gland Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1189">
                  <Axiom>Benign Sweat Gland Neoplasm SubClassOf Sweat Gland Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Sweat Gland Neoplasm EquivalentTo Benign Epithelial Skin Neoplasm and Benign Skin Appendage Neoplasm and Sweat Gland Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1190">
                  <Axiom>Bilateral Malignant Neoplasm SubClassOf Malignant Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Bilateral Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Bilateral Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1192">
                  <Axiom>Borderline Ovarian Serous Surface Papillary Tumor EquivalentTo Borderline Ovarian Serous Tumor and Ovarian Papillary Tumor and (Disease_May_Have_Finding some Psammoma Body Formation)</Axiom>
                  <Source>
                     <Axiom effectual="true">Borderline Ovarian Serous Tumor EquivalentTo Borderline Ovarian Surface Epithelial-Stromal Tumor and Ovarian Papillary Tumor and Ovarian Serous Tumor and (Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS2 Gene Amplification) and (Disease_Excludes_Finding only Atypical Glandular Epithelium Resembling the Normal Endometrium Present)</Axiom>
                     <Axiom effectual="true">Borderline Ovarian Serous Surface Papillary Tumor EquivalentTo Borderline Ovarian Serous Tumor and (Disease_May_Have_Finding some Psammoma Body Formation)</Axiom>
                  </Source>
               </Change>
               <Change id="1191">
                  <Axiom>Borderline Ovarian Serous Tumor EquivalentTo Borderline Ovarian Surface Epithelial-Stromal Tumor and Ovarian Serous Tumor and (Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS2 Gene Amplification) and (Disease_Excludes_Finding only Atypical Glandular Epithelium Resembling the Normal Endometrium Present) and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                  <Source>
                     <Axiom shared="true">Glandular Cell Neoplasm EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Neoplastic Squamous Cell) and (Disease_Excludes_Finding only Mixed Neoplastic Glandular and Squamous Cell Population) and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell)</Axiom>
                     <Axiom effectual="true">Borderline Ovarian Serous Tumor EquivalentTo Borderline Ovarian Surface Epithelial-Stromal Tumor and Ovarian Papillary Tumor and Ovarian Serous Tumor and (Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS2 Gene Amplification) and (Disease_Excludes_Finding only Atypical Glandular Epithelium Resembling the Normal Endometrium Present)</Axiom>
                     <Axiom shared="true">Borderline Ovarian Surface Epithelial-Stromal Tumor EquivalentTo Infrequent Neoplasm and Neoplasm of Uncertain Malignant Potential and Ovarian Surface Epithelial-Stromal Tumor and (Disease_Has_Finding only Absence of Stromal Invasion) and (Disease_Has_Finding only Atypia) and (Disease_Has_Finding only Borderline Lesion)</Axiom>
                     <Axiom effectual="true">Papillary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                     <Axiom shared="true">Ovarian Serous Tumor EquivalentTo Ovarian Surface Epithelial-Stromal Tumor and Serous Neoplasm and (Disease_Excludes_Finding only Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present)</Axiom>
                     <Axiom shared="true">Infrequent Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom shared="true">Serous Neoplasm EquivalentTo Glandular Cell Neoplasm and (Disease_Excludes_Abnormal_Cell only Neoplastic Epithelial Cell with Intracytoplasmic Mucin) and (Disease_Has_Abnormal_Cell only Neoplastic Serous Epithelial Cell)</Axiom>
                     <Axiom effectual="true">Papillary Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and Papillary Neoplasm</Axiom>
                     <Axiom shared="true">Ovarian Papillary Tumor EquivalentTo Ovarian Surface Epithelial-Stromal Tumor and Papillary Epithelial Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Neoplasm of Uncertain Malignant Potential SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom effectual="true">Borderline Ovarian Serous Tumor EquivalentTo Borderline Ovarian Surface Epithelial-Stromal Tumor and Ovarian Papillary Tumor and Ovarian Serous Tumor and (Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS2 Gene Amplification) and (Disease_Excludes_Finding only Atypical Glandular Epithelium Resembling the Normal Endometrium Present)</Axiom>
                     <Axiom shared="true">Borderline Ovarian Surface Epithelial-Stromal Tumor EquivalentTo Infrequent Neoplasm and Neoplasm of Uncertain Malignant Potential and Ovarian Surface Epithelial-Stromal Tumor and (Disease_Has_Finding only Absence of Stromal Invasion) and (Disease_Has_Finding only Atypia) and (Disease_Has_Finding only Borderline Lesion)</Axiom>
                     <Axiom effectual="true">Papillary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                     <Axiom shared="true">Ovarian Surface Epithelial-Stromal Tumor EquivalentTo Epithelial Neoplasm and Ovarian Neoplasm and (Disease_Has_Normal_Tissue_Origin only Ovarian Surface Epithelium) and (Disease_Has_Primary_Anatomic_Site only Female Reproductive System) and (Disease_Has_Primary_Anatomic_Site only Ovary)</Axiom>
                     <Axiom effectual="true">Papillary Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and Papillary Neoplasm</Axiom>
                     <Axiom shared="true">Ovarian Papillary Tumor EquivalentTo Ovarian Surface Epithelial-Stromal Tumor and Papillary Epithelial Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Glandular Cell Neoplasm EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Neoplastic Squamous Cell) and (Disease_Excludes_Finding only Mixed Neoplastic Glandular and Squamous Cell Population) and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell)</Axiom>
                     <Axiom shared="true">Neoplasm of Uncertain Malignant Potential SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom effectual="true">Borderline Ovarian Serous Tumor EquivalentTo Borderline Ovarian Surface Epithelial-Stromal Tumor and Ovarian Papillary Tumor and Ovarian Serous Tumor and (Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS2 Gene Amplification) and (Disease_Excludes_Finding only Atypical Glandular Epithelium Resembling the Normal Endometrium Present)</Axiom>
                     <Axiom shared="true">Borderline Ovarian Surface Epithelial-Stromal Tumor EquivalentTo Infrequent Neoplasm and Neoplasm of Uncertain Malignant Potential and Ovarian Surface Epithelial-Stromal Tumor and (Disease_Has_Finding only Absence of Stromal Invasion) and (Disease_Has_Finding only Atypia) and (Disease_Has_Finding only Borderline Lesion)</Axiom>
                     <Axiom effectual="true">Papillary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                     <Axiom shared="true">Ovarian Serous Tumor EquivalentTo Ovarian Surface Epithelial-Stromal Tumor and Serous Neoplasm and (Disease_Excludes_Finding only Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present)</Axiom>
                     <Axiom shared="true">Serous Neoplasm EquivalentTo Glandular Cell Neoplasm and (Disease_Excludes_Abnormal_Cell only Neoplastic Epithelial Cell with Intracytoplasmic Mucin) and (Disease_Has_Abnormal_Cell only Neoplastic Serous Epithelial Cell)</Axiom>
                     <Axiom effectual="true">Papillary Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and Papillary Neoplasm</Axiom>
                     <Axiom shared="true">Ovarian Papillary Tumor EquivalentTo Ovarian Surface Epithelial-Stromal Tumor and Papillary Epithelial Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Borderline Ovarian Serous Tumor EquivalentTo Borderline Ovarian Surface Epithelial-Stromal Tumor and Ovarian Papillary Tumor and Ovarian Serous Tumor and (Disease_May_Have_Molecular_Abnormality some BRAF Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some KRAS2 Gene Amplification) and (Disease_Excludes_Finding only Atypical Glandular Epithelium Resembling the Normal Endometrium Present)</Axiom>
                     <Axiom shared="true">Borderline Ovarian Surface Epithelial-Stromal Tumor EquivalentTo Infrequent Neoplasm and Neoplasm of Uncertain Malignant Potential and Ovarian Surface Epithelial-Stromal Tumor and (Disease_Has_Finding only Absence of Stromal Invasion) and (Disease_Has_Finding only Atypia) and (Disease_Has_Finding only Borderline Lesion)</Axiom>
                     <Axiom effectual="true">Papillary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                     <Axiom shared="true">Infrequent Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom shared="true">Ovarian Surface Epithelial-Stromal Tumor EquivalentTo Epithelial Neoplasm and Ovarian Neoplasm and (Disease_Has_Normal_Tissue_Origin only Ovarian Surface Epithelium) and (Disease_Has_Primary_Anatomic_Site only Female Reproductive System) and (Disease_Has_Primary_Anatomic_Site only Ovary)</Axiom>
                     <Axiom effectual="true">Papillary Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and Papillary Neoplasm</Axiom>
                     <Axiom shared="true">Ovarian Papillary Tumor EquivalentTo Ovarian Surface Epithelial-Stromal Tumor and Papillary Epithelial Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1193">
                  <Axiom>Bowenoid Papulosis SubClassOf Disease_Has_Finding only Severe Dysplasia</Axiom>
                  <Source>
                     <Axiom effectual="true">Bowenoid Papulosis EquivalentTo Pre-Malignant Skin Epithelial Lesion and (Disease_May_Have_Associated_Disease some Human Papilloma Virus Infection) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Multifocal Lesion) and (Disease_Has_Finding only Severe Dysplasia)</Axiom>
                  </Source>
               </Change>
               <Change id="1194">
                  <Axiom>Bowenoid Papulosis SubClassOf Pre-Malignant Skin Epithelial Lesion</Axiom>
                  <Source>
                     <Axiom effectual="true">Bowenoid Papulosis EquivalentTo Pre-Malignant Skin Epithelial Lesion and (Disease_May_Have_Associated_Disease some Human Papilloma Virus Infection) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Multifocal Lesion) and (Disease_Has_Finding only Severe Dysplasia)</Axiom>
                  </Source>
               </Change>
               <Change id="1196">
                  <Axiom>CNF2024 SubClassOf Antineoplastic Agent</Axiom>
                  <Source>
                     <Axiom effectual="true">CNF2024 SubClassOf Geldanamycin Analogue</Axiom>
                     <Axiom shared="true">Ansamycin Antineoplastic Antibiotic SubClassOf Antineoplastic Antibiotic</Axiom>
                     <Axiom shared="true">Antineoplastic Antibiotic SubClassOf Antineoplastic Agent</Axiom>
                     <Axiom shared="true">Geldanamycin Analogue SubClassOf Ansamycin Antineoplastic Antibiotic</Axiom>
                  </Source>
               </Change>
               <Change id="1197">
                  <Axiom>Cancer Other SubClassOf Neoplasm by Special Category</Axiom>
                  <Source>
                     <Axiom effectual="true">Cancer Other SubClassOf Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Malignant Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                  </Source>
               </Change>
               <Change id="1198">
                  <Axiom>Carcinoma SubClassOf Disease_Has_Abnormal_Cell only Malignant Epithelial Cell</Axiom>
                  <Source>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                  </Source>
               </Change>
               <Change id="1199">
                  <Axiom>Carcinoma SubClassOf Disease_Has_Finding only Carcinomatous Component Present</Axiom>
                  <Source>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                  </Source>
               </Change>
               <Change id="1200">
                  <Axiom>Carcinoma SubClassOf Epithelial Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                  </Source>
               </Change>
               <Change id="1361">
                  <Axiom>Cerebral Lymphoma in Immunocompetent Host SubClassOf Cerebral Lymphoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Cerebral Lymphoma in Immunocompetent Host EquivalentTo Cerebral Lymphoma and (Disease_Excludes_Finding only Immunodeficiency)</Axiom>
                  </Source>
               </Change>
               <Change id="1202">
                  <Axiom>Childhood Brain Meningioma EquivalentTo Childhood Meningioma and Intracranial Meningioma and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
                  <Source>
                     <Axiom effectual="true">Childhood Intracranial Neoplasm EquivalentTo Childhood Central Nervous System Neoplasm and Intracranial Neoplasm</Axiom>
                     <Axiom shared="true">Intracranial Meningioma EquivalentTo Intracranial Neoplasm and Meningioma by Site and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_Has_Primary_Anatomic_Site only Skull)</Axiom>
                     <Axiom effectual="true">Childhood Brain Meningioma EquivalentTo Childhood Intracranial Neoplasm and Childhood Meningioma and Intracranial Meningioma and (Disease_Has_Primary_Anatomic_Site only Brain)</Axiom>
                     <Axiom shared="true">Childhood Meningioma EquivalentTo Childhood Central Nervous System Neoplasm and Meningioma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 15q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 17q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 1q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 20q) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 9q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 14) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 22) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Molecular_Abnormality some NF2 Gene Inactivation)</Axiom>
                  </Source>
               </Change>
               <Change id="1203">
                  <Axiom>Childhood Brain Neoplasm EquivalentTo Brain Neoplasm and Childhood Central Nervous System Neoplasm</Axiom>
                  <Source>
                     <Axiom shared="true">Brain Neoplasm EquivalentTo Intracranial Neoplasm and (Disease_Has_Associated_Anatomic_Site only Brain)</Axiom>
                     <Axiom effectual="true">Childhood Intracranial Neoplasm EquivalentTo Childhood Central Nervous System Neoplasm and Intracranial Neoplasm</Axiom>
                     <Axiom effectual="true">Childhood Brain Neoplasm EquivalentTo Brain Neoplasm and Childhood Intracranial Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1204">
                  <Axiom>Childhood Intracranial Neoplasm SubClassOf Disease_Has_Finding only Childhood Lesion</Axiom>
                  <Source>
                     <Axiom shared="true">Childhood Central Nervous System Neoplasm EquivalentTo Central Nervous System Neoplasm and Childhood Neoplasm</Axiom>
                     <Axiom effectual="true">Childhood Intracranial Neoplasm EquivalentTo Childhood Central Nervous System Neoplasm and Intracranial Neoplasm</Axiom>
                     <Axiom effectual="true">Childhood Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Childhood Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1205">
                  <Axiom>Childhood Intracranial Neoplasm SubClassOf Intracranial Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Childhood Intracranial Neoplasm EquivalentTo Childhood Central Nervous System Neoplasm and Intracranial Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1206">
                  <Axiom>Childhood Neoplasm SubClassOf Disease_Has_Finding only Childhood Lesion</Axiom>
                  <Source>
                     <Axiom effectual="true">Childhood Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Childhood Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1207">
                  <Axiom>Childhood Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                  <Source>
                     <Axiom effectual="true">Childhood Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Childhood Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1208">
                  <Axiom>Classic Type Trichilemmoma SubClassOf Tricholemmoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Classic Type Trichilemmoma EquivalentTo Tricholemmoma and (Disease_Excludes_Finding only Desmoplastic Stroma Formation)</Axiom>
                  </Source>
               </Change>
               <Change id="1209">
                  <Axiom>Classical Poroma SubClassOf Poroma</Axiom>
                  <Source>
                     <Axiom effectual="true">Classical Poroma EquivalentTo Poroma and (Disease_Has_Finding only Dermal Involvement) and (Disease_Has_Finding only Epidermal Involvement)</Axiom>
                  </Source>
               </Change>
               <Change id="1210">
                  <Axiom>Clear Cell Hidradenoma SubClassOf Hidradenoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Clear Cell Hidradenoma EquivalentTo Clear Cell Adenoma and Hidradenoma</Axiom>
                  </Source>
               </Change>
               <Change id="1211">
                  <Axiom>Combined Lung Carcinoma EquivalentTo High Grade Lung Neuroendocrine Neoplasm and Lung Carcinoma and Neuroendocrine Carcinoma and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemoptysis) and (Disease_Has_Finding only Mixed Cellular Population)</Axiom>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Malignant Endocrine Cell SubClassOf Malignant Epithelial Cell</Axiom>
                     <Axiom shared="true">High Grade Lung Neuroendocrine Neoplasm EquivalentTo Lung Neuroendocrine Neoplasm and Malignant Endocrine Neoplasm and Malignant Lung Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Cell) and (Disease_Has_Finding only High Grade Lesion)</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Malignant Endocrine Neoplasm EquivalentTo Endocrine Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Endocrine Cell)</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Endocrine Neoplasm EquivalentTo Endocrine Disorder and Epithelial Neoplasm and Neoplasm by Site and (Disease_Has_Abnormal_Cell only Neoplastic Endocrine Cell)</Axiom>
                     <Axiom effectual="true">Combined Lung Carcinoma EquivalentTo High Grade Lung Neuroendocrine Neoplasm and Lung Carcinoma and Malignant Mixed Neoplasm and Neuroendocrine Carcinoma and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemoptysis)</Axiom>
                     <Axiom shared="true">Malignant Epithelial Cell SubClassOf Malignant Cell</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Malignant Lung Neoplasm EquivalentTo Lung Neoplasm and Malignant Respiratory Tract Neoplasm and Malignant Thoracic Neoplasm</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Malignant Respiratory Tract Neoplasm EquivalentTo Respiratory Tract Neoplasm and (Disease_Excludes_Finding only Premalignant Lesion) and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Lung Carcinoma EquivalentTo Carcinoma and Malignant Lung Neoplasm and (Disease_Has_Primary_Anatomic_Site only Lung)</Axiom>
                     <Axiom effectual="true">Combined Lung Carcinoma EquivalentTo High Grade Lung Neuroendocrine Neoplasm and Lung Carcinoma and Malignant Mixed Neoplasm and Neuroendocrine Carcinoma and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemoptysis)</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Malignant Lung Neoplasm EquivalentTo Lung Neoplasm and Malignant Respiratory Tract Neoplasm and Malignant Thoracic Neoplasm</Axiom>
                     <Axiom shared="true">Neuroendocrine Carcinoma EquivalentTo Carcinoma and Malignant Endocrine Neoplasm and Neuroendocrine Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Cell)</Axiom>
                     <Axiom shared="true">High Grade Lung Neuroendocrine Neoplasm EquivalentTo Lung Neuroendocrine Neoplasm and Malignant Endocrine Neoplasm and Malignant Lung Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Cell) and (Disease_Has_Finding only High Grade Lesion)</Axiom>
                     <Axiom shared="true">Malignant Respiratory Tract Neoplasm EquivalentTo Respiratory Tract Neoplasm and (Disease_Excludes_Finding only Premalignant Lesion) and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Neuroendocrine Neoplasm EquivalentTo Endocrine Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Neuroendocrine Cell) and (Disease_Has_Finding only Neuroendocrine Differentiation) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell)</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Endocrine Neoplasm EquivalentTo Endocrine Disorder and Epithelial Neoplasm and Neoplasm by Site and (Disease_Has_Abnormal_Cell only Neoplastic Endocrine Cell)</Axiom>
                     <Axiom effectual="true">Combined Lung Carcinoma EquivalentTo High Grade Lung Neuroendocrine Neoplasm and Lung Carcinoma and Malignant Mixed Neoplasm and Neuroendocrine Carcinoma and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemoptysis)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Malignant Lung Neoplasm EquivalentTo Lung Neoplasm and Malignant Respiratory Tract Neoplasm and Malignant Thoracic Neoplasm</Axiom>
                     <Axiom shared="true">Neuroendocrine Carcinoma EquivalentTo Carcinoma and Malignant Endocrine Neoplasm and Neuroendocrine Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Cell)</Axiom>
                     <Axiom shared="true">High Grade Lung Neuroendocrine Neoplasm EquivalentTo Lung Neuroendocrine Neoplasm and Malignant Endocrine Neoplasm and Malignant Lung Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Cell) and (Disease_Has_Finding only High Grade Lesion)</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Malignant Respiratory Tract Neoplasm EquivalentTo Respiratory Tract Neoplasm and (Disease_Excludes_Finding only Premalignant Lesion) and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom effectual="true">Combined Lung Carcinoma EquivalentTo High Grade Lung Neuroendocrine Neoplasm and Lung Carcinoma and Malignant Mixed Neoplasm and Neuroendocrine Carcinoma and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemoptysis)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Malignant Lung Neoplasm EquivalentTo Lung Neoplasm and Malignant Respiratory Tract Neoplasm and Malignant Thoracic Neoplasm</Axiom>
                     <Axiom shared="true">High Grade Lung Neuroendocrine Neoplasm EquivalentTo Lung Neuroendocrine Neoplasm and Malignant Endocrine Neoplasm and Malignant Lung Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Cell) and (Disease_Has_Finding only High Grade Lesion)</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Malignant Endocrine Neoplasm EquivalentTo Endocrine Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Endocrine Cell)</Axiom>
                     <Axiom shared="true">Malignant Respiratory Tract Neoplasm EquivalentTo Respiratory Tract Neoplasm and (Disease_Excludes_Finding only Premalignant Lesion) and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Endocrine Neoplasm EquivalentTo Endocrine Disorder and Epithelial Neoplasm and Neoplasm by Site and (Disease_Has_Abnormal_Cell only Neoplastic Endocrine Cell)</Axiom>
                     <Axiom effectual="true">Combined Lung Carcinoma EquivalentTo High Grade Lung Neuroendocrine Neoplasm and Lung Carcinoma and Malignant Mixed Neoplasm and Neuroendocrine Carcinoma and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemoptysis)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Neuroendocrine Carcinoma EquivalentTo Carcinoma and Malignant Endocrine Neoplasm and Neuroendocrine Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Cell)</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom effectual="true">Combined Lung Carcinoma EquivalentTo High Grade Lung Neuroendocrine Neoplasm and Lung Carcinoma and Malignant Mixed Neoplasm and Neuroendocrine Carcinoma and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemoptysis)</Axiom>
                     <Axiom shared="true">Malignant Epithelial Cell SubClassOf Malignant Cell</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Lung Carcinoma EquivalentTo Carcinoma and Malignant Lung Neoplasm and (Disease_Has_Primary_Anatomic_Site only Lung)</Axiom>
                     <Axiom effectual="true">Combined Lung Carcinoma EquivalentTo High Grade Lung Neuroendocrine Neoplasm and Lung Carcinoma and Malignant Mixed Neoplasm and Neuroendocrine Carcinoma and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemoptysis)</Axiom>
                     <Axiom shared="true">Malignant Epithelial Cell SubClassOf Malignant Cell</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">High Grade Lung Neuroendocrine Neoplasm EquivalentTo Lung Neuroendocrine Neoplasm and Malignant Endocrine Neoplasm and Malignant Lung Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Cell) and (Disease_Has_Finding only High Grade Lesion)</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Neuroendocrine Neoplasm EquivalentTo Endocrine Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Neuroendocrine Cell) and (Disease_Has_Finding only Neuroendocrine Differentiation) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell)</Axiom>
                     <Axiom shared="true">Malignant Epithelial Cell SubClassOf Malignant Cell</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Malignant Endocrine Cell SubClassOf Malignant Epithelial Cell</Axiom>
                     <Axiom shared="true">Lung Neuroendocrine Neoplasm EquivalentTo Lung Neoplasm and Neuroendocrine Neoplasm and (Disease_Has_Primary_Anatomic_Site only Lung)</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Malignant Neuroendocrine Cell SubClassOf Malignant Endocrine Cell</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Endocrine Neoplasm EquivalentTo Endocrine Disorder and Epithelial Neoplasm and Neoplasm by Site and (Disease_Has_Abnormal_Cell only Neoplastic Endocrine Cell)</Axiom>
                     <Axiom effectual="true">Combined Lung Carcinoma EquivalentTo High Grade Lung Neuroendocrine Neoplasm and Lung Carcinoma and Malignant Mixed Neoplasm and Neuroendocrine Carcinoma and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemoptysis)</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Neuroendocrine Carcinoma EquivalentTo Carcinoma and Malignant Endocrine Neoplasm and Neuroendocrine Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Cell)</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Neuroendocrine Neoplasm EquivalentTo Endocrine Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Neuroendocrine Cell) and (Disease_Has_Finding only Neuroendocrine Differentiation) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell)</Axiom>
                     <Axiom shared="true">Malignant Epithelial Cell SubClassOf Malignant Cell</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Malignant Endocrine Cell SubClassOf Malignant Epithelial Cell</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Malignant Neuroendocrine Cell SubClassOf Malignant Endocrine Cell</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Endocrine Neoplasm EquivalentTo Endocrine Disorder and Epithelial Neoplasm and Neoplasm by Site and (Disease_Has_Abnormal_Cell only Neoplastic Endocrine Cell)</Axiom>
                     <Axiom effectual="true">Combined Lung Carcinoma EquivalentTo High Grade Lung Neuroendocrine Neoplasm and Lung Carcinoma and Malignant Mixed Neoplasm and Neuroendocrine Carcinoma and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemoptysis)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Malignant Lung Neoplasm EquivalentTo Lung Neoplasm and Malignant Respiratory Tract Neoplasm and Malignant Thoracic Neoplasm</Axiom>
                     <Axiom shared="true">Malignant Thoracic Neoplasm EquivalentTo Thoracic Neoplasm and (Disease_Excludes_Finding only Premalignant Lesion) and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom shared="true">Neuroendocrine Carcinoma EquivalentTo Carcinoma and Malignant Endocrine Neoplasm and Neuroendocrine Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Cell)</Axiom>
                     <Axiom shared="true">High Grade Lung Neuroendocrine Neoplasm EquivalentTo Lung Neuroendocrine Neoplasm and Malignant Endocrine Neoplasm and Malignant Lung Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Cell) and (Disease_Has_Finding only High Grade Lesion)</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom effectual="true">Combined Lung Carcinoma EquivalentTo High Grade Lung Neuroendocrine Neoplasm and Lung Carcinoma and Malignant Mixed Neoplasm and Neuroendocrine Carcinoma and (Disease_May_Have_Finding some Cough) and (Disease_May_Have_Finding some Dyspnea) and (Disease_May_Have_Finding some Fever) and (Disease_May_Have_Finding some Hemoptysis)</Axiom>
                  </Source>
               </Change>
               <Change id="1212">
                  <Axiom>Condyloma Acuminatum EquivalentTo Squamous Cell Neoplasm and (Disease_Excludes_Finding only Endophytic Tumor Growth) and (Disease_Excludes_Finding only Pushing Tumor Margins Present) and (Disease_Has_Associated_Disease only Human Papilloma Virus Infection) and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Exophytic Papillary Lesion) and (Disease_Has_Finding only Papillary Pattern) and (Disease_Has_Normal_Cell_Origin only Squamous Cell) and (Disease_Has_Normal_Tissue_Origin only Squamous Epithelium)</Axiom>
                  <Source>
                     <Axiom effectual="true">Condyloma Acuminatum EquivalentTo Verrucous Lesion and (Disease_Excludes_Finding only Pushing Tumor Margins Present)</Axiom>
                     <Axiom effectual="true">Verrucous Lesion EquivalentTo Squamous Cell Neoplasm and (Disease_Excludes_Finding only Endophytic Tumor Growth) and (Disease_Has_Associated_Disease only Human Papilloma Virus Infection) and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Exophytic Papillary Lesion) and (Disease_Has_Finding only Papillary Pattern) and (Disease_Has_Normal_Cell_Origin only Squamous Cell) and (Disease_Has_Normal_Tissue_Origin only Squamous Epithelium)</Axiom>
                  </Source>
               </Change>
               <Change id="1213">
                  <Axiom>Contributing_Source Range: string</Axiom>
                  <Source>
                     <Axiom effectual="true">Contributing_Source Range: {"CDISC"^^string , "CTCAE"^^string , "FDA"^^string}</Axiom>
                  </Source>
               </Change>
               <Change id="1214">
                  <Axiom>Dental Explorer SubClassOf Diagnostic, Therapeutic, and Research Equipment</Axiom>
                  <Source>
                     <Axiom effectual="true">Dental Explorer SubClassOf Medical Device</Axiom>
                     <Axiom shared="true">Medical Device SubClassOf Diagnostic, Therapeutic, and Research Equipment</Axiom>
                  </Source>
               </Change>
               <Change id="1222">
                  <Axiom>Dermal Duct Tumor SubClassOf Poroma</Axiom>
                  <Source>
                     <Axiom effectual="true">Dermal Duct Tumor EquivalentTo Poroma and (Disease_Excludes_Finding only Epidermal Involvement) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Dermal Involvement)</Axiom>
                  </Source>
               </Change>
               <Change id="1215">
                  <Axiom>Dermal Involvement SubClassOf Integumentary System Finding</Axiom>
                  <Source>
                     <Axiom effectual="true">Dermal Involvement SubClassOf Cutaneous Involvement</Axiom>
                     <Axiom shared="true">Cutaneous Involvement SubClassOf Integumentary System Finding</Axiom>
                  </Source>
               </Change>
               <Change id="1216">
                  <Axiom>Dermal Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Dermis</Axiom>
                  <Source>
                     <Axiom effectual="true">Dermal Neoplasm EquivalentTo Skin Neoplasm and (Disease_Has_Primary_Anatomic_Site only Dermis)</Axiom>
                  </Source>
               </Change>
               <Change id="1217">
                  <Axiom>Dermal Neoplasm SubClassOf Skin Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Dermal Neoplasm EquivalentTo Skin Neoplasm and (Disease_Has_Primary_Anatomic_Site only Dermis)</Axiom>
                  </Source>
               </Change>
               <Change id="1218">
                  <Axiom>Desmoplastic Tricholemmoma SubClassOf Tricholemmoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Desmoplastic Tricholemmoma EquivalentTo Tricholemmoma and (Disease_Has_Finding only Desmoplastic Stroma Formation)</Axiom>
                  </Source>
               </Change>
               <Change id="1219">
                  <Axiom>Diabetic Retinopathy SubClassOf Non-Neoplastic Retinal Disorder</Axiom>
                  <Source>
                     <Axiom effectual="true">Retinopathy SubClassOf Non-Neoplastic Retinal Disorder</Axiom>
                     <Axiom effectual="true">Diabetic Retinopathy SubClassOf Retinopathy</Axiom>
                  </Source>
               </Change>
               <Change id="1220">
                  <Axiom>Eccrine Hidrocystoma SubClassOf Benign Eccrine Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Eccrine Hidrocystoma EquivalentTo Benign Eccrine Neoplasm and Hidrocystoma</Axiom>
                  </Source>
               </Change>
               <Change id="1221">
                  <Axiom>Eccrine Hidrocystoma SubClassOf Hidrocystoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Eccrine Hidrocystoma EquivalentTo Benign Eccrine Neoplasm and Hidrocystoma</Axiom>
                  </Source>
               </Change>
               <Change id="1223">
                  <Axiom>Eccrine Neoplasm SubClassOf Disease_Has_Abnormal_Cell only Neoplastic Eccrine Cell</Axiom>
                  <Source>
                     <Axiom effectual="true">Eccrine Neoplasm EquivalentTo Sweat Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Eccrine Cell) and (Disease_Has_Finding only Eccrine Differentiation) and (Disease_Has_Normal_Cell_Origin only Eccrine Cell) and (Disease_Has_Primary_Anatomic_Site only Eccrine Sweat Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1224">
                  <Axiom>Eccrine Neoplasm SubClassOf Disease_Has_Finding only Eccrine Differentiation</Axiom>
                  <Source>
                     <Axiom effectual="true">Eccrine Neoplasm EquivalentTo Sweat Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Eccrine Cell) and (Disease_Has_Finding only Eccrine Differentiation) and (Disease_Has_Normal_Cell_Origin only Eccrine Cell) and (Disease_Has_Primary_Anatomic_Site only Eccrine Sweat Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1225">
                  <Axiom>Eccrine Neoplasm SubClassOf Disease_Has_Normal_Cell_Origin only Eccrine Cell</Axiom>
                  <Source>
                     <Axiom effectual="true">Eccrine Neoplasm EquivalentTo Sweat Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Eccrine Cell) and (Disease_Has_Finding only Eccrine Differentiation) and (Disease_Has_Normal_Cell_Origin only Eccrine Cell) and (Disease_Has_Primary_Anatomic_Site only Eccrine Sweat Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1226">
                  <Axiom>Eccrine Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Eccrine Sweat Gland</Axiom>
                  <Source>
                     <Axiom effectual="true">Eccrine Neoplasm EquivalentTo Sweat Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Eccrine Cell) and (Disease_Has_Finding only Eccrine Differentiation) and (Disease_Has_Normal_Cell_Origin only Eccrine Cell) and (Disease_Has_Primary_Anatomic_Site only Eccrine Sweat Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1227">
                  <Axiom>Eccrine Neoplasm SubClassOf Sweat Gland Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Eccrine Neoplasm EquivalentTo Sweat Gland Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Eccrine Cell) and (Disease_Has_Finding only Eccrine Differentiation) and (Disease_Has_Normal_Cell_Origin only Eccrine Cell) and (Disease_Has_Primary_Anatomic_Site only Eccrine Sweat Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1230">
                  <Axiom>Embryonal Neoplasm SubClassOf Disease_Has_Normal_Cell_Origin only Embryonic Cell</Axiom>
                  <Source>
                     <Axiom effectual="true">Embryonal Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Normal_Cell_Origin only Embryonic Cell) and (Disease_Has_Normal_Tissue_Origin only Embryonic Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="1231">
                  <Axiom>Embryonal Neoplasm SubClassOf Disease_Has_Normal_Tissue_Origin only Embryonic Tissue</Axiom>
                  <Source>
                     <Axiom effectual="true">Embryonal Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Normal_Cell_Origin only Embryonic Cell) and (Disease_Has_Normal_Tissue_Origin only Embryonic Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="1232">
                  <Axiom>Embryonal Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                  <Source>
                     <Axiom effectual="true">Embryonal Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Normal_Cell_Origin only Embryonic Cell) and (Disease_Has_Normal_Tissue_Origin only Embryonic Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="1233">
                  <Axiom>Encapsulated Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                  <Source>
                     <Axiom effectual="true">Encapsulated Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Encapsulated Mass)</Axiom>
                  </Source>
               </Change>
               <Change id="1234">
                  <Axiom>Epidermal Involvement SubClassOf Integumentary System Finding</Axiom>
                  <Source>
                     <Axiom shared="true">Cutaneous Involvement SubClassOf Integumentary System Finding</Axiom>
                     <Axiom effectual="true">Epidermal Involvement SubClassOf Cutaneous Involvement</Axiom>
                  </Source>
               </Change>
               <Change id="1235">
                  <Axiom>Epidermolytic Acanthoma SubClassOf Acanthoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Epidermolytic Acanthoma EquivalentTo Acanthoma and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Epidermolytic Hyperkeratosis) and (Disease_Has_Normal_Cell_Origin only Keratinocyte)</Axiom>
                  </Source>
               </Change>
               <Change id="1236">
                  <Axiom>Epithelial Neoplasm SubClassOf Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell</Axiom>
                  <Source>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="1237">
                  <Axiom>Epithelial Neoplasm SubClassOf Disease_Has_Finding only Epithelial Component Present</Axiom>
                  <Source>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="1238">
                  <Axiom>Epithelial Neoplasm SubClassOf Disease_Has_Normal_Cell_Origin only Epithelial Cell</Axiom>
                  <Source>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="1239">
                  <Axiom>Epithelial Neoplasm SubClassOf Disease_Has_Normal_Tissue_Origin only Epithelial Tissue</Axiom>
                  <Source>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="1240">
                  <Axiom>Epithelial Neoplasm SubClassOf Neoplasm by Morphology</Axiom>
                  <Source>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="1241">
                  <Axiom>Epithelial Skin Neoplasm SubClassOf Epithelial Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Epithelial Skin Neoplasm EquivalentTo Epithelial Neoplasm and Skin Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1242">
                  <Axiom>Epithelial Skin Neoplasm SubClassOf Skin Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Epithelial Skin Neoplasm EquivalentTo Epithelial Neoplasm and Skin Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1243">
                  <Axiom>External Auditory Canal Ceruminous Adenoma EquivalentTo Apocrine Adenoma and Benign External Ear Neoplasm and Ceruminous Neoplasm and (Disease_Excludes_Finding only Invasive Lesion)</Axiom>
                  <Source>
                     <Axiom effectual="true">Benign Skin Neoplasm EquivalentTo Skin Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Excludes_Finding only Dysplasia) and (Disease_Excludes_Finding only Invasive Lesion) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom ineffectual="true">External Auditory Canal Ceruminous Adenoma EquivalentTo Apocrine Adenoma and Benign External Ear Neoplasm and Ceruminous Neoplasm</Axiom>
                     <Axiom effectual="true">Benign Skin Appendage Neoplasm EquivalentTo Benign Skin Neoplasm and Skin Appendage Neoplasm</Axiom>
                     <Axiom effectual="true">Apocrine Adenoma EquivalentTo Benign Apocrine Neoplasm and Sweat Gland Adenoma</Axiom>
                     <Axiom effectual="true">Benign Apocrine Neoplasm EquivalentTo Apocrine Neoplasm and Benign Sweat Gland Neoplasm</Axiom>
                     <Axiom effectual="true">Benign Sweat Gland Neoplasm EquivalentTo Benign Epithelial Skin Neoplasm and Benign Skin Appendage Neoplasm and Sweat Gland Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Benign Skin Neoplasm EquivalentTo Skin Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Excludes_Finding only Dysplasia) and (Disease_Excludes_Finding only Invasive Lesion) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom effectual="true">Skin Appendage Adenoma EquivalentTo Adenoma and Benign Epithelial Skin Neoplasm and Benign Skin Appendage Neoplasm</Axiom>
                     <Axiom ineffectual="true">External Auditory Canal Ceruminous Adenoma EquivalentTo Apocrine Adenoma and Benign External Ear Neoplasm and Ceruminous Neoplasm</Axiom>
                     <Axiom effectual="true">Benign Skin Appendage Neoplasm EquivalentTo Benign Skin Neoplasm and Skin Appendage Neoplasm</Axiom>
                     <Axiom effectual="true">Sweat Gland Adenoma EquivalentTo Benign Sweat Gland Neoplasm and Skin Appendage Adenoma and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
                     <Axiom effectual="true">Apocrine Adenoma EquivalentTo Benign Apocrine Neoplasm and Sweat Gland Adenoma</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Benign Skin Neoplasm EquivalentTo Skin Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Excludes_Finding only Dysplasia) and (Disease_Excludes_Finding only Invasive Lesion) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom ineffectual="true">External Auditory Canal Ceruminous Adenoma EquivalentTo Apocrine Adenoma and Benign External Ear Neoplasm and Ceruminous Neoplasm</Axiom>
                     <Axiom effectual="true">Benign Epithelial Skin Neoplasm EquivalentTo Benign Epithelial Neoplasm and Benign Skin Neoplasm and Epithelial Skin Neoplasm</Axiom>
                     <Axiom effectual="true">Apocrine Adenoma EquivalentTo Benign Apocrine Neoplasm and Sweat Gland Adenoma</Axiom>
                     <Axiom effectual="true">Benign Apocrine Neoplasm EquivalentTo Apocrine Neoplasm and Benign Sweat Gland Neoplasm</Axiom>
                     <Axiom effectual="true">Benign Sweat Gland Neoplasm EquivalentTo Benign Epithelial Skin Neoplasm and Benign Skin Appendage Neoplasm and Sweat Gland Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Benign Skin Neoplasm EquivalentTo Skin Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Excludes_Finding only Dysplasia) and (Disease_Excludes_Finding only Invasive Lesion) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom ineffectual="true">External Auditory Canal Ceruminous Adenoma EquivalentTo Apocrine Adenoma and Benign External Ear Neoplasm and Ceruminous Neoplasm</Axiom>
                     <Axiom effectual="true">Sweat Gland Adenoma EquivalentTo Benign Sweat Gland Neoplasm and Skin Appendage Adenoma and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
                     <Axiom effectual="true">Benign Epithelial Skin Neoplasm EquivalentTo Benign Epithelial Neoplasm and Benign Skin Neoplasm and Epithelial Skin Neoplasm</Axiom>
                     <Axiom effectual="true">Apocrine Adenoma EquivalentTo Benign Apocrine Neoplasm and Sweat Gland Adenoma</Axiom>
                     <Axiom effectual="true">Benign Sweat Gland Neoplasm EquivalentTo Benign Epithelial Skin Neoplasm and Benign Skin Appendage Neoplasm and Sweat Gland Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Benign Skin Neoplasm EquivalentTo Skin Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Excludes_Finding only Dysplasia) and (Disease_Excludes_Finding only Invasive Lesion) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom ineffectual="true">External Auditory Canal Ceruminous Adenoma EquivalentTo Apocrine Adenoma and Benign External Ear Neoplasm and Ceruminous Neoplasm</Axiom>
                     <Axiom effectual="true">Benign Skin Appendage Neoplasm EquivalentTo Benign Skin Neoplasm and Skin Appendage Neoplasm</Axiom>
                     <Axiom effectual="true">Sweat Gland Adenoma EquivalentTo Benign Sweat Gland Neoplasm and Skin Appendage Adenoma and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
                     <Axiom effectual="true">Apocrine Adenoma EquivalentTo Benign Apocrine Neoplasm and Sweat Gland Adenoma</Axiom>
                     <Axiom effectual="true">Benign Sweat Gland Neoplasm EquivalentTo Benign Epithelial Skin Neoplasm and Benign Skin Appendage Neoplasm and Sweat Gland Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Benign Skin Neoplasm EquivalentTo Skin Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Cell) and (Disease_Excludes_Finding only Dysplasia) and (Disease_Excludes_Finding only Invasive Lesion) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom effectual="true">Skin Appendage Adenoma EquivalentTo Adenoma and Benign Epithelial Skin Neoplasm and Benign Skin Appendage Neoplasm</Axiom>
                     <Axiom ineffectual="true">External Auditory Canal Ceruminous Adenoma EquivalentTo Apocrine Adenoma and Benign External Ear Neoplasm and Ceruminous Neoplasm</Axiom>
                     <Axiom effectual="true">Sweat Gland Adenoma EquivalentTo Benign Sweat Gland Neoplasm and Skin Appendage Adenoma and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
                     <Axiom effectual="true">Benign Epithelial Skin Neoplasm EquivalentTo Benign Epithelial Neoplasm and Benign Skin Neoplasm and Epithelial Skin Neoplasm</Axiom>
                     <Axiom effectual="true">Apocrine Adenoma EquivalentTo Benign Apocrine Neoplasm and Sweat Gland Adenoma</Axiom>
                  </Source>
               </Change>
               <Change id="1244">
                  <Axiom>Eyelid Seborrheic Keratosis SubClassOf Seborrheic Keratosis</Axiom>
                  <Source>
                     <Axiom effectual="true">Eyelid Seborrheic Keratosis EquivalentTo Benign Eyelid Neoplasm and Seborrheic Keratosis</Axiom>
                  </Source>
               </Change>
               <Change id="1245">
                  <Axiom>FDA_Table Range: string</Axiom>
                  <Source>
                     <Axiom effectual="true">FDA_Table Range: {"Dosage Form (C-DRG-00201)"^^string , "Package Type (C-DRG-00907)"^^string , "Patient Code (Appendix B)"^^string , "Potency (C-DRG-00501)"^^string , "Route of Administration (C-DRG-00301)"^^string , "SPL Color (C-DRG-00927)"^^string , "SPL DEA Schedule (C-DRG-0933)"^^string , "SPL Shape (C-DRG-00929)"^^string}</Axiom>
                  </Source>
               </Change>
               <Change id="1246">
                  <Axiom>Flowable Composite SubClassOf Dental Material</Axiom>
                  <Source>
                     <Axiom effectual="true">Restorative Material SubClassOf Dental Material</Axiom>
                     <Axiom effectual="true">Flowable Composite SubClassOf Restorative Material</Axiom>
                  </Source>
               </Change>
               <Change id="1247">
                  <Axiom>Fluoride SubClassOf Inorganic Chemical</Axiom>
                  <Source>
                     <Axiom effectual="true">Fluoride SubClassOf Ion</Axiom>
                     <Axiom shared="true">Ion SubClassOf Inorganic Chemical</Axiom>
                  </Source>
               </Change>
               <Change id="1250">
                  <Axiom>Germinative Follicular Epithelium Neoplasm SubClassOf Disease_Has_Normal_Tissue_Origin only Germinative Follicular Epithelium</Axiom>
                  <Source>
                     <Axiom effectual="true">Germinative Follicular Epithelium Neoplasm EquivalentTo Epithelial Skin Neoplasm and Hair Follicle Neoplasm and (Disease_Has_Normal_Tissue_Origin only Germinative Follicular Epithelium)</Axiom>
                  </Source>
               </Change>
               <Change id="1251">
                  <Axiom>Germinative Follicular Epithelium Neoplasm SubClassOf Epithelial Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Epithelial Skin Neoplasm EquivalentTo Epithelial Neoplasm and Skin Neoplasm</Axiom>
                     <Axiom effectual="true">Germinative Follicular Epithelium Neoplasm EquivalentTo Epithelial Skin Neoplasm and Hair Follicle Neoplasm and (Disease_Has_Normal_Tissue_Origin only Germinative Follicular Epithelium)</Axiom>
                  </Source>
               </Change>
               <Change id="1252">
                  <Axiom>Germinative Follicular Epithelium Neoplasm SubClassOf Hair Follicle Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Germinative Follicular Epithelium Neoplasm EquivalentTo Epithelial Skin Neoplasm and Hair Follicle Neoplasm and (Disease_Has_Normal_Tissue_Origin only Germinative Follicular Epithelium)</Axiom>
                  </Source>
               </Change>
               <Change id="1253">
                  <Axiom>Gold SubClassOf Element</Axiom>
                  <Source>
                     <Axiom effectual="true">Gold SubClassOf Metal</Axiom>
                     <Axiom shared="true">Metal SubClassOf Element</Axiom>
                  </Source>
               </Change>
               <Change id="1254">
                  <Axiom>Hair Follicle Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Hair Follicle</Axiom>
                  <Source>
                     <Axiom effectual="true">Hair Follicle Neoplasm EquivalentTo Hair Disorder and Skin Appendage Neoplasm and (Disease_Has_Primary_Anatomic_Site only Hair Follicle)</Axiom>
                  </Source>
               </Change>
               <Change id="1255">
                  <Axiom>Hair Follicle Neoplasm SubClassOf Hair Disorder</Axiom>
                  <Source>
                     <Axiom effectual="true">Hair Follicle Neoplasm EquivalentTo Hair Disorder and Skin Appendage Neoplasm and (Disease_Has_Primary_Anatomic_Site only Hair Follicle)</Axiom>
                  </Source>
               </Change>
               <Change id="1256">
                  <Axiom>Hair Follicle Neoplasm SubClassOf Skin Appendage Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Hair Follicle Neoplasm EquivalentTo Hair Disorder and Skin Appendage Neoplasm and (Disease_Has_Primary_Anatomic_Site only Hair Follicle)</Axiom>
                  </Source>
               </Change>
               <Change id="1257">
                  <Axiom>Hereditary Glomangioma SubClassOf Disease_Has_Finding only Hereditary Lesion</Axiom>
                  <Source>
                     <Axiom effectual="true">Hereditary Glomangioma EquivalentTo Glomangioma and (Disease_Has_Finding only Hereditary Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1258">
                  <Axiom>Hereditary Glomangioma SubClassOf Glomangioma</Axiom>
                  <Source>
                     <Axiom effectual="true">Hereditary Glomangioma EquivalentTo Glomangioma and (Disease_Has_Finding only Hereditary Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1259">
                  <Axiom>Hidroacanthoma Simplex SubClassOf Poroma</Axiom>
                  <Source>
                     <Axiom effectual="true">Hidroacanthoma Simplex EquivalentTo Poroma and (Disease_Excludes_Finding only Dermal Involvement) and (Disease_Has_Finding only Epidermal Involvement)</Axiom>
                  </Source>
               </Change>
               <Change id="1260">
                  <Axiom>Hidrocystoma SubClassOf Benign Sweat Gland Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Hidrocystoma EquivalentTo Benign Sweat Gland Neoplasm and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Cystic Change)</Axiom>
                  </Source>
               </Change>
               <Change id="1261">
                  <Axiom>Hybrid Composite SubClassOf Dental Material</Axiom>
                  <Source>
                     <Axiom effectual="true">Restorative Material SubClassOf Dental Material</Axiom>
                     <Axiom effectual="true">Hybrid Composite SubClassOf Restorative Material</Axiom>
                  </Source>
               </Change>
               <Change id="1262">
                  <Axiom>Hypertensive Retinopathy SubClassOf Non-Neoplastic Retinal Disorder</Axiom>
                  <Source>
                     <Axiom effectual="true">Hypertensive Retinopathy SubClassOf Retinopathy</Axiom>
                     <Axiom effectual="true">Retinopathy SubClassOf Non-Neoplastic Retinal Disorder</Axiom>
                  </Source>
               </Change>
               <Change id="1263">
                  <Axiom>Hypothalamic Neoplasm SubClassOf Diencephalic Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Hypothalamic Neoplasm EquivalentTo Diencephalic Neoplasm and (Disease_Has_Associated_Anatomic_Site only Hypothalamus)</Axiom>
                  </Source>
               </Change>
               <Change id="1264">
                  <Axiom>Hypothalamic Neoplasm SubClassOf Disease_Has_Associated_Anatomic_Site only Hypothalamus</Axiom>
                  <Source>
                     <Axiom effectual="true">Hypothalamic Neoplasm EquivalentTo Diencephalic Neoplasm and (Disease_Has_Associated_Anatomic_Site only Hypothalamus)</Axiom>
                  </Source>
               </Change>
               <Change id="1265">
                  <Axiom>INO-1001 SubClassOf Enzyme Inhibitor</Axiom>
                  <Source>
                     <Axiom effectual="true">INO-1001 SubClassOf Poly (ADP-Ribose) Polymerase Inhibitor</Axiom>
                     <Axiom effectual="true">Poly (ADP-Ribose) Polymerase Inhibitor SubClassOf Enzyme Inhibitor</Axiom>
                  </Source>
               </Change>
               <Change id="1266">
                  <Axiom>Immunodeficiency-Related Malignant Neoplasm SubClassOf Immunodeficiency-Related Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Immunodeficiency-Related Malignant Neoplasm EquivalentTo Immunodeficiency-Related Neoplasm and Malignant Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1267">
                  <Axiom>Immunodeficiency-Related Neoplasm SubClassOf Immunodeficiency-Related Disorder</Axiom>
                  <Source>
                     <Axiom effectual="true">Immunodeficiency-Related Neoplasm EquivalentTo Immunodeficiency-Related Disorder and Neoplasm by Cause</Axiom>
                  </Source>
               </Change>
               <Change id="1268">
                  <Axiom>Immunodeficiency-Related Neoplasm SubClassOf Neoplasm by Cause</Axiom>
                  <Source>
                     <Axiom effectual="true">Immunodeficiency-Related Neoplasm EquivalentTo Immunodeficiency-Related Disorder and Neoplasm by Cause</Axiom>
                  </Source>
               </Change>
               <Change id="1269">
                  <Axiom>Indolent Myeloma EquivalentTo Plasma Cell Myeloma and (Disease_Excludes_Finding only Bone Pain) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Pathologic Fracture) and (Disease_Has_Finding only Lytic Metastatic Bone Lesion) and (Disease_Has_Finding only Monoclonal Paraproteinemia) and (Disease_Has_Finding only Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Stable Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Osteolytic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Lytic Bone Lesion)</Axiom>
                     <Axiom effectual="true">Indolent Myeloma EquivalentTo Osteolytic Neoplasm and Plasma Cell Myeloma and ((Disease_Excludes_Finding only Bone Pain) and (Disease_Excludes_Finding only Hypercalcemia) and (Disease_Excludes_Finding only Pathologic Fracture) and (Disease_Has_Finding only Lytic Metastatic Bone Lesion)) and (Disease_Has_Finding only Monoclonal Paraproteinemia) and (Disease_Has_Finding only Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells) and (Disease_Has_Finding only Stable Disease)</Axiom>
                     <Axiom shared="true">Common Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom shared="true">Plasma Cell Myeloma EquivalentTo Common Hematopoietic Neoplasm and Plasma Cell Neoplasm and (Disease_Excludes_Finding only Localized Lesion) and (Disease_Has_Associated_Anatomic_Site only Hematopoietic System) and (Disease_Has_Finding only Neoplastic Plasma Cells Present in Bone Marrow) and (Disease_Has_Molecular_Abnormality only Clonal Immunoglobulin Gene Rearrangement) and (Disease_Has_Normal_Cell_Origin only Bone Marrow-Homing Plasma Cell)</Axiom>
                     <Axiom shared="true">Common Hematopoietic Neoplasm SubClassOf Common Neoplasm</Axiom>
                     <Axiom shared="true">Lytic Metastatic Bone Lesion SubClassOf Lytic Bone Lesion</Axiom>
                  </Source>
               </Change>
               <Change id="1270">
                  <Axiom>Invasive Mixed Breast Carcinoma EquivalentTo Invasive Breast Carcinoma and (Disease_Has_Finding only Mixed Cellular Population)</Axiom>
                  <Source>
                     <Axiom shared="true">Invasive Breast Carcinoma EquivalentTo Breast Carcinoma and Invasive Carcinoma and (Disease_May_Have_Finding some Breast Lump) and (Disease_May_Have_Finding some Pain)</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom effectual="true">Invasive Mixed Breast Carcinoma EquivalentTo Invasive Breast Carcinoma and Malignant Mixed Neoplasm</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Breast Carcinoma EquivalentTo Carcinoma and Common Carcinoma and Malignant Breast Neoplasm and (Disease_Has_Normal_Tissue_Origin only Mammary Epithelium) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Malignant Epithelial Cell SubClassOf Malignant Cell</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Invasive Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Invasive Lesion)</Axiom>
                     <Axiom shared="true">Invasive Carcinoma EquivalentTo Carcinoma and Invasive Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Invasive Breast Carcinoma EquivalentTo Breast Carcinoma and Invasive Carcinoma and (Disease_May_Have_Finding some Breast Lump) and (Disease_May_Have_Finding some Pain)</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Malignant Neoplasm SubClassOf Disease_Has_Abnormal_Cell only Malignant Cell</Axiom>
                     <Axiom effectual="true">Invasive Mixed Breast Carcinoma EquivalentTo Invasive Breast Carcinoma and Malignant Mixed Neoplasm</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Invasive Carcinoma EquivalentTo Carcinoma and Invasive Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Invasive Breast Carcinoma EquivalentTo Breast Carcinoma and Invasive Carcinoma and (Disease_May_Have_Finding some Breast Lump) and (Disease_May_Have_Finding some Pain)</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom effectual="true">Invasive Mixed Breast Carcinoma EquivalentTo Invasive Breast Carcinoma and Malignant Mixed Neoplasm</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Malignant Epithelial Cell SubClassOf Malignant Cell</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Invasive Carcinoma EquivalentTo Carcinoma and Invasive Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Mammary Epithelium SubClassOf Mammary Gland Tissue</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Invasive Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Invasive Lesion)</Axiom>
                     <Axiom shared="true">Invasive Breast Carcinoma EquivalentTo Breast Carcinoma and Invasive Carcinoma and (Disease_May_Have_Finding some Breast Lump) and (Disease_May_Have_Finding some Pain)</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Malignant Neoplasm SubClassOf Disease_Has_Abnormal_Cell only Malignant Cell</Axiom>
                     <Axiom effectual="true">Invasive Mixed Breast Carcinoma EquivalentTo Invasive Breast Carcinoma and Malignant Mixed Neoplasm</Axiom>
                     <Axiom shared="true">Breast Carcinoma EquivalentTo Carcinoma and Common Carcinoma and Malignant Breast Neoplasm and (Disease_Has_Normal_Tissue_Origin only Mammary Epithelium) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                     <Axiom shared="true">Mammary Gland Tissue SubClassOf Tissue</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Invasive Breast Carcinoma EquivalentTo Breast Carcinoma and Invasive Carcinoma and (Disease_May_Have_Finding some Breast Lump) and (Disease_May_Have_Finding some Pain)</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Malignant Breast Neoplasm EquivalentTo Breast Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom effectual="true">Invasive Mixed Breast Carcinoma EquivalentTo Invasive Breast Carcinoma and Malignant Mixed Neoplasm</Axiom>
                     <Axiom shared="true">Breast Carcinoma EquivalentTo Carcinoma and Common Carcinoma and Malignant Breast Neoplasm and (Disease_Has_Normal_Tissue_Origin only Mammary Epithelium) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Invasive Breast Carcinoma EquivalentTo Breast Carcinoma and Invasive Carcinoma and (Disease_May_Have_Finding some Breast Lump) and (Disease_May_Have_Finding some Pain)</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Mammary Epithelium SubClassOf Mammary Gland Tissue</Axiom>
                     <Axiom shared="true">Malignant Breast Neoplasm EquivalentTo Breast Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Invasive Mixed Breast Carcinoma EquivalentTo Invasive Breast Carcinoma and Malignant Mixed Neoplasm</Axiom>
                     <Axiom shared="true">Breast Carcinoma EquivalentTo Carcinoma and Common Carcinoma and Malignant Breast Neoplasm and (Disease_Has_Normal_Tissue_Origin only Mammary Epithelium) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Mammary Gland Tissue SubClassOf Tissue</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Invasive Breast Carcinoma EquivalentTo Breast Carcinoma and Invasive Carcinoma and (Disease_May_Have_Finding some Breast Lump) and (Disease_May_Have_Finding some Pain)</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Mammary Epithelium SubClassOf Mammary Gland Tissue</Axiom>
                     <Axiom effectual="true">Invasive Mixed Breast Carcinoma EquivalentTo Invasive Breast Carcinoma and Malignant Mixed Neoplasm</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Breast Carcinoma EquivalentTo Carcinoma and Common Carcinoma and Malignant Breast Neoplasm and (Disease_Has_Normal_Tissue_Origin only Mammary Epithelium) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                     <Axiom shared="true">Mammary Gland Tissue SubClassOf Tissue</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Malignant Epithelial Cell SubClassOf Malignant Cell</Axiom>
                  </Source>
               </Change>
               <Change id="1271">
                  <Axiom>Inverted Follicular Keratosis SubClassOf Disease_Has_Finding only Prominent Squamous Eddies Present</Axiom>
                  <Source>
                     <Axiom effectual="true">Inverted Follicular Keratosis EquivalentTo Seborrheic Keratosis and (Disease_Has_Finding only Prominent Squamous Eddies Present) and (Disease_Has_Primary_Anatomic_Site only Hair Follicle)</Axiom>
                  </Source>
               </Change>
               <Change id="1272">
                  <Axiom>Inverted Follicular Keratosis SubClassOf Disease_Has_Primary_Anatomic_Site only Hair Follicle</Axiom>
                  <Source>
                     <Axiom effectual="true">Inverted Follicular Keratosis EquivalentTo Seborrheic Keratosis and (Disease_Has_Finding only Prominent Squamous Eddies Present) and (Disease_Has_Primary_Anatomic_Site only Hair Follicle)</Axiom>
                  </Source>
               </Change>
               <Change id="1273">
                  <Axiom>Inverted Follicular Keratosis SubClassOf Seborrheic Keratosis</Axiom>
                  <Source>
                     <Axiom effectual="true">Inverted Follicular Keratosis EquivalentTo Seborrheic Keratosis and (Disease_Has_Finding only Prominent Squamous Eddies Present) and (Disease_Has_Primary_Anatomic_Site only Hair Follicle)</Axiom>
                  </Source>
               </Change>
               <Change id="1274">
                  <Axiom>Isotope SubClassOf Inorganic Chemical</Axiom>
                  <Source>
                     <Axiom effectual="true">Isotope SubClassOf Element</Axiom>
                     <Axiom shared="true">Element SubClassOf Inorganic Chemical</Axiom>
                  </Source>
               </Change>
               <Change id="1275">
                  <Axiom>Kaposi's Sarcoma Related to Immunosuppressive Treatment EquivalentTo Iatrogenic Kaposi's Sarcoma and Therapy Related Malignant Neoplasm and (Disease_Has_Finding only Drug Toxicity)</Axiom>
                  <Source>
                     <Axiom effectual="true">Kaposi's Sarcoma Related to Immunosuppressive Treatment EquivalentTo Iatrogenic Kaposi's Sarcoma and (Disease_Has_Finding only Drug Toxicity)</Axiom>
                     <Axiom effectual="true">Iatrogenic Kaposi's Sarcoma EquivalentTo Kaposi's Sarcoma and Therapy Related Malignant Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1276">
                  <Axiom>Keratoacanthoma SubClassOf Disease_Has_Finding only Dome-Shaped Lesion</Axiom>
                  <Source>
                     <Axiom effectual="true">Keratoacanthoma EquivalentTo Epithelial Skin Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte) and (Disease_Has_Finding only Dome-Shaped Lesion) and (Disease_Has_Finding only Endophytic Tumor Growth) and (Disease_Has_Finding only Exophytic Papillary Lesion) and (Disease_Has_Finding only Rapidly Enlarging Mass) and (Disease_Has_Finding only Spontaneous Regression) and (Disease_Has_Finding only Well Differentiated Lesion) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1277">
                  <Axiom>Keratoacanthoma SubClassOf Disease_Has_Finding only Rapidly Enlarging Mass</Axiom>
                  <Source>
                     <Axiom effectual="true">Keratoacanthoma EquivalentTo Epithelial Skin Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte) and (Disease_Has_Finding only Dome-Shaped Lesion) and (Disease_Has_Finding only Endophytic Tumor Growth) and (Disease_Has_Finding only Exophytic Papillary Lesion) and (Disease_Has_Finding only Rapidly Enlarging Mass) and (Disease_Has_Finding only Spontaneous Regression) and (Disease_Has_Finding only Well Differentiated Lesion) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1278">
                  <Axiom>Keratoacanthoma SubClassOf Disease_Has_Finding only Spontaneous Regression</Axiom>
                  <Source>
                     <Axiom effectual="true">Keratoacanthoma EquivalentTo Epithelial Skin Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte) and (Disease_Has_Finding only Dome-Shaped Lesion) and (Disease_Has_Finding only Endophytic Tumor Growth) and (Disease_Has_Finding only Exophytic Papillary Lesion) and (Disease_Has_Finding only Rapidly Enlarging Mass) and (Disease_Has_Finding only Spontaneous Regression) and (Disease_Has_Finding only Well Differentiated Lesion) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1279">
                  <Axiom>Keratoacanthoma SubClassOf Disease_Has_Finding only Well Differentiated Lesion</Axiom>
                  <Source>
                     <Axiom effectual="true">Keratoacanthoma EquivalentTo Epithelial Skin Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte) and (Disease_Has_Finding only Dome-Shaped Lesion) and (Disease_Has_Finding only Endophytic Tumor Growth) and (Disease_Has_Finding only Exophytic Papillary Lesion) and (Disease_Has_Finding only Rapidly Enlarging Mass) and (Disease_Has_Finding only Spontaneous Regression) and (Disease_Has_Finding only Well Differentiated Lesion) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1280">
                  <Axiom>Keratoacanthoma SubClassOf Epithelial Skin Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Keratoacanthoma EquivalentTo Epithelial Skin Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte) and (Disease_Has_Finding only Dome-Shaped Lesion) and (Disease_Has_Finding only Endophytic Tumor Growth) and (Disease_Has_Finding only Exophytic Papillary Lesion) and (Disease_Has_Finding only Rapidly Enlarging Mass) and (Disease_Has_Finding only Spontaneous Regression) and (Disease_Has_Finding only Well Differentiated Lesion) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1281">
                  <Axiom>Large Cell Acanthoma SubClassOf Acanthoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Large Cell Acanthoma EquivalentTo Acanthoma and (Disease_May_Have_Finding some Skin Patch) and (Disease_May_Have_Finding some Skin Plaque) and (Disease_Has_Abnormal_Cell only Large Keratinocyte) and (Disease_Has_Normal_Cell_Origin only Keratinocyte)</Axiom>
                  </Source>
               </Change>
               <Change id="1282">
                  <Axiom>Localized Malignant Neoplasm SubClassOf Malignant Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Localized Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Localized Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1283">
                  <Axiom>Lung Mixed Squamous and Glandular Papilloma EquivalentTo Lung Papilloma and (Disease_May_Have_Finding some Squamous Cell Atypia) and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Squamous Cell) and (Disease_Has_Finding only Mixed Neoplastic Glandular and Squamous Cell Population) and (Disease_Has_Normal_Cell_Origin only Bronchial Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Bronchial Epithelium) and (Disease_Has_Primary_Anatomic_Site only Bronchus)</Axiom>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom ineffectual="true">Papilloma EquivalentTo Benign Epithelial Neoplasm and Papillary Epithelial Neoplasm and (Disease_Excludes_Finding only Diffuse Lesion)</Axiom>
                     <Axiom shared="true">Lung Papilloma EquivalentTo Benign Lung Neoplasm and Papilloma</Axiom>
                     <Axiom effectual="true">Lung Mixed Squamous and Glandular Papilloma EquivalentTo Mixed Neoplasm and Lung Papilloma and (Disease_May_Have_Finding some Squamous Cell Atypia) and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Squamous Cell) and (Disease_Has_Finding only Mixed Neoplastic Glandular and Squamous Cell Population) and (Disease_Has_Normal_Cell_Origin only Bronchial Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Bronchial Epithelium) and (Disease_Has_Primary_Anatomic_Site only Bronchus)</Axiom>
                     <Axiom shared="true">Benign Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Excludes_Finding only Borderline Lesion)</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Mixed Epithelial Cell Population SubClassOf Mixed Cellular Population</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Mixed Neoplastic Glandular and Squamous Cell Population SubClassOf Mixed Epithelial Cell Population</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom ineffectual="true">Papilloma EquivalentTo Benign Epithelial Neoplasm and Papillary Epithelial Neoplasm and (Disease_Excludes_Finding only Diffuse Lesion)</Axiom>
                     <Axiom shared="true">Lung Papilloma EquivalentTo Benign Lung Neoplasm and Papilloma</Axiom>
                     <Axiom effectual="true">Lung Mixed Squamous and Glandular Papilloma EquivalentTo Mixed Neoplasm and Lung Papilloma and (Disease_May_Have_Finding some Squamous Cell Atypia) and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Squamous Cell) and (Disease_Has_Finding only Mixed Neoplastic Glandular and Squamous Cell Population) and (Disease_Has_Normal_Cell_Origin only Bronchial Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Bronchial Epithelium) and (Disease_Has_Primary_Anatomic_Site only Bronchus)</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Mixed Epithelial Cell Population SubClassOf Mixed Cellular Population</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom effectual="true">Papillary Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and Papillary Neoplasm</Axiom>
                     <Axiom shared="true">Mixed Neoplastic Glandular and Squamous Cell Population SubClassOf Mixed Epithelial Cell Population</Axiom>
                  </Source>
               </Change>
               <Change id="1195">
                  <Axiom>Lung Papillary Adenoma EquivalentTo Lung Adenoma and Papillary Epithelial Neoplasm and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                  <Source>
                     <Axiom effectual="true">Papillary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                     <Axiom effectual="true">Papillary Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and Papillary Neoplasm</Axiom>
                     <Axiom ineffectual="true">Lung Papillary Adenoma EquivalentTo Lung Adenoma and Papillary Epithelial Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1284">
                  <Axiom>Malignant Eccrine Neoplasm SubClassOf Disease_Has_Abnormal_Cell only Malignant Eccrine Cell</Axiom>
                  <Source>
                     <Axiom effectual="true">Malignant Eccrine Neoplasm EquivalentTo Eccrine Neoplasm and Malignant Sweat Gland Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Eccrine Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="1285">
                  <Axiom>Malignant Eccrine Neoplasm SubClassOf Eccrine Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Malignant Eccrine Neoplasm EquivalentTo Eccrine Neoplasm and Malignant Sweat Gland Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Eccrine Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="1286">
                  <Axiom>Malignant Eccrine Neoplasm SubClassOf Malignant Sweat Gland Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Malignant Eccrine Neoplasm EquivalentTo Eccrine Neoplasm and Malignant Sweat Gland Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Eccrine Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="1287">
                  <Axiom>Malignant Germinative Follicular Epithelium Neoplasm SubClassOf Germinative Follicular Epithelium Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Malignant Germinative Follicular Epithelium Neoplasm EquivalentTo Germinative Follicular Epithelium Neoplasm and Malignant Hair Follicle Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1288">
                  <Axiom>Malignant Germinative Follicular Epithelium Neoplasm SubClassOf Malignant Hair Follicle Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Malignant Germinative Follicular Epithelium Neoplasm EquivalentTo Germinative Follicular Epithelium Neoplasm and Malignant Hair Follicle Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1289">
                  <Axiom>Malignant Hair Follicle Neoplasm SubClassOf Hair Follicle Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Malignant Hair Follicle Neoplasm EquivalentTo Hair Follicle Neoplasm and Malignant Skin Appendage Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1290">
                  <Axiom>Malignant Hair Follicle Neoplasm SubClassOf Malignant Skin Appendage Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Malignant Hair Follicle Neoplasm EquivalentTo Hair Follicle Neoplasm and Malignant Skin Appendage Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1291">
                  <Axiom>Malignant Outer Hair Sheath and Infundibulum Neoplasm SubClassOf Malignant Hair Follicle Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Malignant Outer Hair Sheath and Infundibulum Neoplasm EquivalentTo Malignant Hair Follicle Neoplasm and Outer Hair Sheath and Infundibulum Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1292">
                  <Axiom>Malignant Outer Hair Sheath and Infundibulum Neoplasm SubClassOf Outer Hair Sheath and Infundibulum Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Malignant Outer Hair Sheath and Infundibulum Neoplasm EquivalentTo Malignant Hair Follicle Neoplasm and Outer Hair Sheath and Infundibulum Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1293">
                  <Axiom>Malignant Ovarian Mixed Epithelial Tumor EquivalentTo Malignant Ovarian Surface Epithelial-Stromal Tumor and Ovarian Mixed Epithelial Tumor and (Disease_May_Have_Abnormal_Cell some Malignant Transitional Cell) and (Disease_May_Have_Abnormal_Cell some Adenocarcinoma Cell with Intracytoplasmic Mucin) and (Disease_May_Have_Abnormal_Cell some Serous Adenocarcinoma Cell) and (Disease_May_Have_Finding some Ascites) and (Disease_May_Have_Finding some Malignant Glandular Epithelium Resembling the Normal Endometrium Present) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)</Axiom>
                  <Source>
                     <Axiom effectual="true">Malignant Ovarian Mixed Epithelial Tumor EquivalentTo Malignant Mixed Neoplasm and Malignant Ovarian Surface Epithelial-Stromal Tumor and Ovarian Mixed Epithelial Tumor and (Disease_May_Have_Abnormal_Cell some Malignant Transitional Cell) and (Disease_May_Have_Abnormal_Cell some Adenocarcinoma Cell with Intracytoplasmic Mucin) and (Disease_May_Have_Abnormal_Cell some Serous Adenocarcinoma Cell) and (Disease_May_Have_Finding some Ascites) and (Disease_May_Have_Finding some Malignant Glandular Epithelium Resembling the Normal Endometrium Present) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)</Axiom>
                     <Axiom shared="true">Malignant Ovarian Surface Epithelial-Stromal Tumor EquivalentTo Malignant Ovarian Neoplasm and Ovarian Surface Epithelial-Stromal Tumor and (Disease_May_Have_Finding some Abdominal Mass) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Stromal Invasion)</Axiom>
                     <Axiom shared="true">Malignant Female Reproductive System Neoplasm EquivalentTo Female Reproductive System Neoplasm and Malignant Reproductive System Neoplasm</Axiom>
                     <Axiom shared="true">Malignant Ovarian Neoplasm EquivalentTo Malignant Female Reproductive System Neoplasm and Ovarian Neoplasm</Axiom>
                     <Axiom effectual="true">Ovarian Mixed Epithelial Tumor EquivalentTo Mixed Neoplasm and Ovarian Surface Epithelial-Stromal Tumor and (Disease_May_Have_Abnormal_Cell some Neoplastic Epithelial Cell with Intracytoplasmic Mucin) and (Disease_May_Have_Abnormal_Cell some Neoplastic Serous Epithelial Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Transitional Cell) and (Disease_May_Have_Finding some Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present) and (Disease_May_Have_Molecular_Abnormality some KRAS2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom shared="true">Malignant Reproductive System Neoplasm EquivalentTo Reproductive System Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Malignant Ovarian Mixed Epithelial Tumor EquivalentTo Malignant Mixed Neoplasm and Malignant Ovarian Surface Epithelial-Stromal Tumor and Ovarian Mixed Epithelial Tumor and (Disease_May_Have_Abnormal_Cell some Malignant Transitional Cell) and (Disease_May_Have_Abnormal_Cell some Adenocarcinoma Cell with Intracytoplasmic Mucin) and (Disease_May_Have_Abnormal_Cell some Serous Adenocarcinoma Cell) and (Disease_May_Have_Finding some Ascites) and (Disease_May_Have_Finding some Malignant Glandular Epithelium Resembling the Normal Endometrium Present) and (Disease_May_Have_Finding some Unfavorable Clinical Outcome)</Axiom>
                     <Axiom shared="true">Malignant Ovarian Surface Epithelial-Stromal Tumor EquivalentTo Malignant Ovarian Neoplasm and Ovarian Surface Epithelial-Stromal Tumor and (Disease_May_Have_Finding some Abdominal Mass) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Stromal Invasion)</Axiom>
                     <Axiom effectual="true">Ovarian Mixed Epithelial Tumor EquivalentTo Mixed Neoplasm and Ovarian Surface Epithelial-Stromal Tumor and (Disease_May_Have_Abnormal_Cell some Neoplastic Epithelial Cell with Intracytoplasmic Mucin) and (Disease_May_Have_Abnormal_Cell some Neoplastic Serous Epithelial Cell) and (Disease_May_Have_Abnormal_Cell some Neoplastic Transitional Cell) and (Disease_May_Have_Finding some Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present) and (Disease_May_Have_Molecular_Abnormality some KRAS2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom shared="true">Malignant Epithelial Cell SubClassOf Malignant Cell</Axiom>
                  </Source>
               </Change>
               <Change id="1294">
                  <Axiom>Malignant Skin Appendage Neoplasm SubClassOf Malignant Skin Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Malignant Skin Appendage Neoplasm EquivalentTo Malignant Skin Neoplasm and Skin Appendage Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1295">
                  <Axiom>Malignant Skin Appendage Neoplasm SubClassOf Skin Appendage Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Malignant Skin Appendage Neoplasm EquivalentTo Malignant Skin Neoplasm and Skin Appendage Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1296">
                  <Axiom>Malignant Sweat Gland Neoplasm SubClassOf Malignant Skin Appendage Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Malignant Sweat Gland Neoplasm EquivalentTo Malignant Skin Appendage Neoplasm and Sweat Gland Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1297">
                  <Axiom>Malignant Sweat Gland Neoplasm SubClassOf Sweat Gland Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Malignant Sweat Gland Neoplasm EquivalentTo Malignant Skin Appendage Neoplasm and Sweat Gland Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1298">
                  <Axiom>Malignant Thalamic Neoplasm SubClassOf Malignant Diencephalic Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Malignant Thalamic Neoplasm EquivalentTo Malignant Diencephalic Neoplasm and Thalamic Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1299">
                  <Axiom>Malignant Thalamic Neoplasm SubClassOf Thalamic Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Malignant Thalamic Neoplasm EquivalentTo Malignant Diencephalic Neoplasm and Thalamic Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1300">
                  <Axiom>Medical Device Component Or Accessory Terminology FDA CDRH SubClassOf Terminology Subset</Axiom>
                  <Source>
                     <Axiom effectual="true">Medical Device Component Or Accessory Terminology FDA CDRH SubClassOf FDA Center For Devices and Radiological Health Terminology</Axiom>
                     <Axiom effectual="true">FDA Center For Devices and Radiological Health Terminology SubClassOf Terminology Subset</Axiom>
                  </Source>
               </Change>
               <Change id="1301">
                  <Axiom>Medical Device Problem Codes FDA CDRH SubClassOf Terminology Subset</Axiom>
                  <Source>
                     <Axiom effectual="true">FDA Center For Devices and Radiological Health Terminology SubClassOf Terminology Subset</Axiom>
                     <Axiom effectual="true">Medical Device Problem Codes FDA CDRH SubClassOf FDA Center For Devices and Radiological Health Terminology</Axiom>
                  </Source>
               </Change>
               <Change id="1302">
                  <Axiom>Melanoacanthoma SubClassOf Seborrheic Keratosis</Axiom>
                  <Source>
                     <Axiom effectual="true">Melanoacanthoma EquivalentTo Seborrheic Keratosis and (Disease_Has_Finding only Melanin Pigment Present)</Axiom>
                  </Source>
               </Change>
               <Change id="1303">
                  <Axiom>Metastasizing Ameloblastoma EquivalentTo Ameloblastoma and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                  <Source>
                     <Axiom shared="true">Ameloblastoma EquivalentTo Odontogenic Neoplasm and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 22) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Normal_Cell_Origin only Ameloblast) and (Disease_Has_Normal_Tissue_Origin only Odontogenic Epithelium)</Axiom>
                     <Axiom effectual="true">Metastasizing Ameloblastoma EquivalentTo Ameloblastoma and Metastatic Neoplasm</Axiom>
                     <Axiom effectual="true">Metastatic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                     <Axiom shared="true">Odontogenic Neoplasm EquivalentTo Dental Disorder and Infrequent Neoplasm and Oral Cavity Neoplasm and (Disease_Has_Normal_Tissue_Origin only Odontogenic Tissue) and (Disease_Has_Primary_Anatomic_Site only Oral Cavity)</Axiom>
                     <Axiom shared="true">Infrequent Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                  </Source>
               </Change>
               <Change id="1304">
                  <Axiom>Metastatic Childhood Soft Tissue Sarcoma EquivalentTo Childhood Soft Tissue Sarcoma and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                  <Source>
                     <Axiom effectual="true">Metastatic Childhood Soft Tissue Sarcoma EquivalentTo Childhood Soft Tissue Sarcoma and Metastatic Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Metastatic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                     <Axiom shared="true">Malignant Childhood Neoplasm EquivalentTo Childhood Neoplasm and Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Childhood Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Childhood Lesion)</Axiom>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm EquivalentTo Malignant Neoplasm and Metastatic Neoplasm</Axiom>
                     <Axiom shared="true">Childhood Soft Tissue Sarcoma EquivalentTo Malignant Childhood Neoplasm and Soft Tissue Sarcoma</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Metastatic Childhood Soft Tissue Sarcoma EquivalentTo Childhood Soft Tissue Sarcoma and Metastatic Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Metastatic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                     <Axiom shared="true">Malignant Childhood Neoplasm EquivalentTo Childhood Neoplasm and Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Malignant Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm EquivalentTo Malignant Neoplasm and Metastatic Neoplasm</Axiom>
                     <Axiom shared="true">Childhood Soft Tissue Sarcoma EquivalentTo Malignant Childhood Neoplasm and Soft Tissue Sarcoma</Axiom>
                  </Source>
               </Change>
               <Change id="1305">
                  <Axiom>Metastatic Extraskeletal Osteosarcoma EquivalentTo Extraskeletal Osteosarcoma and Metastatic Osteosarcoma and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                  <Source>
                     <Axiom effectual="true">Metastatic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                     <Axiom ineffectual="true">Metastatic Extraskeletal Osteosarcoma EquivalentTo Extraskeletal Osteosarcoma and Metastatic Osteosarcoma</Axiom>
                     <Axiom effectual="true">Metastatic Osteosarcoma EquivalentTo Metastatic Malignant Neoplasm and Osteosarcoma</Axiom>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm EquivalentTo Malignant Neoplasm and Metastatic Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1306">
                  <Axiom>Metastatic Malignant Neoplasm EquivalentTo Malignant Neoplasm and Metastatic Neoplasm and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                  <Source>
                     <Axiom effectual="true">Metastatic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm EquivalentTo Malignant Neoplasm and Metastatic Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1310">
                  <Axiom>Metastatic Malignant Neoplasm to the Colon EquivalentTo Malignant Colon Neoplasm and Metastatic Malignant Neoplasm to the Large Intestine and (Disease_Has_Finding only Metastatic Lesion) and (Disease_Has_Metastatic_Anatomic_Site only Colon)</Axiom>
                  <Source>
                     <Axiom effectual="true">Metastatic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                     <Axiom shared="true">Metastatic Malignant Neoplasm to the Large Intestine EquivalentTo Malignant Colorectal Neoplasm and Metastatic Malignant Neoplasm and (Disease_Has_Metastatic_Anatomic_Site only Large Intestine)</Axiom>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm to the Colon EquivalentTo Malignant Colon Neoplasm and Metastatic Malignant Neoplasm to the Large Intestine and (Disease_Has_Metastatic_Anatomic_Site only Colon)</Axiom>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm EquivalentTo Malignant Neoplasm and Metastatic Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1307">
                  <Axiom>Metastatic Malignant Neoplasm to the Ovary EquivalentTo Malignant Ovarian Neoplasm and Metastatic Malignant Neoplasm and (Disease_Has_Finding only Metastatic Lesion) and (Disease_Has_Metastatic_Anatomic_Site only Ovary)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm to the Ovary EquivalentTo Malignant Ovarian Neoplasm and Metastatic Malignant Neoplasm and (Disease_Has_Metastatic_Anatomic_Site only Ovary)</Axiom>
                     <Axiom effectual="true">Metastatic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm EquivalentTo Malignant Neoplasm and Metastatic Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1308">
                  <Axiom>Metastatic Neoplasm SubClassOf Disease_Has_Finding only Metastatic Lesion</Axiom>
                  <Source>
                     <Axiom effectual="true">Metastatic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1309">
                  <Axiom>Metastatic Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                  <Source>
                     <Axiom effectual="true">Metastatic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1311">
                  <Axiom>Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone EquivalentTo Metastatic Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Peripheral Primitive Neuroectodermal Tumor of Bone and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                  <Source>
                     <Axiom effectual="true">Metastatic Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor EquivalentTo Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Metastatic Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Metastatic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                     <Axiom ineffectual="true">Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone EquivalentTo Metastatic Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Peripheral Primitive Neuroectodermal Tumor of Bone</Axiom>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm EquivalentTo Malignant Neoplasm and Metastatic Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1312">
                  <Axiom>Metastatic Signet Ring Cell Breast Carcinoma EquivalentTo Signet Ring Cell Breast Carcinoma and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                  <Source>
                     <Axiom shared="true">Metastatic Adenocarcinoma EquivalentTo Adenocarcinoma and Metastatic Carcinoma</Axiom>
                     <Axiom shared="true">Metastatic Carcinoma EquivalentTo Carcinoma and Metastatic Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Invasive Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Invasive Lesion)</Axiom>
                     <Axiom shared="true">Invasive Carcinoma EquivalentTo Carcinoma and Invasive Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Invasive Breast Carcinoma EquivalentTo Breast Carcinoma and Invasive Carcinoma and (Disease_May_Have_Finding some Breast Lump) and (Disease_May_Have_Finding some Pain)</Axiom>
                     <Axiom shared="true">Breast Adenocarcinoma EquivalentTo Adenocarcinoma and Breast Carcinoma</Axiom>
                     <Axiom shared="true">Signet Ring Cell Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Invasive Breast Carcinoma and Signet Ring Cell Carcinoma</Axiom>
                     <Axiom effectual="true">Metastatic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                     <Axiom shared="true">Malignant Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom effectual="true">Metastatic Signet Ring Cell Breast Carcinoma EquivalentTo Metastatic Adenocarcinoma and Signet Ring Cell Breast Carcinoma</Axiom>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm EquivalentTo Malignant Neoplasm and Metastatic Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Metastatic Adenocarcinoma EquivalentTo Adenocarcinoma and Metastatic Carcinoma</Axiom>
                     <Axiom shared="true">Metastatic Carcinoma EquivalentTo Carcinoma and Metastatic Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Invasive Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Invasive Lesion)</Axiom>
                     <Axiom shared="true">Invasive Carcinoma EquivalentTo Carcinoma and Invasive Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Invasive Breast Carcinoma EquivalentTo Breast Carcinoma and Invasive Carcinoma and (Disease_May_Have_Finding some Breast Lump) and (Disease_May_Have_Finding some Pain)</Axiom>
                     <Axiom shared="true">Signet Ring Cell Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Invasive Breast Carcinoma and Signet Ring Cell Carcinoma</Axiom>
                     <Axiom effectual="true">Metastatic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                     <Axiom shared="true">Signet Ring Cell Carcinoma EquivalentTo Adenocarcinoma and (Disease_Has_Abnormal_Cell only Signet Ring Adenocarcinoma Cell)</Axiom>
                     <Axiom shared="true">Malignant Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom effectual="true">Metastatic Signet Ring Cell Breast Carcinoma EquivalentTo Metastatic Adenocarcinoma and Signet Ring Cell Breast Carcinoma</Axiom>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm EquivalentTo Malignant Neoplasm and Metastatic Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Metastatic Adenocarcinoma EquivalentTo Adenocarcinoma and Metastatic Carcinoma</Axiom>
                     <Axiom shared="true">Invasive Carcinoma EquivalentTo Carcinoma and Invasive Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Metastatic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                     <Axiom shared="true">Signet Ring Cell Carcinoma EquivalentTo Adenocarcinoma and (Disease_Has_Abnormal_Cell only Signet Ring Adenocarcinoma Cell)</Axiom>
                     <Axiom effectual="true">Metastatic Signet Ring Cell Breast Carcinoma EquivalentTo Metastatic Adenocarcinoma and Signet Ring Cell Breast Carcinoma</Axiom>
                     <Axiom shared="true">Metastatic Carcinoma EquivalentTo Carcinoma and Metastatic Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Invasive Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Invasive Lesion)</Axiom>
                     <Axiom shared="true">Invasive Breast Carcinoma EquivalentTo Breast Carcinoma and Invasive Carcinoma and (Disease_May_Have_Finding some Breast Lump) and (Disease_May_Have_Finding some Pain)</Axiom>
                     <Axiom shared="true">Signet Ring Cell Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Invasive Breast Carcinoma and Signet Ring Cell Carcinoma</Axiom>
                     <Axiom shared="true">Common Carcinoma SubClassOf Common Neoplasm</Axiom>
                     <Axiom shared="true">Common Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom shared="true">Breast Carcinoma EquivalentTo Carcinoma and Common Carcinoma and Malignant Breast Neoplasm and (Disease_Has_Normal_Tissue_Origin only Mammary Epithelium) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm EquivalentTo Malignant Neoplasm and Metastatic Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Metastatic Adenocarcinoma EquivalentTo Adenocarcinoma and Metastatic Carcinoma</Axiom>
                     <Axiom shared="true">Invasive Carcinoma EquivalentTo Carcinoma and Invasive Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Metastatic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Metastatic Lesion)</Axiom>
                     <Axiom effectual="true">Metastatic Signet Ring Cell Breast Carcinoma EquivalentTo Metastatic Adenocarcinoma and Signet Ring Cell Breast Carcinoma</Axiom>
                     <Axiom shared="true">Metastatic Carcinoma EquivalentTo Carcinoma and Metastatic Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Invasive Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Invasive Lesion)</Axiom>
                     <Axiom shared="true">Invasive Breast Carcinoma EquivalentTo Breast Carcinoma and Invasive Carcinoma and (Disease_May_Have_Finding some Breast Lump) and (Disease_May_Have_Finding some Pain)</Axiom>
                     <Axiom shared="true">Breast Adenocarcinoma EquivalentTo Adenocarcinoma and Breast Carcinoma</Axiom>
                     <Axiom shared="true">Signet Ring Cell Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Invasive Breast Carcinoma and Signet Ring Cell Carcinoma</Axiom>
                     <Axiom shared="true">Common Carcinoma SubClassOf Common Neoplasm</Axiom>
                     <Axiom shared="true">Common Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom shared="true">Breast Carcinoma EquivalentTo Carcinoma and Common Carcinoma and Malignant Breast Neoplasm and (Disease_Has_Normal_Tissue_Origin only Mammary Epithelium) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                     <Axiom ineffectual="true">Metastatic Malignant Neoplasm EquivalentTo Malignant Neoplasm and Metastatic Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1314">
                  <Axiom>Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm SubClassOf Disease_Has_Abnormal_Cell only Neoplastic Connective and Soft Tissue Cell</Axiom>
                  <Source>
                     <Axiom effectual="true">Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm EquivalentTo Hair Follicle Neoplasm and Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Connective and Soft Tissue Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Finding only Mesenchymal Component Present) and (Disease_Has_Normal_Cell_Origin only Connective and Soft Tissue Cell) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="1315">
                  <Axiom>Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm SubClassOf Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell</Axiom>
                  <Source>
                     <Axiom effectual="true">Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm EquivalentTo Hair Follicle Neoplasm and Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Connective and Soft Tissue Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Finding only Mesenchymal Component Present) and (Disease_Has_Normal_Cell_Origin only Connective and Soft Tissue Cell) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="1316">
                  <Axiom>Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm SubClassOf Disease_Has_Normal_Cell_Origin only Connective and Soft Tissue Cell</Axiom>
                  <Source>
                     <Axiom effectual="true">Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm EquivalentTo Hair Follicle Neoplasm and Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Connective and Soft Tissue Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Finding only Mesenchymal Component Present) and (Disease_Has_Normal_Cell_Origin only Connective and Soft Tissue Cell) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="1317">
                  <Axiom>Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm SubClassOf Disease_Has_Normal_Cell_Origin only Epithelial Cell</Axiom>
                  <Source>
                     <Axiom effectual="true">Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm EquivalentTo Hair Follicle Neoplasm and Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Connective and Soft Tissue Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Finding only Mesenchymal Component Present) and (Disease_Has_Normal_Cell_Origin only Connective and Soft Tissue Cell) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="1318">
                  <Axiom>Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm SubClassOf Hair Follicle Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm EquivalentTo Hair Follicle Neoplasm and Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Connective and Soft Tissue Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Finding only Mesenchymal Component Present) and (Disease_Has_Normal_Cell_Origin only Connective and Soft Tissue Cell) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="1319">
                  <Axiom>Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm SubClassOf Mixed Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm EquivalentTo Hair Follicle Neoplasm and Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Connective and Soft Tissue Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Finding only Mesenchymal Component Present) and (Disease_Has_Normal_Cell_Origin only Connective and Soft Tissue Cell) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell)</Axiom>
                  </Source>
               </Change>
               <Change id="1320">
                  <Axiom>Mixed Glioma EquivalentTo Central Nervous System Neoplasm and Neuroglial Tumor and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Primary_Anatomic_Site only Central Nervous System)</Axiom>
                  <Source>
                     <Axiom shared="true">Neuroepithelial, Perineurial, and Schwann Cell Neoplasm EquivalentTo Neoplasm by Morphology and Nervous System Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Neuroepithelial Cell and Neoplastic Perineural Cell) and (Disease_Has_Normal_Cell_Origin only Neuron, Neuroepithelial Cell, and Supporting Cell of the Nervous System) and (Disease_Has_Normal_Tissue_Origin only Nerve Tissue, Neuroepithelial Tissue, and Nerve Sheaths)</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Neuron, Neuroepithelial Cell, and Supporting Cell of the Nervous System SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Mixed Glioma EquivalentTo Central Nervous System Neoplasm and Mixed Neoplasm and Neuroglial Tumor and (Disease_Has_Primary_Anatomic_Site only Central Nervous System)</Axiom>
                     <Axiom shared="true">Neuroglial Tumor EquivalentTo Neuroepithelial Neoplasm and (Disease_Excludes_Finding only Precise Histogenesis Unknown) and (Disease_Excludes_Finding only Neuronal Differentiation) and (Disease_Has_Abnormal_Cell only Neoplastic Glial Cell) and (Disease_Has_Normal_Cell_Origin only Glial Cell) and (Disease_Has_Primary_Anatomic_Site only Nervous System)</Axiom>
                     <Axiom shared="true">Nerve Tissue, Neuroepithelial Tissue, and Nerve Sheaths SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Neuroepithelial Neoplasm EquivalentTo Neuroepithelial, Perineurial, and Schwann Cell Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Neuroepithelial Cell) and (Disease_Has_Normal_Cell_Origin only Neuroepithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Neuroepithelial Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="1321">
                  <Axiom>Mixed Lobular and Ductal Breast Carcinoma EquivalentTo Breast Adenocarcinoma and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Molecular_Abnormality some CDH1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some Loss of E-cadherin Expression) and (Disease_Has_Abnormal_Cell only Ductal Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Lobular Carcinoma Cell) and (Disease_Has_Associated_Disease only Ductal Breast Carcinoma) and (Disease_Has_Associated_Disease only Lobular Breast Carcinoma) and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit)</Axiom>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Breast Adenocarcinoma EquivalentTo Adenocarcinoma and Breast Carcinoma</Axiom>
                     <Axiom shared="true">Adenocarcinoma EquivalentTo Carcinoma and Glandular Cell Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Squamous Cell) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell)</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom effectual="true">Mixed Lobular and Ductal Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Malignant Mixed Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Molecular_Abnormality some CDH1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some Loss of E-cadherin Expression)) and (Disease_Has_Abnormal_Cell only Ductal Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Lobular Carcinoma Cell) and (Disease_Has_Associated_Disease only Ductal Breast Carcinoma) and (Disease_Has_Associated_Disease only Lobular Breast Carcinoma) and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Malignant Epithelial Cell SubClassOf Malignant Cell</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Glandular Cell Neoplasm EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Neoplastic Squamous Cell) and (Disease_Excludes_Finding only Mixed Neoplastic Glandular and Squamous Cell Population) and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell)</Axiom>
                     <Axiom shared="true">Mammary Epithelium SubClassOf Mammary Gland Tissue</Axiom>
                     <Axiom shared="true">Malignant Breast Neoplasm EquivalentTo Breast Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Breast Adenocarcinoma EquivalentTo Adenocarcinoma and Breast Carcinoma</Axiom>
                     <Axiom shared="true">Adenocarcinoma EquivalentTo Carcinoma and Glandular Cell Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Squamous Cell) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell)</Axiom>
                     <Axiom shared="true">Breast Carcinoma EquivalentTo Carcinoma and Common Carcinoma and Malignant Breast Neoplasm and (Disease_Has_Normal_Tissue_Origin only Mammary Epithelium) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                     <Axiom shared="true">Mammary Gland Tissue SubClassOf Tissue</Axiom>
                     <Axiom effectual="true">Mixed Lobular and Ductal Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Malignant Mixed Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Molecular_Abnormality some CDH1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some Loss of E-cadherin Expression)) and (Disease_Has_Abnormal_Cell only Ductal Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Lobular Carcinoma Cell) and (Disease_Has_Associated_Disease only Ductal Breast Carcinoma) and (Disease_Has_Associated_Disease only Lobular Breast Carcinoma) and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Mammary Epithelium SubClassOf Mammary Gland Tissue</Axiom>
                     <Axiom shared="true">Breast Adenocarcinoma EquivalentTo Adenocarcinoma and Breast Carcinoma</Axiom>
                     <Axiom shared="true">Malignant Breast Neoplasm EquivalentTo Breast Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom shared="true">Breast Carcinoma EquivalentTo Carcinoma and Common Carcinoma and Malignant Breast Neoplasm and (Disease_Has_Normal_Tissue_Origin only Mammary Epithelium) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Mammary Gland Tissue SubClassOf Tissue</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom effectual="true">Mixed Lobular and Ductal Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Malignant Mixed Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Molecular_Abnormality some CDH1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some Loss of E-cadherin Expression)) and (Disease_Has_Abnormal_Cell only Ductal Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Lobular Carcinoma Cell) and (Disease_Has_Associated_Disease only Ductal Breast Carcinoma) and (Disease_Has_Associated_Disease only Lobular Breast Carcinoma) and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Glandular Cell Neoplasm EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Neoplastic Squamous Cell) and (Disease_Excludes_Finding only Mixed Neoplastic Glandular and Squamous Cell Population) and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell)</Axiom>
                     <Axiom shared="true">Terminal Ductal Lobular Unit SubClassOf Mammary Gland Tissue</Axiom>
                     <Axiom shared="true">Malignant Breast Neoplasm EquivalentTo Breast Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Breast Adenocarcinoma EquivalentTo Adenocarcinoma and Breast Carcinoma</Axiom>
                     <Axiom shared="true">Adenocarcinoma EquivalentTo Carcinoma and Glandular Cell Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Squamous Cell) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell)</Axiom>
                     <Axiom shared="true">Breast Carcinoma EquivalentTo Carcinoma and Common Carcinoma and Malignant Breast Neoplasm and (Disease_Has_Normal_Tissue_Origin only Mammary Epithelium) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                     <Axiom shared="true">Mammary Gland Tissue SubClassOf Tissue</Axiom>
                     <Axiom effectual="true">Mixed Lobular and Ductal Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Malignant Mixed Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Molecular_Abnormality some CDH1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some Loss of E-cadherin Expression)) and (Disease_Has_Abnormal_Cell only Ductal Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Lobular Carcinoma Cell) and (Disease_Has_Associated_Disease only Ductal Breast Carcinoma) and (Disease_Has_Associated_Disease only Lobular Breast Carcinoma) and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Mammary Epithelium SubClassOf Mammary Gland Tissue</Axiom>
                     <Axiom shared="true">Breast Adenocarcinoma EquivalentTo Adenocarcinoma and Breast Carcinoma</Axiom>
                     <Axiom shared="true">Breast Carcinoma EquivalentTo Carcinoma and Common Carcinoma and Malignant Breast Neoplasm and (Disease_Has_Normal_Tissue_Origin only Mammary Epithelium) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Mammary Gland Tissue SubClassOf Tissue</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom effectual="true">Mixed Lobular and Ductal Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Malignant Mixed Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Molecular_Abnormality some CDH1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some Loss of E-cadherin Expression)) and (Disease_Has_Abnormal_Cell only Ductal Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Lobular Carcinoma Cell) and (Disease_Has_Associated_Disease only Ductal Breast Carcinoma) and (Disease_Has_Associated_Disease only Lobular Breast Carcinoma) and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Malignant Epithelial Cell SubClassOf Malignant Cell</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Breast Adenocarcinoma EquivalentTo Adenocarcinoma and Breast Carcinoma</Axiom>
                     <Axiom shared="true">Malignant Breast Neoplasm EquivalentTo Breast Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Breast Carcinoma EquivalentTo Carcinoma and Common Carcinoma and Malignant Breast Neoplasm and (Disease_Has_Normal_Tissue_Origin only Mammary Epithelium) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom effectual="true">Mixed Lobular and Ductal Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Malignant Mixed Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Molecular_Abnormality some CDH1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some Loss of E-cadherin Expression)) and (Disease_Has_Abnormal_Cell only Ductal Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Lobular Carcinoma Cell) and (Disease_Has_Associated_Disease only Ductal Breast Carcinoma) and (Disease_Has_Associated_Disease only Lobular Breast Carcinoma) and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Terminal Ductal Lobular Unit SubClassOf Mammary Gland Tissue</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Breast Adenocarcinoma EquivalentTo Adenocarcinoma and Breast Carcinoma</Axiom>
                     <Axiom shared="true">Adenocarcinoma EquivalentTo Carcinoma and Glandular Cell Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Squamous Cell) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell)</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Mammary Gland Tissue SubClassOf Tissue</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom effectual="true">Mixed Lobular and Ductal Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Malignant Mixed Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Molecular_Abnormality some CDH1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some Loss of E-cadherin Expression)) and (Disease_Has_Abnormal_Cell only Ductal Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Lobular Carcinoma Cell) and (Disease_Has_Associated_Disease only Ductal Breast Carcinoma) and (Disease_Has_Associated_Disease only Lobular Breast Carcinoma) and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Malignant Epithelial Cell SubClassOf Malignant Cell</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Breast Adenocarcinoma EquivalentTo Adenocarcinoma and Breast Carcinoma</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Breast Carcinoma EquivalentTo Carcinoma and Common Carcinoma and Malignant Breast Neoplasm and (Disease_Has_Normal_Tissue_Origin only Mammary Epithelium) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom effectual="true">Mixed Lobular and Ductal Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Malignant Mixed Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Molecular_Abnormality some CDH1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some Loss of E-cadherin Expression)) and (Disease_Has_Abnormal_Cell only Ductal Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Lobular Carcinoma Cell) and (Disease_Has_Associated_Disease only Ductal Breast Carcinoma) and (Disease_Has_Associated_Disease only Lobular Breast Carcinoma) and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Malignant Epithelial Cell SubClassOf Malignant Cell</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Terminal Ductal Lobular Unit SubClassOf Mammary Gland Tissue</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Breast Adenocarcinoma EquivalentTo Adenocarcinoma and Breast Carcinoma</Axiom>
                     <Axiom shared="true">Malignant Breast Neoplasm EquivalentTo Breast Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom shared="true">Breast Carcinoma EquivalentTo Carcinoma and Common Carcinoma and Malignant Breast Neoplasm and (Disease_Has_Normal_Tissue_Origin only Mammary Epithelium) and (Disease_Has_Primary_Anatomic_Site only Breast)</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom shared="true">Mammary Gland Tissue SubClassOf Tissue</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom effectual="true">Mixed Lobular and Ductal Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Malignant Mixed Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Molecular_Abnormality some CDH1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some Loss of E-cadherin Expression)) and (Disease_Has_Abnormal_Cell only Ductal Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Lobular Carcinoma Cell) and (Disease_Has_Associated_Disease only Ductal Breast Carcinoma) and (Disease_Has_Associated_Disease only Lobular Breast Carcinoma) and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Glandular Cell Neoplasm EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Neoplastic Squamous Cell) and (Disease_Excludes_Finding only Mixed Neoplastic Glandular and Squamous Cell Population) and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell)</Axiom>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                     <Axiom shared="true">Adenocarcinoma Cell SubClassOf Malignant Epithelial Cell</Axiom>
                     <Axiom shared="true">Breast Adenocarcinoma EquivalentTo Adenocarcinoma and Breast Carcinoma</Axiom>
                     <Axiom shared="true">Adenocarcinoma EquivalentTo Carcinoma and Glandular Cell Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Squamous Cell) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell)</Axiom>
                     <Axiom shared="true">Epithelial Tissue SubClassOf Tissue</Axiom>
                     <Axiom shared="true">Epithelial Cell SubClassOf Cell</Axiom>
                     <Axiom effectual="true">Mixed Lobular and Ductal Breast Carcinoma EquivalentTo Breast Adenocarcinoma and Malignant Mixed Neoplasm and ((Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 16q) and (Disease_May_Have_Molecular_Abnormality some CDH1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some Loss of E-cadherin Expression)) and (Disease_Has_Abnormal_Cell only Ductal Carcinoma Cell) and (Disease_Has_Abnormal_Cell only Lobular Carcinoma Cell) and (Disease_Has_Associated_Disease only Ductal Breast Carcinoma) and (Disease_Has_Associated_Disease only Lobular Breast Carcinoma) and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Terminal Ductal Lobular Unit Cell) and (Disease_Has_Normal_Tissue_Origin only Terminal Ductal Lobular Unit)</Axiom>
                     <Axiom shared="true">Malignant Mixed Neoplasm EquivalentTo Mixed Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Epithelial Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Excludes_Abnormal_Cell only Neoplastic Smooth Muscle Cell) and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Epithelial Component Present) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelial Tissue)</Axiom>
                     <Axiom shared="true">Malignant Epithelial Cell SubClassOf Malignant Cell</Axiom>
                  </Source>
               </Change>
               <Change id="1322">
                  <Axiom>Mixed Neoplasm SubClassOf Disease_Has_Finding only Mixed Cellular Population</Axiom>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="1323">
                  <Axiom>Mixed Neoplasm SubClassOf Disease_Has_Normal_Cell_Origin only Cell</Axiom>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="1324">
                  <Axiom>Mixed Neoplasm SubClassOf Disease_Has_Normal_Tissue_Origin only Tissue</Axiom>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="1325">
                  <Axiom>Mixed Neoplasm SubClassOf Neoplasm by Morphology</Axiom>
                  <Source>
                     <Axiom effectual="true">Mixed Neoplasm EquivalentTo Neoplasm by Morphology and (Disease_Has_Finding only Mixed Cellular Population) and (Disease_Has_Normal_Cell_Origin only Cell) and (Disease_Has_Normal_Tissue_Origin only Tissue)</Axiom>
                  </Source>
               </Change>
               <Change id="1175">
                  <Axiom>Mixed Tumor of the Skin (Chondroid Syringoma) SubClassOf Mixed Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Mixed Tumor of the Skin (Chondroid Syringoma) EquivalentTo Benign Sweat Gland Neoplasm and Mixed Neoplasm and (Disease_May_Have_Finding some Cartilagenous Component Present) and (Disease_May_Have_Finding some Fibrotic Stroma Formation) and (Disease_May_Have_Finding some Myxoid Stroma Formation) and (Disease_May_Have_Finding some Slow Growing Mass) and (Disease_Has_Finding only Mesenchymal Component Present)</Axiom>
                  </Source>
               </Change>
               <Change id="1326">
                  <Axiom>Multiple Adenomatous Polyps SubClassOf Adenomatous Polyp</Axiom>
                  <Source>
                     <Axiom effectual="true">Multiple Adenomatous Polyps EquivalentTo Adenomatous Polyp and (Disease_Has_Finding only Multifocal Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1327">
                  <Axiom>Neuroendocrine Carcinoma of the Skin EquivalentTo Infrequent Neoplasm and Neuroendocrine Carcinoma and Skin Carcinoma and (Disease_May_Have_Finding some Diffuse Pattern) and (Disease_May_Have_Finding some Nodular Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Small Round Cell) and (Disease_Has_Finding only Cytoplasmic Membrane-Bound Granules Present) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Single Cell Necrosis) and (Disease_Has_Primary_Anatomic_Site only Dermis)</Axiom>
                  <Source>
                     <Axiom shared="true">Malignant Dermal Neoplasm EquivalentTo Dermal Neoplasm and Malignant Skin Neoplasm</Axiom>
                     <Axiom shared="true">Skin Carcinoma EquivalentTo Carcinoma and Epithelial Skin Neoplasm and Malignant Skin Neoplasm and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom shared="true">Malignant Skin Neoplasm EquivalentTo Skin Neoplasm and (Disease_Excludes_Normal_Cell_Origin only Activated Skin-Homing T-Lymphocyte) and (Disease_Has_Abnormal_Cell only Malignant Cell)</Axiom>
                     <Axiom effectual="true">Neuroendocrine Carcinoma of the Skin EquivalentTo Infrequent Neoplasm and Malignant Dermal Neoplasm and Neuroendocrine Carcinoma and Skin Carcinoma and (Disease_May_Have_Finding some Diffuse Pattern) and (Disease_May_Have_Finding some Nodular Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Small Round Cell) and (Disease_Has_Finding only Cytoplasmic Membrane-Bound Granules Present) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Single Cell Necrosis)</Axiom>
                     <Axiom effectual="true">Dermal Neoplasm EquivalentTo Skin Neoplasm and (Disease_Has_Primary_Anatomic_Site only Dermis)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Epithelial Skin Neoplasm EquivalentTo Epithelial Neoplasm and Skin Neoplasm</Axiom>
                     <Axiom shared="true">Malignant Dermal Neoplasm EquivalentTo Dermal Neoplasm and Malignant Skin Neoplasm</Axiom>
                     <Axiom shared="true">Skin Carcinoma EquivalentTo Carcinoma and Epithelial Skin Neoplasm and Malignant Skin Neoplasm and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom effectual="true">Neuroendocrine Carcinoma of the Skin EquivalentTo Infrequent Neoplasm and Malignant Dermal Neoplasm and Neuroendocrine Carcinoma and Skin Carcinoma and (Disease_May_Have_Finding some Diffuse Pattern) and (Disease_May_Have_Finding some Nodular Pattern) and (Disease_May_Have_Finding some Trabecular Pattern) and (Disease_Has_Abnormal_Cell only Malignant Neuroendocrine Small Round Cell) and (Disease_Has_Finding only Cytoplasmic Membrane-Bound Granules Present) and (Disease_Has_Finding only High Mitotic Activity) and (Disease_Has_Finding only Single Cell Necrosis)</Axiom>
                     <Axiom effectual="true">Dermal Neoplasm EquivalentTo Skin Neoplasm and (Disease_Has_Primary_Anatomic_Site only Dermis)</Axiom>
                  </Source>
               </Change>
               <Change id="1328">
                  <Axiom>Nicotine Gum SubClassOf Pharmacologic Substance</Axiom>
                  <Source>
                     <Axiom shared="true">Cholinergic Agonist SubClassOf Adjuvant</Axiom>
                     <Axiom shared="true">Adjuvant SubClassOf Pharmacologic Substance</Axiom>
                     <Axiom effectual="true">Nicotine Gum SubClassOf Cholinergic Agonist</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Adjuvant SubClassOf Pharmacologic Substance</Axiom>
                     <Axiom effectual="true">Nicotine Gum SubClassOf CNS Stimulant</Axiom>
                     <Axiom shared="true">CNS Stimulant SubClassOf Adjuvant</Axiom>
                  </Source>
               </Change>
               <Change id="1329">
                  <Axiom>Nodular Hidradenoma SubClassOf Hidradenoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Nodular Hidradenoma EquivalentTo Hidradenoma and (Disease_Has_Finding only Nodular Pattern)</Axiom>
                  </Source>
               </Change>
               <Change id="1331">
                  <Axiom>Osteolytic Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                  <Source>
                     <Axiom effectual="true">Osteolytic Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Lytic Bone Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1332">
                  <Axiom>Outer Hair Sheath and Infundibulum Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Hair Follicle Infundibulum</Axiom>
                  <Source>
                     <Axiom effectual="true">Outer Hair Sheath and Infundibulum Neoplasm EquivalentTo Hair Follicle Neoplasm and (Disease_Has_Primary_Anatomic_Site only Hair Follicle Infundibulum) and (Disease_Has_Primary_Anatomic_Site only Outer Hair Sheath)</Axiom>
                  </Source>
               </Change>
               <Change id="1333">
                  <Axiom>Outer Hair Sheath and Infundibulum Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Outer Hair Sheath</Axiom>
                  <Source>
                     <Axiom effectual="true">Outer Hair Sheath and Infundibulum Neoplasm EquivalentTo Hair Follicle Neoplasm and (Disease_Has_Primary_Anatomic_Site only Hair Follicle Infundibulum) and (Disease_Has_Primary_Anatomic_Site only Outer Hair Sheath)</Axiom>
                  </Source>
               </Change>
               <Change id="1334">
                  <Axiom>Outer Hair Sheath and Infundibulum Neoplasm SubClassOf Hair Follicle Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Outer Hair Sheath and Infundibulum Neoplasm EquivalentTo Hair Follicle Neoplasm and (Disease_Has_Primary_Anatomic_Site only Hair Follicle Infundibulum) and (Disease_Has_Primary_Anatomic_Site only Outer Hair Sheath)</Axiom>
                  </Source>
               </Change>
               <Change id="1335">
                  <Axiom>Ovarian Papillary Cystadenoma EquivalentTo Ovarian Papillary Tumor and Ovarian Serous Cystadenoma and Papillary Cystic Neoplasm and Papillary Serous Cystadenoma</Axiom>
                  <Source>
                     <Axiom shared="true">Ovarian Serous Cystadenoma EquivalentTo Benign Ovarian Serous Tumor and Ovarian Cystadenoma and Serous Cystadenoma</Axiom>
                     <Axiom shared="true">Serous Cystadenoma EquivalentTo Cystadenoma and Serous Neoplasm and (Disease_Has_Finding only Cysts Containing Proteinaceous Fluid Present)</Axiom>
                     <Axiom effectual="true">Cystadenoma EquivalentTo Cystic Neoplasm and Glandular Cell Neoplasm and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Glandular Cell) and (Disease_Has_Normal_Tissue_Origin only Glandular Epithelium)</Axiom>
                     <Axiom shared="true">Ovarian Papillary Tumor EquivalentTo Ovarian Surface Epithelial-Stromal Tumor and Papillary Epithelial Neoplasm</Axiom>
                     <Axiom shared="true">Papillary Cystic Neoplasm EquivalentTo Cystic Neoplasm and Papillary Epithelial Neoplasm</Axiom>
                     <Axiom ineffectual="true">Ovarian Papillary Cystadenoma EquivalentTo Ovarian Papillary Tumor and Ovarian Serous Cystadenoma and Papillary Serous Cystadenoma</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Ovarian Serous Cystadenoma EquivalentTo Benign Ovarian Serous Tumor and Ovarian Cystadenoma and Serous Cystadenoma</Axiom>
                     <Axiom effectual="true">Cystadenoma EquivalentTo Cystic Neoplasm and Glandular Cell Neoplasm and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Glandular Cell) and (Disease_Has_Normal_Tissue_Origin only Glandular Epithelium)</Axiom>
                     <Axiom shared="true">Ovarian Papillary Tumor EquivalentTo Ovarian Surface Epithelial-Stromal Tumor and Papillary Epithelial Neoplasm</Axiom>
                     <Axiom shared="true">Ovarian Cystadenoma EquivalentTo Benign Ovarian Surface Epithelial-Stromal Tumor and Cystadenoma</Axiom>
                     <Axiom shared="true">Papillary Cystic Neoplasm EquivalentTo Cystic Neoplasm and Papillary Epithelial Neoplasm</Axiom>
                     <Axiom ineffectual="true">Ovarian Papillary Cystadenoma EquivalentTo Ovarian Papillary Tumor and Ovarian Serous Cystadenoma and Papillary Serous Cystadenoma</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Papillary Serous Cystadenoma EquivalentTo Papillary Cystadenoma and Serous Cystadenoma</Axiom>
                     <Axiom effectual="true">Papillary Cystadenoma EquivalentTo Cystadenoma and Papillary Cystic Neoplasm</Axiom>
                     <Axiom ineffectual="true">Ovarian Papillary Cystadenoma EquivalentTo Ovarian Papillary Tumor and Ovarian Serous Cystadenoma and Papillary Serous Cystadenoma</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Papillary Serous Cystadenoma EquivalentTo Papillary Cystadenoma and Serous Cystadenoma</Axiom>
                     <Axiom shared="true">Serous Cystadenoma EquivalentTo Cystadenoma and Serous Neoplasm and (Disease_Has_Finding only Cysts Containing Proteinaceous Fluid Present)</Axiom>
                     <Axiom effectual="true">Cystadenoma EquivalentTo Cystic Neoplasm and Glandular Cell Neoplasm and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Glandular Cell) and (Disease_Has_Normal_Tissue_Origin only Glandular Epithelium)</Axiom>
                     <Axiom shared="true">Ovarian Papillary Tumor EquivalentTo Ovarian Surface Epithelial-Stromal Tumor and Papillary Epithelial Neoplasm</Axiom>
                     <Axiom shared="true">Papillary Cystic Neoplasm EquivalentTo Cystic Neoplasm and Papillary Epithelial Neoplasm</Axiom>
                     <Axiom ineffectual="true">Ovarian Papillary Cystadenoma EquivalentTo Ovarian Papillary Tumor and Ovarian Serous Cystadenoma and Papillary Serous Cystadenoma</Axiom>
                  </Source>
               </Change>
               <Change id="1448">
                  <Axiom>Paget's Disease of the Vulva EquivalentTo Extramammary Paget's Disease and Malignant Vulvar Sweat Gland Neoplasm and Vulvar Adenocarcinoma and (Disease_May_Have_Finding some Eczema)</Axiom>
                  <Source>
                     <Axiom effectual="true">Skin Appendage Neoplasm EquivalentTo Skin Neoplasm and (Disease_Has_Finding only Adnexal Differentiation) and (Disease_Has_Primary_Anatomic_Site only Exocrine System) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom shared="true">Sweat Gland Carcinoma EquivalentTo Adenocarcinoma and Adnexal Carcinoma and Malignant Sweat Gland Neoplasm and (Disease_Has_Primary_Anatomic_Site only Sweat Gland)</Axiom>
                     <Axiom effectual="true">Paget's Disease of the Vulva EquivalentTo Extramammary Paget's Disease and Malignant Vulvar Sweat Gland Neoplasm and Sweat Gland Carcinoma and Vulvar Adenocarcinoma and (Disease_May_Have_Finding some Eczema)</Axiom>
                     <Axiom effectual="true">Malignant Skin Appendage Neoplasm EquivalentTo Malignant Skin Neoplasm and Skin Appendage Neoplasm</Axiom>
                     <Axiom effectual="true">Sweat Gland Neoplasm EquivalentTo Skin Appendage Neoplasm and (Disease_Has_Primary_Anatomic_Site only Sweat Gland)</Axiom>
                     <Axiom shared="true">Extramammary Paget's Disease EquivalentTo Paget's Disease and (Disease_Excludes_Primary_Anatomic_Site only Breast)</Axiom>
                     <Axiom shared="true">Malignant Vulvar Sweat Gland Neoplasm EquivalentTo Malignant Sweat Gland Neoplasm and Malignant Vulvar Neoplasm and Vulvar Neoplasm of Skin Appendage Origin</Axiom>
                     <Axiom effectual="true">Malignant Sweat Gland Neoplasm EquivalentTo Malignant Skin Appendage Neoplasm and Sweat Gland Neoplasm</Axiom>
                     <Axiom effectual="true">Epithelial Skin Neoplasm EquivalentTo Epithelial Neoplasm and Skin Neoplasm</Axiom>
                     <Axiom shared="true">Adenocarcinoma EquivalentTo Carcinoma and Glandular Cell Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Squamous Cell) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell)</Axiom>
                     <Axiom shared="true">Skin Carcinoma EquivalentTo Carcinoma and Epithelial Skin Neoplasm and Malignant Skin Neoplasm and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom shared="true">Paget's Disease EquivalentTo Adenocarcinoma and (Disease_Has_Abnormal_Cell only Paget's Cell)</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom shared="true">Adnexal Carcinoma EquivalentTo Malignant Skin Appendage Neoplasm and Skin Carcinoma</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Skin Appendage Neoplasm EquivalentTo Skin Neoplasm and (Disease_Has_Finding only Adnexal Differentiation) and (Disease_Has_Primary_Anatomic_Site only Exocrine System) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom shared="true">Vulvar Adenocarcinoma EquivalentTo Adenocarcinoma and Vulvar Carcinoma and Vulvar Glandular Neoplasm</Axiom>
                     <Axiom shared="true">Vulvar Carcinoma EquivalentTo Carcinoma and Malignant Vulvar Neoplasm and (Disease_Has_Primary_Anatomic_Site only Vulva)</Axiom>
                     <Axiom shared="true">Sweat Gland Carcinoma EquivalentTo Adenocarcinoma and Adnexal Carcinoma and Malignant Sweat Gland Neoplasm and (Disease_Has_Primary_Anatomic_Site only Sweat Gland)</Axiom>
                     <Axiom effectual="true">Paget's Disease of the Vulva EquivalentTo Extramammary Paget's Disease and Malignant Vulvar Sweat Gland Neoplasm and Sweat Gland Carcinoma and Vulvar Adenocarcinoma and (Disease_May_Have_Finding some Eczema)</Axiom>
                     <Axiom effectual="true">Malignant Skin Appendage Neoplasm EquivalentTo Malignant Skin Neoplasm and Skin Appendage Neoplasm</Axiom>
                     <Axiom effectual="true">Sweat Gland Neoplasm EquivalentTo Skin Appendage Neoplasm and (Disease_Has_Primary_Anatomic_Site only Sweat Gland)</Axiom>
                     <Axiom shared="true">Malignant Vulvar Sweat Gland Neoplasm EquivalentTo Malignant Sweat Gland Neoplasm and Malignant Vulvar Neoplasm and Vulvar Neoplasm of Skin Appendage Origin</Axiom>
                     <Axiom effectual="true">Malignant Sweat Gland Neoplasm EquivalentTo Malignant Skin Appendage Neoplasm and Sweat Gland Neoplasm</Axiom>
                     <Axiom effectual="true">Epithelial Skin Neoplasm EquivalentTo Epithelial Neoplasm and Skin Neoplasm</Axiom>
                     <Axiom shared="true">Skin Carcinoma EquivalentTo Carcinoma and Epithelial Skin Neoplasm and Malignant Skin Neoplasm and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom shared="true">Adnexal Carcinoma EquivalentTo Malignant Skin Appendage Neoplasm and Skin Carcinoma</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Glandular Cell Neoplasm EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Neoplastic Squamous Cell) and (Disease_Excludes_Finding only Mixed Neoplastic Glandular and Squamous Cell Population) and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell)</Axiom>
                     <Axiom effectual="true">Skin Appendage Neoplasm EquivalentTo Skin Neoplasm and (Disease_Has_Finding only Adnexal Differentiation) and (Disease_Has_Primary_Anatomic_Site only Exocrine System) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom shared="true">Sweat Gland Carcinoma EquivalentTo Adenocarcinoma and Adnexal Carcinoma and Malignant Sweat Gland Neoplasm and (Disease_Has_Primary_Anatomic_Site only Sweat Gland)</Axiom>
                     <Axiom effectual="true">Paget's Disease of the Vulva EquivalentTo Extramammary Paget's Disease and Malignant Vulvar Sweat Gland Neoplasm and Sweat Gland Carcinoma and Vulvar Adenocarcinoma and (Disease_May_Have_Finding some Eczema)</Axiom>
                     <Axiom effectual="true">Malignant Skin Appendage Neoplasm EquivalentTo Malignant Skin Neoplasm and Skin Appendage Neoplasm</Axiom>
                     <Axiom effectual="true">Sweat Gland Neoplasm EquivalentTo Skin Appendage Neoplasm and (Disease_Has_Primary_Anatomic_Site only Sweat Gland)</Axiom>
                     <Axiom shared="true">Extramammary Paget's Disease EquivalentTo Paget's Disease and (Disease_Excludes_Primary_Anatomic_Site only Breast)</Axiom>
                     <Axiom shared="true">Malignant Vulvar Sweat Gland Neoplasm EquivalentTo Malignant Sweat Gland Neoplasm and Malignant Vulvar Neoplasm and Vulvar Neoplasm of Skin Appendage Origin</Axiom>
                     <Axiom effectual="true">Malignant Sweat Gland Neoplasm EquivalentTo Malignant Skin Appendage Neoplasm and Sweat Gland Neoplasm</Axiom>
                     <Axiom effectual="true">Epithelial Skin Neoplasm EquivalentTo Epithelial Neoplasm and Skin Neoplasm</Axiom>
                     <Axiom shared="true">Adenocarcinoma EquivalentTo Carcinoma and Glandular Cell Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Squamous Cell) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell)</Axiom>
                     <Axiom shared="true">Skin Carcinoma EquivalentTo Carcinoma and Epithelial Skin Neoplasm and Malignant Skin Neoplasm and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom shared="true">Paget's Disease EquivalentTo Adenocarcinoma and (Disease_Has_Abnormal_Cell only Paget's Cell)</Axiom>
                     <Axiom shared="true">Adnexal Carcinoma EquivalentTo Malignant Skin Appendage Neoplasm and Skin Carcinoma</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Glandular Cell Neoplasm EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Neoplastic Squamous Cell) and (Disease_Excludes_Finding only Mixed Neoplastic Glandular and Squamous Cell Population) and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell)</Axiom>
                     <Axiom effectual="true">Skin Appendage Neoplasm EquivalentTo Skin Neoplasm and (Disease_Has_Finding only Adnexal Differentiation) and (Disease_Has_Primary_Anatomic_Site only Exocrine System) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom shared="true">Vulvar Adenocarcinoma EquivalentTo Adenocarcinoma and Vulvar Carcinoma and Vulvar Glandular Neoplasm</Axiom>
                     <Axiom shared="true">Vulvar Carcinoma EquivalentTo Carcinoma and Malignant Vulvar Neoplasm and (Disease_Has_Primary_Anatomic_Site only Vulva)</Axiom>
                     <Axiom shared="true">Sweat Gland Carcinoma EquivalentTo Adenocarcinoma and Adnexal Carcinoma and Malignant Sweat Gland Neoplasm and (Disease_Has_Primary_Anatomic_Site only Sweat Gland)</Axiom>
                     <Axiom effectual="true">Paget's Disease of the Vulva EquivalentTo Extramammary Paget's Disease and Malignant Vulvar Sweat Gland Neoplasm and Sweat Gland Carcinoma and Vulvar Adenocarcinoma and (Disease_May_Have_Finding some Eczema)</Axiom>
                     <Axiom effectual="true">Malignant Skin Appendage Neoplasm EquivalentTo Malignant Skin Neoplasm and Skin Appendage Neoplasm</Axiom>
                     <Axiom effectual="true">Sweat Gland Neoplasm EquivalentTo Skin Appendage Neoplasm and (Disease_Has_Primary_Anatomic_Site only Sweat Gland)</Axiom>
                     <Axiom shared="true">Malignant Vulvar Sweat Gland Neoplasm EquivalentTo Malignant Sweat Gland Neoplasm and Malignant Vulvar Neoplasm and Vulvar Neoplasm of Skin Appendage Origin</Axiom>
                     <Axiom effectual="true">Malignant Sweat Gland Neoplasm EquivalentTo Malignant Skin Appendage Neoplasm and Sweat Gland Neoplasm</Axiom>
                     <Axiom effectual="true">Epithelial Skin Neoplasm EquivalentTo Epithelial Neoplasm and Skin Neoplasm</Axiom>
                     <Axiom shared="true">Skin Carcinoma EquivalentTo Carcinoma and Epithelial Skin Neoplasm and Malignant Skin Neoplasm and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom shared="true">Vulvar Glandular Neoplasm EquivalentTo Glandular Cell Neoplasm and Vulvar Neoplasm and (Disease_Has_Primary_Anatomic_Site only Female Reproductive System) and (Disease_Has_Primary_Anatomic_Site only Vulva)</Axiom>
                     <Axiom shared="true">Adnexal Carcinoma EquivalentTo Malignant Skin Appendage Neoplasm and Skin Carcinoma</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Skin Appendage Neoplasm EquivalentTo Skin Neoplasm and (Disease_Has_Finding only Adnexal Differentiation) and (Disease_Has_Primary_Anatomic_Site only Exocrine System) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom shared="true">Vulvar Adenocarcinoma EquivalentTo Adenocarcinoma and Vulvar Carcinoma and Vulvar Glandular Neoplasm</Axiom>
                     <Axiom shared="true">Sweat Gland Carcinoma EquivalentTo Adenocarcinoma and Adnexal Carcinoma and Malignant Sweat Gland Neoplasm and (Disease_Has_Primary_Anatomic_Site only Sweat Gland)</Axiom>
                     <Axiom effectual="true">Paget's Disease of the Vulva EquivalentTo Extramammary Paget's Disease and Malignant Vulvar Sweat Gland Neoplasm and Sweat Gland Carcinoma and Vulvar Adenocarcinoma and (Disease_May_Have_Finding some Eczema)</Axiom>
                     <Axiom effectual="true">Malignant Skin Appendage Neoplasm EquivalentTo Malignant Skin Neoplasm and Skin Appendage Neoplasm</Axiom>
                     <Axiom effectual="true">Sweat Gland Neoplasm EquivalentTo Skin Appendage Neoplasm and (Disease_Has_Primary_Anatomic_Site only Sweat Gland)</Axiom>
                     <Axiom shared="true">Malignant Vulvar Sweat Gland Neoplasm EquivalentTo Malignant Sweat Gland Neoplasm and Malignant Vulvar Neoplasm and Vulvar Neoplasm of Skin Appendage Origin</Axiom>
                     <Axiom effectual="true">Malignant Sweat Gland Neoplasm EquivalentTo Malignant Skin Appendage Neoplasm and Sweat Gland Neoplasm</Axiom>
                     <Axiom effectual="true">Epithelial Skin Neoplasm EquivalentTo Epithelial Neoplasm and Skin Neoplasm</Axiom>
                     <Axiom shared="true">Adenocarcinoma EquivalentTo Carcinoma and Glandular Cell Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Squamous Cell) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell)</Axiom>
                     <Axiom shared="true">Skin Carcinoma EquivalentTo Carcinoma and Epithelial Skin Neoplasm and Malignant Skin Neoplasm and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom shared="true">Adnexal Carcinoma EquivalentTo Malignant Skin Appendage Neoplasm and Skin Carcinoma</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Glandular Cell Neoplasm EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Neoplastic Squamous Cell) and (Disease_Excludes_Finding only Mixed Neoplastic Glandular and Squamous Cell Population) and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell)</Axiom>
                     <Axiom effectual="true">Skin Appendage Neoplasm EquivalentTo Skin Neoplasm and (Disease_Has_Finding only Adnexal Differentiation) and (Disease_Has_Primary_Anatomic_Site only Exocrine System) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom shared="true">Vulvar Adenocarcinoma EquivalentTo Adenocarcinoma and Vulvar Carcinoma and Vulvar Glandular Neoplasm</Axiom>
                     <Axiom shared="true">Sweat Gland Carcinoma EquivalentTo Adenocarcinoma and Adnexal Carcinoma and Malignant Sweat Gland Neoplasm and (Disease_Has_Primary_Anatomic_Site only Sweat Gland)</Axiom>
                     <Axiom effectual="true">Paget's Disease of the Vulva EquivalentTo Extramammary Paget's Disease and Malignant Vulvar Sweat Gland Neoplasm and Sweat Gland Carcinoma and Vulvar Adenocarcinoma and (Disease_May_Have_Finding some Eczema)</Axiom>
                     <Axiom effectual="true">Malignant Skin Appendage Neoplasm EquivalentTo Malignant Skin Neoplasm and Skin Appendage Neoplasm</Axiom>
                     <Axiom effectual="true">Sweat Gland Neoplasm EquivalentTo Skin Appendage Neoplasm and (Disease_Has_Primary_Anatomic_Site only Sweat Gland)</Axiom>
                     <Axiom shared="true">Malignant Vulvar Sweat Gland Neoplasm EquivalentTo Malignant Sweat Gland Neoplasm and Malignant Vulvar Neoplasm and Vulvar Neoplasm of Skin Appendage Origin</Axiom>
                     <Axiom effectual="true">Malignant Sweat Gland Neoplasm EquivalentTo Malignant Skin Appendage Neoplasm and Sweat Gland Neoplasm</Axiom>
                     <Axiom effectual="true">Epithelial Skin Neoplasm EquivalentTo Epithelial Neoplasm and Skin Neoplasm</Axiom>
                     <Axiom shared="true">Adenocarcinoma EquivalentTo Carcinoma and Glandular Cell Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Squamous Cell) and (Disease_Has_Abnormal_Cell only Adenocarcinoma Cell)</Axiom>
                     <Axiom shared="true">Skin Carcinoma EquivalentTo Carcinoma and Epithelial Skin Neoplasm and Malignant Skin Neoplasm and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom shared="true">Adnexal Carcinoma EquivalentTo Malignant Skin Appendage Neoplasm and Skin Carcinoma</Axiom>
                  </Source>
               </Change>
               <Change id="1337">
                  <Axiom>Pancreatic Borderline Intraductal Papillary-Mucinous Neoplasm EquivalentTo Borderline Exocrine Pancreatic Neoplasm and Pancreatic Intraductal Papillary-Mucinous Neoplasm and (Disease_Excludes_Finding only Severe Dysplasia) and (Disease_Has_Finding only Moderate Dysplasia)</Axiom>
                  <Source>
                     <Axiom shared="true">Glandular Cell Neoplasm EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Neoplastic Squamous Cell) and (Disease_Excludes_Finding only Mixed Neoplastic Glandular and Squamous Cell Population) and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell)</Axiom>
                     <Axiom shared="true">Neoplasm of Uncertain Malignant Potential SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom effectual="true">Papillary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                     <Axiom shared="true">Borderline Exocrine Pancreatic Neoplasm EquivalentTo Neoplasm of Uncertain Malignant Potential and Pancreatic Precancerous Condition and (Disease_Has_Abnormal_Cell only Neoplastic Epithelial Cell) and (Disease_Has_Finding only Borderline Lesion) and (Disease_Has_Normal_Cell_Origin only Epithelial Cell) and (Disease_Has_Normal_Tissue_Origin only Epithelium) and (Disease_Has_Primary_Anatomic_Site only Exocrine Pancreas)</Axiom>
                     <Axiom effectual="true">Pancreatic Borderline Intraductal Papillary-Mucinous Neoplasm EquivalentTo Borderline Exocrine Pancreatic Neoplasm and Pancreatic Intraductal Papillary-Mucinous Neoplasm and Papillary Epithelial Neoplasm and (Disease_Excludes_Finding only Severe Dysplasia) and (Disease_Has_Finding only Moderate Dysplasia)</Axiom>
                     <Axiom effectual="true">Pancreatic Intraductal Papillary-Mucinous Neoplasm EquivalentTo Pancreatic Exocrine Neoplasm and Glandular Cell Neoplasm and (Disease_May_Have_Associated_Disease some Diabetes Mellitus) and (Disease_May_Have_Associated_Disease some Pancreatitis) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 18q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Finding some Abdominal Pain) and (Disease_May_Have_Finding some Jaundice) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Mucoid Stroma Formation) and (Disease_Has_Finding only Papillary Pattern) and (Disease_Has_Primary_Anatomic_Site only Exocrine Pancreas)</Axiom>
                     <Axiom effectual="true">Papillary Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and Papillary Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1336">
                  <Axiom>Pancreatic Intraductal Papillary-Mucinous Carcinoma EquivalentTo Pancreatic Ductal Adenocarcinoma and Pancreatic Intraductal Papillary-Mucinous Neoplasm and (Disease_Has_Finding only Severe Dysplasia)</Axiom>
                  <Source>
                     <Axiom shared="true">Glandular Cell Neoplasm EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Neoplastic Squamous Cell) and (Disease_Excludes_Finding only Mixed Neoplastic Glandular and Squamous Cell Population) and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell)</Axiom>
                     <Axiom shared="true">Pancreatic Carcinoma EquivalentTo Carcinoma and Common Carcinoma and Malignant Exocrine Pancreas Neoplasm and (Disease_Has_Primary_Anatomic_Site only Exocrine Pancreas)</Axiom>
                     <Axiom shared="true">Pancreatic Ductal Adenocarcinoma EquivalentTo Pancreatic Adenocarcinoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 18) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8p) and (Disease_May_Have_Molecular_Abnormality some AKT2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some BRCA2 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some CDKN2A Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some SMAD4/DPC4 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some c-erbB2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some MAP2K4 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some RB1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Finding only Fibrotic Stroma Formation) and (Disease_Has_Primary_Anatomic_Site only Pancreatic Duct)</Axiom>
                     <Axiom shared="true">Common Carcinoma SubClassOf Common Neoplasm</Axiom>
                     <Axiom effectual="true">Papillary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                     <Axiom shared="true">Common Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom effectual="true">Papillary Carcinoma EquivalentTo Carcinoma and Papillary Epithelial Neoplasm</Axiom>
                     <Axiom effectual="true">Pancreatic Intraductal Papillary-Mucinous Carcinoma EquivalentTo Pancreatic Ductal Adenocarcinoma and Pancreatic Intraductal Papillary-Mucinous Neoplasm and Papillary Carcinoma and (Disease_Has_Finding only Severe Dysplasia)</Axiom>
                     <Axiom effectual="true">Pancreatic Intraductal Papillary-Mucinous Neoplasm EquivalentTo Pancreatic Exocrine Neoplasm and Glandular Cell Neoplasm and (Disease_May_Have_Associated_Disease some Diabetes Mellitus) and (Disease_May_Have_Associated_Disease some Pancreatitis) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 18q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Finding some Abdominal Pain) and (Disease_May_Have_Finding some Jaundice) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Mucoid Stroma Formation) and (Disease_Has_Finding only Papillary Pattern) and (Disease_Has_Primary_Anatomic_Site only Exocrine Pancreas)</Axiom>
                     <Axiom shared="true">Pancreatic Adenocarcinoma EquivalentTo Adenocarcinoma and Pancreatic Carcinoma and (Disease_May_Have_Associated_Disease some Diabetes Mellitus) and (Disease_May_Have_Finding some Abdominal Pain) and (Disease_May_Have_Finding some Jaundice) and (Disease_May_Have_Finding some Pruritus) and (Disease_May_Have_Finding some Weight Loss) and (Disease_Has_Normal_Cell_Origin only Glandular Cell) and (Disease_Has_Normal_Tissue_Origin only Glandular Epithelium)</Axiom>
                     <Axiom effectual="true">Papillary Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and Papillary Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Pancreatic Carcinoma EquivalentTo Carcinoma and Common Carcinoma and Malignant Exocrine Pancreas Neoplasm and (Disease_Has_Primary_Anatomic_Site only Exocrine Pancreas)</Axiom>
                     <Axiom shared="true">Pancreatic Ductal Adenocarcinoma EquivalentTo Pancreatic Adenocarcinoma and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 12) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 13) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 18) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 3p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 8p) and (Disease_May_Have_Molecular_Abnormality some AKT2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some BRCA2 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some CDKN2A Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some SMAD4/DPC4 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some c-erbB2 Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some MAP2K4 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some RB1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Finding only Fibrotic Stroma Formation) and (Disease_Has_Primary_Anatomic_Site only Pancreatic Duct)</Axiom>
                     <Axiom shared="true">Common Carcinoma SubClassOf Common Neoplasm</Axiom>
                     <Axiom effectual="true">Papillary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                     <Axiom shared="true">Common Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom effectual="true">Papillary Carcinoma EquivalentTo Carcinoma and Papillary Epithelial Neoplasm</Axiom>
                     <Axiom effectual="true">Pancreatic Intraductal Papillary-Mucinous Carcinoma EquivalentTo Pancreatic Ductal Adenocarcinoma and Pancreatic Intraductal Papillary-Mucinous Neoplasm and Papillary Carcinoma and (Disease_Has_Finding only Severe Dysplasia)</Axiom>
                     <Axiom effectual="true">Pancreatic Intraductal Papillary-Mucinous Neoplasm EquivalentTo Pancreatic Exocrine Neoplasm and Glandular Cell Neoplasm and (Disease_May_Have_Associated_Disease some Diabetes Mellitus) and (Disease_May_Have_Associated_Disease some Pancreatitis) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 17p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 18q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Finding some Abdominal Pain) and (Disease_May_Have_Finding some Jaundice) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some KRAS Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Mucoid Stroma Formation) and (Disease_Has_Finding only Papillary Pattern) and (Disease_Has_Primary_Anatomic_Site only Exocrine Pancreas)</Axiom>
                     <Axiom shared="true">Pancreatic Adenocarcinoma EquivalentTo Adenocarcinoma and Pancreatic Carcinoma and (Disease_May_Have_Associated_Disease some Diabetes Mellitus) and (Disease_May_Have_Finding some Abdominal Pain) and (Disease_May_Have_Finding some Jaundice) and (Disease_May_Have_Finding some Pruritus) and (Disease_May_Have_Finding some Weight Loss) and (Disease_Has_Normal_Cell_Origin only Glandular Cell) and (Disease_Has_Normal_Tissue_Origin only Glandular Epithelium)</Axiom>
                     <Axiom effectual="true">Carcinoma EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Malignant Stromal Cell) and (Disease_Has_Abnormal_Cell only Malignant Epithelial Cell) and (Disease_Has_Finding only Carcinomatous Component Present)</Axiom>
                     <Axiom effectual="true">Papillary Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and Papillary Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1338">
                  <Axiom>Papillary Carcinoma SubClassOf Carcinoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Papillary Carcinoma EquivalentTo Carcinoma and Papillary Epithelial Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1339">
                  <Axiom>Papillary Carcinoma SubClassOf Papillary Epithelial Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Papillary Carcinoma EquivalentTo Carcinoma and Papillary Epithelial Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1340">
                  <Axiom>Papillary Cystadenoma EquivalentTo Cystadenoma and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                  <Source>
                     <Axiom shared="true">Glandular Cell Neoplasm EquivalentTo Epithelial Neoplasm and (Disease_Excludes_Abnormal_Cell only Neoplastic Squamous Cell) and (Disease_Excludes_Finding only Mixed Neoplastic Glandular and Squamous Cell Population) and (Disease_Has_Abnormal_Cell only Neoplastic Glandular Cell)</Axiom>
                     <Axiom effectual="true">Papillary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                     <Axiom shared="true">Cystic Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom effectual="true">Cystadenoma EquivalentTo Cystic Neoplasm and Glandular Cell Neoplasm and (Disease_Has_Finding only Well-Circumscribed Lesion) and (Disease_Has_Normal_Cell_Origin only Glandular Cell) and (Disease_Has_Normal_Tissue_Origin only Glandular Epithelium)</Axiom>
                     <Axiom effectual="true">Papillary Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and Papillary Neoplasm</Axiom>
                     <Axiom effectual="true">Papillary Cystadenoma EquivalentTo Cystadenoma and Papillary Cystic Neoplasm</Axiom>
                     <Axiom shared="true">Papillary Cystic Neoplasm EquivalentTo Cystic Neoplasm and Papillary Epithelial Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1341">
                  <Axiom>Papillary Epithelial Neoplasm SubClassOf Epithelial Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Papillary Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and Papillary Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1342">
                  <Axiom>Papillary Epithelial Neoplasm SubClassOf Papillary Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Papillary Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and Papillary Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1343">
                  <Axiom>Papillary Neoplasm SubClassOf Disease_Has_Finding only Papillary Pattern</Axiom>
                  <Source>
                     <Axiom effectual="true">Papillary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                  </Source>
               </Change>
               <Change id="1344">
                  <Axiom>Papillary Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                  <Source>
                     <Axiom effectual="true">Papillary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                  </Source>
               </Change>
               <Change id="1345">
                  <Axiom>Papilloma EquivalentTo Benign Epithelial Neoplasm and Papillary Epithelial Neoplasm and (Disease_Excludes_Finding only Diffuse Lesion) and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Papilloma EquivalentTo Benign Epithelial Neoplasm and Papillary Epithelial Neoplasm and (Disease_Excludes_Finding only Diffuse Lesion)</Axiom>
                     <Axiom effectual="true">Papillary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Papillary Pattern)</Axiom>
                     <Axiom effectual="true">Papillary Epithelial Neoplasm EquivalentTo Epithelial Neoplasm and Papillary Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1346">
                  <Axiom>Paraganglioma-Like Dermal Melanocytic Tumor SubClassOf Benign Dermal Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Paraganglioma-Like Dermal Melanocytic Tumor EquivalentTo Benign Dermal Neoplasm and Melanocytic Skin Neoplasm and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Finding only Nested Pattern)</Axiom>
                  </Source>
               </Change>
               <Change id="1347">
                  <Axiom>Patient Problem Codes FDA CDRH SubClassOf Terminology Subset</Axiom>
                  <Source>
                     <Axiom effectual="true">Patient Problem Codes FDA CDRH SubClassOf FDA Center For Devices and Radiological Health Terminology</Axiom>
                     <Axiom effectual="true">FDA Center For Devices and Radiological Health Terminology SubClassOf Terminology Subset</Axiom>
                  </Source>
               </Change>
               <Change id="1348">
                  <Axiom>Penile Bowenoid Papulosis EquivalentTo Bowenoid Papulosis and Penile Neoplasm and (Disease_May_Have_Associated_Disease some Human Papilloma Virus Infection) and (Disease_Has_Primary_Anatomic_Site only Penis)</Axiom>
                  <Source>
                     <Axiom effectual="true">Penile Bowenoid Papulosis EquivalentTo Bowenoid Papulosis and Penile Neoplasm and (Disease_Has_Primary_Anatomic_Site only Penis)</Axiom>
                     <Axiom effectual="true">Bowenoid Papulosis EquivalentTo Pre-Malignant Skin Epithelial Lesion and (Disease_May_Have_Associated_Disease some Human Papilloma Virus Infection) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Multifocal Lesion) and (Disease_Has_Finding only Severe Dysplasia)</Axiom>
                  </Source>
               </Change>
               <Change id="1349">
                  <Axiom>Pilar Sheath Acanthoma SubClassOf Acanthoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Pilar Sheath Acanthoma EquivalentTo Acanthoma and Benign Outer Hair Sheath and Infundibulum Neoplasm and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Follicular Differentiation) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Primary_Anatomic_Site only Pilar Sheath)</Axiom>
                  </Source>
               </Change>
               <Change id="1350">
                  <Axiom>Pilar Sheath Acanthoma SubClassOf Benign Outer Hair Sheath and Infundibulum Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Pilar Sheath Acanthoma EquivalentTo Acanthoma and Benign Outer Hair Sheath and Infundibulum Neoplasm and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Follicular Differentiation) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Primary_Anatomic_Site only Pilar Sheath)</Axiom>
                  </Source>
               </Change>
               <Change id="1351">
                  <Axiom>Pilar Sheath Acanthoma SubClassOf Disease_Has_Primary_Anatomic_Site only Pilar Sheath</Axiom>
                  <Source>
                     <Axiom effectual="true">Pilar Sheath Acanthoma EquivalentTo Acanthoma and Benign Outer Hair Sheath and Infundibulum Neoplasm and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Follicular Differentiation) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Primary_Anatomic_Site only Pilar Sheath)</Axiom>
                  </Source>
               </Change>
               <Change id="1353">
                  <Axiom>Pilomatricoma SubClassOf Benign Germinative Follicular Epithelium Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Pilomatricoma EquivalentTo Benign Germinative Follicular Epithelium Neoplasm and (Disease_May_Have_Finding some Calcification) and (Disease_Excludes_Finding only Invasive Lesion) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Follicular Differentiation) and (Disease_Has_Finding only Shadow Cells Present) and (Disease_Has_Finding only Skin Nodule)</Axiom>
                  </Source>
               </Change>
               <Change id="1354">
                  <Axiom>Pilomatricoma SubClassOf Disease_Excludes_Finding only Invasive Lesion</Axiom>
                  <Source>
                     <Axiom effectual="true">Pilomatricoma EquivalentTo Benign Germinative Follicular Epithelium Neoplasm and (Disease_May_Have_Finding some Calcification) and (Disease_Excludes_Finding only Invasive Lesion) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Follicular Differentiation) and (Disease_Has_Finding only Shadow Cells Present) and (Disease_Has_Finding only Skin Nodule)</Axiom>
                  </Source>
               </Change>
               <Change id="1355">
                  <Axiom>Porcelain Veneer SubClassOf Dental Material</Axiom>
                  <Source>
                     <Axiom effectual="true">Restorative Material SubClassOf Dental Material</Axiom>
                     <Axiom effectual="true">Porcelain Veneer SubClassOf Restorative Material</Axiom>
                  </Source>
               </Change>
               <Change id="1356">
                  <Axiom>Poroma SubClassOf Benign Sweat Gland Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Poroma EquivalentTo Benign Sweat Gland Neoplasm and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_May_Have_Finding some Skin Plaque)</Axiom>
                  </Source>
               </Change>
               <Change id="1357">
                  <Axiom>Posterior Foramen Magnum Meningioma SubClassOf Foramen Magnum Meningioma</Axiom>
                  <Source>
                     <Axiom effectual="true">Posterior Foramen Magnum Meningioma EquivalentTo Foramen Magnum Meningioma and (Disease_Has_Primary_Anatomic_Site only Posterior Foramen Magnum)</Axiom>
                  </Source>
               </Change>
               <Change id="1358">
                  <Axiom>Pre-Malignant Skin Epithelial Lesion SubClassOf Cutaneous Precancerous Condition</Axiom>
                  <Source>
                     <Axiom effectual="true">Pre-Malignant Skin Epithelial Lesion EquivalentTo Cutaneous Precancerous Condition and Epithelial Skin Neoplasm and (Disease_Excludes_Finding only Malignant Cellular Infiltrate) and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte) and (Disease_Has_Finding only Absence of Invasion) and (Disease_Has_Finding only Atypia) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Normal_Tissue_Origin only Epidermis) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1359">
                  <Axiom>Pre-Malignant Skin Epithelial Lesion SubClassOf Disease_Has_Finding only Absence of Invasion</Axiom>
                  <Source>
                     <Axiom effectual="true">Pre-Malignant Skin Epithelial Lesion EquivalentTo Cutaneous Precancerous Condition and Epithelial Skin Neoplasm and (Disease_Excludes_Finding only Malignant Cellular Infiltrate) and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte) and (Disease_Has_Finding only Absence of Invasion) and (Disease_Has_Finding only Atypia) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Normal_Tissue_Origin only Epidermis) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1360">
                  <Axiom>Pre-Malignant Skin Epithelial Lesion SubClassOf Epithelial Skin Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Pre-Malignant Skin Epithelial Lesion EquivalentTo Cutaneous Precancerous Condition and Epithelial Skin Neoplasm and (Disease_Excludes_Finding only Malignant Cellular Infiltrate) and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte) and (Disease_Has_Finding only Absence of Invasion) and (Disease_Has_Finding only Atypia) and (Disease_Has_Normal_Cell_Origin only Keratinocyte) and (Disease_Has_Normal_Tissue_Origin only Epidermis) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1352">
                  <Axiom>Proliferating Pilar Tumor SubClassOf Benign Outer Hair Sheath and Infundibulum Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Proliferating Pilar Tumor EquivalentTo Benign Outer Hair Sheath and Infundibulum Neoplasm and (Disease_Has_Finding only Lobular Pattern) and (Disease_Has_Finding only Slow Growing Mass) and (Disease_Has_Primary_Anatomic_Site only Head)</Axiom>
                  </Source>
               </Change>
               <Change id="1362">
                  <Axiom>Pyridoxine Hydrochloride SubClassOf B Vitamin</Axiom>
                  <Source>
                     <Axiom effectual="true">Pyridoxine Hydrochloride SubClassOf Vitamin B6</Axiom>
                     <Axiom shared="true">Vitamin B6 SubClassOf B Vitamin</Axiom>
                  </Source>
               </Change>
               <Change id="1363">
                  <Axiom>Recurrent Adult Acute Myeloid Leukemia EquivalentTo Adult Acute Myeloid Leukemia and Recurrent Hematologic Malignancy and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Adult Acute Myeloid Leukemia EquivalentTo Adult Acute Myeloid Leukemia and Recurrent Hematologic Malignancy</Axiom>
                  </Source>
               </Change>
               <Change id="1364">
                  <Axiom>Recurrent Adult Burkitt's Lymphoma EquivalentTo Adult Burkitt's Lymphoma and Recurrent Aggressive Adult Non-Hodgkin's Lymphoma and Recurrent Burkitt's Lymphoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom shared="true">Recurrent Burkitt's Lymphoma EquivalentTo Burkitt's Lymphoma and Recurrent B-Cell Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom ineffectual="true">Recurrent Adult Burkitt's Lymphoma EquivalentTo Adult Burkitt's Lymphoma and Recurrent Aggressive Adult Non-Hodgkin's Lymphoma and Recurrent Burkitt's Lymphoma</Axiom>
                     <Axiom ineffectual="true">Recurrent B-Cell Non-Hodgkin's Lymphoma EquivalentTo B-Cell Non-Hodgkin's Lymphoma and Recurrent Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Recurrent Hematologic Malignancy</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom shared="true">Recurrent Adult Non-Hodgkin's Lymphoma EquivalentTo Adult Non-Hodgkin's Lymphoma and Recurrent Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom ineffectual="true">Recurrent Adult Burkitt's Lymphoma EquivalentTo Adult Burkitt's Lymphoma and Recurrent Aggressive Adult Non-Hodgkin's Lymphoma and Recurrent Burkitt's Lymphoma</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Recurrent Hematologic Malignancy</Axiom>
                     <Axiom shared="true">Recurrent Aggressive Adult Non-Hodgkin's Lymphoma EquivalentTo Aggressive Adult Non-Hodgkin's Lymphoma and Recurrent Adult Non-Hodgkin's Lymphoma</Axiom>
                  </Source>
               </Change>
               <Change id="1365">
                  <Axiom>Recurrent Adult Immunoblastic Lymphoma EquivalentTo Adult Immunoblastic Lymphoma and Recurrent Adult Non-Hodgkin's Lymphoma and Recurrent Diffuse Large B-Cell Lymphoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom shared="true">Recurrent Adult Non-Hodgkin's Lymphoma EquivalentTo Adult Non-Hodgkin's Lymphoma and Recurrent Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Recurrent Hematologic Malignancy</Axiom>
                     <Axiom ineffectual="true">Recurrent Adult Immunoblastic Lymphoma EquivalentTo Adult Immunoblastic Lymphoma and Recurrent Adult Non-Hodgkin's Lymphoma and Recurrent Diffuse Large B-Cell Lymphoma</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom shared="true">Recurrent Diffuse Large B-Cell Lymphoma EquivalentTo Diffuse Large B-Cell Lymphoma and Recurrent B-Cell Non-Hodgkin's Lymphoma and (Disease_May_Have_Finding some Lymphadenopathy)</Axiom>
                     <Axiom ineffectual="true">Recurrent B-Cell Non-Hodgkin's Lymphoma EquivalentTo B-Cell Non-Hodgkin's Lymphoma and Recurrent Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Recurrent Hematologic Malignancy</Axiom>
                     <Axiom ineffectual="true">Recurrent Adult Immunoblastic Lymphoma EquivalentTo Adult Immunoblastic Lymphoma and Recurrent Adult Non-Hodgkin's Lymphoma and Recurrent Diffuse Large B-Cell Lymphoma</Axiom>
                  </Source>
               </Change>
               <Change id="1366">
                  <Axiom>Recurrent Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and Recurrent Aggressive Adult Non-Hodgkin's Lymphoma and Recurrent Mature T- and NK-Cell Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom shared="true">Recurrent Adult Non-Hodgkin's Lymphoma EquivalentTo Adult Non-Hodgkin's Lymphoma and Recurrent Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom ineffectual="true">Recurrent Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and Recurrent Aggressive Adult Non-Hodgkin's Lymphoma and Recurrent Mature T- and NK-Cell Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Recurrent Hematologic Malignancy</Axiom>
                     <Axiom shared="true">Recurrent Aggressive Adult Non-Hodgkin's Lymphoma EquivalentTo Aggressive Adult Non-Hodgkin's Lymphoma and Recurrent Adult Non-Hodgkin's Lymphoma</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom ineffectual="true">Recurrent Adult T-Cell Lymphoma/Leukemia EquivalentTo Adult T-Cell Lymphoma/Leukemia and Recurrent Aggressive Adult Non-Hodgkin's Lymphoma and Recurrent Mature T- and NK-Cell Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom shared="true">Recurrent T-Cell Non-Hodgkin's Lymphoma EquivalentTo Recurrent Non-Hodgkin's Lymphoma and T-Cell Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom shared="true">Recurrent Mature T- and NK-Cell Non-Hodgkin's Lymphoma EquivalentTo Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma and Recurrent T-Cell Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Recurrent Hematologic Malignancy</Axiom>
                  </Source>
               </Change>
               <Change id="1367">
                  <Axiom>Recurrent B-Cell Non-Hodgkin's Lymphoma EquivalentTo B-Cell Non-Hodgkin's Lymphoma and Recurrent Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom ineffectual="true">Recurrent B-Cell Non-Hodgkin's Lymphoma EquivalentTo B-Cell Non-Hodgkin's Lymphoma and Recurrent Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Recurrent Hematologic Malignancy</Axiom>
                  </Source>
               </Change>
               <Change id="1368">
                  <Axiom>Recurrent Childhood Central Nervous System Neoplasm EquivalentTo Childhood Central Nervous System Neoplasm and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Childhood Central Nervous System Neoplasm EquivalentTo Childhood Central Nervous System Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom shared="true">Childhood Central Nervous System Neoplasm EquivalentTo Central Nervous System Neoplasm and Childhood Neoplasm</Axiom>
                     <Axiom effectual="true">Childhood Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Childhood Lesion)</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1369">
                  <Axiom>Recurrent Childhood Liver Cancer EquivalentTo Childhood Liver Cancer and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom shared="true">Childhood Liver Cancer EquivalentTo Childhood Hepatic Neoplasm and Infrequent Neoplasm and Malignant Childhood Neoplasm and Primary Malignant Neoplasm of Liver and (Disease_Has_Normal_Tissue_Origin only Hepatic Tissue) and (Disease_Has_Primary_Anatomic_Site only Liver)</Axiom>
                     <Axiom effectual="true">Recurrent Childhood Liver Cancer EquivalentTo Childhood Liver Cancer and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Malignant Childhood Neoplasm EquivalentTo Childhood Neoplasm and Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Childhood Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Childhood Lesion)</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom shared="true">Childhood Liver Cancer EquivalentTo Childhood Hepatic Neoplasm and Infrequent Neoplasm and Malignant Childhood Neoplasm and Primary Malignant Neoplasm of Liver and (Disease_Has_Normal_Tissue_Origin only Hepatic Tissue) and (Disease_Has_Primary_Anatomic_Site only Liver)</Axiom>
                     <Axiom effectual="true">Recurrent Childhood Liver Cancer EquivalentTo Childhood Liver Cancer and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Malignant Childhood Neoplasm EquivalentTo Childhood Neoplasm and Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Infrequent Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom shared="true">Childhood Liver Cancer EquivalentTo Childhood Hepatic Neoplasm and Infrequent Neoplasm and Malignant Childhood Neoplasm and Primary Malignant Neoplasm of Liver and (Disease_Has_Normal_Tissue_Origin only Hepatic Tissue) and (Disease_Has_Primary_Anatomic_Site only Liver)</Axiom>
                     <Axiom effectual="true">Recurrent Childhood Liver Cancer EquivalentTo Childhood Liver Cancer and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Malignant Childhood Neoplasm EquivalentTo Childhood Neoplasm and Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Malignant Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1370">
                  <Axiom>Recurrent Childhood Malignant Germ Cell Neoplasm EquivalentTo Malignant Childhood Germ Cell Tumor and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom shared="true">Malignant Childhood Neoplasm EquivalentTo Childhood Neoplasm and Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Childhood Malignant Germ Cell Neoplasm EquivalentTo Malignant Childhood Germ Cell Tumor and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Childhood Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Childhood Lesion)</Axiom>
                     <Axiom shared="true">Malignant Childhood Germ Cell Tumor EquivalentTo Childhood Germ Cell Tumor and Malignant Childhood Neoplasm and Malignant Germ Cell Tumor and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some i(12p))</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom shared="true">Malignant Childhood Neoplasm EquivalentTo Childhood Neoplasm and Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Childhood Malignant Germ Cell Neoplasm EquivalentTo Malignant Childhood Germ Cell Tumor and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Malignant Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom shared="true">Malignant Childhood Germ Cell Tumor EquivalentTo Childhood Germ Cell Tumor and Malignant Childhood Neoplasm and Malignant Germ Cell Tumor and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12p) and (Disease_May_Have_Cytogenetic_Abnormality some i(12p))</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1371">
                  <Axiom>Recurrent Childhood Soft Tissue Sarcoma EquivalentTo Childhood Soft Tissue Sarcoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom shared="true">Malignant Childhood Neoplasm EquivalentTo Childhood Neoplasm and Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Childhood Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Childhood Lesion)</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom effectual="true">Recurrent Childhood Soft Tissue Sarcoma EquivalentTo Childhood Soft Tissue Sarcoma and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Childhood Soft Tissue Sarcoma EquivalentTo Malignant Childhood Neoplasm and Soft Tissue Sarcoma</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom shared="true">Malignant Childhood Neoplasm EquivalentTo Childhood Neoplasm and Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Malignant Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom effectual="true">Recurrent Childhood Soft Tissue Sarcoma EquivalentTo Childhood Soft Tissue Sarcoma and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom shared="true">Childhood Soft Tissue Sarcoma EquivalentTo Malignant Childhood Neoplasm and Soft Tissue Sarcoma</Axiom>
                  </Source>
               </Change>
               <Change id="1372">
                  <Axiom>Recurrent Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and Recurrent Hematologic Malignancy and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom ineffectual="true">Recurrent Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and Recurrent Hematologic Malignancy and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21))</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1397">
                  <Axiom>Recurrent Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and Recurrent Hematologic Malignancy and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Recurrent Disease) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom ineffectual="true">Recurrent Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and Recurrent Hematologic Malignancy and ((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1373">
                  <Axiom>Recurrent Extraskeletal Osteosarcoma EquivalentTo Extraskeletal Osteosarcoma and Recurrent Osteosarcoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Osteosarcoma EquivalentTo Osteosarcoma and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom ineffectual="true">Recurrent Extraskeletal Osteosarcoma EquivalentTo Extraskeletal Osteosarcoma and Recurrent Osteosarcoma</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1374">
                  <Axiom>Recurrent Hodgkin's Lymphoma EquivalentTo Hodgkin's Lymphoma and Recurrent Hematologic Malignancy and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom ineffectual="true">Recurrent Hodgkin's Lymphoma EquivalentTo Hodgkin's Lymphoma and Recurrent Hematologic Malignancy</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1375">
                  <Axiom>Recurrent Lymphomatoid Granulomatosis EquivalentTo Lymphomatoid Granulomatosis and Recurrent Hematologic Malignancy and (Disease_Has_Finding only Angiocentric Pattern) and (Disease_Has_Finding only Angiodestructive Pattern) and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom ineffectual="true">Recurrent Lymphomatoid Granulomatosis EquivalentTo Lymphomatoid Granulomatosis and Recurrent Hematologic Malignancy and (Disease_Has_Finding only Angiocentric Pattern) and (Disease_Has_Finding only Angiodestructive Pattern)</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1376">
                  <Axiom>Recurrent Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia EquivalentTo Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia and Recurrent B-Cell Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom ineffectual="true">Recurrent Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia EquivalentTo Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia and Recurrent B-Cell Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom ineffectual="true">Recurrent B-Cell Non-Hodgkin's Lymphoma EquivalentTo B-Cell Non-Hodgkin's Lymphoma and Recurrent Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Recurrent Hematologic Malignancy</Axiom>
                  </Source>
               </Change>
               <Change id="1377">
                  <Axiom>Recurrent Malignant Neoplasm SubClassOf Malignant Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1378">
                  <Axiom>Recurrent Malignant Neoplasm SubClassOf Recurrent Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1379">
                  <Axiom>Recurrent Neoplasm SubClassOf Disease_Has_Finding only Recurrent Disease</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1380">
                  <Axiom>Recurrent Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1381">
                  <Axiom>Recurrent Neuroblastoma EquivalentTo Neuroblastoma and Recurrent Primitive Neuroectodermal Tumor and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 17q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 11q ATM Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some NMYC Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some MYC Gene Amplification) and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom effectual="true">Recurrent Primitive Neuroectodermal Tumor EquivalentTo Primitive Neuroectodermal Tumor and Recurrent Malignant Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Neuroectodermal Cell)</Axiom>
                     <Axiom ineffectual="true">Recurrent Neuroblastoma EquivalentTo Neuroblastoma and Recurrent Primitive Neuroectodermal Tumor and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 17q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 11q ATM Gene Locus) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 1p) and (Disease_May_Have_Molecular_Abnormality some C-KIT Tyrosine Kinase Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some NMYC Gene Amplification) and (Disease_May_Have_Molecular_Abnormality some MYC Gene Amplification)</Axiom>
                  </Source>
               </Change>
               <Change id="1382">
                  <Axiom>Recurrent Nevus EquivalentTo Benign Melanocytic Skin Nevus and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom shared="true">Melanocytic Skin Neoplasm EquivalentTo Common Neoplasm and Melanocytic Neoplasm and Skin Neoplasm and (Disease_Has_Normal_Tissue_Origin only Skin Tissue) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                     <Axiom shared="true">Benign Melanocytic Skin Nevus EquivalentTo Melanocytic Nevus and Melanocytic Skin Neoplasm and (Disease_Excludes_Finding only Atypia)</Axiom>
                     <Axiom shared="true">Common Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom effectual="true">Recurrent Nevus EquivalentTo Benign Melanocytic Skin Nevus and Recurrent Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1383">
                  <Axiom>Recurrent Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Recurrent Hematologic Malignancy and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                     <Axiom ineffectual="true">Recurrent Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Recurrent Hematologic Malignancy</Axiom>
                  </Source>
               </Change>
               <Change id="1384">
                  <Axiom>Recurrent Precursor T-Lymphoblastic Lymphoma/Leukemia EquivalentTo Precursor T-Lymphoblastic Lymphoma/Leukemia and Recurrent Hematologic Malignancy and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Recurrent Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Recurrent Malignant Neoplasm</Axiom>
                     <Axiom effectual="true">Recurrent Malignant Neoplasm EquivalentTo Malignant Neoplasm and Recurrent Neoplasm</Axiom>
                     <Axiom ineffectual="true">Recurrent Precursor T-Lymphoblastic Lymphoma/Leukemia EquivalentTo Precursor T-Lymphoblastic Lymphoma/Leukemia and Recurrent Hematologic Malignancy</Axiom>
                     <Axiom effectual="true">Recurrent Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Recurrent Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1385">
                  <Axiom>Refractory Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and Refractory Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Refractory Anaplastic Large Cell Lymphoma EquivalentTo Anaplastic Large Cell Lymphoma and Refractory Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom ineffectual="true">Refractory T-Cell Non-Hodgkin's Lymphoma EquivalentTo Refractory Non-Hodgkin's Lymphoma and T-Cell Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom effectual="true">Refractory Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom effectual="true">Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Refractory Neoplasm</Axiom>
                     <Axiom shared="true">Refractory Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma EquivalentTo Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma and Refractory T-Cell Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom ineffectual="true">Refractory Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Refractory Hematologic Malignancy</Axiom>
                  </Source>
               </Change>
               <Change id="1386">
                  <Axiom>Refractory Angioimmunoblastic T-cell Lymphoma EquivalentTo Angioimmunoblastic T-Cell Lymphoma and Refractory Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Refractory T-Cell Non-Hodgkin's Lymphoma EquivalentTo Refractory Non-Hodgkin's Lymphoma and T-Cell Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom effectual="true">Refractory Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom effectual="true">Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Refractory Neoplasm</Axiom>
                     <Axiom shared="true">Refractory Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma EquivalentTo Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma and Refractory T-Cell Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom ineffectual="true">Refractory Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Refractory Hematologic Malignancy</Axiom>
                     <Axiom ineffectual="true">Refractory Angioimmunoblastic T-cell Lymphoma EquivalentTo Angioimmunoblastic T-Cell Lymphoma and Refractory Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma</Axiom>
                  </Source>
               </Change>
               <Change id="1387">
                  <Axiom>Refractory B-Cell Non-Hodgkin's Lymphoma EquivalentTo B-Cell Non-Hodgkin's Lymphoma and Refractory Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Refractory Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom ineffectual="true">Refractory B-Cell Non-Hodgkin's Lymphoma EquivalentTo B-Cell Non-Hodgkin's Lymphoma and Refractory Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom effectual="true">Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Refractory Neoplasm</Axiom>
                     <Axiom ineffectual="true">Refractory Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Refractory Hematologic Malignancy</Axiom>
                  </Source>
               </Change>
               <Change id="1388">
                  <Axiom>Refractory Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and Refractory Hematologic Malignancy and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21)) and (Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement) and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Refractory Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom effectual="true">Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Refractory Neoplasm</Axiom>
                     <Axiom ineffectual="true">Refractory Chronic Lymphocytic Leukemia EquivalentTo Chronic Lymphocytic Leukemia and Refractory Hematologic Malignancy and ((Disease_May_Have_Cytogenetic_Abnormality some t(14;19)(q32;q13.1)) and (Disease_May_Have_Molecular_Abnormality some Clonal BCL3 Gene Rearrangement)) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 12q13) and (Disease_May_Have_Cytogenetic_Abnormality some Trisomy 12) and (Disease_May_Have_Cytogenetic_Abnormality some del(11q22q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(13q14)) and (Disease_May_Have_Cytogenetic_Abnormality some del(17p13)) and (Disease_May_Have_Cytogenetic_Abnormality some del(6q21))</Axiom>
                  </Source>
               </Change>
               <Change id="1389">
                  <Axiom>Refractory Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and Refractory Hematologic Malignancy and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only Refractory Disease) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Refractory Chronic Myelogenous Leukemia EquivalentTo Chronic Myelogenous Leukemia and Refractory Hematologic Malignancy and ((Disease_May_Have_Cytogenetic_Abnormality some Philadelphia Chromosome) and (Disease_May_Have_Cytogenetic_Abnormality some t(9;22)(q34;q11)) and (Disease_May_Have_Molecular_Abnormality some p190 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p210 Fusion Protein Expression) and (Disease_May_Have_Molecular_Abnormality some p230 Fusion Protein Expression)) and (Disease_May_Have_Associated_Disease some Anemia) and (Disease_May_Have_Finding some Chronic Clinical Course) and (Disease_May_Have_Finding some Fatigue) and (Disease_May_Have_Finding some Hepatomegaly) and (Disease_May_Have_Finding some Weight Loss) and (Disease_Has_Finding only Hypercellular Bone Marrow) and (Disease_Has_Finding only White Blood Cell Count Increased)</Axiom>
                     <Axiom effectual="true">Refractory Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom effectual="true">Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Refractory Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1390">
                  <Axiom>Refractory Hodgkin's Lymphoma EquivalentTo Hodgkin's Lymphoma and Refractory Hematologic Malignancy and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Refractory Hodgkin's Lymphoma EquivalentTo Hodgkin's Lymphoma and Refractory Hematologic Malignancy</Axiom>
                     <Axiom effectual="true">Refractory Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom effectual="true">Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Refractory Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1391">
                  <Axiom>Refractory Neoplasm SubClassOf Disease_Has_Finding only Refractory Disease</Axiom>
                  <Source>
                     <Axiom effectual="true">Refractory Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1392">
                  <Axiom>Refractory Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                  <Source>
                     <Axiom effectual="true">Refractory Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  </Source>
               </Change>
               <Change id="1393">
                  <Axiom>Refractory Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Refractory Hematologic Malignancy and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Refractory Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom effectual="true">Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Refractory Neoplasm</Axiom>
                     <Axiom ineffectual="true">Refractory Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Refractory Hematologic Malignancy</Axiom>
                  </Source>
               </Change>
               <Change id="1394">
                  <Axiom>Refractory Plasma Cell Neoplasm EquivalentTo Plasma Cell Neoplasm and Refractory Hematologic Malignancy and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Refractory Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom ineffectual="true">Refractory Plasma Cell Neoplasm EquivalentTo Plasma Cell Neoplasm and Refractory Hematologic Malignancy</Axiom>
                     <Axiom effectual="true">Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Refractory Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1395">
                  <Axiom>Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia EquivalentTo Precursor T-Lymphoblastic Lymphoma/Leukemia and Refractory Hematologic Malignancy and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  <Source>
                     <Axiom effectual="true">Refractory Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom effectual="true">Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Refractory Neoplasm</Axiom>
                     <Axiom ineffectual="true">Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia EquivalentTo Precursor T-Lymphoblastic Lymphoma/Leukemia and Refractory Hematologic Malignancy</Axiom>
                  </Source>
               </Change>
               <Change id="1396">
                  <Axiom>Refractory T-Cell Non-Hodgkin's Lymphoma EquivalentTo Refractory Non-Hodgkin's Lymphoma and T-Cell Non-Hodgkin's Lymphoma and (Disease_Has_Finding only Refractory Disease)</Axiom>
                  <Source>
                     <Axiom ineffectual="true">Refractory T-Cell Non-Hodgkin's Lymphoma EquivalentTo Refractory Non-Hodgkin's Lymphoma and T-Cell Non-Hodgkin's Lymphoma</Axiom>
                     <Axiom effectual="true">Refractory Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Refractory Disease)</Axiom>
                     <Axiom effectual="true">Refractory Hematologic Malignancy EquivalentTo Hematopoietic and Lymphoid Cell Neoplasm and Refractory Neoplasm</Axiom>
                     <Axiom ineffectual="true">Refractory Non-Hodgkin's Lymphoma EquivalentTo Non-Hodgkin's Lymphoma and Refractory Hematologic Malignancy</Axiom>
                  </Source>
               </Change>
               <Change id="1399">
                  <Axiom>Resin Modified Glass Ionomer Liner SubClassOf Dental Material</Axiom>
                  <Source>
                     <Axiom shared="true">Dental Liner SubClassOf Dental Material</Axiom>
                     <Axiom effectual="true">Resin Modified Glass Ionomer Liner SubClassOf Dental Liner</Axiom>
                  </Source>
               </Change>
               <Change id="1398">
                  <Axiom>Resin-Based Composite SubClassOf Dental Material</Axiom>
                  <Source>
                     <Axiom effectual="true">Restorative Material SubClassOf Dental Material</Axiom>
                     <Axiom effectual="true">Resin-Based Composite SubClassOf Restorative Material</Axiom>
                  </Source>
               </Change>
               <Change id="1400">
                  <Axiom>Sebaceous Gland Neoplasm SubClassOf Disease_Has_Abnormal_Cell only Neoplastic Sebocyte</Axiom>
                  <Source>
                     <Axiom effectual="true">Sebaceous Gland Neoplasm EquivalentTo Skin Appendage Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Sebocyte) and (Disease_Has_Finding only Sebaceous Differentiation) and (Disease_Has_Normal_Cell_Origin only Sebocyte) and (Disease_Has_Primary_Anatomic_Site only Sebaceous Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1401">
                  <Axiom>Sebaceous Gland Neoplasm SubClassOf Disease_Has_Finding only Sebaceous Differentiation</Axiom>
                  <Source>
                     <Axiom effectual="true">Sebaceous Gland Neoplasm EquivalentTo Skin Appendage Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Sebocyte) and (Disease_Has_Finding only Sebaceous Differentiation) and (Disease_Has_Normal_Cell_Origin only Sebocyte) and (Disease_Has_Primary_Anatomic_Site only Sebaceous Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1402">
                  <Axiom>Sebaceous Gland Neoplasm SubClassOf Disease_Has_Normal_Cell_Origin only Sebocyte</Axiom>
                  <Source>
                     <Axiom effectual="true">Sebaceous Gland Neoplasm EquivalentTo Skin Appendage Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Sebocyte) and (Disease_Has_Finding only Sebaceous Differentiation) and (Disease_Has_Normal_Cell_Origin only Sebocyte) and (Disease_Has_Primary_Anatomic_Site only Sebaceous Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1403">
                  <Axiom>Sebaceous Gland Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Sebaceous Gland</Axiom>
                  <Source>
                     <Axiom effectual="true">Sebaceous Gland Neoplasm EquivalentTo Skin Appendage Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Sebocyte) and (Disease_Has_Finding only Sebaceous Differentiation) and (Disease_Has_Normal_Cell_Origin only Sebocyte) and (Disease_Has_Primary_Anatomic_Site only Sebaceous Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1404">
                  <Axiom>Sebaceous Gland Neoplasm SubClassOf Skin Appendage Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Sebaceous Gland Neoplasm EquivalentTo Skin Appendage Neoplasm and (Disease_Has_Abnormal_Cell only Neoplastic Sebocyte) and (Disease_Has_Finding only Sebaceous Differentiation) and (Disease_Has_Normal_Cell_Origin only Sebocyte) and (Disease_Has_Primary_Anatomic_Site only Sebaceous Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1405">
                  <Axiom>Seborrheic Keratosis SubClassOf Benign Epithelial Skin Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Seborrheic Keratosis EquivalentTo Acanthoma and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Normal_Cell_Origin only Basal Cell of the Squamous Epithelium)</Axiom>
                     <Axiom effectual="true">Acanthoma EquivalentTo Benign Epithelial Skin Neoplasm and (Disease_Excludes_Primary_Anatomic_Site only Hair Follicle Infundibulum) and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte)</Axiom>
                  </Source>
               </Change>
               <Change id="1406">
                  <Axiom>Seborrheic Keratosis SubClassOf Disease_Has_Finding only Acanthosis</Axiom>
                  <Source>
                     <Axiom effectual="true">Seborrheic Keratosis EquivalentTo Acanthoma and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Normal_Cell_Origin only Basal Cell of the Squamous Epithelium)</Axiom>
                  </Source>
               </Change>
               <Change id="1407">
                  <Axiom>Seborrheic Keratosis SubClassOf Disease_Has_Finding only Cystic Change</Axiom>
                  <Source>
                     <Axiom effectual="true">Seborrheic Keratosis EquivalentTo Acanthoma and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Normal_Cell_Origin only Basal Cell of the Squamous Epithelium)</Axiom>
                  </Source>
               </Change>
               <Change id="1408">
                  <Axiom>Seborrheic Keratosis SubClassOf Disease_Has_Finding only Hyperkeratosis</Axiom>
                  <Source>
                     <Axiom effectual="true">Seborrheic Keratosis EquivalentTo Acanthoma and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Normal_Cell_Origin only Basal Cell of the Squamous Epithelium)</Axiom>
                  </Source>
               </Change>
               <Change id="1409">
                  <Axiom>Seborrheic Keratosis SubClassOf Disease_Has_Normal_Cell_Origin only Basal Cell of the Squamous Epithelium</Axiom>
                  <Source>
                     <Axiom effectual="true">Seborrheic Keratosis EquivalentTo Acanthoma and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Cystic Change) and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Normal_Cell_Origin only Basal Cell of the Squamous Epithelium)</Axiom>
                  </Source>
               </Change>
               <Change id="1410">
                  <Axiom>Secondary Glioblastoma EquivalentTo Glioblastoma and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Has_Finding only Secondary Lesion)</Axiom>
                  <Source>
                     <Axiom effectual="true">Secondary Malignant Neoplasm EquivalentTo Malignant Neoplasm and Secondary Neoplasm</Axiom>
                     <Axiom effectual="true">Anaplastic Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Anaplastic Lesion)</Axiom>
                     <Axiom effectual="true">Secondary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Secondary Lesion)</Axiom>
                     <Axiom shared="true">Astrocytic Tumor EquivalentTo Central Nervous System Neoplasm and Common Neoplasm and Neuroglial Tumor and (Disease_Has_Abnormal_Cell only Neoplastic Astrocyte) and (Disease_Has_Normal_Cell_Origin only Astrocyte) and (Disease_Has_Primary_Anatomic_Site only Central Nervous System)</Axiom>
                     <Axiom shared="true">Common Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom effectual="true">Glioblastoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytic Tumor and Malignant Glioma and (Disease_May_Have_Abnormal_Cell some Fibrillary Neoplastic Astrocyte) and (Disease_May_Have_Abnormal_Cell some Gemistocytic Neoplastic Astrocyte) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q25-26)) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Poorly Differentiated Neoplastic Astrocyte) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Microvascular Proliferation) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 4)</Axiom>
                     <Axiom effectual="true">Secondary Glioblastoma EquivalentTo Glioblastoma and Secondary Malignant Neoplasm and ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression)) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Secondary Malignant Neoplasm EquivalentTo Malignant Neoplasm and Secondary Neoplasm</Axiom>
                     <Axiom effectual="true">Anaplastic Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Anaplastic Lesion)</Axiom>
                     <Axiom effectual="true">Secondary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Secondary Lesion)</Axiom>
                     <Axiom shared="true">Malignant Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom effectual="true">Glioblastoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytic Tumor and Malignant Glioma and (Disease_May_Have_Abnormal_Cell some Fibrillary Neoplastic Astrocyte) and (Disease_May_Have_Abnormal_Cell some Gemistocytic Neoplastic Astrocyte) and (Disease_May_Have_Cytogenetic_Abnormality some Gain of Chromosome 7q) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 10p) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 9p) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q23)) and (Disease_May_Have_Cytogenetic_Abnormality some del(10q25-26)) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_Has_Abnormal_Cell only Poorly Differentiated Neoplastic Astrocyte) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Microvascular Proliferation) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Necrotic Change) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 4)</Axiom>
                     <Axiom effectual="true">Secondary Glioblastoma EquivalentTo Glioblastoma and Secondary Malignant Neoplasm and ((Disease_May_Have_Molecular_Abnormality some PDGFRalpha Gene Mutation) and (Disease_May_Have_Molecular_Abnormality some PDGFRalpha Protein Overexpression)) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation)</Axiom>
                  </Source>
               </Change>
               <Change id="1411">
                  <Axiom>Secondary Malignant Neoplasm SubClassOf Malignant Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Secondary Malignant Neoplasm EquivalentTo Malignant Neoplasm and Secondary Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1412">
                  <Axiom>Secondary Neoplasm SubClassOf Disease_Has_Finding only Secondary Lesion</Axiom>
                  <Source>
                     <Axiom effectual="true">Secondary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Secondary Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1413">
                  <Axiom>Secondary Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                  <Source>
                     <Axiom effectual="true">Secondary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Secondary Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1139">
                  <Axiom>Secondary Supratentorial Anaplastic Astrocytoma EquivalentTo Anaplastic Astrocytoma and Malignant Supratentorial Neoplasm and (Disease_Has_Finding only Secondary Lesion) and (Disease_Has_Primary_Anatomic_Site only Supratentorial Brain)</Axiom>
                  <Source>
                     <Axiom effectual="true">Anaplastic Astrocytoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytoma and Malignant Glioma and (Disease_May_Have_Cytogenetic_Abnormality some CDKN2A Gene Deletion) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Motor Manifestations) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Finding some Sensory Manifestations) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some RB1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Excludes_Finding only Microvascular Proliferation) and (Disease_Excludes_Finding only Necrotic Change) and (Disease_Has_Abnormal_Cell only Anaplastic Astrocyte) and (Disease_Has_Finding only Increased Cellularity Present) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 3)</Axiom>
                     <Axiom effectual="true">Secondary Malignant Neoplasm EquivalentTo Malignant Neoplasm and Secondary Neoplasm</Axiom>
                     <Axiom effectual="true">Anaplastic Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Anaplastic Lesion)</Axiom>
                     <Axiom effectual="true">Secondary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Secondary Lesion)</Axiom>
                     <Axiom shared="true">Astrocytic Tumor EquivalentTo Central Nervous System Neoplasm and Common Neoplasm and Neuroglial Tumor and (Disease_Has_Abnormal_Cell only Neoplastic Astrocyte) and (Disease_Has_Normal_Cell_Origin only Astrocyte) and (Disease_Has_Primary_Anatomic_Site only Central Nervous System)</Axiom>
                     <Axiom shared="true">Common Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom shared="true">Astrocytoma EquivalentTo Astrocytic Tumor and (Disease_Excludes_Finding only Grade 4 Lesion)</Axiom>
                     <Axiom effectual="true">Secondary Supratentorial Anaplastic Astrocytoma EquivalentTo Anaplastic Astrocytoma and Malignant Supratentorial Neoplasm and Secondary Malignant Neoplasm and (Disease_Has_Primary_Anatomic_Site only Supratentorial Brain)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Anaplastic Astrocytoma EquivalentTo Anaplastic Malignant Neoplasm and Astrocytoma and Malignant Glioma and (Disease_May_Have_Cytogenetic_Abnormality some CDKN2A Gene Deletion) and (Disease_May_Have_Cytogenetic_Abnormality some Loss of Chromosome 6) and (Disease_May_Have_Finding some Headache) and (Disease_May_Have_Finding some Motor Manifestations) and (Disease_May_Have_Finding some Seizure) and (Disease_May_Have_Finding some Sensory Manifestations) and (Disease_May_Have_Molecular_Abnormality some PTEN Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some RB1 Gene Inactivation) and (Disease_May_Have_Molecular_Abnormality some TP53 Gene Inactivation) and (Disease_Excludes_Finding only Microvascular Proliferation) and (Disease_Excludes_Finding only Necrotic Change) and (Disease_Has_Abnormal_Cell only Anaplastic Astrocyte) and (Disease_Has_Finding only Increased Cellularity Present) and (Disease_Has_Finding only Infiltrative Growth) and (Disease_Has_Finding only Mitotic Activity) and (Disease_Has_Finding only Nuclear Atypia) and (Disease_Is_Grade only Grade 3)</Axiom>
                     <Axiom effectual="true">Secondary Malignant Neoplasm EquivalentTo Malignant Neoplasm and Secondary Neoplasm</Axiom>
                     <Axiom effectual="true">Anaplastic Malignant Neoplasm EquivalentTo Malignant Neoplasm and (Disease_Has_Finding only Anaplastic Lesion)</Axiom>
                     <Axiom effectual="true">Secondary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Secondary Lesion)</Axiom>
                     <Axiom shared="true">Malignant Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom effectual="true">Secondary Supratentorial Anaplastic Astrocytoma EquivalentTo Anaplastic Astrocytoma and Malignant Supratentorial Neoplasm and Secondary Malignant Neoplasm and (Disease_Has_Primary_Anatomic_Site only Supratentorial Brain)</Axiom>
                  </Source>
               </Change>
               <Change id="1414">
                  <Axiom>Semantic_Type Range: string</Axiom>
                  <Source>
                     <Axiom effectual="true">Semantic_Type Range: {"Acquired Abnormality"^^string , "Activity"^^string , "Age Group"^^string , "Alga"^^string , "Amino Acid Sequence"^^string , "Amino Acid, Peptide, or Protein"^^string , "Amphibian"^^string , "Anatomical Abnormality"^^string , "Anatomical Structure"^^string , "Animal"^^string , "Antibiotic"^^string , "Archaeon"^^string , "Bacterium"^^string , "Behavior"^^string , "Biologic Function"^^string , "Biologically Active Substance"^^string , "Biomedical Occupation or Discipline"^^string , "Biomedical or Dental Material"^^string , "Bird"^^string , "Body Location or Region"^^string , "Body Part, Organ, or Organ Component"^^string , "Body Space or Junction"^^string , "Body Substance"^^string , "Body System"^^string , "Carbohydrate"^^string , "Carbohydrate Sequence"^^string , "Cell"^^string , "Cell Component"^^string , "Cell Function"^^string , "Cell or Molecular Dysfunction"^^string , "Chemical"^^string , "Chemical Viewed Functionally"^^string , "Chemical Viewed Structurally"^^string , "Classification"^^string , "Clinical Attribute"^^string , "Clinical Drug"^^string , "Conceptual Entity"^^string , "Congenital Abnormality"^^string , "Daily or Recreational Activity"^^string , "Diagnostic Procedure"^^string , "Disease or Syndrome"^^string , "Drug Delivery Device"^^string , "Educational Activity"^^string , "Eicosanoid"^^string , "Element, Ion, or Isotope"^^string , "Embryonic Structure"^^string , "Entity"^^string , "Environmental Effect of Humans"^^string , "Enzyme"^^string , "Event"^^string , "Experimental Model of Disease"^^string , "Family Group"^^string , "Finding"^^string , "Fish"^^string , "Food"^^string , "Fully Formed Anatomical Structure"^^string , "Functional Concept"^^string , "Fungus"^^string , "Gene or Genome"^^string , "Genetic Function"^^string , "Geographic Area"^^string , "Governmental or Regulatory Activity"^^string , "Group"^^string , "Group Attribute"^^string , "Hazardous or Poisonous Substance"^^string , "Health Care Activity"^^string , "Health Care Related Organization"^^string , "Hormone"^^string , "Human"^^string , "Human-caused Phenomenon or Process"^^string , "Idea or Concept"^^string , "Immunologic Factor"^^string , "Indicator, Reagent, or Diagnostic Aid"^^string , "Individual Behavior"^^string , "Injury or Poisoning"^^string , "Inorganic Chemical"^^string , "Intellectual Product"^^string , "Invertebrate"^^string , "Laboratory Procedure"^^string , "Laboratory or Test Result"^^string , "Language"^^string , "Lipid"^^string , "Machine Activity"^^string , "Mammal"^^string , "Manufactured Object"^^string , "Medical Device"^^string , "Mental Process"^^string , "Mental or Behavioral Dysfunction"^^string , "Molecular Biology Research Technique"^^string , "Molecular Function"^^string , "Molecular Sequence"^^string , "Natural Phenomenon or Process"^^string , "Neoplastic Process"^^string , "Neuroreactive Substance or Biogenic Amine"^^string , "Nucleic Acid, Nucleoside, or Nucleotide"^^string , "Nucleotide Sequence"^^string , "Occupation or Discipline"^^string , "Occupational Activity"^^string , "Organ or Tissue Function"^^string , "Organic Chemical"^^string , "Organism"^^string , "Organism Attribute"^^string , "Organism Function"^^string , "Organization"^^string , "Organophosphorus Compound"^^string , "Pathologic Function"^^string , "Patient or Disabled Group"^^string , "Pharmacologic Substance"^^string , "Phenomenon or Process"^^string , "Physical Object"^^string , "Physiologic Function"^^string , "Plant"^^string , "Population Group"^^string , "Professional Society"^^string , "Professional or Occupational Group"^^string , "Qualitative Concept"^^string , "Quantitative Concept"^^string , "Receptor"^^string , "Regulation or Law"^^string , "Reptile"^^string , "Research Activity"^^string , "Research Device"^^string , "Rickettsia or Chlamydia"^^string , "Self-help or Relief Organization"^^string , "Sign or Symptom"^^string , "Social Behavior"^^string , "Spatial Concept"^^string , "Steroid"^^string , "Substance"^^string , "Temporal Concept"^^string , "Therapeutic or Preventive Procedure"^^string , "Tissue"^^string , "Vertebrate"^^string , "Virus"^^string , "Vitamin"^^string}</Axiom>
                  </Source>
               </Change>
               <Change id="1415">
                  <Axiom>Skin Appendage Adenoma SubClassOf Adenoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Skin Appendage Adenoma EquivalentTo Adenoma and Benign Epithelial Skin Neoplasm and Benign Skin Appendage Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1416">
                  <Axiom>Skin Appendage Adenoma SubClassOf Benign Epithelial Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Skin Appendage Adenoma EquivalentTo Adenoma and Benign Epithelial Skin Neoplasm and Benign Skin Appendage Neoplasm</Axiom>
                     <Axiom effectual="true">Benign Epithelial Skin Neoplasm EquivalentTo Benign Epithelial Neoplasm and Benign Skin Neoplasm and Epithelial Skin Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1417">
                  <Axiom>Skin Appendage Adenoma SubClassOf Benign Skin Appendage Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Skin Appendage Adenoma EquivalentTo Adenoma and Benign Epithelial Skin Neoplasm and Benign Skin Appendage Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1418">
                  <Axiom>Skin Appendage Neoplasm SubClassOf Disease_Has_Finding only Adnexal Differentiation</Axiom>
                  <Source>
                     <Axiom effectual="true">Skin Appendage Neoplasm EquivalentTo Skin Neoplasm and (Disease_Has_Finding only Adnexal Differentiation) and (Disease_Has_Primary_Anatomic_Site only Exocrine System) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1419">
                  <Axiom>Skin Appendage Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Exocrine System</Axiom>
                  <Source>
                     <Axiom effectual="true">Skin Appendage Neoplasm EquivalentTo Skin Neoplasm and (Disease_Has_Finding only Adnexal Differentiation) and (Disease_Has_Primary_Anatomic_Site only Exocrine System) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1420">
                  <Axiom>Skin Appendage Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Skin</Axiom>
                  <Source>
                     <Axiom effectual="true">Skin Appendage Neoplasm EquivalentTo Skin Neoplasm and (Disease_Has_Finding only Adnexal Differentiation) and (Disease_Has_Primary_Anatomic_Site only Exocrine System) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1421">
                  <Axiom>Skin Appendage Neoplasm SubClassOf Skin Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Skin Appendage Neoplasm EquivalentTo Skin Neoplasm and (Disease_Has_Finding only Adnexal Differentiation) and (Disease_Has_Primary_Anatomic_Site only Exocrine System) and (Disease_Has_Primary_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1422">
                  <Axiom>Skin Neoplasm SubClassOf Disease_Has_Associated_Anatomic_Site only Skin</Axiom>
                  <Source>
                     <Axiom effectual="true">Skin Neoplasm EquivalentTo Neoplasm by Site and Skin Disorder and (Disease_Has_Associated_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1423">
                  <Axiom>Skin Neoplasm SubClassOf Neoplasm by Site</Axiom>
                  <Source>
                     <Axiom effectual="true">Skin Neoplasm EquivalentTo Neoplasm by Site and Skin Disorder and (Disease_Has_Associated_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1424">
                  <Axiom>Skin Neoplasm SubClassOf Skin Disorder</Axiom>
                  <Source>
                     <Axiom effectual="true">Skin Neoplasm EquivalentTo Neoplasm by Site and Skin Disorder and (Disease_Has_Associated_Anatomic_Site only Skin)</Axiom>
                  </Source>
               </Change>
               <Change id="1425">
                  <Axiom>Sporadic Cylindroma SubClassOf Cylindroma</Axiom>
                  <Source>
                     <Axiom effectual="true">Sporadic Cylindroma EquivalentTo Cylindroma and (Disease_Has_Finding only Non-Hereditary Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1426">
                  <Axiom>Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma EquivalentTo Papillary Urothelial Neoplasm and Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma and (Disease_Is_Stage only Stage 0a)</Axiom>
                  <Source>
                     <Axiom shared="true">Papillary Transitional Cell Carcinoma EquivalentTo Papillary Carcinoma and Transitional Cell Carcinoma and (Disease_Has_Normal_Cell_Origin only Transitional Cell) and (Disease_Has_Normal_Tissue_Origin only Transitional Epithelium)</Axiom>
                     <Axiom shared="true">Transitional Cell Carcinoma EquivalentTo Carcinoma and Transitional Cell Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Transitional Cell)</Axiom>
                     <Axiom shared="true">Urothelial Carcinoma EquivalentTo Malignant Urinary System Neoplasm and Transitional Cell Carcinoma and Urothelial Neoplasm and (Disease_Has_Normal_Cell_Origin only Transitional Cell) and (Disease_Has_Normal_Tissue_Origin only Transitional Epithelium)</Axiom>
                     <Axiom effectual="true">Papillary Carcinoma EquivalentTo Carcinoma and Papillary Epithelial Neoplasm</Axiom>
                     <Axiom shared="true">Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma EquivalentTo Intraurothelial Neoplasia and Stage 0 Transitional Cell Carcinoma and Renal Pelvis and Ureter Urothelial Carcinoma</Axiom>
                     <Axiom effectual="true">Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma EquivalentTo Papillary Transitional Cell Carcinoma and Papillary Urothelial Neoplasm and Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma and (Disease_Is_Stage only Stage 0a)</Axiom>
                     <Axiom shared="true">Renal Pelvis and Ureter Urothelial Carcinoma EquivalentTo Renal Pelvis and Ureter Carcinoma and Urothelial Carcinoma</Axiom>
                     <Axiom shared="true">Papillary Urothelial Neoplasm EquivalentTo Papillary Epithelial Neoplasm and Urothelial Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Transitional Cell Intraepithelial Neoplasia EquivalentTo Intraepithelial Neoplasia and Transitional Cell Neoplasm and (Disease_Has_Normal_Cell_Origin only Transitional Cell) and (Disease_Has_Normal_Tissue_Origin only Transitional Epithelium)</Axiom>
                     <Axiom shared="true">Transitional Cell Carcinoma EquivalentTo Carcinoma and Transitional Cell Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Transitional Cell)</Axiom>
                     <Axiom shared="true">Stage 0 Transitional Cell Carcinoma EquivalentTo Transitional Cell Carcinoma and Transitional Cell Intraepithelial Neoplasia and (Disease_Is_Stage only Stage 0)</Axiom>
                     <Axiom shared="true">Papillary Transitional Cell Carcinoma EquivalentTo Papillary Carcinoma and Transitional Cell Carcinoma and (Disease_Has_Normal_Cell_Origin only Transitional Cell) and (Disease_Has_Normal_Tissue_Origin only Transitional Epithelium)</Axiom>
                     <Axiom effectual="true">Papillary Carcinoma EquivalentTo Carcinoma and Papillary Epithelial Neoplasm</Axiom>
                     <Axiom shared="true">Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma EquivalentTo Intraurothelial Neoplasia and Stage 0 Transitional Cell Carcinoma and Renal Pelvis and Ureter Urothelial Carcinoma</Axiom>
                     <Axiom effectual="true">Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma EquivalentTo Papillary Transitional Cell Carcinoma and Papillary Urothelial Neoplasm and Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma and (Disease_Is_Stage only Stage 0a)</Axiom>
                     <Axiom shared="true">Papillary Urothelial Neoplasm EquivalentTo Papillary Epithelial Neoplasm and Urothelial Neoplasm</Axiom>
                  </Source>
                  <Source>
                     <Axiom shared="true">Stage 0 Transitional Cell Carcinoma EquivalentTo Transitional Cell Carcinoma and Transitional Cell Intraepithelial Neoplasia and (Disease_Is_Stage only Stage 0)</Axiom>
                     <Axiom shared="true">Papillary Transitional Cell Carcinoma EquivalentTo Papillary Carcinoma and Transitional Cell Carcinoma and (Disease_Has_Normal_Cell_Origin only Transitional Cell) and (Disease_Has_Normal_Tissue_Origin only Transitional Epithelium)</Axiom>
                     <Axiom shared="true">Urothelium SubClassOf Transitional Epithelium</Axiom>
                     <Axiom shared="true">Transitional Cell Carcinoma EquivalentTo Carcinoma and Transitional Cell Neoplasm and (Disease_Has_Abnormal_Cell only Malignant Transitional Cell)</Axiom>
                     <Axiom shared="true">Urothelial Neoplasm EquivalentTo Transitional Cell Neoplasm and Urinary System Neoplasm and (Disease_Has_Normal_Cell_Origin only Urothelial Cell) and (Disease_Has_Normal_Tissue_Origin only Urothelium) and (Disease_Has_Primary_Anatomic_Site only Urinary System)</Axiom>
                     <Axiom effectual="true">Papillary Carcinoma EquivalentTo Carcinoma and Papillary Epithelial Neoplasm</Axiom>
                     <Axiom shared="true">Urothelial Cell SubClassOf Transitional Cell</Axiom>
                     <Axiom shared="true">Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma EquivalentTo Intraurothelial Neoplasia and Stage 0 Transitional Cell Carcinoma and Renal Pelvis and Ureter Urothelial Carcinoma</Axiom>
                     <Axiom effectual="true">Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma EquivalentTo Papillary Transitional Cell Carcinoma and Papillary Urothelial Neoplasm and Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma and (Disease_Is_Stage only Stage 0a)</Axiom>
                     <Axiom shared="true">Papillary Urothelial Neoplasm EquivalentTo Papillary Epithelial Neoplasm and Urothelial Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1427">
                  <Axiom>Staphylococcus aureus SubClassOf Bacteria</Axiom>
                  <Source>
                     <Axiom effectual="true">Coagulase-Positive Staphylococcus SubClassOf Staphylococcus</Axiom>
                     <Axiom effectual="true">Staphylococcus SubClassOf Bacteria</Axiom>
                     <Axiom effectual="true">Staphylococcus aureus SubClassOf Coagulase-Positive Staphylococcus</Axiom>
                  </Source>
               </Change>
               <Change id="1428">
                  <Axiom>Sweat Gland Adenoma SubClassOf Skin Appendage Adenoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Sweat Gland Adenoma EquivalentTo Benign Sweat Gland Neoplasm and Skin Appendage Adenoma and (Disease_Has_Finding only Well-Circumscribed Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1429">
                  <Axiom>Sweat Gland Neoplasm SubClassOf Disease_Has_Primary_Anatomic_Site only Sweat Gland</Axiom>
                  <Source>
                     <Axiom effectual="true">Sweat Gland Neoplasm EquivalentTo Skin Appendage Neoplasm and (Disease_Has_Primary_Anatomic_Site only Sweat Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1430">
                  <Axiom>Sweat Gland Neoplasm SubClassOf Skin Appendage Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Sweat Gland Neoplasm EquivalentTo Skin Appendage Neoplasm and (Disease_Has_Primary_Anatomic_Site only Sweat Gland)</Axiom>
                  </Source>
               </Change>
               <Change id="1431">
                  <Axiom>Syringoacanthoma SubClassOf Poroma</Axiom>
                  <Source>
                     <Axiom effectual="true">Syringoacanthoma EquivalentTo Poroma and (Disease_Has_Finding only Acanthosis)</Axiom>
                  </Source>
               </Change>
               <Change id="1228">
                  <Axiom>Syringofibroadenoma SubClassOf Benign Eccrine Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Syringofibroadenoma EquivalentTo Benign Eccrine Neoplasm and Sweat Gland Adenoma and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Anastomosing Strands of Tumor Cells Present)</Axiom>
                  </Source>
               </Change>
               <Change id="1229">
                  <Axiom>Syringofibroadenoma SubClassOf Sweat Gland Adenoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Syringofibroadenoma EquivalentTo Benign Eccrine Neoplasm and Sweat Gland Adenoma and (Disease_May_Have_Finding some Skin Nodule) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Anastomosing Strands of Tumor Cells Present)</Axiom>
                  </Source>
               </Change>
               <Change id="1432">
                  <Axiom>Syringoma SubClassOf Benign Eccrine Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Syringoma EquivalentTo Benign Eccrine Neoplasm and (Disease_May_Have_Finding some Multifocal Lesion) and (Disease_May_Have_Finding some Papular Lesion) and (Disease_Has_Finding only Cord-Like Pattern) and (Disease_Has_Finding only Dense Collagenized Tissue Present) and (Disease_Has_Finding only Tubular Pattern)</Axiom>
                  </Source>
               </Change>
               <Change id="1436">
                  <Axiom>Therapy Related Malignant Neoplasm SubClassOf Therapy-Related Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Therapy Related Malignant Neoplasm EquivalentTo Malignant Neoplasm and Therapy-Related Neoplasm</Axiom>
                  </Source>
               </Change>
               <Change id="1433">
                  <Axiom>Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome EquivalentTo Myeloid Neoplasm and Therapy Related Malignant Neoplasm and (Disease_Has_Finding only Ineffective Hematopoiesis) and (Disease_Has_Finding only Secondary Lesion) and (Disease_Has_Finding only Therapy-Related Toxicity)</Axiom>
                  <Source>
                     <Axiom effectual="true">Secondary Malignant Neoplasm EquivalentTo Malignant Neoplasm and Secondary Neoplasm</Axiom>
                     <Axiom effectual="true">Secondary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Secondary Lesion)</Axiom>
                     <Axiom shared="true">Malignant Neoplasm SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom effectual="true">Therapy Related Malignant Neoplasm EquivalentTo Malignant Neoplasm and Therapy-Related Neoplasm</Axiom>
                     <Axiom effectual="true">Therapy-Related Neoplasm EquivalentTo Neoplasm by Cause and (Disease_Has_Finding only Therapy-Related Toxicity)</Axiom>
                     <Axiom effectual="true">Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome EquivalentTo Myeloid Neoplasm and Secondary Malignant Neoplasm and Therapy Related Malignant Neoplasm and (Disease_Has_Finding only Ineffective Hematopoiesis)</Axiom>
                  </Source>
                  <Source>
                     <Axiom effectual="true">Secondary Malignant Neoplasm EquivalentTo Malignant Neoplasm and Secondary Neoplasm</Axiom>
                     <Axiom effectual="true">Secondary Neoplasm EquivalentTo Neoplasm by Special Category and (Disease_Has_Finding only Secondary Lesion)</Axiom>
                     <Axiom shared="true">Neoplasm by Cause SubClassOf Neoplasm by Special Category</Axiom>
                     <Axiom effectual="true">Therapy Related Malignant Neoplasm EquivalentTo Malignant Neoplasm and Therapy-Related Neoplasm</Axiom>
                     <Axiom effectual="true">Therapy-Related Neoplasm EquivalentTo Neoplasm by Cause and (Disease_Has_Finding only Therapy-Related Toxicity)</Axiom>
                     <Axiom effectual="true">Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome EquivalentTo Myeloid Neoplasm and Secondary Malignant Neoplasm and Therapy Related Malignant Neoplasm and (Disease_Has_Finding only Ineffective Hematopoiesis)</Axiom>
                  </Source>
               </Change>
               <Change id="1434">
                  <Axiom>Therapy-Related Neoplasm SubClassOf Disease_Has_Finding only Therapy-Related Toxicity</Axiom>
                  <Source>
                     <Axiom effectual="true">Therapy-Related Neoplasm EquivalentTo Neoplasm by Cause and (Disease_Has_Finding only Therapy-Related Toxicity)</Axiom>
                  </Source>
               </Change>
               <Change id="1435">
                  <Axiom>Therapy-Related Neoplasm SubClassOf Neoplasm by Cause</Axiom>
                  <Source>
                     <Axiom effectual="true">Therapy-Related Neoplasm EquivalentTo Neoplasm by Cause and (Disease_Has_Finding only Therapy-Related Toxicity)</Axiom>
                  </Source>
               </Change>
               <Change id="1438">
                  <Axiom>Trichoadenoma SubClassOf Benign Outer Hair Sheath and Infundibulum Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Trichoadenoma EquivalentTo Benign Outer Hair Sheath and Infundibulum Neoplasm and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Finding only Cystic Change)</Axiom>
                  </Source>
               </Change>
               <Change id="1439">
                  <Axiom>Trichoblastoma SubClassOf Benign Germinative Follicular Epithelium Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Trichoblastoma EquivalentTo Benign Germinative Follicular Epithelium Neoplasm and (Disease_Has_Finding only Fenestrated Pattern) and (Disease_Has_Finding only Papular Lesion) and (Disease_Has_Finding only Trichoblastic Differentiation)</Axiom>
                  </Source>
               </Change>
               <Change id="1437">
                  <Axiom>Tricholemmoma SubClassOf Benign Outer Hair Sheath and Infundibulum Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Tricholemmoma EquivalentTo Benign Outer Hair Sheath and Infundibulum Neoplasm and (Disease_May_Have_Finding some Dome-Shaped Lesion) and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Finding only Parakeratosis) and (Disease_Has_Finding only Tricholemmal Differentiation)</Axiom>
                  </Source>
               </Change>
               <Change id="1440">
                  <Axiom>Tubular Apocrine Adenoma SubClassOf Apocrine Adenoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Tubular Apocrine Adenoma EquivalentTo Apocrine Adenoma and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Finding only Lobulated Growth Pattern) and (Disease_Has_Finding only Tubular Pattern)</Axiom>
                  </Source>
               </Change>
               <Change id="1248">
                  <Axiom>Tumor of the Follicular Infundibulum SubClassOf Benign Outer Hair Sheath and Infundibulum Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Tumor of the Follicular Infundibulum EquivalentTo Benign Outer Hair Sheath and Infundibulum Neoplasm and (Disease_May_Have_Finding some Macular Lesion) and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte) and (Disease_Has_Primary_Anatomic_Site only Hair Follicle Infundibulum)</Axiom>
                  </Source>
               </Change>
               <Change id="1249">
                  <Axiom>Tumor of the Follicular Infundibulum SubClassOf Disease_Has_Primary_Anatomic_Site only Hair Follicle Infundibulum</Axiom>
                  <Source>
                     <Axiom effectual="true">Tumor of the Follicular Infundibulum EquivalentTo Benign Outer Hair Sheath and Infundibulum Neoplasm and (Disease_May_Have_Finding some Macular Lesion) and (Disease_May_Have_Finding some Skin Nodule) and (Disease_Has_Abnormal_Cell only Neoplastic Keratinocyte) and (Disease_Has_Primary_Anatomic_Site only Hair Follicle Infundibulum)</Axiom>
                  </Source>
               </Change>
               <Change id="1441">
                  <Axiom>Turban Tumor SubClassOf Cylindroma</Axiom>
                  <Source>
                     <Axiom effectual="true">Turban Tumor EquivalentTo Cylindroma and (Disease_Has_Finding only Multifocal Lesion) and (Disease_Has_Primary_Anatomic_Site only Head)</Axiom>
                  </Source>
               </Change>
               <Change id="1442">
                  <Axiom>Verruca Plantaris SubClassOf Verrucous Lesion</Axiom>
                  <Source>
                     <Axiom effectual="true">Verruca Plantaris EquivalentTo Benign Epithelial Skin Neoplasm and Benign Squamous Cell Neoplasm and Verrucous Lesion and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Finding only Parakeratosis) and (Disease_Has_Primary_Anatomic_Site only Foot) and (Disease_Has_Primary_Anatomic_Site only Plantar Region)</Axiom>
                  </Source>
               </Change>
               <Change id="1443">
                  <Axiom>Verruca Vulgaris SubClassOf Verrucous Lesion</Axiom>
                  <Source>
                     <Axiom effectual="true">Verruca Vulgaris EquivalentTo Benign Epithelial Skin Neoplasm and Benign Squamous Cell Neoplasm and Verrucous Lesion and (Disease_Excludes_Primary_Anatomic_Site only Foot) and (Disease_Excludes_Primary_Anatomic_Site only Plantar Region) and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Finding only Parakeratosis)</Axiom>
                  </Source>
               </Change>
               <Change id="1444">
                  <Axiom>Verrucous Carcinoma of the Penis EquivalentTo Squamous Cell Carcinoma of the Penis and Verrucous Carcinoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Verrucous Carcinoma of the Penis EquivalentTo Papillary Carcinoma of the Penis and Verrucous Carcinoma</Axiom>
                     <Axiom shared="true">Papillary Carcinoma of the Penis EquivalentTo Papillary Squamous Cell Carcinoma and Squamous Cell Carcinoma of the Penis</Axiom>
                     <Axiom effectual="true">Verrucous Carcinoma EquivalentTo Papillary Squamous Cell Carcinoma and (Disease_Excludes_Finding only Koilocytotic Atypia) and (Disease_Has_Finding only Acanthosis) and (Disease_Has_Finding only Endophytic Tumor Growth) and (Disease_Has_Finding only Exophytic Papillary Lesion) and (Disease_Has_Finding only Hyperkeratosis) and (Disease_Has_Finding only Mild Cytologic Atypia) and (Disease_Has_Finding only Pushing Tumor Margins Present) and (Disease_Has_Finding only Well Differentiated Lesion)</Axiom>
                  </Source>
               </Change>
               <Change id="1445">
                  <Axiom>Vulvar Nodular Hidradenoma SubClassOf Benign Vulvar Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Vulvar Nodular Hidradenoma EquivalentTo Benign Vulvar Neoplasm and Nodular Hidradenoma and Vulvar Neoplasm of Skin Appendage Origin</Axiom>
                  </Source>
               </Change>
               <Change id="1446">
                  <Axiom>Vulvar Nodular Hidradenoma SubClassOf Nodular Hidradenoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Vulvar Nodular Hidradenoma EquivalentTo Benign Vulvar Neoplasm and Nodular Hidradenoma and Vulvar Neoplasm of Skin Appendage Origin</Axiom>
                  </Source>
               </Change>
               <Change id="1447">
                  <Axiom>Vulvar Nodular Hidradenoma SubClassOf Vulvar Neoplasm of Skin Appendage Origin</Axiom>
                  <Source>
                     <Axiom effectual="true">Vulvar Nodular Hidradenoma EquivalentTo Benign Vulvar Neoplasm and Nodular Hidradenoma and Vulvar Neoplasm of Skin Appendage Origin</Axiom>
                  </Source>
               </Change>
               <Change id="1449">
                  <Axiom>Vulvar Syringoma SubClassOf Benign Vulvar Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Vulvar Syringoma EquivalentTo Benign Vulvar Neoplasm and Syringoma and Vulvar Neoplasm of Skin Appendage Origin</Axiom>
                  </Source>
               </Change>
               <Change id="1450">
                  <Axiom>Vulvar Syringoma SubClassOf Syringoma</Axiom>
                  <Source>
                     <Axiom effectual="true">Vulvar Syringoma EquivalentTo Benign Vulvar Neoplasm and Syringoma and Vulvar Neoplasm of Skin Appendage Origin</Axiom>
                  </Source>
               </Change>
               <Change id="1451">
                  <Axiom>Vulvar Syringoma SubClassOf Vulvar Neoplasm of Skin Appendage Origin</Axiom>
                  <Source>
                     <Axiom effectual="true">Vulvar Syringoma EquivalentTo Benign Vulvar Neoplasm and Syringoma and Vulvar Neoplasm of Skin Appendage Origin</Axiom>
                  </Source>
               </Change>
               <Change id="1452">
                  <Axiom>Vulvar Trichoblastoma SubClassOf Benign Vulvar Neoplasm</Axiom>
                  <Source>
                     <Axiom effectual="true">Vulvar Trichoblastoma EquivalentTo Benign Vulvar Neoplasm and Trichoblastoma and Vulvar Neoplasm of Skin Appendage Origin</Axiom>
                  </Source>
               </Change>
               <Change id="1453">
                  <Axiom>Vulvar Trichoblastoma SubClassOf Vulvar Neoplasm of Skin Appendage Origin</Axiom>
                  <Source>
                     <Axiom effectual="true">Vulvar Trichoblastoma EquivalentTo Benign Vulvar Neoplasm and Trichoblastoma and Vulvar Neoplasm of Skin Appendage Origin</Axiom>
                  </Source>
               </Change>
            </RemovedNewProspectiveRedundancy>
         </RemovedProspectiveRedundancy>
      </Ineffectual>
   </Removals>
</root>
